Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" A4GALT "A14GALT, Gb3S, P(k), P1" ENSG00000128274 "Alpha 1,4-galactosyltransferase (P blood group)" Q9NPC4 22 42692112-42721298 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 21.5;ASC TERT1: 17.6;TIME: 15.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "NK-cell: 1.4;plasmacytoid DC: 3.4" "Group enriched" "Detected in many" 13 "dendritic cells: 3.4;NK-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001141 Uncertain Mitochondria Mitochondria "HPA001141: AB_1078139" "unprognostic (2.59e-2)" "prognostic favourable (2.48e-4)" "unprognostic (2.24e-2)" "unprognostic (4.54e-3)" "unprognostic (7.41e-2)" "unprognostic (1.53e-1)" "unprognostic (8.20e-2)" "unprognostic (2.10e-1)" "unprognostic (2.30e-1)" "unprognostic (1.28e-1)" "unprognostic (4.82e-3)" "unprognostic (4.16e-2)" "unprognostic (1.80e-2)" "unprognostic (1.96e-1)" "unprognostic (8.72e-2)" "unprognostic (3.46e-2)" "unprognostic (2.74e-1)" 22.7 5.9 3.5 8.2 3.7 3.8 15.3 1.4 3.8 21.2 12.0 2.3 32.6 4.8 13.0 16.9 15.0 11.7 11.0 26.8 2.3 1.3 30.0 4.4 14.0 6.4 2.9 3.0 11.8 3.4 1.4 7.7 12.6 2.9 15.4 2.1 9.9 15.4 39.8 12.5 8.7 7.0 18.6 5.3 11.4 11.3 6.7 2.4 1.3 10.7 13.0 10.1 16.1 25.6 0.1 3.4 0.0 0.0 1.4 0.0 0.0 0.6 7.3 0.0 0.0 21.5 17.6 11.0 2.9 3.1 0.6 1.1 2.3 1.2 7.1 5.1 5.1 0.7 7.0 3.4 0.1 0.0 1.4 0.1 11.5 0.2 6.5 0.0 0.5 10.3 1.0 3.0 0.5 2.5 0.0 0.0 2.7 10.0 0.0 0.0 0.9 1.8 0.0 1.6 0.7 14.5 12.5 0.1 0.0 8.9 0.2 0.0 5.7 0.8 15.4 0.0 1.4 13.1 3.8 1.5 6.7 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.4 0.0 0.0 3.5 3.7 1.4 3.8 2.3 1.3 2.9 3.0 2.9 2.4 AARS2 "AARSL, bA444E17.1, KIAA1270" ENSG00000124608 "Alanyl-tRNA synthetase 2, mitochondrial" Q5JTZ9 6 44299654-44313326 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Cancer-related genes, Cardiomyopathy, Disease mutation, Premature ovarian failure, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035636, HPA061396" Approved Enhanced Mitochondria Mitochondria "HPA035636: AB_10670837, HPA061396: " "unprognostic (1.56e-1)" "unprognostic (3.24e-2)" "unprognostic (2.58e-2)" "unprognostic (2.04e-3)" "unprognostic (2.83e-1)" "unprognostic (1.69e-1)" "unprognostic (8.83e-3)" "unprognostic (5.12e-2)" "unprognostic (3.64e-2)" "unprognostic (1.38e-1)" "unprognostic (2.19e-2)" "unprognostic (1.37e-2)" "unprognostic (1.74e-1)" "unprognostic (1.84e-1)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (2.02e-1)" 8.6 10.7 15.9 16.2 11.8 11.4 9.9 23.5 19.8 11.4 14.5 11.4 13.0 15.3 14.1 10.4 17.2 13.4 15.9 10.4 13.2 8.9 10.3 12.6 10.9 13.4 12.4 14.3 17.1 13.8 16.2 14.2 10.1 11.1 13.2 9.8 11.2 14.4 14.6 10.2 16.8 18.3 12.1 8.8 14.1 12.3 12.9 14.1 14.7 12.3 10.4 13.4 10.2 13.9 7.1 3.2 3.7 3.4 3.7 5.5 2.8 10.4 7.9 10.3 19.0 6.1 5.7 13.7 8.7 4.5 9.2 8.9 8.5 5.7 11.5 13.9 3.7 7.9 11.4 12.4 3.6 8.1 18.3 13.4 7.7 10.0 4.0 12.4 11.9 4.8 7.9 7.4 7.9 7.8 15.8 11.3 4.9 11.7 10.4 10.7 7.7 7.7 12.4 6.3 7.9 4.8 9.5 24.6 8.9 7.5 8.4 11.6 7.8 16.2 6.6 10.0 10.0 6.1 10.8 6.7 6.2 11.9 5.6 11.0 17.1 3.7 2.4 0.0 3.4 3.3 5.5 3.6 4.8 4.4 2.6 7.1 4.7 4.3 0.7 3.7 3.4 3.2 3.0 2.8 15.9 11.8 23.5 19.8 13.2 8.9 12.4 14.3 11.1 14.1 AATK "AATYK, AATYK1, KIAA0641, LMR1, LMTK1, PPP1R77" ENSG00000181409 "Apoptosis associated tyrosine kinase" Q6ZMQ8 17 81117295-81166077 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.3;intestine: 28.7" "Group enriched" "Detected in some" 6 "CACO-2: 29.6;SH-SY5Y: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 21 "neutrophil: 3.6" "Lineage enriched" "Detected in single" 21 "granulocytes: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009073 Enhanced Uncertain Mitochondria Mitochondria "HPA009073: AB_1078076" "unprognostic (3.47e-3)" "unprognostic (3.01e-2)" "unprognostic (1.12e-1)" "unprognostic (1.95e-4)" "unprognostic (1.96e-1)" "unprognostic (1.94e-1)" "unprognostic (7.29e-2)" "unprognostic (9.85e-2)" "unprognostic (6.09e-2)" "unprognostic (4.27e-2)" "unprognostic (2.88e-3)" "unprognostic (2.48e-1)" "unprognostic (4.28e-6)" "unprognostic (1.58e-3)" "unprognostic (1.21e-1)" "unprognostic (1.39e-1)" "unprognostic (4.57e-2)" 2.8 4.7 14.3 3.2 16.6 3.7 0.9 19.0 29.0 1.2 3.3 16.5 0.0 28.7 1.0 1.1 1.7 1.2 2.7 2.3 23.6 13.9 1.2 1.2 9.7 1.5 20.1 13.6 1.0 17.9 3.6 6.4 2.6 11.0 2.4 1.1 4.1 5.6 3.6 1.1 1.9 20.3 1.3 35.3 5.9 4.5 1.3 9.8 0.0 1.3 0.0 1.0 1.3 1.1 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.2 0.3 2.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 29.6 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 1.6 1.1 1.4 1.8 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 3.1 0.0 0.1 0.5 0.1 1.3 2.4 0.2 0.0 0.0 2.8 10.2 0.2 0.0 1.4 0.3 0.8 1.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 14.3 16.6 19.0 22.3 23.6 13.9 20.1 13.6 11.0 9.8 ABAT GABAT ENSG00000183044 "4-aminobutyrate aminotransferase" P80404 16 8674565-8784575 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Neurotransmitter degradation" "Aminotransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 53.3;liver: 136.5;pancreas: 54.2" "Cell line enhanced" "Detected in many" "Hep G2: 44.3;MCF7: 28.5;RH-30: 25.1;T-47d: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041528, HPA041690" Enhanced Supported Supported Mitochondria 1500000 Mitochondria "HPA041528: AB_10795690, HPA041690: AB_10794674" "unprognostic (1.77e-2)" "unprognostic (3.27e-1)" "unprognostic (1.00e-1)" "unprognostic (2.71e-1)" "unprognostic (2.90e-1)" "unprognostic (2.05e-1)" "prognostic favourable (5.36e-5)" "prognostic favourable (5.93e-4)" "unprognostic (1.71e-1)" "unprognostic (1.30e-1)" "unprognostic (1.56e-2)" "unprognostic (1.04e-1)" "prognostic favourable (5.44e-8)" "unprognostic (2.10e-1)" "unprognostic (2.48e-2)" "unprognostic (3.80e-1)" "unprognostic (1.50e-2)" 2.1 12.6 26.1 2.7 39.3 1.7 3.2 19.9 43.3 2.2 5.2 10.9 0.1 17.5 2.1 5.0 3.0 2.8 2.7 6.2 20.4 30.9 53.3 136.5 2.8 2.8 24.5 26.1 5.3 54.2 4.0 22.1 2.3 14.3 9.9 4.2 2.6 2.6 2.5 1.4 2.1 8.4 2.1 14.1 2.5 3.9 6.3 11.8 1.0 12.7 0.4 3.3 6.4 1.1 2.2 1.9 8.8 5.8 1.6 2.5 1.8 0.2 0.0 11.8 6.7 1.9 0.6 0.5 1.4 0.8 0.7 0.2 4.4 0.3 1.4 0.5 0.8 3.0 0.7 2.8 0.9 0.8 0.6 1.9 0.0 44.3 3.1 0.4 3.0 2.5 1.2 1.2 0.5 0.2 0.3 1.0 0.2 28.5 0.7 0.2 1.0 0.1 3.4 25.1 0.6 0.4 7.0 1.9 5.7 0.6 0.4 0.0 15.6 1.2 0.2 0.2 2.0 0.9 0.0 1.1 0.1 0.3 0.3 2.0 1.4 1.1 3.1 4.1 2.5 3.6 1.1 0.8 1.7 1.7 1.9 2.2 1.1 1.8 8.8 1.6 5.8 0.3 1.6 1.8 26.1 39.3 19.9 35.1 20.4 30.9 24.5 26.1 14.3 11.8 ABCB7 "ABC7, ASAT, Atm1p, EST140535" ENSG00000131269 "ATP binding cassette subfamily B member 7" O75027 X 75051554-75156732 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034982 Approved Supported Mitochondria Mitochondria "HPA034982: AB_10601010" "unprognostic (1.05e-2)" "unprognostic (1.45e-1)" "unprognostic (1.49e-2)" "unprognostic (1.83e-3)" "unprognostic (4.44e-3)" "unprognostic (1.33e-2)" "unprognostic (6.31e-2)" "unprognostic (4.39e-2)" "unprognostic (1.47e-1)" "unprognostic (2.17e-1)" "unprognostic (4.14e-2)" "unprognostic (2.55e-2)" "prognostic favourable (5.31e-6)" "unprognostic (1.95e-1)" "unprognostic (1.27e-1)" "unprognostic (1.45e-1)" "unprognostic (1.08e-1)" 15.1 18.0 12.3 14.7 14.3 13.0 14.6 26.0 16.2 11.6 15.2 12.0 13.7 19.0 14.7 13.6 14.7 11.7 10.0 21.4 11.7 7.1 15.6 22.4 12.2 15.9 13.0 8.5 16.4 12.4 14.7 22.6 11.5 14.0 10.6 15.4 9.5 12.9 15.5 34.6 15.3 15.9 14.9 12.2 13.9 14.8 5.4 16.2 19.7 12.4 19.3 16.0 13.9 13.3 19.4 19.3 7.0 18.7 12.2 21.5 12.4 11.4 11.2 11.5 14.5 7.6 18.9 5.5 8.1 9.1 7.4 12.7 13.9 17.0 18.0 15.6 6.6 12.0 22.2 10.3 12.6 19.3 18.4 12.1 22.5 10.3 6.3 19.6 10.5 13.4 9.8 10.0 13.1 16.0 13.1 23.3 8.0 6.9 14.8 14.4 19.5 15.7 15.0 22.1 21.0 9.6 11.4 13.8 9.1 19.1 17.5 10.9 7.8 13.8 8.3 7.6 14.8 15.8 7.8 7.6 19.3 16.3 7.4 23.6 8.0 5.9 18.7 7.0 11.5 17.7 12.3 18.1 12.8 12.4 19.3 19.4 21.5 16.0 2.2 12.2 13.4 11.9 17.4 12.4 12.3 14.3 26.0 16.2 11.7 7.1 13.0 8.5 14.0 16.2 ABHD10 FLJ11342 ENSG00000144827 "Abhydrolase domain containing 10" Q9NUJ1 3 111979010-111993363 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036991, HPA036992, HPA066081" Supported Approved Mitochondria "Intracellular and membrane" 85000 Mitochondria "HPA036991: , HPA036992: AB_10672345, HPA066081: " "unprognostic (1.65e-1)" "prognostic favourable (7.57e-4)" "unprognostic (1.61e-1)" "unprognostic (1.63e-1)" "unprognostic (1.05e-1)" "unprognostic (1.30e-2)" "unprognostic (8.95e-2)" "unprognostic (1.14e-1)" "unprognostic (8.50e-2)" "unprognostic (1.69e-2)" "unprognostic (1.70e-1)" "unprognostic (3.91e-2)" "prognostic favourable (4.72e-9)" "unprognostic (1.59e-2)" "unprognostic (1.72e-1)" "unprognostic (4.18e-3)" "unprognostic (2.76e-2)" 8.5 18.3 17.5 8.1 27.5 7.6 12.4 23.2 23.2 9.9 11.3 13.7 8.6 9.4 9.4 42.4 7.0 12.5 8.4 19.8 18.6 19.6 39.1 26.6 9.7 14.0 17.0 21.6 16.8 12.1 8.8 26.1 8.8 19.1 17.1 12.3 12.6 19.8 12.0 10.4 8.2 8.6 8.9 14.8 12.4 11.6 12.6 15.1 16.6 25.3 6.7 12.6 8.7 7.9 18.3 19.7 17.7 14.8 7.8 12.7 10.8 18.6 16.2 17.9 5.8 10.3 13.9 9.7 19.7 10.4 16.2 15.7 16.6 10.8 16.9 11.1 8.2 10.4 7.9 11.0 22.4 5.7 10.0 13.9 8.0 14.4 8.2 27.9 15.0 8.5 8.2 8.3 21.1 17.4 6.3 7.2 17.8 6.2 26.2 13.0 11.6 25.7 23.8 11.4 7.8 16.9 8.1 12.1 8.8 15.8 11.5 18.4 12.9 10.2 9.7 9.7 12.5 7.0 10.3 11.6 4.1 28.8 9.8 15.3 10.3 17.7 11.8 17.5 7.4 14.8 12.7 18.3 9.3 8.4 19.7 15.9 12.0 10.5 1.8 7.8 11.6 12.5 8.8 10.8 17.5 27.5 23.2 23.2 18.6 19.6 17.0 21.6 19.1 15.1 ABHD11 "PP1226, WBSCR21" ENSG00000106077 "Abhydrolase domain containing 11" Q8NFV4 7 73736094-73738867 "Disease related genes, Predicted intracellular proteins" Hydrolase "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 34.1;SK-BR-3: 43.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024042, HPA049641" Approved Supported Mitochondria 450000 Mitochondria "HPA024042: AB_1844445, HPA049641: " "unprognostic (4.74e-2)" "unprognostic (8.62e-3)" "unprognostic (1.42e-1)" "unprognostic (2.51e-2)" "unprognostic (3.56e-3)" "unprognostic (1.73e-1)" "unprognostic (1.83e-1)" "unprognostic (1.81e-3)" "unprognostic (1.91e-2)" "unprognostic (9.32e-2)" "unprognostic (7.79e-2)" "unprognostic (1.74e-1)" "prognostic favourable (3.66e-7)" "unprognostic (3.61e-3)" "unprognostic (4.44e-2)" "unprognostic (1.02e-1)" "unprognostic (7.29e-2)" 5.6 8.9 7.7 11.5 8.7 4.2 12.2 8.8 9.2 8.1 28.5 8.3 14.8 15.7 6.0 12.7 8.3 14.0 17.0 20.1 7.1 8.1 21.6 6.6 8.4 6.9 8.6 5.6 5.0 18.9 7.3 10.8 40.2 10.0 14.7 17.5 7.8 23.9 22.2 9.8 7.9 28.1 5.6 5.9 5.2 8.3 6.1 5.6 6.9 20.1 8.4 12.6 5.8 5.4 8.3 12.9 12.2 21.0 9.7 6.7 8.0 17.2 4.0 2.7 6.3 1.4 2.0 15.3 8.0 3.3 4.9 5.8 4.9 19.5 8.2 2.4 3.3 7.6 1.2 4.6 3.4 3.0 5.9 4.0 2.7 3.0 2.6 4.3 4.4 1.8 1.9 6.2 3.0 3.5 5.4 4.7 4.6 34.1 3.3 5.5 3.2 14.9 1.8 4.4 15.1 11.3 8.2 7.0 3.0 6.4 43.4 2.6 14.1 2.9 3.4 4.2 4.0 17.8 8.2 2.9 1.5 5.5 6.7 4.2 7.7 6.1 13.1 12.2 6.0 21.0 4.8 6.3 6.7 6.2 12.9 8.3 6.3 4.4 10.5 9.7 20.7 6.3 4.4 8.0 7.7 8.7 8.8 9.2 7.1 8.1 8.6 5.6 10.0 5.6 AC008982.1 ENSG00000268083 19 38817471-38840178 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "NB-4: 25.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002907, HPA051748" Uncertain Uncertain Mitochondria Mitochondria "HPA002907: AB_1847964, HPA051748: " "unprognostic (1.36e-2)" 1.7 1.0 0.5 0.4 1.0 4.3 0.7 0.8 3.3 0.5 3.1 0.2 0.2 2.2 1.4 3.5 1.1 0.5 0.3 4.9 0.5 0.6 1.6 6.3 5.0 5.3 0.8 0.2 1.3 1.3 0.0 0.5 0.8 0.8 1.3 0.2 0.2 0.6 0.5 5.8 1.0 1.8 0.2 0.8 2.6 1.1 3.2 0.7 2.5 1.0 2.4 0.2 0.7 1.0 1.9 5.9 2.4 2.5 2.5 3.6 2.2 1.4 0.0 0.2 0.3 0.1 0.1 1.6 0.4 0.0 0.5 0.1 0.7 0.1 0.2 1.3 0.1 0.8 0.0 0.0 0.1 1.2 0.4 0.9 0.0 0.0 0.1 0.4 0.9 0.1 0.0 0.1 0.0 0.0 0.5 0.4 0.0 1.0 1.1 25.1 1.8 0.0 1.5 0.7 0.6 0.3 0.3 0.6 3.5 0.0 0.0 4.5 0.4 5.8 0.0 0.1 2.5 1.7 2.3 1.1 0.9 1.9 0.1 0.6 0.1 1.6 2.5 2.4 2.5 2.0 3.6 1.6 2.5 2.7 2.4 1.9 2.3 2.9 0.2 2.5 1.1 5.9 3.4 2.2 0.5 1.0 0.8 3.3 0.5 0.6 0.8 0.2 0.8 0.7 AC024592.3 ENSG00000267740 19 5866171-5903787 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA072209 Uncertain Mitochondria Mitochondria "HPA072209: " "unprognostic (2.12e-2)" "unprognostic (2.24e-1)" "unprognostic (3.38e-1)" 8.8 15.0 8.4 8.8 8.5 11.1 10.9 8.0 17.4 10.6 9.8 5.0 8.9 10.8 9.9 7.8 12.7 6.7 9.6 24.1 7.8 9.9 8.5 14.4 8.0 11.5 9.6 10.0 8.2 16.3 3.2 7.1 6.6 7.5 7.0 3.9 7.5 12.3 8.8 22.7 12.3 10.0 9.9 8.6 7.4 7.3 5.6 5.3 7.9 8.0 16.6 7.0 12.7 8.2 7.2 10.4 6.4 8.5 5.5 7.5 12.1 5.1 6.9 2.1 5.8 4.2 0.8 1.9 3.4 4.9 6.5 4.7 2.5 4.4 4.2 3.4 2.7 3.6 1.3 4.1 1.3 1.8 2.1 1.1 3.1 5.6 2.8 1.9 2.3 1.8 7.0 5.1 2.4 2.2 1.8 5.6 1.0 4.2 6.9 1.5 3.2 3.3 6.5 2.2 5.4 3.2 1.6 3.5 4.9 2.6 3.5 3.4 2.1 6.3 4.2 1.3 3.2 7.9 6.5 5.2 5.5 2.1 4.2 6.7 2.9 6.4 8.5 4.0 6.0 7.1 5.3 7.2 6.3 5.8 8.6 6.7 7.3 5.8 4.8 5.5 6.3 10.4 7.5 12.1 8.4 8.5 8.0 17.4 7.8 9.9 9.6 10.0 7.5 5.3 AC093155.3 ENSG00000267561 1 86993009-87169204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 10.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.8;HEL: 12.9;HMC-1: 16.4;THP-1: 11.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 4.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.6" "HPA043069, HPA043603" Approved Uncertain Mitochondria Mitochondria "HPA043069: AB_10964127, HPA043603: AB_10963432" "unprognostic (4.41e-1)" "unprognostic (3.13e-2)" "unprognostic (2.05e-1)" "unprognostic (1.85e-2)" "unprognostic (3.17e-1)" "unprognostic (2.57e-1)" "unprognostic (4.51e-2)" "unprognostic (5.19e-3)" "unprognostic (3.60e-1)" "unprognostic (1.27e-2)" "unprognostic (1.14e-1)" "unprognostic (2.54e-1)" 10.8 3.2 0.6 0.9 0.8 0.0 3.7 0.8 0.6 2.1 1.3 0.6 0.8 0.5 1.1 0.5 2.1 4.1 0.6 0.6 0.8 4.3 2.5 0.3 0.7 3.7 0.6 0.0 0.5 2.7 0.6 1.2 0.9 0.7 1.6 0.6 1.0 2.0 0.8 0.8 0.7 2.4 0.6 0.0 2.2 0.6 0.1 0.9 4.6 0.1 0.4 0.2 0.1 0.0 0.1 0.8 1.9 2.3 8.8 0.2 0.0 0.1 0.0 0.3 0.6 0.8 0.0 0.2 0.0 0.1 0.3 0.1 0.4 0.1 0.5 12.9 0.3 0.1 0.1 0.3 16.4 1.4 0.3 0.2 0.0 0.1 0.1 0.3 0.2 0.0 0.2 0.2 0.3 0.0 0.2 0.3 0.0 0.4 0.4 0.1 0.4 0.3 0.0 0.4 0.2 11.2 0.0 0.3 0.7 0.1 1.3 0.9 3.4 0.0 0.6 0.0 0.4 2.0 0.1 4.6 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.1 0.0 0.4 0.0 0.9 0.0 0.1 AC131160.1 ENSG00000283765 3 183815568-183884889 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 11.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA019545 Uncertain Approved Mitochondria Mitochondria "HPA019545: AB_1855796" 3.8 3.8 2.9 2.2 3.8 3.2 2.3 2.8 12.7 2.4 2.9 3.3 2.3 1.2 2.2 3.1 4.5 1.7 2.6 4.2 3.0 2.5 3.3 2.8 3.7 2.3 2.5 2.3 7.9 3.2 2.5 2.0 2.3 2.3 3.1 3.6 5.4 5.1 9.7 3.2 3.8 6.0 1.7 2.2 2.2 7.1 2.2 2.8 2.6 3.5 3.3 3.0 0.5 1.0 1.0 3.1 1.2 0.2 1.0 0.6 1.3 0.0 1.6 0.5 0.4 0.4 0.0 1.1 0.7 0.7 0.5 3.7 0.2 1.5 0.2 0.5 0.0 4.4 0.4 1.8 1.8 1.5 2.4 1.2 1.2 0.0 1.3 0.4 1.0 0.9 1.0 0.0 0.0 0.5 1.8 2.3 2.3 2.8 0.1 2.6 0.3 2.9 1.0 3.2 0.5 2.2 1.8 1.6 0.5 1.6 1.5 11.9 0.0 0.0 0.0 1.9 0.2 1.4 2.7 3.6 2.2 0.8 3.0 0.9 0.0 1.0 3.1 1.0 0.5 0.9 1.0 0.4 0.5 0.1 0.4 0.8 0.6 1.1 0.2 1.2 1.0 0.3 0.6 AC139530.2 ENSG00000262660 17 81703371-81720539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 6.4;MOLT-4: 18.0;SK-BR-3: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA022853, HPA023043, HPA023048" Approved Enhanced Mitochondria Mitochondria "HPA022853: AB_1854099, HPA023043: AB_1854100, HPA023048: AB_2301950" "unprognostic (2.36e-3)" "unprognostic (1.17e-1)" "unprognostic (2.87e-1)" "unprognostic (3.83e-1)" 2.4 3.6 2.3 2.3 3.0 1.5 6.3 2.7 5.7 2.3 4.6 0.8 2.7 13.8 3.4 1.5 4.6 2.3 2.7 16.3 2.4 2.3 4.9 16.6 3.0 4.2 2.5 1.5 2.3 9.9 3.6 2.3 3.4 2.2 2.4 1.5 1.1 3.1 2.4 15.5 2.4 5.9 1.6 2.3 3.3 2.6 2.6 0.6 3.0 2.4 12.6 3.0 2.3 2.3 0.0 0.4 0.0 0.1 0.8 0.6 0.1 1.2 0.6 1.8 4.6 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.3 0.3 0.9 0.3 0.0 2.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.2 0.0 0.6 0.3 0.0 6.4 0.0 0.8 18.0 0.7 1.0 0.0 3.2 0.3 1.1 0.0 0.0 3.2 1.5 0.0 6.8 1.8 2.9 1.5 0.0 0.5 1.1 1.0 1.7 0.6 0.0 0.7 1.1 0.5 2.4 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.1 2.3 3.0 2.7 3.7 2.4 2.3 2.5 1.5 2.2 0.6 ACAA2 DSAEC ENSG00000167315 "Acetyl-CoA acyltransferase 2" P42765 18 49782167-49813960 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 245.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042303 Approved Supported Mitochondria 3200000 Mitochondria "HPA042303: AB_10794046" "unprognostic (7.94e-2)" "unprognostic (3.14e-2)" "unprognostic (2.20e-3)" "prognostic unfavourable (8.53e-4)" "unprognostic (2.92e-2)" "unprognostic (2.28e-2)" "unprognostic (7.63e-2)" "unprognostic (1.70e-1)" "unprognostic (7.97e-2)" "unprognostic (8.03e-3)" "unprognostic (1.72e-1)" "unprognostic (3.84e-1)" "prognostic favourable (1.36e-10)" "unprognostic (1.39e-1)" "unprognostic (2.24e-1)" "unprognostic (8.26e-3)" "unprognostic (3.41e-1)" 22.7 12.9 9.4 6.9 10.7 4.4 13.0 3.6 7.0 4.1 27.2 8.0 7.8 25.9 5.1 5.1 7.1 4.1 9.2 38.9 6.8 7.0 60.3 245.7 7.9 7.5 10.7 6.1 6.4 13.6 6.3 7.1 7.5 6.7 7.9 18.4 9.5 3.3 6.2 22.9 4.2 37.0 11.3 9.7 6.9 6.0 6.5 7.5 8.4 15.7 8.8 5.0 8.1 4.9 13.0 31.8 27.5 33.0 35.5 40.9 28.6 0.7 13.9 23.2 21.2 30.7 16.2 11.8 7.1 11.6 12.0 9.3 29.5 12.0 12.4 15.2 26.1 0.9 38.6 4.5 11.9 37.9 9.1 8.8 18.1 34.9 14.5 0.1 16.6 21.4 1.5 19.4 6.1 19.6 7.6 11.7 33.2 16.0 0.5 19.1 21.0 5.6 30.4 49.6 45.4 40.5 0.6 33.3 26.4 0.5 16.3 1.1 9.2 12.8 9.3 10.2 12.9 15.4 7.7 23.8 27.4 31.6 7.3 17.9 9.3 13.1 25.9 27.5 32.1 33.0 40.9 13.0 19.2 28.6 31.8 9.7 16.4 24.3 2.5 35.5 31.1 14.9 22.6 28.6 9.4 10.7 3.6 7.0 6.8 7.0 10.7 6.1 6.7 7.5 ACAD9 "MGC14452, NPD002" ENSG00000177646 "Acyl-CoA dehydrogenase family member 9" Q9H845 3 128879596-128916067 "Disease related genes, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037716, HPA046720" Supported Enhanced Mitochondria Mitochondria "HPA037716: AB_10673638, HPA046720: AB_2679773" "unprognostic (1.04e-1)" "unprognostic (1.28e-2)" "unprognostic (1.15e-1)" "prognostic unfavourable (3.05e-4)" "unprognostic (3.61e-1)" "unprognostic (2.83e-1)" "prognostic unfavourable (3.67e-6)" "unprognostic (1.30e-1)" "unprognostic (3.74e-1)" "unprognostic (3.25e-2)" "unprognostic (1.37e-1)" "unprognostic (6.96e-3)" "prognostic favourable (4.32e-8)" "unprognostic (1.52e-1)" "unprognostic (2.64e-2)" "unprognostic (6.56e-2)" "unprognostic (9.96e-2)" 18.1 20.6 14.0 13.1 15.4 8.0 15.4 14.7 17.9 13.6 13.4 15.9 21.1 11.3 16.9 13.1 21.6 15.6 16.4 21.6 10.7 13.2 15.8 24.0 11.6 10.4 13.6 17.8 13.1 21.1 30.6 14.2 13.8 13.6 13.0 12.4 16.0 19.0 16.0 30.8 45.0 10.1 13.8 10.2 12.1 14.6 19.5 10.8 13.9 14.8 18.2 14.9 12.6 14.0 7.2 14.0 4.1 18.1 5.0 7.5 8.9 25.0 13.1 10.6 7.8 16.4 11.5 11.3 12.5 13.8 24.0 20.6 18.5 15.3 18.6 11.7 15.7 21.0 18.4 24.4 15.9 12.3 12.6 16.9 26.6 13.0 12.0 13.3 7.9 12.5 9.6 13.9 15.8 19.3 8.0 9.0 15.9 25.3 19.5 11.0 6.4 18.8 15.2 9.9 18.9 16.8 16.0 12.3 7.9 19.4 18.3 12.1 24.1 28.7 11.5 10.1 8.7 10.1 11.8 9.0 4.3 16.2 16.0 12.4 12.6 3.1 12.0 4.1 7.5 14.7 7.2 7.2 6.8 6.4 14.0 4.9 5.7 7.3 1.0 5.0 18.1 7.9 6.5 8.9 14.0 15.4 14.7 17.9 10.7 13.2 13.6 17.8 13.6 10.8 ACADM "ACAD1, MCAD, MCADH" ENSG00000117054 "Acyl-CoA dehydrogenase medium chain" P11310 1 75724347-75787575 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 89.7;skeletal muscle: 82.8" "Cell line enhanced" "Detected in all" "Daudi: 75.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006198, HPA026542" Enhanced Enhanced Mitochondria 1200000 Mitochondria "HPA006198: AB_1078087, HPA026542: AB_1844469" "unprognostic (9.04e-3)" "unprognostic (2.36e-1)" "prognostic favourable (7.30e-4)" "unprognostic (5.09e-3)" "unprognostic (1.61e-3)" "unprognostic (5.68e-2)" "unprognostic (6.75e-2)" "unprognostic (1.11e-1)" "unprognostic (8.02e-2)" "unprognostic (4.95e-2)" "unprognostic (9.40e-3)" "unprognostic (3.35e-1)" "prognostic favourable (3.83e-8)" "unprognostic (1.27e-1)" "unprognostic (4.09e-2)" "unprognostic (3.56e-2)" "unprognostic (1.24e-1)" 18.1 25.0 12.3 11.3 13.0 3.9 18.0 12.0 10.8 8.4 21.6 8.3 10.1 25.1 6.7 8.6 21.9 7.6 6.7 49.7 10.5 11.2 71.1 89.7 6.3 9.4 13.0 9.2 10.5 10.3 8.1 12.0 4.2 14.3 9.2 12.1 8.0 9.0 11.7 82.8 5.6 25.1 9.8 10.7 12.3 12.0 8.5 11.0 11.0 12.2 42.1 10.0 9.5 8.1 29.7 16.7 14.1 13.8 16.8 20.0 13.2 6.9 5.5 17.4 7.6 15.0 12.3 4.9 13.0 10.6 12.8 10.8 10.3 11.1 75.9 11.5 9.3 6.4 14.7 11.0 15.9 29.3 7.2 24.9 16.9 15.8 10.5 21.2 6.9 14.2 6.4 11.1 6.7 10.0 25.3 17.2 13.7 2.6 24.9 10.0 14.0 13.3 32.5 22.9 7.9 21.2 18.3 9.4 11.9 10.5 31.4 27.1 9.3 26.9 5.4 8.7 8.6 7.4 21.3 11.2 16.0 33.7 7.4 17.3 9.9 10.7 9.6 14.1 13.2 13.8 20.0 29.7 13.8 15.9 14.3 18.0 15.8 17.6 0.8 16.8 12.7 16.7 13.8 13.2 12.3 13.0 12.0 10.8 10.5 11.2 13.0 9.2 14.3 11.0 ACADSB "ACAD7, SBCAD" ENSG00000196177 "Acyl-CoA dehydrogenase short/branched chain" P45954 10 123008979-123058311 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 28.9;liver: 114.2" "Cell line enhanced" "Detected in all" "Hep G2: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041458 Enhanced Supported Mitochondria 63000 Mitochondria "HPA041458: " "unprognostic (1.53e-2)" "unprognostic (1.31e-1)" "unprognostic (3.91e-3)" "unprognostic (2.02e-1)" "unprognostic (1.25e-1)" "unprognostic (4.87e-2)" "unprognostic (4.15e-2)" "unprognostic (1.32e-3)" "unprognostic (1.30e-1)" "unprognostic (3.67e-1)" "prognostic favourable (3.40e-4)" "unprognostic (9.37e-3)" "prognostic favourable (6.37e-12)" "unprognostic (2.69e-1)" "unprognostic (7.20e-2)" "unprognostic (1.60e-3)" "unprognostic (7.14e-2)" 4.6 9.4 6.7 2.4 9.0 1.4 8.3 10.3 8.3 3.9 5.3 5.5 6.4 16.8 4.1 3.3 4.4 4.1 3.1 13.7 8.5 4.8 28.9 114.2 4.3 2.7 5.1 8.2 5.0 5.3 8.0 4.9 1.9 7.5 7.9 5.8 4.9 5.6 6.0 12.7 4.7 5.5 5.2 4.8 2.7 4.8 2.9 5.4 3.6 4.3 7.9 3.9 5.0 4.1 6.3 6.8 13.5 5.0 9.0 11.7 6.0 9.5 6.8 5.1 9.3 7.0 8.7 4.5 5.9 12.0 5.9 6.0 6.0 3.1 10.0 4.1 5.0 4.0 7.9 4.1 9.9 6.5 8.2 5.2 2.1 34.6 4.9 7.3 5.0 6.4 4.2 3.7 3.4 5.7 5.0 7.4 7.4 4.4 7.0 6.1 3.1 4.3 8.3 10.7 3.1 8.5 10.6 1.0 5.9 9.1 2.7 9.3 8.3 3.6 6.0 3.2 2.9 7.4 7.1 8.3 9.4 5.3 5.0 7.0 2.4 13.5 5.0 12.3 10.0 5.0 11.7 5.9 9.4 8.6 6.8 6.3 8.9 9.9 3.2 9.0 3.0 4.1 7.6 6.0 6.7 9.0 10.3 8.3 8.5 4.8 5.1 8.2 7.5 5.4 ACAT1 "ACAT, THIL" ENSG00000075239 "Acetyl-CoA acetyltransferase 1" P24752 11 108121516-108147776 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 267.1" "Cell line enhanced" "Detected in all" "RPMI-8226: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004428, HPA007569" Enhanced Enhanced Mitochondria 870000 Mitochondria "HPA004428: AB_1078088, HPA007569: AB_1844482" "unprognostic (3.70e-3)" "unprognostic (2.23e-2)" "unprognostic (7.84e-3)" "unprognostic (4.65e-2)" "unprognostic (3.05e-2)" "unprognostic (1.12e-1)" "prognostic favourable (1.43e-5)" "unprognostic (3.59e-3)" "unprognostic (1.26e-1)" "unprognostic (5.20e-2)" "unprognostic (2.64e-2)" "unprognostic (1.13e-2)" "prognostic favourable (0.00e+0)" "unprognostic (1.96e-1)" "unprognostic (1.68e-1)" "unprognostic (8.06e-2)" "unprognostic (6.62e-3)" 18.8 28.5 8.9 6.9 9.5 5.4 16.9 5.6 11.6 8.5 16.8 8.5 9.4 15.5 8.8 8.9 8.8 7.6 5.1 53.8 7.4 7.4 88.8 267.1 7.3 6.0 9.9 9.9 10.3 27.3 14.3 6.3 3.8 22.4 7.6 13.1 10.6 27.1 15.9 65.0 8.2 10.9 16.4 8.1 7.7 13.9 14.2 7.2 1.7 10.1 32.1 5.2 12.3 6.9 18.8 20.2 2.3 14.7 7.7 20.7 11.6 15.8 13.0 10.3 29.6 33.3 29.5 5.7 15.2 16.3 16.5 19.3 35.8 16.4 8.8 26.2 17.0 16.8 29.8 14.4 18.0 17.5 24.4 25.3 14.8 32.5 23.0 23.9 15.0 26.7 16.0 14.4 27.0 17.5 35.1 13.1 26.3 9.1 14.1 22.3 10.1 29.1 19.7 20.3 85.2 22.6 10.4 16.5 19.6 24.8 32.2 16.6 27.5 19.6 19.5 17.8 10.4 16.2 18.3 4.4 12.9 16.5 7.9 47.9 12.6 0.8 9.8 2.3 15.6 14.7 17.7 18.8 17.6 17.5 20.2 10.2 15.5 14.3 1.0 7.7 14.4 7.0 20.7 11.6 8.9 9.5 5.6 11.6 7.4 7.4 9.9 9.9 22.4 7.2 ACO2 ACONM ENSG00000100412 "Aconitase 2" Q99798 22 41469125-41528989 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Lyase "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 121.0;skeletal muscle: 157.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001097 Enhanced Approved Approved Mitochondria 4000000 Mitochondria "HPA001097: AB_1078092" "unprognostic (1.95e-1)" "unprognostic (2.50e-2)" "unprognostic (2.35e-2)" "unprognostic (3.06e-2)" "unprognostic (6.51e-2)" "unprognostic (1.26e-1)" "unprognostic (3.99e-2)" "unprognostic (6.54e-2)" "unprognostic (1.20e-2)" "unprognostic (7.32e-2)" "unprognostic (1.64e-2)" "unprognostic (6.07e-2)" "prognostic favourable (0.00e+0)" "unprognostic (1.46e-2)" "unprognostic (9.60e-2)" "unprognostic (6.45e-2)" "unprognostic (1.12e-2)" 22.8 18.5 41.4 11.1 38.2 9.8 12.2 21.0 43.5 12.2 25.4 27.7 12.3 45.1 9.5 9.9 17.5 15.7 11.1 121.0 33.8 24.2 37.9 22.2 10.0 11.1 27.6 32.7 8.6 17.2 48.5 7.6 9.1 24.9 12.5 20.0 14.7 20.1 15.2 157.9 9.8 46.6 12.5 28.6 10.0 21.0 9.6 23.1 9.5 16.0 42.7 12.0 12.3 8.8 22.9 28.1 7.3 36.6 15.8 16.4 19.4 16.1 18.8 18.9 39.0 32.6 21.3 26.5 14.9 18.8 25.1 23.5 27.7 21.1 37.1 24.4 22.1 37.1 35.1 27.2 13.2 24.5 25.0 18.0 26.3 29.4 28.5 47.9 27.6 37.8 21.9 26.0 27.7 24.8 23.2 40.5 19.7 30.3 24.4 16.2 12.9 37.7 33.2 13.0 51.4 32.3 32.1 13.6 11.6 36.6 43.3 27.6 25.1 25.6 17.6 21.4 24.0 19.5 16.3 24.1 29.9 25.9 34.6 20.9 23.1 4.5 21.1 7.3 14.7 31.3 14.0 22.9 12.5 15.8 28.1 20.2 14.2 14.6 5.3 15.8 36.6 11.2 16.4 19.4 41.4 38.2 21.0 43.5 33.8 24.2 27.6 32.7 24.9 23.1 ACOT1 "ACH2, CTE-1, LACH2" ENSG00000184227 "Acyl-CoA thioesterase 1" Q86TX2 14 73537114-73543794 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 27.6" "Cell line enhanced" "Detected in many" "Hep G2: 17.9;T-47d: 24.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA043705 Approved Approved Mitochondria Mitochondria "HPA043705: " "unprognostic (4.74e-3)" "unprognostic (3.81e-3)" "unprognostic (7.65e-2)" "unprognostic (8.66e-2)" "unprognostic (1.22e-1)" "unprognostic (1.29e-1)" "unprognostic (4.54e-2)" "unprognostic (1.29e-2)" "unprognostic (1.53e-1)" "unprognostic (1.73e-2)" "unprognostic (1.84e-1)" "unprognostic (4.16e-1)" "prognostic favourable (5.09e-8)" "unprognostic (1.35e-3)" "unprognostic (4.60e-2)" "unprognostic (1.75e-1)" "unprognostic (1.43e-1)" 8.5 7.2 5.1 3.7 3.9 1.0 13.7 2.0 7.7 3.0 5.8 4.1 0.9 5.3 6.8 8.8 2.7 3.4 1.8 11.3 4.3 3.6 16.4 27.6 9.0 0.9 3.2 6.0 4.5 1.4 2.9 0.9 4.1 5.6 5.5 3.4 2.4 2.7 6.1 10.7 3.8 12.9 13.0 1.9 1.0 3.4 2.7 2.4 0.9 1.8 5.0 1.9 5.6 1.7 3.8 5.7 1.0 1.7 4.2 6.3 3.1 4.1 5.0 1.9 0.1 9.8 6.0 0.1 1.3 5.3 4.4 8.1 1.9 2.0 0.0 0.0 3.5 2.5 0.0 0.9 2.1 2.3 1.6 2.6 1.2 17.9 9.4 0.1 2.9 7.8 0.4 3.5 0.0 2.0 0.0 0.0 3.4 1.6 0.3 0.5 1.8 1.9 5.1 3.9 0.1 4.3 4.6 2.2 3.8 4.1 12.2 6.7 24.7 6.1 2.2 2.5 3.2 2.2 0.0 0.0 0.0 1.3 3.6 0.0 3.9 0.1 1.3 1.0 6.0 1.7 4.9 3.8 5.5 4.7 5.7 2.6 4.8 5.3 0.2 4.2 1.5 3.2 6.3 3.1 5.1 3.9 2.0 7.7 4.3 3.6 3.2 6.0 5.6 2.4 ACOT2 "Mte1, ZAP128" ENSG00000119673 "Acyl-CoA thioesterase 2" P49753 14 73567620-73575658 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 60.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA043705, HPA060170" Enhanced Approved Mitochondria Mitochondria "HPA043705: , HPA060170: " "unprognostic (4.44e-3)" "unprognostic (1.68e-2)" "unprognostic (3.17e-1)" "unprognostic (8.66e-2)" "unprognostic (1.78e-1)" "unprognostic (1.55e-1)" "unprognostic (2.78e-2)" "unprognostic (6.61e-2)" "unprognostic (4.10e-2)" "unprognostic (9.21e-2)" "unprognostic (6.42e-2)" "unprognostic (1.64e-1)" "prognostic favourable (2.28e-6)" "unprognostic (1.66e-3)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (4.35e-1)" 41.4 16.5 5.9 6.4 5.3 2.7 13.4 3.3 8.7 7.8 11.9 4.6 4.0 12.8 13.9 10.6 9.4 8.3 8.8 35.1 4.5 4.0 25.0 60.5 6.2 4.4 4.3 5.4 6.2 8.1 6.4 2.7 7.9 4.3 8.5 6.2 6.9 7.3 6.8 50.7 3.9 12.0 16.3 3.2 4.3 7.4 5.7 3.7 5.3 7.4 11.6 3.9 11.3 4.6 9.7 13.8 1.8 4.4 9.0 19.0 8.1 11.1 10.9 2.3 9.6 10.2 4.0 0.4 6.0 13.8 9.7 12.9 7.7 7.4 0.0 4.3 3.2 6.1 0.0 0.6 5.1 14.0 13.8 6.7 4.4 26.5 6.6 0.0 19.1 9.0 0.0 3.6 0.0 4.2 0.0 0.0 8.3 4.6 1.0 7.6 3.3 16.5 15.9 9.7 0.1 3.5 4.7 10.0 12.1 14.6 11.4 11.9 27.3 5.4 7.5 8.6 21.4 5.5 5.6 0.0 0.0 4.0 7.1 0.0 8.0 1.5 3.7 1.8 14.6 4.4 10.7 9.7 13.7 11.1 13.8 7.9 12.4 13.5 0.1 9.0 3.9 8.5 19.0 8.1 5.9 5.3 3.3 8.7 4.5 4.0 4.3 5.4 4.3 3.7 ACSS3 FLJ21963 ENSG00000111058 "Acyl-CoA synthetase short chain family member 3" Q9H6R3 12 80936414-81261205 "Enzymes, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 9.3;ASC TERT1: 10.6;Hep G2: 26.2;RH-30: 12.2;SK-BR-3: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "basophil: 8.3;neutrophil: 6.0" "Lineage enriched" "Detected in single" 71 "granulocytes: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039353, HPA047956, HPA061517" Approved Approved Mitochondria Mitochondria "HPA039353: AB_2676460, HPA047956: AB_2680223, HPA061517: " "unprognostic (8.59e-2)" "unprognostic (9.29e-4)" "unprognostic (1.47e-1)" "unprognostic (9.37e-3)" "unprognostic (2.46e-2)" "unprognostic (2.21e-1)" "unprognostic (9.25e-2)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (7.18e-3)" "unprognostic (1.68e-1)" "unprognostic (7.79e-2)" "prognostic favourable (0.00e+0)" "unprognostic (6.16e-4)" "unprognostic (1.63e-1)" "unprognostic (2.00e-1)" "unprognostic (2.00e-4)" 19.6 18.3 7.4 1.9 8.3 1.0 8.1 2.7 7.7 13.2 2.6 5.5 10.8 1.2 18.2 14.4 2.0 8.3 8.1 10.9 6.4 3.9 24.4 37.1 8.8 1.7 7.4 6.5 16.7 2.6 21.3 11.0 4.1 6.5 7.1 1.6 10.3 20.4 11.4 9.8 2.1 1.9 6.6 5.5 2.8 1.9 4.0 4.1 0.0 9.2 2.9 1.6 3.5 6.3 0.0 0.0 8.3 0.0 0.0 0.1 0.0 0.0 0.1 2.1 0.0 9.3 10.6 0.0 1.5 6.9 1.1 1.2 0.3 0.0 0.1 0.0 3.1 0.1 0.0 0.0 0.6 0.0 1.6 0.0 0.1 26.2 3.2 0.3 0.0 7.1 0.0 0.3 0.0 0.2 0.0 0.0 4.9 0.6 0.0 0.1 3.2 0.0 0.0 12.2 1.6 0.0 0.0 2.1 0.0 0.0 11.5 0.0 5.1 0.3 0.0 1.9 1.8 0.2 0.7 0.1 0.1 0.0 2.3 0.0 2.1 8.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 7.4 8.3 2.7 7.7 6.4 3.9 7.4 6.5 6.5 4.1 ADCY1 "AC1, DFNB44" ENSG00000164742 "Adenylate cyclase 1" Q08828 7 45574140-45723116 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, cAMP biosynthesis" "Calmodulin-binding, Lyase" "Cancer-related genes, Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.0" "Cell line enhanced" "Detected in many" "hTERT-HME1: 15.0;SCLC-21H: 9.1;SH-SY5Y: 17.3;SK-MEL-30: 19.9;WM-115: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018364, HPA068274" Uncertain Approved Mitochondria Mitochondria "CAB018364: AB_2223098, HPA068274: " "unprognostic (9.41e-3)" "unprognostic (7.30e-4)" "unprognostic (9.31e-2)" "unprognostic (2.98e-1)" "unprognostic (4.18e-2)" "unprognostic (3.07e-3)" "unprognostic (1.32e-1)" "unprognostic (7.31e-2)" "unprognostic (1.64e-3)" "unprognostic (2.89e-1)" "unprognostic (7.73e-3)" "unprognostic (1.54e-1)" "unprognostic (4.74e-6)" "unprognostic (2.49e-1)" "unprognostic (7.65e-3)" "unprognostic (2.87e-1)" "unprognostic (2.23e-1)" 2.8 2.8 11.5 0.7 11.7 0.4 6.8 22.7 29.0 7.8 0.9 2.0 0.0 0.7 2.7 1.1 1.2 2.4 1.2 4.0 11.6 4.0 1.8 9.6 1.0 0.8 5.8 13.4 1.2 3.6 1.0 1.5 0.9 6.2 4.1 1.0 5.0 0.8 2.1 9.2 0.6 0.7 1.6 2.2 1.0 1.8 3.9 1.2 0.0 3.0 0.2 0.8 1.0 1.5 0.5 0.4 0.6 0.1 0.0 0.2 0.0 0.5 3.8 1.4 2.2 2.8 0.0 2.7 0.1 0.0 0.5 0.2 0.4 0.0 0.0 0.2 0.1 1.2 2.5 0.1 0.0 6.9 1.8 0.0 0.0 0.3 0.0 0.1 0.0 3.4 1.9 0.3 15.0 0.1 0.2 4.6 0.2 4.6 0.0 0.0 5.6 0.0 0.0 0.0 7.5 0.0 3.7 9.1 17.3 1.4 0.0 19.9 1.3 2.3 0.0 0.4 2.9 0.3 2.3 0.0 0.0 0.0 0.0 0.0 11.3 0.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.2 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 11.5 11.7 22.7 29.0 11.6 4.0 5.8 13.4 6.2 1.2 ADGRF4 "FLJ38076, GPR115, PGR18" ENSG00000153294 "Adhesion G protein-coupled receptor F4" Q8IZF3 6 47685864-47722021 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 15.8;placenta: 23.9;skin 1: 30.7;tongue: 17.8" "Cell line enhanced" "Detected in some" "A-431: 5.7;HaCaT: 8.7;HBEC3-KT: 13.9;hTCEpi: 21.6;RT4: 5.4;U-87 MG: 18.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA007131, HPA007158" Enhanced Uncertain Mitochondria Mitochondria "HPA007131: AB_2667756, HPA007158: AB_1849254" "unprognostic (1.40e-2)" "unprognostic (7.06e-3)" "unprognostic (2.11e-1)" "unprognostic (4.68e-2)" "unprognostic (3.79e-2)" "unprognostic (3.77e-2)" "unprognostic (2.04e-3)" "unprognostic (2.64e-1)" "unprognostic (3.47e-1)" "prognostic unfavourable (5.52e-4)" "unprognostic (2.86e-1)" "unprognostic (1.66e-8)" "unprognostic (1.62e-3)" "unprognostic (2.01e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-1)" 0.0 0.5 0.0 0.1 0.1 0.0 1.9 0.3 0.0 7.0 1.0 0.1 0.0 0.0 1.0 0.0 15.8 0.9 0.5 0.3 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 23.9 0.2 1.9 1.2 0.0 1.8 0.0 0.4 30.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 17.8 14.0 2.3 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.8 0.0 0.0 0.0 0.0 0.6 0.0 3.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 8.7 0.0 13.9 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 21.6 0.2 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 AFG3L2 "SCA28, SPAX5" ENSG00000141385 "AFG3 like matrix AAA peptidase subunit 2" Q9Y4W6 18 12328944-12377314 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004479, HPA004480" Enhanced Supported Mitochondria Mitochondria "HPA004479: AB_1078109, HPA004480: AB_1078108" "unprognostic (1.11e-1)" "unprognostic (7.49e-2)" "unprognostic (1.67e-1)" "prognostic unfavourable (8.68e-4)" "unprognostic (1.31e-1)" "unprognostic (5.06e-3)" "unprognostic (1.61e-1)" "unprognostic (2.33e-1)" "unprognostic (5.35e-2)" "unprognostic (1.54e-2)" "unprognostic (4.05e-2)" "unprognostic (3.00e-2)" "prognostic favourable (6.05e-14)" "unprognostic (5.90e-2)" "unprognostic (9.41e-2)" "unprognostic (5.74e-3)" "unprognostic (2.22e-1)" 11.5 15.8 11.8 14.3 14.0 11.7 19.9 17.2 30.3 11.2 25.7 9.5 12.7 33.1 11.4 10.1 18.3 10.4 11.2 77.4 13.2 13.1 27.2 22.9 16.3 23.7 12.0 13.2 12.0 23.1 34.3 12.6 9.9 16.9 10.8 23.5 12.2 14.9 14.8 61.0 17.5 35.0 15.1 14.0 9.9 16.0 8.9 7.1 10.7 16.9 22.4 13.2 14.0 11.6 10.1 15.8 8.5 12.3 19.9 15.2 8.4 16.9 17.4 12.4 14.0 14.4 15.7 16.6 19.0 19.0 27.3 20.0 26.9 10.5 48.9 21.0 17.3 17.1 31.4 21.9 22.3 11.4 13.4 14.6 19.0 25.1 19.7 55.1 22.0 17.4 24.0 25.8 34.2 19.8 32.9 29.0 13.3 26.9 19.7 16.9 17.3 12.8 22.2 39.3 40.8 23.4 37.8 23.2 16.2 29.9 32.4 26.7 14.9 25.0 15.0 32.5 28.0 30.9 24.8 20.4 23.5 31.4 17.8 21.7 14.9 2.6 11.5 8.5 8.7 12.3 10.7 10.1 10.4 13.7 15.8 7.7 13.3 15.2 0.8 19.9 10.8 8.1 6.4 8.4 11.8 14.0 17.2 30.3 13.2 13.1 12.0 13.2 16.9 7.1 AFMID "DKFZp686F03259, KF" ENSG00000183077 Arylformamidase Q63HM1 17 78187317-78207701 "Enzymes, Predicted intracellular proteins" "Tryptophan catabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 78.7" "Cell line enhanced" "Detected in all" "Hep G2: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 14.5" "Group enriched" "Detected in all" 5 "B-cells: 5.1;dendritic cells: 6.7;monocytes: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023861, HPA026536" Uncertain Approved Mitochondria Mitochondria "HPA023861: AB_1844636, HPA026536: AB_1844637" "unprognostic (3.55e-2)" "unprognostic (1.54e-2)" "unprognostic (1.53e-1)" "unprognostic (2.65e-3)" "unprognostic (2.06e-1)" "unprognostic (4.73e-2)" "unprognostic (2.78e-1)" "unprognostic (1.83e-1)" "unprognostic (1.49e-3)" "unprognostic (1.53e-2)" "unprognostic (5.78e-2)" "unprognostic (9.59e-3)" "unprognostic (9.12e-2)" "unprognostic (1.80e-2)" "unprognostic (1.43e-1)" "unprognostic (1.94e-1)" "unprognostic (7.79e-2)" 5.9 3.5 12.1 5.4 17.1 4.6 33.0 27.1 18.3 6.1 7.5 44.8 11.7 8.5 7.5 7.0 7.7 11.3 11.4 9.4 17.3 12.0 39.4 78.7 10.6 5.2 29.7 13.3 15.9 27.7 6.9 4.1 12.4 18.1 10.7 9.2 5.8 24.7 11.8 7.9 15.5 7.1 6.6 27.0 6.2 10.2 6.2 23.9 3.9 6.5 5.6 6.2 6.7 7.4 5.1 6.7 1.7 14.5 1.6 1.1 1.5 6.9 9.9 8.7 7.9 9.8 11.5 4.7 10.0 5.7 7.0 8.5 10.5 5.8 21.8 6.6 7.6 6.0 14.7 8.7 9.9 13.8 11.7 17.5 11.6 61.2 8.6 14.4 9.0 15.4 9.3 8.2 10.7 13.1 17.7 7.6 5.4 6.9 11.0 22.0 7.1 17.0 12.6 8.9 26.0 9.5 6.4 19.3 14.4 8.6 25.9 8.1 7.8 14.0 6.4 10.8 7.1 6.8 7.0 11.7 7.7 22.3 8.9 7.1 2.7 1.1 6.1 0.7 0.7 14.5 1.1 5.1 1.0 1.1 6.7 2.0 0.6 0.6 1.7 1.6 9.3 4.4 0.9 1.5 12.1 17.1 27.1 18.3 17.3 12.0 29.7 13.3 18.1 23.9 AGPAT5 "FLJ11210, LPAAT-e, LPAAT-epsilon" ENSG00000155189 "1-acylglycerol-3-phosphate O-acyltransferase 5" Q9NUQ2 8 6708357-6759666 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010644, HPA010950, HPA011646" Approved Supported Mitochondria Mitochondria "HPA010644: AB_1844647, HPA010950: AB_1844648, HPA011646: " "unprognostic (1.05e-3)" "unprognostic (4.69e-1)" "prognostic favourable (8.82e-4)" "unprognostic (2.05e-2)" "unprognostic (2.99e-1)" "unprognostic (1.44e-2)" "prognostic unfavourable (4.57e-4)" "unprognostic (4.92e-1)" "unprognostic (1.82e-1)" "unprognostic (2.98e-2)" "unprognostic (6.33e-2)" "unprognostic (2.91e-1)" "unprognostic (6.62e-2)" "unprognostic (2.83e-1)" "unprognostic (3.60e-1)" "unprognostic (1.53e-2)" "unprognostic (5.09e-3)" 5.9 12.5 20.0 8.5 20.7 5.1 9.8 10.0 21.2 6.0 12.2 16.5 6.8 9.3 9.3 19.1 8.4 9.7 5.9 4.0 19.3 16.9 14.2 14.3 5.1 16.8 18.7 9.5 6.4 16.2 11.4 18.5 16.3 14.2 11.0 12.3 3.3 5.4 16.0 10.2 5.1 8.4 8.6 30.6 8.6 11.0 30.8 12.7 14.3 7.3 6.8 10.4 7.3 5.7 11.0 8.4 3.0 4.8 5.3 3.9 2.9 9.2 7.4 11.7 6.9 3.1 5.0 10.4 4.9 5.1 7.4 7.1 4.6 7.3 20.2 3.3 3.2 11.0 8.9 9.9 12.9 4.4 6.1 24.9 5.8 10.4 7.8 10.4 10.9 6.6 8.4 7.2 9.6 12.8 18.4 10.9 12.1 6.0 18.8 12.8 20.4 5.8 13.6 14.1 7.9 6.7 13.1 23.9 12.5 4.7 8.7 9.3 3.9 13.7 5.3 12.0 5.7 4.6 13.6 4.1 12.6 11.0 7.1 12.6 14.3 3.0 4.1 2.6 1.9 4.8 3.9 8.7 3.0 3.3 2.7 11.0 2.3 2.7 0.4 5.3 4.2 8.4 2.7 2.9 20.0 20.7 10.0 14.6 19.3 16.9 18.7 9.5 14.2 12.7 AIFM3 "AIFL, FLJ30473" ENSG00000183773 "Apoptosis inducing factor, mitochondria associated 3" Q96NN9 22 20965108-20981360 "Predicted intracellular proteins" "Apoptosis, Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 21.7;intestine: 28.0" "Cell line enhanced" "Detected in some" "Hep G2: 8.6;HMC-1: 12.9;T-47d: 6.2;THP-1: 8.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 7.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "classical monocyte: 2.2;intermediate monocyte: 5.7;myeloid DC: 3.8;non-classical monocyte: 3.4" "Group enriched" "Detected in many" 22 "dendritic cells: 3.8;monocytes: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001271 Approved Mitochondria Mitochondria "HPA001271: AB_1078114" "unprognostic (1.39e-1)" "unprognostic (1.97e-1)" "unprognostic (7.49e-2)" "unprognostic (9.99e-2)" "unprognostic (6.79e-2)" "unprognostic (2.03e-1)" "unprognostic (1.47e-1)" "unprognostic (2.73e-3)" "unprognostic (3.28e-1)" "unprognostic (1.56e-1)" "unprognostic (4.13e-3)" "unprognostic (5.13e-2)" "unprognostic (7.99e-2)" "unprognostic (6.78e-2)" "unprognostic (1.47e-1)" "unprognostic (3.37e-1)" "prognostic favourable (7.13e-5)" 1.3 1.3 20.3 4.6 19.0 5.4 0.8 14.4 18.4 1.2 28.0 9.7 0.0 4.3 0.9 0.8 0.9 1.2 1.6 0.9 14.6 9.9 0.9 0.8 1.5 1.4 14.8 12.4 1.0 0.9 0.9 1.9 1.3 21.7 1.2 13.0 5.0 2.2 1.9 0.7 0.9 3.4 1.9 9.6 2.7 1.6 1.1 7.6 0.0 1.0 0.0 0.8 1.9 0.1 0.2 3.8 0.0 5.7 0.0 0.0 0.9 1.2 2.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 3.5 0.0 0.1 0.0 1.4 0.2 0.0 0.0 0.3 0.0 2.2 0.0 8.6 0.2 0.0 12.9 0.6 0.7 0.1 0.0 0.0 0.1 0.1 0.0 3.5 0.0 0.1 0.0 0.0 0.1 0.0 1.4 0.0 1.5 1.7 1.1 1.0 0.1 0.0 6.2 8.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 5.7 0.0 0.2 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.9 20.3 19.0 14.4 18.4 14.6 9.9 14.8 12.4 21.7 7.6 AK3 "AK3L1, AK6, AKL3L1" ENSG00000147853 "Adenylate kinase 3" Q9UIJ7 9 4709559-4742043 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 85.0;HEL: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063324 Enhanced Supported Mitochondria 68000 Mitochondria "HPA063324: " "unprognostic (1.30e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (1.06e-1)" "unprognostic (6.55e-2)" "unprognostic (1.02e-1)" "unprognostic (2.21e-3)" "unprognostic (6.44e-2)" "unprognostic (2.81e-2)" "unprognostic (9.81e-3)" "unprognostic (1.90e-1)" "unprognostic (2.76e-2)" "prognostic favourable (6.07e-9)" "unprognostic (1.24e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (1.55e-3)" 24.6 25.1 20.9 9.8 22.4 6.8 24.0 14.6 17.5 17.7 23.7 15.3 16.0 24.4 18.9 17.5 28.3 14.0 16.1 90.0 22.4 16.4 37.7 75.1 16.4 13.1 25.2 15.2 22.4 15.7 16.9 14.1 13.0 22.9 19.0 23.0 17.4 14.5 19.1 72.0 18.1 22.0 21.2 24.1 12.1 22.5 9.3 24.9 15.2 20.8 32.8 14.9 20.1 17.1 7.0 14.4 17.0 5.6 14.7 17.1 10.2 8.7 7.3 12.5 5.1 17.5 12.9 0.9 11.0 26.0 6.9 10.4 1.2 9.7 8.1 3.8 14.0 5.6 9.1 10.6 11.8 85.0 6.9 54.4 13.0 22.0 13.8 5.7 2.8 20.4 9.5 5.9 8.2 20.3 4.1 11.1 20.7 5.2 5.5 16.5 11.2 2.7 7.4 4.5 4.0 20.2 12.2 20.7 13.0 12.9 4.2 7.4 5.8 11.4 12.6 5.8 5.9 15.2 8.6 2.8 1.8 10.0 10.6 4.3 4.1 6.8 5.6 17.0 16.2 4.4 14.7 7.0 12.5 14.8 10.5 6.9 16.6 17.1 1.9 14.7 3.4 14.4 16.7 10.2 20.9 22.4 14.6 17.5 22.4 16.4 25.2 15.2 22.9 24.9 AK4 "AK3, AK3L1" ENSG00000162433 "Adenylate kinase 4" P27144 1 65147549-65232145 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 89.7;liver: 50.7" "Cell line enhanced" "Detected in many" "Hep G2: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 6.1;myeloid DC: 5.3" "Group enriched" "Detected in many" 7 "dendritic cells: 5.3;granulocytes: 1.6;monocytes: 6.1" "Low region specificity" "Detected in all" "HPA042753, HPA049461" Enhanced Supported Mitochondria "Intracellular and membrane" 18000 Mitochondria "HPA042753: AB_2678146, HPA049461: AB_2680776" "unprognostic (3.73e-2)" "prognostic unfavourable (4.17e-4)" "unprognostic (2.25e-1)" "unprognostic (3.05e-3)" "unprognostic (1.48e-2)" "prognostic unfavourable (8.83e-4)" "unprognostic (1.16e-3)" "unprognostic (3.89e-2)" "unprognostic (4.03e-1)" "unprognostic (5.39e-2)" "prognostic unfavourable (4.34e-5)" "unprognostic (6.71e-2)" "prognostic unfavourable (4.36e-4)" "prognostic unfavourable (4.87e-4)" "unprognostic (2.69e-1)" "unprognostic (7.07e-2)" "unprognostic (7.57e-2)" 12.4 1.6 11.7 3.7 11.2 2.7 13.4 12.0 9.9 4.0 9.5 4.0 4.7 2.7 3.9 4.4 12.3 4.2 8.6 26.0 9.3 7.1 89.7 50.7 1.6 1.4 6.3 9.1 5.8 1.8 8.2 2.6 4.5 7.2 8.9 7.7 4.4 9.4 7.3 2.2 14.0 3.5 13.6 8.1 1.2 7.8 6.0 5.0 0.4 1.9 5.7 3.2 12.4 7.4 0.5 5.3 1.6 6.1 0.6 0.5 1.4 20.2 1.4 1.6 6.9 15.3 14.6 3.5 3.4 4.3 7.4 20.8 30.4 2.4 10.9 9.0 5.3 13.1 5.4 25.6 30.0 9.1 6.2 10.6 6.8 58.2 0.7 8.2 1.3 8.1 14.4 7.3 21.4 0.2 13.1 0.1 11.3 8.7 0.3 0.3 7.1 12.2 0.0 11.9 1.9 11.0 0.9 5.9 4.5 6.1 0.4 4.8 8.5 3.6 1.2 12.4 10.7 0.9 5.8 11.5 5.1 0.6 20.1 3.0 0.7 1.6 6.1 0.0 0.2 1.4 0.4 0.5 0.2 0.5 5.3 0.4 0.2 0.2 1.0 0.6 0.2 0.8 0.1 1.4 11.7 11.2 12.0 9.9 9.3 7.1 6.3 9.1 7.2 5.0 AKAP1 "AKAP121, AKAP149, AKAP84, D-AKAP1, PPP1R43, PRKA1, S-AKAP84, SAKAP84, TDRD17" ENSG00000121057 "A-kinase anchoring protein 1" Q92667 17 57085092-57121349 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 80.1;testis: 75.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008620, HPA008691, CAB019286" Supported Supported Mitochondria Mitochondria "CAB019286: , HPA008620: , HPA008691: AB_1078119" "unprognostic (5.52e-2)" "unprognostic (1.83e-1)" "unprognostic (6.96e-3)" "unprognostic (1.78e-1)" "unprognostic (1.79e-2)" "unprognostic (6.38e-2)" "unprognostic (7.19e-2)" "unprognostic (1.48e-2)" "unprognostic (8.14e-2)" "unprognostic (2.36e-2)" "unprognostic (3.22e-1)" "unprognostic (3.00e-1)" "prognostic favourable (7.86e-9)" "unprognostic (6.82e-2)" "unprognostic (2.46e-1)" "unprognostic (5.74e-2)" "unprognostic (1.38e-1)" 16.4 6.1 13.5 9.2 16.3 2.8 14.7 13.4 12.5 10.3 28.1 8.7 9.3 22.6 10.2 14.3 18.1 12.5 19.2 35.0 10.0 6.6 11.9 26.4 8.3 4.4 13.6 9.9 9.0 16.4 18.8 7.1 3.3 7.9 15.5 20.6 9.3 13.6 13.9 80.1 10.2 25.2 23.5 8.4 4.9 22.2 75.4 10.1 4.7 14.9 19.7 7.4 20.5 9.8 3.3 6.5 2.8 3.3 6.0 7.4 2.1 16.5 20.7 28.8 9.4 7.5 4.9 17.3 6.9 6.7 9.1 6.5 22.1 14.9 26.6 19.7 5.3 26.3 16.1 15.2 9.2 14.5 23.4 22.6 18.3 42.0 7.0 21.2 8.7 4.3 15.1 10.1 14.2 9.2 15.0 10.3 5.2 14.1 26.7 8.1 10.5 22.3 20.6 12.2 21.7 6.1 19.6 22.1 14.5 5.5 16.1 9.0 11.0 21.9 6.8 8.0 9.0 10.3 15.6 10.2 12.7 20.0 5.1 16.6 7.1 2.8 1.7 0.6 4.7 3.3 4.1 3.3 3.8 3.8 4.0 2.4 7.4 4.0 0.2 6.0 0.9 6.5 2.8 2.1 13.5 16.3 13.4 12.5 10.0 6.6 13.6 9.9 7.9 10.1 AL021546.1 ENSG00000111780 12 120438198-120460006 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 9.7;HEK 293: 12.3;U-266/84: 10.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA062394 Uncertain Approved Mitochondria Mitochondria "HPA062394: " "unprognostic (3.79e-2)" "unprognostic (1.74e-1)" "unprognostic (2.79e-1)" "unprognostic (2.90e-1)" "unprognostic (1.71e-1)" "unprognostic (1.33e-1)" "unprognostic (9.54e-4)" "unprognostic (2.04e-1)" 4.8 6.0 12.8 3.6 11.6 4.7 4.5 8.4 14.8 4.6 16.3 4.2 3.3 3.6 5.1 3.6 6.0 7.1 3.6 6.7 8.9 6.3 11.5 12.1 5.3 4.2 10.5 7.2 9.6 10.3 3.6 4.9 5.8 11.6 6.5 3.6 3.1 5.4 4.3 4.3 4.1 11.4 3.6 5.9 9.2 7.1 4.8 7.7 3.5 6.3 3.8 4.0 6.6 5.1 6.5 12.9 5.8 10.7 2.8 7.4 4.3 2.2 3.0 0.0 0.7 0.0 0.0 0.0 2.0 0.4 0.5 0.0 9.7 0.0 0.6 3.8 0.0 1.0 0.0 0.5 0.0 1.8 12.3 0.8 0.0 0.0 0.0 4.2 1.1 0.0 0.4 0.0 0.0 0.0 1.4 0.3 0.0 0.0 3.5 0.4 0.4 4.9 2.0 1.4 1.0 0.0 0.0 5.1 0.4 3.2 1.0 0.0 1.0 0.5 2.7 1.7 0.5 0.0 1.5 1.0 10.9 3.9 0.7 1.5 0.0 2.0 5.8 5.8 6.5 10.7 7.4 6.5 4.0 7.4 12.9 6.0 4.5 4.0 1.7 2.8 8.1 10.0 7.2 4.3 12.8 11.6 8.4 14.8 8.9 6.3 10.5 7.2 11.6 7.7 AL360181.3 ENSG00000254536 10 133390834-133420495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "Karpas-707: 23.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA037826, HPA037827" Uncertain Approved Mitochondria Mitochondria "HPA037826: , HPA037827: AB_10670959" "unprognostic (3.71e-1)" "unprognostic (1.14e-2)" "unprognostic (3.84e-3)" "unprognostic (3.82e-1)" "unprognostic (9.99e-2)" "unprognostic (3.51e-2)" "unprognostic (6.61e-2)" "unprognostic (1.76e-1)" "unprognostic (8.11e-2)" "unprognostic (3.49e-2)" "unprognostic (2.41e-2)" "unprognostic (7.55e-2)" "unprognostic (1.34e-3)" "unprognostic (4.96e-2)" "unprognostic (4.84e-2)" "unprognostic (7.06e-2)" "unprognostic (9.86e-4)" 0.5 0.2 0.7 1.3 0.2 1.0 0.1 2.3 0.8 0.2 0.5 3.6 0.2 0.0 4.3 0.2 0.8 0.4 0.5 0.0 0.4 2.1 0.3 2.4 0.4 0.3 2.2 0.7 0.4 0.0 1.3 0.4 0.9 1.1 0.7 1.1 2.0 0.0 0.3 1.5 0.3 3.8 0.1 1.1 0.1 1.0 3.0 1.5 0.4 0.9 1.6 1.0 1.4 0.7 0.0 0.2 2.7 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.9 0.0 0.2 0.1 0.0 0.4 0.1 0.3 1.3 0.6 0.4 1.0 0.2 0.3 0.1 0.0 0.3 0.0 0.2 0.0 0.0 23.2 0.1 0.4 0.1 1.3 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.2 0.9 0.0 0.1 0.5 0.0 0.0 5.0 1.5 0.3 0.2 0.0 0.1 0.0 0.4 0.4 0.7 0.6 0.6 3.0 0.7 1.0 1.5 1.9 0.8 0.5 0.0 1.6 0.9 1.3 0.7 1.4 ALDH16A1 MGC10204 ENSG00000161618 "Aldehyde dehydrogenase 16 family member A1" Q8IZ83 19 49453169-49471048 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059488 Approved Approved Mitochondria 910000 Mitochondria "HPA059488: " "unprognostic (2.39e-1)" "unprognostic (3.95e-3)" "unprognostic (7.10e-2)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (2.95e-3)" "unprognostic (5.58e-2)" "unprognostic (1.45e-1)" "unprognostic (3.92e-2)" "unprognostic (4.90e-1)" "unprognostic (1.19e-3)" "unprognostic (4.28e-2)" "unprognostic (1.91e-3)" "unprognostic (2.94e-2)" "unprognostic (4.19e-1)" "unprognostic (1.27e-1)" "unprognostic (5.23e-3)" 13.3 11.0 6.9 16.9 9.6 13.3 10.5 6.0 8.2 12.3 14.2 6.6 7.4 21.0 12.5 7.7 11.4 9.9 15.3 6.2 4.8 3.0 10.5 22.0 8.7 14.2 12.1 3.1 8.9 15.1 6.5 6.0 10.8 8.5 7.8 4.0 6.2 8.0 9.6 6.5 15.2 19.9 5.6 5.2 21.8 12.4 4.5 9.6 16.8 9.4 10.6 14.6 9.6 9.9 13.2 12.0 12.0 19.8 5.8 7.4 4.5 11.4 15.6 3.7 8.8 1.7 1.2 12.3 7.4 2.3 5.8 6.0 8.0 4.4 17.3 11.8 1.0 7.9 1.5 4.2 0.7 10.8 9.0 13.4 5.6 11.4 2.5 8.2 30.1 2.1 2.5 2.8 2.2 3.7 9.3 18.0 1.4 11.6 5.8 23.3 8.1 0.0 9.8 5.3 12.9 2.7 13.6 6.7 7.6 6.6 7.4 6.1 6.8 9.4 8.3 8.5 5.6 3.8 8.1 15.0 17.3 5.0 2.1 11.6 5.9 7.6 7.1 12.0 6.8 17.7 7.4 12.5 6.8 7.4 11.3 13.2 6.3 6.4 1.3 5.8 19.8 12.0 5.4 4.5 6.9 9.6 6.0 8.2 4.8 3.0 12.1 3.1 8.5 9.6 ALDH18A1 "GSAS, P5CS, PYCS, SPG9" ENSG00000059573 "Aldehyde dehydrogenase 18 family member A1" P54886 10 95605929-95656706 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis" "Kinase, Multifunctional enzyme, Oxidoreductase, Transferase" "Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 68.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008333, HPA012604" Approved Supported Mitochondria 23000 Mitochondria "HPA008333: AB_1078125, HPA012604: AB_1844721" "unprognostic (5.97e-3)" "unprognostic (2.08e-2)" "unprognostic (5.75e-2)" "prognostic favourable (4.20e-4)" "unprognostic (1.60e-2)" "unprognostic (1.06e-1)" "unprognostic (8.30e-3)" "unprognostic (7.08e-2)" "unprognostic (4.06e-2)" "unprognostic (8.04e-2)" "unprognostic (1.30e-1)" "unprognostic (1.81e-1)" "prognostic unfavourable (3.60e-9)" "unprognostic (1.02e-3)" "unprognostic (6.57e-2)" "unprognostic (1.29e-3)" "unprognostic (6.43e-2)" 6.3 10.4 7.1 10.4 7.9 5.2 7.7 7.3 9.3 13.7 20.1 7.2 20.5 33.8 9.3 12.3 12.8 8.5 15.2 7.2 6.2 7.1 13.0 28.9 6.6 7.4 6.7 5.3 14.5 40.7 12.7 17.4 14.3 7.7 9.6 19.4 7.9 68.8 20.5 3.5 9.6 45.4 10.0 5.4 8.6 15.2 8.4 5.4 12.7 25.9 9.7 15.9 8.6 8.2 13.1 5.2 0.3 4.0 13.0 16.3 8.0 18.2 17.3 16.6 43.6 22.4 21.7 17.9 21.3 32.1 21.7 27.3 34.6 14.6 62.1 20.0 33.5 24.2 33.3 21.9 24.7 17.6 26.2 19.7 12.3 49.1 14.7 34.3 22.0 22.7 13.5 17.7 34.7 22.7 18.3 13.1 16.2 26.2 31.0 22.1 19.6 17.3 29.2 19.1 21.3 25.3 13.9 16.6 16.5 16.9 13.5 15.7 20.1 16.0 18.8 9.0 14.4 23.2 24.4 15.1 11.2 38.0 17.6 39.8 11.5 0.0 1.4 0.1 15.5 2.7 16.3 13.1 14.2 16.0 5.2 9.0 12.1 13.4 0.3 13.0 4.0 3.1 13.3 8.0 7.1 7.9 7.3 9.3 6.2 7.1 6.7 5.3 7.7 5.4 ALDH1L2 "FLJ38508, mtFDH" ENSG00000136010 "Aldehyde dehydrogenase 1 family member L2" Q3SY69 12 105019784-105084577 "Enzymes, Predicted intracellular proteins" "One-carbon metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "pancreas: 48.9;salivary gland: 31.6" "Cell line enhanced" "Detected in many" "ASC diff: 22.6;ASC TERT1: 30.9;fHDF/TERT166: 35.1;HHSteC: 19.9;HSkMC: 25.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.3" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039481, HPA059282" Approved Enhanced Mitochondria Mitochondria "HPA039481: AB_10795465, HPA059282: " "unprognostic (5.99e-2)" "unprognostic (1.42e-1)" "unprognostic (1.10e-1)" "unprognostic (1.36e-3)" "unprognostic (1.76e-1)" "unprognostic (8.86e-2)" "unprognostic (1.75e-1)" "unprognostic (2.92e-1)" "unprognostic (5.74e-2)" "unprognostic (1.51e-1)" "unprognostic (1.01e-1)" "unprognostic (1.61e-1)" "unprognostic (8.19e-8)" "unprognostic (3.21e-3)" "unprognostic (1.33e-1)" "unprognostic (2.53e-3)" "unprognostic (2.52e-5)" 4.2 1.2 3.2 2.7 1.9 0.7 2.7 5.3 2.7 5.5 2.2 0.9 3.3 2.4 2.9 3.2 1.5 2.6 2.7 2.9 1.6 2.0 0.7 0.4 2.7 2.0 2.0 2.1 1.0 48.9 0.7 2.8 1.1 2.5 3.6 2.3 4.8 31.6 4.5 1.0 1.5 1.3 5.4 5.3 1.2 3.7 0.8 1.3 0.0 2.2 1.4 3.0 3.9 2.2 0.2 1.3 0.0 0.1 0.0 0.1 0.1 4.3 0.4 0.2 9.4 22.6 30.9 0.5 14.0 9.0 1.8 4.8 0.5 0.0 0.0 0.5 35.1 0.0 0.0 0.3 2.3 0.0 0.1 0.2 0.0 1.1 19.9 1.7 0.0 25.0 1.1 4.7 8.9 1.0 0.7 12.6 3.6 0.0 0.0 0.1 0.5 0.1 0.0 0.0 1.3 0.0 0.0 3.3 1.6 0.0 2.9 7.1 2.0 14.9 0.1 1.4 1.3 0.0 0.7 15.7 4.1 0.0 5.7 6.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.1 3.2 1.9 5.3 2.4 1.6 2.0 2.0 2.1 2.5 1.3 ALDH5A1 "SSADH, SSDH" ENSG00000112294 "Aldehyde dehydrogenase 5 family member A1" P51649 6 24494852-24537207 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 62.6" "Cell line enhanced" "Detected in many" "Daudi: 40.3;U-698: 50.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029715, HPA029716" Enhanced Supported Mitochondria 44000 Mitochondria "HPA029715: AB_10599994, HPA029716: AB_10601876" "unprognostic (7.43e-2)" "unprognostic (1.12e-3)" "unprognostic (1.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-1)" "unprognostic (3.27e-1)" "prognostic favourable (7.61e-6)" "unprognostic (2.38e-2)" "unprognostic (2.17e-2)" "prognostic favourable (6.20e-4)" "unprognostic (1.43e-2)" "unprognostic (1.21e-1)" "prognostic favourable (3.68e-4)" "unprognostic (1.04e-2)" "unprognostic (1.16e-1)" "unprognostic (2.00e-2)" "unprognostic (1.08e-2)" 5.8 4.8 23.7 8.3 27.4 3.1 4.1 13.5 21.5 4.1 6.0 9.5 1.2 7.7 3.9 3.1 5.6 13.5 4.4 9.8 17.3 21.0 18.4 62.6 5.0 8.9 16.0 14.7 5.8 6.6 11.4 4.5 2.2 13.0 6.2 5.7 4.1 3.9 4.3 31.1 6.9 5.4 2.8 10.9 4.8 5.2 3.7 8.8 21.4 12.1 4.9 8.8 6.3 5.5 3.9 3.8 0.4 0.2 1.6 6.8 1.2 3.2 2.9 2.1 3.1 0.0 0.0 3.5 0.3 0.6 0.8 0.5 11.5 0.8 40.3 6.1 0.3 0.0 3.4 0.4 0.5 4.1 5.6 6.3 1.9 13.1 0.5 9.7 0.8 0.3 1.6 0.1 0.0 0.0 3.1 0.0 0.6 7.5 11.8 5.8 0.8 1.5 13.6 0.6 0.3 2.4 6.4 3.6 3.2 3.8 0.4 3.9 5.7 5.3 0.0 0.4 2.0 0.1 2.0 5.7 8.5 50.3 0.0 3.1 0.4 0.4 0.1 0.2 1.7 0.0 3.3 3.7 2.4 2.8 0.2 3.9 6.8 5.7 0.4 1.6 0.2 3.8 1.6 1.2 23.7 27.4 13.5 21.5 17.3 21.0 16.0 14.7 13.0 8.8 ALDH6A1 MMSDH ENSG00000119711 "Aldehyde dehydrogenase 6 family member A1" Q02252 14 74056850-74084493 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 140.0;liver: 134.5" "Cell line enhanced" "Detected in all" "T-47d: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 25.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029072, HPA029073, HPA029074, HPA029075" Enhanced Enhanced Mitochondria 9100 Mitochondria "HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005" "unprognostic (1.45e-1)" "unprognostic (5.38e-2)" "unprognostic (6.89e-2)" "unprognostic (6.95e-3)" "unprognostic (1.46e-1)" "unprognostic (7.93e-2)" "unprognostic (1.11e-3)" "prognostic favourable (4.22e-4)" "unprognostic (1.58e-1)" "unprognostic (9.10e-2)" "unprognostic (3.11e-2)" "unprognostic (2.13e-1)" "prognostic favourable (2.00e-15)" "unprognostic (4.59e-1)" "unprognostic (1.92e-1)" "unprognostic (6.05e-3)" "unprognostic (1.12e-1)" 14.1 6.9 31.3 2.8 30.9 2.3 6.7 11.6 26.4 8.0 11.0 20.1 4.6 11.0 5.5 5.5 5.0 6.2 4.8 15.6 21.1 14.2 140.0 134.5 4.7 3.0 19.4 18.5 12.3 11.8 16.4 3.2 4.0 14.8 11.0 7.2 7.1 7.8 7.8 10.5 3.4 9.3 5.6 13.1 3.1 9.6 7.4 18.7 2.0 12.1 4.0 3.1 6.3 3.3 4.5 5.6 25.5 3.8 5.5 6.7 2.8 4.6 4.0 5.7 12.1 20.8 10.2 9.2 3.2 6.1 3.5 6.0 9.0 5.2 5.4 7.2 6.9 2.7 12.9 3.6 7.7 4.8 1.8 2.5 4.2 9.9 23.7 1.3 1.2 15.0 6.5 4.5 11.4 6.1 4.0 7.5 2.4 17.7 3.7 2.0 4.5 2.7 7.6 5.9 7.1 5.6 3.5 2.3 3.6 10.7 11.6 2.8 29.6 4.8 1.9 4.0 4.9 6.2 1.2 5.1 9.1 5.5 5.2 1.6 3.8 13.3 3.8 25.5 4.5 2.9 6.7 4.5 5.1 5.3 5.6 3.6 6.5 4.6 1.5 5.5 2.4 3.2 3.6 2.8 31.3 30.9 11.6 26.4 21.1 14.2 19.4 18.5 14.8 18.7 ALKBH7 "MGC10974, SPATA11" ENSG00000125652 "AlkB homolog 7" Q9BT30 19 6372433-6375251 "Predicted intracellular proteins" Necrosis "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008539, HPA039571, HPA039872" Approved Supported Mitochondria Mitochondria "HPA008539: , HPA039571: AB_2676577, HPA039872: AB_10697710" "unprognostic (5.38e-2)" "unprognostic (3.58e-2)" "unprognostic (2.20e-1)" "unprognostic (1.15e-2)" "unprognostic (7.79e-2)" "unprognostic (3.56e-3)" "unprognostic (1.06e-1)" "unprognostic (1.35e-1)" "unprognostic (3.02e-1)" "unprognostic (6.83e-2)" "unprognostic (1.72e-3)" "unprognostic (1.54e-1)" "prognostic favourable (7.83e-6)" "unprognostic (7.07e-2)" "unprognostic (2.00e-1)" "unprognostic (2.57e-1)" "unprognostic (1.10e-2)" 10.8 14.7 13.7 14.1 15.2 12.7 13.6 16.3 15.8 12.3 25.0 11.1 28.4 30.9 12.4 18.8 17.2 15.4 18.7 49.3 12.6 11.9 17.1 32.7 20.2 26.3 14.2 11.9 19.0 65.0 10.2 14.0 7.9 15.8 15.5 9.8 16.0 29.7 21.5 62.9 11.9 29.6 15.8 15.9 9.9 14.2 96.5 7.3 29.9 19.4 29.5 16.2 12.6 13.6 34.3 43.8 19.7 32.8 18.4 45.9 28.4 9.7 8.4 7.5 13.0 4.2 11.9 9.2 5.8 6.3 6.4 6.8 14.8 6.3 12.5 22.0 9.0 7.5 3.3 5.9 1.2 12.7 11.8 6.7 6.2 13.8 12.4 4.1 10.2 13.6 11.9 5.5 4.4 7.9 7.6 28.2 4.8 19.7 19.8 13.9 10.3 35.4 14.0 3.8 26.4 7.1 7.6 10.0 14.8 3.9 12.7 24.5 14.4 15.3 5.2 6.4 8.3 23.5 6.7 40.6 29.4 8.3 12.1 13.2 5.5 9.9 32.8 4.9 17.1 26.5 23.5 34.3 29.8 23.3 38.8 31.6 45.9 36.0 19.7 18.4 20.4 43.8 25.3 28.4 13.7 15.2 16.3 15.8 12.6 11.9 14.2 11.9 15.8 7.3 ANKRD33B ENSG00000164236 "Ankyrin repeat domain 33B" A6NCL7 5 10564330-10657816 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.3" "Cell line enhanced" "Detected in many" "HDLM-2: 27.1;HMC-1: 18.3" "Cancer enhanced" "Detected in many" "renal cancer: 7.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.1;memory B-cell: 1.4" "Group enriched" "Detected in many" 4 "B-cells: 1.4;granulocytes: 2.1" "Group enriched" "Detected in many" 9 "amygdala: 13.6;basal ganglia: 16.9;cerebral cortex: 26.5;hippocampal formation: 22.4;olfactory region: 16.5" "Group enriched" "Detected in many" 6 "amygdala: 13.7;basal ganglia: 24.2;cerebral cortex: 30.1;hippocampal formation: 25.2;olfactory region: 26.0" HPA056974 Uncertain Approved Mitochondria Mitochondria "HPA056974: " "unprognostic (6.19e-2)" "unprognostic (2.61e-1)" "unprognostic (1.09e-2)" "unprognostic (5.65e-3)" "unprognostic (2.84e-2)" "unprognostic (1.21e-1)" "unprognostic (1.99e-1)" "unprognostic (4.50e-3)" "unprognostic (4.41e-1)" "unprognostic (2.42e-3)" "unprognostic (1.14e-1)" "unprognostic (1.00e-1)" "prognostic favourable (4.16e-5)" "unprognostic (1.17e-1)" "unprognostic (4.80e-2)" "unprognostic (2.39e-2)" "unprognostic (5.47e-2)" 3.8 1.1 6.3 8.6 9.3 13.2 3.6 1.4 25.3 5.2 3.2 0.1 0.4 0.9 7.8 1.1 3.3 5.4 1.9 7.0 8.4 2.3 10.0 1.5 3.0 5.4 2.0 7.5 1.7 2.7 0.5 1.7 3.5 1.3 3.5 2.0 12.7 2.3 4.4 9.0 11.3 3.3 6.9 1.7 11.1 3.1 5.2 1.1 7.2 1.6 12.5 7.2 4.9 16.6 1.4 0.0 2.1 0.0 0.0 0.4 0.4 2.5 3.7 0.2 0.3 8.9 4.2 11.3 0.7 1.2 1.5 1.8 4.6 2.0 13.8 12.7 2.3 2.5 1.3 1.2 1.7 27.1 0.9 5.5 3.3 0.0 4.1 4.1 18.3 2.1 0.9 0.8 5.1 1.9 1.2 6.8 0.4 0.0 0.1 5.0 3.0 1.1 1.1 2.8 0.4 5.1 1.8 0.0 0.1 0.0 0.2 0.4 0.0 5.2 5.4 0.9 5.5 4.6 1.3 7.9 8.6 1.2 0.2 6.7 0.3 0.0 0.0 2.1 0.2 0.0 0.0 1.4 0.4 0.1 0.0 0.8 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.4 6.3 9.3 1.4 25.3 8.4 2.3 2.0 7.5 1.3 1.1 ANKRD34C ENSG00000235711 "Ankyrin repeat domain 34C" P0C6C1 15 79293285-79298235 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 5.8;skin 1: 3.0" "Cell line enriched" "Detected in single" 18 "SCLC-21H: 13.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045329 Uncertain Approved Mitochondria Mitochondria "HPA045329: " "unprognostic (3.20e-1)" "unprognostic (1.08e-1)" "unprognostic (1.52e-2)" "unprognostic (1.81e-1)" "unprognostic (3.42e-3)" "unprognostic (5.31e-2)" "unprognostic (2.48e-1)" 0.5 0.3 0.6 0.0 0.5 0.0 0.0 5.8 5.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.9 5.0 0.1 0.0 0.3 0.0 2.4 0.0 0.7 0.1 1.2 0.0 0.1 0.1 0.0 0.2 0.2 3.0 0.1 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 APBB2 "FE65L, FE65L1, MGC35575" ENSG00000163697 "Amyloid beta precursor protein binding family B member 2" Q92870 4 40810027-41216714 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 40.9;TIME: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "naive B-cell: 9.4" "Lineage enriched" "Detected in single" 14 "B-cells: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023542 Approved Approved Mitochondria Mitochondria "HPA023542: AB_1844909" "unprognostic (4.43e-2)" "unprognostic (4.40e-2)" "unprognostic (2.04e-2)" "prognostic unfavourable (1.97e-4)" "unprognostic (5.91e-3)" "unprognostic (8.13e-2)" "unprognostic (5.77e-2)" "unprognostic (4.00e-3)" "unprognostic (2.51e-1)" "unprognostic (1.21e-2)" "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "unprognostic (2.19e-3)" "unprognostic (9.35e-3)" "unprognostic (3.92e-2)" "unprognostic (2.29e-2)" "unprognostic (2.61e-1)" 35.1 9.1 18.4 5.1 25.5 7.2 20.9 7.6 30.1 13.9 10.8 42.9 8.3 7.9 14.2 5.9 9.0 11.6 15.8 18.8 19.4 15.1 17.0 13.9 17.5 6.7 34.3 16.8 31.5 10.1 9.8 10.2 16.3 29.8 8.4 8.2 13.7 7.6 10.3 22.4 10.6 6.0 14.4 30.7 13.2 10.1 8.8 35.1 2.3 32.9 5.3 5.4 11.8 15.4 9.4 0.3 0.6 0.4 0.2 0.1 0.4 5.2 2.6 6.1 8.5 20.9 16.1 13.5 10.3 13.4 4.1 7.2 9.3 11.2 9.8 5.8 4.5 1.6 10.8 14.2 7.6 0.3 2.1 0.1 6.6 6.1 20.3 5.4 0.3 23.9 7.6 12.3 12.8 40.9 0.3 0.2 26.5 4.6 1.8 1.0 5.0 5.1 14.5 17.6 11.3 6.1 2.5 8.2 4.7 3.2 2.0 2.1 4.9 0.6 54.3 5.9 17.1 4.0 17.7 2.5 5.0 11.8 6.5 8.9 6.9 0.6 0.4 0.2 0.1 0.1 0.1 0.7 0.1 0.1 0.3 9.4 0.1 0.1 0.5 0.2 0.1 0.1 0.1 0.4 18.4 25.5 7.6 24.6 19.4 15.1 34.3 16.8 29.8 35.1 APCDD1L FLJ90166 ENSG00000198768 "APC down-regulated 1 like" Q8NCL9 20 58459101-58515131 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "salivary gland: 39.2;smooth muscle: 10.9" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 42.4;hTEC/SVTERT24-B: 15.0;HUVEC TERT2: 15.2;TIME: 29.8;U-87 MG: 18.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA067015 Uncertain Uncertain Mitochondria Mitochondria "HPA067015: " "unprognostic (2.61e-1)" "unprognostic (8.26e-3)" "unprognostic (4.63e-3)" "unprognostic (1.35e-5)" "unprognostic (4.09e-3)" "unprognostic (9.73e-3)" "unprognostic (1.31e-3)" "unprognostic (1.06e-4)" "unprognostic (7.63e-4)" "unprognostic (2.14e-2)" "unprognostic (7.62e-3)" "unprognostic (2.16e-1)" "unprognostic (6.55e-13)" "unprognostic (5.01e-3)" "unprognostic (3.21e-1)" "unprognostic (2.24e-2)" "unprognostic (1.81e-3)" 0.5 0.6 0.2 0.6 0.2 0.0 5.2 0.6 0.1 3.3 1.2 0.1 0.0 0.1 2.4 0.2 0.8 0.0 2.1 5.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.5 0.0 0.1 3.6 0.7 3.2 39.2 1.7 0.6 0.9 0.8 10.9 0.3 0.0 0.6 0.1 0.0 0.0 0.1 1.0 0.6 6.1 5.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 9.0 0.0 0.9 0.6 0.0 2.7 0.0 0.0 42.4 0.4 0.0 1.4 1.4 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 1.2 0.0 15.0 0.2 15.2 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.8 6.4 0.4 0.0 8.3 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 APOOL "AAIR8193, CXorf33, FAM121A, Mic27, UNQ8193" ENSG00000155008 "Apolipoprotein O like" Q6UXV4 X 85003826-85093316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000612 Approved Approved Mitochondria "Intracellular and membrane" Mitochondria "HPA000612: AB_1078594" "prognostic unfavourable (2.68e-5)" "unprognostic (2.72e-2)" "unprognostic (6.16e-2)" "unprognostic (5.71e-3)" "unprognostic (4.27e-3)" "unprognostic (1.47e-1)" "unprognostic (2.73e-1)" "unprognostic (2.22e-2)" "unprognostic (8.35e-2)" "unprognostic (1.10e-1)" "unprognostic (2.77e-1)" "unprognostic (8.20e-2)" "prognostic favourable (1.35e-12)" "unprognostic (2.67e-2)" "unprognostic (5.65e-2)" "unprognostic (7.11e-2)" "unprognostic (7.51e-2)" 9.9 13.2 6.2 5.2 11.2 4.5 8.6 4.3 11.9 7.8 8.2 7.1 6.6 8.2 8.6 8.4 14.0 7.7 6.3 16.1 8.3 6.8 16.2 20.1 6.7 4.3 8.4 7.4 8.0 14.2 17.0 12.9 7.3 14.0 7.8 9.2 7.4 9.9 6.4 20.4 9.2 10.4 8.9 8.8 4.9 9.2 4.6 8.2 7.3 12.7 11.1 5.6 11.0 9.4 7.8 5.9 7.1 6.7 3.6 5.2 2.1 11.4 9.4 6.4 7.8 16.4 11.3 7.3 7.7 7.3 6.5 7.8 8.2 7.3 8.3 8.6 8.1 8.6 19.3 7.4 11.3 8.9 7.9 8.8 11.8 7.4 9.8 16.1 8.7 12.1 9.8 11.6 19.1 9.3 15.9 13.4 10.3 8.7 6.5 4.7 5.6 14.3 7.3 14.7 8.4 7.0 9.0 0.6 9.0 14.8 11.7 7.1 7.6 6.2 10.8 7.9 12.1 17.0 8.7 6.4 26.8 8.3 9.0 12.6 7.6 7.1 4.7 3.4 4.7 6.7 3.9 7.8 4.4 3.6 5.0 4.5 5.2 4.7 1.0 3.6 5.5 5.9 3.0 2.1 6.2 11.2 4.3 11.9 8.3 6.8 8.4 7.4 14.0 8.2 AR "AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1" ENSG00000169083 "Androgen receptor" P10275 X 67544032-67730619 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 49.0" "Cell line enhanced" "Detected in some" "AF22: 11.0;BJ hTERT+: 9.6;HAP1: 14.1;LHCN-M2: 12.4;RH-30: 20.5;T-47d: 8.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 16 "plasmacytoid DC: 5.4" "Lineage enriched" "Detected in single" 16 "dendritic cells: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000001, HPA065701, CAB065764" Enhanced Approved Mitochondria Mitochondria "CAB000001: AB_2060174, CAB065764: AB_10620739, HPA065701: " "unprognostic (1.34e-1)" "unprognostic (8.10e-3)" "unprognostic (2.49e-2)" "unprognostic (5.95e-2)" "unprognostic (1.04e-2)" "unprognostic (3.35e-2)" "prognostic favourable (8.77e-4)" "unprognostic (4.99e-2)" "unprognostic (1.72e-1)" "unprognostic (7.79e-2)" "unprognostic (2.30e-1)" "unprognostic (2.29e-1)" "prognostic favourable (1.03e-8)" "unprognostic (8.23e-3)" "unprognostic (8.90e-2)" "unprognostic (4.23e-2)" "unprognostic (7.97e-2)" 10.1 1.2 0.9 1.6 0.9 0.1 10.7 0.4 1.6 34.4 1.9 2.4 25.4 0.2 20.5 20.5 2.2 17.5 4.3 5.7 0.9 1.5 6.3 49.0 1.5 0.2 1.2 0.7 14.4 1.0 0.1 2.3 0.3 1.9 28.0 0.5 3.8 1.6 36.1 8.1 3.9 1.1 7.6 1.9 0.9 1.6 9.3 1.2 5.4 3.1 2.0 1.2 6.3 13.1 0.0 5.4 0.3 0.0 0.1 0.0 0.1 0.0 4.6 11.0 0.0 0.0 0.1 0.0 5.8 9.6 0.4 0.1 0.2 0.0 0.0 0.0 0.7 0.0 14.1 0.0 0.1 0.0 1.8 0.0 1.1 0.0 0.6 0.0 0.0 4.5 0.0 1.6 0.0 3.4 4.0 1.8 12.4 1.2 0.0 0.0 4.4 0.0 0.0 20.5 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 8.6 5.2 0.2 0.2 2.0 0.1 2.9 0.0 0.0 0.0 4.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 5.4 0.0 0.1 0.9 0.9 0.4 1.6 0.9 1.5 1.2 0.7 1.9 1.2 AREG "AREGB, SDGF" ENSG00000109321 Amphiregulin P15514 4 74445134-74455009 "Cancer-related genes, Predicted membrane proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 83.5" "Cell line enhanced" "Detected in some" "CACO-2: 41.8;HBEC3-KT: 72.5;hTCEpi: 73.7;hTERT-HME1: 157.7;MCF7: 45.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 9 "basophil: 8.2;eosinophil: 11.6;NK-cell: 3.3" "Group enriched" "Detected in many" 9 "granulocytes: 11.6;NK-cells: 3.3" "Region enriched" "Detected in single" 4 "olfactory region: 1.5" "Low region specificity" "Detected in all" "HPA008720, CAB023519" Approved Approved Mitochondria Mitochondria "CAB023519: AB_2060673, HPA008720: AB_1844978" "unprognostic (1.44e-2)" "unprognostic (1.84e-3)" "unprognostic (3.36e-2)" "unprognostic (2.26e-1)" "unprognostic (3.54e-3)" "prognostic unfavourable (2.61e-5)" "unprognostic (1.02e-2)" "prognostic unfavourable (1.05e-5)" "unprognostic (2.90e-1)" "unprognostic (8.06e-2)" "prognostic unfavourable (8.32e-5)" "unprognostic (2.56e-2)" "unprognostic (2.49e-3)" "unprognostic (2.40e-2)" "unprognostic (1.69e-1)" "unprognostic (1.23e-1)" "unprognostic (6.83e-3)" 19.5 1.1 0.4 9.2 2.1 28.9 20.3 0.3 0.4 5.7 6.7 0.2 0.2 0.7 1.7 1.6 22.3 6.0 34.8 13.6 0.5 0.4 2.5 1.7 14.4 13.3 0.4 0.0 5.8 1.0 0.0 7.8 83.5 1.3 1.9 5.0 1.4 3.9 0.9 9.9 3.4 10.0 1.5 1.0 11.3 5.3 4.6 0.0 1.6 1.2 13.4 13.6 8.7 4.6 0.4 0.8 11.6 0.0 3.3 0.4 0.1 1.7 11.9 0.0 0.0 0.1 0.1 0.0 0.3 0.5 0.0 0.3 41.8 6.7 0.0 0.9 0.0 1.9 0.0 72.5 0.7 0.0 0.0 0.0 0.3 1.9 22.5 0.2 0.0 0.6 73.7 4.3 157.7 0.0 0.1 0.0 1.6 45.5 0.0 0.0 0.0 4.8 0.0 0.0 0.0 4.1 0.3 0.0 0.0 2.4 0.1 0.0 1.3 0.0 0.1 0.0 1.7 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 8.2 0.0 11.6 0.0 0.0 0.0 0.3 0.4 0.0 0.8 0.4 0.2 0.0 0.1 3.3 0.0 0.1 0.0 0.1 0.4 2.1 0.3 0.4 0.5 0.4 0.4 0.0 1.3 0.0 ARG2 ENSG00000081181 "Arginase 2" P78540 14 67619798-67651720 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 53.7;thyroid gland: 75.4" "Cell line enhanced" "Detected in many" "HAP1: 25.0" "Cancer enhanced" "Detected in all" "prostate cancer: 49.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000663, CAB009435" Enhanced Supported Mitochondria Mitochondria "CAB009435: AB_2059089, HPA000663: AB_1078192" "unprognostic (8.74e-3)" "unprognostic (3.06e-2)" "unprognostic (1.35e-2)" "unprognostic (2.29e-1)" "unprognostic (2.30e-1)" "unprognostic (9.13e-2)" "unprognostic (1.10e-2)" "unprognostic (3.43e-3)" "unprognostic (4.62e-3)" "unprognostic (5.37e-2)" "unprognostic (4.66e-3)" "unprognostic (1.72e-1)" "unprognostic (9.39e-2)" "unprognostic (4.26e-1)" "unprognostic (2.31e-1)" "unprognostic (4.34e-1)" "unprognostic (1.26e-1)" 1.5 3.9 2.4 1.7 6.4 0.6 2.7 8.3 5.3 9.3 5.4 0.5 2.0 2.1 3.7 2.3 7.3 0.8 4.9 2.1 3.3 5.5 41.4 2.0 1.7 0.6 3.2 1.7 8.8 2.6 32.1 22.5 4.4 4.6 53.7 1.1 3.4 26.6 3.8 17.2 0.8 10.4 2.2 3.9 0.7 1.4 1.9 2.1 0.1 75.4 13.6 2.2 5.3 4.1 2.5 1.7 2.0 1.4 0.3 2.9 3.4 3.5 0.5 6.2 4.0 0.9 0.0 8.4 2.8 7.5 9.1 15.4 15.3 1.8 6.0 0.7 1.8 0.8 25.0 11.3 11.0 0.2 6.2 2.7 1.1 17.5 2.7 0.6 16.4 0.4 14.8 4.4 21.6 15.3 7.9 0.0 0.6 1.7 0.9 0.6 11.8 0.2 0.2 0.8 6.9 7.4 6.0 13.8 5.2 1.7 1.7 2.6 6.4 0.2 3.1 2.7 6.9 0.2 2.0 0.5 0.9 2.0 5.5 3.1 4.6 0.3 1.4 2.0 1.1 0.5 0.5 0.7 0.3 0.9 1.7 2.5 0.6 0.6 1.7 0.3 1.2 0.1 2.9 3.4 2.4 6.4 8.3 5.3 3.3 5.5 3.2 1.7 4.6 2.1 ARHGAP20 KIAA1391 ENSG00000137727 "Rho GTPase activating protein 20" Q9P2F6 11 110577042-110713189 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 22.4;ASC TERT1: 7.5;HHSteC: 5.0;SiHa: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.2" "Lineage enriched" "Detected in single" 5 "B-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038458, HPA038459, HPA076303" Uncertain Approved Mitochondria Mitochondria "HPA038458: AB_10672517, HPA038459: , HPA076303: " "unprognostic (1.69e-2)" "unprognostic (3.97e-2)" "unprognostic (6.83e-2)" "unprognostic (1.34e-1)" "unprognostic (2.66e-1)" "unprognostic (8.47e-3)" "unprognostic (2.75e-1)" "unprognostic (2.90e-2)" "unprognostic (4.15e-2)" "unprognostic (5.70e-2)" "unprognostic (1.38e-1)" "unprognostic (9.52e-2)" "unprognostic (2.82e-5)" "unprognostic (1.84e-2)" "unprognostic (9.15e-2)" "unprognostic (6.21e-3)" "unprognostic (4.10e-2)" 14.4 4.6 5.9 2.6 13.0 0.6 8.4 7.7 12.0 9.1 3.7 1.9 9.2 2.0 8.3 7.0 4.4 6.2 4.4 1.3 4.8 6.2 1.2 3.4 7.6 2.3 3.4 6.3 4.3 0.8 1.6 2.0 3.4 5.8 7.7 5.5 9.7 2.7 16.8 2.0 2.2 2.9 12.1 3.0 2.7 3.9 14.1 2.2 0.0 8.9 2.1 1.9 6.3 4.9 1.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 7.5 0.0 0.9 2.9 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.3 0.0 5.0 0.0 0.0 2.7 0.0 0.0 0.0 2.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.9 0.3 6.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.9 0.0 0.1 0.0 1.8 0.8 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 13.0 7.7 12.0 4.8 6.2 3.4 6.3 5.8 2.2 ARMC1 "Arcp, FLJ10511" ENSG00000104442 "Armadillo repeat containing 1" Q9NVT9 8 65602456-65634217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026085 Approved Supported Mitochondria Mitochondria "HPA026085: AB_1845031" "prognostic unfavourable (4.81e-4)" "unprognostic (1.35e-1)" "unprognostic (1.87e-1)" "prognostic unfavourable (2.87e-4)" "unprognostic (8.18e-2)" "unprognostic (1.45e-2)" "prognostic unfavourable (7.73e-4)" "unprognostic (4.13e-2)" "unprognostic (7.49e-2)" "unprognostic (2.19e-2)" "prognostic unfavourable (9.15e-4)" "unprognostic (1.81e-1)" "unprognostic (3.30e-3)" "unprognostic (1.08e-1)" "unprognostic (1.07e-1)" "unprognostic (1.98e-1)" "unprognostic (1.66e-1)" 16.2 16.5 25.5 13.1 25.6 11.5 19.2 30.4 32.3 17.1 19.0 22.6 10.2 15.8 19.7 17.8 17.7 14.1 12.3 21.6 26.9 24.0 22.9 23.5 12.6 18.1 24.5 18.7 20.4 15.2 18.4 18.9 16.7 27.1 19.2 17.6 13.1 15.1 18.8 22.2 11.6 15.3 22.5 27.5 15.0 14.5 10.0 18.9 20.7 15.4 10.4 20.0 20.4 14.0 8.8 6.1 20.7 7.9 9.6 10.5 5.8 22.6 16.2 15.8 14.7 15.7 14.4 11.5 20.4 15.2 21.7 16.1 11.9 18.4 35.3 5.2 18.4 15.2 28.3 16.4 29.5 20.0 14.7 27.3 10.3 17.3 21.0 10.3 14.9 13.1 19.0 17.8 24.6 22.2 28.2 25.2 23.2 14.5 37.9 13.6 16.4 18.0 22.1 19.7 12.4 17.2 10.7 11.8 12.8 12.9 16.3 19.2 26.2 12.1 13.1 20.6 15.1 15.6 19.0 18.7 19.7 23.9 19.4 19.2 19.9 20.7 4.8 6.1 7.6 7.9 10.5 8.8 9.1 9.1 6.1 6.8 9.4 9.3 0.6 9.6 7.2 5.3 9.5 5.8 25.5 25.6 30.4 32.3 26.9 24.0 24.5 18.7 27.1 18.9 ARMC10 "MGC3195, SVH" ENSG00000170632 "Armadillo repeat containing 10" Q8N2F6 7 103074881-103099764 "Predicted intracellular proteins, Predicted membrane proteins" "Growth regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011036, HPA011057" Enhanced Enhanced Mitochondria Mitochondria "HPA011036: AB_1080139, HPA011057: AB_1080137" "unprognostic (7.03e-3)" "unprognostic (2.44e-1)" "unprognostic (8.18e-2)" "unprognostic (3.53e-1)" "prognostic unfavourable (8.90e-6)" "unprognostic (3.85e-3)" "prognostic unfavourable (3.58e-4)" "unprognostic (5.57e-2)" "unprognostic (3.49e-2)" "unprognostic (7.90e-2)" "prognostic unfavourable (2.49e-6)" "unprognostic (1.02e-1)" "unprognostic (5.78e-2)" "unprognostic (1.47e-1)" "unprognostic (2.76e-1)" "unprognostic (1.14e-2)" "unprognostic (5.67e-2)" 21.6 21.7 28.0 12.6 25.0 9.1 24.5 11.4 28.0 24.4 18.6 24.7 20.8 14.0 20.4 24.2 22.2 23.2 20.0 16.7 26.2 26.2 27.4 30.2 15.0 15.7 26.3 24.2 26.5 28.7 26.0 12.0 15.4 19.7 22.2 18.8 17.6 15.7 23.4 15.8 21.6 12.8 20.3 25.5 14.4 19.8 14.1 19.6 21.5 30.7 15.6 15.7 22.3 20.5 5.1 6.8 6.6 5.4 3.9 4.7 2.2 12.5 10.7 6.4 12.3 13.3 12.7 6.4 8.8 9.6 6.4 7.8 5.8 14.9 22.6 19.1 7.7 11.3 8.9 9.8 9.1 8.4 10.2 8.0 4.6 2.7 13.4 21.8 9.6 8.2 17.4 8.0 13.2 14.5 19.4 14.0 11.3 23.2 16.0 16.9 14.2 11.6 9.7 6.6 29.3 16.1 8.8 7.2 9.8 12.0 18.2 13.3 7.3 10.9 9.6 9.9 9.5 23.2 13.2 21.5 33.7 18.2 11.2 20.4 12.4 0.0 4.4 6.6 2.6 5.4 4.5 4.0 4.1 4.4 6.8 5.1 4.6 4.7 0.9 3.9 2.8 5.3 4.2 2.2 28.0 25.0 11.4 28.0 26.2 26.2 26.3 24.2 19.7 19.6 AS3MT CYT19 ENSG00000214435 "Arsenite methyltransferase" Q9HBK9 10 102869516-102901899 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 92.8;parathyroid gland: 30.0" "Cell line enhanced" "Detected in many" "AF22: 14.2;REH: 27.1;SH-SY5Y: 14.6;T-47d: 22.7" "Cancer enhanced" "Detected in single" "liver cancer: 1.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "NK-cell: 1.4" "Lineage enriched" "Detected in single" 6 "NK-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017856 Enhanced Approved Mitochondria Mitochondria "HPA017856: AB_1847420" "unprognostic (1.11e-1)" "unprognostic (2.02e-4)" "unprognostic (2.45e-1)" "unprognostic (2.25e-1)" "unprognostic (3.39e-1)" "unprognostic (1.66e-1)" "unprognostic (7.02e-4)" "unprognostic (3.22e-1)" "unprognostic (1.42e-1)" "unprognostic (3.90e-2)" "unprognostic (2.03e-1)" "unprognostic (1.83e-1)" "unprognostic (3.83e-10)" "unprognostic (1.04e-2)" "unprognostic (4.17e-2)" "unprognostic (1.59e-1)" "unprognostic (2.16e-2)" 2.0 92.8 3.7 0.7 8.6 0.5 2.6 4.5 6.4 4.0 2.0 2.2 0.4 1.3 3.8 3.2 2.1 2.1 5.2 10.0 5.7 3.1 7.4 22.4 1.7 0.9 2.8 4.4 3.9 8.7 30.0 2.4 0.5 4.6 4.2 0.8 8.9 2.2 3.4 6.0 1.8 1.3 3.9 2.7 5.6 1.7 3.5 1.6 0.3 3.2 1.0 0.7 1.8 1.8 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 3.9 14.2 8.9 0.3 0.3 2.6 4.1 3.5 6.2 7.6 10.6 0.6 0.2 1.2 5.3 0.2 12.1 0.7 6.4 0.0 3.5 0.0 1.7 10.4 4.1 0.2 0.1 1.9 1.6 0.8 0.0 0.2 0.0 0.2 5.5 0.1 2.4 0.3 6.8 0.6 27.1 0.0 0.1 1.3 0.1 0.4 14.6 0.0 0.2 1.9 22.7 0.3 0.1 1.3 0.0 2.0 0.0 0.3 0.2 0.0 4.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 3.7 8.6 4.5 6.4 5.7 3.1 2.8 4.4 4.6 1.6 ATAD3A FLJ10709 ENSG00000197785 "ATPase family, AAA domain containing 3A" Q9NVI7 1 1512151-1534687 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA058968, HPA064867, HPA065305" Approved Supported Mitochondria Mitochondria "HPA058968: , HPA064867: , HPA065305: " "unprognostic (8.42e-2)" "unprognostic (1.67e-1)" "unprognostic (3.11e-1)" "unprognostic (1.46e-1)" "unprognostic (2.50e-1)" "unprognostic (8.74e-2)" "prognostic unfavourable (5.90e-5)" "unprognostic (6.62e-2)" "unprognostic (9.53e-2)" "unprognostic (5.81e-2)" "unprognostic (4.09e-2)" "unprognostic (7.66e-2)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" "unprognostic (3.09e-1)" "unprognostic (6.25e-2)" "unprognostic (1.87e-3)" 10.8 13.9 11.2 16.3 11.3 25.0 9.3 9.3 14.8 9.2 11.0 11.1 12.5 16.4 10.4 7.6 16.8 9.3 11.9 15.9 9.2 8.2 12.9 26.7 9.7 13.9 10.5 13.3 8.5 20.4 8.1 16.6 11.3 8.3 10.7 6.2 9.6 19.5 9.5 31.1 13.3 12.2 8.9 8.5 12.4 13.0 12.7 9.1 14.0 12.4 21.1 14.3 9.3 9.4 3.3 4.7 1.3 6.2 5.1 4.0 2.1 21.0 11.9 5.2 13.4 2.6 3.2 12.5 17.4 5.2 15.4 9.3 30.4 14.5 11.6 12.0 6.8 18.0 7.4 10.3 2.6 11.2 31.8 20.3 29.2 20.3 5.0 29.1 13.0 3.6 3.3 12.4 5.2 6.6 31.7 9.0 5.5 14.8 21.9 26.7 10.7 25.5 23.8 9.9 24.1 4.2 8.8 26.6 10.5 10.8 16.4 13.7 7.2 14.4 9.0 15.7 12.3 24.0 21.2 13.4 13.2 46.8 15.4 43.8 7.0 0.2 4.0 1.3 3.3 2.9 2.5 3.3 3.8 4.0 4.7 3.0 3.4 1.5 0.1 5.1 6.2 4.4 2.8 2.1 11.2 11.3 9.3 14.8 9.2 8.2 10.5 13.3 8.3 9.1 ATAD3B "KIAA1273, TOB3" ENSG00000160072 "ATPase family, AAA domain containing 3B" Q5T9A4 1 1471769-1497848 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 3.7" "Low lineage specificity" "Detected in many" "HPA058968, HPA064867, HPA065305" Approved Supported Mitochondria Mitochondria "HPA058968: , HPA064867: , HPA065305: " "unprognostic (6.05e-2)" "unprognostic (1.95e-1)" "unprognostic (6.54e-2)" "unprognostic (1.30e-1)" "unprognostic (1.97e-2)" "unprognostic (3.68e-1)" "prognostic unfavourable (1.81e-5)" "unprognostic (1.51e-1)" "unprognostic (2.27e-2)" "unprognostic (2.17e-2)" "unprognostic (8.24e-3)" "unprognostic (3.13e-2)" "prognostic unfavourable (5.48e-9)" "unprognostic (2.38e-2)" "unprognostic (2.80e-1)" "unprognostic (3.00e-2)" "unprognostic (1.68e-1)" 13.7 7.6 7.5 18.9 9.5 24.3 10.4 11.6 10.8 7.4 9.6 8.7 8.2 12.1 10.0 7.0 11.3 8.1 8.4 6.4 7.5 6.5 9.9 14.5 9.8 17.3 9.5 8.1 10.1 16.5 3.2 13.6 10.3 7.6 11.0 3.8 8.8 16.3 16.5 9.9 15.8 12.3 8.8 6.8 14.5 15.4 9.3 8.2 7.9 9.3 6.6 13.1 5.9 10.0 0.3 0.8 1.4 3.7 0.2 2.0 0.5 6.8 0.0 2.1 11.5 0.6 0.9 15.7 11.1 2.6 10.9 8.3 25.5 20.3 9.7 3.5 4.3 12.7 14.0 7.0 2.3 8.3 13.2 6.7 16.7 15.5 2.6 11.2 8.0 2.5 0.4 17.9 1.1 3.7 20.0 2.1 3.9 3.5 13.3 13.1 22.4 25.5 10.7 3.3 7.1 3.1 4.5 8.9 7.1 8.2 10.6 9.4 1.6 4.0 4.7 2.9 6.4 17.2 11.7 6.4 8.8 23.6 9.4 18.7 3.3 0.0 0.7 1.4 1.6 3.7 2.0 0.3 1.0 1.4 0.8 0.0 0.3 0.1 0.0 0.2 1.9 0.5 0.0 0.5 7.5 9.5 11.6 10.8 7.5 6.5 9.5 8.1 7.6 8.2 ATAD3C FLJ34599 ENSG00000215915 "ATPase family, AAA domain containing 3C" Q5T2N8 1 1449689-1470158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "RPMI-8226: 16.1" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA065305 Approved Mitochondria Mitochondria "HPA065305: " "unprognostic (9.23e-2)" "unprognostic (3.48e-2)" "unprognostic (3.20e-2)" "unprognostic (4.35e-3)" "unprognostic (1.11e-2)" "unprognostic (1.71e-2)" "unprognostic (3.79e-2)" "prognostic favourable (5.15e-4)" "unprognostic (1.23e-1)" "unprognostic (1.57e-1)" "unprognostic (1.22e-1)" "unprognostic (2.65e-1)" "unprognostic (3.80e-2)" "unprognostic (1.83e-1)" "unprognostic (5.74e-2)" "unprognostic (2.22e-1)" "unprognostic (2.12e-3)" 0.7 0.0 2.1 1.7 2.3 0.7 2.7 0.3 1.5 1.3 1.8 0.9 1.4 2.6 0.7 2.5 1.3 0.4 2.8 1.5 3.1 4.9 2.2 0.7 2.6 1.1 5.0 0.1 1.5 0.3 4.0 0.6 5.4 4.5 0.2 1.2 0.5 1.3 4.3 0.5 0.5 0.7 4.1 0.9 2.2 0.9 2.1 0.6 2.9 0.6 1.6 4.3 0.7 0.3 0.0 0.3 0.5 0.5 0.1 0.3 0.1 0.1 0.2 0.1 1.6 3.2 0.3 0.4 0.1 0.4 1.3 0.5 0.1 0.1 1.3 0.2 0.9 2.0 0.2 0.3 0.3 0.0 0.2 0.2 1.0 0.0 0.3 3.8 0.1 0.9 0.5 1.0 0.5 0.2 0.4 0.1 16.1 1.1 0.3 2.7 1.0 0.0 0.6 0.2 3.5 0.3 0.3 0.2 0.3 0.5 0.2 1.9 2.6 0.6 0.2 0.4 0.1 2.9 0.6 1.1 1.1 0.4 4.3 2.1 1.5 1.3 0.1 1.3 1.9 1.4 2.5 1.6 0.3 0.6 2.0 0.7 ATP5F1A "ATP5A, ATP5A1, ATP5AL2, ATPM, hATP1, OMR, ORM" ENSG00000152234 "ATP synthase F1 subunit alpha" P25705 18 46080248-46104334 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013067, HPA040622, HPA044202" Enhanced Supported Mitochondria 51000000 Mitochondria "CAB013067: AB_221511, HPA040622: AB_2677048, HPA044202: AB_2678855" "unprognostic (3.08e-2)" "unprognostic (9.13e-2)" "unprognostic (1.84e-2)" "unprognostic (3.54e-1)" "unprognostic (6.36e-2)" "unprognostic (2.61e-1)" "unprognostic (1.89e-2)" "unprognostic (6.79e-2)" "unprognostic (8.31e-2)" "unprognostic (4.79e-2)" "unprognostic (7.30e-3)" "unprognostic (1.50e-2)" "prognostic favourable (1.22e-15)" "unprognostic (4.60e-3)" "unprognostic (2.06e-1)" "unprognostic (1.77e-1)" "unprognostic (4.87e-3)" 30.1 60.0 34.7 30.3 45.8 22.4 33.9 52.6 65.0 27.0 52.1 20.5 39.3 55.6 25.2 30.5 44.4 30.0 27.9 196.2 31.4 36.1 94.0 64.8 25.2 40.2 42.3 31.8 28.6 49.0 73.2 35.9 25.7 41.5 28.3 54.9 37.6 42.6 42.8 182.2 34.0 50.4 36.6 22.6 32.1 46.7 24.0 19.9 45.6 35.1 99.7 41.1 31.5 26.4 58.7 110.9 17.9 64.5 44.2 63.6 124.8 42.5 43.4 57.8 54.2 70.4 78.2 64.1 49.3 69.9 76.0 66.7 64.9 33.7 100.9 30.3 59.7 79.4 99.5 75.7 71.0 44.9 55.9 66.7 56.0 80.4 46.1 141.1 63.4 72.1 53.2 54.8 57.1 78.3 53.8 59.7 64.9 44.3 72.5 69.4 54.1 45.8 71.8 67.2 136.5 103.0 104.2 58.8 54.9 36.1 45.2 60.5 58.2 82.4 45.5 41.9 36.2 21.9 42.9 68.6 58.7 65.0 41.7 84.9 44.5 11.8 64.5 17.9 43.5 58.2 55.8 58.7 52.4 47.5 110.9 44.0 63.6 52.8 6.7 44.2 52.2 54.0 58.9 124.8 34.7 45.8 52.6 65.0 31.4 36.1 42.3 31.8 41.5 19.9 ATP5F1B "ATP5B, ATPSB" ENSG00000110955 "ATP synthase F1 subunit beta" P06576 12 56638175-56646068 "Enzymes, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001520, HPA001528, CAB017527" Enhanced Enhanced Mitochondria 100000000 Mitochondria "CAB017527: AB_1121153, HPA001520: AB_1078243, HPA001528: AB_1078242" "prognostic unfavourable (7.17e-6)" "unprognostic (5.69e-2)" "unprognostic (1.08e-2)" "unprognostic (7.24e-2)" "unprognostic (8.39e-2)" "unprognostic (1.84e-2)" "unprognostic (2.12e-3)" "unprognostic (1.92e-2)" "unprognostic (8.19e-3)" "unprognostic (2.38e-2)" "unprognostic (1.44e-2)" "unprognostic (2.11e-2)" "prognostic favourable (1.43e-9)" "unprognostic (2.79e-1)" "unprognostic (3.22e-1)" "unprognostic (1.33e-1)" "unprognostic (3.30e-2)" 41.3 66.2 32.4 34.1 53.4 39.3 33.1 55.4 92.6 26.1 73.0 34.4 36.1 68.1 27.9 28.5 58.6 28.5 36.9 225.0 33.2 34.9 95.2 85.7 28.3 39.2 40.5 35.5 25.1 42.7 85.2 30.1 31.3 69.6 29.0 78.5 42.8 64.7 38.1 236.2 42.3 74.6 35.5 24.9 33.5 51.0 31.4 18.3 47.5 38.4 123.6 45.8 36.6 32.8 41.2 91.7 40.2 90.1 36.3 46.6 105.6 65.7 80.0 63.6 98.1 57.4 61.4 112.4 66.9 62.5 115.7 65.9 129.9 73.4 117.0 72.5 82.4 88.2 134.0 81.1 104.8 54.8 92.8 128.3 74.7 79.6 71.1 143.5 90.9 75.2 81.9 90.4 116.8 95.0 115.5 134.9 97.0 61.0 106.3 84.4 107.0 154.1 102.4 71.2 149.1 126.0 117.2 72.8 64.7 102.2 146.4 113.7 137.4 108.5 64.4 45.6 50.8 66.5 72.2 65.1 80.9 121.0 68.6 96.0 69.8 40.2 64.6 34.6 40.2 80.6 44.9 41.2 38.0 42.7 91.7 31.7 31.1 36.7 17.8 36.3 90.1 46.3 46.6 105.6 32.4 53.4 55.4 92.6 33.2 34.9 40.5 35.5 69.6 18.3 ATP5IF1 "ATPI, ATPIF1, ATPIP, IP, MGC1167, MGC8898" ENSG00000130770 "ATP synthase inhibitory factor subunit 1" Q9UII2 1 28236109-28246906 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027999 Supported Enhanced Mitochondria 1800000 Mitochondria "HPA027999: AB_10600984" "unprognostic (2.80e-2)" "unprognostic (3.72e-2)" "unprognostic (2.95e-1)" "prognostic favourable (6.38e-8)" "unprognostic (2.04e-1)" "unprognostic (1.76e-1)" "unprognostic (6.57e-2)" "unprognostic (2.93e-2)" "unprognostic (1.40e-2)" "prognostic favourable (8.20e-4)" "unprognostic (5.94e-2)" "unprognostic (3.52e-1)" "unprognostic (6.15e-3)" "unprognostic (4.68e-2)" "unprognostic (2.02e-1)" "unprognostic (2.79e-1)" "unprognostic (1.48e-3)" 17.1 35.1 65.9 32.1 64.0 58.5 20.9 41.8 71.7 24.6 54.5 15.7 33.8 78.2 18.6 24.1 26.4 31.9 38.4 135.2 51.8 60.7 60.2 55.4 20.1 28.7 46.8 58.7 20.5 33.8 20.7 37.6 19.4 53.0 30.4 30.5 24.8 34.5 34.4 135.2 26.3 58.7 15.4 31.0 25.9 45.0 72.4 26.2 24.3 25.0 44.6 23.5 17.9 18.6 56.5 64.2 35.7 35.2 39.1 64.8 55.2 45.1 23.4 13.8 13.0 10.4 11.4 16.4 20.3 10.0 17.4 17.1 22.5 33.1 31.9 30.5 12.3 27.5 15.7 20.2 13.8 23.8 53.0 27.3 101.5 30.3 11.3 20.8 27.7 13.1 33.5 15.5 12.5 16.6 48.2 29.2 12.4 30.0 30.9 38.5 45.8 29.0 29.6 15.3 45.1 33.8 30.0 27.9 20.0 25.1 26.2 25.8 38.9 23.1 17.1 5.6 15.5 22.0 23.9 75.6 45.5 44.1 26.7 57.1 6.5 30.3 35.2 35.7 46.5 31.7 46.2 56.5 49.6 49.1 42.3 43.7 46.7 45.0 30.9 39.1 28.3 64.2 64.8 55.2 65.9 64.0 41.8 71.7 51.8 60.7 46.8 58.7 53.0 26.2 ATP5MD "bA792D24.4, DAPIT, MGC14697, USMG5" ENSG00000173915 "ATP synthase membrane subunit DAPIT" Q96IX5 10 103389041-103396466 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044798 Supported Mitochondria Mitochondria "HPA044798: " "unprognostic (4.41e-2)" "unprognostic (3.08e-2)" "unprognostic (2.59e-1)" "unprognostic (7.93e-2)" "unprognostic (1.65e-1)" "unprognostic (1.95e-2)" "unprognostic (1.63e-1)" "unprognostic (1.51e-1)" "unprognostic (5.67e-2)" "unprognostic (1.57e-2)" "unprognostic (7.41e-2)" "unprognostic (1.01e-1)" "unprognostic (3.32e-2)" "unprognostic (1.74e-1)" "unprognostic (4.66e-2)" "unprognostic (7.46e-2)" "unprognostic (1.03e-2)" 48.0 46.2 91.7 26.2 67.0 26.6 56.1 33.5 71.7 38.4 77.9 21.2 29.2 43.8 22.1 72.3 56.3 28.8 31.0 131.5 67.8 57.4 79.3 92.5 24.6 27.7 65.2 44.4 19.7 58.1 21.1 38.2 25.9 46.0 30.0 75.8 23.4 52.7 43.3 146.9 22.4 57.3 39.1 41.4 26.1 40.9 20.2 30.7 22.9 31.3 125.5 39.8 41.2 28.9 71.3 109.1 101.2 85.2 50.7 76.6 66.4 60.2 64.1 60.6 72.3 67.8 85.2 39.7 58.0 73.2 59.3 66.4 103.1 67.3 34.7 33.7 65.6 61.8 56.7 59.1 81.9 45.5 101.9 36.0 82.5 115.2 65.9 73.4 55.9 68.7 92.8 53.3 84.3 76.4 47.1 57.9 99.1 93.5 59.5 126.4 45.0 108.5 38.7 37.0 54.0 141.0 98.3 23.0 53.2 30.6 47.0 83.4 41.8 68.2 43.2 29.4 45.1 44.5 75.9 61.1 99.8 57.8 62.1 75.3 22.2 101.2 65.9 88.7 55.9 85.2 63.3 71.3 76.6 65.7 73.3 51.5 65.9 65.6 55.8 50.7 80.6 109.1 71.7 66.4 91.7 67.0 33.5 71.7 67.8 57.4 65.2 44.4 46.0 30.7 ATP5ME ATP5I ENSG00000169020 "ATP synthase membrane subunit e" P56385 4 672436-674338 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 221.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035010 Enhanced Supported Mitochondria 220000 Mitochondria "HPA035010: AB_10669853" "unprognostic (1.42e-1)" "unprognostic (4.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (3.44e-1)" "unprognostic (1.23e-1)" "unprognostic (6.95e-2)" "unprognostic (7.92e-2)" "unprognostic (3.32e-1)" "unprognostic (1.35e-3)" "unprognostic (1.21e-2)" "unprognostic (2.41e-2)" "unprognostic (2.46e-3)" "unprognostic (6.89e-2)" "unprognostic (2.18e-1)" "unprognostic (2.48e-1)" "unprognostic (6.45e-3)" 41.2 48.1 69.3 30.8 69.0 34.4 34.2 27.7 67.6 29.3 66.6 28.2 44.4 60.0 20.5 34.1 40.1 23.1 31.6 95.8 62.0 49.2 47.5 68.9 25.8 25.2 68.6 48.7 26.2 57.9 24.5 26.6 19.6 62.2 23.9 43.9 17.8 40.7 37.2 221.8 22.3 55.6 45.8 67.2 23.3 40.7 14.1 47.7 10.9 22.1 98.7 28.1 18.9 31.1 166.1 148.1 142.2 135.7 107.4 127.6 158.4 49.1 46.5 67.0 54.6 56.5 52.5 37.4 47.9 38.4 36.4 32.3 44.7 48.7 25.5 46.1 50.6 31.5 54.0 75.5 20.0 22.5 99.7 75.0 86.2 111.5 58.7 95.4 33.0 65.1 44.4 41.7 42.2 44.5 62.0 27.9 41.3 70.8 82.2 125.0 78.8 121.8 50.1 49.0 55.5 69.5 85.8 65.1 51.1 34.8 46.9 53.2 53.6 65.8 51.5 32.7 31.1 28.8 66.8 65.3 107.7 80.6 48.1 65.8 35.8 103.7 135.7 142.2 98.5 112.1 101.0 166.1 121.1 109.2 135.4 123.2 110.3 110.3 122.3 107.4 97.7 148.1 127.6 158.4 69.3 69.0 27.7 67.6 62.0 49.2 68.6 48.7 62.2 47.7 ATP5MF "ATP5J2, ATP5JL" ENSG00000241468 "ATP synthase membrane subunit f" P56134 7 99448475-99466331 "Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067267, HPA070412" Approved Supported Mitochondria 1400000 Mitochondria "HPA067267: , HPA070412: " "unprognostic (2.43e-2)" "unprognostic (1.42e-1)" "unprognostic (1.23e-2)" "unprognostic (1.90e-1)" "unprognostic (4.55e-3)" "prognostic unfavourable (2.58e-4)" "unprognostic (1.28e-2)" "unprognostic (3.77e-2)" "unprognostic (6.19e-2)" "unprognostic (2.31e-3)" "unprognostic (2.58e-1)" "unprognostic (3.65e-2)" "unprognostic (6.88e-3)" "unprognostic (9.24e-2)" "unprognostic (4.90e-2)" "unprognostic (2.52e-1)" "unprognostic (5.78e-2)" 42.4 49.0 68.0 36.6 52.0 46.4 42.8 37.3 58.8 30.7 62.7 19.0 39.9 62.9 21.2 41.2 57.4 24.8 36.6 94.5 53.9 49.8 59.6 93.5 30.0 35.5 54.6 43.6 20.7 63.6 16.3 36.7 33.4 36.3 35.0 47.3 30.9 57.1 45.2 178.8 27.8 61.5 24.6 33.0 35.6 43.4 58.3 25.5 52.9 37.9 98.0 37.6 27.8 30.2 68.3 129.7 117.2 104.1 58.3 84.0 140.0 87.2 77.0 65.0 104.9 51.2 52.0 41.1 58.0 45.1 62.3 67.5 81.8 80.6 81.8 61.1 35.9 53.8 71.8 66.3 66.6 58.9 92.2 55.4 123.2 105.4 38.7 94.4 63.5 59.3 64.1 54.1 57.4 59.2 112.3 90.3 65.2 205.0 141.2 163.9 92.4 90.8 63.3 54.2 139.9 131.2 97.0 62.5 68.9 75.9 187.7 54.8 47.3 122.6 50.2 54.9 87.7 90.6 84.5 51.7 118.8 170.7 63.4 92.4 84.1 90.0 104.0 117.2 54.2 104.1 51.7 68.3 63.5 61.0 129.7 56.9 55.8 59.5 49.7 58.3 79.2 102.7 84.0 140.0 68.0 52.0 37.3 58.8 53.9 49.8 54.6 43.6 36.3 25.5 ATP5MF-PTCD1 ATP5J2-PTCD1 ENSG00000248919 "ATP5MF-PTCD1 readthrough" 7 99419749-99466197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA020106, HPA047679" Uncertain Approved Mitochondria Mitochondria "HPA020106: AB_2176551, HPA047679: " "unprognostic (1.15e-3)" "unprognostic (3.63e-2)" "unprognostic (1.73e-1)" "unprognostic (2.83e-1)" "unprognostic (3.29e-2)" "unprognostic (3.51e-1)" "unprognostic (1.18e-3)" "unprognostic (2.84e-2)" "unprognostic (6.44e-2)" "unprognostic (2.18e-1)" "unprognostic (3.50e-2)" "unprognostic (1.28e-1)" "unprognostic (1.70e-1)" "unprognostic (2.04e-1)" "unprognostic (7.45e-2)" "unprognostic (2.00e-2)" "unprognostic (7.50e-2)" 9.3 10.3 7.5 8.6 9.2 1.2 8.1 8.2 13.0 9.6 12.4 3.6 9.2 8.7 10.4 8.1 14.8 11.0 8.3 18.6 8.3 6.7 14.5 23.6 7.0 7.8 6.2 10.2 9.0 15.6 11.5 7.1 8.3 8.3 12.3 7.2 6.8 13.9 12.1 35.7 8.7 15.0 8.4 6.7 8.3 8.9 14.2 5.4 12.7 8.7 24.8 8.6 14.1 10.4 4.2 8.7 1.8 8.3 6.2 6.1 6.8 5.5 6.0 5.0 14.2 6.2 3.7 10.7 3.8 4.6 9.5 8.7 23.0 9.1 7.2 9.4 3.5 5.4 8.5 7.8 4.0 8.0 8.1 4.2 4.0 4.8 6.6 5.7 4.4 6.2 7.0 8.6 7.0 3.9 13.7 11.0 6.1 11.5 12.9 7.4 8.8 7.8 7.0 4.7 19.0 5.1 1.8 6.6 6.6 8.1 13.8 8.2 6.8 9.0 2.4 6.7 6.0 14.0 9.9 8.8 7.5 11.3 4.9 6.4 11.9 1.8 6.3 1.7 5.5 8.3 5.8 3.6 4.6 4.6 8.7 4.2 4.9 6.1 0.5 6.2 4.8 4.3 3.5 6.8 7.5 9.2 8.2 13.0 8.3 6.7 6.2 10.2 8.3 5.4 ATP5MG "ATP5JG, ATP5L" ENSG00000167283 "ATP synthase membrane subunit g" O75964 11 118401154-118431496 "Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA044629 Approved Supported Mitochondria 590000 Mitochondria "HPA044629: " "unprognostic (1.70e-1)" "unprognostic (2.40e-2)" "unprognostic (2.21e-1)" "unprognostic (5.45e-2)" "unprognostic (1.61e-1)" "unprognostic (3.27e-2)" "unprognostic (3.90e-2)" "unprognostic (8.19e-2)" "unprognostic (5.13e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-1)" "unprognostic (7.41e-2)" "prognostic favourable (4.09e-5)" "unprognostic (6.26e-2)" "unprognostic (2.56e-1)" "unprognostic (1.50e-2)" "unprognostic (3.05e-2)" 32.3 42.4 45.3 31.8 46.7 36.0 39.6 38.1 40.4 25.6 39.0 21.1 30.3 33.8 33.9 40.4 27.9 26.5 30.1 85.8 37.5 38.4 55.6 42.6 29.1 41.9 39.2 23.6 31.3 70.1 25.8 31.1 23.6 28.3 26.3 41.5 39.0 71.9 29.5 68.4 20.9 39.5 47.3 27.8 30.7 29.5 17.9 15.7 53.2 33.7 60.2 43.7 30.0 23.6 42.7 54.6 30.8 48.0 32.5 53.5 98.1 21.5 11.2 29.5 28.5 25.5 28.6 23.6 22.1 25.2 20.3 21.6 28.2 35.0 42.8 46.2 24.0 27.6 29.6 30.9 22.6 34.1 19.5 67.6 10.5 17.0 26.2 38.4 32.4 30.4 29.3 25.0 23.9 27.3 30.9 35.9 28.3 38.7 53.6 48.0 18.7 31.2 36.9 24.7 47.0 52.8 18.6 23.4 17.7 33.3 54.1 16.3 39.3 35.9 26.8 16.8 18.8 14.3 25.2 16.4 22.4 43.5 12.5 44.8 20.9 28.8 48.0 30.8 27.1 33.3 39.3 42.7 42.9 35.5 49.9 34.6 53.5 40.2 24.0 32.5 31.5 54.6 45.8 98.1 45.3 46.7 38.1 40.4 37.5 38.4 39.2 23.6 28.3 15.7 ATP5MGL "ATP5K2, ATP5L2, dJ222E13.5" ENSG00000249222 "ATP synthase membrane subunit g like" Q7Z4Y8 22 42639803-42640601 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.9;bone marrow: 4.5" "Cell line enhanced" "Detected in some" "RT4: 2.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA044629 Uncertain Supported Mitochondria Mitochondria "HPA044629: " "unprognostic (4.53e-2)" "unprognostic (3.46e-2)" "unprognostic (1.20e-2)" "unprognostic (5.67e-2)" "unprognostic (3.01e-2)" "unprognostic (3.36e-2)" "unprognostic (1.31e-2)" "unprognostic (1.70e-2)" "unprognostic (6.74e-2)" "unprognostic (4.40e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-1)" "unprognostic (4.17e-1)" "unprognostic (5.12e-2)" "unprognostic (1.85e-3)" 0.4 0.7 0.4 0.0 0.4 4.5 0.3 0.6 0.5 0.0 0.2 0.4 0.4 2.4 0.3 0.4 0.4 1.2 0.3 0.4 0.4 0.7 0.2 1.0 0.3 0.5 0.4 0.0 0.4 0.0 0.3 0.0 0.9 0.1 0.7 3.1 0.5 0.0 0.3 0.4 1.0 0.3 0.5 0.1 0.5 0.2 1.2 1.0 3.9 1.2 0.6 1.0 1.1 0.2 0.0 0.4 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.3 1.6 0.3 1.0 0.2 0.6 0.2 0.0 0.0 0.8 0.6 1.2 0.0 2.0 0.7 0.0 0.0 1.2 0.0 0.0 0.9 0.5 0.8 0.0 1.3 0.0 0.5 0.8 1.7 1.5 0.0 0.2 0.0 0.6 0.0 2.4 0.2 0.1 0.0 0.7 0.2 0.2 0.0 0.0 1.2 0.8 0.8 0.6 0.6 1.1 0.1 0.3 0.7 0.9 2.3 1.2 0.7 0.6 0.6 0.5 1.2 0.9 0.6 0.5 1.2 1.0 0.7 3.9 0.6 0.7 1.0 0.7 1.1 ATP5PB ATP5F1 ENSG00000116459 "ATP synthase peripheral stalk-membrane subunit b" P24539 1 111448864-111462773 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046067, HPA057347" Enhanced Supported Mitochondria "Intracellular and membrane" 640000 Mitochondria "HPA046067: AB_10960850, HPA057347: AB_2683416" "unprognostic (4.18e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-3)" "unprognostic (1.73e-2)" "unprognostic (3.56e-2)" "unprognostic (8.18e-2)" "unprognostic (8.52e-3)" "unprognostic (8.82e-2)" "unprognostic (3.67e-2)" "unprognostic (7.18e-3)" "unprognostic (3.29e-1)" "unprognostic (2.92e-1)" "prognostic favourable (3.26e-9)" "prognostic favourable (8.07e-4)" "unprognostic (1.60e-1)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" 11.6 16.0 16.8 11.4 22.6 8.0 10.4 30.7 28.8 10.7 30.0 10.4 11.3 16.1 14.4 10.7 21.1 13.7 9.7 57.1 16.4 15.4 30.5 26.2 10.2 14.2 16.1 15.5 12.6 15.3 18.0 13.3 16.3 22.8 13.4 17.8 9.8 20.4 12.4 83.6 9.7 25.4 13.7 13.9 13.7 13.1 11.4 10.1 18.7 18.6 34.0 15.4 15.5 11.5 8.3 10.8 4.3 10.0 5.9 11.9 22.9 15.3 3.5 13.1 10.1 8.4 7.6 8.4 17.0 18.8 17.7 14.8 6.2 7.8 21.0 15.9 11.2 16.0 19.0 21.0 15.9 16.6 7.4 21.0 4.9 4.2 6.2 26.4 21.2 6.6 9.0 19.5 18.3 14.1 18.4 9.3 10.1 7.1 45.0 6.2 9.9 24.1 11.6 40.7 8.2 14.0 5.2 9.6 3.0 13.3 19.0 14.0 15.2 9.5 13.6 8.3 14.8 16.2 16.8 12.8 12.1 49.9 20.2 20.1 15.5 1.9 10.0 4.3 9.7 6.4 8.6 7.5 10.8 9.2 10.8 8.3 11.9 7.3 2.9 5.9 5.0 5.9 9.0 22.9 16.8 22.6 30.7 28.8 16.4 15.4 16.1 15.5 22.8 10.1 ATP5PD "ATP5H, ATP5JD, ATPQ" ENSG00000167863 "ATP synthase peripheral stalk subunit d" O75947 17 75038863-75046985 "Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042777, HPA048459" Enhanced Supported Mitochondria 1600000 Mitochondria "HPA042777: AB_2678160, HPA048459: AB_2680402" "unprognostic (1.37e-1)" "unprognostic (4.41e-2)" "unprognostic (1.70e-3)" "unprognostic (1.32e-1)" "unprognostic (1.54e-1)" "unprognostic (4.81e-2)" "unprognostic (7.21e-2)" "unprognostic (1.99e-1)" "unprognostic (1.29e-1)" "unprognostic (2.03e-2)" "unprognostic (2.72e-1)" "unprognostic (8.72e-2)" "unprognostic (2.56e-2)" "unprognostic (1.42e-1)" "unprognostic (3.26e-1)" "unprognostic (1.73e-1)" "unprognostic (4.29e-2)" 38.8 38.5 54.3 28.6 48.6 25.6 37.8 34.5 50.4 30.0 52.9 19.6 33.2 46.6 25.8 47.4 58.9 25.7 31.0 143.6 47.7 44.8 78.8 86.2 24.8 29.2 45.7 39.2 28.5 43.3 38.5 29.8 35.4 40.3 33.1 53.1 35.4 56.8 36.3 184.2 35.5 59.9 39.1 32.8 32.7 40.4 15.7 21.3 30.3 48.7 88.5 33.7 45.8 29.0 72.5 100.7 90.9 103.8 54.9 100.0 86.2 66.4 58.4 44.7 58.3 72.9 89.3 60.2 57.2 75.5 64.2 61.3 45.6 52.3 45.1 38.1 71.5 60.6 53.8 74.9 86.1 21.9 45.7 46.0 48.6 89.8 71.8 58.6 30.3 75.8 59.7 52.2 74.7 85.4 47.9 61.5 78.9 64.5 58.0 65.9 34.1 83.0 41.1 129.6 83.5 132.7 65.1 45.1 49.5 67.5 107.7 91.1 106.7 59.8 44.0 80.0 55.9 69.4 66.7 49.4 39.0 46.1 71.6 58.9 51.5 67.2 90.5 90.9 58.3 103.8 67.4 72.5 100.0 71.6 100.7 57.6 90.9 83.5 50.7 54.9 83.1 89.8 94.6 86.2 54.3 48.6 34.5 50.4 47.7 44.8 45.7 39.2 40.3 21.3 ATP5PF "ATP5, ATP5A, ATP5J, ATPM, CF6" ENSG00000154723 "ATP synthase peripheral stalk subunit F6" P18859 21 25716503-25735673 "Plasma proteins, Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031069 Supported Supported Mitochondria 720000 Mitochondria "HPA031069: AB_10603676" "unprognostic (3.52e-2)" "unprognostic (1.33e-1)" "unprognostic (1.46e-1)" "unprognostic (4.57e-2)" "unprognostic (1.14e-1)" "unprognostic (7.87e-2)" "unprognostic (1.43e-1)" "unprognostic (6.32e-2)" "unprognostic (1.48e-1)" "unprognostic (4.87e-2)" "unprognostic (1.77e-1)" "unprognostic (8.83e-2)" "prognostic favourable (2.37e-5)" "unprognostic (1.93e-1)" "unprognostic (9.20e-2)" "unprognostic (1.56e-1)" "unprognostic (2.15e-2)" 39.8 46.8 49.0 20.3 43.6 23.0 32.6 30.8 46.6 25.9 48.6 26.1 22.4 43.0 24.0 57.4 45.2 21.6 19.2 148.9 41.1 37.1 72.8 111.0 18.7 22.2 47.0 27.0 23.9 37.4 31.2 37.5 33.9 45.7 32.6 47.9 33.9 47.1 37.5 164.7 18.7 57.9 46.9 32.8 25.0 37.6 21.0 25.8 31.4 32.1 69.9 29.9 42.0 23.1 87.8 102.4 80.9 91.5 69.1 95.2 112.2 41.6 30.0 38.3 43.0 41.2 38.0 47.5 36.9 42.9 36.1 35.3 68.9 32.9 51.4 24.5 36.4 22.9 51.2 44.2 39.8 44.9 54.4 107.1 61.0 68.4 46.6 78.2 35.1 37.1 54.6 34.5 31.0 41.9 66.8 63.2 52.6 46.6 54.1 79.2 68.8 54.5 42.3 74.4 97.0 77.0 57.0 43.7 48.6 62.0 62.7 56.8 45.3 70.4 31.6 27.6 33.1 25.7 31.7 63.1 103.1 65.0 42.4 81.8 34.5 69.2 88.8 80.9 60.3 91.5 64.0 87.8 80.2 74.6 102.4 71.6 79.6 78.0 56.9 69.1 89.7 96.4 95.2 112.2 49.0 43.6 30.8 46.6 41.1 37.1 47.0 27.0 45.7 25.8 ATP5PO "ATP5O, ATPO, OSCP" ENSG00000241837 "ATP synthase peripheral stalk subunit OSCP" P48047 21 33903453-33915980 "Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB016209, HPA041394" Enhanced Enhanced Mitochondria 4000000 Mitochondria "CAB016209: AB_631361, HPA041394: " "unprognostic (2.08e-1)" "unprognostic (4.77e-3)" "unprognostic (3.30e-1)" "unprognostic (6.12e-3)" "unprognostic (1.51e-1)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (2.34e-1)" "unprognostic (8.47e-2)" "unprognostic (1.42e-1)" "unprognostic (3.27e-1)" "unprognostic (1.81e-1)" "prognostic favourable (9.34e-4)" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (3.26e-2)" "unprognostic (7.89e-3)" 32.6 26.8 49.3 27.7 43.5 34.9 37.8 35.0 44.8 28.7 45.0 21.6 24.2 48.2 25.1 34.3 44.2 28.9 30.3 139.4 40.8 36.7 61.3 57.5 20.6 31.5 45.6 38.4 38.0 40.1 29.5 19.2 25.1 46.4 32.5 52.4 27.2 38.8 28.6 130.6 28.7 57.5 34.8 29.3 27.3 43.2 25.4 20.1 42.7 37.4 98.0 36.2 39.4 26.5 71.9 94.0 48.5 71.5 46.8 73.3 112.2 41.9 19.7 54.9 53.8 37.7 48.4 61.1 24.0 42.2 40.4 39.7 57.7 40.7 56.2 20.7 36.4 23.8 59.1 82.0 47.9 41.9 58.9 84.3 31.5 57.3 43.5 63.8 29.2 49.2 50.2 39.1 64.3 55.6 67.6 73.0 51.9 43.2 48.7 62.7 62.6 58.3 50.3 54.2 106.1 110.7 37.3 44.4 25.7 41.2 61.7 54.6 62.2 70.5 31.3 26.6 31.7 47.4 27.2 48.2 52.6 58.9 49.1 109.6 38.3 33.4 69.9 48.5 44.5 71.5 53.0 71.9 58.8 52.9 94.0 59.0 73.3 61.5 17.2 46.8 62.6 55.9 70.1 112.2 49.3 43.5 35.0 44.8 40.8 36.7 45.6 38.4 46.4 20.1 ATP6V1C2 "ATP6C2, VMA5" ENSG00000143882 "ATPase H+ transporting V1 subunit C2" Q8NEY4 2 10721649-10785110 "Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 49.3;placenta: 39.0;retina: 54.4;salivary gland: 41.8" "Group enriched" "Detected in some" 8 "BEWO: 39.7;SK-BR-3: 14.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA034734, HPA067305" Approved Uncertain Mitochondria Mitochondria "HPA034734: , HPA067305: " "unprognostic (2.29e-1)" "unprognostic (1.86e-1)" "unprognostic (1.15e-2)" "unprognostic (6.55e-3)" "unprognostic (2.69e-2)" "unprognostic (2.20e-2)" "unprognostic (7.03e-3)" "unprognostic (8.53e-2)" "unprognostic (1.29e-1)" "unprognostic (2.11e-2)" "unprognostic (6.77e-2)" "unprognostic (2.73e-2)" "prognostic unfavourable (1.12e-11)" "unprognostic (6.17e-2)" "unprognostic (3.30e-1)" "unprognostic (2.37e-1)" "unprognostic (8.27e-2)" 1.4 0.9 0.4 0.4 0.5 1.1 2.4 0.5 0.8 21.2 0.8 0.6 49.3 0.1 2.1 30.5 6.9 0.8 0.8 0.7 0.8 0.3 13.2 2.0 0.8 0.5 0.4 0.4 0.9 1.1 0.1 8.9 39.0 0.5 1.8 0.7 54.4 41.8 15.1 0.4 36.7 0.7 0.4 0.6 1.3 0.6 0.8 0.4 0.9 1.4 6.0 3.5 0.5 7.2 1.1 0.8 0.6 1.7 0.9 2.2 1.1 0.3 0.4 1.2 1.4 0.0 0.0 39.7 0.5 0.0 0.0 0.0 0.7 1.0 1.0 0.8 0.0 0.6 0.6 0.0 0.0 0.5 1.5 0.5 0.6 1.4 0.0 0.9 0.5 0.0 0.1 0.0 0.0 0.0 0.4 1.9 0.0 1.2 0.3 1.5 1.0 0.4 0.8 0.7 3.2 0.0 0.9 1.0 1.3 0.3 14.2 0.4 1.4 2.1 0.2 0.5 1.0 0.5 0.5 3.4 1.0 0.6 0.6 0.8 0.4 0.3 0.8 0.6 2.2 1.7 1.3 1.1 1.0 1.7 0.5 0.9 1.0 0.5 0.0 0.9 0.8 0.8 0.9 1.1 0.4 0.5 0.5 0.8 0.8 0.3 0.4 0.4 0.5 0.4 ATPAF1 "ATP11, Atp11p, FLJ22351" ENSG00000123472 "ATP synthase mitochondrial F1 complex assembly factor 1" Q5TC12 1 46632737-46673867 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 73.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028382, HPA044950" Approved Approved Mitochondria "Intracellular and membrane" Mitochondria "HPA028382: , HPA044950: " "unprognostic (1.34e-1)" "unprognostic (2.97e-3)" "unprognostic (1.18e-2)" "unprognostic (5.96e-2)" "unprognostic (1.20e-1)" "unprognostic (5.97e-2)" "unprognostic (3.53e-1)" "unprognostic (1.72e-2)" "unprognostic (1.70e-2)" "unprognostic (1.19e-2)" "unprognostic (5.15e-2)" "unprognostic (1.05e-1)" "prognostic favourable (5.33e-7)" "unprognostic (1.36e-1)" "unprognostic (6.52e-2)" "unprognostic (2.44e-1)" "unprognostic (2.62e-1)" 20.6 32.0 32.9 7.5 34.5 7.9 14.0 15.9 31.0 11.1 15.2 16.1 9.3 12.0 7.8 10.8 10.6 9.8 9.0 73.4 22.3 20.8 33.3 31.9 7.5 8.6 28.2 24.9 10.6 18.8 39.5 14.6 11.0 28.5 11.6 16.9 11.9 15.9 10.8 66.9 5.7 11.7 12.7 18.6 6.9 12.8 13.4 18.2 10.8 13.0 13.1 9.4 9.8 6.1 3.1 2.4 5.8 4.2 9.2 6.6 1.8 20.4 16.7 22.6 20.1 24.7 20.0 18.9 15.3 19.2 23.1 18.7 13.3 8.9 12.1 20.6 19.3 15.9 35.5 19.9 31.2 26.5 28.1 21.4 20.8 23.1 19.9 21.1 1.3 19.5 23.9 24.7 21.6 14.4 9.8 24.1 17.6 18.5 31.1 11.8 35.5 25.2 13.5 6.1 26.4 26.3 16.3 26.7 20.0 25.9 27.6 39.9 25.5 29.9 12.4 7.9 19.6 15.9 20.8 30.0 27.2 8.3 13.0 8.2 14.8 0.0 2.5 5.8 3.5 4.2 4.6 3.1 3.7 4.0 2.4 1.7 5.2 2.4 2.1 9.2 1.7 1.8 6.6 1.8 32.9 34.5 15.9 31.0 22.3 20.8 28.2 24.9 28.5 18.2 BAD "BBC2, BCL2L8" ENSG00000002330 "BCL2 associated agonist of cell death" Q92934 11 64269830-64284704 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004205, HPA028185, HPA062105" Approved Enhanced Mitochondria Mitochondria "CAB004205: AB_626717, HPA028185: AB_10603445, HPA062105: " "unprognostic (1.47e-1)" "unprognostic (3.08e-2)" "unprognostic (1.17e-1)" "unprognostic (8.24e-3)" "unprognostic (2.60e-1)" "unprognostic (6.73e-2)" "unprognostic (1.24e-3)" "unprognostic (1.07e-1)" "unprognostic (1.99e-1)" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (1.14e-1)" "unprognostic (8.26e-2)" "unprognostic (9.04e-2)" "unprognostic (2.17e-1)" "unprognostic (1.48e-1)" "unprognostic (7.95e-2)" 23.1 23.2 35.3 12.6 30.7 17.7 20.6 15.9 43.9 21.2 25.7 22.7 20.1 24.0 18.3 19.7 18.8 23.2 22.5 30.3 32.7 23.8 21.4 22.3 17.7 14.3 29.6 20.2 18.8 26.9 19.4 15.2 24.9 18.4 22.9 13.6 23.1 39.9 27.0 23.9 20.4 21.1 17.2 22.9 14.9 37.8 18.6 14.8 19.3 29.2 15.8 14.1 18.2 14.4 26.5 42.0 43.5 32.3 24.0 30.7 23.1 31.9 30.1 8.8 13.2 10.7 13.1 12.9 13.6 15.9 21.0 16.7 18.3 18.4 6.9 24.5 12.7 17.0 5.7 21.4 4.2 26.7 21.0 8.5 27.2 8.7 16.5 7.4 16.0 12.6 18.5 16.1 9.9 13.2 3.2 14.9 9.1 31.8 16.5 16.7 3.4 38.5 15.7 5.2 19.3 12.7 15.1 18.2 24.4 13.7 16.3 16.6 24.5 11.1 10.9 25.7 17.4 39.8 14.9 28.3 21.0 7.0 21.0 5.3 14.0 32.5 32.3 43.5 25.3 24.0 25.8 26.0 26.9 24.6 22.5 26.5 19.4 20.0 41.7 24.0 22.6 42.0 30.7 23.1 35.3 30.7 15.9 43.9 32.7 23.8 29.6 20.2 18.4 14.8 BCAT2 "BCAM, BCT2" ENSG00000105552 "Branched chain amino acid transaminase 2" O15382 19 48795062-48811029 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Branched-chain amino acid biosynthesis" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 72.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054091 Enhanced Supported Mitochondria 3400000 Mitochondria "HPA054091: " "unprognostic (2.58e-2)" "unprognostic (1.23e-2)" "unprognostic (2.16e-1)" "unprognostic (2.51e-3)" "unprognostic (1.54e-1)" "unprognostic (2.97e-2)" "unprognostic (1.69e-1)" "unprognostic (1.17e-2)" "unprognostic (2.98e-2)" "unprognostic (1.03e-1)" "unprognostic (8.32e-3)" "unprognostic (1.06e-1)" "prognostic favourable (3.68e-5)" "unprognostic (1.87e-3)" "unprognostic (1.35e-1)" "unprognostic (2.42e-1)" "unprognostic (7.50e-3)" 11.8 34.1 6.7 10.9 7.7 3.8 15.0 15.0 10.7 11.9 16.7 11.3 15.8 10.2 12.9 9.8 24.6 11.9 15.2 25.1 6.8 6.9 22.6 8.0 19.9 16.3 9.8 7.8 22.3 42.6 9.0 12.3 27.5 22.0 16.8 12.1 6.3 24.7 17.2 23.3 9.8 10.3 17.5 7.6 10.9 22.8 15.9 10.7 12.5 19.1 23.3 16.7 29.2 12.2 15.0 18.2 1.8 9.8 8.8 15.4 7.1 17.4 21.0 5.6 11.8 23.3 7.9 9.9 7.7 3.9 9.5 9.3 21.0 10.7 20.5 8.9 6.9 8.3 8.6 13.5 4.8 12.8 21.7 7.5 9.4 1.3 22.6 10.1 7.1 11.4 8.6 7.1 10.3 13.2 9.6 12.7 3.4 20.8 13.8 10.8 4.9 10.2 21.1 9.6 22.6 9.0 72.2 30.1 8.6 11.8 19.4 5.7 12.3 5.0 7.3 9.3 9.0 10.9 9.6 11.9 15.8 9.8 5.0 15.8 6.0 0.0 8.7 1.8 9.7 9.8 13.6 15.0 11.7 12.4 16.1 12.8 10.8 9.6 0.4 8.8 3.7 18.2 15.4 7.1 6.7 7.7 15.0 10.7 6.8 6.9 9.8 7.8 22.0 10.7 BCKDK ENSG00000103507 "Branched chain ketoacid dehydrogenase kinase" O14874 16 31106107-31112791 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 26.8;granulocytes: 26.6;monocytes: 33.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017995, HPA056067" Supported Supported Mitochondria Mitochondria "HPA017995: AB_1845309, HPA056067: " "unprognostic (1.37e-1)" "unprognostic (2.57e-1)" "unprognostic (6.94e-2)" "unprognostic (5.20e-2)" "unprognostic (5.39e-2)" "unprognostic (3.61e-2)" "unprognostic (1.01e-1)" "unprognostic (5.47e-2)" "unprognostic (1.60e-1)" "unprognostic (1.90e-1)" "unprognostic (1.35e-1)" "unprognostic (3.24e-2)" "unprognostic (2.66e-3)" "unprognostic (4.85e-2)" "unprognostic (3.93e-2)" "unprognostic (1.00e-1)" "unprognostic (4.97e-2)" 15.4 29.7 11.9 13.1 15.0 9.4 18.3 18.8 21.3 11.7 14.1 9.6 19.9 11.2 14.8 14.9 14.9 13.8 15.1 39.2 14.2 10.3 21.3 46.5 18.2 32.5 10.7 17.3 15.1 52.4 17.4 8.9 11.4 13.2 14.9 9.9 10.4 33.9 25.7 67.7 21.5 12.2 19.9 15.6 16.0 19.9 11.2 9.3 8.0 11.7 25.9 10.6 15.3 12.0 6.9 26.8 26.6 33.0 6.3 6.8 13.6 18.1 20.4 11.5 17.3 14.2 14.3 12.5 15.8 19.5 24.6 24.1 13.3 12.1 17.0 23.0 19.7 12.6 8.1 27.5 15.9 13.7 25.3 18.4 13.9 24.2 25.1 9.5 16.9 21.0 11.1 21.1 17.6 26.2 9.3 16.1 36.8 30.9 8.8 12.6 9.8 16.5 17.8 16.8 31.3 18.8 12.5 17.8 16.3 12.3 30.3 9.8 18.2 9.2 16.8 18.8 10.9 19.2 13.1 16.8 6.0 6.0 21.3 13.8 17.6 12.2 33.0 23.1 5.7 27.4 5.6 6.9 5.2 4.2 26.8 5.4 4.4 5.0 26.6 6.3 19.3 5.8 6.8 13.6 11.9 15.0 18.8 21.3 14.2 10.3 10.7 17.3 13.2 9.3 BCL2L1 "Bcl-X, bcl-xL, bcl-xS, BCL2L, BCLX, PPP1R52" ENSG00000171552 "BCL2 like 1" Q07817 20 31664452-31723989 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Apoptosis, Endocytosis" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035734, CAB072801" Approved Approved Mitochondria Mitochondria "CAB072801: , HPA035734: " "unprognostic (2.29e-1)" "unprognostic (5.40e-3)" "unprognostic (1.78e-2)" "prognostic unfavourable (9.10e-4)" "unprognostic (1.37e-1)" "unprognostic (1.09e-1)" "unprognostic (5.04e-2)" "unprognostic (7.82e-3)" "prognostic favourable (9.57e-4)" "unprognostic (1.67e-1)" "prognostic unfavourable (5.87e-4)" "unprognostic (1.06e-1)" "prognostic favourable (8.89e-5)" "unprognostic (9.67e-2)" "unprognostic (3.03e-2)" "unprognostic (2.02e-2)" "unprognostic (3.32e-2)" 30.8 21.4 25.1 16.4 34.3 57.0 40.7 27.7 40.7 28.2 22.6 37.0 13.0 31.3 18.7 12.2 36.9 31.5 35.9 26.9 27.0 23.7 42.6 39.3 40.6 17.8 43.4 24.3 11.5 28.5 17.5 22.8 29.0 33.4 24.8 21.4 31.5 33.8 21.5 21.9 26.1 30.4 19.2 28.8 26.6 28.0 30.2 38.4 56.4 25.8 15.4 20.7 24.5 22.4 3.9 7.8 17.0 8.9 12.5 27.2 16.5 62.7 37.4 6.9 6.6 37.3 27.0 22.1 15.0 24.6 15.7 15.1 88.2 30.5 10.3 38.4 21.7 21.2 9.2 42.5 11.1 10.8 2.4 47.0 8.0 43.9 27.9 4.7 27.9 19.3 17.7 19.9 43.3 22.5 29.1 7.9 53.2 17.9 13.8 4.5 9.5 33.4 8.7 20.8 32.6 64.5 17.5 18.0 8.4 18.4 18.2 8.6 36.2 5.4 31.1 19.9 23.0 7.9 27.0 5.2 29.1 8.5 29.3 20.7 12.5 17.0 8.1 15.4 27.2 8.2 21.0 3.9 12.4 18.1 7.8 3.7 5.7 13.0 9.8 12.5 8.9 4.7 13.8 16.5 25.1 34.3 27.7 40.7 27.0 23.7 43.4 24.3 33.4 38.4 BCL2L13 "BCL-RAMBO, MIL1" ENSG00000099968 "BCL2 like 13" Q9BXK5 22 17628855-17730855 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002052, HPA030994, HPA050377" Uncertain Enhanced Mitochondria Mitochondria "CAB002052: AB_563431, HPA030994: AB_10795024, HPA050377: " "unprognostic (1.59e-1)" "unprognostic (8.17e-2)" "unprognostic (2.18e-3)" "unprognostic (1.86e-1)" "unprognostic (6.27e-2)" "unprognostic (2.69e-2)" "unprognostic (3.38e-1)" "unprognostic (4.97e-2)" "unprognostic (5.04e-2)" "unprognostic (9.46e-2)" "unprognostic (1.45e-2)" "unprognostic (8.21e-2)" "prognostic favourable (1.96e-8)" "unprognostic (3.20e-1)" "unprognostic (1.07e-1)" "unprognostic (4.27e-1)" "unprognostic (2.81e-1)" 15.3 17.4 13.3 7.6 14.2 10.9 17.3 13.0 17.4 9.2 11.9 14.8 8.8 8.3 10.5 10.7 14.5 11.7 10.0 18.9 12.7 12.2 18.9 20.9 10.6 9.3 14.4 13.4 10.4 22.0 25.8 12.3 14.1 12.2 11.1 14.1 15.2 12.4 9.5 61.2 15.5 12.4 11.7 13.0 8.3 11.2 22.9 11.5 12.1 13.5 14.5 12.3 14.6 10.2 6.5 11.3 4.7 17.3 10.4 8.3 9.5 14.0 6.3 10.1 9.6 16.8 16.2 13.4 10.1 17.7 15.0 17.1 7.1 9.4 12.2 7.3 14.4 19.3 11.6 15.5 15.7 11.7 8.8 11.5 5.7 3.7 21.0 16.0 10.0 13.1 18.2 12.8 34.7 13.1 28.5 11.5 16.3 9.5 8.1 5.1 8.0 7.9 8.6 15.6 4.5 15.6 9.7 14.3 9.0 13.3 13.5 24.1 9.2 15.8 13.0 8.9 4.6 12.7 9.6 9.9 8.9 10.5 13.3 12.3 15.2 3.8 17.3 4.7 4.6 15.6 5.7 6.5 6.2 5.7 11.3 5.4 5.5 4.5 4.4 10.4 11.0 5.7 8.3 9.5 13.3 14.2 13.0 17.4 12.7 12.2 14.4 13.4 12.2 11.5 BDH1 "BDH, SDR9C1" ENSG00000161267 "3-hydroxybutyrate dehydrogenase 1" Q02338 3 197509783-197573323 "Candidate cardiovascular disease genes, Enzymes, Predicted intracellular proteins" "Allosteric enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "liver: 156.0" "Cell line enhanced" "Detected in many" "U-937: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030947, HPA058709" Enhanced Enhanced Mitochondria Mitochondria "HPA030947: AB_10669548, HPA058709: " "unprognostic (2.72e-2)" "prognostic favourable (1.09e-4)" "unprognostic (1.13e-1)" "unprognostic (3.93e-1)" "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "prognostic favourable (9.86e-7)" "unprognostic (2.08e-1)" "unprognostic (3.85e-2)" "unprognostic (4.53e-2)" "unprognostic (5.17e-3)" "unprognostic (5.85e-3)" "prognostic favourable (7.12e-8)" "unprognostic (5.62e-2)" "unprognostic (1.74e-1)" "unprognostic (6.22e-2)" "unprognostic (1.02e-1)" 3.5 2.8 6.6 5.2 11.2 4.7 4.6 18.1 13.8 4.0 13.9 4.6 6.3 9.6 2.1 3.6 12.9 5.5 6.1 19.6 6.3 5.8 6.0 156.0 2.0 4.2 5.9 9.1 3.0 2.8 5.8 3.6 1.4 7.7 4.5 11.1 6.2 8.6 4.4 7.3 8.0 13.7 2.4 3.5 2.3 4.7 1.8 3.6 5.4 5.2 11.3 7.4 3.6 3.6 6.1 4.6 2.9 1.6 4.7 9.9 4.0 10.5 1.4 0.6 5.4 0.9 0.0 0.0 1.2 1.0 5.5 3.1 9.5 3.5 0.0 15.7 0.3 4.9 4.8 2.5 2.1 0.1 0.0 5.6 3.6 3.2 4.0 12.4 5.9 1.6 3.0 2.1 4.6 1.3 0.0 4.2 0.1 18.8 9.5 8.4 4.1 1.9 9.1 2.0 14.4 5.8 4.8 10.0 4.3 3.8 0.5 2.0 12.7 10.4 0.1 0.3 1.8 0.0 9.9 4.9 9.2 0.1 0.3 35.3 0.7 2.9 1.6 0.6 5.9 0.2 8.2 6.1 6.5 5.3 4.2 5.5 9.9 5.9 0.0 4.7 0.3 4.6 4.2 4.0 6.6 11.2 18.1 13.8 6.3 5.8 5.9 9.1 7.7 3.6 BMP6 "VGR, VGR1" ENSG00000153162 "Bone morphogenetic protein 6" P22004 6 7726797-7881422 "Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 17.4" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 57.6;Karpas-707: 29.9;SiHa: 25.1;TIME: 26.4" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 8 "basophil: 4.0;neutrophil: 2.3" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002773, HPA062683" Approved Approved Mitochondria "Secreted to blood" 100000 21000 Mitochondria "CAB002773: , HPA062683: " "prognostic favourable (6.45e-4)" "unprognostic (2.99e-1)" "unprognostic (4.20e-1)" "unprognostic (6.71e-2)" "unprognostic (2.44e-1)" "unprognostic (7.27e-2)" "unprognostic (4.66e-2)" "unprognostic (1.29e-1)" "unprognostic (1.26e-1)" "unprognostic (6.94e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (1.26e-1)" "unprognostic (1.82e-2)" "unprognostic (8.29e-2)" "unprognostic (2.95e-1)" "unprognostic (2.29e-3)" 10.5 1.5 1.7 1.3 2.8 0.0 7.7 0.2 1.1 2.5 2.7 1.9 2.1 0.0 1.5 1.1 1.6 3.8 1.7 1.4 6.6 1.4 5.8 0.7 2.2 5.8 0.1 0.0 2.8 17.4 1.5 2.2 1.1 2.2 1.4 1.7 2.0 2.0 1.9 3.4 3.4 1.5 0.5 1.8 2.9 1.7 0.3 0.4 4.0 0.0 0.0 0.2 2.1 0.3 0.9 0.1 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.4 0.1 0.4 0.0 0.0 0.0 2.0 5.5 8.5 0.5 0.3 0.3 5.8 0.0 0.0 0.2 1.0 57.6 0.0 29.9 0.0 0.1 0.0 0.0 0.3 4.1 0.2 0.0 5.2 0.1 0.0 4.3 0.0 25.1 0.0 0.0 0.0 0.0 26.4 0.0 1.6 0.1 0.8 3.8 13.1 0.0 0.9 0.0 0.5 4.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.4 0.3 0.0 0.0 2.3 0.0 0.0 0.2 0.0 2.1 BPHL "Bph-rp, MCNAA, VACVase" ENSG00000137274 "Biphenyl hydrolase like" Q86WA6 6 3118374-3153578 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 61.6;liver: 47.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036752, HPA036753" Enhanced Approved Mitochondria 13000 Mitochondria "HPA036752: AB_10673662, HPA036753: AB_2675291" "unprognostic (2.93e-1)" "unprognostic (1.29e-1)" "unprognostic (8.88e-2)" "unprognostic (1.11e-1)" "unprognostic (3.72e-3)" "unprognostic (1.84e-1)" "unprognostic (8.65e-2)" "unprognostic (3.14e-2)" "unprognostic (1.94e-1)" "prognostic favourable (5.97e-4)" "unprognostic (4.59e-2)" "unprognostic (9.46e-3)" "prognostic favourable (5.16e-7)" "unprognostic (1.60e-2)" "unprognostic (1.51e-2)" "unprognostic (6.98e-2)" "unprognostic (5.20e-2)" 12.8 9.8 8.4 5.1 12.1 4.0 8.1 6.0 10.1 6.7 19.4 6.3 4.5 19.8 6.1 17.8 8.8 7.1 8.2 6.8 7.5 9.6 61.6 47.9 3.8 4.9 7.8 5.9 5.1 9.8 4.8 8.4 3.7 10.3 5.9 6.4 6.4 8.4 4.1 12.0 6.4 29.1 7.0 6.9 2.7 6.5 7.0 3.8 4.9 4.6 8.8 5.6 6.2 5.6 15.8 13.1 7.3 11.2 11.1 11.7 6.5 13.7 10.9 17.8 15.8 11.2 10.4 8.5 7.0 11.8 15.7 13.8 12.8 14.8 16.4 14.1 11.5 13.6 16.0 16.2 36.5 19.4 10.3 8.0 8.2 16.6 3.6 9.9 4.3 8.4 7.5 15.4 22.8 23.0 7.1 8.3 24.1 20.2 12.0 5.9 13.2 24.3 12.6 19.9 16.3 12.7 15.6 17.1 13.4 10.4 5.6 27.1 17.2 4.8 8.1 19.6 16.3 11.6 13.0 7.0 21.3 13.5 4.3 5.7 22.0 7.3 8.7 0.1 7.7 11.2 9.9 15.8 8.9 7.6 13.1 11.8 8.5 11.7 1.0 11.1 6.3 7.3 4.7 6.5 8.4 12.1 6.0 10.1 7.5 9.6 7.8 5.9 10.3 3.8 BTN2A2 "BT2.2, BTF2, BTN2.2" ENSG00000124508 "Butyrophilin subfamily 2 member A2" Q8WVV5 6 26383096-26394874 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 34.1;U-266/70: 27.8" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 29.0" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA051504 Uncertain Approved Mitochondria Mitochondria "HPA051504: " "prognostic favourable (1.01e-4)" "unprognostic (4.93e-3)" "unprognostic (1.37e-2)" "unprognostic (6.78e-2)" "unprognostic (9.26e-2)" "unprognostic (2.01e-2)" "unprognostic (1.78e-1)" "unprognostic (8.04e-3)" "unprognostic (1.01e-1)" "unprognostic (1.22e-2)" "unprognostic (6.67e-2)" "unprognostic (1.93e-1)" "unprognostic (1.73e-2)" "unprognostic (3.45e-1)" "unprognostic (6.54e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-3)" 7.0 12.4 3.2 22.6 5.2 2.7 7.5 29.0 5.2 8.5 5.7 5.1 4.8 5.2 10.2 10.6 7.4 6.7 7.9 9.5 4.1 3.7 7.5 6.1 15.6 21.8 4.4 3.3 10.3 5.8 12.9 5.5 2.8 9.7 8.8 8.0 11.5 9.3 7.9 2.7 8.0 9.9 8.2 5.3 18.0 7.2 5.1 4.2 13.0 7.0 6.2 26.0 8.5 7.6 20.2 14.9 7.8 9.1 5.1 6.3 4.7 4.7 3.0 6.2 6.6 2.1 3.3 0.4 5.2 13.8 8.2 14.3 1.9 1.9 4.3 5.7 9.4 4.4 4.9 4.0 11.0 13.4 8.3 6.7 5.7 3.7 4.4 1.5 2.4 7.0 1.2 15.8 5.4 7.5 5.4 34.1 3.7 2.0 5.3 1.9 2.3 3.1 12.6 8.8 13.3 5.9 2.7 5.9 8.3 3.4 1.3 14.2 6.3 2.9 8.9 3.0 3.5 2.6 8.0 27.8 17.0 7.6 3.0 6.1 7.5 1.2 8.7 1.5 4.2 9.1 3.9 16.2 3.3 3.7 14.9 20.2 2.8 3.4 7.8 5.1 3.6 6.2 6.3 4.7 3.2 5.2 29.0 5.2 4.1 3.7 4.4 3.3 9.7 4.2 C10orf82 "Em:AC016825.4, MGC33547" ENSG00000165863 "Chromosome 10 open reading frame 82" Q8WW14 10 116663696-116670264 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 12.7;testis: 44.7" "Cell line enhanced" "Detected in some" "BEWO: 2.2;HEK 293: 1.3;Hep G2: 5.1;NTERA-2: 2.8;T-47d: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 127 "basophil: 12.7" "Lineage enriched" "Detected in single" 127 "granulocytes: 12.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043022 Approved Mitochondria Mitochondria "HPA043022: " "unprognostic (9.98e-2)" "unprognostic (2.09e-2)" "unprognostic (8.41e-2)" "unprognostic (2.11e-1)" "unprognostic (1.63e-2)" "unprognostic (9.52e-2)" "unprognostic (3.46e-3)" "unprognostic (3.48e-1)" "unprognostic (6.15e-2)" "unprognostic (1.50e-2)" "unprognostic (8.00e-2)" "unprognostic (1.47e-3)" "unprognostic (2.61e-2)" "unprognostic (1.94e-2)" "unprognostic (1.73e-1)" "unprognostic (1.07e-1)" 0.4 1.1 0.4 0.9 1.2 0.2 1.0 0.8 3.3 0.4 0.7 0.0 1.0 0.3 0.3 1.5 1.2 0.3 0.3 0.5 0.4 1.3 0.5 0.3 0.2 0.2 0.4 0.9 3.2 0.9 0.2 1.2 0.3 4.1 1.1 0.4 0.6 1.8 1.1 0.2 0.4 0.6 0.7 2.0 0.3 0.4 44.7 0.0 0.0 3.3 0.0 0.2 0.4 1.9 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.8 3.3 0.4 1.3 0.4 0.9 4.1 0.0 C18orf63 DKFZP781G0119 ENSG00000206043 "Chromosome 18 open reading frame 63" Q68DL7 18 74315813-74359187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 48 "testis: 17.4" "Cell line enhanced" "Detected in single" "CACO-2: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042233 Approved Mitochondria Mitochondria "HPA042233: AB_10960843" "unprognostic (1.40e-1)" "unprognostic (1.43e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C1orf112 FLJ10706 ENSG00000000460 "Chromosome 1 open reading frame 112" Q9NSG2 1 169662007-169854080 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 24.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023778, HPA024451" Uncertain Approved Mitochondria Mitochondria "HPA023778: AB_1848665, HPA024451: AB_1848667" "unprognostic (4.97e-2)" "unprognostic (1.46e-1)" "unprognostic (1.40e-1)" "prognostic unfavourable (9.56e-5)" "unprognostic (1.33e-1)" "unprognostic (9.40e-2)" "unprognostic (2.50e-3)" "unprognostic (2.09e-1)" "unprognostic (9.11e-3)" "unprognostic (8.79e-2)" "unprognostic (3.47e-3)" "unprognostic (5.97e-2)" "unprognostic (1.65e-8)" "unprognostic (1.76e-1)" "unprognostic (2.81e-2)" "unprognostic (6.17e-2)" "unprognostic (2.63e-1)" 3.4 3.1 3.3 7.4 4.9 10.1 5.0 8.4 3.6 5.2 3.2 5.0 2.2 1.5 4.8 3.5 4.0 2.2 1.8 2.3 2.7 2.4 2.6 5.2 2.6 7.4 5.0 1.5 3.3 2.6 20.1 3.7 4.2 4.5 3.2 5.3 4.9 3.3 4.9 1.9 3.1 3.3 3.6 3.6 4.2 3.0 19.7 5.9 24.6 3.2 2.9 9.5 4.0 3.3 2.9 2.7 4.3 4.9 4.9 1.6 1.6 16.3 8.8 11.6 5.9 1.8 2.6 17.1 10.9 5.6 16.0 16.3 9.8 14.4 14.7 4.9 3.5 13.5 14.4 7.6 18.3 8.6 8.5 13.8 11.9 7.1 0.6 18.0 6.2 0.8 1.1 11.8 2.8 6.7 22.3 25.0 12.9 4.0 15.6 5.0 15.3 6.3 11.9 13.0 9.9 2.1 8.3 8.5 8.9 6.8 11.5 3.6 10.9 9.4 4.9 12.9 10.3 9.4 14.7 6.8 10.1 15.6 4.8 13.4 12.5 4.3 1.8 2.2 1.3 4.5 1.0 2.9 1.6 1.4 2.7 2.8 0.6 1.4 0.3 4.9 4.9 0.7 1.6 1.6 3.3 4.9 8.4 3.6 2.7 2.4 5.0 1.5 4.5 5.9 C5orf63 "FLJ44606, YDR286C" ENSG00000164241 "Chromosome 5 open reading frame 63" A6NC05 5 127042558-127073492 "Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-87 MG: 32.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA043240 Approved Approved Approved Mitochondria Mitochondria "HPA043240: AB_10962511" "unprognostic (2.71e-1)" "unprognostic (3.97e-2)" "unprognostic (1.11e-1)" "unprognostic (2.63e-1)" "unprognostic (1.62e-1)" "unprognostic (1.93e-1)" "unprognostic (2.94e-4)" "unprognostic (1.34e-1)" "unprognostic (9.67e-2)" "unprognostic (3.40e-2)" "unprognostic (1.43e-4)" "unprognostic (1.07e-1)" "unprognostic (2.26e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-1)" "unprognostic (3.64e-3)" "unprognostic (1.07e-2)" 4.4 4.4 3.3 10.1 4.6 2.8 5.9 6.8 21.4 2.9 10.9 5.5 3.3 5.6 7.5 4.8 7.6 4.2 3.8 7.3 4.4 4.9 8.0 7.0 4.6 6.8 4.6 4.8 4.4 7.5 9.2 27.7 2.7 6.8 5.5 11.0 11.3 13.7 3.9 6.6 3.3 9.2 3.2 6.2 5.6 6.8 13.8 3.0 8.5 9.0 5.1 9.1 4.9 5.1 11.9 9.8 3.9 1.5 12.3 10.1 2.9 0.5 2.4 0.7 1.4 1.9 2.9 0.3 2.6 0.3 3.3 1.9 6.0 7.6 0.0 10.9 2.1 1.0 4.6 2.9 4.7 1.0 3.7 6.1 9.2 7.1 4.6 3.5 0.3 3.0 7.3 4.2 2.2 2.8 0.4 1.1 3.2 4.9 0.1 3.3 0.4 1.9 2.7 1.6 4.2 3.6 3.7 6.1 5.0 3.4 1.5 0.2 6.3 5.3 2.1 6.9 6.4 7.9 1.6 3.7 9.5 0.2 32.0 0.4 3.6 3.4 0.3 3.9 6.7 1.5 5.3 11.9 6.1 7.1 3.0 10.8 9.2 6.8 1.4 12.3 0.4 9.8 10.1 2.9 3.3 4.6 6.8 3.2 4.4 4.9 4.6 4.8 6.8 3.0 C6orf118 "bA85G2.1, MGC23884" ENSG00000112539 "Chromosome 6 open reading frame 118" Q5T5N4 6 165279664-165309607 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 14.5;fallopian tube: 23.9;pituitary gland: 10.4;testis: 9.6" "Group enriched" "Detected in some" 5 "AF22: 7.2;SCLC-21H: 4.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA029787, HPA029789" Approved Uncertain Mitochondria Mitochondria "HPA029787: AB_10599999, HPA029789: AB_10601002" "unprognostic (2.84e-1)" "unprognostic (3.09e-4)" "unprognostic (2.70e-2)" "unprognostic (7.99e-2)" "unprognostic (5.34e-2)" "unprognostic (1.41e-1)" "unprognostic (2.50e-1)" "unprognostic (4.27e-2)" "unprognostic (4.89e-2)" "unprognostic (8.18e-9)" "unprognostic (3.22e-3)" "unprognostic (3.03e-2)" "unprognostic (6.55e-3)" "unprognostic (4.50e-1)" 0.3 0.3 4.4 0.3 11.4 0.3 0.3 0.1 0.8 1.5 0.3 7.5 0.1 0.3 1.0 7.2 0.3 23.9 0.3 0.3 4.3 2.7 0.3 0.3 4.7 0.3 0.3 1.0 3.4 0.3 0.3 10.4 0.3 14.5 0.3 0.3 0.0 0.3 0.4 0.3 0.3 0.3 0.3 0.8 0.3 0.3 9.6 3.9 0.0 0.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 7.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.2 0.0 0.2 0.0 4.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 11.4 0.1 0.8 4.3 2.7 0.3 1.0 14.5 3.9 C9orf129 bA165J3.3 ENSG00000204352 "Chromosome 9 open reading frame 129" Q5T035 9 93318199-93346414 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in many" 4 "brain: 12.7;testis: 4.3" "Cell line enriched" "Detected in single" 8 "NTERA-2: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA071515 Uncertain Mitochondria Mitochondria "HPA071515: " "unprognostic (1.12e-1)" "unprognostic (2.46e-2)" "unprognostic (1.23e-1)" "unprognostic (9.47e-2)" "unprognostic (1.25e-1)" "unprognostic (1.84e-1)" "unprognostic (4.58e-2)" "unprognostic (1.35e-1)" "unprognostic (3.45e-1)" 0.7 0.6 5.9 1.3 7.2 0.7 0.7 4.7 12.7 1.4 0.8 0.7 0.0 1.1 0.9 2.0 1.0 1.3 0.6 0.9 4.3 5.7 0.6 0.7 0.7 0.7 3.2 9.3 0.6 1.1 0.6 0.6 0.8 4.3 1.0 0.8 0.6 0.6 1.2 1.3 0.6 0.8 1.0 2.1 1.0 1.1 4.3 1.1 0.0 0.7 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 6.9 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 7.2 4.7 12.7 4.3 5.7 3.2 9.3 4.3 1.1 C9orf131 MGC41945 ENSG00000174038 "Chromosome 9 open reading frame 131" Q5VYM1 9 35041095-35045991 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 46.6" "Cell line enhanced" "Detected in some" "HeLa: 3.9;RT4: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA022029 Approved Mitochondria Mitochondria "HPA022029: AB_10960628" "unprognostic (1.10e-2)" "unprognostic (8.99e-2)" "unprognostic (2.06e-1)" "unprognostic (1.31e-1)" "unprognostic (1.91e-1)" "unprognostic (1.23e-3)" "unprognostic (2.47e-1)" "unprognostic (6.57e-2)" "unprognostic (3.66e-1)" "unprognostic (9.45e-2)" "unprognostic (4.63e-2)" "unprognostic (1.75e-2)" "unprognostic (2.37e-2)" "unprognostic (9.34e-2)" "unprognostic (1.82e-1)" "unprognostic (9.90e-4)" "unprognostic (4.19e-3)" 0.2 0.1 0.2 0.2 0.3 1.3 0.3 0.6 0.3 1.0 0.2 0.2 0.2 0.0 2.2 0.8 0.2 0.2 1.4 0.2 0.2 0.2 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.3 0.7 0.2 0.4 0.2 0.2 0.4 0.2 0.2 0.2 0.8 0.5 0.2 0.2 0.2 0.2 0.2 46.6 0.2 0.2 0.3 0.2 0.2 0.3 0.2 1.0 0.1 2.7 0.5 0.9 1.4 0.0 3.3 0.1 0.3 0.8 0.7 0.0 1.0 1.0 0.0 0.0 0.0 0.9 1.8 0.7 0.3 0.0 2.1 0.0 0.0 0.4 0.3 0.5 1.2 3.9 0.9 0.0 0.4 1.2 0.0 0.5 0.0 0.0 0.4 3.3 2.4 0.0 0.5 0.7 1.8 0.6 0.0 0.0 0.3 0.0 0.3 13.7 0.3 0.0 1.2 0.0 0.5 0.7 0.0 0.0 0.0 0.3 0.0 0.3 0.2 0.9 1.3 0.3 0.5 1.5 2.7 0.5 0.0 0.5 0.0 0.0 0.5 0.4 1.4 0.0 1.0 0.5 0.8 1.3 0.9 0.0 0.1 0.1 0.0 0.2 0.3 0.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 CA5B ENSG00000169239 "Carbonic anhydrase 5B" Q9Y2D0 X 15688830-15788409 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 15.4;fHDF/TERT166: 17.5;hTERT-HME1: 23.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA012618 Uncertain Supported Mitochondria Mitochondria "HPA012618: AB_1846000" "unprognostic (1.62e-2)" "unprognostic (2.10e-3)" "unprognostic (2.86e-1)" "unprognostic (1.55e-3)" "unprognostic (1.16e-2)" "unprognostic (4.59e-5)" "unprognostic (2.50e-1)" "unprognostic (6.89e-4)" "unprognostic (4.11e-1)" "unprognostic (3.89e-3)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "prognostic favourable (6.66e-6)" "unprognostic (2.43e-1)" "unprognostic (1.38e-1)" "unprognostic (8.94e-2)" "unprognostic (3.08e-1)" 9.3 4.6 10.6 4.9 11.1 4.1 10.2 3.1 7.8 28.7 3.6 11.5 1.4 2.2 9.8 3.7 8.1 9.5 9.1 6.5 9.9 8.2 10.3 7.8 7.3 8.8 12.2 6.7 15.2 4.4 16.8 4.4 3.9 13.1 6.2 4.7 29.5 8.3 6.2 2.0 7.5 4.1 9.4 7.1 5.3 5.4 23.0 8.1 2.3 8.9 10.9 11.6 6.3 9.4 4.3 3.5 2.7 3.6 7.9 13.3 7.0 2.7 1.6 1.9 3.1 5.8 15.4 1.1 2.9 3.7 2.1 3.1 0.8 1.8 0.8 3.0 17.5 3.0 6.8 3.3 3.8 0.7 3.2 1.5 2.1 0.7 5.7 1.9 3.3 3.6 3.5 2.8 23.0 3.1 0.7 2.0 10.1 1.5 1.5 1.5 0.7 12.2 0.9 1.4 1.4 3.3 2.0 1.7 3.6 4.0 1.4 2.6 2.0 1.9 4.2 2.5 1.7 13.6 1.6 1.5 1.5 0.8 2.8 3.8 4.7 2.7 3.0 0.3 13.1 3.6 11.4 3.6 13.3 12.3 3.5 4.3 9.8 8.3 1.7 7.9 2.3 0.5 10.0 7.0 10.6 11.1 3.1 7.8 9.9 8.2 12.2 6.7 13.1 8.1 CARD16 "COP, COP1, PSEUDO-ICE" ENSG00000204397 "Caspase recruitment domain family member 16" Q5EG05 11 105041326-105101431 "Predicted intracellular proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 126.3;lymphoid tissue: 52.1" "Cell line enhanced" "Detected in many" "AN3-CA: 37.9;HHSteC: 66.6;HUVEC TERT2: 30.5;TIME: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA053981, HPA062805" Uncertain Uncertain Mitochondria Mitochondria "HPA053981: , HPA062805: " "unprognostic (2.25e-3)" "unprognostic (6.56e-2)" "unprognostic (1.49e-1)" "unprognostic (8.12e-2)" "unprognostic (4.45e-3)" "unprognostic (1.76e-1)" "unprognostic (4.71e-1)" "unprognostic (8.68e-2)" "unprognostic (1.56e-1)" "unprognostic (1.17e-2)" "unprognostic (5.12e-2)" "unprognostic (1.04e-1)" "prognostic unfavourable (6.93e-7)" "unprognostic (2.81e-1)" "unprognostic (6.68e-2)" "unprognostic (1.82e-1)" "unprognostic (1.19e-1)" 11.4 4.0 3.8 21.9 6.8 20.9 8.1 2.3 4.3 5.5 13.3 1.7 4.2 16.3 4.4 4.9 9.0 5.4 11.1 6.4 4.7 2.6 8.1 7.3 30.2 14.5 6.4 3.0 7.6 7.2 0.0 3.2 28.5 6.2 8.2 11.8 4.1 5.8 4.4 4.1 5.6 20.2 5.6 9.2 52.1 7.5 2.1 6.2 6.2 5.5 7.4 11.5 10.9 12.8 23.4 57.8 126.3 110.3 19.4 47.9 68.9 0.2 0.0 0.0 37.9 1.0 5.2 0.2 0.8 2.6 0.1 0.7 0.2 0.0 3.9 5.3 2.3 2.7 0.3 5.5 0.0 16.1 0.0 0.8 0.7 0.4 66.6 5.2 0.0 9.4 2.9 3.9 2.6 30.5 0.0 0.0 0.0 0.0 1.7 4.5 0.0 0.1 4.3 0.1 5.0 0.1 2.4 0.0 0.0 6.0 0.8 18.9 0.8 12.6 27.9 2.6 0.3 1.7 0.1 0.0 0.8 0.0 3.1 17.5 0.6 44.0 85.3 61.6 26.4 110.3 25.1 23.4 24.1 25.3 57.8 17.9 14.3 21.8 126.3 19.4 97.2 6.7 47.9 68.9 3.8 6.8 2.3 4.3 4.7 2.6 6.4 3.0 6.2 6.2 CARD19 "bA370F5.1, BinCARD, C9orf89, MGC11115" ENSG00000165233 "Caspase recruitment domain family member 19" Q96LW7 9 93096218-93113283 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 49.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010921, HPA010990, HPA038297" Approved Supported Mitochondria Mitochondria "HPA010921: AB_10670295, HPA010990: , HPA038297: " "unprognostic (7.26e-2)" "unprognostic (1.15e-2)" "unprognostic (2.97e-1)" "unprognostic (2.66e-2)" "prognostic unfavourable (7.47e-5)" "unprognostic (2.22e-1)" "prognostic unfavourable (1.32e-5)" "unprognostic (1.21e-1)" "unprognostic (1.36e-2)" "unprognostic (2.65e-2)" "unprognostic (1.98e-1)" "unprognostic (9.13e-2)" "unprognostic (6.82e-2)" "unprognostic (2.29e-1)" "unprognostic (5.48e-2)" "unprognostic (1.03e-1)" "unprognostic (1.41e-1)" 15.1 17.8 9.9 8.1 10.6 6.8 19.6 19.8 15.0 13.5 18.1 13.9 6.4 13.7 13.8 14.2 12.9 12.3 13.0 14.5 9.7 7.5 18.1 12.2 12.0 7.8 14.8 10.7 9.6 9.1 6.1 8.1 7.6 13.7 10.2 7.6 9.9 12.1 10.7 15.5 14.6 12.2 12.5 12.5 12.5 15.7 19.9 10.3 5.3 10.0 13.4 7.1 15.5 12.6 5.6 17.3 23.0 21.7 9.2 11.5 12.3 11.9 11.7 1.4 3.5 1.9 3.7 4.9 9.9 4.9 7.0 3.1 2.8 4.0 2.6 7.0 3.5 20.8 1.2 8.0 0.6 49.1 4.6 4.5 2.5 6.5 7.9 4.0 4.3 9.2 2.5 5.0 2.0 8.1 2.0 4.8 4.7 23.6 4.3 10.9 1.4 26.6 2.9 7.8 10.4 8.5 4.5 3.6 6.6 5.3 2.6 10.8 5.9 4.3 8.0 3.5 7.1 6.6 3.0 3.9 3.5 0.5 14.6 4.1 12.2 14.1 21.7 12.8 6.1 16.0 6.2 5.6 6.0 6.5 17.3 3.3 5.5 5.5 23.0 9.2 9.1 6.2 11.5 12.3 9.9 10.6 19.8 15.0 9.7 7.5 14.8 10.7 13.7 10.3 CASP9 "APAF-3, ICE-LAP6, MCH6, PPP1R56" ENSG00000132906 "Caspase 9" P55211 1 15490832-15526534 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001473, CAB004348, HPA046488" Approved Approved Mitochondria Mitochondria "CAB004348: AB_673489, HPA001473: AB_1078401, HPA046488: " "prognostic favourable (5.91e-4)" "unprognostic (2.42e-1)" "unprognostic (8.94e-3)" "unprognostic (7.84e-2)" "unprognostic (1.93e-2)" "unprognostic (8.54e-3)" "unprognostic (1.90e-3)" "unprognostic (6.75e-2)" "unprognostic (2.58e-1)" "unprognostic (1.29e-1)" "unprognostic (9.09e-2)" "unprognostic (1.98e-1)" "unprognostic (1.39e-2)" "unprognostic (2.35e-1)" "unprognostic (3.21e-2)" "unprognostic (5.48e-2)" "prognostic favourable (1.67e-5)" 7.4 24.1 7.8 8.2 9.3 8.9 5.5 11.1 8.7 8.3 9.3 10.2 18.9 5.2 11.9 16.5 7.5 13.4 29.1 10.2 8.3 7.2 11.6 9.4 10.8 12.6 10.7 4.3 33.4 29.0 15.6 18.5 14.7 8.8 10.2 6.4 8.7 6.6 19.0 8.2 2.8 13.3 7.8 9.0 11.0 6.7 14.4 7.1 6.2 14.8 7.2 14.6 7.3 8.1 11.2 11.7 23.3 11.2 13.0 5.1 6.1 7.1 10.4 4.1 7.1 9.3 4.6 3.7 5.2 6.9 7.8 10.0 7.3 8.6 10.4 12.3 7.1 2.5 6.8 5.5 9.0 3.6 8.5 7.4 23.2 7.3 8.7 7.2 8.7 6.3 10.2 11.9 3.6 8.3 16.7 9.7 4.6 3.6 2.4 8.2 4.0 5.8 4.8 10.2 12.1 9.6 4.1 3.5 6.8 7.4 1.8 12.3 4.4 5.2 3.3 10.4 4.8 11.2 3.4 9.4 14.1 11.7 7.9 7.8 3.4 22.7 11.2 23.3 5.1 8.2 3.7 9.6 3.0 3.6 11.7 11.2 1.7 2.6 16.0 13.0 7.9 5.2 2.8 6.1 7.8 9.3 11.1 8.7 8.3 7.2 10.7 4.3 8.8 7.1 CCDC120 JM11 ENSG00000147144 "Coiled-coil domain containing 120" Q96HB5 X 49053572-49069857 "Cancer-related genes, Predicted intracellular proteins" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 14.1;BEWO: 20.3;HaCaT: 13.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000561 Uncertain Mitochondria Mitochondria "HPA000561: AB_2244190" "unprognostic (1.65e-1)" "unprognostic (1.79e-1)" "unprognostic (1.19e-1)" "unprognostic (7.59e-3)" "unprognostic (1.80e-3)" "unprognostic (1.08e-2)" "unprognostic (2.59e-3)" "unprognostic (1.23e-1)" "unprognostic (1.04e-1)" "unprognostic (1.72e-1)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (4.85e-2)" "unprognostic (2.64e-2)" "unprognostic (3.82e-3)" "unprognostic (4.54e-3)" "unprognostic (2.34e-3)" 3.3 3.1 5.8 3.1 4.7 2.9 5.0 17.3 5.8 8.4 6.8 1.6 10.4 12.0 5.5 9.9 27.6 5.1 4.1 2.1 4.0 1.6 7.0 4.8 4.4 2.6 1.5 3.3 6.5 7.0 6.1 12.2 13.3 4.0 6.0 3.3 4.7 11.4 10.2 1.5 26.1 12.5 2.5 1.8 3.8 7.7 5.8 1.5 6.0 5.6 8.8 15.1 7.4 12.2 2.5 2.2 3.9 0.8 1.6 1.5 0.4 14.1 1.9 3.1 0.1 0.0 0.0 20.3 0.5 0.7 1.1 1.7 4.7 6.1 0.5 2.2 0.8 13.7 2.4 8.0 0.1 3.6 4.6 1.3 3.3 1.6 1.0 0.0 2.4 1.8 6.4 1.3 0.4 1.7 1.9 0.2 0.0 11.9 4.9 0.3 3.6 0.1 4.4 2.3 1.3 6.1 7.6 4.3 3.3 2.5 5.1 1.4 12.4 1.9 0.8 0.1 3.7 0.1 0.1 4.6 3.1 0.1 0.1 0.0 0.6 2.9 0.8 1.5 1.4 0.2 0.9 0.8 1.5 1.3 0.3 2.5 1.5 1.4 3.9 1.6 0.4 2.2 0.5 0.4 5.8 4.7 17.3 5.8 4.0 1.6 1.5 3.3 4.0 1.5 CCDC191 KIAA1407 ENSG00000163617 "Coiled-coil domain containing 191" Q8NCU4 3 113964137-114056613 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047833 Approved Approved Mitochondria Mitochondria "HPA047833: AB_10961639" "unprognostic (2.59e-2)" "unprognostic (3.93e-2)" "unprognostic (1.86e-1)" "unprognostic (1.31e-2)" "unprognostic (2.60e-1)" "unprognostic (1.42e-2)" "unprognostic (6.57e-2)" "unprognostic (5.91e-2)" "unprognostic (1.08e-1)" "unprognostic (2.90e-1)" "unprognostic (6.33e-2)" "unprognostic (3.64e-2)" "unprognostic (2.53e-2)" "unprognostic (1.51e-1)" "unprognostic (3.62e-1)" "unprognostic (1.54e-1)" "prognostic favourable (3.45e-4)" 3.8 4.5 6.3 4.5 13.3 4.2 7.6 3.0 9.7 7.6 4.0 11.7 11.5 2.9 8.2 12.4 3.4 18.5 5.7 2.4 8.2 7.8 7.7 2.4 7.2 6.1 6.2 9.8 7.7 6.6 16.7 31.1 3.4 12.5 6.5 5.2 7.1 5.0 7.9 1.6 11.4 5.1 7.0 8.9 7.5 4.8 12.7 7.9 3.6 11.3 2.4 6.1 5.2 4.5 10.0 4.4 5.3 0.9 0.8 2.2 1.0 4.8 2.7 4.3 3.6 1.2 6.5 1.4 1.2 2.1 1.7 2.6 0.5 5.7 1.3 2.0 2.2 6.1 1.3 2.4 3.9 0.9 1.0 0.9 0.9 0.5 1.8 1.5 0.7 2.8 6.2 2.2 3.3 3.2 0.4 3.0 1.0 2.3 3.0 0.6 0.7 2.1 2.0 0.9 2.8 6.0 2.5 2.5 4.2 1.9 0.5 2.0 10.4 0.6 3.3 2.6 0.8 1.4 0.8 4.4 3.5 4.9 3.7 0.8 1.4 0.1 0.9 1.8 1.1 0.9 1.2 10.0 2.2 1.8 1.0 9.4 1.1 1.8 5.3 0.8 0.6 4.4 1.6 1.0 6.3 13.3 3.0 9.7 8.2 7.8 6.2 9.8 12.5 7.9 CCDC90B "MDS011, MDS025" ENSG00000137500 "Coiled-coil domain containing 90B" Q9GZT6 11 83259097-83286407 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011130, HPA011931" Supported Enhanced Mitochondria Mitochondria "HPA011130: AB_1846170, HPA011931: AB_2072332" "unprognostic (5.85e-2)" "unprognostic (1.33e-1)" "unprognostic (7.34e-2)" "unprognostic (9.71e-2)" "unprognostic (1.34e-1)" "unprognostic (7.48e-2)" "unprognostic (2.99e-1)" "unprognostic (3.57e-3)" "unprognostic (5.76e-3)" "unprognostic (3.53e-2)" "unprognostic (6.01e-3)" "unprognostic (2.01e-2)" "unprognostic (1.00e-2)" "unprognostic (2.31e-1)" "unprognostic (3.03e-1)" "unprognostic (1.62e-1)" "unprognostic (2.41e-1)" 15.8 32.0 25.0 11.1 23.3 11.6 18.0 14.3 17.9 15.4 14.5 14.6 17.2 12.1 12.6 29.3 14.3 13.5 15.2 18.2 22.3 25.6 16.4 31.3 11.0 15.0 29.9 14.9 19.4 16.6 15.2 29.5 18.3 24.5 16.3 14.9 8.4 14.5 14.8 12.2 11.6 18.2 14.9 43.9 17.1 13.6 42.2 28.3 15.5 21.6 12.3 13.5 14.8 13.0 18.5 12.7 32.6 19.0 22.5 21.1 12.4 7.3 10.9 18.6 6.0 25.3 19.1 11.4 15.0 12.9 9.5 10.2 12.7 25.5 17.9 19.7 22.2 9.4 8.2 19.2 12.7 12.5 6.5 11.0 7.4 10.6 21.3 11.1 9.6 21.3 26.0 12.2 35.1 21.5 16.3 15.3 34.4 13.0 11.2 14.3 15.4 13.6 13.0 16.7 15.4 19.6 10.9 9.1 21.0 10.5 8.5 9.8 22.0 10.4 20.6 18.6 11.7 34.8 10.1 14.9 19.5 18.2 7.5 9.0 18.3 30.8 8.9 32.6 12.3 19.0 15.6 18.5 17.9 17.0 12.7 16.9 15.5 15.5 4.5 22.5 19.0 9.3 21.1 12.4 25.0 23.3 14.3 17.9 22.3 25.6 29.9 14.9 24.5 28.3 CCM2 "C7orf22, MGC4607, OSM" ENSG00000136280 "CCM2 scaffolding protein" Q9BSQ5 7 44999475-45076469 "Disease related genes, Predicted intracellular proteins" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020273, HPA021669, HPA065815" Supported Enhanced Mitochondria Mitochondria "HPA020273: AB_1846185, HPA021669: AB_1846186, HPA065815: " "unprognostic (4.30e-1)" "unprognostic (1.30e-1)" "prognostic unfavourable (1.79e-4)" "unprognostic (3.17e-1)" "prognostic unfavourable (2.45e-4)" "unprognostic (4.85e-2)" "unprognostic (1.55e-2)" "unprognostic (7.37e-3)" "unprognostic (3.92e-1)" "unprognostic (2.65e-1)" "prognostic favourable (1.16e-4)" "unprognostic (3.03e-1)" "prognostic unfavourable (5.06e-7)" "unprognostic (2.45e-1)" "unprognostic (1.79e-1)" "unprognostic (2.81e-2)" "unprognostic (2.48e-1)" 16.7 18.3 31.6 20.7 52.0 11.2 8.6 21.3 36.1 9.7 12.5 13.9 8.6 10.5 7.2 7.0 10.6 8.4 9.1 13.7 29.8 23.1 7.9 31.6 12.4 30.7 29.0 14.2 8.2 17.9 16.5 11.2 11.5 17.8 7.7 8.8 6.9 13.6 12.6 27.0 13.4 10.6 13.3 14.7 20.8 11.2 10.5 11.5 37.5 7.4 8.2 23.4 15.4 12.6 14.8 7.3 32.4 13.8 17.6 50.6 11.1 14.0 15.5 9.3 18.5 17.6 15.5 6.9 17.0 14.0 12.2 16.5 11.2 14.6 19.8 13.2 21.5 18.3 5.7 22.0 8.1 22.0 11.1 8.8 12.4 7.9 15.6 3.6 23.7 17.5 14.5 21.4 9.2 22.2 10.0 16.1 24.4 21.1 17.3 48.0 10.7 17.3 9.3 5.3 16.1 12.5 13.6 18.0 14.0 13.9 11.0 7.5 12.6 16.5 16.8 16.7 14.1 16.6 16.3 28.9 22.6 40.0 16.3 13.1 20.0 27.1 10.5 31.2 17.3 12.1 11.6 13.6 20.5 18.7 7.2 14.8 19.9 14.7 32.4 17.6 13.8 7.3 50.6 11.1 31.6 52.0 21.3 36.1 29.8 23.1 29.0 14.2 17.8 11.5 CCR7 "BLR2, CD197, CDw197, CMKBR7, EBI1" ENSG00000126353 "C-C motif chemokine receptor 7" P32248 17 40553769-40565472 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "blood: 252.3;lymphoid tissue: 110.6" "Cell line enriched" "Detected in some" 79 "HDLM-2: 171.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 252.3" "Lineage enriched" "Detected in many" 4 "T-cells: 252.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB003796, HPA031383, HPA074467" Enhanced Approved Mitochondria Mitochondria "CAB003796: AB_562261, HPA031383: , HPA074467: " "prognostic favourable (3.84e-4)" "prognostic favourable (8.03e-6)" "unprognostic (2.26e-3)" "unprognostic (1.32e-3)" "unprognostic (2.35e-3)" "prognostic favourable (7.61e-7)" "unprognostic (2.71e-4)" "unprognostic (2.58e-2)" "unprognostic (4.48e-2)" "unprognostic (4.68e-4)" "unprognostic (1.10e-2)" "unprognostic (3.11e-1)" "unprognostic (1.08e-3)" "unprognostic (3.12e-1)" "prognostic unfavourable (7.72e-4)" "unprognostic (1.02e-1)" "unprognostic (7.95e-2)" 2.8 0.4 0.2 26.0 0.2 5.2 1.7 0.2 0.3 2.2 1.2 0.3 0.8 0.3 1.2 0.5 1.4 2.3 2.0 1.9 0.2 0.2 1.5 1.7 3.4 110.6 0.3 0.2 1.5 0.3 0.0 1.0 1.0 0.4 1.3 2.1 0.7 8.4 0.2 0.2 1.1 16.2 0.2 0.4 20.3 1.8 1.2 0.3 57.1 2.0 1.2 53.8 4.2 1.3 58.8 2.9 2.3 0.3 44.1 252.3 109.3 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 171.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.9 0.1 1.1 0.2 0.0 0.0 1.1 0.3 0.2 3.1 0.1 3.6 37.2 53.3 15.3 0.2 58.8 252.3 133.9 2.3 44.1 0.2 2.9 30.3 109.3 0.2 0.2 0.2 0.3 0.2 0.2 0.3 0.2 0.4 0.3 CD101 "IGSF2, V7" ENSG00000134256 "CD101 molecule" Q93033 1 117001750-117036476 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.7;lung: 17.5" "Cell line enriched" "Detected in some" 9 "HMC-1: 24.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 33.7" "Group enriched" "Detected in many" 17 "dendritic cells: 12.2;granulocytes: 33.7;monocytes: 17.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA049527, HPA057763" Approved Uncertain Mitochondria 42000 Mitochondria "HPA049527: , HPA057763: " "unprognostic (1.25e-1)" "unprognostic (7.95e-3)" "unprognostic (5.40e-3)" "unprognostic (4.10e-3)" "unprognostic (2.62e-1)" "unprognostic (4.00e-2)" "unprognostic (3.03e-2)" "unprognostic (3.58e-3)" "unprognostic (3.57e-2)" "unprognostic (7.29e-3)" "unprognostic (3.15e-1)" "unprognostic (4.54e-2)" "unprognostic (7.15e-6)" "unprognostic (7.00e-2)" "unprognostic (8.07e-2)" "unprognostic (5.05e-2)" "unprognostic (5.28e-2)" 0.9 1.7 0.8 11.3 1.1 5.7 0.8 0.2 1.1 1.3 5.0 0.6 1.2 4.6 1.7 0.4 1.8 1.5 1.4 2.6 1.1 0.5 1.3 0.8 17.5 4.0 1.3 0.2 1.0 2.3 0.0 0.8 0.5 1.1 1.6 3.2 0.7 2.1 1.3 0.5 1.8 10.9 1.6 2.0 7.8 1.8 0.9 1.2 6.4 0.9 2.4 7.4 2.4 1.8 0.1 12.2 33.7 17.4 0.0 1.2 2.5 0.4 0.0 0.8 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 1.2 1.8 0.1 0.0 0.0 1.0 0.1 0.8 0.0 0.0 0.1 24.7 0.3 1.2 0.0 0.1 0.2 0.1 0.6 0.1 1.5 0.0 2.8 0.8 0.0 0.0 0.5 0.0 0.6 0.6 0.4 0.6 0.4 0.5 0.3 0.9 0.6 0.5 0.1 0.4 0.5 0.2 0.2 0.1 0.0 0.7 1.9 1.5 0.0 7.6 33.7 0.1 10.0 0.7 0.1 0.2 1.2 12.2 0.0 0.3 1.2 0.3 0.0 17.4 0.0 1.1 2.5 0.8 1.1 0.2 1.1 1.1 0.5 1.3 0.2 1.1 1.2 CDRT4 FLJ36674 ENSG00000239704 "CMT1A duplicated region transcript 4" 17 15436015-15503608 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 36.8" "Cell line enhanced" "Detected in many" "Hep G2: 13.5;NB-4: 10.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.9" "Group enriched" "Detected in many" 5 "granulocytes: 3.9;NK-cells: 1.1;T-cells: 1.8" "Low region specificity" "Detected in many" HPA021590 Uncertain Approved Mitochondria Mitochondria "HPA021590: AB_1848906" "unprognostic (5.46e-6)" "unprognostic (9.47e-2)" "unprognostic (7.53e-2)" "unprognostic (1.31e-1)" "unprognostic (3.51e-2)" "unprognostic (7.74e-3)" "unprognostic (9.29e-2)" "unprognostic (2.12e-2)" "unprognostic (3.93e-2)" "unprognostic (1.39e-1)" "unprognostic (2.10e-5)" "unprognostic (2.00e-3)" "unprognostic (1.74e-6)" "unprognostic (1.00e-1)" "unprognostic (4.17e-1)" "unprognostic (4.18e-1)" "unprognostic (9.27e-2)" 2.0 3.2 2.0 2.0 2.3 3.3 6.5 3.7 2.6 2.6 2.3 2.3 2.0 0.2 2.5 17.7 2.0 4.4 2.0 2.0 2.0 2.4 2.0 2.0 3.7 2.8 2.7 2.8 5.3 4.1 0.9 10.9 2.0 2.0 4.1 3.0 2.0 5.0 2.7 2.0 14.6 2.0 2.0 2.0 2.9 2.7 36.8 2.0 2.0 5.3 2.0 2.0 2.1 2.8 0.4 0.3 3.9 0.1 1.1 1.8 0.5 3.3 3.2 4.1 1.3 3.1 2.3 3.9 1.2 3.2 1.5 1.3 1.9 1.1 0.0 1.6 1.7 1.2 4.5 3.7 2.3 0.6 0.6 0.5 2.0 13.5 0.9 1.1 5.6 3.1 4.5 2.1 5.0 3.4 0.7 2.0 3.5 0.5 1.2 10.2 1.6 1.1 0.9 0.1 0.0 3.4 2.6 0.6 1.7 1.1 0.7 1.1 1.4 2.6 3.4 0.8 1.5 1.5 1.2 2.7 1.0 0.2 0.1 0.3 0.4 3.9 0.0 0.4 0.9 0.0 0.6 0.4 0.4 0.8 0.1 0.4 0.1 0.4 0.2 1.1 0.1 0.3 1.8 0.5 2.0 2.3 3.7 2.6 2.0 2.4 2.7 2.8 2.0 2.0 CEND1 "BM88, FLJ90066" ENSG00000184524 "Cell cycle exit and neuronal differentiation 1" Q8N111 11 787104-790123 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 85.2" "Cell line enhanced" "Detected in some" "Karpas-707: 16.7;SCLC-21H: 30.0;SH-SY5Y: 11.2;U-266/70: 11.7;U-87 MG: 15.6" "Cancer enriched" "Detected in many" 13 "glioma: 24.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042527 Enhanced Approved Mitochondria Mitochondria "HPA042527: AB_2678038" "unprognostic (4.62e-3)" "unprognostic (1.34e-4)" "unprognostic (9.66e-3)" "unprognostic (1.27e-2)" "prognostic unfavourable (4.38e-5)" "unprognostic (2.20e-3)" "unprognostic (4.11e-2)" "unprognostic (6.72e-2)" "unprognostic (2.60e-2)" "unprognostic (2.26e-1)" "unprognostic (2.00e-3)" "unprognostic (4.24e-3)" "unprognostic (1.94e-3)" "unprognostic (4.43e-2)" "unprognostic (1.71e-1)" "unprognostic (1.40e-1)" "unprognostic (1.03e-1)" 1.9 8.2 28.5 2.9 34.7 1.8 1.8 46.5 85.2 1.8 2.3 8.3 1.3 2.5 1.9 2.0 2.2 1.8 1.9 2.1 34.2 25.3 2.1 1.8 1.8 2.1 32.0 30.7 1.8 1.9 1.9 5.1 1.8 42.4 3.2 1.9 2.1 1.8 3.6 1.8 1.9 2.7 2.3 10.2 1.8 1.9 1.9 5.9 0.0 1.8 0.0 2.0 2.1 0.1 3.6 0.2 0.0 0.7 0.0 1.9 0.3 0.0 0.4 0.4 0.7 0.1 0.1 0.1 0.7 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.1 0.0 2.9 0.3 0.0 0.4 0.0 0.1 0.0 16.7 0.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 30.0 11.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.4 11.7 3.2 0.7 15.6 0.1 0.2 0.0 0.0 0.0 0.9 0.7 0.3 3.6 1.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.3 28.5 34.7 46.5 65.2 34.2 25.3 32.0 30.7 42.4 5.9 CHAC1 MGC4504 ENSG00000128965 "ChaC glutathione specific gamma-glutamylcyclotransferase 1" Q9BUX1 15 40952962-40956519 "Enzymes, Predicted intracellular proteins" "Apoptosis, Neurogenesis, Notch signaling pathway, Unfolded protein response" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 53.0;salivary gland: 39.9;skeletal muscle: 52.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 34.7;HHSteC: 26.5;hTCEpi: 42.0;SK-MEL-30: 29.6;U-266/70: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.8" "Group enriched" "Detected in many" 6 "B-cells: 1.8;monocytes: 1.1;T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042708, HPA043505" Approved Approved Mitochondria Mitochondria "HPA042708: , HPA043505: " "unprognostic (6.04e-3)" "unprognostic (2.81e-2)" "unprognostic (7.47e-2)" "unprognostic (2.84e-3)" "unprognostic (6.57e-3)" "unprognostic (2.00e-2)" "unprognostic (5.59e-2)" "unprognostic (2.43e-1)" "unprognostic (2.01e-1)" "unprognostic (1.72e-1)" "unprognostic (3.11e-1)" "unprognostic (1.51e-1)" "prognostic unfavourable (2.23e-7)" "unprognostic (1.37e-2)" "unprognostic (1.44e-1)" "unprognostic (1.67e-2)" "unprognostic (3.91e-2)" 6.0 1.0 2.6 1.5 2.1 1.7 1.0 1.7 5.6 1.1 1.9 0.3 1.1 1.9 1.1 1.8 18.6 1.5 5.7 2.2 2.6 4.8 3.1 14.1 1.5 1.1 2.6 2.2 11.3 53.0 0.9 1.3 1.1 6.2 1.5 1.1 0.2 39.9 1.3 52.4 1.3 1.5 1.1 5.3 1.1 11.2 0.9 1.0 0.0 1.7 4.7 4.6 2.7 2.7 1.8 0.1 0.2 1.1 0.0 1.3 0.2 2.8 1.9 0.5 8.7 1.4 1.0 3.5 16.8 34.7 1.8 5.0 4.6 0.7 0.8 1.3 1.5 1.8 3.8 1.3 1.3 3.2 0.7 0.7 0.5 0.0 26.5 2.2 0.0 11.8 42.0 5.5 7.6 1.7 2.3 4.0 1.5 1.6 1.6 0.0 1.6 6.5 1.4 0.0 3.8 0.9 1.0 1.7 2.5 0.5 3.0 29.6 1.1 15.9 0.5 0.3 5.2 0.4 3.0 26.0 5.5 3.3 1.6 3.1 3.9 0.0 0.4 0.0 1.3 0.4 0.0 1.8 0.2 0.8 0.1 0.0 0.0 1.0 0.2 0.0 1.1 0.0 0.0 0.2 2.6 2.1 1.7 5.6 2.6 4.8 2.6 2.2 6.2 1.0 CHCHD10 "C22orf16, N27C7-4" ENSG00000250479 "Coiled-coil-helix-coiled-coil-helix domain containing 10" Q8WYQ3 22 23765834-23768443 "Disease related genes, Predicted intracellular proteins" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 127.0;skeletal muscle: 226.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003440 Enhanced Supported Mitochondria Mitochondria "HPA003440: AB_1078348" "unprognostic (3.88e-2)" "unprognostic (2.36e-3)" "unprognostic (8.90e-2)" "unprognostic (9.80e-2)" "unprognostic (7.68e-2)" "unprognostic (5.97e-3)" "unprognostic (1.59e-1)" "unprognostic (1.85e-1)" "unprognostic (2.23e-2)" "unprognostic (2.40e-1)" "unprognostic (1.61e-1)" "unprognostic (5.13e-2)" "prognostic favourable (2.15e-7)" "unprognostic (5.19e-3)" "unprognostic (2.06e-1)" "unprognostic (5.68e-3)" "unprognostic (2.62e-3)" 23.1 14.9 25.8 16.4 33.9 5.7 20.0 11.8 31.0 17.3 39.4 9.6 18.3 30.6 6.1 15.5 20.2 7.6 11.3 127.0 23.7 23.5 40.4 86.1 8.3 16.9 25.8 18.4 4.8 24.3 36.4 12.7 11.7 14.5 11.7 31.6 24.3 33.7 22.2 226.6 7.2 30.2 12.8 12.2 13.0 17.3 4.1 9.6 3.0 27.8 73.1 15.8 13.8 9.3 9.4 7.3 7.6 7.8 0.8 5.0 1.0 6.0 16.4 5.1 21.2 11.2 7.1 8.2 2.1 5.8 6.0 7.0 30.6 8.2 18.5 5.7 10.4 19.5 27.8 8.7 5.5 6.0 30.3 4.7 13.0 28.9 19.1 13.6 22.0 13.8 23.1 9.1 2.4 7.3 8.4 11.9 5.4 30.5 4.3 8.6 3.7 41.6 16.0 0.8 42.6 28.4 13.7 9.0 4.8 2.9 36.5 28.0 13.0 10.7 3.2 0.2 0.2 3.7 0.0 4.7 2.0 12.8 5.0 11.4 2.7 0.2 3.9 7.6 2.8 7.8 1.9 9.4 3.2 4.0 1.7 7.8 5.0 3.6 0.1 0.8 6.9 7.3 3.7 1.0 25.8 33.9 11.8 31.0 23.7 23.5 25.8 18.4 14.5 9.6 CHCHD2 C7orf17 ENSG00000106153 "Coiled-coil-helix-coiled-coil-helix domain containing 2" Q9Y6H1 7 56101569-56106576 "Disease related genes, Predicted intracellular proteins" Transcription Activator "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 220.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027407, HPA052510" Uncertain Enhanced Mitochondria Mitochondria "HPA027407: AB_10959659, HPA052510: AB_2681856" "unprognostic (8.68e-3)" "unprognostic (2.79e-1)" "unprognostic (8.48e-2)" "unprognostic (2.32e-1)" "unprognostic (3.90e-2)" "prognostic unfavourable (1.90e-5)" "prognostic unfavourable (9.41e-5)" "unprognostic (4.38e-2)" "unprognostic (3.61e-1)" "unprognostic (2.30e-2)" "unprognostic (1.37e-1)" "unprognostic (2.79e-2)" "unprognostic (2.60e-2)" "unprognostic (4.01e-2)" "unprognostic (1.79e-1)" "unprognostic (2.09e-1)" "unprognostic (2.40e-2)" 41.5 112.8 57.2 33.0 59.5 73.0 46.0 39.3 56.9 38.0 46.6 33.2 45.5 51.9 34.2 53.8 50.1 39.2 44.3 75.3 46.8 50.2 56.2 66.9 34.2 62.6 58.3 49.0 43.8 77.8 28.4 42.8 38.4 42.3 41.3 40.1 45.3 56.5 70.0 147.2 33.0 49.3 45.7 42.6 34.1 44.2 27.1 28.1 48.9 62.1 65.9 38.8 38.5 30.9 63.2 107.7 52.6 69.1 51.5 72.8 121.3 220.2 38.6 25.4 52.5 20.1 27.8 18.8 32.4 30.8 41.8 40.5 35.3 36.9 64.6 42.9 19.8 37.5 32.2 35.5 33.7 41.9 58.5 38.1 32.5 50.2 37.5 51.3 61.6 24.7 40.6 31.3 38.5 31.2 79.9 39.3 34.0 30.5 69.0 158.9 55.0 61.5 46.6 24.8 106.0 37.4 28.8 48.5 60.4 25.5 63.0 40.7 72.0 73.4 24.9 25.8 60.5 106.8 47.6 36.3 51.7 115.2 40.6 55.4 32.0 40.5 69.1 52.6 53.1 61.0 54.8 63.2 57.2 56.3 79.5 57.8 51.6 52.8 37.0 51.5 59.5 107.7 72.8 121.3 57.2 59.5 39.3 56.9 46.8 50.2 58.3 49.0 42.3 28.1 CHCHD3 "FLJ20420, Mic19, MINOS3, PPP1R22" ENSG00000106554 "Coiled-coil-helix-coiled-coil-helix domain containing 3" Q9NX63 7 132784868-133082088 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 109.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042935 Enhanced Supported Mitochondria 110000 Mitochondria "HPA042935: AB_10794538" "unprognostic (1.53e-1)" "unprognostic (2.50e-1)" "unprognostic (4.15e-2)" "unprognostic (3.00e-3)" "unprognostic (5.69e-2)" "unprognostic (4.75e-3)" "prognostic unfavourable (3.25e-4)" "unprognostic (1.39e-2)" "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" "unprognostic (1.69e-3)" "unprognostic (2.04e-1)" "prognostic favourable (1.15e-4)" "unprognostic (4.98e-2)" "unprognostic (1.20e-1)" "unprognostic (2.57e-1)" "unprognostic (8.03e-2)" 15.2 15.8 9.9 13.4 11.6 15.4 13.7 10.1 14.2 10.5 17.3 9.8 7.9 19.9 13.2 9.7 10.5 9.7 10.4 42.6 9.5 8.9 23.2 17.9 11.7 10.6 10.4 8.0 11.6 9.8 13.9 17.0 10.7 10.9 10.5 18.3 11.5 10.6 11.1 109.1 9.0 20.5 13.9 9.7 12.2 13.9 6.4 10.8 19.7 14.6 30.1 13.2 12.9 13.6 19.0 28.2 15.4 29.9 21.2 19.9 15.3 23.8 24.5 25.0 34.4 18.1 16.6 14.8 23.5 22.3 26.7 29.7 28.8 26.6 19.9 9.3 14.8 16.8 28.9 20.2 37.8 25.9 27.3 20.5 25.3 16.7 35.8 45.9 15.3 15.0 13.9 36.6 38.4 18.7 43.6 18.3 24.8 31.5 66.8 40.4 40.9 28.4 33.3 36.5 28.4 26.1 19.9 31.8 39.8 19.5 15.3 44.3 12.9 27.5 15.4 25.7 11.0 40.2 42.0 17.6 22.5 50.1 40.4 39.4 35.9 14.9 21.8 15.4 16.1 29.9 15.3 19.0 14.7 15.5 28.2 11.7 13.0 14.5 3.1 21.2 24.1 24.6 19.9 15.3 9.9 11.6 10.1 14.2 9.5 8.9 10.4 8.0 10.9 10.8 CHCHD4 "FLJ31709, MIA40, TIMM40" ENSG00000163528 "Coiled-coil-helix-coiled-coil-helix domain containing 4" Q8N4Q1 3 14112077-14124870 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA034688, HPA063727" Uncertain Supported Mitochondria Mitochondria "HPA034688: AB_10696361, HPA063727: " "unprognostic (3.89e-3)" "unprognostic (8.82e-2)" "unprognostic (1.50e-2)" "unprognostic (7.34e-2)" "unprognostic (1.11e-2)" "unprognostic (9.12e-2)" "unprognostic (2.63e-3)" "unprognostic (1.02e-1)" "unprognostic (1.82e-1)" "unprognostic (5.55e-2)" "unprognostic (3.59e-2)" "unprognostic (1.43e-1)" "prognostic favourable (8.63e-5)" "unprognostic (1.53e-1)" "unprognostic (2.34e-1)" "unprognostic (9.65e-2)" "unprognostic (7.85e-3)" 11.4 13.3 15.0 8.8 16.4 3.3 12.8 11.6 17.7 9.2 15.8 12.6 9.5 15.7 8.7 11.7 12.1 10.9 9.8 27.3 13.7 13.5 22.3 20.1 7.8 8.9 17.0 10.7 11.5 18.8 21.7 9.3 9.2 13.5 12.7 17.2 9.6 10.7 13.8 32.2 8.9 12.7 15.3 11.1 9.6 11.9 9.4 14.3 7.2 13.4 12.4 13.2 14.0 16.4 14.1 19.8 7.9 18.1 16.6 14.3 8.6 8.0 16.7 8.7 8.6 7.6 8.6 25.4 8.7 8.1 10.8 9.5 9.8 6.6 17.4 8.6 6.6 6.6 18.0 18.0 13.3 10.8 18.0 20.3 12.4 13.0 12.7 13.6 8.8 7.5 19.2 17.6 28.3 12.0 21.0 15.6 11.4 17.0 17.0 8.2 13.4 22.6 12.3 8.8 37.0 12.1 8.8 7.2 8.9 9.8 31.6 12.6 15.1 13.9 4.3 9.9 7.2 12.2 15.8 8.7 23.0 17.3 9.8 21.1 7.2 5.7 12.5 7.9 6.6 18.1 11.4 11.2 11.0 9.9 19.8 14.1 14.3 9.7 5.4 16.6 17.5 8.1 12.2 8.6 15.0 16.4 11.6 17.7 13.7 13.5 17.0 10.7 13.5 14.3 CHCHD5 "C2orf9, MGC11104, MIC14, MIX14" ENSG00000125611 "Coiled-coil-helix-coiled-coil-helix domain containing 5" Q9BSY4 2 112584240-112589275 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038263 Approved Supported Mitochondria Mitochondria "HPA038263: AB_10671525" "unprognostic (3.56e-2)" "unprognostic (3.41e-2)" "unprognostic (3.36e-2)" "unprognostic (4.57e-2)" "unprognostic (1.85e-1)" "unprognostic (7.75e-2)" "unprognostic (2.72e-1)" "unprognostic (7.18e-3)" "unprognostic (8.04e-2)" "unprognostic (4.96e-2)" "unprognostic (2.07e-1)" "unprognostic (4.95e-2)" "unprognostic (1.39e-2)" "unprognostic (3.91e-2)" "unprognostic (2.36e-1)" "unprognostic (1.87e-1)" "unprognostic (1.12e-2)" 12.7 17.8 15.1 11.4 15.0 15.7 15.6 9.0 13.4 10.5 12.4 11.7 19.8 17.5 11.4 17.5 16.2 20.0 16.7 20.3 12.0 12.1 20.3 36.6 12.9 17.6 16.7 11.4 10.7 36.8 10.2 20.0 11.9 10.1 13.4 6.5 11.0 12.6 37.7 33.3 12.9 16.1 11.8 12.1 11.7 15.2 50.0 12.9 20.7 20.2 23.4 8.6 13.0 12.1 27.9 40.2 32.1 35.4 28.6 37.1 28.6 13.4 22.5 10.1 0.0 4.1 8.8 9.6 5.9 7.8 12.3 8.8 24.4 16.6 10.3 23.7 8.2 9.9 3.8 13.2 1.6 11.1 18.4 13.9 7.3 19.2 18.2 11.8 9.8 11.7 11.3 16.2 10.0 6.7 14.4 15.7 7.7 33.4 10.5 18.6 11.2 11.1 0.3 8.4 20.2 16.1 12.3 12.9 14.5 7.5 11.4 13.2 14.6 10.5 9.3 12.3 17.5 7.4 8.5 28.3 26.6 11.9 17.1 3.2 14.5 11.1 35.4 32.1 26.3 31.6 22.3 24.0 25.1 24.9 31.8 27.9 26.1 26.9 19.2 28.6 28.7 40.2 37.1 28.6 15.1 15.0 9.0 13.2 12.0 12.1 16.7 11.4 10.1 12.9 CHCHD6 "CHCM1, MGC13016, Mic25, PPP1R23" ENSG00000159685 "Coiled-coil-helix-coiled-coil-helix domain containing 6" Q9BRQ6 3 126704220-126960406 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Cancer enhanced" "Detected in all" "melanoma: 34.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047673, HPA051975" Approved Supported Mitochondria Mitochondria "HPA047673: AB_10961761, HPA051975: " "unprognostic (3.94e-2)" "prognostic favourable (7.46e-4)" "unprognostic (6.20e-2)" "unprognostic (1.91e-2)" "unprognostic (2.60e-1)" "unprognostic (1.16e-1)" "unprognostic (6.83e-3)" "unprognostic (1.87e-1)" "unprognostic (1.47e-1)" "unprognostic (1.31e-1)" "unprognostic (6.79e-2)" "unprognostic (2.08e-1)" "prognostic favourable (6.76e-4)" "unprognostic (6.47e-2)" "unprognostic (2.27e-1)" "unprognostic (2.79e-1)" "unprognostic (3.11e-3)" 5.5 13.8 23.2 5.8 20.8 3.8 8.7 8.9 27.0 7.4 5.3 8.7 4.9 4.1 6.7 5.6 7.2 14.6 5.6 11.6 31.1 17.0 7.5 6.1 8.3 3.7 15.3 18.8 14.5 15.1 6.7 7.7 4.4 11.4 7.0 3.4 7.6 14.2 8.9 4.0 8.1 4.6 5.8 9.9 4.8 7.4 34.0 7.6 3.3 12.3 5.9 4.3 5.0 7.4 10.5 6.3 1.8 3.5 6.3 11.1 4.3 18.6 10.9 9.7 23.4 3.4 5.3 5.6 7.2 4.9 8.5 8.2 15.0 8.2 8.2 16.8 4.3 11.0 7.2 19.8 4.2 2.2 19.7 6.7 8.0 14.6 10.3 14.7 4.5 5.3 12.1 4.1 8.7 5.5 6.1 4.9 7.4 14.0 21.4 14.6 11.6 12.4 11.5 14.8 19.7 7.4 8.1 17.8 11.1 7.4 12.7 23.0 7.4 5.5 4.9 9.5 11.9 12.8 7.4 6.3 2.9 10.1 10.7 4.8 8.8 0.0 2.3 1.8 6.9 3.5 8.7 7.8 9.8 8.1 6.3 10.5 9.5 11.1 0.0 6.3 3.3 4.4 8.9 4.3 23.2 20.8 8.9 25.6 31.1 17.0 15.3 18.8 11.4 7.6 CIAPIN1 Anamorsin ENSG00000005194 "Cytokine induced apoptosis inhibitor 1" Q6FI81 16 57428169-57447528 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041350, HPA042182" Enhanced Supported Mitochondria 6400 Mitochondria "HPA041350: AB_10796665, HPA042182: AB_10794646" "unprognostic (1.78e-2)" "unprognostic (9.62e-2)" "unprognostic (6.44e-2)" "unprognostic (2.23e-1)" "unprognostic (1.73e-2)" "prognostic unfavourable (4.35e-4)" "unprognostic (1.41e-3)" "unprognostic (8.15e-3)" "unprognostic (1.99e-1)" "unprognostic (2.48e-2)" "unprognostic (4.70e-3)" "unprognostic (1.62e-1)" "prognostic favourable (4.42e-4)" "unprognostic (5.61e-2)" "unprognostic (3.86e-2)" "unprognostic (8.90e-3)" "unprognostic (1.16e-1)" 13.5 21.0 12.8 12.6 19.1 11.5 12.2 18.3 29.3 10.6 19.3 14.8 8.7 14.5 11.9 10.7 18.9 10.8 15.9 23.9 12.8 16.5 20.7 19.7 13.1 14.1 15.6 17.6 10.5 17.2 18.9 11.9 21.8 21.0 11.7 17.3 14.2 15.0 11.3 35.3 17.5 15.0 14.2 10.6 14.4 13.7 44.0 10.7 19.2 15.8 18.0 20.9 13.1 12.1 22.7 32.4 17.3 27.5 27.5 48.8 45.5 15.9 23.8 25.6 19.8 14.7 10.1 22.2 18.8 15.9 32.6 15.3 26.7 13.0 17.1 27.1 14.1 30.8 34.2 25.0 28.2 10.0 20.9 22.0 20.9 28.0 24.1 26.7 22.9 16.0 27.6 23.4 29.9 31.7 30.8 10.6 18.6 15.8 26.4 21.4 34.8 35.0 49.4 30.8 35.8 21.7 18.1 22.6 28.3 40.1 28.7 18.1 21.0 23.4 20.3 14.3 18.7 14.4 20.8 28.2 35.9 57.3 17.4 25.7 22.5 13.9 27.5 17.3 26.9 25.7 24.8 22.7 22.7 28.3 32.4 22.3 48.8 43.0 6.7 27.5 20.8 27.7 24.3 45.5 12.8 19.1 18.3 29.3 12.8 16.5 15.6 17.6 21.0 10.7 CISD1 "C10orf70, MDS029, mitoNEET, ZCD1" ENSG00000122873 "CDGSH iron sulfur domain 1" Q9NZ45 10 58269058-58289586 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 63.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074383 Supported Mitochondria Mitochondria "HPA074383: " "prognostic unfavourable (1.11e-4)" "unprognostic (8.60e-3)" "unprognostic (1.07e-1)" "unprognostic (4.10e-3)" "unprognostic (2.41e-2)" "unprognostic (3.22e-2)" "prognostic unfavourable (4.15e-4)" "unprognostic (1.87e-2)" "unprognostic (2.35e-1)" "unprognostic (7.78e-2)" "unprognostic (1.33e-2)" "unprognostic (7.23e-2)" "unprognostic (1.34e-3)" "unprognostic (4.19e-2)" "unprognostic (7.20e-2)" "unprognostic (8.07e-2)" "prognostic unfavourable (6.69e-4)" 4.7 8.9 14.0 5.4 21.6 1.4 5.4 14.8 24.9 6.2 10.3 3.7 3.6 17.8 5.2 3.9 9.5 5.7 6.4 32.1 16.2 17.6 20.8 13.2 4.1 4.9 14.7 19.5 6.4 4.8 63.1 10.5 5.0 16.6 6.9 7.7 5.8 8.0 6.7 43.9 7.2 16.7 8.9 9.0 4.2 6.4 3.0 6.0 3.5 8.7 20.4 5.1 8.3 4.4 7.6 9.5 3.0 5.8 6.1 8.3 5.1 11.9 6.1 4.9 8.9 6.6 7.4 2.9 10.2 11.7 10.2 14.1 14.4 11.3 21.4 8.6 10.5 7.9 13.2 9.1 9.2 9.6 17.9 5.6 10.2 11.5 7.5 9.9 4.4 9.2 7.5 9.7 14.9 11.9 12.4 10.0 7.1 4.0 8.4 10.7 5.2 19.2 6.5 18.1 11.2 13.7 4.2 15.5 5.5 7.8 20.9 7.2 13.9 5.3 11.7 4.4 7.9 12.6 12.0 10.2 16.7 16.1 11.8 9.9 4.2 0.0 5.8 0.3 5.7 4.2 6.7 7.6 6.6 6.6 9.5 6.0 7.7 7.5 3.0 6.1 2.6 6.2 8.3 5.1 14.0 21.6 14.8 24.9 16.2 17.6 14.7 19.5 16.6 6.0 CLPP ENSG00000125656 "Caseinolytic mitochondrial matrix peptidase proteolytic subunit" Q16740 19 6361452-6368910 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010649 Supported Supported Mitochondria Mitochondria "HPA010649: AB_1078538" "unprognostic (2.28e-1)" "unprognostic (7.14e-2)" "unprognostic (2.82e-1)" "unprognostic (4.34e-2)" "unprognostic (2.17e-2)" "unprognostic (1.15e-2)" "unprognostic (6.17e-3)" "unprognostic (7.43e-2)" "unprognostic (2.76e-1)" "unprognostic (1.31e-1)" "prognostic favourable (6.50e-4)" "unprognostic (1.21e-1)" "unprognostic (5.65e-2)" "unprognostic (6.97e-2)" "unprognostic (1.83e-1)" "unprognostic (1.03e-1)" "unprognostic (5.86e-3)" 22.1 27.3 18.4 22.5 18.8 20.1 19.9 16.6 20.9 16.1 23.2 17.9 22.2 25.4 16.9 15.1 26.6 15.3 19.2 28.9 17.4 16.7 28.5 64.7 15.5 35.5 19.0 15.2 23.7 32.7 11.6 18.5 18.4 13.6 19.1 14.1 18.6 26.3 23.4 73.1 17.8 26.0 14.8 16.7 21.2 21.3 21.1 11.4 54.8 27.0 25.1 25.3 20.7 23.2 29.7 37.5 14.9 20.0 27.6 46.3 32.9 31.6 21.1 15.4 28.1 9.7 13.5 16.0 18.8 13.8 26.8 24.0 16.9 11.6 31.9 29.3 15.0 19.8 15.2 23.7 10.1 33.1 47.9 23.5 18.6 25.0 26.3 21.2 31.1 17.1 17.4 18.6 20.8 26.0 23.2 43.2 17.5 37.0 36.3 22.2 22.2 49.4 25.6 18.6 48.3 19.9 17.7 25.5 24.4 11.9 29.1 27.6 15.0 30.4 18.1 17.7 16.4 41.6 35.4 55.6 46.4 30.7 24.3 29.9 28.1 5.5 20.0 10.5 28.0 17.7 33.2 28.3 39.9 34.5 24.1 29.7 35.2 34.1 14.9 27.6 12.1 37.5 46.3 32.9 18.4 18.8 16.6 20.9 17.4 16.7 19.0 15.2 13.6 11.4 CMC2 "C16orf61, DC13, MGC45036" ENSG00000103121 "C-X9-C motif containing 2" Q9NRP2 16 80966448-81020270 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006871, CAB026396" Approved Supported Mitochondria Mitochondria "CAB026396: , HPA006871: AB_1845581" "unprognostic (2.43e-1)" "unprognostic (3.63e-2)" "unprognostic (1.70e-1)" "unprognostic (3.52e-2)" "unprognostic (1.50e-1)" "unprognostic (3.01e-3)" "unprognostic (2.48e-2)" "unprognostic (6.36e-2)" "unprognostic (9.20e-2)" "unprognostic (3.84e-3)" "unprognostic (3.48e-2)" "unprognostic (4.57e-3)" "prognostic favourable (2.64e-5)" "unprognostic (1.08e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-1)" "unprognostic (2.68e-1)" 8.2 17.0 31.5 8.9 30.9 25.5 15.0 18.7 28.7 7.2 11.8 22.2 8.7 12.8 6.4 11.9 12.5 5.5 11.5 42.3 28.3 27.9 24.7 29.1 9.5 13.3 30.7 16.0 5.7 19.7 19.2 11.1 11.0 23.9 15.2 11.8 7.0 10.3 9.3 32.0 6.2 13.5 10.6 27.8 9.5 13.5 28.1 20.3 9.8 10.3 13.0 11.0 11.8 7.0 21.9 25.3 20.1 17.9 24.7 34.6 10.3 21.8 31.2 23.4 14.0 7.8 7.9 13.8 22.2 10.1 19.8 10.2 21.3 15.0 10.1 16.6 10.6 15.8 15.9 12.9 26.3 14.8 19.1 15.4 22.3 22.7 12.8 12.6 26.4 6.8 7.3 23.9 13.5 17.5 36.4 13.6 19.2 41.7 19.7 41.0 13.8 18.8 24.8 12.7 12.9 15.3 11.0 19.7 11.4 33.8 12.0 25.4 23.9 11.7 10.1 18.0 25.3 17.3 22.3 14.0 30.4 56.2 13.7 16.4 20.9 14.9 16.6 20.1 17.4 16.0 16.3 21.9 22.1 17.9 17.8 18.9 15.7 17.8 7.1 24.7 17.9 25.3 34.6 10.3 31.5 30.9 18.7 28.7 28.3 27.9 30.7 16.0 23.9 20.3 CMC4 "MTCP1, MTCP1NB, p8, P8MTCP1" ENSG00000182712 "C-X9-C motif containing 4" P56277 X 155061622-155071362 "Disease related genes, Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 36.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045866 Approved Supported Mitochondria Mitochondria "HPA045866: AB_10964642" "unprognostic (4.54e-3)" "unprognostic (7.31e-2)" 11.5 9.2 13.4 9.2 12.6 6.2 26.7 7.1 8.9 11.0 11.3 6.7 13.2 9.7 9.9 13.6 12.5 8.9 8.3 49.6 10.9 10.0 12.0 21.8 15.0 26.2 13.7 5.7 11.9 34.6 7.1 11.4 6.8 11.6 10.5 6.0 7.6 14.5 12.6 21.2 8.2 11.4 15.2 15.8 8.3 8.5 7.3 7.4 5.4 14.5 10.0 7.7 12.4 8.7 11.3 10.8 11.8 7.5 12.0 9.0 4.6 19.6 5.0 3.0 6.6 8.4 8.1 4.7 3.9 5.6 5.6 9.5 3.7 3.8 13.5 10.3 4.3 6.5 4.0 5.2 4.0 14.3 10.1 2.2 3.4 4.5 8.6 4.2 3.1 7.7 8.5 5.8 7.6 4.7 2.2 5.0 5.8 7.4 5.6 7.9 1.8 14.3 4.3 7.0 8.8 6.3 1.2 6.2 5.1 5.2 5.8 6.8 4.3 2.4 5.5 8.6 5.3 5.5 5.2 20.3 20.4 36.0 8.1 9.7 5.6 1.1 7.5 11.8 9.0 4.2 8.7 11.0 7.1 8.3 10.8 11.3 2.2 5.9 0.8 12.0 1.5 2.1 8.2 4.6 13.4 12.6 7.1 8.9 10.9 10.0 13.7 5.7 11.6 7.4 CMPK2 "NDK, TYKi, UMP-CMPK2" ENSG00000134326 "Cytidine/uridine monophosphate kinase 2" Q5EBM0 2 6840570-6866635 "Enzymes, Predicted intracellular proteins" "Pyrimidine biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 13.9;BJ hTERT+ SV40 Large T+ RasG12V: 12.7;HEL: 19.7;MOLT-4: 10.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041430 Approved Approved Mitochondria Mitochondria "HPA041430: AB_10796674" "unprognostic (2.37e-1)" "unprognostic (6.07e-2)" "unprognostic (5.71e-2)" "prognostic unfavourable (4.71e-4)" "unprognostic (1.82e-1)" "unprognostic (5.08e-2)" "unprognostic (3.80e-2)" "unprognostic (8.93e-2)" "unprognostic (6.63e-2)" "unprognostic (4.54e-3)" "unprognostic (7.39e-3)" "unprognostic (1.43e-1)" "unprognostic (1.09e-3)" "unprognostic (1.28e-1)" "unprognostic (1.77e-2)" "unprognostic (7.69e-2)" "unprognostic (4.32e-2)" 8.8 3.8 3.0 6.8 8.1 14.5 4.2 0.9 5.0 2.7 4.2 4.0 1.3 5.0 2.5 6.4 1.8 2.3 3.4 3.7 3.3 3.9 4.0 3.1 17.9 13.4 3.2 5.7 1.3 3.7 2.9 3.0 4.7 3.6 2.1 2.2 4.7 20.8 4.3 3.0 1.2 6.1 3.1 3.8 7.9 7.4 9.2 0.4 8.8 3.1 1.6 2.6 2.7 1.6 1.4 1.9 7.8 6.4 0.9 0.7 1.2 0.2 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.2 13.9 12.7 0.0 1.4 3.1 0.8 0.0 0.2 0.0 0.0 0.0 0.3 0.2 19.7 0.0 0.0 0.0 0.6 1.4 0.0 0.0 0.1 0.0 0.0 4.8 0.1 0.0 0.1 10.8 3.6 0.3 1.0 3.4 0.0 0.0 0.0 0.4 0.3 0.5 0.2 0.0 1.7 0.0 1.3 0.0 0.0 0.2 0.0 0.0 3.3 0.4 0.0 0.0 3.6 0.8 5.5 2.8 7.8 0.7 6.4 0.4 1.4 0.5 0.4 1.9 0.2 0.5 0.5 1.8 0.9 3.2 0.1 0.6 1.2 3.0 8.1 0.9 5.0 3.3 3.9 3.2 5.7 3.6 0.4 COA1 "C7orf44, FLJ10803, MITRAC15" ENSG00000106603 "Cytochrome c oxidase assembly factor 1 homolog" Q9GZY4 7 43608456-43729717 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA011944 Approved Supported Mitochondria Mitochondria "HPA011944: AB_1848671" "unprognostic (1.16e-1)" "unprognostic (1.50e-1)" "unprognostic (2.22e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (2.85e-3)" "prognostic unfavourable (7.84e-5)" "unprognostic (2.21e-1)" "unprognostic (4.42e-2)" "unprognostic (2.22e-2)" "unprognostic (5.22e-2)" "unprognostic (6.74e-2)" "unprognostic (1.52e-1)" "unprognostic (3.52e-1)" "unprognostic (1.02e-2)" "unprognostic (2.56e-2)" "unprognostic (5.39e-2)" 13.8 16.2 22.4 14.4 21.7 17.6 14.5 13.8 24.0 11.8 10.9 14.4 17.4 11.4 14.8 14.3 15.1 9.6 10.9 47.8 19.7 18.5 23.4 14.4 11.9 24.2 23.0 13.2 11.1 23.9 9.4 22.1 11.3 17.4 10.9 14.7 17.9 17.5 17.7 55.5 7.0 12.6 9.7 19.9 16.2 14.5 11.8 14.3 16.2 15.8 22.4 28.3 14.8 8.8 21.0 17.9 24.2 17.2 18.6 21.0 14.4 10.6 28.7 23.8 23.5 7.0 7.9 15.9 15.0 25.7 20.3 21.2 21.9 24.5 20.3 25.3 9.1 15.6 27.5 23.0 25.8 18.2 25.2 25.2 17.0 20.1 11.6 19.6 11.2 6.5 14.8 14.8 22.0 18.5 42.7 17.7 16.6 14.6 28.8 49.3 14.9 20.8 17.5 21.8 37.5 24.9 12.0 14.7 26.3 15.0 27.9 9.6 20.9 13.2 13.7 10.1 22.1 9.9 21.1 42.6 34.4 36.4 28.8 25.3 26.9 1.3 15.3 16.0 12.9 17.2 9.5 19.7 12.0 13.2 17.9 21.0 16.9 21.0 24.2 18.6 14.6 16.0 11.5 14.4 22.4 21.7 13.8 24.0 19.7 18.5 23.0 13.2 17.4 14.3 COA3 "CCDC56, COX25, HSPC009, MITRAC12" ENSG00000183978 "Cytochrome c oxidase assembly factor 3" Q9Y2R0 17 42795147-42798704 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031966 Approved Supported Mitochondria Mitochondria "HPA031966: AB_10602115" "unprognostic (1.20e-1)" "prognostic favourable (3.40e-4)" "unprognostic (5.65e-2)" "prognostic favourable (8.93e-4)" "unprognostic (7.62e-2)" "unprognostic (2.19e-1)" "unprognostic (4.78e-2)" "unprognostic (1.16e-2)" "unprognostic (1.48e-1)" "unprognostic (2.25e-2)" "unprognostic (8.44e-3)" "unprognostic (1.52e-1)" "prognostic favourable (6.62e-4)" "unprognostic (1.64e-1)" "unprognostic (2.70e-1)" "unprognostic (3.16e-2)" "unprognostic (3.01e-2)" 13.4 17.8 34.5 11.1 26.7 4.6 20.6 19.5 31.8 18.7 33.7 18.0 18.2 35.9 14.0 62.6 30.2 26.2 20.0 26.3 29.3 26.0 57.2 44.1 13.7 14.1 31.2 22.2 17.0 97.0 16.2 15.0 17.8 26.1 22.0 31.6 14.9 30.3 25.1 28.7 12.6 33.5 14.5 21.6 12.2 27.1 9.5 17.1 13.1 22.8 28.6 19.8 14.1 18.1 56.1 49.2 46.0 59.1 46.2 50.5 59.7 16.0 54.5 25.1 13.7 23.2 19.8 15.5 12.6 19.3 30.3 27.5 21.5 20.4 0.9 35.9 15.4 15.7 19.3 30.9 28.7 15.7 50.7 10.8 25.7 67.9 16.5 14.6 13.2 20.0 23.3 28.5 16.4 24.0 17.3 14.0 26.8 26.4 4.8 32.1 11.4 19.7 19.2 36.7 27.6 30.7 22.2 18.7 15.7 12.9 13.7 21.9 42.7 19.2 14.6 33.2 17.3 14.0 16.7 16.5 17.8 8.6 24.9 14.6 22.4 46.0 59.1 36.8 39.8 54.9 41.6 56.1 41.4 40.2 49.2 51.2 38.4 38.2 6.3 46.2 45.5 32.9 50.5 59.7 34.5 26.7 19.5 31.8 29.3 26.0 31.2 22.2 26.1 17.1 COA5 "C2orf64, FLJ27524, MGC52110, Pet191" ENSG00000183513 "Cytochrome c oxidase assembly factor 5" Q86WW8 2 98599310-98608515 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057768 Uncertain Supported Mitochondria Mitochondria "HPA057768: " "unprognostic (1.00e-1)" "unprognostic (4.19e-2)" "unprognostic (3.85e-2)" "unprognostic (1.67e-3)" "unprognostic (2.61e-2)" "unprognostic (7.11e-2)" "unprognostic (4.69e-2)" "prognostic favourable (2.65e-4)" "unprognostic (1.32e-3)" "unprognostic (3.71e-3)" "unprognostic (8.00e-3)" "unprognostic (3.08e-2)" "unprognostic (1.40e-1)" "unprognostic (1.29e-1)" "unprognostic (4.93e-2)" "unprognostic (2.50e-1)" "prognostic favourable (1.00e-5)" 13.7 21.4 30.9 12.2 29.3 9.1 20.6 31.3 28.2 18.6 15.0 20.3 18.5 15.4 20.2 33.5 11.1 20.5 13.4 19.3 28.3 26.5 28.1 23.4 13.9 15.8 30.7 29.0 23.6 16.8 21.0 19.1 14.2 23.4 19.8 15.9 13.7 16.2 20.3 30.7 18.0 13.5 14.7 32.7 15.6 16.0 15.6 21.5 15.3 24.5 10.1 16.1 13.9 15.0 24.7 30.3 28.1 25.5 18.1 30.0 22.0 12.7 5.4 16.9 12.3 19.9 16.5 14.1 7.4 5.9 8.0 8.4 11.0 11.0 6.5 13.5 5.9 9.0 14.7 7.8 9.7 16.8 13.7 9.0 11.1 18.0 14.5 8.5 8.4 15.9 17.0 5.6 7.4 8.6 12.6 7.6 8.8 10.7 11.4 15.2 11.7 12.0 7.0 12.6 14.2 17.5 6.9 12.9 16.3 6.3 7.8 18.5 9.7 18.0 7.5 12.3 11.0 7.3 6.1 12.4 17.4 8.2 14.8 19.0 10.0 18.2 25.5 28.0 25.2 22.7 21.9 23.5 23.0 24.1 24.1 24.7 28.1 27.9 28.1 18.1 23.7 30.3 30.0 22.0 30.9 29.3 31.3 25.9 28.3 26.5 30.7 29.0 23.4 21.5 COQ4 CGI-92 ENSG00000167113 "Coenzyme Q4" Q9Y3A0 9 128322536-128334072 "Disease related genes, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021406, HPA042945" Supported Supported Mitochondria Mitochondria "HPA021406: , HPA042945: AB_10961047" "unprognostic (9.15e-2)" "prognostic favourable (2.97e-5)" "unprognostic (2.29e-1)" "prognostic favourable (4.93e-6)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (1.25e-1)" "unprognostic (1.04e-1)" "unprognostic (7.51e-2)" "unprognostic (2.11e-1)" "unprognostic (1.31e-3)" "unprognostic (2.89e-2)" "prognostic favourable (5.76e-6)" "unprognostic (6.21e-3)" "unprognostic (1.98e-1)" "unprognostic (1.42e-1)" "unprognostic (5.14e-3)" 15.5 29.4 22.6 21.4 29.9 12.2 25.4 20.7 33.8 19.8 23.0 15.7 34.8 53.8 14.8 30.5 32.8 37.7 24.0 23.9 22.6 21.7 31.8 33.4 28.9 28.6 18.9 31.4 18.1 43.8 24.7 30.7 13.1 27.7 22.2 18.0 15.2 32.9 50.7 29.6 31.6 37.3 20.1 25.7 15.9 23.1 17.5 14.3 13.6 34.5 25.0 16.7 18.5 17.9 18.3 28.2 8.0 15.5 14.1 21.1 13.2 11.0 16.7 10.1 11.1 7.4 10.5 18.3 9.8 6.4 12.8 9.1 14.3 13.9 14.9 8.7 7.5 31.7 8.6 11.6 4.8 7.2 17.2 5.4 36.0 15.9 12.2 15.5 8.3 12.2 13.6 10.6 11.6 10.1 36.2 10.2 8.1 30.7 18.9 11.9 11.2 19.6 18.5 14.0 28.3 15.7 10.9 18.9 13.5 19.1 22.8 11.9 29.3 5.3 13.8 12.2 11.4 17.6 13.1 17.4 14.3 12.2 15.5 7.5 8.4 7.8 14.2 8.0 21.1 15.5 19.1 18.3 19.2 20.9 17.7 16.0 15.5 18.9 1.8 14.1 15.2 28.2 15.2 13.2 22.6 29.9 20.7 33.8 22.6 21.7 18.9 31.4 27.7 14.3 COQ8A "ADCK3, CABC1, COQ8, SCAR9" ENSG00000163050 "Coenzyme Q8A" Q8NI60 1 226897536-226987545 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Kinase, Transferase" "Disease mutation, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 216.5" "Cell line enhanced" "Detected in many" "HEK 293: 33.0;RPMI-8226: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061662 Supported Mitochondria Mitochondria "HPA061662: " "unprognostic (6.37e-3)" "unprognostic (2.09e-2)" "unprognostic (2.29e-1)" "unprognostic (9.06e-2)" "unprognostic (8.94e-2)" "unprognostic (2.49e-1)" "unprognostic (4.42e-2)" "unprognostic (3.50e-3)" "unprognostic (1.81e-1)" "unprognostic (4.02e-1)" "unprognostic (4.15e-3)" "unprognostic (8.67e-2)" "unprognostic (2.40e-2)" "unprognostic (9.24e-2)" "unprognostic (2.82e-1)" "unprognostic (8.88e-2)" "unprognostic (2.62e-1)" 13.3 25.4 2.8 2.7 4.5 5.3 8.5 14.5 3.9 3.2 7.3 4.1 4.2 6.9 3.6 5.5 7.3 5.0 6.1 41.0 2.7 1.8 3.8 17.7 2.7 4.1 5.0 2.4 7.2 20.3 1.6 1.6 2.0 3.8 6.5 2.0 1.9 7.2 5.0 216.5 4.4 4.4 7.8 2.9 3.5 8.8 3.0 4.7 2.7 4.6 50.2 5.8 10.2 3.5 15.2 9.3 32.3 11.5 9.9 11.8 11.6 3.2 5.8 1.5 4.5 4.7 3.1 23.6 1.5 1.3 2.2 2.9 9.2 5.2 9.5 7.3 1.0 3.7 2.9 3.3 0.5 9.9 33.0 6.6 4.8 15.1 1.0 10.0 4.1 5.9 5.1 1.7 2.3 1.0 11.4 7.8 0.3 4.3 5.8 14.7 6.4 12.0 5.7 7.1 30.2 0.7 2.4 24.3 9.9 3.0 11.8 8.5 6.2 13.6 1.2 2.5 2.3 3.5 5.5 17.6 15.4 5.0 2.3 11.4 2.4 19.7 11.5 32.3 8.7 8.6 8.3 12.1 8.5 7.7 9.3 15.2 11.8 9.0 21.9 9.9 6.5 4.1 10.6 11.6 2.8 4.5 14.5 3.9 2.7 1.8 5.0 2.4 3.8 4.7 COQ8B "ADCK4, COQ8, FLJ12229" ENSG00000123815 "Coenzyme Q8B" Q96D53 19 40691529-40718207 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027229, HPA027277, HPA027279, HPA028303" Supported Enhanced Mitochondria Mitochondria "HPA027229: AB_10600100, HPA027277: AB_10599857, HPA027279: AB_10601219, HPA028303: AB_2672551" "unprognostic (7.57e-2)" "unprognostic (9.48e-2)" "unprognostic (1.61e-1)" "unprognostic (2.36e-2)" "unprognostic (2.33e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (4.63e-2)" "unprognostic (1.85e-1)" "unprognostic (2.27e-1)" "unprognostic (2.82e-2)" "unprognostic (1.48e-1)" "unprognostic (2.93e-2)" "unprognostic (6.18e-2)" "unprognostic (1.46e-1)" "unprognostic (7.17e-2)" "unprognostic (2.65e-2)" 13.6 17.8 21.1 13.1 16.4 11.5 10.0 24.1 19.2 13.6 13.6 18.6 14.8 17.9 15.0 13.2 16.6 26.5 16.7 14.7 15.7 10.7 11.8 15.6 12.1 12.2 15.5 12.1 16.3 19.4 12.6 32.7 7.9 13.2 15.1 5.7 12.3 16.8 17.6 10.3 12.9 18.6 16.2 15.6 12.1 17.5 12.5 16.7 16.8 15.5 6.9 13.2 14.8 11.8 12.9 15.0 17.7 15.6 9.7 13.1 10.5 8.2 33.7 6.9 13.3 6.2 6.0 6.4 7.7 8.3 5.8 6.2 10.5 15.0 11.0 14.9 4.4 7.1 4.8 8.6 2.1 13.2 10.0 10.6 20.5 5.8 10.7 3.6 16.5 7.9 9.2 4.2 5.1 6.5 5.6 6.0 4.0 5.0 4.7 4.4 5.3 3.5 7.9 9.7 8.3 10.1 13.9 12.4 10.1 10.3 15.8 16.7 14.2 13.8 6.1 5.0 17.0 3.6 4.5 6.7 5.4 5.6 18.9 4.2 6.9 15.8 15.6 14.6 11.6 15.4 13.1 12.9 9.0 12.4 15.0 11.7 8.9 9.1 17.7 9.7 13.7 8.7 8.8 10.5 21.1 16.4 24.1 19.2 15.7 10.7 15.5 12.1 13.2 16.7 COX14 "C12orf62, MGC14288" ENSG00000178449 "COX14, cytochrome c oxidase assembly factor" Q96I36 12 50111979-50120457 "Disease related genes, Predicted membrane proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044618, HPA062014" Approved Supported Mitochondria Mitochondria "HPA044618: AB_10960419, HPA062014: " "unprognostic (5.71e-2)" "unprognostic (1.86e-2)" "unprognostic (1.43e-1)" "unprognostic (4.04e-1)" "unprognostic (1.87e-2)" "unprognostic (3.66e-2)" "unprognostic (2.20e-2)" "unprognostic (4.20e-3)" "prognostic unfavourable (7.90e-4)" "unprognostic (7.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.34e-2)" "unprognostic (7.09e-3)" "unprognostic (3.24e-1)" "unprognostic (1.90e-1)" "unprognostic (1.84e-2)" "unprognostic (3.07e-3)" 33.1 30.2 25.9 16.7 33.7 17.5 27.8 46.4 28.9 18.5 24.0 16.7 29.7 28.1 13.9 34.0 17.6 17.1 22.1 60.1 23.4 24.9 39.5 40.4 18.2 18.6 29.6 28.7 16.6 19.6 19.5 26.1 15.0 27.8 18.5 22.0 25.1 26.4 30.5 75.4 13.1 27.1 20.5 24.8 19.0 20.9 8.4 26.6 8.7 25.4 38.5 16.7 19.3 21.8 56.8 65.7 56.4 52.2 38.7 58.6 52.5 16.4 31.6 7.0 15.9 31.1 19.1 14.0 12.7 16.4 18.7 16.2 30.1 21.3 15.5 36.6 15.4 16.0 11.8 17.9 16.2 17.0 44.5 30.4 28.0 24.3 13.0 23.7 27.1 24.0 24.8 14.0 16.3 17.1 14.7 30.2 19.0 36.0 19.2 33.7 11.5 42.5 15.8 12.3 35.5 27.1 27.3 18.7 11.1 19.4 35.1 36.9 23.4 20.1 14.9 11.6 12.7 18.9 11.1 22.1 31.6 18.8 17.0 20.6 6.3 56.4 52.2 46.0 43.2 48.9 45.4 56.8 54.5 47.6 49.5 47.1 52.0 50.9 18.8 38.7 44.3 65.7 58.6 52.5 25.9 33.7 46.4 28.9 23.4 24.9 29.6 28.7 27.8 26.6 COX15 CEMCOX2 ENSG00000014919 "COX15, cytochrome c oxidase assembly homolog" Q7KZN9 10 99711844-99732100 "Disease related genes, Predicted membrane proteins" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037727, HPA037728, HPA066096" Uncertain Supported Mitochondria Mitochondria "HPA037727: AB_10672391, HPA037728: AB_10672463, HPA066096: " "unprognostic (9.74e-2)" "unprognostic (1.20e-1)" "unprognostic (1.99e-1)" "unprognostic (6.55e-3)" "unprognostic (1.50e-2)" "unprognostic (1.34e-1)" "unprognostic (5.36e-2)" "unprognostic (2.96e-1)" "unprognostic (6.84e-2)" "unprognostic (1.76e-1)" "unprognostic (3.40e-2)" "unprognostic (8.34e-2)" "prognostic favourable (9.21e-6)" "unprognostic (2.08e-2)" "unprognostic (2.21e-2)" "unprognostic (1.86e-2)" "unprognostic (3.40e-2)" 14.0 31.6 15.5 13.5 23.8 7.8 15.3 15.2 25.6 13.8 17.9 23.0 14.2 15.5 18.2 15.5 17.3 16.4 16.8 19.3 14.4 15.5 25.3 27.1 11.0 15.4 15.2 16.2 20.7 15.3 17.0 26.7 17.1 22.7 15.9 20.1 21.9 13.5 14.0 28.8 14.4 14.1 16.0 14.6 17.0 15.1 14.2 14.0 21.0 18.9 12.0 23.0 19.4 13.6 17.4 18.0 21.7 23.1 11.7 13.0 12.9 14.5 31.5 13.4 29.2 19.3 15.1 10.9 11.2 14.3 16.9 16.0 23.5 20.9 27.2 18.4 9.7 21.5 28.6 15.7 18.4 12.5 14.0 15.6 16.0 24.3 20.3 21.0 14.9 16.4 14.6 17.8 28.9 17.6 17.7 21.1 15.4 15.4 15.1 15.5 14.8 14.9 18.7 19.5 17.5 15.6 10.5 11.0 18.2 20.1 11.0 19.0 42.1 8.7 13.9 8.8 12.6 13.1 16.6 17.2 22.3 18.3 15.6 34.1 7.4 21.7 17.4 16.4 10.7 20.1 12.4 17.4 12.2 12.3 18.0 16.5 12.6 12.9 13.3 11.7 23.1 8.3 13.0 12.9 15.5 23.8 15.2 25.6 14.4 15.5 15.2 16.2 22.7 14.0 COX16 "C14orf112, HSPC203" ENSG00000133983 "COX16, cytochrome c oxidase assembly homolog" Q9P0S2 14 70325081-70359731 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062659 Uncertain Supported Mitochondria Mitochondria "HPA062659: " "unprognostic (5.44e-2)" "unprognostic (1.31e-1)" "unprognostic (2.68e-1)" "unprognostic (1.21e-2)" "unprognostic (3.63e-1)" "unprognostic (6.37e-3)" "unprognostic (1.80e-2)" "unprognostic (8.22e-2)" "unprognostic (1.88e-1)" "unprognostic (1.73e-2)" "unprognostic (6.80e-2)" "unprognostic (7.44e-2)" "prognostic favourable (1.03e-12)" "unprognostic (4.08e-1)" "unprognostic (1.73e-1)" "unprognostic (3.97e-1)" "unprognostic (1.72e-1)" 19.3 25.2 23.6 15.4 20.4 10.9 23.5 14.8 23.3 16.2 19.6 16.8 16.8 21.8 12.4 29.6 19.9 18.3 18.5 24.0 19.4 20.1 30.6 40.6 15.3 16.0 20.9 16.2 16.9 32.3 12.3 18.3 19.1 20.3 19.7 21.2 13.4 28.9 16.7 39.7 17.0 24.6 11.3 20.6 23.5 24.4 11.7 15.3 19.9 25.9 29.2 18.4 14.2 14.2 22.3 22.9 11.1 17.2 20.4 19.4 18.0 31.4 14.8 18.8 18.1 11.9 18.4 14.5 16.3 14.4 15.2 15.9 10.7 29.4 10.5 12.2 15.1 13.0 13.8 17.1 19.9 9.2 14.8 11.8 11.9 10.7 6.9 13.7 14.7 16.3 12.8 9.5 9.3 16.4 8.4 16.6 18.7 25.2 20.5 14.2 18.9 22.5 15.0 18.8 17.2 20.2 14.7 20.7 18.1 15.5 30.7 11.0 23.0 20.2 15.5 14.1 25.7 14.7 15.5 14.8 12.6 9.6 24.9 5.1 16.6 11.1 16.7 3.9 13.3 17.1 15.5 22.3 17.2 15.2 17.6 17.9 17.3 17.6 1.3 20.4 17.2 22.9 19.4 18.0 23.6 20.4 14.8 23.3 19.4 20.1 20.9 16.2 20.3 15.3 COX17 ENSG00000138495 "COX17, cytochrome c oxidase copper chaperone" Q14061 3 119654513-119677454 "Cancer-related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042226, HPA048158" Supported Supported Mitochondria 1000000 Mitochondria "HPA042226: , HPA048158: " "unprognostic (1.98e-2)" "unprognostic (3.49e-2)" "unprognostic (1.96e-2)" "unprognostic (8.29e-2)" "unprognostic (2.88e-2)" "unprognostic (6.63e-3)" "unprognostic (3.49e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-1)" "unprognostic (7.11e-3)" "unprognostic (2.12e-1)" "unprognostic (4.45e-2)" "unprognostic (1.33e-2)" "unprognostic (2.15e-2)" "unprognostic (1.65e-1)" "unprognostic (9.19e-2)" "unprognostic (2.64e-2)" 16.6 42.9 20.0 18.2 19.4 21.2 30.4 21.1 20.4 10.2 16.8 9.2 43.5 22.0 11.9 22.9 11.7 11.0 13.6 53.5 17.2 23.0 27.6 37.0 17.8 20.3 23.2 15.2 7.9 39.9 21.1 45.7 18.2 33.7 17.2 16.2 19.4 25.6 33.3 80.4 8.7 21.0 15.4 20.8 15.3 22.3 13.4 16.7 11.1 16.6 37.1 17.2 13.7 20.1 35.6 53.5 52.8 46.9 19.8 33.9 22.0 27.2 28.5 15.6 3.8 6.0 5.6 5.6 15.2 9.2 14.1 14.7 25.1 19.8 19.7 18.5 7.2 10.3 15.4 15.5 8.5 24.8 18.5 17.1 22.6 19.8 6.9 24.9 32.0 6.4 15.0 8.8 12.1 9.1 13.9 47.5 16.3 44.4 25.0 35.9 17.5 47.6 11.1 10.5 32.6 21.9 16.1 26.0 11.4 18.8 18.1 22.8 22.7 39.7 7.2 12.1 19.0 7.6 20.9 33.8 33.7 41.8 17.2 19.1 20.8 50.1 22.4 52.8 21.8 33.2 23.0 35.6 27.2 24.7 22.9 27.2 21.7 22.6 17.7 19.8 46.9 53.5 33.9 22.0 20.0 19.4 21.1 20.4 17.2 23.0 23.2 15.2 33.7 16.7 COX20 "FAM36A, FLJ43269" ENSG00000203667 "COX20, cytochrome c oxidase assembly factor" Q5RI15 1 244835322-244845057 "Disease related genes, Predicted membrane proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043617, HPA045490" Approved Enhanced Mitochondria Mitochondria "HPA043617: AB_10965694, HPA045490: AB_10962869" "unprognostic (5.84e-3)" "unprognostic (1.20e-1)" "unprognostic (7.33e-2)" "unprognostic (2.86e-1)" "unprognostic (3.62e-1)" "unprognostic (3.70e-2)" "unprognostic (1.07e-1)" "unprognostic (1.62e-1)" "unprognostic (1.03e-1)" "prognostic favourable (3.13e-4)" "unprognostic (1.99e-1)" "unprognostic (6.38e-2)" "unprognostic (3.44e-2)" "unprognostic (2.54e-2)" "unprognostic (3.70e-2)" "unprognostic (3.10e-1)" "unprognostic (7.02e-3)" 13.1 37.9 30.2 17.5 28.9 12.5 14.9 22.0 25.8 11.8 20.5 11.8 9.3 18.2 17.5 16.9 20.6 11.4 16.2 35.4 22.8 27.7 36.7 23.6 11.1 13.4 32.1 18.3 26.7 15.1 14.3 15.1 15.0 19.2 20.2 11.8 27.9 11.3 15.5 33.3 8.1 19.4 42.5 22.0 10.1 17.9 21.1 17.0 10.4 17.5 20.2 10.7 23.0 16.5 18.2 16.3 11.6 18.4 12.2 22.5 10.5 36.2 9.1 9.2 28.7 6.3 4.8 21.6 15.3 10.2 8.7 7.9 25.9 25.4 5.5 19.4 10.3 9.5 4.8 12.3 11.9 15.4 3.3 10.6 13.4 23.8 8.4 26.1 16.4 4.3 5.9 12.9 9.0 10.0 21.9 23.0 18.0 9.0 14.0 11.6 24.3 18.9 10.3 11.4 33.6 16.3 8.6 5.4 14.7 19.1 10.1 19.8 18.7 7.5 19.4 19.5 25.7 17.0 32.8 36.5 50.1 11.7 24.9 29.1 18.6 5.7 8.8 11.6 15.4 18.4 15.1 18.2 18.3 16.8 15.0 16.0 11.0 16.9 1.7 12.2 17.8 16.3 22.5 10.5 30.2 28.9 22.0 25.8 22.8 27.7 32.1 18.3 19.2 17.0 COX4I1 "COX4, COX4-1" ENSG00000131143 "Cytochrome c oxidase subunit 4I1" P13073 16 85798633-85807044 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002485, CAB004080" Supported Supported Mitochondria 970000 Mitochondria "CAB004080: AB_2085427, HPA002485: AB_1078559" "unprognostic (4.73e-2)" "unprognostic (9.14e-3)" "unprognostic (2.65e-1)" "unprognostic (6.18e-3)" "unprognostic (2.47e-1)" "unprognostic (4.52e-2)" "unprognostic (2.65e-1)" "unprognostic (1.46e-1)" "unprognostic (5.97e-2)" "unprognostic (7.82e-3)" "unprognostic (3.32e-2)" "unprognostic (2.29e-1)" "prognostic favourable (2.56e-8)" "unprognostic (4.23e-2)" "unprognostic (4.06e-1)" "unprognostic (1.01e-1)" "unprognostic (2.38e-2)" 41.6 38.6 101.1 54.0 100.2 66.5 60.6 51.6 86.9 38.1 87.1 38.9 43.9 77.6 33.9 69.3 54.7 50.4 59.8 218.6 82.3 73.0 59.7 69.5 29.6 49.1 100.1 65.9 45.4 71.2 55.7 36.3 36.8 57.0 37.6 98.4 40.6 65.9 53.1 172.3 48.0 76.5 51.2 58.4 40.1 56.5 21.8 38.7 46.6 49.1 112.6 70.2 47.1 52.4 123.0 144.1 74.8 130.8 74.7 121.9 222.6 44.1 72.0 48.9 65.3 90.7 85.1 84.5 40.3 82.5 76.4 38.2 121.7 66.9 72.4 49.6 64.2 88.9 69.6 81.0 68.0 24.6 71.9 40.4 60.9 118.2 81.8 36.6 30.1 98.6 125.8 62.5 85.4 79.7 67.9 29.7 64.7 159.1 73.4 113.6 65.7 84.8 83.3 30.8 63.3 113.3 87.6 58.2 47.3 85.4 54.3 65.3 79.6 102.4 56.0 38.3 44.4 35.2 43.1 60.0 57.0 166.4 58.5 72.7 43.0 50.9 130.8 74.8 72.5 112.8 88.4 123.0 96.3 85.0 144.1 116.1 121.9 100.0 50.7 74.7 98.6 107.7 102.7 222.6 101.1 100.2 51.6 86.9 82.3 73.0 100.1 65.9 57.0 38.7 COX5B ENSG00000135940 "Cytochrome c oxidase subunit 5B" P10606 2 97646040-97648383 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 336.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034517 Supported Enhanced Mitochondria 2200000 Mitochondria "HPA034517: AB_10603561" "unprognostic (4.61e-2)" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (1.39e-1)" "unprognostic (1.92e-2)" "unprognostic (2.48e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-1)" "unprognostic (2.72e-2)" "unprognostic (1.79e-2)" "unprognostic (4.20e-2)" "unprognostic (4.02e-2)" "unprognostic (3.32e-1)" "unprognostic (1.01e-1)" "unprognostic (1.34e-1)" "prognostic favourable (2.73e-4)" 39.8 25.3 54.5 20.8 46.1 27.6 23.9 22.6 46.4 19.5 58.6 16.0 27.6 44.5 13.1 22.3 31.9 19.4 24.0 160.6 39.9 36.0 44.8 52.5 13.8 16.1 48.1 32.5 17.7 24.6 19.9 17.5 18.1 39.0 21.5 31.5 14.3 36.5 29.2 336.2 18.9 38.6 19.9 30.8 17.9 40.4 13.4 23.0 14.2 25.8 65.4 15.3 19.4 16.7 85.1 111.2 115.8 122.5 48.1 83.6 145.2 19.5 22.9 14.1 23.4 16.7 15.2 61.0 25.2 14.1 16.7 18.7 63.1 20.5 33.0 54.2 16.1 29.9 16.3 25.3 7.6 25.7 69.2 44.4 25.3 75.3 32.1 42.2 32.6 28.1 22.4 16.1 12.6 14.3 32.6 14.6 12.9 48.4 26.6 61.1 27.8 120.1 26.1 24.3 49.4 22.5 30.1 28.1 30.0 24.5 29.6 47.3 15.7 44.1 26.0 15.3 26.1 24.5 16.2 38.1 36.0 25.2 27.8 36.2 15.8 96.9 122.5 99.8 54.7 114.1 52.6 85.1 66.3 57.1 111.2 68.8 64.5 57.5 115.8 48.1 95.9 75.8 83.6 145.2 54.5 46.1 22.6 46.4 39.9 36.0 48.1 32.5 39.0 23.0 COX6A1 COX6A ENSG00000111775 "Cytochrome c oxidase subunit 6A1" P12074 12 120438090-120440742 "Disease related genes, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062394 Approved Supported Mitochondria Mitochondria "HPA062394: " "unprognostic (1.18e-1)" "unprognostic (1.03e-2)" "unprognostic (5.10e-2)" "unprognostic (6.16e-2)" "unprognostic (1.47e-1)" "unprognostic (8.78e-2)" "unprognostic (3.33e-1)" "unprognostic (1.34e-1)" "unprognostic (1.09e-1)" "unprognostic (1.13e-2)" "unprognostic (3.22e-2)" "unprognostic (2.82e-1)" "prognostic favourable (6.50e-7)" "unprognostic (2.53e-1)" "unprognostic (1.31e-1)" "unprognostic (5.48e-2)" "unprognostic (2.63e-2)" 49.2 48.0 171.0 32.1 103.0 52.6 43.8 44.4 107.5 37.3 96.8 38.5 32.4 102.8 28.0 47.0 59.3 41.8 37.6 41.5 121.5 92.0 85.8 102.6 32.4 39.6 140.0 57.9 27.7 62.7 43.8 38.3 44.4 86.9 43.1 74.3 31.3 63.8 44.2 10.6 37.7 85.7 38.1 67.2 32.1 60.8 28.1 61.2 33.7 48.2 36.0 40.1 42.1 35.0 74.5 102.2 60.5 69.8 47.8 87.4 83.0 46.7 100.0 57.0 59.5 43.9 37.4 69.8 29.8 39.8 52.9 45.2 120.9 47.7 98.5 89.1 42.0 78.2 55.5 65.3 34.4 59.0 119.6 52.8 57.2 88.6 40.6 57.9 38.0 45.0 80.7 48.3 57.3 44.5 51.8 30.8 43.9 130.8 83.4 146.6 51.9 146.8 57.1 38.2 92.2 83.5 112.7 75.2 65.4 54.6 53.6 70.0 96.1 66.1 33.5 33.0 40.8 34.0 41.4 47.9 65.8 76.2 51.8 56.8 43.9 38.5 65.5 58.3 54.4 69.5 58.5 74.5 64.3 59.5 95.1 59.2 59.1 59.3 60.5 47.8 69.8 102.2 87.4 83.0 171.0 103.0 44.4 107.5 121.5 92.0 140.0 57.9 86.9 61.2 COX6B1 "COX6B, COXG" ENSG00000126267 "Cytochrome c oxidase subunit 6B1" P14854 19 35648223-35658861 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004192 Supported Supported Mitochondria 1200000 Mitochondria "HPA004192: AB_1847180" "unprognostic (5.12e-2)" "unprognostic (1.86e-2)" "unprognostic (3.81e-2)" "unprognostic (1.22e-1)" "unprognostic (1.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.18e-1)" "unprognostic (6.16e-2)" "unprognostic (3.52e-1)" "unprognostic (4.80e-2)" "unprognostic (1.64e-1)" "unprognostic (1.88e-1)" "prognostic favourable (5.42e-4)" "unprognostic (2.10e-2)" "unprognostic (6.98e-2)" "unprognostic (5.74e-2)" "unprognostic (5.48e-3)" 37.2 32.2 62.1 32.1 58.7 46.2 42.8 31.1 57.6 34.1 65.0 25.2 41.2 52.7 27.1 70.2 52.4 36.3 39.8 132.5 51.5 52.2 61.1 68.9 24.7 40.4 57.4 60.2 29.2 41.1 41.4 28.8 30.2 39.2 30.2 77.1 31.8 54.9 44.2 168.4 35.1 63.2 37.6 38.7 30.7 42.0 21.0 29.0 42.7 37.6 110.6 52.7 33.8 31.6 110.6 115.5 111.1 116.1 61.2 107.9 167.5 42.8 102.5 44.5 59.3 58.5 59.9 41.3 34.9 53.0 57.7 58.4 83.6 43.2 48.4 61.9 55.0 31.5 71.3 59.3 56.8 56.2 48.9 82.8 54.8 81.9 46.2 74.4 43.2 70.3 74.4 53.9 31.3 56.0 51.6 72.5 58.0 83.0 52.2 54.9 33.0 69.1 45.3 48.9 80.0 131.6 85.7 39.1 44.7 56.2 96.9 34.5 38.4 80.8 33.4 33.4 38.3 35.4 54.3 43.5 52.2 65.7 44.1 57.7 42.9 87.7 108.6 94.7 65.5 116.1 62.4 110.6 90.5 76.1 111.8 92.7 89.6 79.4 111.1 61.2 107.8 115.5 107.9 167.5 62.1 58.7 31.1 57.6 51.5 52.2 57.4 60.2 39.2 29.0 COX6C ENSG00000164919 "Cytochrome c oxidase subunit 6C" P09669 8 99873200-99894062 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 232.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014295, CAB016244" Enhanced Enhanced Mitochondria 53000 Mitochondria "CAB016244: AB_2085703, HPA014295: " "unprognostic (4.91e-2)" "unprognostic (2.90e-2)" "unprognostic (6.90e-2)" "unprognostic (3.37e-2)" "unprognostic (1.58e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-2)" "unprognostic (1.29e-1)" "unprognostic (3.51e-1)" "unprognostic (3.70e-1)" "unprognostic (8.86e-2)" "unprognostic (3.47e-3)" "unprognostic (1.10e-1)" "unprognostic (5.31e-2)" "unprognostic (1.07e-1)" "unprognostic (6.99e-3)" 20.5 43.1 66.1 21.6 56.2 44.4 23.3 28.5 63.8 18.7 46.0 14.3 29.4 113.7 38.8 64.1 31.6 27.4 23.5 113.0 54.8 46.9 38.7 66.8 18.2 23.2 58.8 36.7 32.7 26.5 12.1 24.0 30.7 38.8 23.3 38.1 20.6 32.4 30.1 232.1 31.2 55.8 38.7 40.4 23.7 35.1 29.6 23.5 17.9 19.5 80.6 17.8 31.0 21.3 45.9 62.3 55.7 50.6 37.2 73.5 48.0 16.7 6.7 7.9 32.2 18.0 13.1 13.2 5.5 5.2 3.8 4.3 6.8 35.9 40.7 41.6 8.5 22.3 4.5 45.6 6.3 7.3 11.4 84.4 8.1 19.8 11.7 38.9 26.1 12.1 60.7 3.1 7.0 5.6 5.9 73.1 6.3 16.0 40.4 35.8 15.1 15.6 46.9 2.6 39.8 57.2 89.2 24.5 14.9 3.8 83.6 40.8 58.9 24.9 4.8 28.6 37.2 30.2 7.8 18.2 14.6 24.1 40.2 15.8 25.3 55.7 29.3 22.1 40.1 42.3 41.8 45.9 61.0 42.5 43.8 41.7 73.5 65.7 3.5 37.2 50.6 62.3 56.9 48.0 66.1 56.2 28.5 63.8 54.8 46.9 58.8 36.7 38.8 23.5 CPOX "CPO, CPX, HCP" ENSG00000080819 "Coproporphyrinogen oxidase" P36551 3 98521132-98593723 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Heme biosynthesis, Porphyrin biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.9" "Cell line enhanced" "Detected in all" "HEL: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015736, HPA054448" Enhanced Mitochondria 140000 Mitochondria "HPA015736: AB_1847194, HPA054448: " "unprognostic (2.14e-1)" "unprognostic (1.04e-1)" "unprognostic (4.07e-2)" "unprognostic (6.09e-2)" "unprognostic (2.71e-1)" "unprognostic (2.34e-2)" "unprognostic (8.58e-3)" "unprognostic (7.14e-2)" "unprognostic (2.53e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-2)" "unprognostic (1.86e-2)" "prognostic unfavourable (1.04e-5)" "unprognostic (1.62e-1)" "unprognostic (2.67e-2)" "unprognostic (2.15e-2)" "unprognostic (2.57e-1)" 6.6 8.9 12.6 9.0 29.9 30.2 6.6 10.1 21.1 7.5 8.2 29.6 5.7 17.7 8.8 6.4 14.1 6.4 7.2 6.9 17.5 11.7 5.6 29.3 6.3 9.1 42.9 16.2 9.5 6.9 9.9 5.5 14.8 23.7 7.4 10.3 3.4 7.2 7.2 8.5 10.8 12.3 7.7 32.8 9.1 7.7 3.9 36.0 7.7 6.2 7.0 9.8 8.5 10.4 1.7 1.7 0.0 2.1 2.1 3.0 0.7 16.3 7.9 7.0 12.4 13.2 9.8 20.3 10.5 7.6 10.9 12.4 13.1 5.1 1.7 11.9 5.5 11.9 8.7 11.4 18.6 5.2 7.6 56.9 4.5 16.9 6.7 12.0 13.5 7.7 9.6 10.3 4.3 10.3 10.9 7.4 10.2 5.0 12.1 10.3 8.3 14.5 8.6 16.0 7.5 9.2 6.8 4.6 4.6 11.1 3.8 31.6 5.9 7.7 8.6 16.2 15.9 9.2 7.7 11.3 8.9 9.1 16.1 13.2 11.8 0.0 2.1 0.0 1.4 1.0 2.5 1.7 2.4 2.9 1.7 1.5 0.8 3.0 0.0 2.1 0.7 1.1 1.1 0.7 12.6 29.9 10.1 21.1 17.5 11.7 42.9 16.2 23.7 36.0 CPT1A "CPT1, CPT1-L, L-CPT1" ENSG00000110090 "Carnitine palmitoyltransferase 1A" P50416 11 68754620-68844410 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008835 Supported Supported Mitochondria 790000 Mitochondria "HPA008835: AB_1078563" "prognostic unfavourable (3.84e-4)" "unprognostic (1.38e-3)" "unprognostic (3.04e-3)" "unprognostic (2.46e-2)" "unprognostic (1.45e-1)" "unprognostic (7.25e-2)" "unprognostic (2.17e-1)" "unprognostic (4.99e-2)" "unprognostic (2.72e-1)" "unprognostic (1.47e-2)" "unprognostic (2.92e-2)" "unprognostic (2.34e-1)" "prognostic favourable (2.67e-7)" "unprognostic (9.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.49e-1)" "unprognostic (2.46e-3)" 18.0 18.3 9.9 9.9 12.1 15.8 24.4 7.0 10.3 12.8 31.9 8.2 14.1 33.7 17.0 7.2 11.2 12.8 14.7 14.6 12.0 6.6 30.6 62.0 13.1 10.1 10.5 8.6 17.0 24.4 16.9 13.8 8.7 10.8 15.6 22.0 19.7 12.9 11.4 6.9 10.3 33.4 16.9 8.7 18.9 16.8 10.4 9.0 17.9 13.2 7.5 7.6 11.3 30.2 2.5 11.9 10.6 8.6 5.7 8.8 2.5 8.3 14.8 2.1 14.5 9.5 8.6 0.6 6.7 5.5 5.3 1.1 0.5 28.3 0.0 24.8 17.6 27.5 18.8 4.0 1.6 13.4 1.8 20.5 16.2 6.8 14.2 11.9 24.9 8.9 1.9 10.6 6.4 18.8 2.1 16.9 4.8 24.0 9.7 21.1 0.2 15.8 27.1 0.3 36.5 12.5 20.9 0.3 9.5 18.5 35.7 5.9 31.9 11.6 18.8 11.6 0.2 23.2 9.6 13.2 16.8 8.5 12.2 8.8 12.6 9.2 7.8 10.6 8.8 8.6 5.1 2.3 5.5 5.3 5.0 2.5 3.4 7.0 3.8 5.7 7.2 11.9 2.9 2.5 9.9 12.1 7.0 10.3 12.0 6.6 10.5 8.6 10.8 9.0 CS ENSG00000062485 "Citrate synthase" O75390 12 56271699-56300392 "Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Tricarboxylic acid cycle" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 125.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA038460, HPA038461, CAB075750, CAB075751, CAB075752, CAB075753, CAB075754" Enhanced Enhanced Mitochondria 4400000 Mitochondria "CAB075750: , CAB075751: , CAB075752: , CAB075753: , CAB075754: , HPA038460: AB_2676023, HPA038461: AB_2676024" "unprognostic (7.67e-3)" "unprognostic (3.80e-1)" "unprognostic (2.59e-2)" "unprognostic (2.50e-2)" "unprognostic (2.70e-2)" "unprognostic (1.25e-1)" "unprognostic (6.09e-3)" "unprognostic (3.34e-2)" "unprognostic (2.43e-1)" "unprognostic (5.58e-2)" "unprognostic (2.56e-1)" "unprognostic (1.97e-2)" "prognostic favourable (1.17e-4)" "unprognostic (1.20e-1)" "unprognostic (2.09e-1)" "unprognostic (1.30e-2)" "unprognostic (2.02e-1)" 37.1 35.5 11.9 16.3 20.4 19.3 55.6 28.5 43.8 17.2 27.4 14.1 11.3 25.3 19.9 10.8 31.7 16.5 14.0 79.2 11.2 14.5 26.7 12.3 17.3 30.8 12.3 14.2 16.9 20.7 28.1 14.3 11.9 24.8 16.2 32.7 19.8 23.1 17.5 125.9 22.8 27.0 21.2 15.0 18.4 21.4 7.9 11.1 20.7 17.9 48.2 26.1 22.9 19.1 19.5 37.1 59.6 27.8 15.9 19.7 18.2 35.4 38.4 31.3 40.7 41.7 38.8 20.4 29.6 29.1 52.1 36.5 54.1 34.9 69.4 29.1 37.3 38.5 86.6 44.5 49.9 24.1 44.0 47.7 27.9 39.0 23.4 58.3 34.3 42.7 42.6 40.9 49.6 58.6 49.3 41.7 45.5 28.5 48.2 18.0 24.9 55.5 47.0 36.8 52.4 32.3 36.1 41.2 27.0 38.3 45.6 30.0 63.5 34.0 38.8 26.3 36.9 37.1 31.2 27.5 41.9 45.2 24.3 42.9 24.7 14.5 22.0 59.6 15.2 27.8 19.7 19.5 18.3 14.3 37.1 16.7 19.4 15.4 9.8 15.9 27.0 20.5 19.3 18.2 11.9 20.4 28.5 43.8 11.2 14.5 12.3 14.2 24.8 11.1 CTU2 "C16orf84, NCS2" ENSG00000174177 "Cytosolic thiouridylase subunit 2" Q2VPK5 16 88706463-88715386 "Predicted intracellular proteins" "tRNA processing" "Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041135, HPA041894" Uncertain Supported Mitochondria Mitochondria "HPA041135: AB_10794543, HPA041894: AB_10796463" "unprognostic (4.19e-1)" "unprognostic (3.62e-2)" "unprognostic (5.19e-2)" "unprognostic (5.77e-2)" "unprognostic (3.00e-2)" "unprognostic (5.96e-2)" "prognostic unfavourable (5.68e-4)" "unprognostic (4.83e-2)" "unprognostic (1.56e-1)" "unprognostic (4.43e-2)" "unprognostic (1.19e-3)" "unprognostic (2.90e-2)" "unprognostic (1.25e-2)" "unprognostic (3.03e-2)" "unprognostic (5.83e-2)" "unprognostic (1.13e-1)" "unprognostic (1.74e-1)" 10.9 10.5 13.0 10.9 12.8 12.0 7.8 11.6 17.4 9.0 8.8 11.7 4.6 9.5 11.4 6.7 8.1 8.8 8.5 11.0 12.8 10.2 6.5 11.4 7.7 12.2 12.9 15.3 12.5 15.7 7.0 10.9 7.5 9.9 8.3 4.4 5.8 15.6 9.6 25.4 11.5 7.8 14.7 8.7 9.1 9.5 22.8 11.2 9.3 9.7 11.1 7.9 8.3 7.2 7.5 7.7 1.4 8.0 8.1 9.3 4.6 6.9 10.9 4.3 9.2 3.7 3.8 10.6 7.3 5.6 8.1 4.0 12.8 6.6 10.2 9.8 4.6 6.9 7.1 7.1 2.2 3.1 21.4 7.1 4.5 12.8 6.2 6.9 5.4 4.2 5.2 6.4 6.9 6.8 26.1 2.9 3.0 18.6 18.9 15.7 6.4 17.7 15.3 3.3 10.7 2.8 2.7 14.2 6.9 11.9 2.2 4.5 6.5 7.6 7.6 8.5 10.9 9.6 7.9 9.6 4.8 29.0 7.1 15.0 9.2 1.4 6.4 0.0 9.3 8.0 7.8 6.9 8.4 9.0 7.7 7.5 8.9 7.1 0.5 8.1 6.5 7.6 4.7 4.6 13.0 12.8 11.6 17.4 12.8 10.2 12.9 15.3 9.9 11.2 CYCS "CYC, HCS" ENSG00000172115 "Cytochrome c, somatic" P99999 7 25120091-25125361 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Electron transport, Respiratory chain, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 109.6;skeletal muscle: 103.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB004222, CAB005126, CAB018597" Enhanced Supported Mitochondria 190000000 Mitochondria "CAB004222: AB_627385, CAB005126: AB_2090472, CAB018597: AB_627383" "unprognostic (3.06e-2)" "unprognostic (3.39e-1)" "unprognostic (3.32e-2)" "unprognostic (4.11e-3)" "unprognostic (1.15e-1)" "prognostic unfavourable (2.81e-4)" "unprognostic (4.44e-2)" "unprognostic (7.04e-3)" "unprognostic (5.67e-2)" "unprognostic (6.22e-2)" "unprognostic (2.41e-1)" "unprognostic (1.52e-1)" "prognostic favourable (1.30e-5)" "unprognostic (1.18e-1)" "unprognostic (4.94e-2)" "unprognostic (8.75e-3)" "unprognostic (7.04e-2)" 20.3 29.3 29.8 20.0 44.8 17.1 14.7 25.1 41.1 12.1 62.1 13.3 9.6 35.4 11.4 10.7 26.6 11.0 13.1 109.6 30.2 26.4 39.8 37.0 13.4 13.8 30.7 34.7 12.2 9.3 24.8 18.6 10.3 29.9 13.7 58.5 13.5 14.9 15.7 103.7 11.3 30.2 21.8 28.0 15.6 24.3 23.5 18.1 17.3 18.3 41.2 20.0 15.9 14.3 35.5 38.0 17.1 38.3 25.2 31.0 25.2 43.0 24.1 26.1 36.3 15.0 11.6 26.9 41.5 17.1 31.1 36.2 39.9 29.5 49.6 20.4 18.1 51.2 53.0 39.1 55.0 14.7 23.8 41.3 28.6 28.3 23.6 94.3 36.8 15.4 35.0 31.1 67.5 27.8 75.6 52.6 33.0 19.9 51.5 36.7 48.9 45.7 36.3 31.4 47.4 48.4 42.3 53.0 25.2 21.6 92.4 33.4 47.9 56.5 20.1 28.6 52.1 44.1 76.6 54.4 63.0 110.8 38.1 68.7 79.2 17.1 20.0 14.0 25.3 38.3 31.0 35.5 23.4 26.8 38.0 26.0 22.4 26.8 3.0 25.2 33.6 27.8 29.5 25.2 29.8 44.8 25.1 41.1 30.2 26.4 30.7 34.7 29.9 18.1 CYP19A1 "ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM" ENSG00000137869 "Cytochrome P450 family 19 subfamily A member 1" P11511 15 51208057-51338610 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 49 "placenta: 440.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 44.8;HDLM-2: 7.8;HSkMC: 15.0" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in single" 8 "basal ganglia: 5.9" "Cell type enriched" "Detected in single" 17 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000355, HPA051194" Enhanced Approved Mitochondria Mitochondria "CAB000355: , HPA051194: " "unprognostic (9.41e-2)" "unprognostic (7.44e-2)" "unprognostic (9.52e-5)" "unprognostic (6.81e-2)" "unprognostic (2.72e-1)" "unprognostic (4.25e-4)" "unprognostic (5.18e-5)" "unprognostic (1.54e-3)" "unprognostic (2.38e-2)" "unprognostic (2.52e-1)" "unprognostic (1.97e-1)" "unprognostic (5.37e-2)" "unprognostic (1.54e-5)" "unprognostic (2.52e-3)" "unprognostic (2.11e-1)" "unprognostic (1.40e-2)" "unprognostic (1.11e-1)" 9.0 4.6 0.2 0.2 5.9 0.1 2.1 0.2 0.3 0.9 0.3 0.3 0.2 0.4 0.2 0.3 0.3 0.2 0.3 1.3 0.2 0.7 0.3 0.2 0.6 0.2 0.2 0.2 4.4 0.6 0.1 0.2 440.1 0.2 0.5 0.1 0.2 0.9 1.4 0.8 2.3 0.2 0.7 0.5 0.5 0.1 3.0 0.2 0.3 3.0 0.2 0.2 1.2 0.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 44.8 2.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 7.8 0.0 0.3 0.1 3.7 0.2 0.0 0.0 15.0 0.0 0.1 1.8 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 1.4 0.6 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 5.9 0.2 0.3 0.2 0.7 0.2 0.2 0.2 0.2 CYP1B1 "CP1B, GLC3A" ENSG00000138061 "Cytochrome P450 family 1 subfamily B member 1" Q16678 2 38066973-38109902 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism, Steroid metabolism" "Lyase, Monooxygenase, Oxidoreductase" "Disease mutation, Glaucoma, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 45.0;lung: 39.2" "Cell line enhanced" "Detected in many" "ASC diff: 24.2;ASC TERT1: 25.9;HSkMC: 103.9;SiHa: 48.4;U-87 MG: 26.4" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "classical monocyte: 45.0" "Lineage enriched" "Detected in many" 22 "monocytes: 45.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB011705, HPA026863" Approved Uncertain Mitochondria Mitochondria "CAB011705: AB_731810, HPA026863: AB_10600900" "unprognostic (7.25e-3)" "unprognostic (2.28e-1)" "unprognostic (1.24e-3)" "unprognostic (2.27e-1)" "unprognostic (2.04e-2)" "unprognostic (1.68e-1)" "unprognostic (5.45e-2)" "unprognostic (1.80e-1)" "unprognostic (3.38e-1)" "unprognostic (9.69e-2)" "unprognostic (4.20e-1)" "unprognostic (1.84e-1)" "prognostic unfavourable (4.39e-6)" "unprognostic (1.87e-3)" "unprognostic (1.81e-1)" "unprognostic (6.67e-2)" "prognostic unfavourable (2.76e-4)" 9.1 3.1 0.5 9.4 1.2 0.0 11.4 1.0 1.2 11.4 2.1 0.7 4.5 0.0 12.8 5.9 3.5 15.0 6.9 17.5 1.2 8.8 3.5 39.2 26.3 3.1 1.0 6.1 3.6 0.0 1.3 0.8 3.3 10.7 0.0 19.3 0.0 13.0 4.8 0.5 1.4 10.6 5.1 15.7 0.3 3.9 0.5 5.1 2.5 1.1 4.2 6.9 2.1 0.0 0.4 2.0 45.0 0.0 0.0 16.2 1.2 13.0 0.4 0.0 24.2 25.9 0.0 0.1 0.8 0.2 2.3 0.0 5.4 0.0 3.5 3.2 10.6 0.0 0.7 0.4 0.9 0.7 0.0 3.9 0.0 6.6 0.0 0.0 103.9 10.1 5.6 0.2 0.0 0.1 0.0 0.1 5.1 0.0 3.9 1.4 2.5 0.0 0.0 0.0 2.4 0.1 0.1 0.4 48.4 7.0 0.0 9.0 1.9 0.0 0.1 0.0 19.8 0.0 0.0 0.0 0.0 26.4 0.0 2.1 0.4 45.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.0 0.0 5.5 0.2 0.0 16.2 CYP27A1 "CP27, CTX, CYP27" ENSG00000135929 "Cytochrome P450 family 27 subfamily A member 1" Q02318 2 218781749-218815293 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 149.0" "Cell line enhanced" "Detected in some" "Hep G2: 72.6;HSkMC: 13.9;RPTEC TERT1: 18.5;SK-MEL-30: 29.8;WM-115: 11.6" "Cancer enhanced" "Detected in all" "liver cancer: 176.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 38.2;neutrophil: 30.6" "Group enriched" "Detected in many" 20 "granulocytes: 30.6;monocytes: 38.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059155 Enhanced Supported Mitochondria Mitochondria "HPA059155: " "prognostic favourable (1.05e-4)" "unprognostic (4.21e-2)" "unprognostic (2.34e-1)" "unprognostic (1.83e-3)" "unprognostic (3.71e-3)" "unprognostic (1.31e-2)" "prognostic favourable (8.62e-6)" "unprognostic (6.04e-2)" "unprognostic (1.73e-1)" "unprognostic (4.04e-1)" "unprognostic (1.25e-3)" "unprognostic (8.76e-3)" "unprognostic (1.09e-3)" "unprognostic (1.08e-1)" "unprognostic (7.51e-2)" "unprognostic (1.64e-1)" "unprognostic (1.36e-1)" 14.4 12.3 6.3 4.7 13.4 0.7 5.5 2.4 7.5 6.5 21.9 16.9 24.9 21.0 5.0 5.4 3.5 9.2 5.1 6.9 8.3 6.2 12.6 149.0 22.4 5.6 19.9 5.7 9.5 2.4 6.3 7.1 2.0 12.1 11.6 6.0 15.1 10.0 21.5 10.0 3.9 36.8 5.0 18.8 3.1 3.5 3.7 15.7 3.7 3.1 4.0 7.6 5.5 5.7 0.1 1.7 30.6 38.2 0.0 0.1 10.0 0.0 0.0 0.7 0.0 1.3 0.8 0.1 0.8 3.0 1.0 2.1 3.6 0.1 0.0 1.5 2.0 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.1 72.6 4.2 0.1 0.0 13.9 0.1 0.0 0.0 1.4 0.0 0.0 2.0 0.0 0.0 0.1 0.8 0.1 0.0 0.7 0.1 18.5 0.0 0.0 0.0 0.0 0.0 29.8 0.5 0.7 1.6 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 11.6 0.0 38.2 0.1 0.0 4.3 0.0 0.1 0.0 0.1 1.7 0.0 0.0 0.0 30.6 0.0 0.3 0.2 0.0 10.0 6.3 13.4 2.4 7.5 8.3 6.2 19.9 5.7 12.1 15.7 D2HGDH "D2HGD, FLJ42195, MGC25181" ENSG00000180902 "D-2-hydroxyglutarate dehydrogenase" Q8N465 2 241734579-241768816 "Disease related genes, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 5.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056216, HPA060548" Uncertain Supported Mitochondria "Intracellular and membrane" Mitochondria "HPA056216: , HPA060548: " "unprognostic (2.85e-1)" "unprognostic (3.35e-2)" "unprognostic (6.98e-3)" "unprognostic (7.88e-2)" "unprognostic (2.42e-1)" "prognostic favourable (9.11e-4)" "unprognostic (2.49e-3)" "unprognostic (1.67e-2)" "unprognostic (1.03e-1)" "unprognostic (1.65e-2)" "unprognostic (7.82e-3)" "unprognostic (1.21e-1)" "unprognostic (7.63e-2)" "unprognostic (1.48e-2)" "unprognostic (1.50e-1)" "unprognostic (9.60e-2)" "unprognostic (3.05e-2)" 7.3 17.0 10.9 13.3 10.7 11.5 7.7 9.8 9.5 12.2 15.9 11.7 32.4 7.8 14.6 30.6 12.0 11.7 22.6 8.7 11.3 7.9 13.8 18.7 8.7 7.7 12.2 8.5 10.6 17.1 18.7 26.4 7.4 13.0 12.3 10.1 13.1 13.8 22.2 24.3 27.1 10.5 11.8 7.0 10.0 9.9 4.3 11.3 6.1 15.2 14.0 12.5 11.3 9.5 5.0 1.1 0.0 0.6 0.0 2.8 0.3 6.5 7.0 4.1 6.6 10.0 5.4 14.4 6.0 8.0 6.4 5.1 7.6 14.4 5.4 2.9 6.2 15.1 3.9 5.0 2.8 5.9 3.8 10.0 6.3 13.1 5.6 11.9 8.0 9.6 9.1 5.0 5.0 6.2 12.9 3.4 5.6 11.0 9.9 12.2 1.9 13.5 12.4 4.6 10.2 11.7 23.7 13.5 4.5 6.1 15.8 4.1 9.6 4.2 2.5 9.9 3.8 5.1 3.7 6.4 1.2 8.3 6.9 13.2 6.5 0.0 0.5 0.0 0.8 0.6 1.2 5.0 0.3 2.8 1.1 0.6 1.6 0.6 0.0 0.0 0.6 0.3 1.9 0.3 10.9 10.7 9.8 9.5 11.3 7.9 12.2 8.5 13.0 11.3 DAND5 "CER2, CKTSF1B3, Coco, DANTE, DTE, FLJ38607, GREM3" ENSG00000179284 "DAN domain BMP antagonist family member 5" Q8N907 19 12965159-12974762 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.3;heart muscle: 13.7" "Cell line enriched" "Detected in some" 15 "SH-SY5Y: 20.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 5.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043493, HPA049472" Uncertain Approved Mitochondria "Secreted in other tissues" Mitochondria "HPA043493: , HPA049472: " "unprognostic (1.18e-2)" "unprognostic (4.63e-2)" "unprognostic (7.51e-2)" "unprognostic (4.63e-2)" "unprognostic (3.82e-2)" "unprognostic (8.71e-2)" "unprognostic (2.29e-2)" "unprognostic (3.18e-1)" "unprognostic (5.95e-3)" "unprognostic (7.27e-3)" "unprognostic (8.17e-2)" "unprognostic (2.15e-1)" "unprognostic (2.48e-10)" "unprognostic (4.43e-1)" "unprognostic (2.48e-2)" "unprognostic (6.77e-2)" "unprognostic (1.37e-1)" 0.2 2.0 0.9 0.9 2.5 3.0 0.4 1.4 1.4 0.2 3.6 2.1 0.0 0.4 0.4 0.4 0.3 0.1 0.7 13.7 0.4 0.3 0.1 0.1 0.2 0.3 0.5 0.0 0.4 0.4 0.4 0.2 0.0 3.8 0.2 0.5 3.6 2.6 0.0 0.2 0.7 2.5 0.4 1.6 0.1 0.7 0.8 0.3 0.0 0.5 0.0 0.0 0.3 0.2 1.6 1.4 5.3 0.6 1.4 1.2 0.3 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.4 0.0 0.7 0.3 0.0 0.0 0.2 0.2 0.0 0.3 0.0 0.1 0.4 1.3 0.0 0.5 0.3 0.1 0.2 0.2 0.2 0.0 0.3 0.2 0.1 1.1 20.5 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.3 0.1 0.2 0.5 0.1 0.1 0.0 0.3 0.1 2.7 0.6 1.3 0.7 0.4 0.6 0.9 0.4 0.4 0.2 1.6 0.7 1.2 5.3 1.4 0.3 1.4 0.2 0.3 0.9 2.5 1.4 0.8 0.4 0.3 0.5 0.0 3.8 0.3 DBT ENSG00000137992 "Dihydrolipoamide branched chain transacylase E2" P11182 1 100186919-100249834 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Transferase" "Disease mutation, Maple syrup urine disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026481, HPA026485, HPA026533" Enhanced Supported Mitochondria Mitochondria "HPA026481: AB_1847504, HPA026485: AB_1847505, HPA026533: AB_1847506" "unprognostic (1.23e-1)" "unprognostic (1.23e-1)" "unprognostic (3.67e-2)" "unprognostic (5.29e-2)" "unprognostic (1.92e-2)" "unprognostic (1.63e-1)" "unprognostic (3.88e-2)" "unprognostic (1.65e-2)" "unprognostic (6.01e-2)" "unprognostic (1.21e-1)" "unprognostic (2.37e-2)" "unprognostic (2.90e-1)" "prognostic favourable (8.79e-12)" "unprognostic (1.63e-1)" "unprognostic (3.77e-1)" "unprognostic (9.67e-2)" "unprognostic (9.92e-2)" 8.6 14.1 8.3 5.0 13.6 3.9 8.7 8.0 11.8 8.5 7.8 7.9 13.6 6.6 9.8 6.6 13.6 8.6 5.2 18.1 8.6 7.3 22.2 29.1 8.0 5.3 10.2 8.2 9.1 13.7 10.2 12.3 7.3 9.4 12.0 7.6 5.2 11.3 8.3 15.7 8.1 5.8 11.2 8.6 6.0 12.6 5.7 8.2 9.6 13.0 8.7 6.3 12.8 7.7 4.4 2.6 3.3 3.1 4.0 5.0 2.1 11.5 5.7 5.2 10.6 11.6 10.1 12.2 7.9 6.4 7.1 8.6 11.8 4.4 10.5 11.6 4.7 10.4 11.6 8.4 8.9 11.1 6.7 7.6 10.9 5.8 9.9 10.0 3.6 9.8 9.3 5.8 9.1 6.6 12.2 11.5 5.6 2.6 8.3 3.2 11.0 11.4 8.1 19.2 7.9 7.8 10.5 9.2 5.7 17.5 15.6 13.2 12.3 6.2 7.6 7.0 4.7 8.9 7.1 8.1 8.2 5.4 8.3 6.2 3.1 3.3 2.2 1.8 4.9 3.1 5.0 4.4 4.4 4.2 2.2 4.1 4.5 4.2 2.1 4.0 2.7 2.6 3.4 2.1 8.3 13.6 8.0 11.8 8.6 7.3 10.2 8.2 9.4 8.2 DCAF5 "BCRG2, BCRP2, D14S1461E, KIAA1824, WDR22" ENSG00000139990 "DDB1 and CUL4 associated factor 5" Q96JK2 14 69050881-69153150 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041575, HPA048098" Uncertain Approved Mitochondria Mitochondria "HPA041575: , HPA048098: " "unprognostic (8.12e-2)" "unprognostic (3.28e-2)" "unprognostic (4.26e-3)" "unprognostic (3.30e-1)" "unprognostic (1.58e-1)" "unprognostic (3.44e-1)" "unprognostic (2.27e-2)" "unprognostic (3.13e-2)" "unprognostic (1.25e-1)" "unprognostic (2.43e-1)" "unprognostic (5.80e-2)" "unprognostic (1.02e-1)" "unprognostic (1.63e-2)" "unprognostic (2.80e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-1)" "unprognostic (2.06e-1)" 23.5 18.1 18.5 18.1 21.7 19.0 21.7 23.5 24.0 23.1 24.4 21.4 20.2 15.6 26.9 17.2 24.5 22.0 19.9 22.2 17.9 11.7 19.3 23.8 23.8 18.4 13.6 13.5 24.5 17.8 32.6 30.1 20.6 15.5 23.7 16.0 23.4 20.6 24.9 47.7 23.4 20.5 24.5 20.1 22.3 20.6 41.8 17.5 38.7 25.0 14.0 27.9 24.2 24.6 5.3 3.5 9.6 2.5 17.5 19.4 7.2 25.9 8.3 19.6 18.2 21.8 19.1 12.8 12.3 17.9 14.1 17.9 10.6 16.6 14.4 11.3 19.1 12.8 13.8 18.4 13.3 19.4 7.6 15.4 8.4 7.6 16.6 5.8 18.9 21.6 19.2 12.6 17.7 21.0 11.9 12.1 14.0 15.5 18.5 10.3 8.7 13.2 12.3 18.6 5.7 18.7 20.4 14.0 15.8 16.4 17.2 10.9 21.0 12.0 19.0 24.2 22.8 11.0 7.2 16.1 5.2 13.2 16.1 7.1 7.2 9.6 2.5 9.0 19.4 2.4 16.4 5.0 10.5 14.2 3.3 5.3 10.1 12.5 3.2 17.5 1.6 3.5 4.7 7.2 18.5 21.7 23.5 24.0 17.9 11.7 13.6 13.5 15.5 17.5 DDT DDCT ENSG00000099977 "D-dopachrome tautomerase" P30046 22 23971365-23980469 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Melanin biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 52.8;liver: 58.4" "Cell line enhanced" "Detected in all" "HEK 293: 67.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA049871 Approved Approved Mitochondria Mitochondria "HPA049871: " "unprognostic (1.77e-2)" "unprognostic (1.13e-1)" "unprognostic (1.40e-1)" "unprognostic (1.22e-2)" "unprognostic (8.09e-2)" "unprognostic (4.00e-3)" "unprognostic (2.02e-3)" "unprognostic (6.58e-2)" "unprognostic (4.66e-2)" "unprognostic (2.23e-2)" "unprognostic (1.96e-1)" "unprognostic (6.06e-3)" "unprognostic (1.12e-1)" "unprognostic (7.34e-2)" "unprognostic (3.30e-1)" "unprognostic (3.81e-1)" "unprognostic (2.61e-3)" 9.7 6.6 5.4 3.4 4.8 8.8 4.5 2.1 4.4 3.0 9.8 11.8 2.7 4.3 5.8 2.8 1.4 7.7 4.2 4.0 11.3 58.4 3.2 2.9 5.4 4.1 14.4 1.3 1.8 2.5 5.8 6.4 7.1 4.4 10.4 3.7 11.6 2.0 4.6 3.2 8.2 1.2 3.7 2.7 4.3 3.2 30.4 52.8 27.8 38.0 23.8 29.0 28.6 26.7 11.4 4.0 9.3 7.6 6.7 24.2 7.8 5.3 6.8 7.1 10.1 7.7 25.6 7.3 4.1 22.2 9.8 9.7 4.5 10.8 67.6 15.4 15.6 21.9 7.7 33.8 15.5 6.7 7.4 6.8 6.0 7.3 13.9 10.4 6.8 13.1 7.4 30.6 12.0 34.5 16.3 7.4 36.6 12.1 9.9 13.5 13.0 16.1 30.4 22.9 7.7 10.6 8.4 7.1 15.8 7.2 8.1 32.0 10.6 16.1 13.9 12.6 13.6 20.7 38.0 27.8 19.9 32.4 20.3 30.4 24.1 21.1 35.7 28.4 21.9 21.3 24.2 23.8 29.6 52.8 29.0 28.6 DEGS1 "DEGS-1, Des-1, DES1, FADS7, MLD" ENSG00000143753 "Delta 4-desaturase, sphingolipid 1" O15121 1 224175756-224193441 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 164.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076422 Supported Mitochondria Mitochondria "HPA076422: " "unprognostic (2.34e-2)" "unprognostic (6.91e-2)" "unprognostic (2.48e-2)" "prognostic unfavourable (7.74e-5)" "unprognostic (1.50e-1)" "unprognostic (2.74e-1)" "prognostic unfavourable (4.29e-5)" "unprognostic (7.70e-2)" "unprognostic (2.31e-1)" "unprognostic (3.20e-1)" "unprognostic (3.63e-1)" "unprognostic (1.27e-1)" "prognostic unfavourable (6.83e-7)" "unprognostic (2.87e-1)" "unprognostic (1.61e-1)" "unprognostic (3.86e-2)" "prognostic unfavourable (2.53e-4)" 19.2 10.7 14.7 14.1 15.7 20.0 28.6 11.9 17.8 17.8 17.0 19.9 15.8 15.0 17.2 13.4 16.1 13.1 13.5 16.6 15.1 16.4 12.8 17.3 16.1 24.5 22.0 17.4 14.4 9.3 11.8 15.1 40.1 17.9 27.6 9.4 15.9 14.8 20.1 7.6 164.4 12.1 23.3 22.1 13.0 14.6 9.2 19.3 7.7 19.7 12.3 15.7 15.5 24.9 31.7 39.5 43.6 25.7 16.1 24.4 16.8 14.8 10.5 13.9 10.2 60.2 38.9 10.7 41.5 46.7 29.2 35.0 9.6 11.4 11.8 54.0 37.5 15.7 16.1 14.1 32.4 17.2 28.7 8.5 11.5 5.8 36.6 17.0 18.4 38.7 31.6 26.8 15.1 28.7 12.5 13.0 37.3 5.4 8.6 9.2 17.2 15.5 7.9 19.6 7.6 37.0 4.0 9.0 14.5 22.1 34.8 21.9 11.8 24.8 26.1 28.0 8.9 32.2 40.4 9.3 11.0 10.8 30.2 8.5 31.4 32.3 22.3 43.6 12.7 25.7 24.4 23.9 21.5 17.5 39.5 31.7 17.1 15.0 26.1 16.1 17.4 13.2 22.0 16.8 14.7 15.7 11.9 17.8 15.1 16.4 22.0 17.4 17.9 19.3 DHFR ENSG00000228716 "Dihydrofolate reductase" P00374 5 80626228-80654983 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Methotrexate resistance, One-carbon metabolism" "Oxidoreductase, RNA-binding" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "CAB037129, HPA051465" Uncertain Supported Mitochondria Mitochondria "CAB037129: AB_439683, HPA051465: " "unprognostic (1.44e-2)" "unprognostic (1.03e-2)" "unprognostic (2.24e-3)" "unprognostic (2.91e-3)" "unprognostic (3.27e-1)" "unprognostic (1.32e-1)" "unprognostic (2.83e-2)" "unprognostic (2.35e-2)" "unprognostic (2.02e-2)" "unprognostic (4.19e-3)" "unprognostic (1.83e-2)" "unprognostic (2.55e-1)" "unprognostic (1.15e-2)" "unprognostic (1.82e-2)" "unprognostic (2.49e-1)" "unprognostic (1.57e-1)" "unprognostic (1.09e-1)" 17.7 6.1 16.0 11.6 13.9 28.3 10.9 10.2 14.0 7.5 12.6 18.1 11.7 14.5 5.9 9.0 9.8 4.7 6.9 9.7 17.3 14.4 13.1 35.5 8.6 23.2 18.9 9.4 7.5 4.9 9.6 7.2 8.5 13.0 5.9 15.5 8.6 8.0 8.4 10.4 5.9 14.5 7.3 25.3 9.1 7.4 10.5 11.5 13.4 9.2 2.3 22.8 7.9 6.1 2.4 3.3 3.5 2.6 2.1 4.0 2.1 19.6 13.6 34.6 25.6 6.6 6.9 12.7 15.7 12.1 27.4 31.7 12.9 23.7 39.8 6.9 9.1 13.8 44.4 20.3 44.4 17.6 27.4 19.1 22.6 12.0 1.4 22.2 8.5 4.8 2.1 24.5 2.7 13.2 21.4 30.6 27.7 19.7 54.7 9.0 17.4 8.0 35.5 67.9 39.4 15.7 12.5 28.3 19.8 22.2 10.4 11.2 20.5 22.0 7.9 8.7 13.2 24.3 30.0 14.4 28.8 43.1 19.4 45.2 22.3 0.8 1.2 1.1 2.3 2.6 1.1 2.1 2.7 3.2 1.9 2.4 2.1 2.7 3.5 2.1 1.7 3.3 4.0 2.1 16.0 13.9 10.2 14.0 17.3 14.4 18.9 9.4 13.0 11.5 DHFR2 "DHFRL1, DHFRP4, FLJ16119" ENSG00000178700 "Dihydrofolate reductase 2" Q86XF0 3 94047836-94063389 "Enzymes, Predicted intracellular proteins" "One-carbon metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA051465 Uncertain Supported Mitochondria Mitochondria "HPA051465: " "unprognostic (1.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.10e-2)" "unprognostic (3.50e-2)" "unprognostic (2.07e-1)" "unprognostic (1.38e-1)" "unprognostic (5.92e-2)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (4.62e-2)" "unprognostic (2.95e-1)" "unprognostic (1.52e-1)" "prognostic favourable (2.30e-6)" "unprognostic (1.63e-1)" "unprognostic (1.79e-1)" "unprognostic (1.13e-1)" "unprognostic (2.96e-2)" 6.6 8.0 9.7 5.2 10.9 2.2 7.7 5.2 13.2 9.8 6.3 15.2 2.8 5.8 11.7 9.9 5.3 9.4 7.6 5.1 9.8 8.1 10.6 9.3 7.1 7.3 10.2 6.9 15.3 10.8 15.4 13.1 4.5 12.2 9.5 6.7 6.2 6.6 8.9 2.8 5.8 10.1 9.0 12.6 9.4 6.6 8.2 8.6 16.9 10.3 4.8 6.4 7.3 6.2 5.0 4.1 3.8 3.3 2.8 7.3 2.5 4.2 6.6 5.1 5.1 7.0 8.9 2.0 6.6 7.2 3.3 3.8 1.3 7.0 2.8 4.5 3.5 5.9 3.8 4.6 5.2 9.4 2.1 3.5 3.1 3.7 7.2 2.3 4.1 9.0 6.3 3.9 5.1 3.4 1.8 6.5 4.3 5.1 12.0 1.4 4.1 8.1 3.1 6.6 4.6 4.6 2.2 6.3 6.4 9.5 2.5 10.7 6.5 3.5 5.3 5.3 8.9 2.1 2.4 4.8 4.8 4.0 5.2 6.1 7.1 3.6 2.2 3.8 3.8 3.2 7.3 3.8 5.1 6.1 1.4 5.0 6.9 6.2 3.5 2.8 3.3 4.1 6.1 2.5 9.7 10.9 5.2 13.2 9.8 8.1 10.2 6.9 12.2 8.6 DHTKD1 "CMT2Q, DKFZP762M115, KIAA1630, MGC3090" ENSG00000181192 "Dehydrogenase E1 and transketolase domain containing 1" Q96HY7 10 12068972-12123225 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Oxidoreductase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.5" "Cell line enhanced" "Detected in all" "T-47d: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037949, HPA037950, HPA066098" Approved Supported Mitochondria Mitochondria "HPA037949: , HPA037950: AB_10673650, HPA066098: " "unprognostic (3.76e-2)" "unprognostic (8.08e-3)" "unprognostic (2.24e-1)" "unprognostic (1.15e-1)" "unprognostic (1.34e-1)" "unprognostic (3.04e-3)" "unprognostic (3.83e-3)" "unprognostic (5.01e-2)" "unprognostic (5.34e-2)" "unprognostic (3.02e-3)" "unprognostic (3.46e-1)" "unprognostic (1.56e-1)" "prognostic favourable (3.43e-4)" "unprognostic (2.12e-1)" "unprognostic (1.31e-1)" "unprognostic (1.74e-2)" "unprognostic (2.88e-3)" 5.7 6.3 6.5 4.7 6.6 2.2 5.0 5.7 7.2 5.5 5.7 9.8 5.0 4.5 4.7 5.0 5.1 4.2 4.5 7.7 5.3 4.8 23.8 69.5 4.2 6.9 7.5 5.2 7.1 16.6 5.4 4.1 4.7 6.2 7.6 6.3 7.2 9.7 7.1 10.5 3.6 4.3 3.5 6.1 5.1 6.1 4.4 6.6 10.1 6.8 6.7 8.0 5.2 4.1 9.5 12.5 16.8 11.0 10.2 4.1 3.3 11.2 8.7 13.0 10.3 8.1 4.8 15.7 5.7 3.7 10.2 9.1 5.5 6.7 8.1 1.9 3.5 16.1 13.6 4.4 11.7 4.5 6.1 4.4 3.4 4.2 7.9 1.7 1.7 5.9 3.5 5.9 2.4 5.5 6.9 6.6 2.7 21.8 5.9 3.2 7.2 2.0 10.1 4.2 6.8 6.6 2.7 3.4 15.3 11.2 20.1 6.7 44.2 6.4 2.4 3.3 2.4 6.9 4.1 5.9 4.1 5.2 4.3 3.1 5.5 16.8 4.8 10.7 3.2 6.8 3.4 9.5 2.5 2.1 8.6 7.8 2.5 3.3 14.0 10.2 11.0 12.5 4.1 3.3 6.5 6.6 5.7 7.2 5.3 4.8 7.5 5.2 6.2 6.6 DIABLO "DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC" ENSG00000184047 "Diablo IAP-binding mitochondrial protein" Q9NR28 12 122207663-122226568 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA001825, CAB003857, CAB016688" Supported Enhanced Mitochondria 21000 Mitochondria "CAB003857: AB_365498, CAB016688: AB_1615783, HPA001825: AB_1857247" "unprognostic (3.67e-2)" "unprognostic (1.90e-1)" "unprognostic (1.11e-1)" "unprognostic (3.10e-3)" "unprognostic (1.64e-1)" "unprognostic (2.38e-3)" "unprognostic (1.40e-3)" "unprognostic (5.06e-2)" "unprognostic (1.48e-1)" "unprognostic (1.03e-1)" "unprognostic (1.33e-2)" "unprognostic (4.05e-2)" "prognostic unfavourable (5.35e-4)" "unprognostic (6.68e-2)" "unprognostic (2.36e-1)" "unprognostic (2.00e-1)" "unprognostic (1.40e-1)" 17.2 29.7 21.9 15.5 24.0 26.7 24.8 21.9 30.1 20.4 25.9 29.0 14.3 20.6 22.2 36.6 23.5 21.8 19.2 20.3 21.2 26.8 31.7 37.2 15.8 20.9 28.3 23.6 22.4 32.6 22.9 30.6 28.5 27.0 21.1 24.2 22.4 22.2 20.2 25.8 18.2 21.3 21.8 29.2 18.5 19.8 62.7 21.8 23.2 26.9 23.0 22.8 20.5 17.9 32.8 35.0 27.5 29.1 29.9 32.1 26.8 19.0 37.8 26.7 18.1 19.2 18.8 20.5 19.8 19.5 23.3 21.0 32.6 10.0 23.3 18.7 17.9 19.0 29.0 23.7 27.7 20.1 22.7 25.5 15.6 29.9 27.4 27.4 10.6 26.0 16.9 27.5 41.3 26.9 29.2 9.9 22.6 28.4 22.4 40.3 21.5 35.5 20.4 26.6 25.6 26.3 29.7 25.3 25.8 26.5 10.6 21.5 35.8 19.3 18.3 18.0 22.2 20.4 17.8 21.6 36.1 33.4 23.0 21.1 23.6 23.6 28.9 27.5 30.4 29.1 29.1 32.8 28.4 28.4 35.0 26.0 27.9 28.2 12.7 29.9 26.5 26.8 32.1 26.8 21.9 24.0 21.9 30.1 21.2 26.8 28.3 23.6 27.0 21.8 DIABLO "DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC" ENSG00000284934 "Diablo IAP-binding mitochondrial protein" Q9NR28 12 122207662-122227534 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 8.7;intestine: 5.3;lymphoid tissue: 3.8" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 20.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA001825 Uncertain Approved Mitochondria 21000 Mitochondria "HPA001825: AB_1857247" 0.1 8.7 0.0 3.8 0.0 0.0 0.0 0.0 0.5 0.2 5.3 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.0 2.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.1 0.0 0.9 2.4 0.0 1.2 0.6 1.1 0.6 0.6 2.3 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.5 0.4 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.3 0.1 0.2 0.0 0.1 0.7 0.0 0.4 1.8 20.8 0.4 0.1 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.7 0.5 0.3 1.4 0.6 1.0 0.3 1.0 2.3 0.6 1.2 0.3 1.3 1.1 0.6 0.2 0.4 2.2 0.5 DLAT "DLTA, PDC-E2" ENSG00000150768 "Dihydrolipoamide S-acetyltransferase" P10515 11 112024814-112064390 "Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 55.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003782, HPA040786, HPA062766" Supported Enhanced Mitochondria Mitochondria "CAB003782: , HPA040786: AB_2677136, HPA062766: AB_2684864" "unprognostic (4.57e-3)" "unprognostic (1.75e-1)" "prognostic favourable (6.19e-6)" "unprognostic (7.68e-2)" "unprognostic (2.41e-1)" "unprognostic (1.70e-2)" "prognostic unfavourable (7.49e-5)" "unprognostic (8.68e-2)" "unprognostic (5.36e-2)" "unprognostic (2.93e-1)" "unprognostic (2.23e-3)" "unprognostic (6.25e-2)" "prognostic favourable (1.95e-14)" "unprognostic (5.82e-2)" "unprognostic (4.12e-2)" "unprognostic (2.17e-1)" "unprognostic (6.15e-2)" 14.1 10.7 10.6 8.8 11.9 4.8 10.9 10.5 14.2 6.7 13.3 6.3 7.8 12.4 6.3 8.1 12.2 7.2 6.4 55.4 10.4 13.5 19.1 12.0 6.6 8.7 11.2 9.7 7.9 6.0 15.8 7.8 8.3 13.0 8.3 13.5 7.6 10.4 9.9 41.0 7.2 13.0 6.6 7.3 6.9 8.1 7.3 4.2 12.7 10.7 22.1 8.8 7.5 6.7 9.2 9.1 7.9 8.9 7.2 10.3 8.0 6.0 6.1 8.1 10.8 11.4 8.5 9.7 8.3 4.8 9.2 10.4 19.3 17.8 24.8 16.3 7.6 13.0 16.9 8.9 10.5 8.9 10.5 15.7 6.5 11.9 8.2 19.9 9.0 10.3 9.8 9.2 9.3 8.4 25.7 11.9 10.8 4.7 9.0 23.9 9.5 11.8 14.0 11.0 27.9 16.9 6.4 15.6 9.5 10.0 28.3 6.3 21.0 12.4 5.6 9.2 10.0 9.2 10.6 3.9 6.2 37.6 2.6 21.8 7.2 7.9 6.6 4.7 8.3 8.9 9.5 9.2 8.2 8.9 9.1 7.5 10.3 8.3 0.5 7.2 8.9 7.4 8.8 8.0 10.6 11.9 10.5 14.2 10.4 13.5 11.2 9.7 13.0 4.2 DLD "DLDH, GCSL, LAD" ENSG00000091140 "Dihydrolipoamide dehydrogenase" P09622 7 107890970-107931730 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044849 Supported Supported Mitochondria 16000000 Mitochondria "HPA044849: " "unprognostic (2.01e-3)" "unprognostic (2.26e-1)" "unprognostic (1.27e-2)" "unprognostic (9.27e-2)" "unprognostic (5.01e-3)" "unprognostic (9.27e-2)" "unprognostic (2.48e-1)" "unprognostic (2.83e-2)" "unprognostic (1.19e-1)" "unprognostic (3.95e-2)" "unprognostic (9.43e-2)" "unprognostic (7.35e-2)" "prognostic favourable (7.58e-9)" "unprognostic (4.08e-2)" "unprognostic (1.88e-1)" "unprognostic (4.45e-3)" "unprognostic (1.18e-1)" 25.7 37.9 14.5 12.7 25.4 12.0 15.2 16.6 27.2 13.2 28.0 10.6 12.2 20.9 13.6 9.6 25.6 11.6 12.7 69.1 16.4 14.4 40.7 37.9 11.0 13.0 16.7 20.1 15.1 14.8 24.6 22.4 15.4 29.3 14.7 26.8 12.8 19.4 14.4 71.5 13.8 29.5 23.7 10.6 17.4 23.0 10.6 10.7 18.7 17.0 31.8 16.9 20.1 11.7 13.5 30.4 45.8 37.8 22.9 19.4 20.2 39.9 32.4 18.0 31.0 25.9 22.9 20.4 23.0 19.4 26.8 20.8 37.9 22.4 39.1 39.7 24.4 26.6 36.2 32.4 40.5 26.1 21.5 27.5 43.0 27.0 19.9 45.2 28.4 26.1 23.6 28.4 15.5 32.1 68.6 29.2 29.0 44.9 36.9 32.8 21.4 23.5 26.6 28.8 53.0 36.6 59.8 22.4 23.7 37.7 63.7 33.8 24.2 38.7 20.3 29.6 24.3 57.6 34.9 22.1 42.1 26.3 27.9 48.3 30.6 36.5 22.3 45.8 17.5 28.2 18.5 13.5 17.7 17.3 30.4 12.3 18.7 19.4 14.0 22.9 37.8 10.5 16.8 20.2 14.5 25.4 16.6 27.2 16.4 14.4 16.7 20.1 29.3 10.7 DMAC2 "ATP5SL, FLJ10241" ENSG00000105341 "Distal membrane arm assembly complex 2" Q9NW81 19 41431318-41440717 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041427 Approved Approved Mitochondria Mitochondria "HPA041427: AB_2677473" "unprognostic (1.42e-3)" "unprognostic (1.12e-1)" "unprognostic (3.17e-2)" "unprognostic (1.20e-1)" "unprognostic (6.88e-3)" "unprognostic (1.55e-1)" "prognostic unfavourable (1.77e-4)" "unprognostic (4.37e-1)" "unprognostic (3.83e-2)" "unprognostic (1.18e-2)" "unprognostic (1.52e-2)" "unprognostic (2.10e-1)" "prognostic favourable (4.07e-5)" "unprognostic (5.20e-2)" "unprognostic (2.48e-1)" "unprognostic (6.60e-2)" "unprognostic (7.29e-3)" 12.9 16.2 12.3 9.9 13.5 10.3 18.3 10.9 21.9 12.1 21.4 14.1 11.1 28.9 15.8 7.2 15.8 13.1 13.5 48.1 12.5 11.1 18.6 20.0 15.2 15.7 12.9 13.7 12.3 18.3 14.2 11.3 12.2 15.4 14.9 11.9 13.6 16.3 14.4 38.7 14.0 31.4 16.2 11.6 12.9 17.3 10.6 10.9 17.9 22.3 22.0 14.1 16.8 12.1 14.3 29.4 17.0 20.3 15.0 17.8 15.1 15.3 54.7 19.9 13.3 14.2 13.1 11.8 13.0 15.0 22.9 20.7 38.8 17.7 16.1 19.8 18.8 11.6 15.1 23.6 11.8 14.7 19.3 15.0 15.7 28.1 21.1 25.3 15.2 22.0 22.0 18.6 13.2 27.2 20.3 16.1 15.5 19.1 23.1 10.5 24.8 16.7 19.2 15.3 14.1 22.1 21.5 14.2 23.6 20.7 17.2 14.0 16.1 28.8 20.2 20.0 21.9 12.0 22.1 17.0 16.0 14.4 17.8 18.4 14.2 9.7 20.3 17.0 17.2 18.8 17.8 13.1 13.1 17.1 29.4 14.3 14.2 13.4 6.7 15.0 15.4 19.1 15.3 15.1 12.3 13.5 10.9 21.9 12.5 11.1 12.9 13.7 15.4 10.9 DMGDH ENSG00000132837 "Dimethylglycine dehydrogenase" Q9UI17 5 78997606-79236038 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "kidney: 50.2;liver: 81.8" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.6;Hep G2: 11.3;hTEC/SVTERT24-B: 3.5;Karpas-707: 3.6" "Group enriched" "Detected in some" 12 "liver cancer: 15.6;renal cancer: 12.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036441, HPA036442, HPA077849" Enhanced Supported Mitochondria 440000 Mitochondria "HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: " "unprognostic (3.11e-2)" "unprognostic (3.36e-1)" "unprognostic (6.70e-2)" "unprognostic (1.81e-1)" "unprognostic (3.15e-1)" "unprognostic (2.52e-3)" "prognostic favourable (5.32e-5)" "unprognostic (2.21e-1)" "unprognostic (3.05e-2)" "unprognostic (3.19e-2)" "unprognostic (1.07e-4)" "unprognostic (1.89e-1)" "prognostic favourable (1.17e-5)" "unprognostic (2.03e-2)" "unprognostic (9.75e-4)" "unprognostic (1.46e-1)" "unprognostic (2.26e-1)" 2.8 2.2 0.8 0.8 1.3 0.0 1.5 0.4 0.6 0.5 0.5 0.7 1.9 0.1 0.9 5.9 0.4 0.4 0.6 1.3 0.8 0.8 50.2 81.8 0.1 0.1 0.8 0.3 1.0 0.5 0.3 2.1 0.0 1.1 0.9 0.1 2.7 0.4 1.1 0.6 0.2 0.3 2.0 1.7 0.0 0.4 1.2 0.2 0.0 1.5 0.8 0.1 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.5 0.5 1.4 0.4 0.3 5.6 1.3 2.3 0.0 0.1 0.0 0.4 1.7 0.0 0.1 0.0 1.8 0.3 0.0 0.0 0.0 11.3 3.1 0.0 0.0 2.7 3.3 3.5 2.5 0.0 0.0 3.6 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.2 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.8 1.3 0.4 0.6 0.8 0.8 0.8 0.3 1.1 0.2 DNA2 "DNA2L, KIAA0083" ENSG00000138346 "DNA replication helicase/nuclease 2" P51530 10 68414064-68472121 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease" "Disease mutation, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "lymphoid tissue: 49.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "NK-cell: 5.5" "Lineage enriched" "Detected in single" 6 "NK-cells: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA037487, HPA057526" Approved Supported Mitochondria Mitochondria "HPA037487: AB_10672493, HPA057526: " "unprognostic (1.79e-1)" "unprognostic (1.35e-1)" "unprognostic (4.37e-3)" "unprognostic (4.60e-3)" "unprognostic (1.53e-1)" "unprognostic (1.86e-2)" "unprognostic (4.50e-5)" "unprognostic (3.36e-2)" "unprognostic (4.70e-2)" "unprognostic (3.72e-2)" "unprognostic (1.30e-2)" "unprognostic (3.29e-4)" "unprognostic (1.09e-10)" "unprognostic (3.43e-2)" "unprognostic (1.98e-1)" "unprognostic (9.36e-2)" "unprognostic (1.23e-2)" 1.6 1.2 2.0 13.7 2.4 7.0 3.0 6.2 3.8 1.6 4.5 1.1 0.8 3.5 3.0 1.8 3.2 1.0 2.4 2.0 2.5 2.2 3.4 6.2 3.3 8.4 2.9 5.0 1.9 2.4 1.1 2.3 4.0 1.7 3.0 5.0 0.9 2.3 0.8 2.3 2.9 5.2 1.9 3.0 5.2 2.6 7.0 1.4 49.1 1.5 5.1 10.8 2.3 2.0 0.4 0.1 0.9 0.1 5.5 0.6 0.1 13.7 7.1 16.3 11.5 1.8 1.3 11.5 6.8 5.7 9.8 12.1 17.0 9.0 14.1 2.6 2.1 8.5 9.3 3.6 11.8 8.7 7.0 8.6 4.4 6.5 0.5 14.7 9.3 1.0 1.4 7.0 2.0 4.4 12.5 12.8 5.6 4.8 22.7 10.7 11.5 13.4 17.8 11.3 4.5 4.2 6.4 7.4 8.9 9.4 11.9 2.2 9.2 6.3 1.8 3.8 11.7 4.8 12.9 6.5 7.3 21.1 3.2 14.1 4.9 0.0 0.0 0.9 0.2 0.0 0.2 0.4 0.2 0.6 0.1 0.4 0.3 0.3 0.1 5.5 0.1 0.0 0.4 0.1 2.0 2.4 6.2 3.8 2.5 2.2 2.9 5.0 1.7 1.4 DNASE1L2 DNAS1L2 ENSG00000167968 "Deoxyribonuclease 1 like 2" Q92874 16 2235816-2238711 "Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 11.7;skin 1: 20.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "eosinophil: 1.4;neutrophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044714 Approved Mitochondria "Secreted in other tissues" Mitochondria "HPA044714: AB_10962870" "unprognostic (9.88e-2)" "unprognostic (1.11e-3)" "unprognostic (6.80e-4)" "unprognostic (4.29e-2)" "unprognostic (2.35e-1)" "unprognostic (1.55e-1)" "unprognostic (2.72e-2)" "unprognostic (2.50e-1)" "unprognostic (2.72e-1)" "unprognostic (1.86e-1)" "unprognostic (2.96e-3)" "unprognostic (2.17e-2)" "unprognostic (4.67e-4)" "unprognostic (1.40e-4)" "unprognostic (3.51e-1)" "unprognostic (2.28e-1)" "unprognostic (2.94e-4)" 0.6 1.3 1.3 0.6 2.1 0.8 2.1 8.8 2.8 0.6 0.6 0.6 0.6 0.8 1.2 3.5 0.6 0.4 0.6 0.6 1.6 2.1 0.9 1.6 0.6 0.6 1.5 0.6 0.7 1.9 0.2 2.1 1.3 1.3 0.8 0.2 0.6 11.7 0.6 0.7 20.6 0.8 0.6 1.3 1.0 0.9 1.9 0.6 2.4 2.7 7.1 3.4 0.6 0.6 0.0 0.0 1.6 0.0 0.0 0.2 0.0 1.9 3.9 1.7 1.7 1.4 0.7 6.8 0.6 0.5 1.6 0.8 4.3 4.1 2.6 2.1 0.2 0.6 0.6 0.2 0.1 5.0 3.7 1.1 6.2 1.0 0.2 1.2 4.1 0.9 1.4 1.2 0.3 0.3 3.5 3.8 0.6 4.5 3.5 7.4 1.6 2.6 6.6 2.0 3.5 0.9 0.8 3.5 1.8 0.9 1.5 2.7 6.1 2.7 0.1 3.3 4.4 1.9 1.3 9.3 4.5 2.3 1.1 2.4 1.7 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.3 2.1 8.8 2.8 1.6 2.1 1.5 0.6 1.3 0.6 DTNB ENSG00000138101 "Dystrobrevin beta" O60941 2 25377198-25673647 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 49.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061357 Uncertain Approved Mitochondria Mitochondria "HPA061357: " "unprognostic (1.14e-1)" "unprognostic (1.39e-2)" "unprognostic (3.17e-2)" "unprognostic (7.40e-2)" "unprognostic (1.17e-1)" "unprognostic (1.16e-2)" "prognostic unfavourable (2.54e-4)" "unprognostic (1.78e-2)" "unprognostic (3.67e-3)" "unprognostic (3.98e-2)" "unprognostic (9.45e-2)" "unprognostic (4.67e-2)" "prognostic favourable (3.47e-4)" "unprognostic (1.86e-1)" "unprognostic (1.40e-1)" "unprognostic (3.16e-2)" "unprognostic (6.49e-2)" 3.6 3.5 19.1 5.2 21.3 4.7 13.9 14.5 24.6 7.7 2.7 9.5 13.6 2.2 4.7 14.0 4.6 7.3 5.9 3.4 20.6 12.6 6.3 5.1 6.6 4.6 12.4 11.7 7.2 10.3 12.2 9.6 5.4 13.2 10.5 2.4 4.2 49.4 13.9 2.7 4.6 2.3 3.1 13.1 4.4 7.7 9.0 7.3 6.3 15.7 1.0 5.4 5.2 4.3 7.4 1.1 7.2 2.2 5.1 7.4 2.8 8.8 7.5 6.2 6.8 3.6 4.5 0.2 2.7 3.7 3.4 4.8 2.9 2.3 4.7 1.1 2.2 3.2 4.3 11.6 1.9 7.1 9.9 3.7 2.3 8.8 2.5 4.7 3.6 3.6 9.9 3.6 6.2 4.6 0.3 7.2 2.5 8.9 7.6 3.9 7.0 5.1 6.1 9.9 8.8 6.4 8.3 8.1 11.8 8.8 15.6 10.8 8.2 2.7 1.9 1.3 6.4 2.0 4.8 12.6 5.5 8.4 4.0 8.5 5.0 0.5 2.2 7.2 5.8 1.1 6.6 5.7 7.4 5.2 0.7 7.4 7.3 5.0 4.3 5.1 0.6 1.1 6.4 2.8 19.1 21.3 14.5 24.6 20.6 12.6 12.4 11.7 13.2 7.3 DTYMK "CDC8, TMPK, TYMK" ENSG00000168393 "Deoxythymidylate kinase" P23919 2 241675742-241686991 "Enzymes, Predicted intracellular proteins" "Nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042593, HPA042719" Approved Approved Mitochondria Mitochondria "HPA042593: AB_10959590, HPA042719: AB_10960633" "unprognostic (1.90e-1)" "unprognostic (6.95e-2)" "unprognostic (4.14e-1)" "unprognostic (8.61e-2)" "unprognostic (1.89e-1)" "unprognostic (9.45e-2)" "prognostic unfavourable (1.73e-5)" "unprognostic (1.44e-2)" "unprognostic (2.64e-2)" "unprognostic (5.50e-2)" "unprognostic (2.60e-2)" "unprognostic (6.94e-2)" "prognostic unfavourable (1.22e-4)" "unprognostic (7.13e-2)" "unprognostic (6.81e-2)" "unprognostic (5.07e-2)" "unprognostic (9.19e-2)" 12.4 17.6 11.6 17.3 15.0 29.1 14.4 14.5 12.4 10.0 13.8 16.5 9.3 12.0 12.4 9.7 20.0 9.7 10.2 9.4 9.0 6.5 15.5 19.5 10.5 21.0 14.0 9.5 9.5 13.6 5.0 8.8 10.4 11.8 11.5 11.7 10.8 9.6 10.0 6.7 17.9 13.0 13.0 9.5 18.8 13.5 11.1 15.1 20.7 9.4 16.1 17.9 11.7 11.9 19.8 21.1 12.0 24.7 15.7 21.8 15.7 25.2 27.9 24.2 30.8 8.0 8.7 25.7 20.7 15.6 27.5 32.5 12.7 30.6 12.2 6.4 16.7 21.3 22.3 25.1 14.8 28.8 26.5 26.2 23.4 24.1 6.6 16.6 21.7 6.1 6.8 26.6 10.8 26.4 29.4 10.3 29.2 26.3 30.6 28.8 23.9 23.5 26.2 35.7 17.0 15.9 14.6 29.3 18.3 13.4 20.7 16.5 18.8 29.7 17.1 40.2 28.9 25.6 38.1 11.6 12.2 34.3 32.2 26.6 46.7 12.0 14.9 9.5 17.4 24.7 16.8 19.2 16.1 18.2 10.5 19.8 16.0 14.7 2.5 15.7 18.8 21.1 21.8 15.7 11.6 15.0 14.5 12.4 9.0 6.5 14.0 9.5 11.8 15.1 DYNC2H1 "DHC1b, DHC2, DNCH2, DYH1B, hdhc11" ENSG00000187240 "Dynein cytoplasmic 2 heavy chain 1" Q8NCM8 11 103109431-103479863 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein, Motor protein" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 35.7" "Cell line enhanced" "Detected in many" "ASC TERT1: 17.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.9" "Group enriched" "Detected in many" 5 "NK-cells: 2.9;T-cells: 2.2" "Low region specificity" "Detected in all" "HPA039015, HPA039016" Approved Supported Mitochondria Mitochondria "HPA039015: , HPA039016: AB_10673410" "unprognostic (3.11e-1)" "unprognostic (2.60e-1)" "unprognostic (1.28e-2)" "unprognostic (1.54e-1)" "unprognostic (7.11e-2)" "unprognostic (2.08e-1)" "unprognostic (4.14e-3)" "unprognostic (2.07e-2)" "unprognostic (2.05e-1)" "unprognostic (4.10e-2)" "unprognostic (2.87e-2)" "unprognostic (7.13e-2)" "prognostic favourable (8.49e-5)" "unprognostic (3.75e-3)" "unprognostic (1.62e-1)" "unprognostic (3.88e-2)" "unprognostic (4.11e-3)" 7.3 5.7 6.3 3.8 8.9 1.4 8.4 13.2 9.3 11.5 4.8 5.5 11.0 4.1 11.3 9.6 3.9 14.6 7.8 3.7 7.1 7.1 8.5 2.6 10.2 2.6 4.8 7.9 11.4 5.1 24.2 35.7 3.9 11.2 7.6 2.6 6.2 4.5 10.7 1.6 5.7 3.4 7.8 5.1 4.8 4.2 14.3 5.2 1.1 10.7 3.0 2.4 6.1 6.6 0.5 0.4 0.4 0.2 2.9 2.2 0.0 1.0 2.1 5.7 2.7 7.9 17.9 0.3 3.2 5.2 5.3 5.8 1.2 1.1 0.0 4.4 6.2 4.3 4.4 5.9 4.3 0.0 4.0 0.8 3.7 0.1 7.6 1.7 1.0 11.1 2.3 12.0 13.8 2.1 0.1 0.0 6.9 4.1 0.5 0.4 1.5 6.0 0.0 4.7 0.1 5.7 0.7 4.1 2.9 5.0 1.4 2.3 5.3 1.1 5.0 6.4 2.6 6.0 2.1 0.0 0.0 0.0 1.9 5.2 1.9 0.4 0.2 0.0 0.9 0.1 2.2 0.5 0.7 1.1 0.4 0.3 0.8 1.1 0.0 2.9 0.1 0.2 0.0 0.0 6.3 8.9 13.2 9.3 7.1 7.1 4.8 7.9 11.2 5.2 ECH1 HPXEL ENSG00000104823 "Enoyl-CoA hydratase 1" Q13011 19 38815422-38832005 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002907, HPA005835" Supported Supported Enhanced Mitochondria 5700000 Mitochondria "HPA002907: AB_1847964, HPA005835: AB_1847965" "unprognostic (1.91e-1)" "unprognostic (3.03e-2)" "unprognostic (3.64e-2)" "unprognostic (6.43e-2)" "unprognostic (5.73e-3)" "unprognostic (6.90e-2)" "unprognostic (1.28e-1)" "unprognostic (1.79e-1)" "unprognostic (2.43e-1)" "unprognostic (5.86e-2)" "unprognostic (2.24e-1)" "unprognostic (3.37e-1)" "unprognostic (7.01e-2)" "prognostic unfavourable (2.23e-4)" "unprognostic (3.54e-1)" "unprognostic (3.52e-1)" "unprognostic (1.74e-2)" 33.0 52.0 17.6 21.7 20.9 14.7 29.6 11.4 19.8 14.8 34.1 19.5 19.8 25.8 16.8 15.4 30.2 18.9 30.6 130.6 18.6 15.5 40.0 105.8 16.9 19.6 22.2 17.2 16.0 36.5 11.5 11.3 32.8 17.5 20.9 27.1 20.8 27.4 15.2 130.9 18.7 24.4 27.0 13.3 28.1 24.8 26.2 20.6 15.9 24.5 43.5 21.5 21.3 19.3 68.7 60.7 49.9 61.1 61.4 72.6 83.3 12.8 56.5 8.8 14.5 34.2 17.8 12.8 6.3 11.1 5.6 5.7 36.2 25.5 20.1 24.9 15.0 6.1 14.6 15.1 4.4 69.6 8.1 24.3 17.2 29.2 34.8 25.8 24.7 23.6 39.2 7.3 12.7 13.2 11.5 33.6 12.3 24.1 17.9 14.9 5.8 13.7 20.4 26.4 40.0 35.3 29.3 11.0 14.1 33.2 16.5 17.5 22.2 58.0 11.1 9.9 8.5 9.7 5.9 25.5 29.5 19.2 15.0 33.3 18.9 49.1 61.1 49.9 51.9 46.8 48.9 68.7 50.9 51.2 60.7 62.2 45.7 51.4 8.1 61.4 38.3 41.4 72.6 83.3 17.6 20.9 11.4 19.8 18.6 15.5 22.2 17.2 17.5 20.6 ECHDC2 FLJ10948 ENSG00000121310 "Enoyl-CoA hydratase domain containing 2" Q86YB7 1 52895910-52927212 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.9" "Cell line enhanced" "Detected in many" "BEWO: 15.2;HHSteC: 11.0;THP-1: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026731, HPA026768" Enhanced Approved Mitochondria 410000 Mitochondria "HPA026731: AB_1847969, HPA026768: AB_1847970" "unprognostic (2.73e-3)" "unprognostic (1.52e-2)" "unprognostic (4.08e-2)" "unprognostic (3.76e-1)" "unprognostic (7.67e-2)" "prognostic favourable (6.65e-4)" "unprognostic (1.51e-3)" "unprognostic (1.40e-3)" "unprognostic (6.11e-2)" "unprognostic (7.16e-2)" "unprognostic (2.98e-3)" "unprognostic (4.40e-2)" "unprognostic (5.47e-2)" "unprognostic (5.12e-2)" "unprognostic (2.93e-1)" "unprognostic (3.62e-1)" "prognostic favourable (2.70e-4)" 10.2 13.3 4.8 9.3 7.4 3.1 10.3 12.3 2.9 10.0 11.2 2.6 20.3 14.5 10.4 20.5 10.2 9.1 20.7 11.1 4.8 2.6 21.3 74.9 9.2 2.5 2.9 3.6 11.8 9.9 8.4 18.1 4.4 5.3 10.9 3.8 15.9 11.2 25.6 22.2 6.0 13.3 16.2 4.6 3.8 10.2 3.8 4.2 1.8 16.4 11.1 8.1 8.0 10.7 5.2 8.2 1.7 1.8 4.8 11.0 3.8 0.0 1.5 0.0 0.0 1.1 0.5 15.2 1.2 7.0 1.5 2.3 0.0 1.1 0.0 7.0 1.2 0.8 0.0 1.2 0.3 0.0 7.1 0.0 2.5 3.2 11.0 0.0 2.1 1.6 3.2 0.9 1.1 4.3 1.1 0.2 0.0 3.7 0.0 0.7 0.1 1.6 0.0 0.1 0.6 4.9 5.9 0.7 0.3 2.1 5.5 0.1 1.1 9.2 1.7 0.0 0.0 0.7 0.1 0.3 0.5 0.0 0.4 0.0 0.3 0.0 1.8 1.7 11.0 1.4 8.2 5.2 9.0 10.3 8.2 2.6 10.2 6.2 0.4 4.8 0.7 2.0 10.8 3.8 4.8 7.4 12.3 2.9 4.8 2.6 2.9 3.6 5.3 4.2 ECHS1 SCEH ENSG00000127884 "Enoyl-CoA hydratase, short chain 1" P30084 10 133362480-133373689 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 148.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003783, HPA021995, HPA022476" Enhanced Enhanced Mitochondria 1500000 Mitochondria "CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975" "unprognostic (3.68e-1)" "unprognostic (2.46e-3)" "unprognostic (9.57e-2)" "unprognostic (4.70e-2)" "unprognostic (1.59e-1)" "unprognostic (3.14e-1)" "unprognostic (2.51e-3)" "unprognostic (2.30e-1)" "unprognostic (1.82e-2)" "unprognostic (2.28e-2)" "unprognostic (1.60e-1)" "unprognostic (1.27e-1)" "prognostic favourable (8.57e-5)" "unprognostic (2.84e-2)" "unprognostic (1.19e-2)" "unprognostic (3.04e-2)" "unprognostic (2.50e-2)" 36.5 18.7 16.6 9.1 16.6 5.0 15.2 8.2 18.3 8.8 21.8 13.0 34.7 22.8 9.5 14.1 16.5 12.2 17.4 29.8 14.6 11.5 62.1 148.2 6.3 7.8 14.8 10.3 11.6 16.3 9.2 11.0 12.8 11.1 13.9 14.0 11.0 40.2 38.4 35.7 8.8 32.1 9.9 11.9 7.3 11.0 10.2 10.2 3.9 16.2 17.5 13.0 11.2 7.8 39.4 53.7 18.3 45.7 33.5 32.1 44.5 28.7 36.1 19.7 49.1 28.6 18.4 18.0 21.2 28.0 29.6 25.1 79.2 28.0 21.7 18.4 23.8 27.0 25.5 21.5 21.4 16.6 44.8 21.6 21.8 56.3 24.0 28.0 15.4 20.5 18.6 19.6 25.1 26.2 19.5 19.1 28.8 68.2 13.9 54.7 13.7 43.4 24.0 23.9 11.6 36.5 36.9 12.7 20.2 21.9 36.4 27.5 28.3 27.0 21.0 13.4 19.4 27.7 27.9 14.4 8.8 24.6 31.7 15.3 11.0 17.0 41.7 18.3 24.9 45.7 32.1 39.4 28.1 27.1 53.7 32.2 28.9 27.9 4.4 33.5 34.3 23.2 26.0 44.5 16.6 16.6 8.2 18.3 14.6 11.5 14.8 10.3 11.1 10.2 ECI1 DCI ENSG00000167969 "Enoyl-CoA delta isomerase 1" P42126 16 2239395-2252300 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 90.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041746, HPA043227" Enhanced Enhanced Mitochondria 11000000 Mitochondria "HPA041746: AB_10960693, HPA043227: AB_10960273" "unprognostic (4.99e-2)" "prognostic favourable (3.04e-5)" "unprognostic (3.75e-1)" "unprognostic (2.92e-3)" "unprognostic (8.90e-2)" "unprognostic (2.85e-2)" "prognostic favourable (1.07e-4)" "unprognostic (1.98e-1)" "unprognostic (2.17e-1)" "unprognostic (5.14e-3)" "unprognostic (6.32e-2)" "unprognostic (2.66e-2)" "prognostic favourable (8.99e-8)" "unprognostic (2.61e-2)" "unprognostic (3.31e-1)" "unprognostic (1.97e-1)" "unprognostic (6.08e-3)" 15.7 12.5 12.5 9.8 10.8 9.1 16.8 12.8 11.3 10.9 27.6 9.7 20.3 30.9 10.6 16.7 15.5 13.4 17.3 56.4 10.1 10.3 36.5 57.4 10.3 10.7 12.4 8.8 10.8 30.4 11.1 11.9 10.6 13.0 13.4 8.4 16.3 40.9 19.1 90.3 10.4 31.2 14.1 10.1 8.0 17.2 8.4 9.6 10.4 38.7 25.4 10.5 14.4 11.5 7.6 6.5 3.9 7.1 5.8 6.7 1.7 7.3 17.5 6.7 27.6 2.6 3.6 25.3 7.4 5.1 6.1 9.0 30.9 22.5 10.6 18.6 4.6 18.1 7.9 7.0 0.8 18.4 40.4 3.2 16.4 38.1 23.6 9.5 1.5 6.8 16.7 5.0 11.0 6.1 17.6 22.6 2.0 30.2 0.9 14.3 15.6 17.8 33.4 7.3 51.1 11.6 8.3 23.2 14.7 17.9 33.9 22.4 21.8 17.0 5.0 4.8 18.0 5.1 8.2 25.0 14.7 17.3 6.3 8.9 6.7 3.2 6.8 2.7 3.8 7.1 6.0 7.6 5.5 2.9 5.5 7.4 6.7 5.6 3.9 5.8 4.2 6.5 6.7 1.7 12.5 10.8 12.8 11.3 10.1 10.3 12.4 8.8 13.0 9.6 EEF1G EF1G ENSG00000254772 "Eukaryotic translation elongation factor 1 gamma" P26641 11 62559601-62574086 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 334.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA040688, HPA055316" Enhanced Approved Mitochondria 4600000 Mitochondria "HPA040688: AB_10961632, HPA055316: AB_2732593" "unprognostic (2.12e-1)" "unprognostic (1.23e-1)" "unprognostic (2.44e-1)" "unprognostic (1.37e-2)" "unprognostic (2.28e-1)" "unprognostic (1.60e-1)" "unprognostic (9.22e-4)" "unprognostic (1.14e-1)" "unprognostic (5.14e-2)" "unprognostic (5.07e-3)" "unprognostic (1.86e-1)" "unprognostic (8.59e-2)" "unprognostic (8.99e-2)" "unprognostic (1.00e-1)" "unprognostic (1.08e-1)" "unprognostic (1.16e-1)" "unprognostic (6.04e-2)" 46.5 38.1 33.0 41.3 40.0 60.6 84.9 30.4 56.5 53.8 45.4 30.6 29.7 40.9 48.6 43.0 71.1 61.0 35.1 62.2 34.6 24.7 49.4 64.5 41.7 98.8 29.1 31.8 105.3 103.9 29.9 31.7 41.4 51.4 50.4 49.2 29.0 58.9 35.5 207.2 88.5 45.0 38.2 39.6 48.4 45.8 236.9 28.8 43.9 41.1 118.6 70.9 47.7 66.1 203.5 136.9 27.4 83.9 114.5 251.4 334.5 88.4 94.3 98.5 139.5 148.6 192.7 98.9 77.5 140.7 97.3 74.6 104.8 112.7 263.5 123.7 123.3 104.9 116.5 114.2 89.2 84.6 108.4 68.6 106.1 107.1 161.7 138.3 81.1 220.1 207.0 96.2 236.7 133.8 137.4 127.3 114.5 182.8 150.2 247.5 118.7 82.6 125.8 126.8 250.5 129.7 117.2 85.5 106.4 46.7 158.6 210.7 181.7 154.4 90.1 56.6 79.4 109.2 67.0 89.1 86.3 131.7 64.3 102.6 79.2 27.4 83.9 21.0 87.3 78.5 173.5 203.5 167.7 112.9 136.9 187.5 251.4 169.1 12.3 114.5 64.0 108.5 119.2 334.5 33.0 40.0 30.4 56.5 34.6 24.7 29.1 31.8 51.4 28.8 EFEMP1 "DHRD, FBLN3, FBNL, MTLV, S1-5" ENSG00000115380 "EGF containing fibulin extracellular matrix protein 1" Q12805 2 55865967-55924139 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 64.8;HUVEC TERT2: 263.9;TIME: 233.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB016368, HPA049806, HPA070841, HPA071588" Supported Supported Mitochondria "Secreted to extracellular matrix" 1800000000 Mitochondria "CAB016368: AB_2277777, HPA049806: , HPA070841: , HPA071588: " "unprognostic (8.21e-2)" "unprognostic (7.68e-2)" "unprognostic (9.01e-3)" "prognostic unfavourable (4.72e-4)" "unprognostic (3.43e-2)" "unprognostic (1.73e-2)" "unprognostic (4.86e-2)" "unprognostic (1.38e-1)" "unprognostic (3.46e-1)" "unprognostic (9.07e-2)" "unprognostic (1.55e-2)" "unprognostic (1.50e-1)" "prognostic unfavourable (3.89e-8)" "unprognostic (3.15e-3)" "unprognostic (4.94e-2)" "unprognostic (3.09e-1)" "prognostic unfavourable (6.68e-5)" 63.1 14.1 13.6 14.1 35.1 0.1 45.5 8.0 12.8 14.8 20.4 22.0 16.6 6.2 20.1 31.9 22.0 38.6 37.1 55.4 8.2 9.7 16.3 3.5 38.5 24.5 12.5 15.5 52.9 10.9 3.3 6.6 84.5 25.8 47.5 22.9 116.9 26.8 40.5 15.6 13.8 12.0 29.9 8.6 10.1 12.6 9.3 13.5 0.9 57.4 18.1 7.3 45.5 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 0.2 0.4 0.0 20.1 13.0 0.0 12.5 13.4 1.5 1.1 0.0 1.2 0.0 8.1 15.1 21.0 0.0 15.0 0.5 0.0 0.0 0.0 5.3 0.0 55.1 0.0 0.0 64.8 6.9 1.5 17.3 263.9 0.0 0.0 5.6 2.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.0 17.4 6.5 0.0 20.2 0.0 233.7 0.1 7.0 25.9 8.0 0.7 0.0 0.0 4.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 35.1 8.0 8.8 8.2 9.7 12.5 15.5 25.8 13.5 ETFA "EMA, GA2, MADD" ENSG00000140374 "Electron transfer flavoprotein alpha subunit" P13804 15 76215355-76311472 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018990, HPA018993, HPA018996, HPA024089" Enhanced Enhanced Mitochondria 6300000 Mitochondria "HPA018990: AB_1848277, HPA018993: AB_1848275, HPA018996: AB_1848276, HPA024089: AB_1848278" "unprognostic (3.44e-3)" "unprognostic (1.50e-1)" "unprognostic (2.29e-1)" "unprognostic (2.26e-1)" "unprognostic (3.71e-3)" "unprognostic (5.99e-2)" "unprognostic (6.81e-3)" "unprognostic (3.02e-1)" "unprognostic (5.01e-2)" "unprognostic (6.01e-2)" "unprognostic (3.38e-3)" "unprognostic (1.99e-1)" "prognostic favourable (5.04e-8)" "unprognostic (2.87e-1)" "unprognostic (4.90e-2)" "unprognostic (9.22e-2)" "unprognostic (2.90e-2)" 18.8 39.9 12.8 16.4 13.6 10.7 26.1 7.6 13.4 8.6 26.4 7.3 9.6 27.5 10.1 11.1 18.9 7.7 12.6 84.4 13.3 8.5 36.4 78.3 9.8 15.7 11.9 12.9 7.8 28.1 7.6 11.0 24.0 11.8 11.2 26.0 9.4 15.8 10.8 84.0 12.3 29.2 17.3 11.8 11.7 18.5 9.7 10.8 10.8 11.9 37.9 12.8 14.8 11.5 24.6 50.7 25.2 38.8 36.0 29.3 39.4 21.7 35.9 23.8 24.9 26.8 28.6 37.5 26.3 30.5 34.2 30.7 31.7 40.7 36.5 26.5 26.1 55.9 92.3 36.6 39.9 43.8 18.0 39.7 26.1 36.6 21.9 37.9 29.7 21.4 34.7 17.3 28.9 34.5 37.5 38.0 35.0 34.3 7.8 31.7 18.5 10.8 34.3 29.6 48.8 37.6 70.1 24.9 12.6 39.9 91.2 36.1 46.8 40.2 20.2 33.4 22.7 29.2 31.7 18.5 38.0 45.0 24.0 50.5 23.6 11.2 38.8 25.2 22.1 34.5 20.8 24.6 20.8 22.7 50.7 20.2 17.0 21.1 9.9 36.0 28.4 20.3 29.3 39.4 12.8 13.6 7.6 13.4 13.3 8.5 11.9 12.9 11.8 10.8 ETFB ENSG00000105379 "Electron transfer flavoprotein beta subunit" P38117 19 51345169-51366418 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 108.6;liver: 106.6" "Cell line enriched" "Detected in all" 4 "Hep G2: 185.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018910, HPA018921, HPA018923" Supported Enhanced Mitochondria 640000 Mitochondria "HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282" "unprognostic (1.44e-1)" "prognostic favourable (6.45e-4)" "unprognostic (8.66e-2)" "unprognostic (3.08e-1)" "unprognostic (1.77e-1)" "unprognostic (3.94e-2)" "unprognostic (3.20e-1)" "unprognostic (6.93e-3)" "unprognostic (2.63e-2)" "unprognostic (7.79e-2)" "unprognostic (1.23e-1)" "unprognostic (4.75e-1)" "prognostic favourable (6.45e-5)" "unprognostic (2.19e-1)" "unprognostic (2.54e-1)" "unprognostic (4.83e-1)" "unprognostic (1.99e-1)" 35.8 28.7 26.1 12.0 30.7 14.3 16.7 9.4 19.5 9.1 27.2 17.7 11.3 33.2 9.8 10.1 24.2 13.2 31.5 108.6 22.2 19.2 32.1 106.6 10.2 12.3 27.9 17.1 11.1 23.0 12.8 11.7 10.5 18.1 12.9 10.1 18.4 46.7 10.2 72.9 13.6 30.6 16.6 22.2 10.6 19.1 7.7 15.9 17.7 14.2 47.7 14.6 11.4 9.9 66.0 62.5 27.0 49.3 46.2 50.7 31.9 13.2 34.2 4.7 13.0 15.2 17.8 7.5 9.0 6.9 7.3 7.3 28.7 21.8 13.2 9.2 14.5 11.7 9.4 19.2 2.2 19.7 36.6 10.4 20.9 185.6 16.7 9.9 7.8 27.6 5.7 9.9 10.2 6.2 15.6 14.9 9.4 26.8 10.3 9.4 3.0 42.3 11.5 12.8 24.7 10.0 15.2 10.6 5.1 19.9 5.7 10.3 14.9 9.6 8.7 7.6 8.0 8.2 8.2 22.9 13.9 11.8 39.0 14.8 19.6 26.7 46.9 27.0 26.4 49.3 34.4 63.9 39.6 33.7 53.5 66.0 42.2 35.0 23.6 46.2 36.6 62.5 50.7 31.9 26.1 30.7 9.4 19.5 22.2 19.2 27.9 17.1 18.1 15.9 ETHE1 "HSCO, YF13H12" ENSG00000105755 "ETHE1, persulfide dioxygenase" O95571 19 43506719-43527244 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 80.7" "Cell line enhanced" "Detected in many" "BJ hTERT+: 57.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028360, HPA029028, HPA029029" Enhanced Enhanced Mitochondria 13000 Mitochondria "HPA028360: AB_10599297, HPA029028: AB_10602092, HPA029029: AB_10601998" "unprognostic (8.04e-2)" "unprognostic (3.33e-1)" "unprognostic (1.50e-2)" "unprognostic (2.45e-1)" "unprognostic (8.34e-2)" "unprognostic (1.25e-2)" "unprognostic (2.58e-1)" "prognostic unfavourable (9.58e-4)" "unprognostic (7.75e-2)" "unprognostic (2.28e-1)" "unprognostic (5.47e-2)" "unprognostic (3.24e-1)" "unprognostic (1.01e-1)" "unprognostic (5.27e-2)" "unprognostic (1.75e-1)" "unprognostic (9.72e-3)" "unprognostic (2.73e-2)" 7.7 10.5 5.2 28.3 6.3 13.1 8.8 4.5 6.7 10.9 80.7 4.6 9.6 27.4 7.1 12.2 28.2 7.1 18.4 8.9 4.4 4.1 19.0 21.3 11.4 15.5 5.6 4.9 7.4 12.7 3.0 7.2 16.7 5.1 12.0 72.1 5.6 18.5 6.7 9.4 9.1 40.3 11.8 4.5 11.0 13.2 3.3 4.7 12.0 26.2 23.3 24.4 10.9 13.3 7.9 35.8 7.4 24.3 9.9 20.2 15.1 13.4 17.7 3.6 12.6 19.8 13.5 1.4 20.9 57.0 18.0 18.5 5.3 13.8 0.0 15.7 20.0 11.0 5.2 31.5 4.8 6.7 1.7 3.4 7.7 14.7 9.0 5.0 4.7 13.8 24.8 6.9 19.5 13.3 2.2 22.6 8.8 9.1 5.8 4.6 0.9 8.6 6.6 1.6 3.0 39.1 28.0 0.0 4.5 5.3 19.2 12.5 5.8 8.4 11.2 2.9 12.4 3.5 3.8 6.4 5.0 0.3 12.6 20.8 15.0 7.4 24.3 0.6 17.2 12.7 20.0 7.9 20.2 16.3 35.8 3.4 15.6 14.8 0.7 9.9 8.5 7.1 19.4 15.1 5.2 6.3 4.5 6.7 4.4 4.1 5.6 4.9 5.1 4.7 EVC2 LBN ENSG00000173040 "EvC ciliary complex subunit 2" Q86UK5 4 5542772-5709548 "Disease related genes, Predicted membrane proteins" "Ciliopathy, Disease mutation, Dwarfism, Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 12.2;hTERT-HME1: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040910, HPA048122" Uncertain Approved Mitochondria Mitochondria "HPA040910: , HPA048122: " "unprognostic (6.56e-2)" "unprognostic (6.74e-2)" "unprognostic (5.10e-2)" "unprognostic (2.25e-1)" "unprognostic (8.23e-3)" "unprognostic (2.80e-1)" "unprognostic (2.05e-2)" "unprognostic (1.22e-2)" "unprognostic (1.71e-1)" "unprognostic (1.28e-1)" "unprognostic (8.57e-2)" "unprognostic (9.37e-2)" "prognostic favourable (1.58e-4)" "unprognostic (2.51e-2)" "unprognostic (3.14e-1)" "unprognostic (5.61e-2)" "unprognostic (6.29e-5)" 6.9 1.2 1.2 7.6 1.6 0.3 15.7 1.6 1.0 13.2 5.2 1.1 3.4 1.3 14.1 8.5 5.1 6.3 8.2 4.7 1.9 0.7 8.0 1.4 4.1 3.7 1.6 0.5 14.4 5.0 8.1 2.5 2.6 1.3 8.6 1.3 7.7 5.0 4.2 2.8 5.6 2.9 14.2 1.7 3.6 3.5 4.5 0.6 1.1 12.4 3.7 7.9 7.2 24.6 0.8 0.0 0.0 0.1 0.0 1.2 0.0 0.0 2.4 0.0 6.0 7.9 8.8 0.0 3.6 8.7 3.3 5.5 0.0 0.0 4.5 0.0 2.9 2.5 0.0 1.5 3.1 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 5.5 4.2 4.2 9.8 3.5 0.0 0.2 4.7 0.0 0.0 0.0 3.5 0.0 7.5 7.5 0.0 0.3 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.5 5.9 0.0 0.0 2.2 0.0 3.8 4.0 1.1 2.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.8 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 1.2 1.6 1.6 1.0 1.9 0.7 1.6 0.5 1.3 0.6 EXOG "ENDOGL1, ENDOGL2, ENGL, ENGL-a, ENGL-b" ENSG00000157036 "Exo/endonuclease G" Q9Y2C4 3 38496127-38542161 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012531, HPA071050" Enhanced Supported Mitochondria "Intracellular and membrane" Mitochondria "HPA012531: , HPA071050: " "unprognostic (2.88e-1)" "unprognostic (5.81e-3)" "unprognostic (3.55e-3)" "unprognostic (2.77e-1)" "unprognostic (8.32e-3)" "unprognostic (8.90e-3)" "unprognostic (4.78e-4)" "unprognostic (3.59e-2)" "unprognostic (3.99e-2)" "unprognostic (3.10e-2)" "prognostic favourable (1.92e-5)" "prognostic unfavourable (4.90e-4)" "unprognostic (6.51e-2)" "unprognostic (1.64e-2)" "unprognostic (4.79e-2)" "unprognostic (1.10e-1)" "unprognostic (2.78e-2)" 7.4 9.9 14.1 12.8 14.2 8.1 6.6 18.5 14.1 8.2 8.0 10.5 6.6 5.4 9.7 8.9 5.2 7.4 9.0 22.8 11.7 9.1 7.2 5.8 7.2 12.9 11.1 11.0 8.0 7.4 7.6 16.8 7.3 8.7 9.4 8.2 6.8 5.9 9.3 9.5 4.8 8.1 11.2 8.0 10.8 6.6 9.7 11.2 11.5 8.7 4.0 11.0 9.0 6.4 24.5 6.8 2.1 5.2 12.0 13.6 2.6 3.7 6.6 7.6 6.6 5.2 7.6 3.1 11.9 7.7 10.4 11.8 6.0 3.7 12.9 3.2 4.8 3.8 9.6 4.2 8.8 14.4 8.6 9.7 10.0 6.3 6.3 10.5 8.1 5.9 4.6 9.3 4.9 14.0 4.4 8.6 16.5 2.4 7.3 3.5 7.3 8.5 4.8 4.2 5.7 5.4 5.0 3.5 1.8 7.4 1.8 3.2 2.6 5.0 11.7 8.7 6.1 9.2 9.6 4.8 8.2 11.8 6.5 9.1 6.2 0.4 5.0 2.1 13.6 4.4 11.9 24.5 13.0 13.0 3.4 22.4 13.1 13.0 0.2 12.0 5.2 6.8 5.8 2.6 14.1 14.2 18.5 14.1 11.7 9.1 11.1 11.0 8.7 11.2 F7 ENSG00000057593 "Coagulation factor VII" P08709 13 113105788-113120681 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Protease, Serine protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "liver: 68.0" "Group enriched" "Detected in some" 9 "CACO-2: 16.2;Hep G2: 10.1" "Cancer enriched" "Detected in some" 17 "liver cancer: 41.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "gdT-cell: 1.7;MAIT T-cell: 1.2;memory CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA004826 Approved Mitochondria "Secreted to blood" 3600000 1500000000 Mitochondria "HPA004826: AB_10602805" "unprognostic (2.06e-1)" "unprognostic (2.55e-1)" "unprognostic (1.03e-1)" "unprognostic (1.34e-1)" "unprognostic (3.27e-1)" "unprognostic (1.91e-1)" "unprognostic (1.50e-3)" "unprognostic (3.81e-1)" "unprognostic (4.36e-3)" "unprognostic (1.16e-1)" "unprognostic (4.19e-3)" "unprognostic (1.15e-1)" "unprognostic (1.35e-3)" "unprognostic (3.36e-3)" "unprognostic (1.09e-1)" "unprognostic (2.86e-1)" "unprognostic (1.47e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.4 0.2 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 68.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 1.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.1 FAM136A FLJ14668 ENSG00000035141 "Family with sequence similarity 136 member A" Q96C01 2 70295975-70302090 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030103, HPA030104" Enhanced Approved Mitochondria Mitochondria "HPA030103: AB_10600194, HPA030104: AB_10600534" "unprognostic (2.81e-1)" "unprognostic (5.76e-2)" "unprognostic (9.16e-2)" "unprognostic (3.69e-2)" "unprognostic (5.53e-2)" "unprognostic (1.35e-1)" "prognostic unfavourable (2.66e-4)" "unprognostic (1.14e-1)" "unprognostic (1.12e-2)" "unprognostic (1.28e-2)" "unprognostic (5.91e-2)" "unprognostic (2.09e-1)" "prognostic unfavourable (1.33e-6)" "unprognostic (4.95e-3)" "unprognostic (3.03e-1)" "unprognostic (4.03e-1)" "unprognostic (2.00e-3)" 8.9 12.2 16.4 12.9 17.7 13.2 13.0 18.0 16.5 12.4 19.4 6.4 18.4 19.9 13.4 11.8 18.1 11.2 13.7 18.0 13.3 17.5 18.7 26.3 9.1 12.0 15.3 10.3 9.0 53.1 14.0 11.4 15.9 17.6 13.4 21.4 8.8 38.3 17.7 16.6 11.0 23.0 14.9 9.0 17.1 16.7 9.6 7.6 13.6 16.1 14.0 15.7 13.3 11.9 21.8 22.2 17.1 22.9 29.1 19.8 16.0 24.8 22.5 14.1 19.7 7.4 11.1 21.8 13.5 12.9 18.7 13.0 59.1 14.4 17.3 12.3 11.6 11.6 28.9 10.7 19.2 17.6 33.2 26.3 16.8 36.6 10.7 43.4 17.5 7.5 7.5 17.5 15.0 20.0 42.0 14.0 13.8 36.6 27.9 37.9 35.5 24.5 18.9 26.4 28.3 28.7 17.5 33.1 14.4 10.1 24.7 19.8 10.2 12.6 12.0 8.0 23.6 12.3 25.5 11.7 17.9 20.0 20.0 24.7 13.6 17.1 16.7 12.1 13.7 22.9 19.8 21.8 15.1 16.1 22.2 18.4 17.6 17.9 1.5 29.1 15.3 14.7 11.8 16.0 16.4 17.7 18.0 16.5 13.3 17.5 15.3 10.3 17.6 7.6 FAM160A2 "C11orf56, DKFZP566M1046, FHIP, FLJ22665, KIAA1759" ENSG00000051009 "Family with sequence similarity 160 member A2" Q8N612 11 6211335-6234711 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055994, HPA063987" Approved Approved Mitochondria Mitochondria "HPA055994: , HPA063987: " "unprognostic (1.40e-1)" "unprognostic (1.58e-1)" "unprognostic (3.44e-2)" "unprognostic (9.59e-3)" "unprognostic (2.20e-2)" "unprognostic (1.51e-1)" "unprognostic (4.16e-2)" "unprognostic (2.64e-1)" "unprognostic (2.19e-1)" "unprognostic (5.02e-2)" "unprognostic (2.16e-1)" "unprognostic (8.04e-2)" "unprognostic (6.65e-2)" "unprognostic (1.93e-1)" "unprognostic (1.64e-1)" "unprognostic (9.58e-2)" "unprognostic (1.85e-1)" 13.6 12.9 11.5 10.5 21.6 29.8 15.6 23.0 23.8 16.6 20.7 15.7 20.5 26.6 19.8 11.7 11.7 18.4 18.6 10.7 9.9 6.0 12.6 17.4 14.1 12.5 12.5 12.3 20.2 21.0 19.6 15.8 10.7 12.0 14.0 22.4 16.1 15.9 15.0 11.3 18.2 25.9 12.9 9.7 12.2 15.9 26.5 9.8 10.5 20.3 9.0 12.8 14.2 14.5 2.8 3.7 6.1 6.0 1.9 6.0 3.1 10.7 10.7 7.5 11.1 10.2 11.1 16.3 6.2 7.5 9.3 8.9 9.1 20.1 8.5 6.9 7.2 14.3 7.6 11.3 5.7 9.2 11.0 2.8 17.6 4.8 8.4 7.0 9.8 10.0 14.2 8.4 15.0 9.4 9.1 10.6 5.8 8.6 6.7 13.6 11.2 10.1 7.5 3.9 6.8 8.7 7.8 10.1 6.6 8.9 10.6 5.5 7.2 10.0 8.0 11.5 8.9 17.0 6.5 14.2 12.1 6.4 12.7 5.7 10.1 1.7 6.0 5.9 6.0 2.5 3.7 2.5 2.4 4.4 3.7 2.8 1.9 3.3 6.1 1.9 1.9 1.1 0.4 3.1 11.5 21.6 23.0 23.8 9.9 6.0 12.5 12.3 12.0 9.8 FAM167A C8orf13 ENSG00000154319 "Family with sequence similarity 167 member A" Q96KS9 8 11421463-11474715 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.0;thyroid gland: 51.1" "Cell line enhanced" "Detected in many" "Daudi: 24.4;RPMI-8226: 25.8;SH-SY5Y: 19.6;U-698: 19.5;U-87 MG: 16.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 16.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023915, HPA030426" Approved Approved Mitochondria Mitochondria "HPA023915: AB_1845768, HPA030426: AB_10601318" "unprognostic (8.51e-3)" "unprognostic (2.43e-1)" "unprognostic (1.25e-3)" "prognostic unfavourable (5.96e-4)" "unprognostic (3.08e-2)" "unprognostic (4.62e-3)" "unprognostic (1.79e-1)" "unprognostic (1.45e-1)" "unprognostic (1.51e-1)" "unprognostic (1.39e-1)" "unprognostic (4.06e-2)" "unprognostic (7.17e-2)" "unprognostic (1.77e-2)" "unprognostic (7.13e-2)" "unprognostic (1.56e-1)" "unprognostic (4.30e-2)" "unprognostic (2.21e-2)" 0.8 1.6 13.8 1.8 11.2 1.3 2.0 7.1 20.0 1.1 1.4 12.6 0.0 1.1 0.9 1.3 1.4 2.0 1.8 0.9 13.8 7.6 6.6 0.8 10.5 2.8 8.6 11.8 0.8 2.8 0.8 12.3 2.5 12.2 2.1 1.4 0.5 3.3 5.7 0.8 11.8 1.3 0.8 7.0 1.9 2.7 3.2 7.6 0.8 51.1 0.3 3.5 1.3 1.0 4.0 1.3 0.1 1.8 0.9 0.1 0.1 2.0 1.3 2.7 0.2 0.2 1.1 0.0 7.3 7.0 4.4 1.9 0.0 0.6 24.4 0.4 7.8 0.7 0.0 1.7 5.3 10.5 0.3 0.0 0.0 0.0 9.3 0.0 0.0 1.3 1.1 2.3 14.4 0.0 0.1 0.9 2.6 0.7 0.0 0.0 0.7 0.0 0.1 0.0 25.8 2.2 0.2 11.6 19.6 0.3 2.1 0.9 0.8 0.0 12.4 0.4 0.7 11.3 0.1 7.8 5.6 19.5 16.1 0.0 0.7 0.1 0.2 0.0 0.0 1.8 0.1 4.0 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.9 1.7 1.3 0.0 0.1 13.8 11.2 7.1 12.5 13.8 7.6 8.6 11.8 12.2 7.6 FAM92A "FAM92A1, FLJ38979" ENSG00000188343 "Family with sequence similarity 92 member A" A1XBS5 8 93698561-93731527 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 6.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034760, HPA058942" Enhanced Approved Mitochondria Mitochondria "HPA034760: AB_10599947, HPA058942: " "unprognostic (2.65e-3)" "unprognostic (6.81e-2)" "unprognostic (2.48e-3)" "unprognostic (2.44e-1)" "unprognostic (1.62e-2)" "unprognostic (2.93e-1)" "unprognostic (3.56e-1)" "unprognostic (3.13e-1)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (2.28e-3)" "unprognostic (1.97e-1)" "unprognostic (1.71e-1)" "unprognostic (6.85e-3)" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (3.07e-2)" 11.2 13.3 15.9 4.2 14.7 2.8 8.4 13.6 19.1 9.4 7.0 2.9 5.5 2.8 12.0 19.9 5.5 10.1 10.5 16.3 12.9 11.2 15.3 11.4 7.1 4.2 8.4 15.9 13.8 15.1 15.2 21.6 7.5 9.7 9.8 4.8 5.2 3.3 9.2 6.9 5.1 4.1 11.1 6.2 3.7 5.4 71.0 6.4 1.8 9.4 3.1 2.7 11.6 10.6 0.9 6.2 0.3 3.8 2.8 1.6 1.0 13.6 7.3 19.8 20.4 21.4 30.8 5.3 12.6 18.4 17.1 16.5 1.3 3.1 1.1 16.3 18.5 9.8 20.0 11.9 15.5 0.4 11.1 8.0 7.4 6.8 24.7 0.3 2.0 19.3 5.4 16.6 13.6 18.1 4.7 0.6 13.4 5.1 8.4 1.4 8.3 0.4 0.8 14.9 0.2 13.3 3.1 5.7 7.3 9.0 0.1 15.2 3.0 4.3 10.0 16.8 6.7 17.4 10.2 0.9 0.9 0.4 14.7 1.1 5.8 0.3 3.8 0.0 0.4 2.2 0.5 0.9 1.1 0.4 6.2 0.2 0.2 0.7 0.1 2.8 0.3 0.8 1.6 1.0 15.9 14.7 13.6 19.1 12.9 11.2 8.4 15.9 9.7 6.4 FASTKD2 KIAA0971 ENSG00000118246 "FAST kinase domains 2" Q9NYY8 2 206765357-206792509 "Predicted intracellular proteins" "Ribosome biogenesis" "RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067191 Supported Mitochondria Mitochondria "HPA067191: " "unprognostic (1.19e-1)" "unprognostic (2.45e-1)" "unprognostic (3.50e-3)" "unprognostic (1.36e-3)" "unprognostic (7.40e-2)" "unprognostic (2.69e-3)" "prognostic unfavourable (8.29e-4)" "unprognostic (1.69e-2)" "unprognostic (2.98e-2)" "unprognostic (1.11e-1)" "unprognostic (1.38e-3)" "unprognostic (1.48e-1)" "unprognostic (6.32e-2)" "unprognostic (4.87e-2)" "unprognostic (7.18e-2)" "unprognostic (1.03e-3)" "unprognostic (3.57e-2)" 17.2 20.0 12.8 11.2 24.2 9.4 17.1 18.7 23.9 15.5 15.0 9.0 13.1 14.1 19.7 12.7 20.9 15.5 11.2 23.9 12.1 8.4 19.0 27.4 12.8 12.4 10.4 18.1 16.9 15.1 16.6 29.4 12.3 21.2 13.5 17.0 10.3 15.5 11.5 42.0 17.1 14.5 15.6 11.0 14.0 16.3 10.8 11.8 14.2 17.7 19.4 16.0 16.7 14.2 13.4 19.6 5.1 13.9 19.2 19.5 12.8 14.9 13.7 12.8 14.5 14.6 17.5 24.0 17.5 14.9 30.1 17.2 24.3 16.4 18.9 19.7 18.2 20.5 15.9 24.7 26.7 5.8 10.3 14.7 14.1 23.4 17.8 31.8 13.8 18.8 25.3 22.8 25.1 20.2 27.8 9.6 22.1 12.8 13.5 13.6 22.9 26.3 11.8 19.9 19.4 20.8 25.1 18.7 12.0 13.5 23.0 20.8 10.8 16.7 15.7 18.4 16.5 12.6 18.2 9.7 15.9 24.4 21.4 14.8 15.1 5.1 13.9 3.2 13.1 13.5 14.4 13.4 14.6 13.7 19.6 10.8 19.5 17.5 0.8 19.2 9.8 9.4 11.3 12.8 12.8 24.2 18.7 23.9 12.1 8.4 10.4 18.1 21.2 11.8 FBP1 FBP ENSG00000165140 "Fructose-bisphosphatase 1" P09467 9 94603133-94640249 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Gluconeogenesis" "Allosteric enzyme, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 248.1;lung: 87.8" "Cell line enhanced" "Detected in some" "HaCaT: 20.1;MCF7: 62.8;RT4: 41.2;SK-BR-3: 12.0;U-698: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "eosinophil: 73.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA005857, HPA012513, CAB033869" Enhanced Uncertain Mitochondria 23000000 Mitochondria "CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446" "unprognostic (4.95e-2)" "unprognostic (1.40e-2)" "unprognostic (1.40e-1)" "prognostic favourable (5.16e-4)" "unprognostic (1.13e-2)" "unprognostic (1.37e-1)" "prognostic favourable (1.79e-4)" "unprognostic (6.94e-3)" "unprognostic (4.52e-2)" "unprognostic (7.79e-2)" "unprognostic (7.59e-2)" "unprognostic (1.12e-1)" "prognostic favourable (6.86e-7)" "unprognostic (6.91e-2)" "unprognostic (3.22e-2)" "unprognostic (1.07e-1)" "prognostic favourable (1.64e-5)" 19.3 5.8 0.6 2.3 0.9 1.1 7.0 0.4 0.8 2.2 48.8 0.7 17.6 40.7 0.6 2.5 0.7 0.9 9.7 1.3 0.8 0.5 34.6 248.1 87.8 8.9 0.9 0.7 1.0 8.1 17.1 1.9 1.0 1.0 6.4 3.0 1.5 9.1 17.7 0.5 1.7 60.4 3.1 1.2 2.8 10.4 1.0 0.8 0.5 4.3 1.0 1.1 22.4 9.6 0.6 17.1 73.5 30.7 2.8 3.3 5.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.1 20.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.3 5.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 62.8 0.0 1.1 0.2 2.2 0.0 0.2 0.4 0.0 41.2 0.2 1.2 0.1 12.0 0.0 7.2 1.7 0.0 0.0 0.2 0.2 0.0 0.0 0.1 29.9 0.0 0.3 0.0 10.6 13.0 73.5 1.5 30.7 2.3 0.6 0.9 0.9 17.1 0.6 3.3 1.6 2.3 2.8 16.3 6.1 0.4 5.2 0.6 0.9 0.4 0.8 0.8 0.5 0.9 0.7 1.0 0.8 FBXL12 "Fbl12, FLJ20188" ENSG00000127452 "F-box and leucine rich repeat protein 12" Q9NXK8 19 9810267-9827816 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 87.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002843 Approved Mitochondria Mitochondria "HPA002843: " "unprognostic (7.65e-2)" "unprognostic (5.88e-2)" "unprognostic (7.72e-2)" "unprognostic (3.82e-2)" "unprognostic (8.21e-2)" "prognostic favourable (3.21e-4)" "prognostic unfavourable (1.41e-4)" "unprognostic (6.45e-2)" "prognostic unfavourable (4.96e-4)" "unprognostic (1.38e-3)" "unprognostic (1.49e-2)" "unprognostic (4.07e-3)" "unprognostic (9.28e-3)" "unprognostic (1.41e-1)" "unprognostic (1.36e-1)" "unprognostic (2.61e-1)" "unprognostic (4.77e-3)" 14.3 10.4 6.6 12.4 9.8 25.1 16.3 12.2 12.6 14.7 16.8 10.5 8.6 16.2 18.6 18.7 13.2 17.0 15.6 12.1 6.9 7.1 12.0 15.3 14.8 14.1 8.8 8.7 19.3 12.4 8.2 13.4 16.3 10.5 16.5 11.7 10.0 9.9 17.8 17.3 11.3 18.6 14.5 6.7 13.9 12.9 11.8 7.6 87.9 13.5 9.2 12.7 17.8 13.4 19.0 17.1 27.3 14.7 22.5 18.4 11.6 9.5 4.8 11.3 10.8 12.8 11.4 12.8 10.4 10.7 11.4 13.5 14.7 6.4 9.0 16.8 10.4 9.1 8.4 9.1 9.1 8.9 16.3 17.3 9.7 14.6 16.6 12.4 10.7 16.3 6.2 10.9 9.7 8.1 13.0 18.8 5.9 7.6 18.4 38.7 12.8 9.1 10.8 8.3 16.2 8.1 13.0 6.9 9.5 7.6 5.7 11.8 7.8 14.9 9.2 15.6 7.6 20.8 10.2 25.3 9.8 14.0 6.6 11.4 7.4 20.8 14.7 27.3 15.9 12.1 18.2 13.6 15.6 18.3 16.6 19.0 18.4 14.5 10.9 22.5 11.3 17.1 16.5 11.6 6.6 9.8 12.2 12.6 6.9 7.1 8.8 8.7 10.5 7.6 FBXO21 "FBX21, KIAA0875" ENSG00000135108 "F-box protein 21" O94952 12 117141988-117190531 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 78.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062411, HPA071452" Approved Approved Mitochondria Mitochondria "HPA062411: , HPA071452: " "unprognostic (6.38e-2)" "unprognostic (4.43e-2)" "unprognostic (2.58e-2)" "unprognostic (9.00e-3)" "unprognostic (1.57e-1)" "unprognostic (8.89e-2)" "unprognostic (1.84e-1)" "unprognostic (1.37e-1)" "unprognostic (8.99e-2)" "unprognostic (7.01e-3)" "unprognostic (1.28e-2)" "unprognostic (9.44e-2)" "prognostic favourable (2.05e-8)" "unprognostic (1.69e-2)" "unprognostic (1.17e-1)" "unprognostic (2.01e-1)" "unprognostic (7.29e-2)" 8.1 29.4 17.8 8.8 21.6 5.2 11.4 27.0 28.0 12.6 10.5 18.8 25.5 10.6 16.1 70.1 10.2 78.4 14.2 18.9 17.9 18.4 33.3 17.0 11.2 8.2 13.5 21.4 38.8 19.0 17.3 18.8 12.3 17.5 17.4 9.8 14.0 10.7 19.8 16.3 11.8 9.5 12.8 17.0 11.6 11.8 27.8 14.2 9.9 19.1 6.9 9.3 12.7 10.2 12.8 8.5 3.7 10.5 9.2 13.0 7.1 9.4 22.4 14.2 7.8 11.7 12.2 16.2 12.6 13.7 11.9 9.7 14.4 6.7 12.4 12.5 12.9 12.9 16.6 12.6 14.3 6.9 14.9 0.6 12.4 11.6 10.6 4.0 4.4 12.0 12.2 9.5 15.2 16.5 4.9 4.1 10.1 15.4 11.4 2.9 21.1 14.7 13.6 20.6 13.0 11.9 22.6 28.1 17.0 31.6 8.4 6.8 19.5 1.6 12.7 7.9 10.3 9.2 8.1 7.3 7.5 16.3 11.5 6.3 11.0 1.1 5.8 3.7 10.7 10.5 11.2 9.8 11.3 11.1 8.5 12.8 13.0 11.7 0.5 9.2 10.1 5.8 11.4 7.1 17.8 21.6 27.0 28.0 17.9 18.4 13.5 21.4 17.5 14.2 FBXW5 "DKFZP434B205, Fbw5, MGC20962" ENSG00000159069 "F-box and WD repeat domain containing 5" Q969U6 9 136940435-136944696 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046615 Approved Approved Mitochondria Mitochondria "HPA046615: AB_10965648" "unprognostic (1.11e-1)" "unprognostic (1.10e-2)" "unprognostic (1.56e-2)" "prognostic favourable (1.02e-4)" "unprognostic (4.26e-2)" "unprognostic (1.29e-1)" "unprognostic (2.22e-2)" "unprognostic (7.16e-3)" "unprognostic (2.64e-2)" "unprognostic (7.05e-2)" "unprognostic (3.51e-3)" "unprognostic (3.23e-2)" "prognostic favourable (4.74e-4)" "unprognostic (1.73e-2)" "unprognostic (3.64e-1)" "unprognostic (2.32e-1)" "unprognostic (2.13e-1)" 17.6 13.9 13.3 12.4 14.4 14.7 11.8 11.2 24.3 9.8 17.0 9.6 12.7 23.7 11.1 11.8 19.5 8.5 15.9 30.7 15.3 9.6 13.4 31.0 9.0 10.8 11.8 10.9 8.4 25.9 8.8 10.5 12.8 12.0 13.7 7.5 9.3 25.7 16.1 68.2 11.5 23.4 18.2 6.5 12.7 16.4 67.8 9.6 16.2 12.8 17.3 16.0 14.4 11.6 16.3 38.7 33.0 28.4 20.1 41.2 26.0 15.1 26.3 6.0 14.7 14.7 9.6 35.7 15.8 10.9 11.1 6.1 17.5 19.8 10.4 18.4 16.2 20.0 5.4 13.8 1.8 13.9 18.3 9.0 35.9 18.0 16.3 13.0 23.2 11.0 12.4 10.1 8.4 11.3 17.5 17.2 8.3 40.0 10.2 15.6 11.1 28.7 11.5 9.2 18.9 9.6 15.4 12.7 12.8 19.6 21.2 21.0 24.4 20.7 21.9 16.6 15.0 30.8 13.7 14.3 17.1 6.9 22.6 11.7 12.5 19.6 24.8 33.0 41.2 28.4 31.3 16.3 31.3 34.5 23.3 12.9 14.0 23.2 13.1 20.1 21.9 38.7 36.3 26.0 13.3 14.4 11.2 24.3 15.3 9.6 11.8 10.9 12.0 9.6 FDX1 "ADX, FDX" ENSG00000137714 "Ferredoxin 1" P10109 11 110429883-110464881 "Predicted intracellular proteins" "Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Steroidogenesis, Sterol metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 113.9;seminal vesicle: 55.6" "Cell line enhanced" "Detected in all" "U-698: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041630, HPA062087" Enhanced Enhanced Mitochondria Mitochondria "HPA041630: AB_10793970, HPA062087: AB_2630366" "unprognostic (1.66e-1)" "unprognostic (1.68e-2)" "unprognostic (5.29e-3)" "unprognostic (4.67e-2)" "unprognostic (2.39e-1)" "unprognostic (4.32e-3)" "unprognostic (1.23e-2)" "unprognostic (2.07e-1)" "unprognostic (2.19e-2)" "unprognostic (4.12e-1)" "unprognostic (3.10e-2)" "unprognostic (5.48e-2)" "prognostic favourable (3.58e-7)" "prognostic favourable (2.53e-4)" "unprognostic (1.10e-1)" "unprognostic (1.94e-1)" "unprognostic (2.80e-1)" 5.5 113.9 3.9 4.7 4.5 3.9 5.6 2.7 4.0 3.2 7.5 5.2 33.7 7.9 3.2 3.9 5.1 3.0 5.6 9.6 3.6 4.3 10.7 22.8 7.8 4.7 4.5 2.5 3.5 8.6 3.5 3.7 48.4 3.1 4.8 4.2 4.2 4.1 55.6 7.3 3.3 12.3 3.6 3.4 3.9 5.0 5.3 2.6 5.2 8.7 5.0 3.5 5.6 5.4 10.7 6.9 3.4 5.8 4.4 8.7 2.9 5.2 3.7 5.7 6.2 5.6 10.0 12.8 4.9 6.0 4.3 7.4 12.6 8.9 12.4 14.4 6.3 6.3 6.6 7.4 5.9 11.8 8.4 6.2 6.5 7.7 9.8 6.5 10.2 17.3 6.1 3.9 9.3 8.8 6.2 18.5 9.2 5.8 9.2 14.6 5.1 7.0 13.7 5.4 11.4 9.4 9.5 7.8 4.0 9.3 10.6 6.2 6.2 4.5 5.2 4.4 5.4 5.3 5.2 4.2 3.2 37.2 3.3 13.4 5.6 1.8 5.7 3.4 5.3 4.2 5.8 10.7 7.3 7.4 6.9 7.5 8.6 6.1 0.7 4.4 5.8 5.3 8.7 2.9 3.9 4.5 2.7 4.0 3.6 4.3 4.5 2.5 3.1 2.6 FDXR ADXR ENSG00000161513 "Ferredoxin reductase" P22570 17 74862497-74873031 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport" Oxidoreductase "Deafness, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 93.9" "Cell line enhanced" "Detected in many" "BEWO: 29.5;Hep G2: 54.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008597, CAB009818, HPA044393, HPA053673" Enhanced Enhanced Mitochondria Mitochondria "CAB008597: AB_1615557, CAB009818: AB_2102601, HPA044393: AB_2678927, HPA053673: AB_2682225" "unprognostic (2.69e-2)" "unprognostic (1.17e-3)" "unprognostic (7.51e-2)" "prognostic favourable (2.38e-4)" "unprognostic (3.43e-2)" "unprognostic (1.20e-1)" "unprognostic (1.53e-1)" "unprognostic (1.68e-2)" "unprognostic (2.29e-1)" "unprognostic (1.50e-1)" "unprognostic (1.09e-1)" "unprognostic (6.30e-2)" "unprognostic (1.42e-2)" "unprognostic (1.19e-2)" "unprognostic (4.50e-2)" "unprognostic (4.03e-2)" "unprognostic (2.13e-1)" 1.7 93.9 2.6 2.1 3.1 1.3 1.8 8.4 2.7 2.1 4.6 3.2 6.4 2.6 2.6 23.8 8.7 6.6 6.1 1.9 3.4 1.7 2.7 4.1 4.4 1.7 2.9 3.5 7.1 3.9 2.3 1.5 2.6 3.6 3.3 2.1 0.9 5.3 4.2 7.9 5.6 2.5 2.0 4.4 9.7 2.2 32.1 3.0 3.9 2.0 7.7 3.7 3.0 3.0 5.4 7.4 4.8 6.4 10.0 15.2 5.6 3.9 21.1 3.1 3.5 2.3 3.0 29.5 4.7 5.2 2.8 5.7 5.9 3.5 9.4 0.8 2.0 8.1 2.3 5.9 0.8 8.9 4.9 7.1 3.5 54.0 6.4 1.5 25.0 9.9 6.7 2.9 1.0 14.4 11.3 1.5 4.3 16.7 6.1 3.3 1.7 4.6 3.3 5.3 5.0 2.3 6.7 1.7 4.0 3.2 7.1 3.4 15.4 1.5 6.7 1.9 17.6 3.1 2.3 4.4 0.7 2.0 5.3 2.4 6.6 1.8 6.4 4.8 6.2 4.3 5.3 5.4 5.6 7.3 7.4 2.8 4.9 6.1 2.1 10.0 3.2 1.4 15.2 5.6 2.6 3.1 8.4 2.7 3.4 1.7 2.9 3.5 3.6 3.0 FGFR1OP2 DKFZp564O1863 ENSG00000111790 "FGFR1 oncogene partner 2" Q9NVK5 12 26938383-26966650 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038308, HPA038696" Supported Approved Mitochondria Mitochondria "HPA038308: AB_10672524, HPA038696: AB_10675948" "unprognostic (1.68e-1)" "unprognostic (6.49e-2)" "unprognostic (1.95e-1)" "unprognostic (2.34e-1)" "unprognostic (4.01e-2)" "unprognostic (1.19e-1)" "unprognostic (4.37e-3)" "unprognostic (1.72e-1)" "unprognostic (8.17e-2)" "unprognostic (1.31e-1)" "unprognostic (1.11e-1)" "unprognostic (3.41e-2)" "unprognostic (1.55e-2)" "unprognostic (6.82e-2)" "unprognostic (1.40e-1)" "unprognostic (5.33e-2)" "unprognostic (1.36e-2)" 22.4 32.2 25.5 21.4 30.5 38.5 19.9 20.8 40.1 20.4 18.1 18.2 13.8 16.9 24.0 23.0 17.5 17.9 21.9 23.5 26.9 21.0 23.4 20.5 20.1 28.5 24.7 28.5 46.6 11.6 16.4 30.7 19.8 25.6 17.0 15.4 12.1 14.5 14.9 18.7 17.4 16.9 20.4 32.5 23.3 14.8 16.7 25.7 30.4 18.3 16.3 22.1 20.3 21.6 12.5 13.4 34.0 17.3 13.3 31.8 12.7 11.3 14.0 12.0 16.2 20.9 15.2 17.4 20.0 23.3 15.4 16.9 21.8 13.3 16.8 9.9 17.5 12.2 8.3 14.9 22.1 12.6 12.0 28.4 15.6 14.5 24.7 16.2 21.8 11.0 9.8 18.8 24.5 22.1 16.8 12.9 18.0 13.6 21.6 40.2 19.8 23.3 13.1 33.3 14.1 13.6 14.0 3.7 7.3 22.8 8.5 19.5 15.1 25.2 23.9 20.7 20.7 37.8 18.5 9.1 9.2 35.7 17.3 19.2 16.7 34.0 17.3 20.9 18.2 16.2 16.4 12.5 19.2 17.5 13.4 10.4 17.9 19.3 17.5 13.3 15.3 11.2 31.8 12.7 25.5 30.5 20.8 40.1 26.9 21.0 24.7 28.5 25.6 25.7 FH fumarase ENSG00000091483 "Fumarate hydratase" P07954 1 241497603-241519761 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Tricarboxylic acid cycle" Lyase "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 93.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017785, HPA025770, HPA025948, HPA027341" Enhanced Supported Enhanced Mitochondria 2800000 Mitochondria "CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222" "unprognostic (1.03e-2)" "unprognostic (3.82e-2)" "unprognostic (9.46e-3)" "unprognostic (2.18e-1)" "unprognostic (2.10e-1)" "unprognostic (2.07e-1)" "unprognostic (2.28e-2)" "unprognostic (1.55e-1)" "unprognostic (5.14e-2)" "unprognostic (1.85e-2)" "unprognostic (1.27e-2)" "unprognostic (1.09e-1)" "prognostic favourable (2.76e-7)" "unprognostic (1.05e-1)" "unprognostic (1.05e-1)" "unprognostic (4.41e-2)" "unprognostic (1.24e-2)" 14.3 28.1 15.7 10.4 20.2 9.3 13.3 15.7 24.4 10.5 22.7 9.9 16.7 23.2 13.7 10.7 17.7 10.3 9.5 59.0 22.9 13.9 35.0 93.4 9.9 13.3 15.2 19.4 9.4 13.9 25.2 11.4 14.3 18.4 12.3 24.4 10.2 18.4 20.6 65.1 13.4 21.4 14.7 14.4 11.1 17.5 14.0 11.7 13.8 12.3 45.2 13.4 13.4 11.2 16.0 26.4 4.5 18.8 10.4 13.9 8.9 29.2 24.5 23.3 21.0 22.9 27.0 36.9 36.3 28.5 41.0 25.8 35.1 18.3 18.6 24.1 27.8 41.7 35.6 27.0 35.8 21.2 11.5 17.4 26.0 29.9 20.5 40.7 15.9 19.5 16.8 23.0 26.0 25.2 53.0 24.1 29.8 14.6 35.1 27.2 24.7 52.7 29.0 25.5 83.5 39.5 24.9 30.0 25.9 30.6 36.3 23.2 27.6 27.7 24.7 18.4 23.8 32.5 60.5 21.6 23.1 22.6 20.6 46.8 26.4 4.5 12.8 2.7 9.7 18.8 12.6 16.0 11.4 9.0 26.4 14.1 13.9 12.7 0.7 10.4 15.7 13.2 13.2 8.9 15.7 20.2 15.7 24.4 22.9 13.9 15.2 19.4 18.4 11.7 FIS1 "CGI-135, Fis1, H_NH0132A01.6, TTC11" ENSG00000214253 "Fission, mitochondrial 1" Q9Y3D6 7 101239458-101252316 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017430 Approved Supported Mitochondria 590000 Mitochondria "HPA017430: AB_1848608" "unprognostic (1.45e-2)" "unprognostic (8.20e-2)" "unprognostic (4.31e-2)" "unprognostic (1.78e-1)" "unprognostic (1.48e-2)" "unprognostic (1.63e-1)" "unprognostic (7.73e-2)" "unprognostic (6.54e-2)" "unprognostic (5.33e-2)" "unprognostic (2.93e-1)" "unprognostic (1.36e-3)" "unprognostic (3.47e-2)" "prognostic favourable (1.08e-7)" "unprognostic (1.29e-2)" "unprognostic (1.49e-1)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" 35.1 46.8 53.4 22.3 49.9 32.7 35.8 26.0 60.0 30.3 34.4 57.9 38.0 30.0 31.1 42.7 35.6 47.0 39.4 78.6 52.6 44.8 39.6 58.3 27.8 23.6 65.3 37.8 41.2 56.6 39.5 37.1 34.0 45.1 29.3 26.3 28.8 45.2 43.8 120.5 29.7 29.2 32.4 87.9 28.1 31.1 30.4 44.1 21.3 47.1 48.8 22.6 30.5 29.3 73.0 73.4 63.6 67.4 55.6 72.8 87.9 24.7 29.2 21.9 31.4 25.3 33.9 15.0 26.9 32.8 24.6 21.2 20.1 40.8 24.3 36.0 36.9 14.6 15.3 43.5 13.8 18.8 22.2 11.0 42.5 26.6 30.2 20.5 17.1 32.2 41.0 17.2 26.4 44.5 23.1 33.4 37.0 113.9 31.9 37.0 24.3 28.4 15.6 12.3 53.2 37.2 28.7 28.4 33.3 12.8 61.9 18.2 20.6 23.3 36.4 28.9 18.6 29.9 28.6 28.3 21.6 14.0 26.8 23.3 37.7 58.9 67.4 63.6 63.2 65.5 65.1 72.2 61.0 59.7 73.4 73.0 60.7 63.5 51.4 55.6 59.0 61.4 72.8 87.9 53.4 49.9 26.0 60.0 52.6 44.8 65.3 37.8 45.1 44.1 FMC1 "C7orf55, HSPC268" ENSG00000164898 "Formation of mitochondrial complex V assembly factor 1 homolog" Q96HJ9 7 139339457-139346319 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045663, HPA050553" Approved Approved Mitochondria Mitochondria "HPA045663: , HPA050553: " "unprognostic (3.71e-2)" "unprognostic (1.15e-2)" "unprognostic (3.69e-1)" "unprognostic (3.80e-2)" "unprognostic (8.90e-2)" "unprognostic (9.00e-2)" "unprognostic (4.39e-2)" "prognostic favourable (1.08e-4)" "unprognostic (2.19e-1)" "prognostic favourable (5.63e-6)" "unprognostic (1.04e-3)" "unprognostic (2.39e-2)" "prognostic favourable (2.05e-5)" "unprognostic (1.50e-1)" "unprognostic (3.40e-2)" "unprognostic (4.67e-1)" "unprognostic (3.02e-2)" 9.2 9.7 11.2 6.0 16.9 7.0 10.2 6.2 18.6 8.4 8.8 7.2 15.1 8.4 7.1 13.6 6.5 11.5 9.7 26.7 10.3 10.0 12.2 17.5 7.2 7.9 12.8 10.2 10.6 22.1 5.5 10.7 4.4 12.2 12.9 6.2 7.1 14.2 13.2 28.3 5.2 6.0 8.1 9.2 6.0 8.7 6.4 11.9 5.3 15.4 18.7 4.0 7.9 10.9 15.9 15.0 7.4 7.7 10.4 12.1 5.3 2.4 9.0 5.3 5.5 2.9 2.5 2.2 0.8 2.2 6.2 4.5 3.0 3.2 5.8 5.4 2.6 2.0 5.0 2.2 1.4 2.9 30.2 2.9 9.2 12.5 6.0 2.3 3.9 6.2 4.3 2.0 1.7 4.7 5.5 8.4 3.4 17.2 5.6 14.4 5.0 12.9 3.5 2.6 7.5 4.8 2.2 10.0 6.6 2.7 2.3 3.8 1.1 1.8 2.3 2.2 2.0 2.7 2.3 2.9 2.9 6.4 5.3 5.2 3.5 7.4 7.7 7.4 8.3 4.6 7.4 15.9 10.3 8.3 8.4 14.6 12.1 8.7 3.5 10.4 5.0 15.0 11.3 5.3 11.2 16.9 6.2 18.6 10.3 10.0 12.8 10.2 12.2 11.9 FN3K ENSG00000167363 "Fructosamine 3 kinase" Q9H479 17 82735575-82751197 "Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 17.4;Hep G2: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059151, HPA061358" Supported Approved Mitochondria 1400000 Mitochondria "HPA059151: , HPA061358: " "unprognostic (4.74e-2)" "unprognostic (9.19e-2)" "unprognostic (4.22e-2)" "prognostic favourable (1.10e-4)" "unprognostic (6.10e-2)" "unprognostic (1.39e-1)" "unprognostic (6.45e-2)" "unprognostic (9.86e-2)" "unprognostic (5.08e-2)" "unprognostic (2.61e-1)" "prognostic favourable (2.40e-4)" "unprognostic (6.66e-2)" "prognostic favourable (1.39e-6)" "unprognostic (2.68e-2)" "unprognostic (8.02e-2)" "unprognostic (4.77e-1)" "unprognostic (1.22e-2)" 12.0 29.4 25.7 3.1 32.7 8.9 5.0 24.8 48.1 10.0 11.0 44.8 6.4 19.4 7.8 7.0 4.7 11.9 6.6 38.1 24.7 22.8 41.7 34.7 7.4 2.6 28.9 25.3 14.0 14.9 17.9 11.9 5.2 34.2 10.4 8.8 11.4 24.6 11.9 14.8 5.0 12.4 6.6 30.8 4.4 10.7 4.6 25.3 0.0 8.2 3.5 2.7 5.6 4.5 0.2 0.0 0.0 0.0 0.9 0.4 0.2 0.6 8.0 2.2 11.8 3.6 3.0 1.5 1.4 1.1 2.8 1.4 10.4 1.7 0.1 2.0 1.3 0.3 17.4 1.3 1.0 0.5 1.2 6.1 6.7 32.3 9.9 0.1 5.2 2.5 4.6 1.1 0.0 5.4 10.9 0.3 0.5 0.9 0.1 0.1 1.4 6.6 1.0 0.1 0.0 5.8 2.2 3.6 11.7 2.7 0.6 7.5 7.8 2.2 1.2 0.2 0.8 2.9 2.1 0.6 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.2 25.7 32.7 24.8 48.1 24.7 22.8 28.9 25.3 34.2 25.3 FOCAD "FLJ20375, KIAA1797" ENSG00000188352 Focadhesin Q5VW36 9 20658309-20995955 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 62.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "pons and medulla: 62.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055015 Uncertain Uncertain Mitochondria Mitochondria "HPA055015: " "unprognostic (3.05e-2)" "unprognostic (1.02e-1)" "prognostic favourable (3.25e-4)" "unprognostic (3.69e-3)" "unprognostic (4.14e-2)" "unprognostic (5.35e-2)" "prognostic unfavourable (4.41e-5)" "unprognostic (9.64e-2)" "unprognostic (7.38e-2)" "unprognostic (1.23e-1)" "unprognostic (5.26e-2)" "unprognostic (9.15e-2)" "prognostic favourable (3.09e-8)" "unprognostic (1.90e-1)" "unprognostic (2.33e-1)" "unprognostic (3.99e-2)" "unprognostic (1.41e-2)" 3.6 9.0 4.5 3.6 7.2 1.9 3.9 8.7 9.0 4.9 4.8 15.0 3.6 1.8 3.9 6.3 3.6 7.4 3.6 5.3 7.1 7.3 3.8 3.6 3.7 3.6 4.4 3.6 3.6 5.5 10.4 11.8 4.1 62.1 5.6 5.6 6.8 5.8 3.7 5.1 4.2 3.6 4.7 3.6 3.6 4.2 3.6 3.6 3.6 11.8 3.6 3.6 3.6 3.6 3.4 6.9 8.9 5.7 4.5 7.1 3.1 16.1 11.2 12.2 9.1 11.4 13.1 6.4 9.6 15.4 6.8 7.9 7.4 5.6 6.6 5.1 13.7 5.6 10.5 19.0 12.0 29.4 7.8 5.2 13.8 9.1 5.9 8.6 6.7 12.1 13.1 6.8 11.2 26.1 0.1 9.8 11.4 6.2 6.4 16.2 9.6 11.3 0.0 5.5 4.4 10.6 7.0 8.1 4.1 6.3 10.9 2.6 6.8 5.0 15.9 0.0 4.5 7.5 8.7 2.4 13.5 7.5 0.0 12.1 4.0 8.9 2.8 8.0 5.3 5.7 7.1 2.7 4.7 5.1 6.9 3.4 4.2 5.0 2.2 4.5 3.1 2.8 4.3 3.1 4.5 7.2 8.7 9.0 7.1 7.3 4.4 3.6 62.1 3.6 FOXRED1 H17 ENSG00000110074 "FAD dependent oxidoreductase domain containing 1" Q96CU9 11 126269055-126278131 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039620, HPA046192" Uncertain Supported Mitochondria Mitochondria "HPA039620: , HPA046192: " "prognostic unfavourable (7.36e-4)" "unprognostic (4.62e-2)" "unprognostic (2.71e-1)" "unprognostic (3.47e-3)" "unprognostic (1.76e-1)" "unprognostic (1.84e-1)" "unprognostic (9.59e-2)" "unprognostic (1.43e-1)" "unprognostic (8.14e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-2)" "unprognostic (1.59e-1)" "prognostic favourable (2.01e-6)" "unprognostic (1.57e-1)" "unprognostic (1.10e-1)" "unprognostic (2.00e-1)" "unprognostic (1.94e-1)" 7.2 12.3 14.6 8.5 14.9 10.4 7.8 12.6 19.2 6.1 11.7 9.2 6.4 10.3 6.8 6.9 7.7 7.7 7.5 20.1 11.1 11.7 14.6 36.2 5.1 9.2 12.9 18.2 4.3 7.5 9.2 7.7 7.1 13.6 5.8 13.0 8.0 7.5 11.9 15.0 6.1 8.2 8.0 8.7 9.5 8.8 6.8 11.7 8.3 6.2 9.8 10.0 8.0 4.9 7.5 16.5 5.3 12.4 8.5 8.9 7.7 9.5 11.0 8.1 10.1 6.1 2.8 11.2 5.0 6.2 9.4 9.4 16.3 9.8 15.6 13.9 4.0 16.0 21.6 13.0 5.9 8.3 5.9 32.5 7.2 19.2 8.0 8.0 7.0 2.6 5.0 6.2 11.2 10.3 18.6 8.5 7.9 13.1 9.1 14.0 6.7 19.0 14.9 14.4 18.4 8.5 4.9 10.5 9.0 9.9 15.0 5.4 36.2 13.4 3.7 5.6 4.6 10.1 8.0 5.2 7.4 12.8 6.9 27.3 7.7 1.6 9.7 5.3 6.9 12.4 7.1 7.5 5.5 8.9 11.8 6.2 7.9 6.9 1.9 8.5 8.9 16.5 7.6 7.7 14.6 14.9 12.6 19.2 11.1 11.7 12.9 18.2 13.6 11.7 FRMD6 "C14orf31, EX1, MGC17921, willin" ENSG00000139926 "FERM domain containing 6" Q96NE9 14 51489100-51730727 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 56.9;fHDF/TERT166: 119.2;U-138 MG: 48.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.3;naive CD4 T-cell: 2.5" "Group enriched" "Detected in many" 5 "granulocytes: 3.3;T-cells: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001297 Uncertain Supported Approved Mitochondria Mitochondria "HPA001297: AB_1078913" "unprognostic (1.30e-1)" "unprognostic (1.09e-1)" "unprognostic (1.84e-1)" "unprognostic (2.29e-1)" "unprognostic (2.64e-2)" "unprognostic (8.05e-2)" "unprognostic (8.19e-2)" "unprognostic (3.55e-3)" "unprognostic (1.28e-1)" "unprognostic (2.45e-2)" "prognostic unfavourable (2.66e-4)" "unprognostic (3.18e-2)" "prognostic unfavourable (1.28e-4)" "prognostic unfavourable (3.50e-4)" "unprognostic (1.18e-1)" "unprognostic (2.11e-2)" "unprognostic (1.20e-2)" 7.8 6.4 2.7 7.6 5.3 0.2 12.9 14.3 4.6 44.6 9.8 4.8 14.1 2.2 52.3 11.6 32.8 8.8 16.0 9.0 4.3 2.1 2.7 4.7 5.4 4.1 3.8 2.8 12.0 2.8 1.0 2.7 10.7 4.4 21.5 5.0 13.2 10.7 23.0 3.8 20.4 4.8 27.5 3.6 8.3 5.4 14.0 2.1 5.2 4.8 20.9 23.3 20.3 18.5 0.1 0.0 3.3 0.6 0.3 2.5 0.7 11.9 2.0 3.4 6.6 7.2 10.9 1.4 56.9 29.6 31.8 28.6 7.5 2.7 0.2 1.7 119.2 12.4 1.0 18.2 38.2 0.1 1.3 0.1 1.1 0.3 9.1 0.0 0.6 9.4 7.4 26.3 32.7 9.6 0.1 3.9 32.9 1.8 1.0 0.0 0.7 4.2 0.1 13.3 0.1 5.9 18.0 0.6 7.7 4.0 0.8 5.5 0.5 0.1 35.7 48.7 18.6 12.2 12.1 2.9 2.4 0.0 3.1 0.0 19.3 3.3 0.3 0.0 0.1 0.2 0.0 0.1 0.7 0.0 0.0 0.0 2.5 1.9 0.2 0.3 0.6 0.0 0.0 0.7 2.7 5.3 14.3 4.6 4.3 2.1 3.8 2.8 4.4 2.1 FXYD2 "ATP1G1, HOMG2, MGC12372" ENSG00000137731 "FXYD domain containing ion transport regulator 2" P54710 11 117800844-117828698 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Disease mutation, FDA approved drug targets, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 258.1;pancreas: 68.9;salivary gland: 91.7" "Group enriched" "Detected in some" 29 "MOLT-4: 137.7;RPTEC TERT1: 315.9" "Cancer enriched" "Detected in some" 8 "renal cancer: 49.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 14.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 9 "midbrain: 2.6" "HPA064218, HPA068838" Supported Approved Mitochondria 26000 Mitochondria "HPA064218: , HPA068838: " "unprognostic (4.11e-4)" "unprognostic (1.14e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-3)" "unprognostic (1.09e-3)" "unprognostic (2.30e-2)" "unprognostic (3.65e-2)" "unprognostic (4.62e-1)" "unprognostic (4.01e-2)" "unprognostic (4.91e-2)" "unprognostic (1.24e-2)" "unprognostic (2.64e-1)" "prognostic favourable (3.23e-9)" "unprognostic (3.22e-3)" "unprognostic (4.38e-2)" "unprognostic (4.62e-1)" "unprognostic (3.00e-2)" 0.3 0.2 0.2 0.2 0.1 0.0 0.7 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.3 2.8 0.3 0.3 54.7 0.2 0.1 0.2 258.1 2.2 0.2 0.6 0.1 0.0 0.4 68.9 0.0 0.3 0.6 0.1 0.3 0.0 0.1 91.7 0.1 0.1 0.2 0.3 0.1 0.1 0.4 0.2 0.2 0.0 9.5 0.2 0.3 0.4 0.2 0.6 0.4 3.2 0.0 1.1 8.4 14.1 2.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 137.7 0.0 0.0 0.0 0.0 0.0 0.2 315.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.0 0.0 1.1 0.2 1.8 14.1 0.2 0.4 5.1 4.1 0.0 8.4 0.0 3.2 1.6 2.0 0.2 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.1 0.0 GADD45GIP1 "CKBBP2, CKbetaBP2, CRIF1, MGC4667, MGC4758, PLINP-1, Plinp1, PRG6" ENSG00000179271 "GADD45G interacting protein 1" Q8TAE8 19 12953119-12957236 "Predicted intracellular proteins, Ribosomal proteins" "Cell cycle, Host-virus interaction" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055205, HPA065048, HPA071910" Supported Enhanced Mitochondria Mitochondria "HPA055205: , HPA065048: , HPA071910: " "unprognostic (5.82e-2)" "unprognostic (2.62e-2)" "unprognostic (4.49e-2)" "unprognostic (2.08e-1)" "unprognostic (8.14e-3)" "unprognostic (2.49e-1)" "unprognostic (1.20e-1)" "unprognostic (1.65e-1)" "unprognostic (9.67e-2)" "unprognostic (7.73e-3)" "unprognostic (1.06e-1)" "unprognostic (7.09e-2)" "unprognostic (1.03e-1)" "unprognostic (1.62e-1)" "unprognostic (1.25e-1)" "unprognostic (1.50e-2)" "unprognostic (1.73e-1)" 23.9 31.8 32.7 22.3 29.1 28.1 19.3 17.2 31.4 16.9 18.9 11.2 17.9 21.1 19.2 20.0 22.3 17.5 25.0 41.9 26.4 27.6 24.3 31.5 15.3 21.0 26.0 23.6 20.7 29.6 10.1 18.5 21.3 17.7 18.7 9.7 13.1 36.2 21.7 85.5 18.4 19.2 19.5 19.3 19.8 20.0 17.2 17.1 14.8 27.0 37.9 14.8 17.5 21.5 34.2 17.7 4.8 14.1 16.1 23.6 10.6 19.8 17.0 7.1 10.0 5.0 6.5 10.0 14.7 7.4 14.7 12.1 23.4 8.1 14.4 24.6 8.8 14.0 8.7 14.4 3.8 9.3 42.7 10.2 22.9 26.2 12.2 16.9 15.6 7.7 11.7 10.2 8.4 8.5 15.4 5.6 9.1 29.3 26.7 35.6 19.7 53.7 19.8 7.2 23.0 11.3 11.8 22.0 20.1 11.0 14.8 16.6 11.6 16.0 13.8 28.6 10.0 24.8 27.0 22.4 15.6 14.9 19.8 21.3 16.4 4.1 14.1 4.8 14.4 13.4 14.5 34.2 22.1 22.8 17.7 28.0 23.6 17.4 0.9 16.1 11.3 16.9 17.5 10.6 32.7 29.1 17.2 29.1 26.4 27.6 26.0 23.6 17.7 17.1 GALNT18 "GalNAc-T18, GALNT15, GALNTL4, MGC71806" ENSG00000110328 "Polypeptide N-acetylgalactosaminyltransferase 18" Q6P9A2 11 11270876-11622005 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 18.5;HaCaT: 23.8;HBEC3-KT: 16.6;PC-3: 16.7;RPMI-8226: 17.4;SK-BR-3: 21.7;U-87 MG: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 17 "gdT-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012955 Approved Approved Mitochondria 200000 Mitochondria "HPA012955: AB_1849460" "unprognostic (1.26e-1)" "unprognostic (2.80e-1)" "unprognostic (3.69e-2)" "prognostic unfavourable (1.29e-4)" "unprognostic (7.37e-2)" "unprognostic (1.22e-1)" "unprognostic (6.42e-3)" "unprognostic (6.68e-2)" "unprognostic (6.04e-2)" "unprognostic (2.05e-1)" "unprognostic (5.24e-2)" "unprognostic (1.70e-1)" "unprognostic (2.66e-3)" "unprognostic (3.54e-2)" "unprognostic (1.63e-1)" "unprognostic (2.10e-1)" "unprognostic (1.81e-2)" 18.6 6.0 15.5 4.9 13.5 0.8 9.1 21.3 16.2 7.0 13.3 5.8 8.3 3.9 15.0 6.4 7.8 7.6 12.6 21.9 13.1 7.0 19.7 6.6 31.2 5.8 10.0 12.1 3.8 9.5 9.1 4.3 26.6 12.8 8.2 4.3 7.1 10.4 11.5 6.1 7.6 4.9 15.0 6.5 4.0 4.1 13.3 8.4 0.7 39.2 5.6 4.2 10.3 9.1 0.0 0.0 0.0 0.0 0.0 1.7 0.3 18.5 6.8 0.9 4.2 0.0 0.0 0.1 2.0 5.1 0.2 0.0 0.7 2.4 0.0 1.4 0.0 23.8 4.5 16.6 0.0 0.0 6.7 0.0 0.0 0.0 0.2 0.0 0.0 0.1 6.9 0.0 6.3 0.0 0.0 0.0 0.9 4.5 0.2 0.0 0.7 16.7 0.0 0.0 17.4 12.8 2.3 0.3 1.9 3.4 21.7 0.1 4.5 0.0 0.0 0.3 3.8 0.1 0.1 0.0 0.0 0.0 15.8 0.0 4.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 15.5 13.5 21.3 16.2 13.1 7.0 10.0 12.1 12.8 8.4 GATB "PET112, PET112L" ENSG00000059691 "Glutamyl-tRNA amidotransferase subunit B" O75879 4 151670504-151761023 "Predicted intracellular proteins" "Protein biosynthesis" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042610 Uncertain Supported Mitochondria Mitochondria "HPA042610: AB_10797502" "unprognostic (2.52e-1)" "unprognostic (3.33e-1)" "unprognostic (1.01e-3)" "unprognostic (5.08e-2)" "unprognostic (2.31e-1)" "unprognostic (6.91e-2)" "unprognostic (2.24e-1)" "unprognostic (5.77e-2)" "unprognostic (2.06e-1)" "unprognostic (6.76e-2)" "unprognostic (1.37e-1)" "unprognostic (8.17e-2)" "prognostic favourable (1.20e-10)" "unprognostic (1.91e-1)" "unprognostic (8.39e-2)" "unprognostic (3.09e-2)" "unprognostic (2.46e-1)" 11.2 17.0 12.3 10.5 13.6 8.2 9.2 10.7 19.8 7.3 9.7 11.2 6.4 5.8 5.9 8.9 10.1 9.1 7.0 31.3 10.7 10.8 21.4 21.8 5.3 6.8 15.8 11.1 12.1 6.8 14.6 8.4 9.9 10.6 5.9 9.9 7.8 7.7 7.1 22.7 8.5 6.3 8.1 22.6 6.9 7.4 7.8 10.4 10.5 7.7 18.9 9.3 8.0 5.8 9.1 17.0 1.5 13.2 6.8 6.8 8.3 8.6 6.8 9.8 9.4 14.3 13.7 8.5 11.5 15.1 20.5 16.0 11.4 14.3 11.8 3.0 12.0 8.1 20.9 22.0 22.0 6.6 12.8 5.4 9.5 23.6 14.0 11.1 5.4 14.2 14.2 19.7 6.9 15.2 21.1 10.4 15.7 9.6 13.9 12.1 10.0 12.8 11.8 9.3 9.3 18.5 7.3 10.1 11.3 9.2 12.8 13.5 10.8 8.1 8.3 10.3 5.6 7.1 7.9 12.4 16.1 9.8 14.5 9.9 7.5 0.7 9.4 1.5 4.0 13.2 6.3 9.1 5.3 5.6 17.0 8.2 6.8 6.4 0.9 6.8 9.4 6.7 5.4 8.3 12.3 13.6 10.7 19.8 10.7 10.8 15.8 11.1 10.6 10.4 GATM AGAT ENSG00000171766 "Glycine amidinotransferase" P50440 15 45361124-45402327 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "kidney: 186.3;liver: 252.2;pancreas: 286.1" "Group enriched" "Detected in some" 4 "RH-30: 55.9;RT4: 14.7;U-266/70: 34.5;U-266/84: 43.6" "Cancer enhanced" "Detected in all" "liver cancer: 135.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 12.8;myeloid DC: 6.9;naive B-cell: 5.9;plasmacytoid DC: 6.8" "Group enriched" "Detected in many" 6 "B-cells: 12.8;dendritic cells: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026077 Enhanced Supported Mitochondria 620000 Mitochondria "HPA026077: AB_1849528" "unprognostic (1.91e-1)" "unprognostic (1.33e-2)" "unprognostic (2.77e-2)" "unprognostic (6.57e-2)" "unprognostic (9.43e-2)" "unprognostic (1.67e-2)" "unprognostic (6.99e-3)" "unprognostic (1.04e-1)" "unprognostic (4.51e-2)" "unprognostic (3.36e-2)" "unprognostic (1.33e-1)" "unprognostic (5.67e-2)" "prognostic favourable (1.38e-4)" "unprognostic (1.09e-1)" "unprognostic (4.07e-2)" "unprognostic (3.60e-2)" "unprognostic (1.80e-1)" 1.8 2.5 18.5 1.6 14.7 0.6 2.9 11.4 16.2 1.5 3.1 24.9 0.3 17.8 1.3 2.2 3.0 1.7 5.0 5.5 15.2 10.3 186.3 252.2 1.2 2.1 20.6 14.3 17.6 286.1 0.7 1.2 7.8 14.5 1.7 1.7 1.5 5.5 2.1 13.5 13.9 10.8 2.7 26.1 3.5 10.0 8.0 18.4 0.7 6.6 2.5 3.1 2.2 2.0 12.8 6.9 0.3 1.5 0.1 1.5 0.8 3.4 1.7 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 5.7 8.8 0.3 0.0 0.6 4.4 0.1 0.1 0.4 0.0 0.7 0.0 0.0 0.2 5.1 0.7 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.6 0.1 3.1 0.0 0.1 55.9 0.4 0.9 14.7 6.5 1.1 1.8 0.1 0.3 0.7 5.8 0.0 0.0 0.1 0.0 1.7 34.5 43.6 0.2 0.4 0.1 0.3 0.0 1.1 0.3 0.3 1.5 0.0 12.8 0.0 0.3 6.9 5.9 0.0 1.5 0.0 0.1 0.6 6.8 0.0 0.8 18.5 14.7 11.4 16.2 15.2 10.3 20.6 14.3 14.5 18.4 GCDH ACAD5 ENSG00000105607 "Glutaryl-CoA dehydrogenase" Q92947 19 12891026-12914207 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 62.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043252, HPA048492" Enhanced Supported Mitochondria Mitochondria "HPA043252: AB_2678390, HPA048492: AB_2680418" "unprognostic (2.46e-1)" "unprognostic (1.64e-3)" "unprognostic (6.79e-3)" "unprognostic (8.07e-3)" "unprognostic (8.20e-3)" "unprognostic (3.14e-2)" "prognostic favourable (7.28e-5)" "prognostic favourable (3.35e-4)" "unprognostic (1.62e-1)" "unprognostic (3.03e-2)" "unprognostic (7.50e-3)" "unprognostic (7.46e-2)" "prognostic favourable (6.79e-8)" "unprognostic (7.09e-3)" "unprognostic (3.42e-1)" "unprognostic (5.32e-2)" "unprognostic (1.59e-1)" 12.5 12.1 11.4 8.6 13.3 8.2 9.5 11.5 14.0 9.5 10.5 15.5 8.6 9.1 11.7 7.3 9.1 10.5 7.5 19.8 9.3 8.0 20.2 62.6 6.3 12.1 15.5 14.1 13.7 12.3 7.9 8.7 4.9 9.7 10.4 6.9 9.6 14.7 9.7 17.5 6.6 8.1 8.2 8.7 8.6 11.3 4.9 11.8 13.0 10.9 13.7 9.0 12.0 6.6 10.9 14.5 7.2 8.1 21.7 20.6 12.3 11.2 6.2 6.7 12.4 9.9 4.9 6.2 8.4 5.0 9.8 7.4 11.5 4.8 16.3 15.8 4.6 7.1 9.3 7.2 4.9 14.0 9.9 10.4 10.9 14.1 11.3 19.6 8.3 6.3 9.0 6.9 7.5 8.4 25.3 5.1 4.8 12.3 23.0 17.2 7.6 16.2 22.0 6.9 31.6 5.7 5.1 14.9 9.0 11.8 10.3 7.2 8.0 13.0 5.9 8.0 6.0 14.8 8.0 27.3 13.8 17.1 5.6 22.5 6.9 7.2 8.1 4.6 11.7 7.1 11.6 10.7 15.0 13.7 14.5 10.9 20.6 15.5 2.0 21.7 5.3 8.6 12.5 12.3 11.4 13.3 11.5 14.0 9.3 8.0 15.5 14.1 9.7 11.8 GHITM "DERP2, HSPC282, My021, PTD010, TMBIM5" ENSG00000165678 "Growth hormone inducible transmembrane protein" Q9H3K2 10 84139440-84153245 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016464, HPA061664" Approved Supported Mitochondria Mitochondria "HPA016464: AB_1849656, HPA061664: " "unprognostic (6.26e-3)" "unprognostic (1.85e-1)" "unprognostic (2.75e-2)" "unprognostic (1.51e-1)" "unprognostic (4.61e-2)" "prognostic unfavourable (1.76e-4)" "unprognostic (5.71e-2)" "unprognostic (4.56e-2)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "unprognostic (8.14e-2)" "unprognostic (5.71e-2)" "prognostic favourable (2.32e-10)" "unprognostic (2.46e-2)" "unprognostic (2.09e-1)" "unprognostic (3.56e-2)" "unprognostic (1.25e-1)" 28.7 50.7 46.0 21.9 53.3 25.3 26.0 30.9 62.7 21.4 45.5 20.2 23.9 43.3 21.2 24.5 30.0 19.9 21.8 94.9 40.8 42.8 80.5 71.6 19.2 23.2 45.2 42.4 20.7 25.1 29.9 24.0 20.9 62.8 22.6 46.0 24.3 26.0 24.5 87.6 19.9 35.6 28.9 24.6 20.1 30.1 41.7 17.5 21.5 29.3 47.6 26.6 26.1 19.1 46.8 63.7 60.6 67.5 44.4 51.6 106.0 41.2 43.0 18.4 42.1 31.6 28.2 32.7 28.5 50.3 37.1 34.7 52.2 34.4 32.7 32.1 37.7 37.3 39.0 37.3 35.9 32.6 29.6 23.2 44.9 51.3 59.9 72.2 38.1 31.7 73.4 38.2 111.5 32.0 53.8 61.2 34.0 36.0 25.5 57.8 18.5 38.3 23.3 16.9 49.1 51.4 33.3 15.1 17.6 28.8 25.3 57.6 51.6 46.4 27.0 18.0 24.3 26.2 45.8 43.3 47.1 36.7 47.4 67.0 12.5 52.6 64.3 60.6 42.2 67.5 47.1 46.8 44.2 44.9 63.7 37.2 41.5 44.4 51.3 44.4 59.6 33.0 51.6 106.0 46.0 53.3 30.9 62.7 40.8 42.8 45.2 42.4 62.8 17.5 GJB2 "CX26, DFNA3, DFNB1, NSRD1" ENSG00000165474 "Gap junction protein beta 2" P29033 13 20187463-20193010 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Hearing "Deafness, Disease mutation, Ectodermal dysplasia, Ichthyosis, Non-syndromic deafness, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "cervix, uterine: 52.8;esophagus: 128.1;lymphoid tissue: 71.1;tongue: 129.0;vagina: 64.9" "Group enriched" "Detected in some" 5 "CAPAN-2: 43.5;hTCEpi: 32.4;RT4: 50.5" "Cancer enhanced" "Detected in all" "head and neck cancer: 447.5" "Region enhanced" "Detected in some" "pons and medulla: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013093, HPA014362" Uncertain Approved Mitochondria Mitochondria "CAB013093: AB_2533903, HPA014362: " "unprognostic (2.21e-1)" "unprognostic (1.25e-3)" "unprognostic (2.43e-2)" "unprognostic (6.14e-2)" "prognostic unfavourable (4.45e-4)" "unprognostic (9.77e-2)" "unprognostic (2.92e-1)" "prognostic unfavourable (6.25e-4)" "unprognostic (1.33e-1)" "unprognostic (3.69e-3)" "prognostic unfavourable (2.90e-4)" "unprognostic (3.22e-2)" "prognostic unfavourable (2.53e-6)" "unprognostic (5.78e-3)" "unprognostic (2.40e-1)" "unprognostic (1.17e-2)" "unprognostic (8.93e-3)" 0.2 0.0 0.2 1.5 0.3 0.5 0.7 1.0 0.5 52.8 3.9 0.4 0.4 2.4 4.2 0.6 128.1 0.1 2.7 0.1 0.5 0.1 3.5 9.1 0.1 0.0 1.3 0.7 0.1 0.1 0.0 0.5 0.2 4.5 0.3 3.4 0.3 19.7 0.2 0.2 10.3 1.9 0.4 3.7 0.0 1.5 0.2 0.2 3.2 0.2 129.0 71.1 2.3 64.9 0.0 0.0 0.4 0.6 0.0 0.0 0.0 2.5 0.2 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.3 43.5 0.0 0.2 0.0 8.6 1.6 4.3 0.0 3.6 0.5 0.0 0.0 0.1 0.0 0.0 1.5 0.7 32.4 0.5 6.0 0.0 0.0 3.2 0.0 0.4 0.3 0.0 0.1 4.3 0.0 0.0 2.4 0.0 50.5 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.7 6.5 2.6 2.7 0.0 5.2 0.0 0.6 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.3 1.0 0.5 0.5 0.1 1.3 0.7 4.5 0.2 GLCE "HSEPI, KIAA0836" ENSG00000138604 "Glucuronic acid epimerase" O94923 15 69160584-69272217 "Enzymes, Plasma proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.4" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 49.9" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 58.4" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 4.0;monocytes: 4.4;T-cells: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040481, HPA048216" Uncertain Approved Mitochondria "Intracellular and membrane" 78000 Mitochondria "HPA040481: , HPA048216: " "unprognostic (1.30e-1)" "unprognostic (2.39e-1)" "unprognostic (1.20e-3)" "unprognostic (7.77e-2)" "unprognostic (1.58e-1)" "unprognostic (5.55e-3)" "unprognostic (1.00e-1)" "unprognostic (2.84e-1)" "unprognostic (1.48e-1)" "unprognostic (2.56e-1)" "unprognostic (7.47e-2)" "unprognostic (1.41e-1)" "unprognostic (2.40e-2)" "unprognostic (1.53e-1)" "unprognostic (6.00e-2)" "unprognostic (5.23e-1)" "unprognostic (4.07e-2)" 8.3 12.2 6.5 4.9 14.2 0.6 8.8 58.4 12.1 8.4 12.1 12.4 7.8 13.5 6.3 6.9 10.2 5.9 7.2 5.5 5.8 8.5 13.3 16.0 8.4 5.3 9.4 8.1 12.9 5.9 9.0 12.0 12.6 14.4 5.7 14.0 10.8 11.7 8.9 4.1 9.8 11.2 6.8 10.2 4.0 8.8 6.1 7.6 5.4 4.1 8.4 5.8 6.3 5.6 0.6 4.0 0.1 4.4 0.5 4.0 1.9 3.9 3.5 2.3 4.1 8.0 7.7 0.8 7.3 9.7 5.6 10.8 2.9 9.8 2.3 3.6 5.9 5.8 5.0 4.7 11.6 0.9 5.6 3.9 6.6 2.9 7.8 1.7 8.1 5.2 3.3 7.0 8.0 49.9 1.5 2.5 10.6 2.3 1.0 2.9 1.1 2.4 2.3 9.6 2.9 5.2 4.1 7.6 1.6 7.4 4.6 15.4 3.3 2.4 17.3 5.5 6.8 6.0 6.4 1.0 1.5 0.5 5.5 2.8 7.9 0.0 4.4 0.1 0.7 3.4 1.2 0.6 1.8 0.8 3.6 0.5 1.2 1.5 0.1 0.5 4.4 4.0 4.0 1.9 6.5 14.2 58.4 12.1 5.8 8.5 9.4 8.1 14.4 7.6 GLOD5 ENSG00000171433 "Glyoxalase domain containing 5" A6NK44 X 48761750-48773648 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 25.2;kidney: 10.2;liver: 7.8" "Cell line enhanced" "Detected in some" "Hep G2: 2.2;K-562: 1.9;MCF7: 6.3;SCLC-21H: 1.3;T-47d: 1.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010667 Enhanced Uncertain Mitochondria Mitochondria "HPA010667: AB_1078975" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (7.78e-2)" "unprognostic (7.04e-2)" "unprognostic (3.14e-1)" "unprognostic (6.11e-2)" "unprognostic (1.80e-2)" "unprognostic (2.64e-1)" "unprognostic (2.76e-1)" "unprognostic (2.21e-1)" "unprognostic (1.05e-8)" "unprognostic (2.08e-2)" "unprognostic (1.73e-1)" "unprognostic (5.07e-2)" "unprognostic (6.79e-4)" 0.2 0.0 0.2 0.2 0.2 0.0 0.4 0.2 0.2 0.4 14.7 0.2 0.2 10.3 0.4 5.6 0.3 1.6 3.5 0.2 0.2 0.0 10.2 7.8 1.5 0.2 0.2 0.2 0.4 1.1 0.0 0.6 0.2 0.2 0.4 5.7 1.5 0.6 0.2 0.2 0.1 25.2 0.2 0.2 0.2 1.3 0.7 0.2 0.4 1.9 0.2 0.5 0.2 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.3 0.4 0.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 GLRX5 "C14orf87, GRX5, PR01238" ENSG00000182512 "Glutaredoxin 5" Q86SX6 14 95533503-95544724 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042465, HPA063716" Approved Supported Mitochondria Mitochondria "HPA042465: AB_10794048, HPA063716: " "unprognostic (2.57e-1)" "unprognostic (6.76e-2)" "unprognostic (1.60e-2)" "unprognostic (2.69e-2)" "unprognostic (3.72e-2)" "unprognostic (2.43e-3)" "unprognostic (1.29e-1)" "unprognostic (5.41e-2)" "unprognostic (8.28e-2)" "prognostic favourable (1.08e-5)" "unprognostic (1.85e-1)" "unprognostic (1.02e-1)" "prognostic favourable (7.83e-10)" "unprognostic (1.44e-1)" "unprognostic (3.81e-2)" "unprognostic (2.66e-2)" "unprognostic (8.91e-2)" 13.7 24.1 19.3 11.2 16.9 54.8 9.7 10.5 17.3 7.4 16.6 7.7 8.1 17.6 9.1 10.8 10.7 8.4 12.6 45.3 16.1 14.5 22.5 43.3 7.7 8.4 15.5 9.5 15.8 19.1 8.3 9.4 27.3 10.4 9.9 9.9 13.3 11.6 11.0 68.8 7.9 15.7 12.6 8.3 9.1 12.8 24.2 7.1 19.9 14.8 25.6 9.7 10.0 10.8 6.0 9.9 5.5 4.5 4.8 8.7 3.0 13.9 18.7 8.6 11.4 8.5 6.2 39.0 10.3 6.7 8.9 8.5 24.4 15.3 20.1 15.3 5.2 14.1 12.8 10.3 7.5 13.2 19.3 17.2 12.0 36.5 9.7 27.5 18.5 7.6 8.6 6.4 9.0 8.9 20.4 15.8 6.3 39.2 21.6 27.9 14.7 20.9 39.5 30.6 12.0 9.9 16.8 22.9 14.3 9.9 12.5 14.1 19.2 11.8 10.6 5.7 12.6 13.8 14.5 8.6 10.2 15.3 12.4 16.6 13.1 1.0 3.5 5.5 5.2 4.5 6.1 6.0 6.4 7.7 5.4 5.8 5.9 5.8 2.2 4.8 2.7 9.9 8.7 3.0 19.3 16.9 10.5 17.3 16.1 14.5 15.5 9.5 10.4 7.1 GLS "GLS1, KIAA0838" ENSG00000115419 Glutaminase O94925 2 190880827-190965552 "Enzymes, Predicted intracellular proteins" Hydrolase "Cataract, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 127.9" "Cell line enhanced" "Detected in all" "EFO-21: 138.9;RPTEC TERT1: 63.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036223 Enhanced Supported Mitochondria "Intracellular and membrane" 25000 Mitochondria "HPA036223: AB_10669984" "unprognostic (7.45e-2)" "unprognostic (3.42e-2)" "unprognostic (3.21e-1)" "prognostic unfavourable (3.45e-4)" "unprognostic (1.17e-1)" "unprognostic (2.08e-3)" "unprognostic (2.51e-3)" "unprognostic (4.24e-2)" "unprognostic (1.59e-1)" "unprognostic (2.40e-1)" "unprognostic (8.01e-2)" "unprognostic (9.06e-2)" "unprognostic (5.41e-2)" "unprognostic (1.62e-1)" "unprognostic (5.03e-2)" "unprognostic (2.13e-1)" "unprognostic (4.12e-1)" 16.5 37.3 37.8 20.4 24.7 10.7 34.3 43.8 47.3 11.9 13.1 5.8 8.9 36.9 14.6 11.9 7.6 11.0 17.7 15.7 23.3 22.8 127.9 5.3 22.6 25.4 20.6 36.8 14.1 17.0 26.4 10.1 14.8 35.1 9.4 13.1 10.8 9.0 13.9 7.4 13.0 40.9 15.5 11.7 19.3 8.7 6.9 12.1 15.0 17.7 8.0 22.9 14.1 16.1 5.2 5.0 6.0 2.1 3.9 9.4 1.5 6.2 7.0 4.9 6.4 15.4 10.7 12.7 18.8 14.3 13.7 15.8 8.5 6.2 12.9 138.9 39.7 8.2 8.6 7.4 20.1 31.8 5.6 21.4 10.3 10.5 14.1 12.5 10.1 9.7 7.7 10.8 7.4 17.8 9.9 26.4 30.5 3.3 8.4 12.1 13.1 11.5 10.7 12.7 11.2 63.8 11.6 6.8 7.1 25.7 5.7 23.9 2.2 7.7 12.6 19.9 14.6 9.9 22.8 8.5 19.4 17.8 7.1 10.3 15.7 6.0 1.5 2.5 5.5 2.1 9.4 4.8 6.5 7.0 2.2 5.2 6.8 8.1 3.0 3.9 1.4 5.0 5.6 1.5 37.8 24.7 43.8 47.3 23.3 22.8 20.6 36.8 35.1 12.1 GLT8D1 "AD-017, FLJ14611" ENSG00000016864 "Glycosyltransferase 8 domain containing 1" Q68CQ7 3 52694488-52706032 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010588 Approved Approved Mitochondria Mitochondria "HPA010588: AB_1078098" "unprognostic (1.37e-1)" "unprognostic (2.96e-1)" "unprognostic (1.38e-2)" "prognostic favourable (2.76e-4)" "unprognostic (3.17e-2)" "unprognostic (1.55e-1)" "unprognostic (2.03e-1)" "unprognostic (1.82e-3)" "unprognostic (7.12e-2)" "unprognostic (9.81e-2)" "unprognostic (1.23e-1)" "unprognostic (1.07e-1)" "unprognostic (5.82e-3)" "unprognostic (2.42e-3)" "unprognostic (3.97e-1)" "unprognostic (3.34e-2)" "unprognostic (6.21e-2)" 18.6 23.7 16.1 14.5 20.9 4.7 21.0 15.3 19.9 29.3 17.3 18.3 22.1 14.6 23.5 26.8 14.1 31.9 19.9 19.3 16.6 17.0 23.2 39.4 16.8 16.0 17.9 14.4 32.4 23.6 24.3 40.8 34.7 18.1 21.1 18.9 19.7 22.0 25.2 11.5 13.0 15.2 18.7 17.4 14.8 16.0 43.3 21.6 17.5 37.8 11.6 14.7 21.8 16.8 8.6 15.7 20.5 8.4 20.1 16.3 6.6 8.1 9.8 19.8 15.6 44.1 56.1 11.1 20.7 32.1 18.3 21.1 4.5 15.6 7.0 5.9 36.0 9.3 12.5 21.3 24.3 12.5 9.1 6.5 17.9 20.7 21.1 9.7 20.6 32.2 19.0 15.7 20.4 27.2 8.3 16.1 24.0 8.4 6.5 15.0 10.1 18.4 5.0 11.3 23.4 21.4 9.0 8.2 14.0 17.3 8.4 14.0 14.2 12.9 19.8 13.3 10.4 19.2 11.5 18.2 20.7 7.7 23.3 15.6 16.7 20.5 8.4 14.1 13.3 5.7 13.2 8.6 16.0 14.3 8.1 6.4 16.3 11.5 4.8 20.1 6.0 15.7 10.6 6.6 16.1 20.9 15.3 19.9 16.6 17.0 17.9 14.4 18.1 21.6 GLUD1 "GDH, GLUD" ENSG00000148672 "Glutamate dehydrogenase 1" P00367 10 87050486-87094866 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 182.4" "Cell line enhanced" "Detected in all" "Hep G2: 106.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042492, HPA044839, HPA061369" Approved Supported Mitochondria "Intracellular and membrane" 26000000 Mitochondria "HPA042492: , HPA044839: , HPA061369: " "unprognostic (1.48e-1)" "unprognostic (1.26e-2)" "unprognostic (3.55e-1)" "unprognostic (1.07e-1)" "prognostic favourable (3.81e-4)" "unprognostic (1.31e-1)" "unprognostic (1.91e-2)" "unprognostic (5.50e-2)" "unprognostic (2.06e-1)" "unprognostic (4.57e-3)" "prognostic unfavourable (1.76e-5)" "unprognostic (1.13e-1)" "prognostic favourable (1.44e-6)" "unprognostic (2.29e-1)" "unprognostic (4.23e-2)" "unprognostic (7.19e-2)" "unprognostic (4.27e-2)" 15.5 21.5 57.8 9.9 54.5 5.9 23.2 13.4 37.9 12.1 14.5 19.9 5.5 18.4 10.9 7.5 17.0 11.5 12.6 16.7 44.1 35.3 56.2 182.4 13.1 11.5 40.6 30.8 17.5 15.2 8.7 6.6 13.5 31.1 26.5 14.6 8.1 10.0 13.3 9.2 15.3 19.8 14.0 22.7 10.2 12.2 6.4 33.2 12.6 16.1 8.7 13.1 14.0 9.5 9.2 15.8 9.2 14.6 13.7 11.9 5.9 24.0 19.5 15.3 25.9 29.1 35.9 16.7 19.0 33.0 18.5 20.3 44.9 23.6 27.1 15.6 27.7 38.0 19.9 19.2 19.8 19.5 15.7 13.1 11.7 106.0 65.0 30.7 19.1 24.7 36.2 20.5 61.4 22.0 13.2 24.5 19.9 17.5 27.6 27.6 17.4 15.7 21.0 19.5 17.6 53.1 19.7 7.9 14.8 17.1 13.6 24.3 18.6 21.6 21.8 9.6 8.5 19.4 19.3 14.7 15.1 32.4 23.2 35.2 5.7 5.5 13.8 9.2 8.7 11.1 10.9 9.2 11.8 10.6 15.8 8.8 10.6 8.5 1.3 13.7 14.6 5.9 11.9 5.9 57.8 54.5 13.4 37.9 44.1 35.3 40.6 30.8 31.1 33.2 GLUD2 GLUDP1 ENSG00000182890 "Glutamate dehydrogenase 2" P49448 X 121047588-121050080 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 11.3;testis: 31.9" "Cell line enhanced" "Detected in some" "HAP1: 7.8;K-562: 8.6;SK-MEL-30: 11.1;THP-1: 5.5;WM-115: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA042492, HPA044839, HPA061369" Uncertain Supported Mitochondria Mitochondria "HPA042492: , HPA044839: , HPA061369: " "unprognostic (1.44e-1)" "unprognostic (5.49e-2)" "unprognostic (1.90e-2)" "unprognostic (1.39e-2)" "unprognostic (1.27e-3)" "unprognostic (1.29e-1)" "unprognostic (1.77e-2)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (2.42e-1)" "unprognostic (2.61e-1)" "unprognostic (2.35e-1)" "prognostic favourable (1.98e-4)" "unprognostic (1.04e-2)" "unprognostic (1.49e-2)" "unprognostic (4.77e-3)" "unprognostic (5.96e-2)" 3.1 2.5 4.8 0.8 7.3 0.5 1.6 2.2 3.5 1.1 0.7 2.0 0.6 0.6 1.0 5.2 0.7 1.0 1.6 1.5 5.7 1.8 4.7 11.3 0.9 0.9 2.7 6.2 0.7 1.5 0.7 0.7 2.7 4.3 0.8 0.6 0.2 0.9 3.1 0.7 0.8 1.0 1.0 1.5 0.5 0.9 31.9 4.1 0.0 1.4 0.0 0.8 0.8 0.6 0.8 1.2 0.7 1.1 1.2 0.7 0.4 0.0 2.1 0.5 0.0 0.0 0.0 0.1 0.6 0.6 0.1 0.3 0.0 1.1 0.0 0.8 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.9 2.1 0.0 0.0 0.0 0.0 8.6 0.0 0.0 1.7 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.4 11.1 2.7 5.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.5 0.6 0.8 0.7 0.4 1.1 0.7 0.8 0.7 0.7 1.2 0.4 0.7 0.5 0.0 1.2 1.1 0.2 0.7 0.4 4.8 7.3 2.2 3.5 5.7 1.8 2.7 6.2 4.3 4.1 GLYATL2 "BXMAS2-10, MGC24009" ENSG00000156689 "Glycine-N-acyltransferase like 2" Q8WU03 11 58834065-58904215 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 11.2;cervix, uterine: 18.8;lymphoid tissue: 9.9;salivary gland: 25.8" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.8;BJ hTERT+ SV40 Large T+ RasG12V: 4.1;HAP1: 6.5;SK-BR-3: 15.5;U-2197: 7.5" "Cancer enhanced" "Detected in many" "breast cancer: 16.7;endometrial cancer: 15.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.1" "Not detected" "Not detected" "HPA060292, HPA065454" Uncertain Approved Mitochondria Mitochondria "HPA060292: , HPA065454: " "unprognostic (1.02e-2)" "unprognostic (3.79e-3)" "unprognostic (8.11e-4)" "prognostic favourable (9.05e-7)" "unprognostic (1.05e-1)" "unprognostic (8.41e-2)" "unprognostic (2.66e-2)" "unprognostic (9.98e-3)" "unprognostic (1.27e-1)" "unprognostic (9.18e-3)" "unprognostic (1.64e-1)" "unprognostic (1.59e-1)" "unprognostic (7.42e-5)" "unprognostic (7.79e-3)" "unprognostic (8.28e-2)" "unprognostic (9.11e-3)" "unprognostic (2.31e-2)" 0.4 0.0 0.4 0.1 0.2 0.0 11.2 0.1 0.3 18.8 0.1 0.1 0.1 0.1 1.2 0.1 0.8 0.1 6.6 0.2 0.3 0.4 0.1 0.1 0.6 0.2 0.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.7 0.0 0.1 25.8 0.1 0.1 1.2 0.1 0.1 1.5 1.1 0.1 0.1 0.1 0.1 0.1 4.4 9.9 0.1 0.3 0.4 0.1 2.1 0.4 0.2 0.2 0.9 0.0 0.0 0.5 0.0 0.9 3.0 0.0 1.9 5.8 2.5 4.1 0.0 0.0 0.2 0.0 1.6 0.5 6.5 0.0 2.1 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.3 0.6 0.0 0.6 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.2 15.5 0.0 0.0 0.0 0.0 2.1 0.1 7.5 2.2 0.0 0.0 0.1 0.0 0.0 0.8 0.8 0.2 0.2 0.2 0.4 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.1 2.1 0.2 0.0 0.1 0.0 0.9 0.4 0.2 0.1 0.3 0.3 0.4 0.6 0.1 0.1 0.1 GNG12 ENSG00000172380 "G protein subunit gamma 12" Q9UBI6 1 67701466-67833467 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA057790, HPA062208" Enhanced Supported Approved Mitochondria Mitochondria "HPA057790: , HPA062208: " "unprognostic (5.18e-2)" "unprognostic (1.76e-3)" "unprognostic (4.46e-3)" "unprognostic (7.77e-2)" "unprognostic (1.06e-1)" "unprognostic (4.71e-2)" "unprognostic (5.29e-2)" "unprognostic (5.84e-3)" "unprognostic (5.50e-2)" "unprognostic (3.41e-2)" "unprognostic (4.46e-3)" "unprognostic (8.13e-2)" "unprognostic (4.12e-3)" "unprognostic (2.33e-2)" "unprognostic (9.33e-2)" "unprognostic (7.78e-2)" "unprognostic (2.14e-3)" 28.7 23.8 10.3 13.8 9.4 0.0 49.4 5.1 7.7 28.3 34.5 10.9 16.6 40.1 41.5 20.7 34.0 21.2 27.2 14.2 11.8 9.3 36.1 15.4 16.4 12.4 9.1 6.3 24.9 16.0 23.9 17.1 40.1 14.3 21.4 22.2 14.6 16.4 19.3 9.0 33.0 86.2 51.8 22.9 17.5 19.5 11.6 9.6 3.6 23.1 20.5 16.5 31.5 26.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 9.8 9.3 9.9 5.3 42.3 36.8 10.2 30.7 40.2 27.2 24.5 4.3 9.8 0.0 13.1 43.0 7.4 6.2 25.2 47.9 0.0 4.7 0.1 8.3 0.0 16.9 0.0 0.5 22.0 15.1 28.9 38.5 42.6 0.5 0.0 29.8 1.6 0.0 0.0 7.5 11.6 0.0 20.5 0.1 26.1 8.9 2.2 4.6 21.3 8.9 41.2 4.5 0.1 54.7 31.6 20.6 56.8 18.9 0.5 0.0 0.0 20.0 1.1 42.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 10.3 9.4 5.1 7.7 11.8 9.3 9.1 6.3 14.3 9.6 GPAM "GPAT1, KIAA1560, MGC26846" ENSG00000119927 "Glycerol-3-phosphate acyltransferase, mitochondrial" Q9HCL2 10 112149864-112215377 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 107.3;liver: 56.6" "Cell line enhanced" "Detected in all" "ASC diff: 75.2;Hep G2: 20.2" "Cancer enriched" "Detected in all" 5 "liver cancer: 20.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046339, HPA060090" Approved Approved Mitochondria Mitochondria "HPA046339: , HPA060090: " "unprognostic (1.82e-1)" "unprognostic (6.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.30e-1)" "unprognostic (6.80e-2)" "unprognostic (8.75e-2)" "unprognostic (1.40e-2)" "unprognostic (2.16e-2)" "unprognostic (4.59e-1)" "unprognostic (4.80e-1)" "unprognostic (2.37e-2)" "unprognostic (5.44e-2)" "prognostic favourable (4.54e-6)" "unprognostic (2.84e-1)" "unprognostic (4.41e-2)" "unprognostic (2.52e-2)" "unprognostic (1.37e-1)" 107.3 17.2 11.4 2.6 12.1 1.8 30.8 6.6 11.0 2.0 3.2 6.5 5.1 2.2 4.1 32.1 2.4 1.9 3.0 5.8 12.2 2.9 2.4 56.6 2.2 2.3 7.2 7.3 3.5 2.8 3.2 2.3 1.8 5.6 2.3 2.6 12.0 6.8 2.9 3.6 1.8 3.3 3.4 3.8 1.7 2.4 2.8 7.2 2.8 6.1 2.4 2.3 3.2 1.6 3.2 2.0 0.5 1.2 1.1 3.4 1.0 2.7 2.1 2.8 3.7 75.2 2.7 3.7 2.6 3.0 1.9 1.5 4.9 1.6 1.9 1.4 1.8 3.5 4.5 2.2 3.6 1.4 2.4 1.8 2.3 20.2 2.3 3.1 1.0 13.1 3.8 3.4 7.0 1.6 2.3 1.7 2.2 1.5 2.6 2.4 2.3 2.9 2.7 7.4 1.4 1.2 1.9 1.2 3.6 3.6 1.7 4.1 1.8 1.1 1.2 2.2 1.3 2.7 4.2 1.8 2.0 4.1 2.6 2.7 1.6 0.0 1.0 0.5 2.5 1.2 3.2 1.9 1.9 1.9 1.2 3.2 2.0 3.4 0.0 1.1 1.0 2.0 1.9 1.0 11.4 12.1 6.6 11.0 12.2 2.9 7.2 7.3 5.6 7.2 GPAT2 CT123 ENSG00000186281 "Glycerol-3-phosphate acyltransferase 2, mitochondrial" Q6NUI2 2 96021946-96039451 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 7.3;BJ hTERT+ SV40 Large T+: 18.0;BJ hTERT+ SV40 Large T+ RasG12V: 10.7;HBF TERT88: 4.1;U-2 OS: 10.3" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" HPA036841 Uncertain Approved Mitochondria Mitochondria "HPA036841: AB_10601479" "unprognostic (1.42e-2)" "unprognostic (2.39e-2)" "unprognostic (6.69e-2)" "unprognostic (3.83e-1)" "unprognostic (1.44e-1)" "unprognostic (2.38e-3)" "unprognostic (4.99e-2)" "unprognostic (3.28e-2)" "unprognostic (1.70e-1)" "unprognostic (1.44e-2)" "unprognostic (5.96e-2)" "unprognostic (4.67e-2)" "unprognostic (7.43e-6)" "unprognostic (2.11e-1)" "unprognostic (7.68e-2)" "unprognostic (3.49e-1)" "unprognostic (3.65e-1)" 4.3 1.1 1.5 1.9 3.1 1.5 3.6 0.2 1.6 0.8 1.0 0.0 1.1 5.1 0.9 1.0 2.2 3.9 1.1 0.7 0.5 0.5 1.3 3.2 1.2 0.9 1.1 0.0 0.2 2.0 0.6 1.5 1.8 4.9 1.4 0.5 1.3 2.4 2.3 4.4 3.0 7.3 1.2 2.6 2.6 0.8 4.3 1.1 0.5 2.5 0.2 3.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.3 0.0 18.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.4 0.0 2.6 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 2.6 1.9 2.8 4.3 1.3 2.0 1.1 4.1 0.8 3.0 0.0 0.2 2.5 0.0 1.3 1.5 GPT2 ALT2 ENSG00000166123 "Glutamic--pyruvic transaminase 2" Q8TD30 16 46884378-46931297 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 103.0;skeletal muscle: 60.9" "Cell line enhanced" "Detected in many" "Hep G2: 48.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051514 Approved Approved Mitochondria Mitochondria "HPA051514: " "unprognostic (1.65e-2)" "unprognostic (3.32e-2)" "unprognostic (2.87e-1)" "unprognostic (3.87e-2)" "unprognostic (3.41e-1)" "unprognostic (1.27e-1)" "unprognostic (1.95e-3)" "unprognostic (3.44e-2)" "unprognostic (6.12e-2)" "prognostic favourable (3.17e-4)" "unprognostic (1.90e-1)" "unprognostic (1.30e-1)" "unprognostic (1.56e-1)" "unprognostic (1.44e-2)" "unprognostic (4.86e-1)" "unprognostic (3.54e-3)" "unprognostic (3.18e-1)" 19.9 4.1 20.2 2.1 17.8 1.9 6.4 3.9 15.1 2.5 3.4 11.8 10.0 1.3 2.1 13.4 30.8 3.7 4.4 3.0 13.4 8.0 9.8 40.4 1.4 2.1 12.9 7.8 1.5 103.0 4.3 4.3 1.8 11.3 10.2 2.6 1.5 27.6 8.5 60.9 14.9 1.7 1.9 11.3 1.4 15.4 6.0 12.3 0.7 3.6 19.0 14.6 1.9 2.1 4.2 1.4 1.3 0.7 0.0 0.4 0.4 12.9 5.9 7.5 28.5 10.6 2.3 13.7 9.0 3.4 9.7 6.2 20.1 5.5 9.1 7.9 6.4 10.4 13.5 13.3 6.5 4.2 6.6 3.2 3.4 48.5 7.3 22.7 3.0 4.9 11.7 9.5 14.8 4.7 2.6 7.3 3.2 23.1 4.5 19.0 7.9 17.0 0.1 8.3 21.1 3.9 6.4 23.5 12.0 4.6 24.1 12.2 6.2 20.8 3.5 6.8 13.3 4.5 7.2 35.1 10.6 25.7 10.4 14.8 3.6 1.3 0.7 0.0 0.3 0.0 0.0 4.2 0.0 0.3 1.4 2.5 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.4 20.2 17.8 3.9 15.1 13.4 8.0 12.9 7.8 11.3 12.3 GRK6 GPRK6 ENSG00000198055 "G protein-coupled receptor kinase 6" P43250 5 177403204-177442901 "Enzymes, Predicted intracellular proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 68.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA015327, HPA018903" Approved Approved Mitochondria 7500 Mitochondria "HPA015327: AB_1850334, HPA018903: AB_1850335" "unprognostic (1.06e-1)" "unprognostic (3.39e-2)" "unprognostic (4.46e-2)" "unprognostic (3.87e-2)" "unprognostic (2.35e-3)" "unprognostic (1.53e-1)" "prognostic unfavourable (5.66e-6)" "unprognostic (2.63e-1)" "unprognostic (6.45e-2)" "unprognostic (8.96e-2)" "prognostic favourable (1.22e-4)" "unprognostic (1.74e-2)" "unprognostic (1.99e-2)" "unprognostic (1.83e-3)" "unprognostic (1.15e-1)" "unprognostic (4.00e-2)" "unprognostic (3.47e-1)" 6.8 5.5 7.8 26.8 7.3 68.1 10.2 7.7 10.9 5.9 9.2 6.6 5.0 10.9 8.0 6.0 11.0 6.6 9.3 6.2 8.0 7.3 5.7 6.6 11.1 37.6 7.1 10.7 6.1 12.1 3.5 5.6 4.9 6.7 8.1 5.5 5.0 10.8 5.2 7.4 7.7 14.5 7.8 5.4 34.3 9.1 10.5 5.1 32.3 5.3 6.4 26.5 11.4 6.5 9.2 5.7 32.1 22.6 17.4 11.7 9.1 12.1 13.2 4.8 21.1 1.4 2.4 20.7 8.9 4.7 11.3 11.2 30.8 10.4 14.4 13.7 4.7 8.9 7.5 20.4 4.4 39.6 23.4 12.8 10.8 10.4 7.8 17.2 16.3 3.8 5.1 11.2 6.6 6.3 13.3 52.2 3.4 34.7 17.7 18.0 8.3 14.6 17.0 7.8 20.8 3.3 9.9 11.2 15.2 7.4 13.1 17.2 10.3 19.0 8.0 9.1 13.8 9.7 22.3 15.1 18.2 11.7 6.2 28.2 8.9 4.5 9.5 32.1 11.7 16.5 8.4 9.2 9.8 10.7 5.5 9.2 10.4 9.0 23.2 17.4 22.6 5.7 11.7 9.1 7.8 7.3 7.7 10.9 8.0 7.3 7.1 10.7 6.7 5.1 GRPEL1 "FLJ25609, GrpE, hMGE" ENSG00000109519 "GrpE like 1, mitochondrial" Q9HAV7 4 7058906-7068197 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036647 Supported Supported Mitochondria 1900000 Mitochondria "HPA036647: AB_10672359" "unprognostic (6.13e-3)" "unprognostic (3.66e-2)" "unprognostic (1.92e-2)" "unprognostic (6.31e-2)" "unprognostic (9.77e-2)" "unprognostic (2.12e-3)" "unprognostic (2.17e-1)" "unprognostic (2.21e-3)" "unprognostic (1.51e-1)" "unprognostic (5.53e-2)" "unprognostic (4.99e-2)" "unprognostic (3.86e-2)" "prognostic favourable (2.00e-6)" "unprognostic (9.61e-2)" "unprognostic (7.18e-2)" "unprognostic (2.81e-1)" "unprognostic (7.30e-2)" 14.7 35.8 11.5 7.3 10.8 20.7 11.4 10.6 15.2 7.9 9.9 9.3 8.5 8.9 7.8 8.8 11.4 8.7 7.6 22.8 10.9 11.6 22.6 46.8 8.1 9.0 12.5 10.9 10.9 12.9 9.6 7.7 11.0 14.8 8.3 9.9 7.2 9.1 8.5 38.0 10.2 10.4 8.4 11.4 17.2 10.7 14.2 11.7 8.1 9.4 15.8 10.7 11.2 8.3 17.6 22.9 24.8 16.8 15.8 21.5 15.8 9.9 9.4 5.4 10.7 10.6 8.9 6.7 13.2 10.6 15.0 11.1 16.6 13.1 21.6 8.9 10.1 10.2 21.5 15.1 17.6 5.2 13.5 23.1 8.6 17.9 12.3 23.3 11.8 8.8 20.1 13.2 16.0 13.1 13.5 9.1 17.5 10.1 18.3 28.9 8.1 31.5 12.4 20.4 9.0 14.9 10.5 15.4 7.5 10.4 10.3 11.2 9.2 13.6 11.2 10.0 6.2 14.2 22.9 9.8 14.0 14.6 13.6 15.2 7.9 6.3 16.0 24.8 15.3 16.8 21.5 17.6 16.7 17.3 22.9 12.8 21.4 16.4 5.5 15.8 13.4 13.9 16.3 15.8 11.5 10.8 10.6 15.2 10.9 11.6 12.5 10.9 14.8 11.7 GRPEL2 "DKFZp451C205, FLJ23713, Mt-GrpE#2" ENSG00000164284 "GrpE like 2, mitochondrial" Q8TAA5 5 149345430-149354583 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 43.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018173, HPA023211" Uncertain Enhanced Mitochondria Mitochondria "HPA018173: AB_1850358, HPA023211: AB_1850360" "unprognostic (3.13e-2)" "unprognostic (1.69e-1)" "prognostic favourable (3.87e-5)" "prognostic unfavourable (2.21e-4)" "unprognostic (3.22e-1)" "unprognostic (2.07e-2)" "prognostic unfavourable (6.16e-8)" "unprognostic (1.34e-1)" "unprognostic (8.16e-2)" "unprognostic (3.43e-2)" "unprognostic (2.21e-2)" "unprognostic (1.04e-1)" "prognostic unfavourable (4.20e-4)" "unprognostic (3.40e-1)" "unprognostic (1.79e-1)" "unprognostic (2.20e-1)" "unprognostic (2.26e-1)" 7.4 5.1 5.4 6.5 6.4 5.3 9.8 10.9 8.9 13.3 4.8 3.7 3.9 6.0 5.4 5.8 43.1 5.1 4.3 6.3 5.5 5.6 7.5 5.7 10.2 8.1 5.1 5.2 7.5 6.8 7.2 6.5 8.5 8.4 5.1 4.8 3.7 7.2 6.7 7.8 5.4 5.8 4.3 4.4 5.9 6.1 4.9 5.1 7.4 7.9 14.4 12.8 6.1 11.5 3.5 3.8 8.2 2.5 3.7 13.5 4.6 9.0 4.9 7.1 25.5 4.5 4.7 14.3 8.0 6.8 7.8 11.0 12.0 6.1 9.4 8.5 4.2 7.0 11.3 11.7 10.0 5.0 9.5 11.9 9.4 6.8 13.6 11.1 6.0 6.9 14.4 9.7 15.2 4.7 10.3 23.2 5.8 6.4 7.2 9.5 9.4 17.9 9.1 9.9 12.4 5.0 8.4 14.7 12.2 8.1 15.0 23.9 13.1 13.3 5.3 8.5 9.4 6.1 11.8 8.6 11.4 9.1 8.6 16.2 7.7 8.2 2.5 3.3 5.1 2.4 6.2 3.5 7.7 5.7 3.8 1.9 10.3 7.7 1.9 3.7 2.5 1.0 13.5 4.6 5.4 6.4 10.9 8.9 5.5 5.6 5.1 5.2 8.4 5.1 GRSF1 ENSG00000132463 "G-rich RNA sequence binding factor 1" Q12849 4 70815782-70839945 "Predicted intracellular proteins" "mRNA processing, tRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 101.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036984, HPA036985" Enhanced Enhanced Mitochondria Mitochondria "HPA036984: AB_2675415, HPA036985: AB_10672785" "unprognostic (1.45e-3)" "unprognostic (1.82e-2)" "prognostic favourable (1.47e-5)" "unprognostic (8.63e-2)" "unprognostic (6.73e-2)" "unprognostic (4.15e-3)" "prognostic unfavourable (8.29e-5)" "unprognostic (1.94e-1)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (7.68e-2)" "unprognostic (8.05e-2)" "prognostic favourable (2.72e-9)" "unprognostic (6.12e-2)" "unprognostic (1.23e-1)" "unprognostic (1.78e-1)" "unprognostic (9.65e-3)" 17.9 33.4 21.3 22.3 19.9 8.8 29.0 19.1 42.5 16.8 22.7 19.7 15.0 18.1 17.2 18.2 21.7 18.9 22.9 33.3 22.9 22.6 23.9 23.6 23.7 24.6 24.8 20.2 17.3 26.9 19.6 13.7 18.3 23.6 17.7 27.1 12.0 32.1 20.9 101.8 18.7 17.2 18.1 24.1 17.3 22.5 13.6 19.1 37.0 19.7 31.1 21.7 21.1 15.4 5.7 20.0 7.6 11.6 14.3 11.7 5.6 31.9 21.8 25.7 26.7 27.3 31.9 36.9 38.8 24.6 29.3 24.1 22.2 32.9 46.2 29.7 39.9 12.2 45.4 30.3 39.3 25.1 14.9 24.3 22.4 30.7 33.7 35.5 14.0 26.8 29.2 29.6 20.6 30.1 27.8 26.9 40.7 34.2 58.3 25.0 27.4 23.1 24.1 40.0 19.6 36.2 40.0 26.8 24.2 18.3 52.2 64.0 22.6 17.4 27.5 27.4 29.0 22.6 24.4 22.4 17.8 29.7 22.7 23.1 26.7 7.6 11.6 5.2 7.6 8.8 9.5 5.7 11.2 11.7 20.0 4.9 11.2 9.5 1.6 14.3 10.5 19.3 9.3 5.6 21.3 19.9 19.1 42.5 22.9 22.6 24.8 20.2 23.6 19.1 GSDMC MLZE ENSG00000147697 "Gasdermin C" Q9BYG8 8 129748196-129786888 "Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 25.9;lymphoid tissue: 25.0;skin 1: 14.1;tongue: 19.2" "Cell line enhanced" "Detected in some" "A-431: 8.2;HaCaT: 5.8;hTCEpi: 3.0;HUVEC TERT2: 3.2;TIME: 8.5" "Group enriched" "Detected in many" 6 "cervical cancer: 11.8;head and neck cancer: 19.0;lung cancer: 5.3;urothelial cancer: 4.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "HPA023670, HPA024767, HPA026317" Supported Enhanced Mitochondria Mitochondria "HPA023670: AB_1854006, HPA024767: AB_1854007, HPA026317: AB_1854008" "unprognostic (6.33e-3)" "unprognostic (1.49e-1)" "unprognostic (2.61e-3)" "unprognostic (4.23e-2)" "unprognostic (2.11e-2)" "unprognostic (4.22e-3)" "unprognostic (1.43e-2)" "unprognostic (1.15e-1)" "unprognostic (8.28e-2)" "unprognostic (7.51e-2)" "unprognostic (4.92e-3)" "unprognostic (5.71e-2)" "unprognostic (2.93e-3)" "unprognostic (1.87e-2)" "unprognostic (1.88e-1)" "unprognostic (8.66e-2)" "unprognostic (1.90e-1)" 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.5 0.2 25.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.7 0.1 0.0 3.4 0.0 0.0 14.1 0.0 0.0 0.2 25.0 0.0 0.0 0.0 0.1 0.1 19.2 17.5 1.4 5.9 0.3 0.3 1.2 0.1 0.4 0.3 0.0 8.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 5.8 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.3 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.1 8.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.2 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.2 0.9 0.4 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 GTPBP3 "FLJ14700, GTPBG3, MSS1, MTGP1, THDF1" ENSG00000130299 "GTP binding protein 3, mitochondrial" Q969Y2 19 17334920-17342735 "Disease related genes, Predicted intracellular proteins" "tRNA processing" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042158 Approved Supported Mitochondria Mitochondria "HPA042158: AB_10964400" "unprognostic (1.52e-1)" "unprognostic (1.08e-2)" "unprognostic (2.23e-1)" "unprognostic (3.08e-3)" "unprognostic (1.34e-1)" "unprognostic (2.18e-2)" "prognostic unfavourable (1.86e-4)" "unprognostic (6.32e-2)" "unprognostic (1.82e-1)" "unprognostic (2.70e-2)" "unprognostic (3.25e-2)" "prognostic unfavourable (2.81e-4)" "prognostic unfavourable (1.64e-4)" "unprognostic (4.94e-3)" "unprognostic (1.21e-1)" "unprognostic (2.56e-1)" "unprognostic (1.79e-1)" 8.0 13.8 8.1 12.0 14.7 10.0 9.3 11.7 12.6 9.6 8.2 7.4 9.8 12.5 10.2 6.9 13.0 9.8 12.4 7.9 11.3 10.7 9.2 13.7 7.5 13.4 7.8 11.6 11.3 12.3 14.8 11.0 8.0 11.4 10.6 7.2 10.3 13.2 15.6 14.3 22.9 10.6 8.6 6.7 13.2 11.0 3.5 6.3 16.7 9.2 10.9 16.2 8.5 10.0 6.6 9.3 1.3 4.4 6.3 7.3 3.7 9.1 5.5 5.1 6.6 1.7 1.6 25.0 4.3 1.8 4.0 3.9 7.6 7.4 13.9 11.1 1.6 8.2 6.5 3.7 3.2 11.5 30.2 8.4 8.0 9.9 2.2 8.9 5.5 1.7 5.4 3.7 4.8 3.1 15.8 6.3 2.0 7.2 10.6 7.9 10.8 24.8 12.7 4.0 13.1 3.6 4.2 12.0 10.7 4.6 7.2 5.9 6.3 3.7 3.4 6.2 5.5 13.6 7.6 10.7 16.6 16.8 4.8 11.7 4.7 0.5 3.1 0.6 7.1 4.4 5.8 4.5 6.5 6.1 4.8 6.6 7.3 6.8 1.3 6.3 2.4 9.3 4.4 3.7 8.1 14.7 11.7 12.6 11.3 10.7 7.8 11.6 11.4 6.3 GTPBP6 "FLJ20977, PGPL" ENSG00000178605 "GTP binding protein 6 (putative)" X 304529-318819 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034924, HPA035467, HPA055418" Approved Uncertain Mitochondria Mitochondria "CAB034924: AB_2115410, HPA035467: AB_10671104, HPA055418: " "unprognostic (5.00e-2)" "unprognostic (5.10e-2)" "unprognostic (1.60e-1)" "unprognostic (1.10e-2)" "unprognostic (4.90e-2)" "unprognostic (2.30e-3)" "prognostic unfavourable (8.87e-4)" "unprognostic (1.17e-1)" "unprognostic (2.95e-1)" "unprognostic (6.10e-2)" "prognostic favourable (1.71e-4)" "unprognostic (3.38e-2)" "unprognostic (4.45e-2)" "unprognostic (4.99e-3)" "unprognostic (2.23e-1)" "unprognostic (2.35e-1)" "unprognostic (5.05e-2)" 6.3 4.9 22.2 5.6 40.5 8.1 33.6 30.5 29.9 18.9 5.2 0.6 0.6 7.0 17.0 0.6 4.7 6.3 3.1 19.7 22.7 5.9 21.1 4.0 4.1 6.0 39.5 15.0 18.2 11.9 2.1 16.6 16.6 26.4 4.1 1.6 0.6 11.2 4.7 22.8 5.7 7.6 1.9 25.5 6.4 7.5 2.4 34.2 0.6 4.1 0.6 1.9 3.7 25.4 7.3 11.1 8.1 6.3 5.3 9.2 3.8 15.2 25.3 5.6 11.7 6.5 7.1 20.9 9.5 7.1 12.1 11.1 38.6 12.8 19.1 13.5 5.3 9.5 5.9 9.2 2.0 15.9 17.2 15.8 12.4 26.4 17.6 10.6 15.5 8.8 12.3 8.0 5.9 9.7 11.6 9.0 4.9 30.1 18.8 14.0 13.7 18.0 8.4 9.9 30.6 7.0 17.8 15.8 13.5 10.4 11.8 17.5 10.5 9.3 12.8 17.7 12.2 26.1 14.6 12.3 11.0 29.5 9.2 14.0 8.1 8.1 6.3 6.7 7.8 6.3 7.6 7.3 6.9 8.7 6.1 6.0 8.5 7.7 0.9 5.3 5.8 11.1 9.2 3.8 22.2 40.5 30.5 29.9 22.7 5.9 39.5 15.0 26.4 34.2 GTPBP8 HSPC135 ENSG00000163607 "GTP binding protein 8 (putative)" Q8N3Z3 3 112990918-113015060 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034831, HPA058631" Approved Enhanced Mitochondria Mitochondria "HPA034831: AB_10671506, HPA058631: " "unprognostic (1.98e-1)" "unprognostic (1.02e-2)" "unprognostic (4.36e-2)" "unprognostic (1.99e-3)" "unprognostic (4.39e-2)" "unprognostic (2.00e-2)" "unprognostic (7.18e-3)" "unprognostic (1.80e-2)" "unprognostic (1.06e-2)" "unprognostic (2.08e-1)" "unprognostic (1.35e-2)" "unprognostic (1.21e-2)" "prognostic favourable (3.07e-5)" "unprognostic (7.10e-2)" "unprognostic (7.21e-2)" "unprognostic (4.57e-1)" "unprognostic (2.69e-1)" 7.5 9.3 7.4 7.3 7.8 9.5 7.3 8.5 10.1 7.1 11.9 9.2 8.3 8.0 8.3 5.2 12.2 6.4 7.4 20.0 7.6 7.6 12.2 8.2 6.2 13.2 7.6 8.3 10.4 12.1 13.0 12.1 9.3 9.5 8.2 9.3 6.6 9.6 5.2 25.3 6.5 11.8 7.4 11.7 9.3 9.1 22.7 8.9 25.4 13.4 14.3 10.2 9.6 8.0 6.7 12.2 6.7 7.0 11.9 15.8 7.8 19.2 8.8 11.7 13.1 7.1 12.4 9.3 13.3 11.6 13.7 17.1 15.4 8.3 12.6 7.9 7.3 13.2 15.5 12.9 15.8 5.6 10.8 34.5 8.9 8.0 6.8 22.0 8.5 9.8 9.3 7.5 5.4 12.6 12.2 15.0 13.2 7.6 14.0 10.8 24.0 16.7 12.0 10.7 8.0 9.6 12.2 13.5 13.7 10.8 8.5 17.7 9.6 15.0 7.5 10.0 14.8 3.6 12.4 9.8 12.8 17.7 10.0 18.3 11.0 6.7 7.0 4.5 10.4 4.6 9.1 6.7 11.9 10.0 12.2 5.9 15.8 10.3 1.0 11.9 3.9 5.8 8.2 7.8 7.4 7.8 8.5 10.1 7.6 7.6 7.6 8.3 9.5 8.9 HADH "HADH1, HADHSC, SCHAD" ENSG00000138796 "Hydroxyacyl-CoA dehydrogenase" Q16836 4 107989714-108035175 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 98.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039588, HPA043888" Supported Supported Mitochondria 8700000 Mitochondria "HPA039588: AB_10673425, HPA043888: AB_2678716" "unprognostic (1.73e-1)" "unprognostic (3.32e-3)" "unprognostic (3.05e-3)" "unprognostic (8.86e-3)" "unprognostic (1.83e-1)" "unprognostic (6.83e-2)" "unprognostic (9.26e-3)" "unprognostic (1.55e-2)" "unprognostic (9.22e-2)" "unprognostic (3.24e-2)" "unprognostic (2.96e-1)" "unprognostic (1.18e-2)" "prognostic favourable (0.00e+0)" "unprognostic (1.67e-1)" "unprognostic (4.22e-2)" "unprognostic (5.67e-2)" "unprognostic (1.88e-2)" 36.6 19.5 8.5 15.6 9.2 6.1 41.7 5.4 9.7 15.2 29.7 10.6 9.4 23.3 18.3 13.3 20.5 15.7 12.4 98.3 7.8 8.1 37.2 60.3 10.6 8.8 10.0 7.0 17.1 17.8 9.8 6.8 5.1 9.2 15.6 25.0 11.6 20.4 12.5 64.6 9.0 37.1 19.6 10.2 8.0 19.1 12.6 7.2 40.9 16.1 38.0 13.1 14.2 10.6 18.6 22.6 5.6 10.7 20.2 13.0 8.9 8.8 8.3 18.0 13.1 43.3 13.9 8.7 13.0 19.4 14.2 14.0 5.9 16.7 50.4 7.0 10.7 11.9 23.9 18.1 15.7 15.4 12.5 11.7 15.9 13.2 6.9 24.7 5.5 14.5 9.7 10.0 9.2 9.5 14.5 26.8 16.0 16.1 41.9 9.9 8.5 11.1 32.0 25.2 25.2 15.3 36.1 21.7 12.5 12.6 45.1 12.8 21.5 19.6 5.3 10.0 5.7 14.1 7.1 15.2 17.6 21.9 13.6 16.8 7.7 0.0 6.1 5.6 10.1 7.8 12.5 18.6 11.4 12.1 19.7 15.5 13.0 13.0 0.7 20.2 10.7 22.6 10.0 8.9 8.5 9.2 5.4 9.7 7.8 8.1 10.0 7.0 9.2 7.2 HADHA "GBP, LCEH, LCHAD, MTPA" ENSG00000084754 "Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha" P40939 2 26190635-26244726 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Lyase, Multifunctional enzyme, Oxidoreductase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015536, HPA056070" Approved Enhanced Mitochondria 2700000 Mitochondria "HPA015536: AB_1850473, HPA056070: " "unprognostic (2.02e-1)" "unprognostic (1.38e-2)" "unprognostic (2.55e-1)" "unprognostic (3.43e-1)" "unprognostic (2.67e-2)" "unprognostic (3.23e-2)" "unprognostic (1.25e-2)" "unprognostic (2.02e-1)" "unprognostic (5.16e-2)" "unprognostic (3.45e-1)" "unprognostic (3.81e-1)" "unprognostic (1.16e-1)" "prognostic favourable (3.68e-5)" "unprognostic (7.97e-2)" "unprognostic (1.71e-1)" "unprognostic (2.87e-3)" "unprognostic (2.64e-2)" 41.6 35.3 18.1 13.1 19.5 17.0 23.9 17.4 16.9 20.2 44.9 26.5 15.7 48.1 21.1 15.3 30.8 20.5 15.1 80.0 15.6 15.5 41.3 71.7 17.7 19.3 21.6 13.1 27.3 37.5 29.8 23.5 21.3 24.8 21.9 32.2 23.6 21.1 16.6 117.5 23.3 66.4 25.1 27.8 24.0 24.1 18.7 19.0 25.2 25.1 41.3 24.6 26.9 18.8 15.3 28.9 12.4 32.2 13.5 17.6 26.0 23.3 20.8 13.7 22.4 54.5 34.1 11.7 18.3 19.8 18.9 16.4 26.3 22.7 15.4 12.0 32.1 14.9 24.0 35.5 17.1 34.5 29.4 23.1 22.1 43.8 18.8 29.1 17.0 34.8 23.3 26.8 26.9 31.6 31.4 31.3 24.3 28.6 12.7 32.6 11.7 40.2 11.7 29.6 33.1 21.6 28.2 9.7 19.3 21.5 22.4 24.8 11.9 28.2 28.9 11.0 16.3 16.4 13.4 10.3 20.3 27.4 17.1 34.5 13.2 8.1 27.7 12.4 12.3 32.2 14.8 15.3 14.2 15.0 28.9 11.2 16.7 15.3 7.4 13.5 28.0 11.0 17.6 26.0 18.1 19.5 17.4 16.9 15.6 15.5 21.6 13.1 24.8 19.0 HADHB MTPB ENSG00000138029 "Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta" P55084 2 26243170-26290468 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 126.0;skeletal muscle: 155.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037539, HPA037540, HPA066099" Enhanced Supported Mitochondria 1100000 Mitochondria "HPA037539: AB_10671374, HPA037540: AB_2675531, HPA066099: AB_2685618" "unprognostic (5.15e-2)" "unprognostic (8.72e-2)" "unprognostic (8.21e-2)" "unprognostic (8.67e-2)" "unprognostic (7.70e-2)" "unprognostic (2.59e-2)" "unprognostic (7.29e-2)" "unprognostic (9.70e-2)" "unprognostic (2.01e-1)" "unprognostic (2.09e-1)" "unprognostic (2.03e-1)" "unprognostic (8.94e-2)" "prognostic favourable (1.37e-9)" "unprognostic (2.47e-1)" "unprognostic (2.50e-1)" "unprognostic (2.88e-1)" "unprognostic (9.68e-2)" 23.3 45.5 24.8 11.0 24.7 9.9 16.6 16.6 17.4 13.8 21.4 31.1 19.3 43.6 17.1 16.2 20.6 13.9 12.6 126.0 18.0 20.0 45.8 62.4 12.8 16.1 34.8 18.3 16.2 23.7 19.9 13.1 12.6 27.8 15.8 22.8 19.9 27.2 15.9 155.6 13.2 35.0 20.3 29.5 15.3 19.5 15.8 23.8 10.6 22.4 44.9 14.5 18.5 12.8 20.2 45.2 21.5 49.1 23.8 26.8 33.9 22.7 18.0 12.6 22.5 77.7 43.0 12.7 19.2 29.4 19.8 19.4 21.5 22.2 11.4 13.5 31.4 18.0 20.9 27.1 24.3 25.7 18.2 26.2 10.7 42.0 33.3 21.1 20.1 41.6 44.8 20.5 33.5 36.6 21.9 18.5 41.2 16.7 11.8 40.8 8.7 19.6 13.1 41.6 21.7 40.7 32.4 6.0 20.7 32.9 37.5 50.4 23.2 37.8 25.3 18.7 19.5 17.5 13.8 13.9 20.9 20.1 21.5 33.8 18.5 21.0 49.1 18.9 14.2 43.4 18.1 20.2 19.3 17.6 45.2 14.8 18.0 16.3 21.5 23.8 33.2 15.3 26.8 33.9 24.8 24.7 16.6 17.4 18.0 20.0 34.8 18.3 27.8 23.8 HAX1 "HCLSBP1, HS1BP1" ENSG00000143575 "HCLS1 associated protein X-1" O00165 1 154272511-154275875 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055141, HPA075289" Approved Supported Mitochondria Mitochondria "HPA055141: , HPA075289: " "unprognostic (1.32e-1)" "unprognostic (2.68e-1)" "unprognostic (9.50e-2)" "unprognostic (6.93e-2)" "unprognostic (2.88e-2)" "unprognostic (1.73e-2)" "unprognostic (1.55e-3)" "unprognostic (2.34e-1)" "unprognostic (2.20e-1)" "unprognostic (9.09e-3)" "unprognostic (3.09e-2)" "unprognostic (8.91e-2)" "prognostic unfavourable (1.34e-5)" "unprognostic (1.52e-1)" "unprognostic (1.59e-1)" "unprognostic (1.69e-1)" "unprognostic (3.96e-1)" 24.0 25.4 28.6 16.0 33.9 12.2 29.2 15.1 36.6 24.9 24.8 21.9 22.9 18.6 20.2 42.7 27.7 24.5 20.2 59.5 24.7 26.3 32.1 61.7 17.3 20.3 25.8 20.3 29.3 47.8 21.0 35.2 18.4 23.5 26.1 25.0 26.6 52.0 26.3 90.4 17.8 27.8 25.1 22.6 23.2 23.9 31.3 17.0 23.8 32.4 45.8 27.7 27.0 18.6 39.1 34.9 59.1 39.6 30.9 51.8 42.8 20.4 17.5 14.9 32.5 18.4 20.6 24.1 19.5 32.0 41.4 38.5 23.2 23.0 29.8 28.3 33.0 17.7 34.0 27.0 32.0 30.5 25.5 14.5 14.4 20.0 41.0 30.2 31.5 19.1 49.9 31.1 37.3 23.0 28.3 44.6 26.6 49.3 30.2 25.0 16.4 38.4 21.5 10.9 57.3 21.8 11.5 22.8 22.8 17.4 42.3 58.9 34.9 83.4 11.4 17.2 23.2 18.0 26.8 52.0 54.2 55.9 26.2 27.9 28.4 58.3 28.4 59.1 34.2 33.5 39.1 39.1 43.1 38.7 34.0 38.2 51.8 41.2 17.2 30.9 39.6 34.9 50.8 42.8 28.6 33.9 15.1 36.6 24.7 26.3 25.8 20.3 23.5 17.0 HCCS "CCHL, MLS" ENSG00000004961 "Holocytochrome c synthase" P53701 X 11111301-11123078 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002946 Approved Enhanced Mitochondria "Intracellular and membrane" Mitochondria "HPA002946: AB_1079041" "prognostic unfavourable (8.69e-5)" "unprognostic (6.89e-3)" "unprognostic (8.46e-3)" "unprognostic (4.92e-2)" "unprognostic (1.34e-1)" "unprognostic (5.44e-2)" "prognostic unfavourable (1.35e-5)" "unprognostic (9.18e-2)" "unprognostic (2.73e-1)" "unprognostic (2.52e-2)" "unprognostic (2.10e-2)" "unprognostic (1.60e-1)" "prognostic favourable (6.17e-8)" "unprognostic (2.66e-2)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (1.93e-2)" 10.6 14.2 8.8 9.0 12.7 11.8 9.6 11.0 17.7 6.7 15.5 7.4 8.0 17.2 8.5 5.5 15.8 6.9 9.8 36.9 8.4 8.3 15.9 19.0 9.5 10.1 8.2 11.1 10.0 11.4 11.5 10.0 12.8 10.6 7.8 15.2 9.3 12.8 8.0 41.6 13.8 14.4 10.4 6.3 12.3 12.2 10.5 6.0 10.3 10.8 16.4 11.8 11.4 17.3 18.1 28.4 13.3 29.7 8.4 11.1 8.7 23.2 26.8 12.5 12.0 11.8 11.4 13.3 23.5 17.9 29.7 25.5 31.1 17.0 14.5 12.1 18.8 21.6 25.9 22.4 29.0 13.5 20.3 14.5 34.4 15.5 20.9 15.8 17.7 11.1 17.5 28.2 19.3 21.0 26.8 16.8 19.9 31.5 11.4 12.8 22.7 29.0 11.2 25.2 28.4 20.0 18.3 9.1 10.7 23.4 25.5 15.0 19.7 11.4 20.6 19.3 10.4 49.2 20.0 12.4 12.6 19.2 15.5 12.7 18.4 10.1 22.5 13.3 9.9 29.7 9.5 18.1 9.7 8.9 28.4 15.5 8.5 11.1 6.2 8.4 24.8 25.9 10.4 8.7 8.8 12.7 11.0 17.7 8.4 8.3 8.2 11.1 10.6 6.0 HDHD5 CECR5 ENSG00000069998 "Haloacid dehalogenase like hydrolase domain containing 5" Q9BXW7 22 17137511-17165287 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005548 Approved Approved Mitochondria "Intracellular and membrane" Mitochondria "HPA005548: AB_1078497" "unprognostic (4.04e-2)" "unprognostic (5.04e-2)" "unprognostic (4.54e-3)" "unprognostic (6.61e-2)" "unprognostic (1.20e-1)" "unprognostic (5.71e-2)" "unprognostic (1.04e-3)" "unprognostic (7.35e-2)" "unprognostic (1.70e-1)" "unprognostic (4.98e-2)" "unprognostic (5.76e-2)" "unprognostic (2.35e-1)" "unprognostic (1.10e-1)" "unprognostic (7.07e-3)" "unprognostic (1.71e-1)" "unprognostic (1.20e-2)" "unprognostic (7.21e-3)" 12.2 22.2 10.3 11.3 13.3 12.8 14.7 13.2 13.2 10.6 23.7 11.3 8.8 23.7 12.6 10.1 15.3 11.9 16.0 29.5 9.9 8.4 14.7 29.8 12.5 12.4 16.4 10.4 13.6 25.3 8.9 9.6 7.4 13.2 12.7 13.1 7.7 17.3 10.0 37.2 15.7 16.5 12.0 9.9 14.6 13.6 12.4 13.7 15.1 9.4 25.9 11.6 11.9 10.7 10.1 29.3 2.9 34.6 11.1 15.0 17.5 23.2 15.4 11.6 15.6 6.9 4.2 14.8 6.7 7.4 18.0 19.3 22.5 8.7 38.2 11.2 8.0 16.4 14.6 15.7 8.4 11.5 21.3 0.0 11.1 0.0 11.5 17.2 9.0 10.2 19.4 8.0 8.9 12.5 11.1 9.9 9.3 22.6 30.1 35.3 17.6 13.8 17.3 17.4 9.6 12.3 12.8 23.5 17.7 13.0 18.9 19.9 18.9 21.5 10.8 15.3 11.4 10.7 11.4 15.8 17.1 28.1 12.3 0.0 12.8 2.9 34.6 1.6 11.8 21.4 14.7 10.1 11.2 10.7 29.3 9.6 15.0 12.5 1.7 11.1 11.6 12.1 11.3 17.5 10.3 13.3 13.2 13.2 9.9 8.4 16.4 10.4 13.2 13.7 HEATR6 "ABC1, FLJ22087" ENSG00000068097 "HEAT repeat containing 6" Q6AI08 17 60043194-60078931 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030789, HPA062157" Uncertain Approved Mitochondria Mitochondria "HPA030789: AB_10601660, HPA062157: " "unprognostic (1.98e-1)" "unprognostic (7.95e-2)" "unprognostic (4.32e-1)" "prognostic unfavourable (2.03e-4)" "unprognostic (4.22e-1)" "unprognostic (1.00e-1)" "prognostic unfavourable (5.02e-6)" "unprognostic (2.24e-1)" "unprognostic (2.86e-1)" "unprognostic (1.97e-1)" "unprognostic (6.81e-3)" "unprognostic (9.84e-2)" "prognostic unfavourable (6.73e-4)" "unprognostic (5.01e-2)" "unprognostic (1.81e-1)" "unprognostic (5.50e-2)" "unprognostic (2.11e-1)" 8.3 14.5 14.6 9.2 15.4 12.0 10.3 28.5 15.1 12.2 13.0 18.0 11.1 6.8 14.4 12.6 9.4 13.0 9.1 12.3 11.2 9.9 9.0 7.1 11.8 11.0 15.3 12.6 17.8 10.3 16.7 18.4 10.7 13.7 13.2 10.6 10.0 11.3 13.0 12.6 13.3 11.2 15.0 12.8 14.1 9.5 10.5 15.8 10.0 9.5 7.2 9.7 12.3 18.9 10.8 12.8 6.8 10.4 4.1 6.8 4.6 4.6 9.1 8.0 5.5 5.4 8.0 5.8 4.6 7.8 8.7 8.4 3.9 3.5 1.6 7.5 8.1 5.5 6.4 6.3 11.4 3.2 8.1 8.9 7.1 5.9 6.9 5.5 8.0 7.9 10.2 6.3 9.0 5.0 5.1 5.6 5.7 48.1 7.5 2.0 4.1 8.5 2.8 13.9 4.9 4.7 5.7 5.3 12.1 4.3 1.6 4.6 7.0 3.8 4.6 8.1 12.3 6.1 7.5 4.7 5.0 0.0 7.1 4.3 6.2 5.1 6.1 6.8 6.8 10.4 5.5 10.8 5.5 5.7 12.8 8.4 5.9 5.1 1.2 4.1 9.9 4.4 5.6 4.6 14.6 15.4 28.5 15.1 11.2 9.9 15.3 12.6 13.7 15.8 HINT2 ENSG00000137133 "Histidine triad nucleotide binding protein 2" Q9BX68 9 35812960-35815354 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020961, HPA059109" Supported Enhanced Mitochondria "Intracellular and membrane" 1100000 Mitochondria "HPA020961: AB_1850715, HPA059109: " "unprognostic (9.64e-3)" "unprognostic (1.53e-2)" "unprognostic (3.02e-1)" "unprognostic (3.01e-2)" "unprognostic (5.51e-2)" "unprognostic (3.97e-2)" "unprognostic (1.07e-1)" "unprognostic (2.38e-2)" "unprognostic (2.61e-1)" "prognostic favourable (1.66e-4)" "unprognostic (3.71e-3)" "unprognostic (2.87e-2)" "prognostic favourable (2.97e-9)" "unprognostic (4.29e-2)" "unprognostic (1.41e-1)" "unprognostic (8.78e-2)" "unprognostic (1.72e-1)" 18.4 27.2 16.0 14.5 15.5 10.3 15.6 9.5 16.5 10.0 16.4 11.0 26.1 15.3 8.9 24.1 12.6 14.4 21.7 33.7 13.3 13.3 34.8 68.7 15.2 14.2 15.3 13.6 6.8 30.8 21.0 14.1 12.8 12.5 10.8 16.4 12.2 20.2 31.0 30.9 10.3 15.8 17.0 12.3 11.3 16.7 10.3 8.2 16.8 14.9 29.8 11.8 10.4 7.5 24.6 62.0 7.8 20.3 15.1 25.5 18.5 9.7 26.8 16.7 16.1 10.7 9.0 11.0 9.2 13.8 15.1 16.7 17.6 10.9 12.7 10.7 8.8 9.8 7.6 14.4 16.0 27.7 13.8 13.9 23.4 15.8 24.8 7.8 14.0 10.0 13.2 14.4 23.5 11.7 8.1 41.5 12.0 20.8 19.5 9.8 7.4 46.2 19.7 11.1 17.5 21.6 7.6 13.3 15.9 12.0 14.9 16.0 16.1 15.1 5.3 8.1 12.8 10.5 11.6 36.1 40.1 18.3 18.0 10.8 12.7 7.8 20.3 1.1 18.5 14.3 16.7 24.6 19.9 18.5 28.6 23.8 15.4 15.9 1.9 15.1 13.0 62.0 25.5 18.5 16.0 15.5 9.5 16.5 13.3 13.3 15.3 13.6 12.5 8.2 HK1 ENSG00000156515 "Hexokinase 1" P19367 10 69269984-69401884 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycolysis, Immunity, Inflammatory response, Innate immunity" "Allosteric enzyme, Kinase, Transferase" "Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007043, HPA007044, CAB010052, HPA011956" Supported Supported Mitochondria 16000000 Mitochondria "CAB010052: AB_627721, HPA007043: AB_1850652, HPA007044: AB_1079049, HPA011956: AB_1850758" "unprognostic (8.80e-2)" "unprognostic (1.78e-1)" "unprognostic (2.03e-1)" "unprognostic (2.00e-3)" "unprognostic (1.15e-2)" "prognostic unfavourable (3.39e-6)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (4.29e-2)" "unprognostic (1.16e-1)" "unprognostic (3.93e-3)" "unprognostic (1.12e-1)" "unprognostic (1.37e-3)" "unprognostic (7.25e-2)" "unprognostic (1.40e-2)" "unprognostic (2.00e-3)" "unprognostic (3.86e-2)" 17.5 10.5 21.1 19.9 30.4 23.5 15.8 40.0 48.6 16.6 16.9 10.1 7.6 6.3 13.5 9.4 44.8 15.2 12.6 61.6 19.8 23.3 10.8 4.4 17.2 14.3 19.8 31.3 9.0 4.6 12.5 14.7 22.6 31.3 25.5 15.4 21.2 21.5 26.8 62.1 30.7 8.6 25.6 9.7 13.3 20.3 28.9 10.6 18.9 33.6 32.6 23.0 25.8 23.1 11.4 25.5 17.8 39.3 8.9 23.0 29.6 17.4 9.9 13.3 12.7 14.9 11.2 8.5 17.4 45.8 23.3 25.2 2.9 1.9 1.2 13.8 29.1 15.3 12.4 38.9 22.3 11.6 9.7 43.4 10.6 0.2 17.0 0.8 32.9 16.9 22.7 33.3 74.5 24.1 72.3 9.2 31.9 28.9 5.0 2.2 20.4 44.3 7.7 8.1 0.1 16.1 20.6 13.7 16.1 19.9 38.7 11.5 21.1 2.8 24.7 34.8 15.9 19.1 24.2 11.0 7.2 3.0 45.1 22.8 10.0 17.8 27.3 13.4 14.0 39.3 23.0 11.4 16.2 15.8 25.5 6.8 14.5 11.5 6.6 8.9 39.3 2.9 17.8 29.6 21.1 30.4 40.0 48.6 19.8 23.3 19.8 31.3 31.3 10.6 HKDC1 "FLJ22761, FLJ37767" ENSG00000156510 "Hexokinase domain containing 1" Q2TB90 10 69220303-69267559 "Enzymes, Predicted intracellular proteins" Glycolysis "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 77.4" "Cell line enhanced" "Detected in some" "A549: 14.7;CACO-2: 20.9;CAPAN-2: 41.4;EFO-21: 12.8;Hep G2: 12.1;RPTEC TERT1: 30.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 8.3;T-reg: 6.6" "Lineage enriched" "Detected in single" 29 "T-cells: 8.3" "Region enhanced" "Detected in some" "cerebral cortex: 12.2" "Low region specificity" "Detected in all" "HPA011956, HPA064198, HPA064230" Approved Enhanced Mitochondria Mitochondria "HPA011956: AB_1850758, HPA064198: , HPA064230: " "unprognostic (1.29e-2)" "unprognostic (2.26e-2)" "unprognostic (1.86e-1)" "unprognostic (8.47e-2)" "unprognostic (1.55e-1)" "unprognostic (3.05e-1)" "unprognostic (6.31e-3)" "unprognostic (5.03e-2)" "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (1.23e-3)" "unprognostic (3.11e-1)" "unprognostic (1.04e-3)" "unprognostic (1.35e-1)" "unprognostic (2.24e-1)" "unprognostic (2.10e-3)" "unprognostic (2.19e-1)" 0.2 0.0 0.9 1.2 1.6 0.0 0.2 0.8 1.4 0.5 29.8 0.5 0.2 29.9 0.5 1.0 0.3 2.5 11.2 0.2 0.5 0.6 15.6 4.6 1.3 0.3 0.3 0.2 1.0 4.7 0.0 0.5 0.2 0.4 0.2 2.3 12.0 0.2 0.2 0.2 0.0 77.4 0.2 0.2 0.2 0.4 0.6 0.2 0.2 5.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 8.3 1.6 0.4 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 20.9 41.4 0.0 12.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.1 1.0 0.0 0.0 0.0 0.1 0.1 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 30.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.1 0.2 0.0 0.0 0.0 3.1 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.7 0.0 4.4 1.4 0.0 0.0 8.3 3.2 0.0 0.2 0.0 0.0 6.6 1.6 0.9 1.6 0.8 0.4 0.5 0.6 0.3 0.2 0.4 0.2 HMGCS2 ENSG00000134240 "3-hydroxy-3-methylglutaryl-CoA synthase 2" P54868 1 119747996-119768905 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 257.0" "Cell line enriched" "Detected in some" 16 "RT4: 66.2" "Cancer enhanced" "Detected in many" "liver cancer: 441.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA027423, HPA027442, CAB032906" Enhanced Supported Mitochondria 820000 Mitochondria "CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277" "unprognostic (2.57e-1)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" "unprognostic (7.62e-2)" "unprognostic (1.49e-2)" "prognostic favourable (2.43e-7)" "unprognostic (9.68e-2)" "unprognostic (3.21e-2)" "prognostic favourable (2.17e-4)" "unprognostic (1.20e-1)" "unprognostic (6.42e-2)" "prognostic favourable (3.43e-5)" "unprognostic (9.57e-2)" "unprognostic (2.31e-1)" "unprognostic (5.00e-2)" "unprognostic (1.54e-3)" 0.3 0.1 0.3 8.7 0.3 0.0 20.6 0.3 0.3 0.3 30.8 0.4 0.3 13.8 0.3 0.3 0.7 0.1 4.4 42.0 0.4 0.0 7.4 257.0 0.8 0.3 0.3 0.3 0.3 1.4 0.0 0.3 0.8 0.7 3.8 19.8 18.9 5.1 0.3 1.4 1.8 12.2 1.9 0.3 0.3 8.1 6.1 0.3 0.4 0.3 0.6 2.1 7.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 66.2 0.0 0.2 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.4 0.0 0.3 0.3 0.7 0.3 HPDL "4-HPPD-L, GLOXD1, MGC15668" ENSG00000186603 "4-hydroxyphenylpyruvate dioxygenase like" Q96IR7 1 45326905-45328533 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 38.4" "Cell line enhanced" "Detected in some" "BEWO: 46.3;HL-60: 13.1;NB-4: 16.3;SK-BR-3: 29.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 18 "hippocampal formation: 0.7;hypothalamus: 0.9;midbrain: 2.0;pons and medulla: 0.9;thalamus: 0.8" "HPA031997, HPA057346" Supported Mitochondria Mitochondria "HPA031997: AB_10602909, HPA057346: " "prognostic favourable (1.81e-4)" "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "prognostic unfavourable (1.60e-5)" "unprognostic (1.02e-2)" "unprognostic (6.71e-2)" "unprognostic (3.93e-3)" "unprognostic (1.25e-1)" "unprognostic (1.63e-1)" "prognostic favourable (1.03e-4)" "unprognostic (1.08e-3)" "unprognostic (2.52e-2)" "unprognostic (6.66e-2)" "unprognostic (1.26e-2)" "unprognostic (1.00e-1)" "unprognostic (3.03e-2)" "unprognostic (1.43e-1)" 0.9 0.7 2.7 3.1 4.2 3.6 1.0 7.6 3.4 2.0 8.4 2.4 0.0 5.4 1.0 1.3 3.6 1.0 1.8 3.0 2.7 2.4 0.7 0.2 0.8 2.6 2.5 1.8 1.0 0.3 0.2 0.4 5.1 3.1 1.7 7.1 38.4 1.3 0.6 3.3 1.1 4.7 0.9 2.2 2.8 7.8 1.4 0.6 6.4 1.0 4.2 2.3 0.8 1.6 3.1 0.7 0.0 0.3 2.1 1.5 0.8 0.0 0.4 0.1 0.0 0.0 0.1 46.3 0.6 0.0 0.8 0.1 11.5 3.0 2.3 0.1 0.5 2.8 0.0 0.1 0.2 0.0 0.1 0.2 5.0 0.0 0.3 13.1 0.3 0.5 0.1 0.4 0.0 0.9 0.0 2.1 0.1 5.7 8.4 16.3 0.2 0.0 2.5 0.0 7.6 0.1 0.1 9.1 0.6 5.8 29.3 4.5 0.0 2.4 0.4 0.0 0.1 0.4 0.0 0.3 0.1 8.2 0.0 0.0 0.5 0.0 0.3 0.0 0.4 0.1 1.5 3.1 0.7 1.2 0.7 0.3 0.9 0.8 0.0 2.1 0.0 0.0 0.4 0.8 2.7 4.2 7.6 3.4 2.7 2.4 2.5 1.8 3.1 0.6 HRASLS2 FLJ20556 ENSG00000133328 "HRAS like suppressor 2" Q9NWW9 11 63552770-63563383 "Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 16.1;intestine: 42.5" "Cell line enriched" "Detected in some" 8 "U-266/70: 53.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "memory B-cell: 16.1;naive B-cell: 5.3" "Lineage enriched" "Detected in many" 12 "B-cells: 16.1" HPA058997 Approved Approved Mitochondria Mitochondria "HPA058997: " "unprognostic (4.76e-2)" "prognostic favourable (6.87e-4)" "unprognostic (1.20e-1)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" "unprognostic (9.69e-2)" "unprognostic (3.91e-3)" "prognostic unfavourable (5.27e-5)" "unprognostic (1.56e-1)" "unprognostic (2.29e-1)" "unprognostic (1.38e-2)" "unprognostic (2.51e-1)" "unprognostic (2.43e-1)" "unprognostic (1.57e-2)" 0.4 0.0 0.4 1.5 0.4 0.0 4.7 0.4 0.4 0.6 20.6 0.5 0.4 33.4 0.6 1.1 0.5 2.1 0.4 1.0 0.4 0.2 5.5 1.9 3.3 1.1 0.4 0.4 0.4 0.4 0.0 0.4 1.4 0.4 0.4 6.5 0.4 0.7 0.4 0.4 0.2 42.5 0.4 0.4 0.7 8.8 0.4 0.4 0.4 0.4 0.4 0.5 0.4 0.4 16.1 0.8 0.1 0.1 1.2 0.9 3.6 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 6.3 0.0 0.3 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 53.2 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.9 16.1 0.2 0.9 0.0 5.3 0.2 0.6 0.1 1.2 0.0 0.8 0.0 3.6 0.4 0.4 0.4 0.4 0.4 0.2 0.4 0.4 0.4 0.4 HRNR "FLG3, S100A16, S100a18" ENSG00000197915 Hornerin Q86YZ3 1 152212082-152224193 "Plasma proteins, Predicted intracellular proteins" Keratinization "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 4.0" "Cell line enhanced" "Detected in some" "A549: 1.5;HaCaT: 1.5;HDLM-2: 1.3;NTERA-2: 6.1;U-2 OS: 1.5;U-2197: 1.4" "Cancer enhanced" "Detected in single" "melanoma: 1.0" "Cell type enriched" "Detected in single" 16 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.5" HPA031469 Uncertain Approved Mitochondria 210000000 Mitochondria "HPA031469: AB_10603771" "unprognostic (1.34e-1)" "unprognostic (4.51e-2)" "unprognostic (3.01e-2)" "unprognostic (8.72e-4)" "unprognostic (1.61e-2)" "unprognostic (1.45e-1)" "unprognostic (2.11e-1)" "unprognostic (1.79e-1)" "unprognostic (6.09e-2)" "unprognostic (3.38e-2)" "unprognostic (1.87e-2)" "unprognostic (1.59e-2)" "unprognostic (1.65e-2)" "unprognostic (2.49e-2)" "unprognostic (1.71e-1)" "unprognostic (2.07e-1)" "unprognostic (3.64e-2)" 0.3 0.4 0.0 0.1 0.2 0.1 0.3 0.0 1.3 0.7 0.1 0.1 0.5 0.0 1.8 0.8 0.6 0.5 0.1 0.1 1.0 0.0 0.1 0.4 0.0 1.6 1.5 0.0 0.4 0.1 0.6 0.0 0.2 0.0 0.1 4.0 0.2 0.0 0.1 0.1 0.1 1.3 1.6 0.0 0.4 0.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.2 0.0 0.1 0.0 1.5 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.6 1.2 0.1 1.5 1.4 0.3 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 HS2ST1 KIAA0448 ENSG00000153936 "Heparan sulfate 2-O-sulfotransferase 1" Q7LGA3 1 86914648-87109998 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA043069, HPA043603, HPA075001" Supported Approved Mitochondria "Intracellular and membrane" Mitochondria "HPA043069: AB_10964127, HPA043603: AB_10963432, HPA075001: " "unprognostic (1.04e-1)" "unprognostic (1.50e-1)" "unprognostic (1.28e-3)" "unprognostic (8.06e-2)" "unprognostic (1.87e-1)" "unprognostic (7.13e-2)" "prognostic unfavourable (6.88e-4)" "unprognostic (7.20e-2)" "unprognostic (5.34e-2)" "unprognostic (7.70e-2)" "unprognostic (1.70e-3)" "unprognostic (1.45e-1)" "unprognostic (5.80e-2)" "unprognostic (1.63e-2)" "unprognostic (5.07e-2)" "unprognostic (3.24e-1)" "unprognostic (7.58e-2)" 8.8 28.7 15.5 9.6 25.2 2.8 7.3 8.9 15.1 10.3 9.5 6.2 5.4 8.6 9.0 9.4 6.4 6.5 9.6 6.8 14.7 10.2 12.8 15.5 8.0 9.7 9.2 13.8 12.3 9.0 15.9 12.1 7.5 10.1 8.9 8.3 8.2 8.3 9.7 5.3 7.2 8.0 7.1 7.6 18.6 7.2 8.0 7.7 16.5 11.8 4.3 10.0 9.2 7.1 5.6 1.3 9.0 4.3 1.8 3.0 1.8 9.7 8.4 24.5 15.9 13.6 39.8 8.5 9.5 12.5 8.0 8.9 31.7 12.6 21.4 9.3 6.6 5.9 11.2 7.9 13.0 16.8 9.3 25.8 9.2 25.3 5.7 13.3 13.0 16.3 7.1 12.9 10.8 11.8 17.5 11.4 11.6 3.4 13.2 8.0 8.5 5.5 16.4 23.2 4.6 9.8 20.5 5.3 7.9 12.7 10.8 11.0 7.1 6.1 10.4 10.1 12.6 17.6 11.9 10.5 7.7 20.2 6.2 9.6 10.3 9.0 2.0 1.7 2.6 1.2 3.0 2.0 2.8 2.8 1.3 5.6 2.8 1.8 2.1 1.8 4.3 1.3 1.5 1.8 15.5 25.2 8.9 15.1 14.7 10.2 9.2 13.8 10.1 7.7 HSDL2 "C9orf99, SDR13C1" ENSG00000119471 "Hydroxysteroid dehydrogenase like 2" Q6YN16 9 112379937-112472410 "Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 70.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 5 "granulocytes: 23.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042890, HPA050453" Enhanced Enhanced Mitochondria Mitochondria "HPA042890: AB_2678216, HPA050453: AB_2681131" "unprognostic (3.17e-3)" "unprognostic (1.62e-2)" "unprognostic (1.90e-3)" "prognostic favourable (9.23e-6)" "unprognostic (3.94e-2)" "unprognostic (1.43e-2)" "unprognostic (1.17e-1)" "unprognostic (5.15e-2)" "unprognostic (7.58e-2)" "unprognostic (6.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.82e-1)" "prognostic favourable (9.29e-7)" "unprognostic (1.44e-1)" "unprognostic (2.33e-1)" "unprognostic (1.35e-2)" "unprognostic (7.35e-2)" 31.0 26.3 18.3 5.8 17.7 4.1 13.8 5.7 12.1 10.1 14.1 11.9 6.2 15.2 11.0 5.0 14.4 8.8 7.6 52.1 16.1 13.7 29.3 70.5 11.4 7.8 17.9 10.8 21.3 11.4 7.9 7.7 9.9 12.4 12.2 11.0 10.2 7.3 6.9 54.1 12.5 18.3 13.3 12.9 10.1 9.9 5.9 14.5 5.7 13.2 27.7 6.9 14.2 10.7 3.6 4.6 23.3 5.0 2.6 4.1 2.4 15.2 13.7 10.3 5.2 17.9 17.8 11.9 10.5 6.5 7.5 6.3 26.3 17.2 9.8 5.8 15.3 17.6 11.1 14.7 9.3 41.2 7.3 10.2 22.2 25.7 11.2 5.7 6.6 18.9 10.7 11.2 8.1 8.7 14.1 6.6 20.4 10.1 14.2 5.3 6.0 17.8 9.2 31.2 14.4 15.9 13.9 7.4 5.3 26.3 17.5 8.8 24.7 7.0 9.8 10.8 10.1 30.2 10.2 7.8 19.2 4.6 13.4 8.5 6.3 21.9 4.0 15.2 2.3 3.9 3.5 3.3 2.5 2.6 4.5 3.6 3.0 3.1 23.3 2.6 5.0 4.6 4.1 2.4 18.3 17.7 5.7 12.1 16.1 13.7 17.9 10.8 12.4 14.5 HSPA9 "GRP75, HSPA9B, mot-2, mthsp75, PBP74" ENSG00000113013 "Heat shock protein family A (Hsp70) member 9" P38646 5 138554882-138575444 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Chaperone "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000898, CAB005219" Supported Supported Mitochondria 3100000 Mitochondria "CAB005219: AB_647720, HPA000898: AB_1079032" "prognostic unfavourable (2.93e-4)" "unprognostic (1.86e-1)" "prognostic favourable (4.53e-4)" "unprognostic (3.73e-2)" "unprognostic (2.33e-1)" "unprognostic (9.06e-2)" "unprognostic (2.05e-2)" "unprognostic (1.10e-1)" "unprognostic (9.85e-2)" "unprognostic (2.53e-1)" "unprognostic (2.74e-1)" "unprognostic (1.31e-1)" "unprognostic (8.78e-3)" "unprognostic (1.02e-1)" "unprognostic (2.15e-1)" "unprognostic (3.27e-2)" "unprognostic (2.29e-1)" 26.4 76.4 30.9 22.1 33.2 39.8 27.7 24.3 39.5 20.0 28.7 30.4 24.0 27.8 23.1 29.7 28.5 19.1 19.3 55.0 28.2 32.5 59.9 117.7 20.5 22.8 35.5 31.3 28.9 31.9 56.7 25.5 24.6 43.7 25.3 32.7 20.6 26.0 26.4 84.2 24.0 25.7 24.0 29.3 24.6 27.7 18.6 32.0 21.1 41.0 32.8 29.1 23.7 33.1 19.3 24.1 6.6 20.9 20.5 28.3 23.3 32.7 41.5 23.7 45.4 24.9 16.3 48.8 34.8 30.9 39.1 42.6 79.1 35.0 62.8 47.8 25.8 27.8 63.1 46.6 54.3 31.5 30.9 34.6 37.3 52.7 67.3 34.8 38.5 27.7 70.8 43.1 97.4 18.5 43.2 54.1 30.8 40.2 36.5 30.0 34.7 34.5 41.0 34.3 48.6 43.9 47.3 28.5 21.7 40.3 64.2 131.7 36.9 40.9 17.7 38.4 24.3 32.0 55.1 66.8 47.8 63.2 47.3 61.5 38.2 6.6 16.9 6.5 24.0 20.9 28.3 19.3 20.6 23.0 24.1 14.1 23.0 22.8 3.9 20.5 20.6 14.1 18.2 23.3 30.9 33.2 24.3 39.5 28.2 32.5 35.5 31.3 43.7 32.0 HSPBAP1 "FLJ22623, PASS1" ENSG00000169087 "HSPB1 associated protein 1" Q96EW2 3 122740003-122793824 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044930 Approved Approved Mitochondria Mitochondria "HPA044930: AB_10961122" "unprognostic (3.40e-3)" "unprognostic (1.22e-2)" "unprognostic (2.98e-2)" "unprognostic (6.70e-3)" "unprognostic (3.40e-3)" "unprognostic (3.40e-2)" "unprognostic (8.61e-4)" "unprognostic (2.68e-2)" "unprognostic (6.95e-2)" "unprognostic (3.35e-2)" "unprognostic (2.36e-1)" "unprognostic (8.91e-2)" "unprognostic (1.24e-3)" "unprognostic (4.29e-1)" "unprognostic (1.33e-1)" "unprognostic (3.34e-1)" "unprognostic (4.12e-3)" 7.2 9.3 6.7 9.2 6.9 4.5 13.1 3.1 6.7 6.8 6.0 7.0 9.1 4.1 7.9 5.3 5.2 5.3 6.0 6.1 6.0 5.3 7.1 5.8 10.4 9.1 7.8 4.5 5.8 6.3 5.3 9.0 17.0 8.7 5.8 5.9 10.2 6.0 6.4 25.4 7.0 5.9 8.1 10.8 11.4 5.4 16.5 8.3 9.1 10.6 8.9 8.8 7.9 5.6 8.3 9.2 22.0 15.5 4.5 7.2 5.8 4.5 3.5 5.1 4.5 6.1 4.6 10.0 2.3 5.8 5.4 7.6 4.8 3.6 5.9 3.7 1.6 5.6 7.8 4.3 6.3 3.6 2.1 3.8 4.1 2.7 13.9 3.5 5.4 6.8 15.8 4.5 14.4 5.0 2.5 5.0 4.8 2.9 5.0 4.4 5.8 7.1 5.2 6.8 5.6 5.5 1.7 5.6 5.8 5.3 2.1 19.2 2.5 7.4 5.0 6.3 3.7 2.0 3.1 5.0 5.0 6.9 3.9 5.2 6.1 13.3 12.1 8.3 4.7 8.6 5.8 8.3 6.1 4.6 9.2 5.6 6.8 6.5 22.0 4.5 15.5 3.1 7.2 5.8 6.7 6.9 3.1 6.7 6.0 5.3 7.8 4.5 8.7 8.3 HSPD1 "GroEL, HSP60, SPG13" ENSG00000144381 "Heat shock protein family D (Hsp60) member 1" P10809 2 197486581-197516737 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction" "Chaperone, Isomerase" "Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 162.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA001523, CAB002775, HPA050025, CAB072816" Supported Enhanced Mitochondria 53000000 Mitochondria "CAB002775: , CAB072816: , HPA001523: AB_1079028, HPA050025: AB_2680995" "unprognostic (2.79e-2)" "unprognostic (1.72e-2)" "unprognostic (5.21e-2)" "prognostic unfavourable (1.61e-4)" "unprognostic (2.59e-1)" "unprognostic (3.57e-3)" "prognostic unfavourable (2.25e-4)" "unprognostic (3.51e-2)" "unprognostic (9.91e-2)" "unprognostic (8.63e-3)" "unprognostic (3.47e-2)" "unprognostic (7.83e-3)" "unprognostic (5.64e-3)" "unprognostic (1.73e-2)" "unprognostic (1.52e-1)" "unprognostic (2.61e-2)" "unprognostic (4.10e-2)" 28.5 125.2 28.7 23.4 31.8 21.0 55.9 18.2 24.3 17.4 30.3 17.8 23.3 28.9 17.5 18.5 27.2 25.3 16.3 24.0 24.2 27.8 67.1 147.5 22.4 25.3 35.5 16.1 30.2 50.6 32.5 25.9 27.1 33.6 25.9 37.2 11.9 17.6 21.0 36.4 13.7 32.0 23.6 32.4 22.7 25.2 10.9 35.8 22.7 38.7 29.4 30.3 33.3 162.6 25.6 30.3 6.2 29.3 23.1 33.5 22.2 40.4 49.8 41.8 37.5 28.7 30.0 60.8 42.2 22.3 50.8 37.3 167.0 24.4 123.1 55.1 22.0 41.4 163.6 46.5 72.1 30.2 65.6 87.4 80.6 193.3 27.0 96.8 27.5 33.9 54.0 45.0 79.4 39.8 107.6 48.3 37.3 51.8 60.1 98.0 82.6 104.2 72.3 51.6 88.9 53.4 42.3 54.8 31.0 42.3 45.8 54.1 31.7 57.5 17.7 31.6 43.8 40.6 66.6 27.1 59.6 102.2 37.1 58.5 33.9 4.5 19.7 5.3 15.5 29.3 28.8 25.6 25.0 21.8 30.3 21.0 33.5 29.0 6.2 23.1 25.8 20.2 19.7 22.2 28.7 31.8 18.2 24.3 24.2 27.8 35.5 16.1 33.6 35.8 HTRA2 "OMI, PARK13, PRSS25" ENSG00000115317 "HtrA serine peptidase 2" O43464 2 74529377-74533348 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" Apoptosis "Hydrolase, Protease, Serine protease" "Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004004, HPA006602, HPA027366" Uncertain Supported Mitochondria Mitochondria "CAB004004: AB_326421, HPA006602: , HPA027366: AB_1851301" "unprognostic (3.09e-1)" "unprognostic (4.06e-2)" "unprognostic (2.82e-1)" "unprognostic (2.58e-2)" "unprognostic (1.56e-1)" "unprognostic (1.37e-1)" "prognostic unfavourable (7.77e-8)" "unprognostic (2.12e-3)" "unprognostic (4.18e-1)" "unprognostic (1.15e-1)" "unprognostic (4.57e-2)" "unprognostic (8.15e-2)" "unprognostic (7.23e-3)" "unprognostic (4.03e-1)" "unprognostic (1.73e-1)" "unprognostic (1.72e-1)" "unprognostic (2.06e-2)" 16.4 12.7 10.6 14.9 11.3 18.9 12.9 10.7 17.7 12.3 12.8 12.6 9.7 12.6 12.9 6.9 10.7 10.6 9.0 12.9 11.6 8.7 13.1 11.4 11.3 13.2 10.8 11.9 18.7 12.9 10.5 9.0 10.4 13.5 11.6 5.5 10.2 13.1 9.2 17.6 9.0 12.6 11.8 9.1 17.3 11.8 13.9 12.6 12.2 16.8 12.6 9.3 10.4 15.2 12.9 9.4 5.9 8.1 5.5 7.8 7.0 7.9 4.9 5.7 4.9 7.9 3.2 15.2 6.9 3.6 4.2 2.4 9.1 3.5 7.2 5.4 3.9 9.0 6.7 7.9 1.1 16.2 13.4 14.4 4.7 8.0 7.4 6.7 10.6 3.8 5.3 7.9 6.7 5.2 18.9 10.7 3.1 5.2 12.4 14.2 4.7 14.2 8.5 16.1 7.9 3.4 3.2 6.6 7.9 3.7 8.5 13.2 3.9 6.6 3.7 7.3 9.0 14.7 15.4 13.1 4.3 4.7 6.3 10.7 5.8 5.9 8.1 4.8 7.3 6.2 7.8 12.9 7.3 6.2 9.4 11.6 6.3 6.4 3.2 5.5 4.7 6.6 7.4 7.0 10.6 11.3 10.7 17.7 11.6 8.7 10.8 11.9 13.5 12.6 IARS2 FLJ10326 ENSG00000067704 "Isoleucyl-tRNA synthetase 2, mitochondrial" Q9NSE4 1 220094102-220148041 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Cataract, Deafness, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024212, HPA024594, HPA024596" Enhanced Enhanced Mitochondria 26000 Mitochondria "HPA024212: AB_1851363, HPA024594: AB_1851368, HPA024596: AB_1851370" "unprognostic (2.15e-2)" "prognostic unfavourable (1.04e-4)" "unprognostic (2.42e-3)" "unprognostic (3.22e-2)" "unprognostic (2.04e-1)" "unprognostic (1.55e-1)" "unprognostic (1.91e-1)" "unprognostic (7.81e-2)" "unprognostic (1.78e-1)" "unprognostic (1.91e-1)" "prognostic unfavourable (9.24e-5)" "unprognostic (9.48e-2)" "unprognostic (2.10e-2)" "unprognostic (3.01e-1)" "unprognostic (2.16e-1)" "unprognostic (8.87e-2)" "unprognostic (6.27e-3)" 25.9 39.3 18.0 17.9 16.9 6.7 31.9 15.1 20.8 16.9 26.2 14.8 24.3 18.9 21.5 16.8 23.8 18.8 16.5 40.0 17.5 12.6 29.5 37.3 16.8 25.9 15.6 16.0 20.5 20.5 42.5 15.3 26.2 17.4 18.5 24.9 15.0 22.4 22.3 57.8 22.2 23.4 17.7 15.7 16.1 18.5 15.7 13.7 19.5 17.8 25.9 20.1 24.9 18.7 16.8 20.0 17.2 19.0 18.5 22.6 16.8 37.7 35.4 20.4 20.0 30.8 31.1 49.1 23.0 24.8 25.5 20.7 34.0 39.5 34.9 31.2 28.5 36.7 28.2 28.7 29.5 24.1 34.0 17.3 29.0 38.2 19.1 27.5 18.8 22.4 29.3 27.5 28.5 24.7 42.7 20.3 33.3 20.9 21.6 19.8 26.4 23.5 19.2 40.6 55.8 36.7 25.4 11.0 30.9 34.8 54.1 35.8 62.6 31.1 25.3 25.1 21.0 33.7 38.5 17.4 26.7 25.4 26.6 21.6 27.8 17.2 16.7 15.1 16.8 19.0 22.6 16.8 18.4 22.0 20.0 13.6 20.8 19.0 3.3 18.5 14.5 7.3 19.7 16.8 18.0 16.9 15.1 20.8 17.5 12.6 15.6 16.0 17.4 13.7 IBA57 "C1orf69, FLJ12734" ENSG00000181873 "IBA57, iron-sulfur cluster assembly" Q5T440 1 228165815-228182257 "Disease related genes, Predicted intracellular proteins" "Heme biosynthesis" Transferase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030555, HPA030556, HPA030557" Approved Supported Mitochondria Mitochondria "HPA030555: AB_2673522, HPA030556: , HPA030557: AB_10670433" "unprognostic (3.00e-2)" "unprognostic (1.71e-1)" "unprognostic (1.36e-1)" "unprognostic (1.29e-2)" "unprognostic (1.34e-1)" "unprognostic (8.16e-3)" "unprognostic (1.03e-1)" "unprognostic (6.11e-2)" "unprognostic (7.01e-2)" "unprognostic (8.00e-3)" "unprognostic (2.87e-2)" "unprognostic (1.61e-1)" "prognostic favourable (1.71e-9)" "unprognostic (4.94e-2)" "unprognostic (5.02e-1)" "unprognostic (5.04e-3)" "unprognostic (7.14e-2)" 5.2 7.5 4.7 5.3 5.5 8.2 6.1 7.8 5.1 4.7 4.5 4.1 3.8 4.5 5.3 4.2 4.7 3.8 6.8 7.9 4.9 3.2 5.8 9.5 6.3 12.7 3.5 4.5 5.9 18.3 7.4 2.9 6.4 5.2 4.5 3.9 4.9 5.3 3.1 22.9 8.0 5.7 4.9 3.5 4.9 5.3 3.1 3.2 5.0 5.2 6.4 4.7 3.6 3.7 2.8 3.4 4.7 1.7 2.8 3.5 0.9 3.3 3.4 3.8 1.7 2.0 2.3 4.6 2.0 1.0 1.6 0.9 7.3 2.9 7.2 4.5 2.1 6.2 2.9 4.4 1.4 1.5 6.3 4.2 4.3 3.5 1.7 4.8 4.8 3.1 2.7 1.8 2.2 2.2 7.1 3.4 1.5 2.6 4.8 2.9 2.8 4.0 6.0 4.3 1.2 2.3 6.9 5.8 4.0 3.4 10.4 2.6 8.3 6.6 5.1 4.3 4.0 2.9 5.1 2.5 1.2 3.6 1.9 2.0 3.2 4.7 1.7 0.8 2.3 1.4 3.5 1.5 1.9 1.8 1.2 2.8 2.8 2.6 2.7 2.8 1.5 3.4 1.7 0.9 4.7 5.5 7.8 4.6 4.9 3.2 3.5 4.5 5.2 3.2 ICA1L "ALS2CR14, ALS2CR15" ENSG00000163596 "Islet cell autoantigen 1 like" Q8NDH6 2 202773150-202871985 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 20.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042507 Approved Supported Mitochondria Mitochondria "HPA042507: AB_10797016" "unprognostic (4.14e-3)" "unprognostic (3.60e-3)" "unprognostic (5.15e-2)" "unprognostic (5.63e-3)" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (1.38e-1)" "unprognostic (8.05e-4)" "unprognostic (1.66e-1)" "unprognostic (9.60e-2)" "unprognostic (4.50e-4)" "unprognostic (4.15e-1)" "unprognostic (8.15e-3)" "unprognostic (2.97e-2)" "unprognostic (1.74e-1)" "unprognostic (9.79e-2)" "unprognostic (1.58e-3)" 3.3 7.3 11.6 2.2 15.6 5.4 3.8 24.8 19.8 5.8 5.2 8.5 4.1 2.3 10.1 8.9 4.2 12.6 5.5 6.5 11.1 12.1 3.3 1.2 3.2 2.2 7.3 14.0 9.4 3.2 15.2 22.6 7.6 9.1 8.8 2.7 5.8 1.9 9.5 8.1 3.0 2.0 7.6 7.2 2.2 3.6 11.9 7.8 1.0 7.8 1.8 2.1 4.5 3.2 5.3 4.6 4.2 5.3 6.7 4.2 1.6 1.5 1.1 2.8 8.3 2.8 5.0 20.5 2.7 3.6 1.9 2.4 1.6 0.6 1.6 0.8 3.2 0.8 4.0 1.3 2.5 1.9 3.1 3.2 1.6 1.8 1.6 4.0 2.1 2.0 2.4 1.9 1.5 2.3 2.8 1.5 2.3 0.7 3.4 5.4 7.8 2.8 4.1 4.0 0.7 1.6 3.7 7.9 7.9 4.1 0.2 1.7 1.0 3.1 1.6 7.3 1.7 1.5 4.0 5.7 7.9 4.7 4.0 1.2 1.4 2.2 2.6 1.5 2.6 2.7 2.2 4.0 1.9 2.1 4.6 5.3 3.1 4.2 4.2 6.7 5.3 2.8 1.8 1.6 11.6 15.6 24.8 16.9 11.1 12.1 7.3 14.0 9.1 7.8 IDH2 ENSG00000182054 "Isocitrate dehydrogenase (NADP(+)) 2, mitochondrial" P48735 15 90083045-90102504 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Glyoxylate bypass, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 126.2;skeletal muscle: 190.7" "Cell line enhanced" "Detected in all" "MOLT-4: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007831 Enhanced Supported Mitochondria 53000000 Mitochondria "HPA007831: AB_1851397" "unprognostic (2.45e-2)" "prognostic favourable (5.15e-5)" "unprognostic (2.92e-1)" "unprognostic (1.53e-1)" "unprognostic (3.53e-1)" "unprognostic (8.46e-2)" "unprognostic (3.83e-2)" "unprognostic (2.55e-3)" "unprognostic (1.86e-2)" "unprognostic (1.89e-2)" "unprognostic (2.76e-1)" "unprognostic (4.90e-2)" "unprognostic (2.19e-3)" "unprognostic (3.92e-3)" "unprognostic (4.46e-1)" "unprognostic (1.30e-2)" "unprognostic (2.58e-2)" 5.4 2.0 14.9 10.1 16.6 22.6 8.8 4.9 19.1 6.4 16.2 13.8 12.4 16.1 5.9 15.3 23.7 6.0 9.4 126.2 10.2 9.3 25.0 93.2 6.9 15.8 14.4 12.0 3.0 25.1 8.4 3.3 15.1 11.9 13.3 14.5 6.0 28.0 21.9 190.7 11.0 13.9 15.8 11.0 7.5 27.9 1.2 7.6 28.2 3.4 69.0 13.6 11.0 8.6 16.8 32.8 17.2 56.3 22.2 29.5 31.2 10.2 5.8 30.2 30.0 4.2 5.2 25.7 12.8 19.5 12.1 13.0 2.7 8.9 12.2 3.6 10.6 3.5 4.4 3.9 5.8 23.9 2.9 20.8 2.2 20.3 5.1 14.2 21.1 10.8 2.2 2.9 2.3 24.8 3.1 10.5 9.3 29.8 68.3 22.1 9.0 2.4 57.9 21.7 36.3 18.7 12.3 43.6 22.1 15.9 63.6 5.1 51.3 43.9 5.9 21.7 3.1 2.8 5.9 17.3 3.2 1.4 6.9 30.0 12.5 9.0 26.4 17.2 26.1 48.0 12.4 16.8 18.7 29.5 32.8 9.8 10.2 18.2 5.1 22.2 56.3 17.8 15.9 31.2 14.9 16.6 4.9 19.1 10.2 9.3 14.4 12.0 11.9 7.6 IDH3A ENSG00000166411 "Isocitrate dehydrogenase 3 (NAD(+)) alpha" P50213 15 78131498-78171949 "Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 47.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041465, HPA062971" Supported Enhanced Mitochondria 2000000 Mitochondria "HPA041465: AB_10794377, HPA062971: AB_2684913" "unprognostic (2.33e-1)" "unprognostic (1.21e-1)" "unprognostic (5.76e-3)" "unprognostic (2.26e-1)" "unprognostic (1.02e-1)" "unprognostic (4.01e-1)" "unprognostic (2.29e-1)" "unprognostic (6.47e-2)" "unprognostic (1.69e-2)" "unprognostic (2.30e-1)" "unprognostic (3.05e-1)" "unprognostic (1.42e-1)" "prognostic favourable (6.49e-8)" "unprognostic (1.40e-1)" "unprognostic (3.08e-2)" "unprognostic (4.49e-2)" "unprognostic (3.39e-2)" 14.6 18.1 18.0 13.0 25.3 6.5 7.7 16.1 29.5 9.9 17.6 11.9 6.1 24.5 11.2 5.9 12.0 8.4 6.5 41.5 16.6 16.8 15.2 10.4 8.8 11.0 20.6 18.1 8.0 9.2 18.5 12.4 8.4 29.0 10.1 18.8 10.4 11.2 11.9 47.7 11.1 23.8 11.9 18.1 10.1 8.9 11.5 13.8 16.2 8.1 26.5 16.4 11.1 10.3 10.1 47.2 6.1 17.0 5.5 6.0 7.4 15.9 21.9 4.0 13.9 10.0 10.2 8.7 19.0 9.3 15.5 11.8 15.5 9.7 34.0 14.1 11.1 24.1 36.9 14.7 14.4 14.9 12.2 13.1 23.7 7.0 8.5 25.4 18.8 7.7 9.1 15.1 15.9 9.7 16.8 14.0 9.8 15.2 18.6 6.8 4.9 8.2 10.8 17.0 10.6 12.9 21.7 15.9 6.1 21.8 31.2 17.6 12.4 13.8 10.0 18.3 17.0 24.1 30.6 16.0 35.6 18.1 12.9 24.3 14.3 4.2 9.4 2.7 5.3 17.0 5.7 9.2 5.2 4.8 14.2 10.1 5.6 6.0 6.1 5.5 16.6 47.2 5.6 7.4 18.0 25.3 16.1 29.5 16.6 16.8 20.6 18.1 29.0 13.8 IDH3B RP46 ENSG00000101365 "Isocitrate dehydrogenase 3 (NAD(+)) beta" O43837 20 2658395-2664219 "Citric acid cycle related proteins, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049387, HPA054180" Supported Enhanced Mitochondria Mitochondria "HPA049387: AB_2680740, HPA054180: AB_2682407" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (2.12e-1)" "unprognostic (2.43e-2)" "unprognostic (3.24e-2)" "unprognostic (6.83e-2)" "prognostic unfavourable (1.59e-4)" "unprognostic (2.76e-2)" "unprognostic (2.99e-1)" "unprognostic (5.69e-2)" "unprognostic (4.75e-3)" "unprognostic (1.39e-2)" "prognostic favourable (6.78e-8)" "unprognostic (8.89e-2)" "unprognostic (4.02e-2)" "unprognostic (2.79e-1)" "unprognostic (1.16e-1)" 19.5 20.0 19.4 15.5 31.7 20.6 18.5 32.1 30.5 16.4 23.9 16.9 14.5 30.5 19.2 16.7 20.7 17.9 19.2 57.3 19.8 20.0 29.7 25.2 15.1 17.6 24.0 29.4 20.2 15.2 27.6 12.2 17.0 31.2 15.4 25.6 16.2 19.3 19.5 75.5 20.9 24.9 21.5 17.1 19.2 19.9 19.6 16.0 19.7 19.1 37.7 22.5 16.7 17.4 34.7 49.4 25.8 44.7 29.5 38.6 33.9 26.1 35.5 16.2 14.1 18.0 14.2 18.8 14.1 18.0 33.3 26.6 45.7 27.6 29.6 12.9 19.3 37.0 29.9 45.7 30.6 8.1 23.5 35.9 13.8 47.3 17.6 39.0 7.8 18.8 17.6 31.1 16.4 19.6 45.3 16.6 20.2 14.4 33.9 44.8 31.5 33.7 27.8 29.6 33.2 19.1 24.6 29.3 21.2 17.3 57.7 29.7 28.9 17.4 17.4 26.0 16.4 8.8 32.3 22.6 51.6 31.2 12.2 40.4 24.6 22.2 41.7 25.8 33.9 44.7 25.6 34.7 29.4 30.7 49.4 30.6 34.4 29.8 11.9 29.5 38.3 22.9 38.6 33.9 19.4 31.7 32.1 30.5 19.8 20.0 24.0 29.4 31.2 16.0 IFI6 "6-16, FAM14C, G1P3, IFI-6-16, IFI616" ENSG00000126709 "Interferon alpha inducible protein 6" P09912 1 27666061-27672218 "Predicted membrane proteins" "Antiviral defense, Apoptosis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 225.6" "Group enriched" "Detected in many" 5 "BJ hTERT+ SV40 Large T+: 131.9;BJ hTERT+ SV40 Large T+ RasG12V: 154.2;EFO-21: 53.0;SK-MEL-30: 93.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005543 Approved Approved Mitochondria Mitochondria "HPA005543: AB_1849342" "unprognostic (4.31e-1)" "unprognostic (1.03e-1)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (2.70e-1)" "unprognostic (6.96e-2)" "unprognostic (9.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.06e-1)" "unprognostic (6.77e-3)" "unprognostic (5.04e-2)" "unprognostic (1.64e-2)" "unprognostic (1.92e-3)" "unprognostic (1.81e-1)" "unprognostic (8.40e-2)" "unprognostic (3.42e-2)" "unprognostic (1.72e-2)" 32.3 27.5 24.9 13.5 28.2 37.3 10.9 14.2 36.1 11.4 13.8 22.9 6.5 16.5 26.8 68.0 8.6 11.9 113.9 19.3 23.0 42.3 44.8 23.5 31.6 5.8 20.0 17.0 14.1 21.3 5.9 60.1 225.6 34.3 13.9 10.1 31.6 111.4 10.1 7.4 5.4 12.5 17.0 26.0 27.3 35.4 15.4 6.8 24.8 35.2 7.9 9.7 7.8 7.6 9.7 19.4 84.9 58.6 15.8 27.5 16.8 1.4 0.4 2.2 1.3 7.1 3.9 8.8 4.6 21.3 131.9 154.2 0.7 5.6 0.5 53.0 2.1 0.5 0.5 1.0 4.3 10.8 1.7 3.4 1.1 0.4 1.9 1.1 4.4 4.2 0.1 7.9 0.1 1.2 0.2 9.3 1.4 0.4 4.0 14.2 0.4 4.5 2.7 1.2 1.3 1.1 0.0 3.1 2.8 5.7 1.3 93.6 0.6 4.4 2.0 1.2 1.9 0.9 0.8 11.1 6.3 0.3 2.4 9.9 3.4 29.3 44.4 39.4 22.7 58.6 22.4 9.7 23.0 20.7 19.4 8.0 24.3 23.6 84.9 15.8 38.8 2.0 27.5 16.8 24.9 28.2 14.2 36.1 23.0 42.3 20.0 17.0 34.3 6.8 IL18R1 "CD218a, IL-1Rrp, IL1RRP" ENSG00000115604 "Interleukin 18 receptor 1" Q13478 2 102311529-102398775 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 39.3" "Cell line enhanced" "Detected in some" "HDLM-2: 13.5;HHSteC: 29.2;HMC-1: 19.6;U-937: 31.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 26.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA007615 Approved Approved Mitochondria "Intracellular and membrane" Mitochondria "HPA007615: AB_1851675" "unprognostic (3.60e-3)" "unprognostic (9.75e-3)" "unprognostic (1.12e-3)" "unprognostic (3.01e-2)" "unprognostic (2.34e-3)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.74e-2)" "unprognostic (3.59e-1)" "unprognostic (7.86e-2)" "unprognostic (3.40e-2)" "unprognostic (1.70e-1)" "prognostic unfavourable (4.52e-4)" "unprognostic (2.62e-1)" "unprognostic (1.62e-2)" "unprognostic (5.71e-2)" "unprognostic (2.48e-2)" 17.8 2.6 1.4 8.3 1.7 12.5 11.2 0.8 1.3 8.2 8.1 0.7 6.6 5.1 4.2 5.7 4.5 4.5 14.1 10.5 1.7 1.9 7.4 8.8 39.3 29.6 2.0 0.1 3.3 2.6 0.8 4.6 10.7 1.6 6.3 3.4 5.0 3.0 28.4 2.8 3.2 10.7 7.9 1.9 19.5 4.6 2.4 0.4 2.5 3.2 3.2 6.6 8.2 12.9 0.1 6.8 5.5 0.1 26.8 10.6 1.1 0.8 0.2 0.0 0.0 0.7 0.7 1.6 0.0 0.5 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.5 0.0 1.8 0.0 13.5 0.7 2.4 0.6 0.1 29.2 5.1 19.6 6.7 1.1 2.1 3.5 4.9 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.5 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.4 0.6 0.4 2.3 0.4 0.0 0.0 0.0 0.1 31.3 2.3 5.5 0.0 2.4 4.2 0.1 10.6 0.1 2.4 3.0 2.0 0.1 0.4 0.8 4.1 26.8 0.0 6.8 2.4 1.1 1.4 1.7 0.8 1.3 1.7 1.9 2.0 0.1 1.6 0.4 IMMP2L "IMMP2L-IT1, IMP2" ENSG00000184903 "Inner mitochondrial membrane peptidase subunit 2" Q96T52 7 110663051-111562517 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026711 Approved Approved Mitochondria Mitochondria "HPA026711: AB_1851760" "unprognostic (2.55e-2)" "unprognostic (1.40e-2)" "unprognostic (4.29e-1)" "unprognostic (1.04e-1)" "unprognostic (3.76e-2)" "prognostic unfavourable (1.89e-5)" "unprognostic (5.64e-3)" "unprognostic (1.00e-1)" "unprognostic (4.17e-1)" "unprognostic (5.68e-3)" "unprognostic (1.12e-1)" "unprognostic (1.09e-1)" "unprognostic (2.89e-3)" "unprognostic (1.32e-1)" "unprognostic (6.65e-2)" "unprognostic (1.79e-1)" "unprognostic (2.71e-1)" 12.4 12.4 7.9 7.3 10.8 2.9 11.8 5.4 9.1 12.4 11.1 5.7 10.6 5.2 23.8 10.4 8.0 11.5 5.8 8.6 7.1 6.0 23.8 17.7 7.4 4.4 5.7 6.1 14.4 10.0 13.4 15.7 8.0 6.3 13.8 5.8 31.6 11.6 15.8 18.6 7.5 10.9 14.4 5.6 5.3 9.8 9.0 5.6 8.2 16.7 8.3 9.5 11.0 9.2 18.1 11.7 5.8 8.4 24.3 15.1 5.1 7.8 4.7 2.8 11.7 7.6 7.7 5.0 5.4 5.5 3.6 3.8 2.3 9.2 12.9 14.9 4.7 4.4 3.0 10.9 6.0 8.0 3.1 4.4 18.7 6.4 11.6 8.1 0.5 13.4 14.5 1.5 10.1 4.7 14.1 10.0 2.7 5.4 10.8 9.1 2.8 7.4 2.3 23.5 6.7 13.2 3.3 3.3 10.4 2.3 11.1 30.0 4.5 4.7 3.0 5.6 5.8 5.6 6.5 5.7 1.5 7.9 6.1 3.8 29.3 5.8 5.1 1.6 6.4 6.4 11.4 16.3 10.8 7.2 9.4 18.1 15.1 10.5 0.2 24.3 8.4 11.7 6.4 5.1 7.9 10.8 5.4 9.1 7.1 6.0 5.7 6.1 6.3 5.6 IMMT "HMP, Mic60, MINOS2, P87, P89" ENSG00000132305 "Inner membrane mitochondrial protein" Q16891 2 86143932-86195770 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022439, HPA036164, HPA036165" Supported Enhanced Mitochondria 240000 Mitochondria "CAB022439: , HPA036164: AB_2674979, HPA036165: AB_2674980" "unprognostic (3.83e-3)" "unprognostic (1.56e-1)" "unprognostic (1.95e-2)" "prognostic unfavourable (1.06e-4)" "unprognostic (1.40e-1)" "unprognostic (2.45e-2)" "prognostic unfavourable (2.03e-4)" "unprognostic (5.66e-2)" "unprognostic (1.53e-1)" "unprognostic (8.10e-2)" "unprognostic (7.35e-2)" "unprognostic (2.21e-1)" "prognostic favourable (3.51e-6)" "unprognostic (2.06e-3)" "unprognostic (6.35e-2)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" 20.0 36.9 15.6 17.0 23.5 15.3 15.4 17.5 27.1 13.6 24.8 16.0 15.4 25.1 16.5 13.6 19.1 13.9 12.3 67.3 15.1 18.0 37.5 35.1 14.3 17.7 18.4 18.8 13.3 23.1 31.4 17.6 21.6 32.2 12.8 26.3 17.3 16.7 21.2 78.6 15.4 25.6 17.9 12.1 20.0 22.0 28.3 15.0 29.1 16.2 38.3 19.9 18.0 14.1 10.9 21.5 7.6 21.6 13.2 16.1 14.4 34.0 33.7 30.5 14.0 29.8 27.5 31.2 24.5 25.7 33.2 30.2 48.4 27.1 52.3 24.6 25.9 25.4 39.1 35.4 40.7 21.1 31.9 41.3 21.3 57.2 30.3 39.8 28.4 31.4 25.8 31.2 37.4 37.4 40.2 29.8 32.0 29.3 39.6 41.6 36.4 26.9 26.5 65.4 47.0 37.8 38.7 37.2 27.6 25.1 38.2 37.4 21.7 28.3 28.0 23.9 26.3 34.5 30.4 23.7 29.9 35.9 27.2 47.6 28.9 7.5 18.6 7.6 16.1 21.6 14.6 10.9 14.4 13.3 21.5 8.8 13.1 15.5 2.5 13.2 19.9 11.1 14.9 14.4 15.6 23.5 17.5 27.1 15.1 18.0 18.4 18.8 32.2 15.0 ITPK1 ENSG00000100605 "Inositol-tetrakisphosphate 1-kinase" Q13572 14 92936914-93116320 "Enzymes, Predicted intracellular proteins" "Hydrolase, Isomerase, Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 24.2" "Group enriched" "Detected in all" 5 "granulocytes: 24.2;monocytes: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055230 Approved Approved Mitochondria Mitochondria "HPA055230: " "unprognostic (1.93e-3)" "unprognostic (2.50e-1)" "unprognostic (2.15e-1)" "prognostic favourable (8.56e-4)" "unprognostic (4.27e-1)" "unprognostic (2.04e-2)" "unprognostic (6.97e-2)" "unprognostic (1.32e-1)" "unprognostic (1.24e-2)" "unprognostic (2.86e-2)" "unprognostic (8.14e-2)" "unprognostic (2.27e-1)" "unprognostic (1.37e-3)" "unprognostic (2.39e-1)" "unprognostic (2.02e-1)" "unprognostic (4.20e-1)" "unprognostic (7.25e-3)" 32.0 10.2 44.3 11.9 49.5 12.2 14.4 19.3 50.5 23.8 20.0 29.7 9.6 34.9 20.2 10.2 18.7 15.9 16.1 18.4 49.0 30.6 11.4 13.4 13.0 7.6 42.1 27.1 11.4 15.0 13.2 5.3 11.2 18.5 15.1 13.6 14.5 8.3 19.1 9.4 5.5 36.6 19.4 44.8 14.1 11.9 9.4 26.1 3.4 10.0 3.2 5.5 16.7 16.2 1.9 3.9 24.2 13.0 1.3 1.9 2.4 10.2 21.3 4.0 10.0 8.9 5.0 10.6 4.4 6.6 8.8 5.4 12.2 18.5 6.5 22.0 6.9 12.2 11.4 18.9 2.8 24.1 4.9 14.4 5.7 10.5 6.6 6.5 16.0 3.2 11.4 4.5 10.2 8.6 7.8 7.5 4.2 27.5 5.6 9.3 8.3 9.6 10.6 5.8 9.7 5.9 17.3 10.8 13.6 11.1 22.5 18.8 30.2 8.0 6.7 6.2 6.7 10.3 6.9 7.4 6.7 4.2 5.6 5.1 42.1 2.5 5.2 9.5 1.9 8.6 1.1 1.9 1.2 1.2 3.9 0.7 0.7 1.3 24.2 1.3 13.0 1.9 1.7 2.4 44.3 49.5 19.3 50.5 49.0 30.6 42.1 27.1 18.5 26.1 JADE1 "JADE-1, PHF17" ENSG00000077684 "Jade family PHD finger 1" Q6IE81 4 128809623-128875224 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020016 Approved Approved Mitochondria Mitochondria "HPA020016: AB_1855292" "unprognostic (1.91e-2)" "unprognostic (1.81e-1)" "unprognostic (4.79e-2)" "unprognostic (1.63e-2)" "unprognostic (3.19e-1)" "unprognostic (2.09e-2)" "unprognostic (7.59e-2)" "unprognostic (6.96e-3)" "unprognostic (6.93e-2)" "unprognostic (8.16e-2)" "unprognostic (9.39e-2)" "unprognostic (8.38e-3)" "prognostic favourable (8.22e-6)" "unprognostic (1.45e-2)" "unprognostic (2.58e-1)" "unprognostic (9.92e-2)" "unprognostic (1.68e-1)" 20.5 14.6 5.7 12.7 7.9 25.9 27.9 16.3 9.7 10.8 9.8 4.6 18.9 5.6 8.4 9.0 8.1 11.8 14.3 14.2 5.7 7.1 22.1 7.4 12.6 13.2 6.9 4.9 18.6 55.7 17.4 10.8 7.2 7.3 12.0 4.3 8.5 25.6 16.8 10.5 8.6 10.6 16.3 5.4 10.2 12.5 6.1 8.5 13.3 28.7 7.2 7.9 12.1 31.1 12.6 6.9 23.0 14.3 20.1 18.4 10.4 6.1 12.1 12.1 8.9 16.6 11.8 15.9 9.9 5.9 10.8 10.0 10.6 10.9 19.0 11.8 5.7 2.1 14.2 3.5 12.1 14.7 6.2 10.5 16.8 9.6 28.7 17.1 8.5 13.1 5.6 13.2 9.8 11.7 16.7 26.2 8.4 7.5 21.6 12.9 32.5 6.1 15.5 8.3 10.2 17.2 3.0 15.7 11.5 9.5 7.8 7.7 6.2 9.7 8.1 10.7 17.6 8.1 11.6 17.4 13.8 21.5 11.7 17.2 8.7 17.2 7.2 23.0 12.3 11.6 15.3 9.5 13.4 13.5 6.9 12.6 18.4 14.5 9.1 20.1 14.3 3.3 9.4 10.4 5.7 7.9 16.3 9.7 5.7 7.1 6.9 4.9 7.3 8.5 KCNAB3 "AKR6A9, KCNA3B" ENSG00000170049 "Potassium voltage-gated channel subfamily A regulatory beta subunit 3" O43448 17 7921859-7929803 "Predicted intracellular proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 36.1;endometrium 1: 17.2" "Cell line enhanced" "Detected in many" "REH: 14.9;SH-SY5Y: 8.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 5 "cerebellum: 36.1;cerebral cortex: 31.6" "Cell type enhanced" "Detected in some" "myeloid DC: 1.5;plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077993 Approved Mitochondria Mitochondria "HPA077993: " "unprognostic (3.02e-2)" "unprognostic (5.59e-2)" "unprognostic (6.95e-2)" "unprognostic (2.62e-2)" "unprognostic (6.13e-2)" "unprognostic (5.84e-4)" "unprognostic (2.19e-1)" "unprognostic (5.72e-2)" "unprognostic (8.50e-2)" "unprognostic (8.55e-2)" "unprognostic (3.27e-4)" "unprognostic (7.47e-3)" "unprognostic (3.03e-6)" "unprognostic (2.12e-1)" "unprognostic (5.00e-2)" "unprognostic (4.97e-2)" "unprognostic (9.54e-3)" 1.4 0.7 4.2 2.7 5.2 5.5 1.2 36.1 31.6 1.8 1.4 0.8 0.0 1.3 17.2 2.2 0.8 3.5 2.1 0.7 4.7 2.9 1.7 1.1 1.5 3.8 2.4 6.3 2.1 1.0 0.8 4.9 1.6 5.9 2.3 2.0 3.8 1.3 1.4 1.0 3.3 1.9 11.4 5.2 2.6 2.2 1.7 1.9 0.8 1.6 0.0 3.3 1.0 1.0 0.1 1.7 0.5 0.2 0.0 0.7 0.1 1.3 1.1 5.5 1.4 0.6 1.4 1.9 4.9 3.1 4.2 4.8 0.7 0.3 2.2 0.3 0.8 0.4 1.5 0.7 6.0 1.8 2.3 0.7 0.9 0.0 5.1 0.2 3.0 2.1 1.6 4.5 0.2 0.3 0.5 0.3 0.7 1.0 0.8 2.6 0.8 0.7 14.9 1.5 0.6 0.5 1.7 0.3 8.0 0.4 0.0 0.9 1.4 0.1 0.3 0.7 2.8 1.1 0.4 1.1 1.2 1.2 2.1 2.9 1.0 0.0 0.2 0.0 0.5 0.0 0.7 0.0 0.0 0.0 1.5 0.1 0.2 0.2 0.5 0.0 0.0 1.7 0.0 0.1 4.2 5.2 36.1 31.6 4.7 2.9 2.4 6.3 5.9 1.9 KCTD12 "C13orf2, KIAA1778, PFET1" ENSG00000178695 "Potassium channel tetramerization domain containing 12" Q96CX2 13 76880166-76886390 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 30.2;HUVEC TERT2: 60.0;TIME: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 6.4;myeloid DC: 5.9" "Group enriched" "Detected in many" 17 "dendritic cells: 5.9;granulocytes: 1.6;monocytes: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056987, HPA077376" Supported Approved Mitochondria 19000000 Mitochondria "HPA056987: , HPA077376: " "unprognostic (6.42e-2)" "unprognostic (2.67e-1)" "unprognostic (5.13e-1)" "unprognostic (1.04e-3)" "unprognostic (5.82e-2)" "unprognostic (3.98e-2)" "unprognostic (2.02e-1)" "unprognostic (1.32e-3)" "unprognostic (1.35e-2)" "unprognostic (1.90e-1)" "unprognostic (9.83e-3)" "unprognostic (1.23e-1)" "prognostic favourable (1.14e-4)" "unprognostic (2.11e-2)" "unprognostic (1.65e-2)" "unprognostic (1.07e-1)" "unprognostic (9.25e-2)" 29.6 7.5 12.1 14.3 17.9 2.1 24.7 11.7 9.4 13.1 10.3 10.3 5.1 5.5 14.2 9.2 10.7 21.6 15.1 10.3 10.5 8.2 8.5 6.4 17.2 21.5 17.0 5.9 13.6 6.8 8.2 6.6 22.9 13.8 9.9 11.7 13.8 8.4 4.9 11.2 7.7 8.4 17.9 14.0 21.3 8.3 10.0 13.5 3.1 8.4 5.8 8.4 11.0 15.0 0.0 5.9 1.6 6.4 0.0 0.2 1.4 0.4 0.3 4.0 0.0 30.2 14.4 1.1 1.7 0.4 1.1 1.5 0.1 0.0 0.0 1.0 4.8 14.0 1.7 17.2 0.9 0.3 9.2 0.0 10.4 0.0 1.3 4.6 0.0 5.8 5.7 0.7 13.1 60.0 0.0 0.0 14.1 0.3 2.1 0.0 2.0 2.0 0.1 1.9 5.0 4.6 0.0 1.1 2.1 4.5 0.1 0.6 0.2 3.1 48.2 0.7 1.3 0.1 3.6 0.7 0.1 0.0 11.4 1.0 4.2 0.0 6.4 1.1 0.0 4.1 0.0 0.0 0.1 0.0 5.9 0.0 0.1 0.2 1.6 0.0 2.3 3.0 0.0 1.4 12.1 17.9 11.7 7.5 10.5 8.2 17.0 5.9 13.8 13.5 KCTD18 "6530404F10Rik, FLJ31322, FLJ37818" ENSG00000155729 "Potassium channel tetramerization domain containing 18" Q6PI47 2 200488952-200519784 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045498, HPA058028" Approved Approved Mitochondria Mitochondria "HPA045498: AB_10959387, HPA058028: " "unprognostic (2.90e-1)" "unprognostic (1.81e-1)" "unprognostic (1.57e-1)" "unprognostic (2.55e-1)" "unprognostic (4.01e-1)" "unprognostic (3.64e-2)" "unprognostic (1.02e-1)" "unprognostic (2.16e-1)" "unprognostic (2.76e-2)" "unprognostic (2.40e-2)" "unprognostic (1.18e-2)" "unprognostic (5.21e-1)" "unprognostic (1.81e-1)" "unprognostic (2.04e-1)" "unprognostic (6.58e-2)" "unprognostic (1.05e-2)" "unprognostic (1.31e-1)" 14.3 14.6 13.7 13.1 15.4 11.5 14.3 9.2 14.8 12.3 13.8 17.4 15.5 11.6 13.5 19.4 16.1 12.5 16.5 14.8 13.6 11.2 13.8 13.3 11.4 14.9 16.3 11.4 15.0 16.5 17.1 13.2 10.0 14.9 15.9 11.7 13.7 14.1 14.0 14.7 12.3 11.3 24.0 17.6 13.0 12.9 9.3 14.6 18.0 19.4 19.9 14.6 17.4 11.7 7.2 7.2 11.4 7.9 7.1 9.6 5.6 7.2 6.7 3.3 12.4 16.1 20.1 8.6 8.9 11.3 5.7 7.5 5.4 8.3 5.1 6.8 8.9 7.0 3.3 10.7 7.4 12.3 3.6 7.3 4.8 3.7 11.0 5.9 8.7 13.4 20.4 6.6 12.7 4.9 5.0 6.9 10.2 7.4 12.7 5.8 1.9 6.1 8.9 7.5 5.9 7.5 7.2 3.8 5.3 7.0 6.1 10.5 8.0 9.6 8.1 11.8 2.7 5.9 4.2 13.4 9.7 5.8 13.5 6.3 8.3 11.4 5.5 10.4 5.9 7.9 9.0 7.2 7.7 8.5 5.9 7.1 9.6 9.6 4.4 7.1 5.2 7.2 8.5 5.6 13.7 15.4 9.2 14.8 13.6 11.2 16.3 11.4 14.9 14.6 KIF16B "C20orf23, dJ971B4.1, FLJ20135, SNX23" ENSG00000089177 "Kinesin family member 16B" Q96L93 20 16272104-16573434 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051198 Approved Uncertain Mitochondria Mitochondria "HPA051198: " "unprognostic (3.33e-1)" "unprognostic (1.74e-1)" "unprognostic (6.18e-2)" "unprognostic (2.09e-1)" "unprognostic (3.92e-2)" "unprognostic (2.44e-1)" "unprognostic (6.32e-3)" "unprognostic (7.85e-2)" "unprognostic (2.38e-1)" "unprognostic (5.34e-2)" "unprognostic (3.95e-2)" "unprognostic (5.52e-1)" "prognostic favourable (7.61e-6)" "unprognostic (4.04e-2)" "unprognostic (2.78e-1)" "unprognostic (4.74e-2)" "unprognostic (1.61e-2)" 11.3 26.2 10.5 14.8 11.2 4.8 15.1 6.3 11.2 9.4 21.6 10.3 15.7 15.1 10.6 12.8 10.3 6.1 9.4 10.7 10.3 8.4 16.6 10.9 12.9 5.6 12.1 7.0 13.0 8.4 25.7 13.9 5.7 8.4 8.4 17.8 6.6 8.5 28.2 22.8 11.3 23.7 11.7 15.3 9.9 11.6 5.7 11.1 6.5 10.5 8.6 8.2 10.6 15.0 5.2 5.8 0.9 3.7 8.2 5.0 2.6 4.9 12.6 6.1 5.5 4.7 3.4 5.9 4.9 3.0 3.0 3.4 6.2 12.2 6.9 3.2 5.2 4.5 7.1 7.2 4.6 3.6 4.1 3.1 3.2 11.3 2.9 0.0 7.0 5.4 14.4 3.6 7.2 1.2 5.5 0.0 4.9 7.8 0.1 1.2 1.7 5.7 5.2 4.8 12.1 4.8 7.9 2.7 5.3 5.2 25.4 15.4 7.5 4.0 2.4 4.7 4.0 7.6 2.2 0.0 3.0 2.0 4.5 2.0 9.4 0.1 3.7 0.9 3.7 3.0 5.0 4.2 4.1 2.8 5.8 5.2 4.5 3.2 0.4 8.2 2.9 2.8 2.7 2.6 10.5 11.2 6.3 11.2 10.3 8.4 12.1 7.0 8.4 11.1 L2HGDH "C14orf160, FLJ12618" ENSG00000087299 "L-2-hydroxyglutarate dehydrogenase" Q9H9P8 14 50237563-50312548 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065409, HPA069708" Approved Enhanced Mitochondria Mitochondria "HPA065409: , HPA069708: " "unprognostic (1.74e-1)" "unprognostic (1.15e-2)" "unprognostic (1.13e-2)" "unprognostic (1.23e-3)" "unprognostic (1.04e-2)" "unprognostic (4.33e-2)" "unprognostic (8.84e-2)" "unprognostic (1.58e-2)" "unprognostic (4.17e-2)" "unprognostic (9.91e-2)" "unprognostic (2.84e-1)" "unprognostic (1.97e-1)" "prognostic favourable (9.75e-10)" "unprognostic (1.24e-2)" "unprognostic (5.88e-2)" "unprognostic (1.45e-1)" "unprognostic (1.02e-2)" 5.4 5.1 6.9 3.6 8.4 3.5 5.1 12.7 10.9 3.5 5.6 4.9 4.8 6.2 3.4 4.3 9.0 4.4 3.2 7.7 6.1 4.7 25.5 16.0 2.5 3.3 7.7 4.7 4.2 5.4 7.1 5.8 2.6 5.7 4.6 6.8 7.7 5.0 5.6 17.7 7.0 5.0 4.7 5.3 2.3 5.6 6.0 6.0 3.7 6.5 6.2 5.2 4.6 4.4 1.4 1.5 10.5 0.6 2.4 3.3 0.8 13.8 9.8 4.0 3.9 2.0 1.3 11.4 4.6 2.6 7.3 8.7 15.6 6.4 10.9 5.4 1.8 10.2 12.1 4.8 8.2 8.7 6.9 23.7 6.7 2.1 1.9 8.3 8.2 1.2 3.1 4.8 4.2 3.1 8.3 6.9 1.9 16.7 9.4 3.8 5.9 10.4 8.9 13.2 8.5 6.8 16.3 8.3 5.9 13.6 10.4 5.9 13.6 2.3 2.9 4.6 13.1 5.3 6.1 6.3 14.3 15.4 2.6 4.2 5.2 10.5 0.6 1.4 1.5 0.3 3.3 1.4 1.7 1.6 0.9 1.2 2.1 2.6 0.9 2.4 0.3 1.5 2.4 0.8 6.9 8.4 12.7 10.9 6.1 4.7 7.7 4.7 5.7 6.0 LACTB "FLJ14902, MRPL56" ENSG00000103642 "Lactamase beta" P83111 15 63121800-63142061 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" "Hydrolase, Protease" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036361, HPA036362" Supported Supported Mitochondria "Intracellular and membrane" Mitochondria "HPA036361: AB_10672244, HPA036362: AB_10670798" "unprognostic (6.07e-2)" "unprognostic (2.02e-1)" "unprognostic (2.22e-2)" "unprognostic (2.87e-1)" "unprognostic (1.20e-2)" "unprognostic (3.10e-2)" "unprognostic (8.08e-2)" "unprognostic (6.25e-2)" "unprognostic (8.98e-2)" "unprognostic (3.08e-1)" "unprognostic (6.22e-3)" "unprognostic (5.16e-3)" "unprognostic (6.28e-2)" "unprognostic (3.24e-1)" "unprognostic (8.64e-2)" "unprognostic (7.90e-2)" "unprognostic (3.88e-3)" 26.5 22.7 9.2 13.1 12.2 31.5 9.3 7.3 9.1 6.8 11.4 6.3 4.0 12.5 7.0 6.9 9.8 5.7 9.2 24.9 7.9 6.1 20.5 38.3 18.8 12.9 8.5 6.1 7.2 9.3 6.7 10.4 7.4 9.5 7.6 10.4 5.8 9.3 4.7 37.3 10.1 19.6 8.1 8.0 21.6 8.3 13.2 9.8 8.3 8.4 11.1 9.0 11.5 12.8 3.3 10.4 5.8 8.9 2.3 3.1 2.0 21.4 13.5 3.8 2.6 19.5 10.5 3.2 9.4 14.5 16.2 30.2 3.4 13.8 2.8 11.6 13.6 6.0 13.1 6.1 20.3 19.7 3.2 5.5 4.6 8.4 18.2 5.0 9.6 14.2 13.0 16.6 13.7 16.6 5.2 8.2 27.3 8.1 3.8 6.0 5.8 4.2 2.8 9.9 6.5 8.7 33.6 3.5 1.6 6.8 7.7 20.2 5.8 8.2 29.7 21.8 17.1 9.8 11.8 8.6 7.5 0.7 16.7 14.1 10.0 3.6 8.8 4.6 1.3 8.9 2.0 3.3 1.1 1.0 10.4 2.9 1.0 1.6 5.8 2.3 7.6 0.9 3.1 2.0 9.2 12.2 7.3 9.1 7.9 6.1 8.5 6.1 9.5 9.8 LANCL3 FLJ42925 ENSG00000147036 "LanC like 3" Q6ZV70 X 37571569-37684463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 7.1;lung: 6.8" "Cell line enhanced" "Detected in some" "HEL: 16.8;HMC-1: 5.5;K-562: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 7.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005470, HPA076575" Approved Approved Mitochondria Mitochondria "HPA005470: AB_2134886, HPA076575: " "unprognostic (6.76e-2)" "unprognostic (4.21e-2)" "unprognostic (1.52e-1)" "unprognostic (1.85e-1)" "unprognostic (5.20e-2)" "unprognostic (5.26e-2)" "unprognostic (3.60e-1)" "unprognostic (1.21e-3)" "unprognostic (1.22e-1)" "unprognostic (7.11e-2)" "unprognostic (2.81e-2)" "unprognostic (2.88e-1)" "unprognostic (7.90e-5)" "unprognostic (4.01e-3)" "unprognostic (7.93e-3)" "unprognostic (1.11e-2)" "unprognostic (2.08e-2)" 1.2 0.8 0.7 0.3 2.3 0.9 0.4 2.5 2.4 1.2 3.8 0.7 0.2 0.6 0.5 0.3 4.6 0.2 0.9 0.7 1.1 2.8 0.4 0.2 6.8 0.4 1.3 1.3 1.3 0.2 0.1 1.7 0.2 2.2 0.6 2.8 2.5 1.1 0.9 1.0 2.6 1.1 1.9 1.8 0.2 2.2 1.8 0.9 0.2 1.2 1.7 1.2 1.8 2.9 0.3 0.2 7.1 0.2 1.1 1.8 0.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 1.1 2.4 0.3 0.0 0.0 0.3 16.8 1.7 0.0 0.0 0.0 5.5 0.0 0.4 0.0 0.1 0.3 3.8 0.0 1.2 0.0 0.2 0.3 0.4 1.7 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.2 0.0 0.0 1.5 0.7 0.0 0.0 2.8 0.0 0.4 7.1 0.2 0.9 1.0 0.2 0.8 0.2 0.4 1.8 0.1 0.3 0.1 1.0 1.1 1.1 0.2 0.2 0.6 0.7 0.7 2.3 2.5 2.4 1.1 2.8 1.3 1.3 2.2 0.9 LETM1 SLC55A1 ENSG00000168924 "Leucine zipper and EF-hand containing transmembrane protein 1" O95202 4 1811479-1856247 "Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011029, HPA011100" Supported Supported Mitochondria Mitochondria "HPA011029: AB_1852804, HPA011100: AB_1852802" "unprognostic (1.16e-1)" "unprognostic (1.80e-1)" "unprognostic (3.85e-2)" "unprognostic (5.04e-2)" "unprognostic (5.48e-1)" "unprognostic (1.17e-1)" "prognostic unfavourable (1.79e-4)" "unprognostic (1.37e-3)" "unprognostic (1.87e-1)" "unprognostic (3.29e-1)" "unprognostic (1.80e-1)" "prognostic unfavourable (1.77e-4)" "prognostic favourable (8.90e-4)" "unprognostic (8.06e-3)" "unprognostic (3.24e-1)" "unprognostic (1.57e-2)" "unprognostic (2.42e-1)" 16.9 15.3 11.9 11.2 13.1 9.9 16.8 17.3 19.9 6.7 23.7 10.0 7.5 20.3 8.5 6.9 22.0 8.1 15.0 18.9 10.2 10.2 16.2 20.4 9.4 10.7 10.6 10.5 9.5 19.7 13.0 8.7 7.6 10.7 8.2 16.3 9.2 9.7 7.2 17.2 18.5 19.4 8.0 7.7 10.6 15.6 12.6 9.0 50.7 10.9 19.9 16.6 8.0 9.7 5.0 14.7 3.8 5.6 6.7 7.1 2.1 12.1 20.6 6.4 19.9 9.9 7.0 11.5 12.0 5.9 12.1 9.5 19.0 13.5 20.0 8.6 12.6 12.3 16.4 17.0 7.5 13.3 17.1 20.5 16.8 13.6 12.9 20.7 16.9 11.3 12.2 13.8 12.3 10.4 26.9 12.6 8.3 13.3 29.9 23.7 16.8 23.8 17.2 9.0 11.7 9.5 16.9 16.4 14.5 13.7 17.4 7.2 16.3 10.9 15.6 13.9 8.3 11.7 20.0 11.0 16.9 16.0 12.3 18.1 11.1 3.8 4.5 2.1 7.1 5.6 7.0 5.0 6.0 6.1 4.7 4.6 4.0 5.9 0.7 6.7 5.3 14.7 4.6 2.1 11.9 13.1 17.3 19.9 10.2 10.2 10.6 10.5 10.7 9.0 LINGO3 "LERN2, LRRN6B" ENSG00000220008 "Leucine rich repeat and Ig domain containing 3" P0C6S8 19 2289784-2292024 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.9;brain: 15.7;lymphoid tissue: 7.1" "Cell line enriched" "Detected in some" 4 "HMC-1: 19.2" "Cancer enhanced" "Detected in some" "glioma: 1.4" "Cell type enhanced" "Detected in some" "eosinophil: 6.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 6.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "basal ganglia: 34.0;cerebellum: 34.4;hippocampal formation: 11.5" "HPA043781, HPA059558" Enhanced Approved Mitochondria Mitochondria "HPA043781: , HPA059558: " "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (7.16e-3)" "unprognostic (3.10e-1)" "unprognostic (1.59e-1)" "unprognostic (3.61e-3)" "unprognostic (3.53e-1)" "unprognostic (7.45e-3)" "unprognostic (1.11e-2)" "unprognostic (3.19e-2)" "unprognostic (4.03e-4)" "unprognostic (2.35e-2)" "unprognostic (1.36e-2)" "unprognostic (1.79e-1)" "unprognostic (5.74e-2)" "unprognostic (1.05e-1)" "unprognostic (4.14e-2)" 0.1 0.2 2.2 3.1 15.7 2.8 0.0 4.6 2.9 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.2 0.0 0.0 0.2 2.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 1.2 0.0 0.4 7.1 1.2 0.1 0.0 0.0 0.0 0.0 1.0 0.1 6.9 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 2.1 19.2 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 2.5 0.2 0.1 1.8 0.0 4.7 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 1.9 0.1 6.9 0.4 0.0 0.4 0.5 0.0 0.2 0.1 1.0 0.1 0.0 2.9 0.3 0.1 0.0 0.6 0.0 LRP11 "bA350J20.3, MANSC3" ENSG00000120256 "LDL receptor related protein 11" Q86VZ4 6 149818798-149864026 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064002 Approved Mitochondria 640000 Mitochondria "HPA064002: " "prognostic unfavourable (2.31e-8)" "unprognostic (3.85e-3)" "unprognostic (1.68e-1)" "unprognostic (1.30e-2)" "unprognostic (5.17e-2)" "unprognostic (4.25e-3)" "prognostic unfavourable (2.01e-5)" "unprognostic (5.05e-2)" "unprognostic (1.47e-1)" "unprognostic (2.49e-1)" "unprognostic (3.29e-1)" "unprognostic (2.63e-1)" "unprognostic (4.76e-2)" "unprognostic (2.47e-1)" "unprognostic (6.75e-2)" "unprognostic (1.34e-2)" "unprognostic (4.23e-2)" 12.0 16.5 17.8 4.4 26.9 1.6 11.2 17.9 25.6 14.0 11.5 15.1 9.4 10.5 10.6 14.8 20.2 20.2 10.5 8.0 19.7 19.3 18.2 9.0 12.1 2.2 15.0 16.9 15.3 17.2 46.2 15.2 14.7 20.6 23.3 11.4 10.8 14.2 12.3 8.1 20.2 8.7 10.9 13.3 3.6 14.4 7.2 15.6 0.8 20.8 13.8 6.4 17.3 14.2 3.5 1.0 0.0 1.7 0.0 0.7 0.1 9.7 8.5 6.5 5.7 14.5 26.5 1.3 10.2 19.8 7.1 8.6 2.5 20.3 0.1 13.9 15.9 25.9 7.3 18.5 5.1 15.6 7.3 4.6 31.3 11.2 8.9 4.7 0.1 16.5 36.0 9.1 18.1 10.9 9.4 4.3 8.4 16.7 0.1 0.1 3.9 8.5 5.0 9.7 2.3 12.8 19.9 8.6 5.7 32.1 17.9 6.0 14.7 9.7 8.5 8.9 2.1 18.6 7.7 0.0 3.1 2.3 16.1 4.7 5.1 0.0 0.1 0.0 0.2 0.4 0.0 3.5 0.7 0.6 1.0 0.6 0.2 0.3 0.0 0.0 1.7 0.0 0.0 0.1 17.8 26.9 17.9 25.6 19.7 19.3 15.0 16.9 20.6 15.6 LRPPRC "GP130, LRP130, LSFC" ENSG00000138095 "Leucine rich pentatricopeptide repeat containing" P42704 2 43886508-43996005 "Disease related genes, Predicted intracellular proteins" "mRNA transport, Transcription, Transcription regulation, Transport" "DNA-binding, RNA-binding" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033786, HPA036408, HPA036409" Enhanced Enhanced Mitochondria 16000 Mitochondria "CAB033786: AB_2137450, HPA036408: AB_10670438, HPA036409: AB_2675108" "unprognostic (1.49e-1)" "unprognostic (1.30e-1)" "unprognostic (1.61e-3)" "prognostic unfavourable (1.72e-5)" "unprognostic (1.68e-1)" "unprognostic (8.34e-3)" "prognostic unfavourable (2.31e-7)" "unprognostic (1.02e-1)" "unprognostic (1.25e-1)" "unprognostic (1.11e-1)" "unprognostic (2.44e-3)" "unprognostic (7.68e-2)" "prognostic favourable (6.65e-6)" "unprognostic (9.07e-2)" "unprognostic (1.92e-1)" "unprognostic (1.12e-1)" "unprognostic (5.00e-2)" 20.6 25.5 20.2 27.7 24.8 26.7 37.2 34.3 51.8 16.4 31.7 15.1 15.9 21.8 21.5 19.2 22.5 18.6 15.2 36.6 24.3 21.9 41.7 31.6 26.3 38.0 21.9 22.9 23.6 28.0 33.3 19.7 17.6 29.2 18.9 32.5 13.6 17.8 22.8 63.2 22.4 19.1 32.6 17.9 18.0 20.7 20.7 16.0 25.4 20.5 30.5 19.9 20.4 17.8 15.8 15.5 5.5 11.7 13.2 18.1 12.4 30.1 24.7 15.6 19.8 15.4 20.5 26.8 20.1 14.6 21.9 17.0 39.6 16.0 43.3 19.4 12.4 25.6 29.1 21.5 29.4 26.1 18.4 39.2 19.5 52.4 22.7 56.3 17.8 20.3 18.9 20.3 32.9 17.6 57.7 17.6 19.3 16.7 29.5 65.2 26.0 17.6 33.1 34.9 35.2 24.0 27.7 27.6 26.8 22.7 30.5 36.5 22.4 34.2 15.1 15.8 21.7 16.7 21.4 17.9 20.2 37.8 15.2 35.0 13.6 5.5 10.7 1.8 9.5 10.8 18.0 15.2 12.8 12.6 15.5 15.8 18.1 15.4 0.8 13.2 11.7 6.2 10.5 12.4 20.2 24.8 34.3 51.8 24.3 21.9 21.9 22.9 29.2 16.0 MACC1 "7A5, SH3BP4L" ENSG00000183742 "MACC1, MET transcriptional regulator" Q6ZN28 7 20134655-20217404 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Growth factor, Mitogen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 29.5;kidney: 23.9" "Cell line enhanced" "Detected in some" "A-431: 40.5;CAPAN-2: 9.5;HaCaT: 28.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA020081, HPA020103, HPA029476, CAB068194" Supported Approved Mitochondria Mitochondria "CAB068194: , HPA020081: AB_1844386, HPA020103: AB_1844387, HPA029476: AB_10610136" "unprognostic (1.59e-2)" "unprognostic (1.88e-1)" "unprognostic (3.43e-2)" "prognostic unfavourable (1.56e-5)" "unprognostic (2.26e-1)" "unprognostic (1.42e-2)" "unprognostic (7.01e-2)" "unprognostic (2.52e-2)" "unprognostic (2.05e-1)" "unprognostic (2.43e-2)" "unprognostic (2.43e-3)" "unprognostic (1.03e-1)" "prognostic favourable (5.71e-9)" "unprognostic (4.49e-2)" "unprognostic (2.91e-1)" "unprognostic (1.78e-1)" "unprognostic (6.93e-3)" 4.8 2.6 0.5 5.6 0.4 0.7 4.5 0.4 0.5 8.3 13.7 0.0 4.4 10.1 0.7 6.1 14.1 0.9 9.6 0.5 0.5 0.5 23.9 1.0 13.3 1.1 0.4 0.0 1.3 11.3 0.1 4.0 1.6 0.1 3.9 3.3 0.1 11.4 6.0 0.5 4.5 29.5 0.1 0.8 6.0 5.0 0.8 0.0 1.7 1.5 16.0 13.6 4.0 5.1 2.3 1.0 1.4 1.0 0.8 0.6 0.5 40.5 0.1 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 9.0 9.5 5.7 0.4 0.0 28.5 0.1 0.3 0.0 0.0 0.1 5.4 0.1 0.0 0.0 2.2 0.1 0.0 0.3 0.0 0.0 0.0 5.8 2.8 0.0 3.4 0.0 0.5 0.4 0.0 0.0 0.3 4.4 7.2 2.8 0.1 0.2 0.0 3.2 0.0 1.7 0.1 0.1 0.1 0.0 0.0 0.1 8.7 0.4 2.1 0.0 0.3 0.0 1.0 0.6 0.3 0.3 0.7 0.6 2.3 0.2 0.5 0.3 2.0 0.3 0.3 1.4 0.8 1.0 1.0 0.2 0.5 0.5 0.4 0.4 0.5 0.5 0.5 0.4 0.0 0.1 0.0 MAIP1 "C2orf47, DKFZp666A212, FLJ22555" ENSG00000162972 "Matrix AAA peptidase interacting protein 1" Q8WWC4 2 199955317-200008540 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064013, HPA072231" Approved Approved Mitochondria Mitochondria "HPA064013: , HPA072231: " "unprognostic (4.89e-2)" "unprognostic (7.36e-2)" "unprognostic (7.40e-3)" "prognostic unfavourable (2.14e-4)" "unprognostic (2.74e-1)" "prognostic unfavourable (3.81e-4)" "unprognostic (4.86e-2)" "unprognostic (1.03e-1)" "prognostic unfavourable (1.87e-4)" "unprognostic (1.02e-3)" "unprognostic (7.03e-2)" "unprognostic (2.00e-2)" "unprognostic (5.21e-3)" "unprognostic (1.45e-1)" "unprognostic (1.94e-1)" "unprognostic (1.63e-1)" "unprognostic (2.70e-2)" 11.3 16.7 10.5 8.6 10.7 14.4 18.5 13.6 14.4 7.1 12.6 5.9 9.2 18.3 8.2 7.5 11.6 8.3 11.0 16.2 8.3 8.1 26.8 39.4 11.3 14.6 10.3 8.4 7.6 14.7 7.6 7.2 10.5 9.0 8.5 11.9 6.1 9.3 8.8 18.1 9.2 16.3 8.8 7.8 8.7 11.4 5.2 10.4 13.6 9.1 12.7 8.9 8.6 7.8 13.2 16.9 9.0 13.1 8.9 14.0 8.3 12.7 11.9 10.7 8.4 9.6 9.7 24.9 11.5 11.2 17.2 16.6 32.2 11.6 8.4 16.7 7.9 14.1 15.8 12.4 16.3 13.1 18.1 14.2 11.0 29.3 12.9 19.4 10.1 10.3 10.2 11.3 12.3 10.8 18.5 11.0 11.1 16.7 14.6 18.1 13.7 28.6 14.1 12.8 16.8 20.2 16.5 12.2 8.5 11.9 13.5 21.0 12.0 11.9 9.6 10.1 14.5 8.7 12.8 10.5 12.2 18.2 15.2 11.4 10.3 7.2 13.1 9.0 11.4 12.5 14.0 13.2 11.6 8.2 16.9 12.0 11.1 9.4 2.2 8.9 11.9 13.7 13.6 8.3 10.5 10.7 13.6 14.4 8.3 8.1 10.3 8.4 9.0 10.4 MALSU1 "C7orf30, mtRsfA" ENSG00000156928 "Mitochondrial assembly of ribosomal large subunit 1" Q96EH3 7 23298739-23311729 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AN3-CA: 27.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020487, HPA052210" Approved Enhanced Mitochondria "Intracellular and membrane" Mitochondria "HPA020487: AB_1845757, HPA052210: " "unprognostic (3.62e-1)" "unprognostic (3.68e-1)" "unprognostic (1.43e-1)" "unprognostic (4.66e-3)" "unprognostic (5.24e-3)" "prognostic unfavourable (9.71e-4)" "unprognostic (1.08e-1)" "unprognostic (1.51e-2)" "unprognostic (9.79e-2)" "unprognostic (1.83e-3)" "unprognostic (3.15e-2)" "unprognostic (7.15e-2)" "unprognostic (2.37e-2)" "unprognostic (1.25e-1)" "unprognostic (1.43e-2)" "unprognostic (4.51e-2)" "unprognostic (1.68e-1)" 7.9 11.3 9.5 6.9 9.4 7.6 11.0 8.6 11.1 7.9 8.4 8.3 5.8 5.1 9.2 10.2 12.3 10.1 7.6 29.8 8.8 9.1 12.5 21.2 8.2 10.2 8.9 7.2 10.3 10.1 8.0 7.8 12.6 12.7 7.9 7.8 17.2 10.6 10.3 20.1 6.7 7.0 8.9 8.1 6.9 7.5 13.7 5.6 8.5 14.8 14.9 8.0 9.2 7.5 6.1 4.8 3.5 5.4 4.2 7.3 5.1 5.0 6.3 4.6 27.2 4.6 3.2 4.7 3.9 2.8 3.6 3.3 10.6 4.2 5.1 4.2 2.4 5.2 4.5 2.4 4.4 2.5 8.2 3.0 8.6 16.3 3.0 6.6 1.8 2.7 3.8 3.0 3.4 3.3 9.0 1.3 4.5 3.5 4.6 20.8 8.5 17.0 3.9 3.9 6.7 3.5 4.5 4.2 5.1 3.2 5.1 8.0 2.6 3.9 5.7 2.9 2.6 5.5 6.8 2.0 5.0 8.8 11.0 8.2 9.0 3.4 5.4 3.5 4.4 4.0 5.0 6.1 6.1 4.9 4.7 5.7 7.3 4.9 3.4 4.2 3.3 4.8 5.7 5.1 9.5 9.4 8.6 11.1 8.8 9.1 8.9 7.2 12.7 5.6 MAPK11 "p38-2, p38Beta, PRKM11, SAPK2" ENSG00000185386 "Mitogen-activated protein kinase 11" Q15759 22 50263713-50270767 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012961, HPA045069" Approved Approved Mitochondria Mitochondria "CAB012961: AB_2533144, HPA045069: " "unprognostic (1.11e-1)" "unprognostic (1.28e-1)" "unprognostic (1.49e-2)" "unprognostic (1.92e-1)" "unprognostic (1.18e-2)" "unprognostic (1.64e-3)" "unprognostic (1.02e-1)" "unprognostic (5.84e-2)" "unprognostic (5.89e-2)" "unprognostic (2.46e-1)" "unprognostic (4.96e-3)" "unprognostic (2.18e-1)" "prognostic unfavourable (6.02e-6)" "unprognostic (9.84e-2)" "unprognostic (4.25e-2)" "unprognostic (9.16e-2)" "unprognostic (2.10e-2)" 20.4 5.7 14.2 7.5 17.3 0.8 8.2 22.0 23.7 6.6 2.7 2.8 1.0 1.9 8.2 6.2 5.3 7.0 8.8 8.8 11.7 9.1 5.0 1.5 8.5 8.5 7.2 19.9 5.3 3.1 6.4 10.9 8.4 6.6 7.2 2.7 4.1 5.7 8.0 5.0 6.4 2.6 9.8 5.5 7.3 4.6 3.1 4.1 0.9 4.5 5.3 6.1 6.0 4.4 1.1 0.0 0.0 0.3 0.0 0.9 0.0 1.7 4.2 4.6 17.3 6.1 9.2 0.1 6.4 4.6 4.3 1.7 1.6 3.2 0.0 5.8 6.0 4.2 3.0 2.6 0.3 8.9 2.1 6.1 5.5 0.4 7.0 1.5 9.5 12.8 7.6 1.2 0.5 9.4 4.9 16.7 4.2 7.4 0.3 5.6 0.4 4.8 16.7 0.1 5.9 6.5 0.0 4.3 11.5 5.5 2.3 4.6 7.6 4.8 14.7 12.9 10.8 0.9 2.4 0.7 1.9 7.1 6.5 1.7 10.8 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.4 0.2 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 14.2 17.3 22.0 23.7 11.7 9.1 7.2 19.9 6.6 4.1 MARC1 "FLJ22390, MOSC1" ENSG00000186205 "Mitochondrial amidoxime reducing component 1" Q5VT66 1 220786759-220819657 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 71.3;breast: 81.3" "Cell line enhanced" "Detected in many" "BEWO: 51.0;HeLa: 21.7;Hep G2: 25.0;NTERA-2: 21.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "basophil: 12.0;classical monocyte: 20.6;eosinophil: 8.1;neutrophil: 28.5" "Group enriched" "Detected in many" 32 "granulocytes: 28.5;monocytes: 20.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA028702 Approved Supported Mitochondria Mitochondria "HPA028702: AB_10601135" "unprognostic (3.15e-2)" "unprognostic (1.27e-1)" "unprognostic (2.16e-2)" "unprognostic (5.04e-2)" "unprognostic (2.90e-1)" "unprognostic (2.31e-1)" "unprognostic (3.71e-3)" "unprognostic (1.39e-1)" "unprognostic (7.51e-2)" "unprognostic (7.71e-3)" "unprognostic (3.71e-1)" "unprognostic (4.30e-1)" "prognostic unfavourable (4.51e-4)" "unprognostic (3.85e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" "unprognostic (1.50e-1)" 71.3 3.0 4.6 7.5 6.1 7.3 81.3 3.1 4.0 3.4 7.8 2.1 18.7 3.3 1.4 5.5 3.4 2.8 6.4 6.7 3.7 4.6 3.4 33.6 4.3 4.3 4.0 3.3 2.5 4.0 4.0 3.3 9.7 4.3 14.9 6.8 4.4 27.8 10.5 4.2 1.4 3.8 2.6 2.6 4.3 3.2 0.6 1.4 0.1 22.0 2.7 1.4 3.9 7.5 0.2 0.7 28.5 20.6 0.0 0.1 4.9 5.6 3.1 2.0 0.0 0.4 0.1 51.0 0.5 0.4 0.3 0.5 16.8 0.3 0.0 2.1 0.5 0.0 10.6 1.0 0.7 0.0 10.7 0.0 21.7 25.0 1.3 0.1 0.1 2.0 0.6 0.0 0.0 0.3 1.6 0.1 0.3 5.5 0.0 10.7 21.5 9.4 0.0 0.0 0.1 2.4 6.3 6.0 14.0 3.0 3.7 0.0 14.2 12.8 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 12.0 20.6 8.1 0.1 1.5 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.0 28.5 0.0 0.4 0.2 0.0 4.9 4.6 6.1 3.1 4.0 3.7 4.6 4.0 3.3 4.3 1.4 MARCH1 "FLJ20668, MARCH-I, RNF171" ENSG00000145416 "Membrane associated ring-CH-type finger 1" Q8TCQ1 4 163524298-164384050 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.4;lymphoid tissue: 32.4" "Cell line enhanced" "Detected in many" "Daudi: 9.4;U-266/70: 9.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 95 "classical monocyte: 16.8;eosinophil: 9.9;intermediate monocyte: 17.0;memory B-cell: 18.5;myeloid DC: 18.1;naive B-cell: 15.7;non-classical monocyte: 17.2;plasmacytoid DC: 6.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014600 Uncertain Supported Mitochondria Mitochondria "HPA014600: AB_1853573" "unprognostic (7.29e-2)" "unprognostic (5.82e-2)" "unprognostic (1.48e-1)" "unprognostic (9.09e-2)" "unprognostic (8.25e-2)" "unprognostic (2.98e-2)" "unprognostic (4.79e-3)" "unprognostic (9.00e-2)" "unprognostic (3.00e-2)" "unprognostic (2.18e-1)" "unprognostic (1.13e-1)" "unprognostic (2.20e-1)" "unprognostic (1.24e-1)" "unprognostic (7.00e-2)" "unprognostic (2.48e-2)" "unprognostic (2.70e-1)" "unprognostic (2.91e-2)" 7.7 4.2 11.6 20.5 19.7 3.9 4.0 3.1 14.5 3.7 3.9 8.5 0.1 4.4 3.9 4.6 3.6 4.2 5.9 2.6 12.6 10.1 3.0 4.5 8.3 28.5 17.3 6.3 4.2 4.1 1.5 4.1 10.2 13.5 3.5 5.1 2.4 4.6 1.8 1.6 4.9 9.0 6.5 24.4 32.4 4.1 2.3 17.9 2.6 3.2 1.4 24.6 9.0 4.2 18.5 18.1 9.9 17.2 0.1 0.0 6.6 0.8 0.7 2.9 1.7 0.0 0.0 1.8 1.2 0.1 0.0 0.0 1.6 3.3 9.4 3.5 0.0 1.4 0.0 0.0 0.0 1.0 1.0 6.7 3.7 0.6 0.0 4.1 2.2 0.0 0.0 0.0 0.2 0.0 2.5 4.9 3.3 1.0 2.3 2.6 3.6 1.3 2.6 0.5 0.7 0.1 1.5 1.5 1.3 0.9 1.4 0.5 4.0 0.7 3.1 1.1 2.0 0.7 2.3 9.7 3.2 2.6 1.3 2.1 1.5 0.0 16.8 9.9 0.0 17.0 0.0 18.5 0.0 0.0 18.1 15.7 0.0 0.0 0.1 0.1 17.2 6.8 0.0 6.6 11.6 19.7 3.1 12.5 12.6 10.1 17.3 6.3 13.5 17.9 MARCH5 "FLJ20445, MARCH-V, MITOL, RNF153" ENSG00000198060 "Membrane associated ring-CH-type finger 5" Q9NX47 10 92291163-92353964 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056596 Supported Mitochondria Mitochondria "HPA056596: " "unprognostic (4.00e-2)" "unprognostic (5.15e-2)" "unprognostic (1.25e-1)" "unprognostic (4.10e-2)" "unprognostic (5.47e-3)" "unprognostic (2.33e-3)" "unprognostic (4.43e-1)" "unprognostic (1.63e-1)" "unprognostic (1.24e-2)" "unprognostic (9.77e-2)" "unprognostic (5.50e-3)" "unprognostic (4.02e-3)" "unprognostic (6.14e-2)" "unprognostic (2.87e-1)" "unprognostic (1.62e-1)" "unprognostic (4.53e-1)" "unprognostic (2.85e-2)" 18.2 21.7 17.5 17.7 18.3 20.7 27.1 16.8 25.7 15.5 15.4 12.7 20.7 15.8 19.3 18.8 28.0 14.8 15.4 18.4 15.8 15.1 21.7 27.6 16.5 16.6 16.3 17.9 20.9 16.7 16.3 12.3 16.3 14.8 22.2 14.8 14.5 19.4 19.3 42.6 13.7 16.0 18.1 14.0 12.1 14.4 20.1 13.5 25.0 24.5 21.5 17.3 14.7 21.0 7.3 9.4 16.8 10.2 6.5 8.7 6.6 16.4 8.9 17.6 20.2 12.1 12.6 9.1 14.7 16.2 18.4 18.9 5.9 11.8 9.6 10.2 14.4 13.6 12.3 12.3 26.5 7.2 14.5 7.7 8.4 13.9 14.6 12.3 7.7 12.8 16.7 12.1 25.5 16.1 8.4 12.0 14.7 10.4 10.8 14.1 4.1 13.5 11.8 18.1 5.7 18.8 10.7 8.2 15.2 12.8 9.5 15.6 16.5 9.6 15.6 8.6 9.5 9.4 20.1 12.2 9.3 8.5 7.9 17.0 5.7 5.2 8.3 9.0 7.6 10.2 7.6 7.3 8.4 8.0 9.4 6.7 8.7 8.3 16.8 6.5 8.5 6.2 7.8 6.6 17.5 18.3 16.8 25.7 15.8 15.1 16.3 17.9 14.8 13.5 MAVS "Cardif, IPS-1, KIAA1271, VISA" ENSG00000088888 "Mitochondrial antiviral signaling protein" Q7Z434 20 3846799-3876123 "Predicted membrane proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009187, HPA049850, HPA053524" Enhanced Enhanced Mitochondria 230000 Mitochondria "CAB009187: , HPA049850: AB_2680912, HPA053524: AB_2682177" "unprognostic (1.30e-2)" "unprognostic (4.51e-2)" "unprognostic (2.17e-1)" "unprognostic (6.67e-2)" "unprognostic (1.42e-1)" "unprognostic (1.75e-1)" "unprognostic (1.18e-3)" "unprognostic (2.23e-2)" "unprognostic (2.30e-2)" "unprognostic (5.95e-2)" "prognostic favourable (3.81e-4)" "unprognostic (1.92e-1)" "prognostic favourable (4.13e-5)" "unprognostic (4.97e-2)" "unprognostic (3.03e-1)" "unprognostic (3.12e-2)" "unprognostic (7.39e-2)" 15.9 13.9 13.0 15.5 17.7 10.8 25.5 17.7 15.7 12.3 18.5 17.2 15.1 17.2 14.9 10.6 17.3 13.8 12.2 15.4 12.3 8.0 13.3 13.9 18.1 17.4 19.9 9.0 18.9 22.5 23.4 13.7 12.0 13.8 13.1 18.6 13.6 15.3 22.4 39.4 22.1 17.0 17.1 13.7 12.7 15.8 5.9 17.1 15.1 14.6 14.0 14.3 18.2 21.6 5.1 5.6 6.4 6.9 5.9 4.8 4.6 17.2 20.1 8.2 10.2 22.6 15.5 6.4 10.5 13.4 11.2 8.2 15.7 11.2 7.5 6.4 14.7 21.8 9.8 15.7 11.5 4.6 4.7 14.4 7.4 24.9 12.5 9.0 6.1 15.6 13.4 18.9 11.3 11.3 16.2 5.8 10.9 15.6 13.6 7.7 5.2 11.1 10.3 11.4 7.5 11.9 17.4 6.2 6.4 11.9 23.3 10.0 12.4 8.4 17.0 15.3 5.7 18.0 12.1 11.9 14.2 5.3 6.1 11.1 7.7 4.4 6.9 6.1 4.8 5.1 3.6 3.8 3.8 3.7 4.4 5.1 4.4 4.4 6.4 5.9 5.5 5.6 3.0 4.6 13.0 17.7 17.7 15.7 12.3 8.0 19.9 9.0 13.8 17.1 MCAT "fabD, FASN2C, MCT, MCT1, MT, NET62" ENSG00000100294 "Malonyl-CoA-acyl carrier protein transacylase" Q8IVS2 22 43132206-43143394 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003122, HPA035471" Approved Supported Mitochondria Mitochondria "HPA003122: , HPA035471: AB_10670590" "unprognostic (1.05e-1)" "unprognostic (1.57e-2)" "unprognostic (1.39e-2)" "prognostic favourable (5.53e-4)" "unprognostic (3.52e-1)" "unprognostic (1.34e-1)" "unprognostic (1.36e-3)" "unprognostic (4.71e-2)" "unprognostic (5.13e-2)" "unprognostic (2.94e-1)" "unprognostic (1.32e-1)" "unprognostic (9.86e-2)" "prognostic favourable (2.18e-4)" "prognostic favourable (3.89e-4)" "unprognostic (3.67e-2)" "unprognostic (1.76e-1)" "unprognostic (3.08e-1)" 10.4 18.2 13.3 8.2 17.2 11.0 12.8 10.4 24.6 10.6 11.9 9.4 10.7 9.5 11.0 17.2 12.3 20.7 21.4 12.9 14.4 14.2 25.6 24.3 8.6 7.1 12.0 12.0 14.4 16.2 20.3 14.3 9.2 15.1 12.8 10.6 9.9 14.5 10.2 17.7 11.7 9.7 8.6 6.0 7.6 12.1 19.6 5.2 18.4 20.1 14.0 9.9 8.5 8.1 10.2 13.9 2.5 9.5 11.6 10.3 5.6 7.1 9.4 6.7 11.7 5.6 6.0 6.8 8.0 7.1 10.8 10.1 9.4 7.3 12.0 8.3 5.9 12.0 12.6 10.6 8.1 4.1 37.3 4.5 10.8 10.4 9.0 21.3 5.4 4.5 10.3 10.5 8.4 7.7 10.5 4.9 5.2 13.2 9.9 23.2 6.4 16.7 13.2 6.6 19.0 13.5 6.2 8.8 4.7 8.6 16.8 12.1 8.7 13.8 4.6 4.7 9.3 10.2 11.2 8.8 9.0 8.6 10.1 8.1 5.6 0.0 9.5 0.7 7.7 9.1 10.3 8.3 8.6 10.1 13.9 10.2 10.1 7.1 2.5 11.6 5.5 13.7 5.5 5.6 13.3 17.2 10.4 24.6 14.4 14.2 12.0 12.0 15.1 5.2 MCCC1 MCCA ENSG00000078070 "Methylcrotonoyl-CoA carboxylase 1" Q96RQ3 3 183015218-183116075 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 52.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008310 Approved Supported Mitochondria "Intracellular and membrane" Mitochondria "HPA008310: AB_1853620" "unprognostic (4.01e-2)" "unprognostic (1.83e-3)" "unprognostic (2.05e-2)" "unprognostic (2.59e-3)" "unprognostic (3.46e-2)" "unprognostic (4.16e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-3)" "unprognostic (2.57e-3)" "unprognostic (9.82e-2)" "unprognostic (9.74e-2)" "unprognostic (7.65e-2)" "prognostic favourable (3.68e-4)" "unprognostic (4.73e-1)" "unprognostic (2.21e-1)" "unprognostic (2.95e-1)" "unprognostic (1.36e-1)" 25.1 26.0 14.1 10.4 16.4 9.0 24.6 23.1 20.6 9.0 12.6 15.1 10.1 12.6 11.0 11.4 15.8 9.5 11.6 24.4 12.2 10.1 42.4 41.1 13.8 8.0 17.0 14.4 12.8 32.3 10.2 15.8 5.5 13.4 11.4 13.7 9.9 14.2 15.6 19.4 11.5 10.1 11.3 10.5 8.3 17.7 8.9 16.4 8.9 14.0 8.5 13.2 23.2 9.5 13.1 19.4 17.1 11.3 18.9 11.6 7.6 14.1 5.4 3.4 3.6 15.0 6.8 6.9 6.5 9.1 7.2 8.2 7.4 5.7 15.6 10.6 5.7 7.3 5.2 4.3 9.2 5.2 5.8 13.3 6.2 7.8 9.9 8.9 7.6 7.7 4.9 3.4 7.7 9.6 7.3 8.2 8.0 11.6 8.6 4.4 3.8 5.9 7.2 7.7 20.0 10.5 22.5 7.7 5.6 24.9 34.4 7.0 52.6 12.5 4.6 5.5 4.4 4.4 9.6 8.4 15.4 15.8 6.0 12.8 5.1 8.5 9.7 17.1 8.3 11.3 9.4 13.1 10.8 9.0 19.4 11.1 11.6 10.4 1.6 18.9 11.2 12.7 6.8 7.6 14.1 16.4 23.1 20.6 12.2 10.1 17.0 14.4 13.4 16.4 MCCC2 MCCB ENSG00000131844 "Methylcrotonoyl-CoA carboxylase 2" Q9HCC0 5 71587288-71658704 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 74.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038300, HPA038301, HPA061546" Enhanced Enhanced Mitochondria Mitochondria "HPA038300: AB_2675941, HPA038301: AB_10670661, HPA061546: AB_2684557" "unprognostic (2.39e-1)" "unprognostic (6.89e-3)" "prognostic favourable (3.62e-4)" "unprognostic (1.79e-2)" "unprognostic (1.89e-2)" "unprognostic (8.07e-2)" "prognostic favourable (1.70e-4)" "unprognostic (1.01e-1)" "unprognostic (3.37e-1)" "unprognostic (5.39e-2)" "unprognostic (2.90e-1)" "unprognostic (2.38e-1)" "prognostic favourable (6.43e-8)" "unprognostic (1.27e-1)" "unprognostic (1.29e-1)" "unprognostic (5.15e-2)" "unprognostic (3.47e-2)" 12.4 29.4 9.2 11.8 13.6 2.7 30.5 7.9 10.0 11.2 15.3 12.2 15.1 13.0 9.7 20.0 14.5 9.1 12.3 74.3 7.6 8.1 35.6 61.9 8.4 11.6 7.8 8.0 9.6 18.9 14.1 10.3 15.1 13.4 24.6 18.1 12.8 20.6 29.4 17.6 10.8 14.1 7.8 17.0 11.0 13.6 6.9 6.9 9.4 22.2 13.3 14.3 15.7 8.5 8.8 16.7 1.7 11.5 12.9 10.2 6.7 11.8 16.3 7.0 26.9 7.5 7.8 12.0 5.6 9.5 11.7 8.5 28.7 15.1 27.5 20.9 8.2 9.8 12.2 18.9 14.7 14.5 15.6 14.9 8.5 31.5 13.2 7.4 14.2 9.9 9.9 10.7 8.5 10.3 18.8 10.3 8.1 32.3 0.1 13.5 9.2 9.2 14.4 20.2 40.4 30.4 21.4 11.1 12.3 24.7 36.7 12.0 30.4 18.8 7.5 4.8 7.4 8.6 15.2 7.4 13.7 17.0 7.8 20.6 11.8 1.7 7.4 1.6 6.1 11.5 7.9 8.8 7.9 6.9 16.7 8.6 8.0 8.7 1.2 12.9 6.8 7.4 10.2 6.7 9.2 13.6 7.9 10.0 7.6 8.1 7.8 8.0 13.4 6.9 MCL1 "BCL2L3, Mcl-1" ENSG00000143384 "MCL1, BCL2 family apoptosis regulator" Q07820 1 150574551-150579738 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 12 "U-698: 328.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 42.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002781, HPA008455, HPA031125, CAB068195" Approved Enhanced Mitochondria Mitochondria "CAB002781: , CAB068195: , HPA008455: AB_1079334, HPA031125: AB_10602026" "unprognostic (3.82e-2)" "unprognostic (8.79e-2)" "unprognostic (9.15e-2)" "unprognostic (2.05e-2)" "unprognostic (1.34e-1)" "unprognostic (3.91e-2)" "unprognostic (3.16e-2)" "unprognostic (2.43e-2)" "unprognostic (1.29e-1)" "unprognostic (8.60e-2)" "unprognostic (1.57e-2)" "unprognostic (1.65e-2)" "prognostic unfavourable (7.16e-4)" "unprognostic (3.22e-2)" "unprognostic (1.94e-1)" "unprognostic (4.87e-2)" "unprognostic (4.46e-2)" 67.7 37.1 19.0 59.3 21.6 134.5 46.3 15.3 18.9 35.9 38.5 19.0 23.9 21.2 36.1 27.6 56.5 57.2 73.3 32.5 20.4 14.9 30.5 76.7 61.8 52.4 28.2 11.4 32.1 41.9 20.3 27.7 59.4 26.7 34.0 30.7 31.0 36.0 24.5 39.8 45.7 50.2 38.9 26.4 51.1 44.3 19.8 23.0 32.3 45.4 53.3 57.4 40.6 59.4 5.0 6.2 42.1 8.0 3.8 11.1 3.9 9.8 5.0 9.4 5.6 19.1 20.2 12.9 12.1 12.4 12.7 10.3 6.3 8.1 12.5 7.1 8.6 13.2 7.1 14.4 12.8 10.3 4.9 5.1 8.1 7.2 15.1 8.6 11.6 11.0 16.6 12.4 24.2 13.9 11.4 18.2 16.6 10.8 4.2 6.6 17.4 8.9 6.5 7.6 6.5 14.0 7.1 7.3 9.9 8.6 11.7 15.5 7.4 13.3 17.1 8.1 8.5 5.1 15.1 23.3 27.3 328.0 13.9 6.8 10.6 7.6 8.0 18.8 6.1 6.5 7.2 5.0 8.0 6.7 6.2 4.6 9.6 7.2 42.1 3.8 5.8 3.7 11.1 3.9 19.0 21.6 15.3 18.9 20.4 14.9 28.2 11.4 26.7 23.0 MCU "C10orf42, CCDC109A, FLJ46135" ENSG00000156026 "Mitochondrial calcium uniporter" Q8NE86 10 72692131-72887694 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 41.0" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016480 Approved Supported Mitochondria 1400000 Mitochondria "HPA016480: AB_2071893" "unprognostic (2.42e-2)" "unprognostic (1.58e-2)" "unprognostic (3.01e-2)" "unprognostic (5.37e-2)" "unprognostic (7.84e-2)" "unprognostic (3.05e-1)" "prognostic unfavourable (6.06e-5)" "unprognostic (1.23e-1)" "unprognostic (2.28e-1)" "unprognostic (2.33e-1)" "unprognostic (5.12e-3)" "unprognostic (1.73e-1)" "prognostic favourable (5.07e-4)" "unprognostic (4.51e-2)" "unprognostic (3.79e-1)" "unprognostic (2.74e-2)" "unprognostic (2.48e-2)" 8.2 6.5 6.3 9.4 6.1 12.3 9.8 41.0 6.8 7.0 19.8 4.1 8.5 19.1 10.9 7.4 13.4 7.8 11.5 6.9 4.8 4.3 11.1 7.2 10.1 7.4 3.4 4.1 5.8 12.1 8.2 5.5 8.8 5.5 4.6 21.9 5.1 9.5 5.8 41.4 9.0 23.0 11.0 3.8 4.9 29.4 4.7 3.5 4.9 5.4 14.9 7.3 10.1 15.0 3.4 5.4 16.6 7.6 1.9 4.6 3.6 19.7 32.0 8.3 6.0 12.7 14.3 8.5 12.2 17.4 12.2 13.0 19.0 18.9 8.4 9.8 14.8 18.0 10.9 14.5 16.3 9.2 10.2 10.5 12.0 10.5 9.9 26.3 8.9 14.5 12.3 10.9 23.4 14.6 6.5 6.3 11.3 11.4 7.1 5.7 9.1 6.7 7.4 17.8 2.2 16.5 10.8 8.9 3.9 15.0 16.8 3.6 3.3 6.9 11.8 5.9 10.2 12.7 8.1 4.7 5.9 5.9 7.9 13.2 4.5 1.7 6.1 16.6 2.9 6.7 3.1 3.4 3.0 3.5 5.4 1.7 2.3 2.6 8.2 1.9 7.6 1.9 4.6 3.6 6.3 6.1 41.0 6.8 4.8 4.3 3.4 4.1 5.5 3.5 MDH2 ENSG00000146701 "Malate dehydrogenase 2" P40926 7 76048051-76067508 "Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 175.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019714, HPA019716, HPA019848, HPA026720" Enhanced Enhanced Mitochondria 47000000 Mitochondria "HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685" "unprognostic (3.20e-2)" "unprognostic (2.85e-1)" "unprognostic (1.11e-1)" "unprognostic (1.43e-2)" "unprognostic (5.55e-3)" "unprognostic (8.94e-2)" "unprognostic (6.45e-2)" "unprognostic (3.77e-2)" "unprognostic (3.60e-1)" "unprognostic (2.02e-2)" "unprognostic (1.40e-1)" "unprognostic (9.70e-2)" "prognostic favourable (1.49e-5)" "unprognostic (8.57e-2)" "unprognostic (9.64e-2)" "unprognostic (5.68e-2)" "unprognostic (2.66e-1)" 18.1 39.1 17.4 15.4 20.6 18.3 22.2 15.3 34.4 14.9 27.0 13.5 16.9 32.5 16.6 13.5 31.8 19.4 17.6 103.1 17.1 18.8 29.1 101.9 13.8 26.6 17.4 21.9 17.3 35.5 16.8 16.9 17.5 20.5 17.9 24.3 15.0 26.8 21.5 175.8 24.6 26.7 21.9 12.8 21.1 22.3 17.6 9.5 22.4 20.1 76.2 23.8 19.9 17.8 37.1 52.8 22.1 45.3 30.1 45.6 44.7 28.6 47.0 17.0 42.6 19.5 21.4 29.3 19.3 24.9 27.6 25.0 41.3 34.5 43.4 8.7 25.4 29.3 43.7 28.8 19.8 30.9 63.2 24.1 25.3 38.1 24.0 37.4 24.9 27.0 25.7 26.8 40.1 25.7 75.8 25.4 25.5 64.9 32.4 66.1 37.9 59.3 26.5 21.0 62.4 25.8 37.9 42.7 38.9 19.3 96.8 39.7 55.0 42.3 19.8 27.8 26.3 30.0 38.3 28.5 23.5 48.0 24.1 48.0 42.1 22.1 38.9 18.2 32.7 43.5 34.2 37.1 36.9 35.3 52.8 32.1 36.0 33.1 10.2 30.1 45.3 47.1 45.6 44.7 17.4 20.6 15.3 34.4 17.1 18.8 17.4 21.9 20.5 9.5 ME2 ENSG00000082212 "Malic enzyme 2" P23368 18 50878734-50954257 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Allosteric enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008247, HPA008880" Enhanced Supported Mitochondria 3400000 Mitochondria "HPA008247: AB_1853704, HPA008880: AB_1853702" "unprognostic (1.23e-1)" "unprognostic (3.26e-1)" "unprognostic (9.57e-3)" "unprognostic (2.22e-1)" "unprognostic (4.97e-2)" "unprognostic (1.23e-1)" "prognostic unfavourable (8.29e-8)" "unprognostic (1.97e-1)" "unprognostic (3.66e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-2)" "unprognostic (4.75e-2)" "unprognostic (1.43e-2)" "unprognostic (4.27e-3)" "unprognostic (2.30e-1)" "unprognostic (2.47e-1)" "unprognostic (4.09e-1)" 12.6 18.1 17.1 18.4 16.2 11.6 10.7 13.2 16.0 9.4 26.4 14.3 16.8 30.2 10.5 7.7 10.6 9.3 10.5 34.6 15.8 17.8 12.1 12.1 10.3 24.1 18.7 14.0 11.1 16.7 20.6 20.2 10.5 47.7 11.8 26.6 9.4 8.8 23.1 29.5 7.1 44.8 16.9 18.9 36.6 20.3 15.3 8.7 24.3 9.0 7.8 17.3 14.2 15.7 4.9 9.6 14.3 17.4 6.7 6.0 4.5 12.9 13.0 17.4 20.2 7.9 8.8 8.0 10.8 8.1 14.2 12.0 5.9 7.1 46.2 4.3 9.6 10.8 25.8 10.9 16.3 19.1 4.0 11.8 8.2 6.9 23.4 39.2 14.2 5.4 13.5 17.8 29.0 18.1 12.5 11.3 9.6 2.7 28.3 3.9 11.6 5.3 18.6 8.6 13.3 15.4 2.8 21.5 11.4 10.1 6.2 10.8 4.7 19.0 11.1 10.1 11.3 5.2 14.3 21.1 8.5 22.7 10.2 28.0 10.7 5.0 11.6 14.3 5.0 13.1 4.1 4.9 3.3 6.0 9.6 4.9 2.9 3.5 13.3 6.7 17.4 3.2 3.1 4.5 17.1 16.2 13.2 16.0 15.8 17.8 18.7 14.0 47.7 8.7 MECR "CGI-63, ETR1, FASN2B, NRBF1" ENSG00000116353 "Mitochondrial trans-2-enoyl-CoA reductase" Q9BV79 1 29192873-29230942 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA022018, HPA022030, HPA028740" Enhanced Supported Mitochondria Mitochondria "HPA022018: AB_1853714, HPA022030: AB_1853716, HPA028740: AB_10601133" "unprognostic (2.53e-1)" "unprognostic (1.09e-2)" "unprognostic (1.52e-1)" "unprognostic (1.84e-1)" "unprognostic (1.07e-1)" "unprognostic (2.46e-1)" "unprognostic (1.39e-1)" "unprognostic (2.07e-1)" "unprognostic (1.34e-1)" "unprognostic (1.69e-1)" "unprognostic (3.06e-2)" "unprognostic (8.66e-2)" "prognostic favourable (5.81e-6)" "unprognostic (7.01e-3)" "unprognostic (3.29e-2)" "unprognostic (2.59e-1)" "prognostic unfavourable (5.29e-4)" 16.4 11.9 16.0 6.6 17.0 6.0 12.3 7.8 17.7 13.0 9.7 8.6 7.1 7.8 10.5 8.4 9.4 10.9 8.5 24.8 15.7 11.5 11.0 13.7 8.3 10.0 14.7 16.3 11.7 14.3 8.1 10.0 10.8 12.8 7.5 8.9 10.8 12.6 10.0 45.5 11.3 5.9 10.2 10.7 5.4 8.1 8.2 10.5 4.4 8.3 12.8 7.6 8.0 7.2 8.3 14.7 0.3 11.5 11.6 13.1 6.5 10.3 9.9 4.8 22.5 4.9 8.8 17.8 7.8 8.9 10.3 10.0 7.5 21.2 13.6 15.8 7.7 12.9 6.1 16.0 6.4 9.3 12.6 11.8 6.3 9.5 15.4 13.0 6.0 8.7 14.2 5.4 20.1 11.3 10.1 14.1 12.8 11.6 11.0 7.2 13.0 12.7 6.8 8.2 24.0 10.9 6.0 7.4 11.4 11.6 16.5 14.5 6.1 12.6 11.4 7.5 8.1 11.7 11.6 13.5 5.6 10.2 20.2 17.4 14.1 0.1 7.0 0.0 8.3 11.5 13.1 8.3 7.8 6.7 14.7 7.4 8.4 8.5 0.3 11.6 7.0 8.6 6.3 6.5 16.0 17.0 7.8 17.7 15.7 11.5 14.7 16.3 12.8 10.5 METTL4 "FLJ23017, HsT661" ENSG00000101574 "Methyltransferase like 4" Q8N3J2 18 2537525-2571509 "Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040061, HPA046734" Approved Approved Mitochondria Mitochondria "HPA040061: AB_10697713, HPA046734: " "unprognostic (1.85e-2)" "unprognostic (1.27e-1)" "unprognostic (7.31e-2)" "unprognostic (1.07e-1)" "unprognostic (1.11e-1)" "unprognostic (5.06e-3)" "unprognostic (1.12e-5)" "unprognostic (1.74e-1)" "unprognostic (5.12e-2)" "unprognostic (2.23e-2)" "unprognostic (2.24e-1)" "unprognostic (1.89e-1)" "unprognostic (7.72e-2)" "unprognostic (3.26e-1)" "unprognostic (4.00e-1)" "unprognostic (2.96e-2)" "unprognostic (1.05e-3)" 13.2 8.9 10.1 13.5 15.7 6.1 15.8 18.4 15.6 13.5 10.6 8.6 15.7 9.7 14.0 12.3 11.9 11.1 10.9 9.9 10.1 11.8 10.5 9.2 11.2 19.9 15.9 8.5 13.9 8.6 16.3 23.6 10.4 14.2 12.9 12.7 10.1 17.7 15.6 6.4 11.0 14.6 12.6 17.3 19.9 10.0 12.4 15.8 15.3 16.2 7.2 19.5 13.8 16.8 7.5 3.5 14.4 2.5 5.6 9.4 4.8 7.6 3.3 10.6 6.3 4.8 7.4 12.2 12.1 11.0 12.6 12.5 6.7 5.8 16.2 7.6 5.6 6.8 17.0 6.4 16.3 11.6 5.8 6.2 6.7 5.7 7.4 14.3 8.2 4.8 14.5 12.9 8.3 13.0 8.6 20.3 10.8 3.8 10.7 4.7 6.1 5.5 7.3 8.4 11.1 7.4 4.8 19.0 8.7 9.6 6.6 12.6 7.5 9.9 8.4 14.5 18.2 14.0 17.2 10.1 25.9 9.4 9.7 10.1 16.7 14.4 2.5 6.5 6.6 2.3 8.0 6.8 7.6 8.6 1.9 7.5 9.4 8.6 10.1 5.6 2.0 3.5 8.4 4.8 10.1 15.7 18.4 15.6 10.1 11.8 15.9 8.5 14.2 15.8 MFF "C2orf33, GL004" ENSG00000168958 "Mitochondrial fission factor" Q9GZY8 2 227325151-227357836 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010968, HPA074625" Enhanced Supported Mitochondria Mitochondria "HPA010968: AB_1845714, HPA074625: " "unprognostic (2.75e-2)" "unprognostic (1.35e-1)" "unprognostic (2.16e-1)" "unprognostic (1.15e-2)" "unprognostic (1.73e-2)" "unprognostic (1.46e-1)" "prognostic unfavourable (1.20e-4)" "unprognostic (3.07e-2)" "unprognostic (1.32e-1)" "unprognostic (6.07e-2)" "unprognostic (3.00e-2)" "unprognostic (6.24e-3)" "unprognostic (5.50e-2)" "unprognostic (1.00e-1)" "unprognostic (2.70e-2)" "unprognostic (1.51e-1)" "unprognostic (3.22e-1)" 20.2 23.9 31.6 18.0 27.6 22.3 21.3 25.7 38.4 19.6 22.5 26.5 14.7 22.1 21.9 20.9 21.5 18.0 17.1 40.5 27.8 28.4 33.7 24.4 16.6 27.1 30.2 20.2 25.7 27.6 25.0 19.3 17.7 28.0 20.6 22.5 25.6 20.6 27.6 37.4 16.7 18.6 22.9 33.4 16.9 18.8 97.0 20.6 25.9 19.8 22.2 23.3 20.7 17.8 40.2 34.9 59.9 33.8 29.3 44.1 33.1 22.8 19.6 24.2 33.3 31.3 30.2 32.1 22.8 30.9 27.9 29.8 21.4 16.4 13.1 27.3 24.9 19.0 39.8 29.0 37.9 27.7 31.9 27.6 50.8 53.5 41.4 26.7 24.8 27.0 38.3 26.4 28.3 24.0 24.0 39.4 24.6 23.1 28.2 41.1 32.8 20.8 25.6 30.6 25.3 40.7 21.6 25.7 24.1 50.1 23.3 33.3 14.9 26.5 16.2 27.2 23.0 40.1 25.3 32.1 21.8 26.3 35.9 23.8 36.9 42.4 32.9 59.9 32.8 33.8 35.3 40.2 34.5 32.0 34.5 38.2 36.6 31.0 31.0 29.3 30.6 34.9 44.1 33.1 31.6 27.6 25.7 38.4 27.8 28.4 30.2 20.2 28.0 20.6 MFN1 FLJ20693 ENSG00000171109 "Mitofusin 1" 3 179347692-179394931 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033437, HPA059230" Approved Supported Mitochondria Mitochondria "CAB033437: AB_2250540, HPA059230: " "unprognostic (2.94e-2)" "unprognostic (5.56e-2)" "unprognostic (5.44e-3)" "prognostic unfavourable (6.70e-4)" "prognostic favourable (6.11e-4)" "unprognostic (1.23e-1)" "prognostic unfavourable (8.08e-5)" "unprognostic (6.37e-2)" "unprognostic (1.86e-2)" "unprognostic (3.70e-2)" "unprognostic (3.76e-3)" "unprognostic (7.91e-2)" "unprognostic (7.90e-2)" "unprognostic (1.58e-1)" "unprognostic (3.83e-1)" "unprognostic (6.24e-2)" "unprognostic (9.79e-2)" 13.7 16.5 12.2 12.1 17.2 9.9 15.4 24.3 22.4 18.4 16.5 15.9 19.4 12.0 19.6 21.3 19.6 18.5 13.4 31.1 12.0 11.4 17.9 14.9 12.3 16.0 16.9 14.5 16.6 29.9 18.2 22.3 12.4 21.5 17.7 14.6 12.8 17.4 17.4 21.7 19.6 16.6 15.7 16.0 18.2 17.8 11.8 17.0 16.9 14.5 20.1 19.6 17.6 15.1 10.5 4.1 8.9 4.5 4.1 7.3 2.1 16.7 5.0 9.7 15.7 13.9 13.0 12.9 10.4 10.8 11.0 13.2 12.4 6.9 5.7 11.0 15.4 9.9 13.6 10.3 19.4 8.9 10.5 9.3 11.6 6.8 11.4 4.9 8.9 9.0 9.1 11.9 8.4 14.0 6.8 7.6 15.4 8.9 7.2 3.7 11.5 9.3 5.1 15.3 21.1 10.5 17.7 9.2 13.1 9.8 26.3 14.2 36.0 3.6 11.7 9.7 10.8 15.0 15.2 10.2 11.0 9.5 10.8 8.3 10.4 5.5 3.8 8.5 4.3 4.5 7.3 7.8 4.9 4.4 3.4 10.5 4.6 5.1 8.9 4.1 3.6 4.1 4.4 2.1 12.2 17.2 24.3 22.4 12.0 11.4 16.9 14.5 21.5 17.0 MGARP "C4orf49, CESP-1, HUMMR, OSAP" ENSG00000137463 "Mitochondria localized glutamic acid rich protein" Q8TDB4 4 139266163-139280338 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 88.9;retina: 30.7" "Cell line enhanced" "Detected in some" "BJ: 10.5;fHDF/TERT166: 15.6;HHSteC: 12.7;HUVEC TERT2: 31.7" "Cancer enhanced" "Detected in some" "renal cancer: 4.1" "Group enriched" "Detected in many" 4 "basal ganglia: 4.5;cerebellum: 8.0" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" HPA015994 Enhanced Supported Mitochondria Mitochondria "HPA015994: " "unprognostic (2.68e-1)" "unprognostic (1.73e-1)" "unprognostic (8.18e-2)" "unprognostic (4.25e-2)" "unprognostic (3.54e-2)" "unprognostic (3.11e-2)" "unprognostic (3.42e-2)" "unprognostic (1.02e-3)" "unprognostic (2.90e-2)" "unprognostic (4.96e-2)" "unprognostic (1.50e-2)" "unprognostic (1.31e-1)" "unprognostic (4.08e-2)" "unprognostic (1.47e-2)" "unprognostic (9.91e-2)" "unprognostic (2.09e-2)" "unprognostic (2.36e-1)" 3.2 88.9 1.0 0.5 4.5 0.4 1.2 8.0 1.2 3.6 1.0 2.1 1.1 0.4 2.6 3.0 0.5 0.8 1.3 6.1 0.8 1.4 1.0 0.4 0.5 0.6 1.0 0.0 20.1 0.5 0.4 15.3 0.5 1.5 2.0 0.5 30.7 0.4 2.0 0.6 0.5 0.4 2.3 0.7 0.6 0.4 5.9 0.5 0.0 0.5 0.0 0.5 2.1 1.0 0.5 0.0 0.0 0.3 0.5 1.7 0.3 0.0 0.5 0.3 0.2 0.8 0.4 0.0 10.5 0.0 1.5 0.0 0.0 0.1 0.0 0.1 15.6 0.2 2.2 0.0 0.9 0.0 1.0 0.0 0.0 0.1 12.7 0.1 0.1 3.8 0.3 1.7 0.1 31.7 0.2 0.2 2.6 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.6 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.2 4.4 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 1.7 0.4 0.0 0.3 1.6 0.7 0.0 0.5 0.2 0.0 0.3 0.3 1.0 4.5 8.0 1.2 0.8 1.4 1.0 0.0 1.5 0.5 MGME1 "bA504H3.4, C20orf72, DDK1" ENSG00000125871 "Mitochondrial genome maintenance exonuclease 1" Q9BQP7 20 17968913-17991122 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040913 Approved Supported Mitochondria Mitochondria "HPA040913: AB_10962835" "unprognostic (5.81e-3)" "unprognostic (5.96e-2)" "unprognostic (1.28e-1)" "unprognostic (1.29e-3)" "unprognostic (5.42e-2)" "unprognostic (1.44e-2)" "prognostic unfavourable (6.98e-8)" "unprognostic (5.31e-2)" "unprognostic (7.05e-2)" "unprognostic (2.91e-2)" "unprognostic (1.06e-2)" "unprognostic (7.45e-2)" "prognostic unfavourable (1.13e-7)" "unprognostic (2.04e-1)" "unprognostic (3.22e-2)" "unprognostic (8.70e-2)" "unprognostic (6.89e-2)" 8.7 14.2 6.4 12.0 7.6 10.9 14.9 7.0 6.7 8.4 10.5 11.7 8.2 10.2 7.3 8.6 14.3 5.4 6.5 10.5 7.3 4.8 10.5 11.3 6.5 13.9 11.5 7.2 5.8 9.6 7.1 14.1 19.9 8.4 8.5 10.7 10.4 11.0 7.8 17.8 26.9 10.9 5.2 9.8 19.5 7.6 12.9 8.3 31.8 15.5 7.6 16.9 10.6 9.6 13.2 10.9 24.1 8.5 8.8 9.2 4.5 16.9 19.7 16.2 15.2 6.7 11.8 21.8 14.3 10.6 13.8 18.9 24.3 17.3 20.2 8.1 6.3 25.4 16.7 21.3 21.1 7.4 13.8 13.1 11.0 36.6 4.9 8.5 22.5 7.1 15.0 20.5 10.8 11.0 17.8 13.2 27.7 12.7 15.2 11.7 14.2 17.5 11.6 36.3 19.1 12.0 12.5 12.5 10.4 10.1 24.7 21.6 23.6 6.0 8.8 24.0 19.4 11.8 15.4 9.9 22.0 17.3 6.1 6.6 17.4 24.0 8.5 24.1 4.9 8.1 6.4 11.4 6.3 6.4 6.8 13.2 4.5 4.3 8.2 8.8 7.5 10.9 9.2 4.5 6.4 7.6 7.0 6.7 7.3 4.8 11.5 7.2 8.4 8.3 MICU1 "CALC, CBARA1, EFHA3, FLJ12684" ENSG00000107745 "Mitochondrial calcium uptake 1" Q9BPX6 10 72367327-72626191 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" Allergen "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037479, HPA037480" Uncertain Supported Mitochondria Mitochondria "HPA037479: AB_2675495, HPA037480: AB_10696934" "unprognostic (8.18e-2)" "unprognostic (6.98e-3)" "unprognostic (6.71e-2)" "unprognostic (8.06e-2)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (8.91e-2)" "unprognostic (3.60e-2)" "unprognostic (2.96e-3)" "unprognostic (3.38e-2)" "unprognostic (7.43e-2)" "unprognostic (2.23e-2)" "prognostic favourable (4.66e-7)" "unprognostic (1.70e-1)" "unprognostic (1.55e-1)" "unprognostic (5.35e-2)" "unprognostic (6.70e-2)" 16.8 36.4 22.9 14.4 25.3 17.0 15.4 56.3 30.7 18.2 16.9 18.9 11.6 20.9 29.7 14.3 13.3 20.5 18.6 24.0 23.3 21.7 58.9 64.7 16.7 11.2 20.9 22.7 25.0 11.6 21.1 23.4 16.3 25.2 14.9 19.2 15.1 15.5 13.8 36.9 16.3 21.5 22.2 17.5 18.1 24.1 11.8 15.0 15.1 13.8 14.6 11.9 20.0 15.2 6.5 9.5 39.0 21.7 5.6 6.5 11.5 15.8 28.0 17.9 20.9 28.9 27.2 8.1 17.5 39.8 26.2 36.2 16.4 30.1 21.5 14.9 24.5 19.0 22.4 15.8 31.0 19.1 18.3 14.5 15.7 23.7 22.9 19.9 16.0 27.1 14.3 28.7 26.8 22.5 22.3 25.4 30.4 14.4 17.4 18.9 7.5 6.8 19.1 24.1 14.1 32.1 11.8 13.8 19.8 20.7 25.9 16.1 15.4 19.3 13.8 13.0 20.2 25.7 14.5 13.5 22.4 15.1 26.0 26.6 8.8 7.3 21.7 39.0 6.5 18.3 5.7 5.8 5.8 6.0 9.5 6.5 5.7 4.8 18.3 5.6 18.4 6.1 5.5 11.5 22.9 25.3 56.3 30.7 23.3 21.7 20.9 22.7 25.2 15.0 MIGA1 "FAM73A, FLJ35093" ENSG00000180488 "Mitoguardin 1" Q8NAN2 1 77779624-77879539 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017589 Approved Supported Mitochondria Mitochondria "HPA017589: AB_1848409" "unprognostic (3.27e-1)" "unprognostic (1.19e-2)" "unprognostic (7.31e-3)" "unprognostic (4.62e-3)" "unprognostic (2.40e-1)" "unprognostic (3.48e-2)" "unprognostic (2.70e-2)" "unprognostic (7.27e-2)" "unprognostic (1.88e-1)" "unprognostic (1.02e-1)" "unprognostic (1.30e-1)" "unprognostic (6.82e-2)" "unprognostic (3.13e-3)" "unprognostic (1.89e-1)" "unprognostic (1.68e-1)" "unprognostic (4.71e-2)" "unprognostic (4.75e-2)" 11.7 11.0 12.2 6.9 23.7 8.1 19.2 18.1 25.4 10.5 8.2 20.3 7.2 9.7 12.0 7.5 8.7 9.1 10.3 8.6 15.7 16.1 20.2 11.2 8.3 6.6 19.2 19.7 12.7 8.9 28.0 13.9 10.1 26.4 13.3 8.0 7.6 12.1 9.6 15.7 7.6 10.6 10.1 29.9 7.5 9.8 7.6 18.8 5.9 21.8 5.1 5.9 10.5 8.1 6.2 3.7 7.3 6.8 5.8 6.7 3.2 8.5 5.5 3.5 4.4 8.6 11.2 9.2 12.4 5.9 7.3 7.5 6.1 5.9 3.7 13.8 8.5 5.9 4.7 7.3 13.9 5.4 4.8 4.3 6.8 2.8 8.8 4.0 3.4 8.0 8.0 14.9 10.9 7.3 2.4 5.1 11.0 1.3 3.9 2.3 3.0 6.9 2.1 8.5 1.9 8.8 9.3 7.0 5.7 5.7 8.7 15.8 3.3 2.6 11.7 10.5 4.9 15.8 12.9 3.0 4.3 2.3 9.3 3.5 4.5 7.3 5.5 6.6 5.9 6.8 6.2 4.6 4.7 4.7 3.7 6.2 6.7 5.9 3.5 5.8 4.3 3.0 4.3 3.2 12.2 23.7 18.1 25.4 15.7 16.1 19.2 19.7 26.4 18.8 MINOS1 "C1orf151, FLJ36999, Mic10, MIO10, RP5-1056L3.2" ENSG00000173436 "Mitochondrial inner membrane organizing system 1" Q5TGZ0 1 19596977-19629821 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059930 Enhanced Supported Mitochondria Mitochondria "HPA059930: " "unprognostic (3.84e-2)" "unprognostic (8.74e-3)" "unprognostic (2.66e-2)" "unprognostic (3.03e-1)" "unprognostic (1.35e-1)" "unprognostic (6.98e-2)" "prognostic unfavourable (7.23e-4)" "unprognostic (2.88e-1)" "unprognostic (8.74e-2)" "unprognostic (3.96e-1)" "unprognostic (1.37e-1)" "unprognostic (2.43e-2)" "unprognostic (1.24e-3)" "unprognostic (7.13e-2)" "unprognostic (1.20e-1)" "unprognostic (2.03e-2)" "prognostic favourable (8.11e-4)" 10.1 9.7 22.0 8.1 21.3 5.4 12.6 20.4 22.2 17.7 16.3 7.2 7.5 10.6 14.5 13.7 15.1 15.2 13.7 25.4 18.3 21.4 19.8 12.5 9.7 8.3 20.6 15.5 14.0 13.3 14.5 16.6 8.3 17.0 17.2 18.3 9.3 13.8 17.8 25.2 10.1 17.4 18.2 12.1 8.9 11.4 5.0 11.8 7.7 13.7 20.3 11.8 13.9 10.9 7.0 8.4 9.0 10.5 3.7 11.3 8.9 7.5 10.5 6.0 6.5 11.5 10.9 3.7 6.6 7.4 7.8 7.9 7.3 7.0 6.4 5.5 8.7 5.6 10.3 8.7 12.6 9.7 7.2 5.6 16.8 10.1 5.1 8.7 4.2 8.9 14.3 7.7 9.5 11.3 12.0 4.8 11.6 13.4 4.4 11.4 5.1 13.3 4.4 7.2 8.5 19.1 4.6 12.4 5.5 7.3 5.9 5.7 5.8 4.9 7.5 6.1 4.7 7.7 6.5 3.1 5.1 6.6 4.8 16.6 5.7 5.6 8.1 9.0 6.4 10.5 5.8 7.0 8.7 7.0 8.2 6.7 11.3 8.1 5.5 3.7 10.5 8.4 7.8 8.9 22.0 21.3 20.4 22.2 18.3 21.4 20.6 15.5 17.0 11.8 MIPEP MIP ENSG00000027001 "Mitochondrial intermediate peptidase" Q99797 13 23730189-23889419 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030676, HPA031669, HPA031670" Approved Enhanced Mitochondria Mitochondria "HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198" "unprognostic (2.05e-1)" "unprognostic (3.17e-2)" "unprognostic (3.75e-3)" "unprognostic (3.72e-2)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (2.41e-1)" "unprognostic (2.21e-1)" "unprognostic (4.69e-2)" "unprognostic (1.12e-1)" "unprognostic (7.54e-2)" "unprognostic (4.76e-1)" "prognostic favourable (7.66e-12)" "unprognostic (1.62e-2)" "unprognostic (4.95e-2)" "unprognostic (2.79e-1)" "unprognostic (6.90e-3)" 7.3 14.9 6.2 7.1 12.2 4.4 11.0 4.7 10.3 8.1 12.2 12.9 12.1 8.4 9.6 20.4 14.4 17.1 11.7 16.9 8.8 5.3 24.7 12.0 8.2 8.4 5.1 8.0 8.5 14.7 8.1 15.4 5.3 9.1 10.9 13.1 9.1 12.9 10.1 16.2 22.0 8.9 11.5 4.4 6.5 9.8 13.9 4.9 8.9 10.9 15.7 11.1 11.2 8.6 9.2 6.5 1.2 10.6 9.7 10.0 3.9 8.9 10.1 5.0 11.7 11.5 15.5 10.7 6.5 10.1 9.8 8.2 13.4 17.8 10.5 6.6 5.2 22.6 11.5 13.6 12.2 6.1 7.3 4.6 4.8 11.5 9.4 10.7 2.5 7.6 17.1 10.1 9.0 12.2 8.8 1.7 15.2 6.6 7.6 6.0 6.9 10.2 8.5 13.5 9.1 21.8 6.0 11.8 3.9 6.9 11.4 13.6 11.7 6.0 6.7 6.0 5.0 9.8 6.9 1.7 2.4 5.6 10.3 5.5 7.4 0.0 3.0 1.2 7.9 3.7 10.0 9.2 7.7 7.1 6.5 7.7 7.4 7.3 0.0 9.7 10.6 5.6 5.1 3.9 6.2 12.2 4.7 10.3 8.8 5.3 5.1 8.0 9.1 4.9 MMAB "cblB, CFAP23" ENSG00000139428 "Methylmalonic aciduria (cobalamin deficiency) cblB type" Q96EY8 12 109553737-109573874 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039017 Approved Approved Mitochondria Mitochondria "HPA039017: AB_10673603" "unprognostic (1.16e-1)" "unprognostic (1.25e-2)" "unprognostic (1.90e-1)" "unprognostic (1.79e-1)" "unprognostic (4.38e-2)" "unprognostic (2.10e-1)" "unprognostic (1.38e-1)" "unprognostic (4.22e-1)" "unprognostic (2.04e-2)" "unprognostic (5.15e-2)" "unprognostic (1.47e-3)" "unprognostic (2.58e-1)" "prognostic favourable (1.55e-4)" "unprognostic (4.90e-2)" "unprognostic (1.51e-1)" "unprognostic (2.23e-1)" "unprognostic (9.65e-2)" 7.3 26.1 12.7 7.2 12.2 5.2 13.0 7.2 17.2 7.0 12.2 12.6 9.4 12.7 7.7 21.9 14.8 9.8 11.8 18.1 11.6 11.5 13.6 47.9 11.8 13.0 12.4 8.2 14.2 20.2 9.1 11.7 5.3 14.0 15.7 8.3 11.2 15.1 10.6 16.5 8.9 8.5 8.7 15.7 6.7 10.7 7.8 14.8 4.3 16.6 15.7 7.5 6.0 7.5 14.1 9.4 3.8 8.1 8.5 13.9 9.2 13.2 9.0 9.4 7.4 3.8 7.8 4.8 2.9 6.9 4.3 4.6 10.5 12.5 8.5 8.6 3.3 13.9 6.2 23.0 2.0 3.3 25.3 3.5 6.7 17.2 13.7 7.4 3.1 10.5 14.4 9.5 4.2 4.1 11.1 6.5 3.1 30.7 6.7 12.0 11.6 12.9 5.6 3.6 22.1 19.2 12.6 14.6 6.3 6.7 12.4 5.1 25.9 20.9 2.2 3.8 1.5 2.6 4.3 5.1 3.8 9.6 8.2 9.1 10.2 3.8 5.9 0.8 13.5 8.1 10.8 11.1 9.9 10.7 9.4 14.1 13.9 13.1 1.7 8.5 8.0 7.7 4.7 9.2 12.7 12.2 7.2 17.2 11.6 11.5 12.4 8.2 14.0 14.8 MPC1 "BRP44L, CGI-129, dJ68L15.3, SLC54A1" ENSG00000060762 "Mitochondrial pyruvate carrier 1" Q9Y5U8 6 166364919-166383013 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 149.8;liver: 129.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045119, HPA055790" Enhanced Enhanced Mitochondria Mitochondria "HPA045119: AB_10960421, HPA055790: " "unprognostic (3.30e-2)" "prognostic favourable (1.45e-4)" "unprognostic (5.24e-3)" "unprognostic (1.68e-1)" "unprognostic (3.17e-2)" "unprognostic (2.85e-2)" "unprognostic (7.61e-2)" "prognostic favourable (1.29e-4)" "unprognostic (3.27e-1)" "unprognostic (1.19e-1)" "unprognostic (1.11e-3)" "unprognostic (5.64e-2)" "prognostic favourable (4.79e-11)" "unprognostic (4.13e-2)" "unprognostic (1.03e-1)" "unprognostic (7.48e-2)" "unprognostic (8.45e-2)" 13.1 9.4 27.1 7.2 28.5 10.9 12.2 12.3 21.6 12.4 21.1 26.1 8.3 18.8 8.4 10.5 16.0 8.3 9.5 149.8 27.6 21.5 56.1 129.7 10.0 8.7 39.2 18.3 10.5 14.9 12.4 9.4 5.4 23.8 10.3 19.9 11.5 23.0 10.5 63.3 9.2 16.9 11.0 43.3 9.2 19.7 5.0 25.8 9.0 18.6 43.9 9.9 10.6 8.1 12.2 26.5 32.2 43.7 13.9 24.5 17.1 6.5 1.9 8.1 28.1 23.8 13.7 12.1 7.6 12.3 11.9 11.6 10.0 4.6 13.8 13.7 11.7 6.3 12.2 9.5 8.4 9.3 20.9 6.8 10.1 33.1 9.9 26.4 9.0 10.9 13.5 9.7 7.0 9.6 23.8 22.0 7.3 10.4 18.3 48.9 4.2 9.3 10.1 13.6 34.5 22.1 5.2 25.6 22.8 8.7 38.2 8.7 9.0 39.6 6.6 6.9 7.2 24.4 7.7 15.1 10.3 11.5 6.3 32.6 11.0 18.6 23.0 32.2 16.4 35.3 15.4 12.2 19.4 17.6 26.5 9.2 18.2 17.4 20.4 13.9 43.7 15.7 24.5 17.1 27.1 28.5 12.3 21.6 27.6 21.5 39.2 18.3 23.8 25.8 MRM1 FLJ22578 ENSG00000278619 "Mitochondrial rRNA methyltransferase 1" Q6IN84 17 36601572-36608971 "Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 15.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021598 Supported Supported Mitochondria Mitochondria "HPA021598: AB_1854097" "unprognostic (9.07e-3)" "unprognostic (1.50e-1)" "unprognostic (1.86e-1)" "unprognostic (1.19e-1)" "unprognostic (4.86e-2)" "unprognostic (1.43e-1)" "unprognostic (1.08e-2)" "unprognostic (2.46e-1)" "unprognostic (1.42e-1)" "unprognostic (4.90e-2)" "unprognostic (2.47e-2)" "unprognostic (8.56e-2)" "unprognostic (2.75e-1)" "unprognostic (5.67e-2)" "unprognostic (2.36e-1)" "unprognostic (3.95e-1)" "unprognostic (1.74e-2)" 2.2 6.8 2.9 3.9 6.4 2.9 3.5 1.9 4.9 1.2 4.2 5.2 3.2 5.9 3.2 3.4 3.6 4.0 3.4 3.8 3.7 2.4 4.0 2.2 4.6 6.5 3.0 4.2 4.1 0.9 0.9 1.0 2.8 2.1 5.6 2.4 2.9 4.7 5.9 2.2 4.5 1.2 3.4 5.2 2.5 1.5 3.5 0.9 3.2 1.8 3.8 3.4 0.0 6.7 3.3 0.0 4.4 7.3 7.6 3.7 0.9 6.2 0.0 3.6 3.2 3.9 11.9 0.2 0.0 0.0 0.0 0.4 0.1 0.4 7.2 0.0 15.3 0.1 0.2 0.0 4.7 2.2 10.7 3.5 6.5 1.9 5.2 5.5 3.0 0.3 7.6 0.0 3.8 6.3 4.0 4.4 0.1 10.6 3.2 0.1 0.1 8.5 0.0 13.7 3.1 7.2 2.9 1.9 0.0 4.5 4.6 4.7 1.8 1.8 3.6 6.1 4.2 0.0 9.4 10.9 4.6 0.0 6.0 2.6 0.0 2.9 0.0 4.3 4.4 7.6 6.7 3.6 4.1 2.9 6.1 5.5 5.8 0.0 7.3 1.8 3.3 2.8 3.7 MRM3 "FLJ10581, HC90, RMTL1, RNMTL1" ENSG00000171861 "Mitochondrial rRNA methyltransferase 3" Q9HC36 17 782273-792509 "Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022534, HPA023031, HPA023292" Enhanced Supported Mitochondria Mitochondria "HPA022534: AB_1856386, HPA023031: AB_1856387, HPA023292: AB_1856388" "unprognostic (1.66e-1)" "unprognostic (5.83e-3)" "unprognostic (6.72e-2)" "prognostic favourable (2.81e-4)" "unprognostic (2.67e-1)" "unprognostic (1.83e-1)" "unprognostic (2.48e-1)" "unprognostic (1.54e-1)" "unprognostic (1.46e-1)" "unprognostic (8.20e-2)" "unprognostic (3.72e-3)" "unprognostic (8.47e-2)" "prognostic favourable (3.00e-4)" "unprognostic (3.82e-2)" "unprognostic (9.98e-2)" "unprognostic (1.05e-2)" "unprognostic (1.42e-2)" 10.0 13.8 7.2 12.4 11.9 16.4 10.5 12.8 11.8 7.1 9.1 7.8 8.0 8.6 8.6 8.2 12.0 9.4 10.1 14.7 7.1 7.2 11.1 20.5 6.5 11.9 9.7 7.7 10.3 21.2 8.3 9.2 7.6 10.1 8.2 8.9 7.0 11.4 8.6 31.0 14.6 8.2 8.7 4.8 10.8 12.4 21.4 8.9 12.2 10.1 13.8 10.1 8.7 10.8 22.1 14.8 8.0 14.2 17.6 20.2 14.8 13.3 27.9 6.1 10.4 9.0 7.7 12.0 7.2 6.8 14.5 12.4 16.3 6.3 24.2 7.5 5.7 11.4 17.9 6.4 14.1 8.1 29.2 9.3 16.2 14.2 9.1 8.0 8.5 9.0 8.9 15.5 13.5 11.1 15.6 10.9 7.8 14.4 13.7 10.5 8.9 14.7 16.8 4.3 12.8 9.7 7.3 8.1 9.3 10.3 8.7 13.5 10.8 7.2 8.6 7.8 6.0 11.3 19.8 4.2 6.0 9.7 9.8 11.2 10.5 4.9 14.2 8.0 15.2 11.3 16.4 22.1 16.6 18.5 14.8 20.9 20.2 17.6 1.1 17.6 10.9 11.8 17.2 14.8 7.2 11.9 12.8 11.8 7.1 7.2 9.7 7.7 10.1 8.9 MRPL1 BM022 ENSG00000169288 "Mitochondrial ribosomal protein L1" Q9BYD6 4 77862520-77952790 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043656 Supported Supported Mitochondria Mitochondria "HPA043656: " "unprognostic (9.03e-3)" "unprognostic (3.25e-1)" "unprognostic (1.11e-3)" "unprognostic (2.88e-1)" "unprognostic (4.52e-2)" "unprognostic (5.29e-3)" "unprognostic (4.69e-3)" "unprognostic (5.44e-2)" "unprognostic (1.66e-2)" "unprognostic (5.14e-3)" "unprognostic (8.79e-2)" "unprognostic (2.22e-2)" "prognostic favourable (3.35e-5)" "unprognostic (7.63e-2)" "unprognostic (1.87e-1)" "unprognostic (7.13e-2)" "unprognostic (9.17e-3)" 13.6 16.5 14.8 10.9 16.0 13.5 14.0 12.3 20.3 13.6 16.2 4.4 9.6 11.8 12.5 13.6 17.2 10.5 6.9 23.5 18.5 14.7 22.4 22.4 7.6 12.4 13.5 14.0 12.0 12.0 10.5 18.9 16.1 16.6 17.3 17.9 4.3 11.1 11.5 46.6 8.2 12.0 20.3 12.1 15.4 12.3 5.4 9.5 11.9 11.7 24.7 13.4 17.2 14.3 14.9 12.0 4.7 10.1 12.6 18.3 8.9 12.1 7.6 15.1 12.6 11.6 15.3 13.1 14.0 8.7 18.1 12.4 15.5 22.0 21.5 17.4 11.2 10.3 21.8 25.1 23.7 14.4 11.4 18.3 8.2 16.3 15.4 37.8 8.9 11.9 23.7 16.0 16.3 21.6 26.4 7.3 22.7 13.0 23.7 24.5 16.7 10.1 27.1 18.8 12.3 35.1 11.8 16.4 8.3 10.8 28.1 25.8 13.6 19.1 12.7 12.0 18.0 12.0 19.8 6.5 8.1 22.5 10.1 21.5 15.3 4.7 6.5 3.9 12.7 10.1 12.5 14.9 14.0 13.9 12.0 14.3 16.8 18.3 1.1 12.6 8.5 9.8 16.6 8.9 14.8 16.0 12.3 20.3 18.5 14.7 13.5 14.0 16.6 9.5 MRPL10 "L10MT, MGC17973, MRP-L10, MRP-L8, MRPL8, RPML8" ENSG00000159111 "Mitochondrial ribosomal protein L10" Q7Z7H8 17 47823272-47831534 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021234, HPA029885" Enhanced Enhanced Mitochondria Mitochondria "HPA021234: AB_1854098, HPA029885: AB_2673233" "unprognostic (6.84e-3)" "unprognostic (1.03e-1)" "unprognostic (8.05e-2)" "unprognostic (9.09e-3)" "unprognostic (1.97e-1)" "unprognostic (4.01e-3)" "prognostic unfavourable (6.67e-4)" "unprognostic (5.21e-2)" "unprognostic (1.03e-1)" "unprognostic (8.91e-2)" "unprognostic (1.38e-1)" "unprognostic (6.16e-2)" "unprognostic (1.29e-1)" "unprognostic (2.82e-1)" "unprognostic (1.87e-2)" "unprognostic (1.60e-1)" "unprognostic (6.87e-2)" 20.8 23.2 18.3 23.8 25.2 17.7 34.3 22.2 25.9 19.2 24.7 11.5 24.4 21.2 22.8 26.5 20.3 25.6 28.7 44.0 18.9 18.1 21.6 26.0 29.6 39.6 18.0 19.4 42.9 34.7 17.8 12.3 19.3 16.9 17.6 19.6 16.5 18.2 27.5 43.2 15.5 17.6 37.9 21.4 19.6 23.8 18.6 13.2 19.2 20.4 26.6 21.2 26.0 19.6 17.7 20.4 11.2 18.3 11.6 31.6 17.7 12.6 27.9 11.8 11.9 28.2 26.0 22.0 11.1 18.7 19.2 16.4 53.7 17.4 20.5 26.0 14.3 12.0 16.7 21.7 17.1 19.7 26.6 16.4 15.0 37.6 24.4 14.7 9.2 29.2 18.9 22.7 32.3 18.4 21.9 20.6 14.7 24.8 15.0 18.5 19.4 26.8 12.1 23.1 22.7 20.9 12.4 14.2 22.8 8.5 9.8 23.7 29.0 15.6 11.3 17.3 14.3 11.6 15.6 36.2 27.9 16.5 15.2 11.2 11.5 11.2 17.6 8.2 31.6 18.3 29.8 15.9 21.8 27.9 20.4 17.7 18.6 21.9 7.1 11.6 14.7 12.4 24.3 17.7 18.3 25.2 22.2 25.9 18.9 18.1 18.0 19.4 16.9 13.2 MRPL11 ENSG00000174547 "Mitochondrial ribosomal protein L11" Q9Y3B7 11 66435075-66466738 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057685 Approved Supported Mitochondria Mitochondria "HPA057685: " "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (2.21e-2)" "unprognostic (1.79e-2)" "unprognostic (9.30e-2)" "unprognostic (1.12e-2)" "unprognostic (1.81e-3)" "unprognostic (1.58e-1)" "unprognostic (4.87e-1)" "unprognostic (8.32e-3)" "unprognostic (2.85e-2)" "unprognostic (3.21e-1)" "unprognostic (1.31e-2)" "unprognostic (9.34e-2)" "unprognostic (6.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.72e-1)" 13.9 12.9 10.1 18.9 10.6 18.2 25.6 10.6 12.5 13.7 20.7 7.0 13.5 15.7 16.5 16.2 22.3 16.3 17.5 32.0 8.5 8.7 19.4 33.1 15.7 27.5 9.0 7.5 20.2 36.6 15.1 9.5 14.8 7.7 15.2 23.2 10.8 21.5 17.7 41.4 13.5 21.8 18.5 7.5 18.5 18.5 14.0 6.7 23.3 19.8 29.7 19.0 16.4 17.7 23.4 25.5 3.4 20.2 16.3 20.9 19.2 19.8 15.9 15.1 14.4 7.5 8.5 21.6 11.6 13.3 22.2 17.1 44.3 24.7 25.1 20.3 11.0 17.4 22.0 22.8 15.7 11.5 14.6 15.7 13.6 23.4 9.1 26.0 10.6 10.1 13.6 13.6 17.0 16.4 22.8 11.0 9.6 33.9 29.9 41.5 27.6 23.2 19.0 30.1 31.3 9.6 13.7 15.9 13.8 12.8 19.4 39.9 22.0 13.7 9.2 13.4 18.0 12.6 13.6 8.1 12.6 28.3 13.8 16.8 9.0 0.8 16.3 3.4 17.7 20.2 18.9 23.4 19.7 17.4 25.5 19.3 20.9 19.1 1.1 16.3 17.7 15.4 19.8 19.2 10.1 10.6 10.6 12.5 8.5 8.7 9.0 7.5 7.7 6.7 MRPL12 "MRPL7, MRPL7/L12, RPML12" ENSG00000262814 "Mitochondrial ribosomal protein L12" P52815 17 81703357-81707526 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022853, HPA023043" Supported Supported Mitochondria Mitochondria "HPA022853: AB_1854099, HPA023043: AB_1854100" "unprognostic (1.16e-1)" "unprognostic (1.65e-1)" "unprognostic (6.59e-2)" "unprognostic (1.66e-2)" "unprognostic (9.52e-2)" "unprognostic (5.97e-2)" "unprognostic (5.97e-3)" "prognostic unfavourable (2.35e-4)" "unprognostic (1.78e-1)" "unprognostic (6.47e-3)" "unprognostic (8.17e-2)" "unprognostic (3.07e-1)" "unprognostic (8.77e-3)" "unprognostic (3.41e-2)" "unprognostic (2.16e-1)" "unprognostic (1.18e-1)" "unprognostic (9.26e-2)" 15.7 18.6 15.3 14.5 16.9 14.4 27.7 13.6 18.6 9.8 27.2 8.3 14.9 25.2 10.7 8.6 24.4 12.6 14.8 63.7 14.8 13.7 22.8 64.9 15.4 20.4 17.8 10.5 8.9 40.7 13.3 10.7 12.8 13.1 11.6 20.5 9.3 19.6 13.9 79.1 12.6 18.2 11.4 9.4 17.2 15.2 14.4 7.5 16.1 12.2 50.4 16.0 10.9 11.2 24.7 34.6 5.0 30.0 14.7 20.5 17.7 27.7 47.6 12.8 14.8 9.7 10.7 23.6 21.8 13.4 33.0 24.6 39.8 13.4 43.3 13.2 14.3 23.6 16.4 28.0 16.8 10.1 82.0 33.0 25.4 44.5 14.4 36.1 17.3 12.3 20.5 22.6 25.4 27.3 32.1 14.4 16.3 35.0 30.7 53.6 20.0 62.0 29.3 20.8 32.0 24.3 23.2 32.7 42.0 16.0 69.2 35.6 35.1 33.1 14.2 25.1 29.8 19.6 44.1 27.9 9.5 24.6 17.2 26.2 18.8 5.0 24.1 3.2 15.0 30.0 20.5 24.7 15.1 16.6 34.6 23.1 16.0 14.3 2.6 14.7 17.3 28.4 12.9 17.7 15.3 16.9 13.6 18.6 14.8 13.7 17.8 10.5 13.1 7.5 MRPL14 "MRP-L32, RPML32" ENSG00000180992 "Mitochondrial ribosomal protein L14" Q6P1L8 6 44113454-44127457 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038769, HPA076790" Uncertain Supported Mitochondria Mitochondria "HPA038769: AB_10673288, HPA076790: " "unprognostic (4.58e-1)" "unprognostic (8.39e-2)" "unprognostic (1.84e-1)" "unprognostic (7.25e-2)" "unprognostic (1.15e-1)" "unprognostic (1.20e-2)" "unprognostic (1.19e-2)" "unprognostic (3.21e-2)" "unprognostic (7.20e-2)" "prognostic favourable (4.81e-4)" "unprognostic (1.74e-2)" "unprognostic (3.75e-1)" "prognostic unfavourable (7.46e-5)" "unprognostic (7.13e-2)" "unprognostic (1.65e-1)" "prognostic favourable (1.08e-4)" "unprognostic (3.27e-2)" 10.1 16.1 12.5 9.6 12.8 7.9 11.7 10.5 12.7 10.5 16.4 9.6 8.4 16.2 12.1 12.3 15.7 10.4 14.8 18.5 10.0 8.4 12.4 35.5 25.9 10.4 10.9 11.5 7.1 17.5 4.9 9.6 11.8 10.6 9.7 16.3 13.7 14.0 9.4 61.4 16.0 14.0 12.7 7.9 10.2 12.7 19.0 10.4 13.1 26.3 27.8 12.4 12.3 10.0 33.2 36.4 9.0 36.1 46.7 32.5 30.3 51.5 22.1 15.6 21.6 13.6 13.3 20.0 19.3 19.3 25.8 25.8 46.0 18.2 22.5 21.9 16.4 21.1 17.6 31.4 20.5 26.7 48.0 23.2 19.6 56.2 16.8 21.9 16.3 12.4 17.1 24.3 14.5 21.3 48.7 14.5 22.7 52.1 26.2 34.6 13.7 21.3 18.9 17.6 30.5 42.4 25.6 35.0 13.6 12.4 24.3 24.0 22.3 22.6 16.9 23.0 34.4 16.4 33.3 18.1 16.0 52.8 26.0 21.9 16.7 9.0 36.1 7.5 25.4 32.7 29.9 33.2 32.5 28.6 32.4 30.2 25.8 26.5 2.0 46.7 21.9 36.4 21.9 30.3 12.5 12.8 10.5 12.7 10.0 8.4 10.9 11.5 10.6 10.4 MRPL19 "KIAA0104, MRP-L15, RLX1, RPML15" ENSG00000115364 "Mitochondrial ribosomal protein L19" P49406 2 75646783-75690851 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046805, HPA056622" Approved Supported Mitochondria Mitochondria "HPA046805: , HPA056622: " "unprognostic (9.24e-2)" "unprognostic (3.84e-2)" "prognostic favourable (7.39e-4)" "unprognostic (8.40e-2)" "unprognostic (1.59e-2)" "unprognostic (7.52e-3)" "unprognostic (5.75e-2)" "unprognostic (9.86e-2)" "unprognostic (6.21e-3)" "unprognostic (9.71e-3)" "prognostic unfavourable (1.97e-5)" "unprognostic (2.42e-1)" "unprognostic (3.67e-2)" "unprognostic (1.55e-1)" "unprognostic (3.30e-1)" "unprognostic (1.12e-1)" "unprognostic (1.20e-1)" 21.3 33.9 22.5 13.0 25.2 8.8 21.1 15.9 26.7 23.0 19.5 24.1 12.1 16.8 19.1 19.6 25.7 13.9 15.6 24.4 21.3 20.4 40.8 44.9 13.0 13.5 26.0 21.2 17.3 17.8 30.9 20.6 18.4 26.6 16.4 23.0 13.2 17.7 19.6 47.3 17.2 16.3 21.1 27.7 18.1 16.3 12.0 24.4 19.2 27.3 22.0 17.3 15.1 15.9 18.5 23.7 9.6 17.1 15.5 18.0 11.1 36.0 21.0 20.0 17.9 21.9 26.4 28.3 23.2 21.0 29.6 23.5 32.4 15.0 20.4 23.4 25.3 25.5 31.0 35.1 44.6 22.6 26.6 27.8 16.5 40.9 23.4 29.5 16.7 17.4 27.1 29.9 27.5 31.0 30.5 12.0 29.1 22.0 26.8 23.3 26.0 23.5 33.8 43.6 26.8 50.1 22.6 22.1 19.1 22.8 26.4 25.8 22.6 11.9 20.8 25.9 28.6 22.9 34.2 12.5 18.7 16.9 20.4 29.3 22.5 9.6 14.1 9.2 16.0 17.1 18.0 18.5 16.5 16.9 19.9 16.1 14.7 18.0 0.9 15.5 15.4 23.7 17.4 11.1 22.5 25.2 15.9 26.7 21.3 20.4 26.0 21.2 26.6 24.4 MRPL20 FLJ10024 ENSG00000242485 "Mitochondrial ribosomal protein L20" Q9BYC9 1 1401908-1407313 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047074 Supported Supported Mitochondria Mitochondria "HPA047074: AB_10964064" "unprognostic (4.04e-2)" "unprognostic (1.06e-1)" "unprognostic (3.55e-2)" "unprognostic (5.79e-2)" "unprognostic (3.71e-1)" "unprognostic (2.66e-1)" "unprognostic (1.07e-1)" "unprognostic (2.35e-1)" "unprognostic (1.03e-1)" "unprognostic (1.78e-2)" "unprognostic (2.80e-2)" "unprognostic (2.33e-1)" "unprognostic (4.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.25e-1)" "unprognostic (4.34e-2)" "unprognostic (1.64e-1)" 36.7 36.2 44.4 31.0 40.7 22.6 41.2 30.3 46.8 24.8 33.4 24.2 38.8 30.7 28.1 52.3 33.8 32.7 39.9 75.3 37.3 38.6 40.1 48.8 31.5 59.7 39.9 31.4 26.5 72.8 28.4 36.3 27.2 35.6 35.1 33.1 29.1 50.5 47.7 121.8 27.3 28.9 44.5 39.1 30.5 33.6 27.7 29.7 22.8 34.3 54.8 35.9 27.1 26.9 50.6 77.5 37.5 52.1 40.5 59.9 51.7 39.3 38.1 28.7 29.0 22.1 24.1 21.2 35.3 27.1 46.0 33.0 45.3 48.1 42.1 49.5 30.2 25.1 46.6 38.1 35.8 36.4 66.0 45.5 67.1 44.5 30.7 66.8 29.4 28.1 14.7 35.3 38.0 34.0 45.8 25.2 38.5 39.5 51.3 51.0 29.7 77.2 34.1 26.5 53.7 35.8 26.5 51.0 42.0 33.6 70.4 51.8 30.2 49.5 29.0 28.1 32.7 42.0 43.5 38.6 54.9 82.0 43.4 54.4 19.5 27.8 52.1 37.5 46.8 49.1 52.4 50.6 52.3 46.4 53.2 47.5 59.9 57.3 24.1 40.5 37.7 77.5 45.0 51.7 44.4 40.7 30.3 46.8 37.3 38.6 39.9 31.4 35.6 29.7 MRPL22 "HSPC158, MRP-L25, RPML25" ENSG00000082515 "Mitochondrial ribosomal protein L22" Q9NWU5 5 154941070-154969411 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA047063 Uncertain Approved Mitochondria Mitochondria "HPA047063: " "unprognostic (9.17e-2)" "unprognostic (1.18e-2)" "unprognostic (2.16e-2)" "unprognostic (2.56e-2)" "unprognostic (5.42e-2)" "unprognostic (6.65e-2)" "unprognostic (1.80e-2)" "unprognostic (4.86e-2)" "unprognostic (2.03e-1)" "unprognostic (3.01e-3)" "unprognostic (3.40e-1)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (3.54e-1)" "unprognostic (2.69e-1)" "unprognostic (4.09e-2)" "unprognostic (4.29e-2)" 16.3 29.7 16.7 14.5 21.8 25.9 20.2 18.8 19.6 15.2 21.0 18.8 8.3 19.3 16.5 20.6 23.0 14.6 11.9 29.7 16.8 16.2 27.8 38.9 14.7 19.2 21.1 19.5 14.6 25.2 15.9 22.6 19.2 21.6 14.5 21.6 15.6 24.4 18.8 28.2 16.5 18.4 18.3 17.7 20.0 19.3 29.0 16.0 20.1 19.7 20.7 19.3 17.3 15.8 35.7 34.0 21.6 29.5 30.6 36.7 30.7 20.3 20.1 17.8 24.6 13.9 17.7 21.2 14.5 17.2 29.5 37.4 57.8 25.4 28.1 26.1 12.1 18.7 25.6 27.5 31.5 9.6 29.0 10.8 20.9 32.8 18.2 24.1 14.7 11.6 18.5 19.8 24.2 49.7 16.2 25.4 18.1 30.0 21.7 23.3 13.5 15.6 20.1 15.5 29.1 28.6 15.4 20.5 7.6 19.1 27.6 30.6 40.3 21.5 14.4 18.2 18.1 15.9 26.7 13.6 16.7 30.8 18.3 29.9 17.0 15.3 26.1 21.6 26.1 29.5 26.1 35.7 28.8 27.7 34.0 29.4 26.9 30.6 10.1 30.6 28.8 26.4 36.7 30.7 16.7 21.8 18.8 19.6 16.8 16.2 21.1 19.5 21.6 16.0 MRPL28 "MAAT1, p15" ENSG00000086504 "Mitochondrial ribosomal protein L28" Q13084 16 367384-370527 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030594, CAB033542, HPA055589" Supported Supported Mitochondria Mitochondria "CAB033542: AB_2145899, HPA030594: AB_10601136, HPA055589: AB_2682855" "unprognostic (2.39e-1)" "unprognostic (7.39e-3)" "unprognostic (1.53e-1)" "unprognostic (1.26e-1)" "unprognostic (2.15e-2)" "unprognostic (9.92e-2)" "unprognostic (2.92e-1)" "unprognostic (3.45e-3)" "unprognostic (6.76e-2)" "unprognostic (1.73e-1)" "unprognostic (7.69e-2)" "unprognostic (1.71e-1)" "unprognostic (2.62e-2)" "unprognostic (2.43e-1)" "unprognostic (4.36e-1)" "unprognostic (2.60e-1)" "unprognostic (6.56e-2)" 18.3 21.7 32.2 18.6 36.6 25.1 19.5 17.9 38.4 15.3 26.0 19.1 14.6 21.7 16.8 21.3 21.1 21.2 20.0 49.6 30.9 22.5 26.9 35.5 15.1 24.5 24.9 20.9 15.7 21.4 23.6 15.5 15.8 17.7 16.2 12.0 16.8 21.7 18.4 42.1 16.0 19.2 19.6 16.8 18.1 15.8 25.7 10.4 24.9 20.3 36.3 20.4 16.9 14.7 38.0 47.1 48.2 42.0 28.0 47.7 33.7 17.6 41.3 17.7 21.2 10.0 12.9 24.2 20.7 27.1 37.5 37.1 50.7 24.6 26.0 23.6 20.9 23.2 27.0 43.7 20.0 23.4 65.6 19.1 31.9 41.6 32.3 23.7 25.8 19.4 21.8 34.8 28.1 27.4 35.0 19.5 23.3 71.5 37.3 27.0 28.4 26.4 46.6 21.6 37.4 30.7 10.9 30.5 27.8 25.6 26.2 21.2 33.7 24.7 21.5 23.1 32.2 18.3 23.0 30.9 23.8 34.5 15.5 17.3 36.1 30.4 42.0 45.8 30.1 40.8 24.6 34.3 26.2 28.4 37.7 38.0 18.6 23.8 48.2 28.0 40.7 47.1 47.7 33.7 32.2 36.6 17.9 38.4 30.9 22.5 24.9 20.9 17.7 10.4 MRPL37 "MRP-L2, RPML2" ENSG00000116221 "Mitochondrial ribosomal protein L37" Q9BZE1 1 54184041-54225464 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025767, HPA025826, HPA025951" Supported Supported Mitochondria Mitochondria "HPA025767: AB_1854105, HPA025826: AB_1854106, HPA025951: AB_1854107" "unprognostic (2.00e-1)" "unprognostic (6.81e-2)" "prognostic favourable (6.99e-4)" "unprognostic (1.71e-3)" "unprognostic (8.24e-2)" "unprognostic (1.00e-1)" "prognostic unfavourable (6.45e-5)" "unprognostic (2.49e-2)" "unprognostic (1.56e-1)" "unprognostic (1.64e-1)" "unprognostic (1.92e-2)" "unprognostic (1.84e-1)" "unprognostic (3.07e-1)" "prognostic favourable (9.25e-4)" "unprognostic (2.43e-1)" "unprognostic (2.62e-1)" "unprognostic (7.67e-3)" 21.3 35.0 16.2 15.8 24.0 26.0 18.0 16.9 34.8 15.8 22.9 18.0 13.9 23.5 17.6 13.7 29.0 18.2 18.6 32.0 15.4 14.0 25.1 65.2 13.8 20.6 16.0 14.6 21.2 30.8 15.4 10.9 19.4 23.0 16.2 25.2 20.1 33.5 15.3 68.0 24.0 25.0 19.3 11.9 17.9 20.9 20.0 9.0 31.4 18.1 39.9 28.1 16.2 17.5 39.0 40.8 14.8 35.3 29.1 37.4 38.5 38.8 22.5 20.5 27.6 20.7 27.8 36.7 26.5 24.9 47.3 41.3 44.9 18.0 53.0 24.0 29.6 31.4 40.3 39.2 37.1 25.8 50.8 45.5 47.5 45.3 35.6 53.8 21.2 30.7 33.7 49.1 38.5 42.2 50.2 16.0 33.6 28.7 37.0 52.5 41.9 50.1 40.8 41.7 44.6 26.9 29.2 40.6 18.9 36.6 63.1 48.7 27.3 61.1 21.0 30.4 27.6 38.2 53.1 20.3 28.4 41.3 39.6 55.0 28.7 14.8 35.3 14.6 24.1 29.9 28.2 39.0 29.8 27.2 40.8 32.8 30.3 27.0 1.9 29.1 27.9 34.1 37.4 38.5 16.2 24.0 16.9 34.8 15.4 14.0 16.0 14.6 23.0 9.0 MRPL38 "HSPC262, MGC4810, MRP-L3, RPML3" ENSG00000204316 "Mitochondrial ribosomal protein L38" Q96DV4 17 75898643-75905413 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023054, HPA023135" Approved Supported Mitochondria Mitochondria "HPA023054: AB_1854109, HPA023135: AB_1854110" "unprognostic (1.17e-1)" "unprognostic (3.77e-3)" "unprognostic (1.83e-1)" "unprognostic (3.68e-3)" "unprognostic (2.47e-2)" "unprognostic (1.50e-2)" "unprognostic (4.44e-2)" "unprognostic (1.61e-1)" "unprognostic (7.59e-2)" "unprognostic (5.24e-2)" "prognostic favourable (4.23e-4)" "unprognostic (2.16e-3)" "prognostic unfavourable (5.58e-4)" "unprognostic (3.06e-2)" "unprognostic (2.40e-1)" "unprognostic (3.72e-1)" "prognostic favourable (9.21e-5)" 10.8 14.1 12.4 6.7 14.8 6.0 8.2 8.4 20.8 9.6 11.7 23.3 6.5 10.6 9.5 7.8 11.2 15.4 10.2 21.2 11.7 9.2 11.7 17.6 8.4 8.1 15.7 18.1 12.0 17.5 8.7 7.7 7.3 14.8 8.7 8.2 8.8 17.1 13.6 41.8 9.5 8.9 17.9 11.3 8.8 10.3 15.1 14.7 8.3 8.8 14.1 9.5 10.9 7.5 28.5 29.4 9.9 21.8 24.0 24.6 21.3 17.6 24.8 5.0 6.1 7.3 6.0 20.4 6.0 10.5 23.3 16.9 30.3 10.6 17.1 7.1 10.2 12.5 17.8 16.2 6.1 5.1 33.5 11.4 7.0 27.0 18.4 15.1 10.2 8.8 18.5 15.0 12.2 22.6 14.2 7.8 8.3 36.9 18.3 15.0 6.4 24.6 13.7 17.2 18.4 17.3 8.8 9.8 11.0 11.2 26.2 24.2 24.4 15.1 6.9 8.9 15.3 7.0 15.8 10.1 6.3 4.9 10.8 11.7 8.1 4.5 20.0 9.9 23.7 21.8 23.8 28.3 24.5 22.2 29.4 28.5 24.6 23.7 1.6 24.0 17.5 20.9 24.5 21.3 12.4 14.8 8.4 20.8 11.7 9.2 15.7 18.1 14.8 14.7 MRPL41 "BMRP, MRP-L27, MRPL27, PIG3, RPML27" ENSG00000182154 "Mitochondrial ribosomal protein L41" Q8IXM3 9 137551199-137552555 "Predicted intracellular proteins, Ribosomal proteins" "Apoptosis, Cell cycle" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 55.8;skeletal muscle: 60.6" "Cell line enhanced" "Detected in many" "MCF7: 48.3;PC-3: 47.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024550, HPA027160" Supported Supported Mitochondria Mitochondria "HPA024550: AB_1854112, HPA027160: AB_1854113" "unprognostic (3.92e-1)" "unprognostic (1.61e-2)" "unprognostic (6.92e-2)" "unprognostic (1.22e-3)" "unprognostic (5.86e-3)" "unprognostic (8.04e-2)" "unprognostic (2.05e-1)" "unprognostic (1.60e-1)" "unprognostic (1.47e-1)" "unprognostic (1.14e-1)" "unprognostic (4.83e-3)" "unprognostic (3.24e-2)" "unprognostic (2.06e-3)" "unprognostic (3.28e-2)" "unprognostic (1.01e-1)" "unprognostic (2.43e-1)" "unprognostic (3.32e-2)" 15.3 8.0 12.8 3.5 14.4 3.1 2.8 4.1 10.7 2.4 8.3 7.1 2.3 1.0 1.7 2.1 1.5 16.4 10.3 7.7 6.8 10.7 2.6 3.3 8.5 4.2 6.3 1.8 2.9 1.6 9.5 2.2 10.8 3.8 60.6 5.3 6.2 1.5 4.0 6.2 10.5 2.1 2.0 1.5 2.7 2.1 38.3 55.8 43.7 42.5 21.8 42.2 42.8 9.8 16.7 2.8 6.7 4.2 3.5 13.0 12.7 3.3 5.8 4.7 11.6 5.6 7.2 16.7 3.1 21.0 3.8 6.0 0.6 10.6 20.8 6.7 9.2 18.1 9.7 10.8 30.9 7.0 8.3 5.3 1.8 5.3 14.5 3.1 3.1 48.3 3.7 35.3 10.8 47.3 4.6 4.9 10.1 5.0 6.6 9.3 10.0 8.4 15.6 20.6 14.7 9.9 10.5 10.2 14.1 18.2 16.4 9.4 13.1 12.9 11.7 10.7 7.7 43.7 42.5 31.5 31.2 34.1 29.5 38.3 33.8 35.9 34.6 28.5 32.2 30.2 5.1 21.8 31.1 55.8 42.2 42.8 MRPL45 MGC11321 ENSG00000278845 "Mitochondrial ribosomal protein L45" 17 38297023-38323218 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 12.4;Daudi: 29.7;K-562: 18.0;REH: 14.5;U-266/84: 17.2;U-698: 21.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023373, HPA023385" Enhanced Enhanced Mitochondria Mitochondria "HPA023373: AB_1854114, HPA023385: AB_1854115" "unprognostic (8.56e-3)" "unprognostic (4.09e-2)" "unprognostic (1.11e-2)" "unprognostic (3.08e-1)" "unprognostic (9.50e-2)" "unprognostic (2.22e-3)" "unprognostic (1.11e-2)" "unprognostic (1.60e-1)" "unprognostic (7.21e-2)" "unprognostic (1.37e-2)" "unprognostic (3.65e-1)" "unprognostic (1.35e-1)" "unprognostic (6.01e-3)" "unprognostic (3.07e-1)" "unprognostic (1.00e-1)" "unprognostic (2.40e-1)" "unprognostic (8.13e-2)" 3.1 0.6 1.4 2.6 2.4 1.8 4.9 1.8 6.3 9.6 3.6 1.4 0.7 0.3 10.3 1.1 2.1 0.4 5.8 3.7 1.2 5.9 7.0 2.6 9.6 1.7 1.7 3.9 9.1 0.3 2.4 2.5 2.7 7.7 6.9 1.8 3.8 1.1 11.1 2.4 13.2 1.4 1.8 1.2 1.4 1.7 1.3 1.2 2.6 2.8 10.5 0.9 1.5 6.1 9.3 1.6 5.9 6.9 8.7 4.3 0.0 0.1 12.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.5 29.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.3 4.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 14.5 0.0 11.0 0.0 11.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 6.1 0.0 0.0 0.0 8.6 17.2 21.9 0.0 0.0 0.1 0.4 5.7 1.6 4.7 5.9 5.5 6.1 7.0 3.7 9.3 5.2 8.7 5.3 0.1 6.9 1.2 3.3 5.2 4.3 MRPL47 "CGI-204, NCM1" ENSG00000136522 "Mitochondrial ribosomal protein L47" Q9HD33 3 179588285-179604654 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037553, HPA047779" Approved Supported Mitochondria Mitochondria "HPA037553: AB_10671375, HPA047779: " "unprognostic (6.37e-2)" "prognostic favourable (6.44e-4)" "unprognostic (7.21e-2)" "prognostic unfavourable (3.15e-4)" "unprognostic (1.53e-1)" "unprognostic (8.55e-3)" "unprognostic (1.16e-2)" "unprognostic (1.82e-2)" "unprognostic (1.58e-1)" "unprognostic (8.03e-3)" "unprognostic (1.70e-2)" "unprognostic (1.29e-2)" "unprognostic (5.64e-2)" "unprognostic (3.06e-1)" "unprognostic (1.75e-1)" "unprognostic (1.71e-1)" "unprognostic (8.84e-2)" 17.4 23.5 22.3 16.4 21.7 29.6 20.2 23.9 25.0 14.2 22.5 12.8 13.0 16.7 16.8 17.3 21.3 13.3 13.4 35.5 21.1 21.8 34.0 31.8 14.8 19.3 25.6 19.4 15.2 12.1 18.1 23.8 17.8 28.5 15.9 23.6 11.2 14.5 14.7 31.7 13.5 20.3 17.8 20.1 20.2 17.4 32.8 22.0 25.3 20.1 27.8 20.7 16.3 13.9 21.0 28.2 24.6 29.0 22.7 28.1 18.9 31.7 12.4 21.6 19.8 13.7 14.4 24.7 18.7 16.7 29.4 24.6 50.1 13.3 26.1 37.0 15.9 24.1 26.4 19.5 31.7 30.0 23.2 25.0 12.4 28.0 26.7 44.9 14.2 13.2 17.1 21.7 22.3 19.7 14.6 21.0 22.8 24.6 24.0 42.0 37.4 29.7 25.6 21.2 43.7 30.9 20.2 18.8 21.8 20.5 33.3 36.7 51.3 34.5 15.7 16.0 22.9 20.0 50.8 26.6 43.5 57.1 18.7 36.9 19.3 15.9 19.3 24.6 20.0 24.8 19.9 21.0 22.2 21.5 28.2 17.4 19.9 20.2 5.1 22.7 29.0 24.4 28.1 18.9 22.3 21.7 23.9 25.0 21.1 21.8 25.6 19.4 28.5 22.0 MRPL51 "bMRP64, CDA09, HSPC241, MRP64" ENSG00000111639 "Mitochondrial ribosomal protein L51" Q4U2R6 12 6491886-6493841 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039923 Approved Supported Mitochondria Mitochondria "HPA039923: AB_10795373" "unprognostic (1.31e-1)" "unprognostic (1.05e-1)" "unprognostic (2.97e-1)" "unprognostic (1.44e-2)" "unprognostic (1.75e-1)" "unprognostic (2.87e-1)" "unprognostic (3.81e-3)" "unprognostic (4.95e-2)" "unprognostic (1.01e-1)" "unprognostic (1.18e-2)" "unprognostic (1.43e-1)" "unprognostic (3.06e-1)" "unprognostic (1.50e-1)" "unprognostic (3.36e-1)" "unprognostic (2.62e-1)" "unprognostic (1.17e-1)" "unprognostic (8.33e-2)" 21.4 32.4 36.3 30.4 31.8 24.4 29.1 14.7 29.5 21.0 29.2 18.8 27.2 20.7 22.0 35.2 35.8 20.8 26.8 48.9 29.3 29.6 38.5 50.1 18.1 29.8 36.9 21.3 20.9 52.7 18.8 26.2 26.6 28.4 23.2 30.0 15.8 36.2 28.7 74.0 19.5 24.3 21.5 28.9 27.3 24.0 46.6 25.8 37.5 32.8 52.1 36.7 21.7 26.7 58.4 85.4 59.7 56.2 50.2 61.2 69.5 36.2 44.4 52.6 35.6 34.5 31.4 56.5 25.4 31.4 38.3 37.1 61.3 48.6 45.0 17.8 38.3 32.4 36.6 41.4 58.3 55.4 46.2 31.1 64.5 52.0 32.0 42.3 30.9 30.3 32.9 35.4 46.1 35.1 22.1 16.9 49.4 56.7 49.6 68.1 106.9 45.1 34.4 51.2 38.6 35.2 49.6 18.9 33.7 39.1 53.8 44.1 16.3 48.5 26.9 34.6 48.6 27.8 56.9 16.7 24.0 115.9 44.1 32.3 46.0 49.1 56.2 59.7 52.2 51.2 58.7 58.4 56.4 57.5 63.4 54.4 57.6 59.4 21.2 50.2 49.6 85.4 61.2 69.5 36.3 31.8 14.7 29.5 29.3 29.6 36.9 21.3 28.4 25.8 MRPL53 ENSG00000204822 "Mitochondrial ribosomal protein L53" Q96EL3 2 74471958-74473322 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034612, HPA056185" Uncertain Supported Mitochondria Mitochondria "HPA034612: , HPA056185: " "unprognostic (2.22e-2)" "unprognostic (1.94e-2)" "unprognostic (2.81e-2)" "unprognostic (1.81e-1)" "unprognostic (2.04e-1)" "unprognostic (2.88e-2)" "prognostic unfavourable (7.36e-5)" "unprognostic (3.60e-2)" "unprognostic (1.24e-1)" "unprognostic (4.06e-2)" "prognostic favourable (1.37e-4)" "unprognostic (1.26e-1)" "prognostic unfavourable (1.16e-8)" "unprognostic (8.76e-2)" "unprognostic (2.79e-1)" "unprognostic (4.13e-1)" "unprognostic (2.45e-2)" 16.8 26.4 15.8 16.9 15.2 14.0 23.2 14.8 17.7 14.1 16.9 15.2 8.5 18.6 15.1 14.6 19.4 17.5 16.8 40.2 14.0 13.2 25.5 44.8 16.0 28.2 16.6 12.3 23.8 31.2 14.8 18.4 19.9 13.3 18.6 8.9 20.1 36.9 19.8 44.1 12.5 16.3 16.1 15.5 20.3 17.8 13.2 12.2 27.7 28.9 20.3 18.9 14.3 14.6 45.9 42.9 26.1 35.6 19.0 42.5 38.9 7.9 29.5 9.8 6.4 11.0 10.0 14.4 8.5 8.0 10.2 8.1 33.3 11.2 6.7 5.2 7.7 9.6 4.4 14.2 3.6 16.8 25.9 9.0 11.0 21.9 8.1 5.6 9.1 12.4 8.6 13.1 6.6 9.7 9.4 18.6 8.7 40.6 13.7 16.9 6.2 16.2 10.5 17.7 16.2 10.4 7.2 10.6 10.0 5.8 18.6 10.5 8.3 7.1 6.1 13.5 12.1 10.9 10.6 19.5 18.1 12.6 10.1 7.3 11.8 24.7 35.6 14.3 21.6 31.9 26.3 44.8 30.2 23.8 29.3 45.9 42.5 31.2 26.1 19.0 29.9 42.9 34.9 38.9 15.8 15.2 14.8 17.7 14.0 13.2 16.6 12.3 13.3 12.2 MRPL54 ENSG00000183617 "Mitochondrial ribosomal protein L54" Q6P161 19 3762664-3768575 "Predicted intracellular proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042117, HPA046767" Uncertain Approved Mitochondria Mitochondria "HPA042117: , HPA046767: " "unprognostic (2.09e-1)" "unprognostic (1.00e-3)" "unprognostic (3.81e-2)" "unprognostic (1.85e-3)" "unprognostic (1.00e-1)" "unprognostic (4.43e-2)" "unprognostic (1.23e-2)" "unprognostic (1.32e-3)" "unprognostic (7.19e-2)" "unprognostic (1.70e-2)" "unprognostic (2.22e-2)" "unprognostic (2.88e-2)" "unprognostic (1.34e-3)" "unprognostic (1.78e-1)" "unprognostic (2.26e-1)" "unprognostic (2.64e-2)" "unprognostic (6.54e-3)" 23.8 34.2 26.2 20.7 27.0 42.4 24.4 19.4 28.8 16.5 27.8 12.7 32.9 25.0 20.5 29.2 26.2 27.5 32.3 34.1 22.2 20.7 28.9 56.7 26.2 35.5 23.2 30.0 20.6 54.0 16.0 26.4 28.6 19.5 22.3 20.7 16.5 44.4 29.7 32.9 19.8 22.1 25.8 21.8 21.8 26.0 38.2 16.0 20.6 26.7 26.9 22.4 18.7 19.5 46.1 45.6 26.0 43.0 41.5 54.4 45.4 33.6 19.3 17.9 17.5 10.6 17.1 15.2 16.2 20.7 38.9 33.4 16.5 12.0 24.3 16.8 19.8 21.6 23.5 21.2 16.5 15.5 35.8 12.3 11.1 20.9 27.9 26.1 29.3 20.0 36.8 16.3 28.6 31.8 23.1 48.0 20.2 22.8 23.4 27.7 23.8 14.1 20.5 10.2 36.0 29.3 17.2 25.1 20.8 13.2 31.6 23.9 21.2 37.6 22.6 24.7 14.2 41.9 34.5 29.5 39.1 23.7 24.4 41.7 18.3 24.9 41.7 26.0 37.0 43.0 34.1 46.1 40.8 43.3 45.6 42.5 39.4 36.2 12.0 41.5 40.9 41.4 54.4 45.4 26.2 27.0 19.4 28.8 22.2 20.7 23.2 30.0 19.5 16.0 MRPL57 MRP63 ENSG00000173141 "Mitochondrial ribosomal protein L57" Q9BQC6 13 21176645-21179084 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039779, HPA059370" Supported Supported Mitochondria Mitochondria "HPA039779: AB_10673362, HPA059370: " "unprognostic (1.00e-1)" "unprognostic (1.92e-1)" "unprognostic (4.32e-2)" "unprognostic (9.57e-3)" "unprognostic (1.51e-1)" "unprognostic (5.54e-2)" "unprognostic (1.47e-1)" "unprognostic (1.68e-1)" "unprognostic (2.64e-1)" "unprognostic (1.68e-2)" "prognostic favourable (8.35e-4)" "unprognostic (7.65e-2)" "unprognostic (2.01e-1)" "unprognostic (5.72e-2)" "unprognostic (1.32e-1)" "unprognostic (1.10e-1)" "unprognostic (6.78e-2)" 14.0 28.8 23.2 13.8 21.4 16.2 16.5 16.1 22.6 14.6 15.3 12.6 12.9 18.4 13.4 21.0 16.1 17.3 18.7 29.3 20.5 24.7 24.8 40.9 15.0 16.5 21.3 17.9 19.6 30.2 12.3 26.8 12.5 17.1 21.6 12.3 15.1 23.2 18.8 48.0 15.3 17.5 16.4 17.8 16.6 18.1 20.2 13.0 26.4 25.1 24.7 13.8 13.4 12.8 26.1 43.9 23.0 31.5 21.8 32.8 28.8 8.1 14.8 10.5 9.4 8.0 6.6 11.0 9.8 6.1 9.3 7.0 19.4 15.1 4.7 11.5 6.1 14.1 9.1 9.4 7.1 12.3 15.3 21.4 10.6 21.7 11.9 11.7 10.7 6.8 10.4 7.4 7.0 8.9 9.3 6.2 6.5 28.5 25.4 31.0 7.6 17.4 15.5 15.8 8.2 11.4 9.9 21.0 9.8 8.0 10.0 14.4 10.1 11.0 6.1 4.9 9.0 10.3 8.7 8.7 7.0 8.4 4.3 13.9 12.2 17.8 31.5 23.0 22.8 24.4 25.8 26.1 29.0 24.3 27.5 25.8 32.8 26.1 4.8 21.8 20.1 43.9 28.8 28.8 23.2 21.4 16.1 22.2 20.5 24.7 21.3 17.9 17.1 13.0 MRPL9 ENSG00000143436 "Mitochondrial ribosomal protein L9" Q9BYD2 1 151759643-151763564 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008579 Approved Supported Mitochondria Mitochondria "HPA008579: AB_1079412" "unprognostic (2.55e-1)" "unprognostic (1.75e-1)" "unprognostic (2.34e-1)" "unprognostic (7.43e-3)" "unprognostic (7.66e-2)" "unprognostic (2.73e-1)" "prognostic unfavourable (1.04e-7)" "unprognostic (1.47e-1)" "unprognostic (5.22e-2)" "unprognostic (9.51e-3)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" "prognostic unfavourable (1.44e-5)" "unprognostic (1.79e-1)" "unprognostic (1.79e-1)" "unprognostic (2.10e-2)" "unprognostic (6.30e-2)" 28.5 22.3 23.3 26.3 25.3 23.0 26.4 27.3 30.9 22.1 26.7 22.2 19.8 21.7 26.8 25.4 28.4 22.5 24.3 24.5 21.7 24.6 29.9 35.1 19.5 28.7 24.0 19.4 33.2 31.9 35.1 18.4 29.0 27.6 29.0 22.3 19.7 40.6 25.3 50.7 25.7 23.1 23.7 21.2 28.5 23.0 24.0 18.3 41.2 38.2 34.2 29.3 25.3 23.5 30.6 31.5 15.0 16.5 24.4 37.6 21.6 29.0 23.8 15.7 18.4 11.3 12.7 25.7 16.1 15.4 25.2 20.2 36.3 27.1 19.0 32.8 16.2 25.7 27.3 20.3 20.1 25.9 26.4 14.9 20.2 23.0 18.4 41.5 14.1 13.8 18.8 22.4 28.2 24.3 31.1 25.0 19.4 67.6 25.7 29.8 34.0 34.4 22.7 18.8 36.7 15.2 22.9 25.9 26.5 19.2 27.7 22.6 41.9 50.4 18.0 20.0 20.3 17.1 35.7 28.1 39.8 60.5 25.0 27.5 22.2 15.0 13.6 8.8 27.8 16.5 31.8 30.6 32.1 32.3 31.5 27.8 30.9 28.8 1.6 24.4 14.2 26.5 37.6 21.6 23.3 25.3 27.3 30.9 21.7 24.6 24.0 19.4 27.6 18.3 MRPS11 "FLJ22512, FLJ23406, HCC-2" ENSG00000181991 "Mitochondrial ribosomal protein S11" P82912 15 88467453-88480773 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043752, HPA050345" Enhanced Supported Mitochondria Mitochondria "HPA043752: AB_2678653, HPA050345: " "unprognostic (2.66e-1)" "prognostic favourable (3.60e-4)" "unprognostic (6.51e-2)" "unprognostic (1.35e-1)" "unprognostic (1.12e-1)" "unprognostic (3.21e-1)" "unprognostic (3.45e-1)" "unprognostic (1.44e-1)" "unprognostic (6.45e-2)" "prognostic favourable (4.75e-4)" "unprognostic (8.31e-2)" "unprognostic (3.37e-1)" "unprognostic (1.83e-1)" "unprognostic (9.44e-2)" "unprognostic (7.26e-2)" "unprognostic (7.85e-2)" "unprognostic (1.74e-1)" 12.4 19.1 19.5 9.0 18.3 6.1 13.5 11.2 19.6 7.0 13.4 8.0 11.0 17.6 7.3 9.3 15.1 11.4 10.3 31.0 19.1 17.3 16.5 28.5 8.2 10.5 18.3 15.0 6.0 22.5 9.6 9.3 9.0 15.8 8.9 8.6 8.0 11.4 10.4 44.3 11.5 13.1 10.0 13.7 9.5 10.7 9.9 10.4 12.9 17.7 12.9 10.4 9.7 7.9 18.5 23.0 18.9 19.0 20.9 24.4 17.4 5.5 22.1 3.1 5.7 7.7 3.9 9.1 4.7 7.9 5.8 6.4 15.2 8.6 5.0 9.4 3.7 7.9 9.2 6.2 2.9 6.7 24.1 6.8 14.3 16.5 9.2 2.4 4.5 7.5 6.1 5.0 5.0 7.9 5.0 2.2 9.7 23.6 4.7 9.8 9.2 23.5 10.1 6.3 11.9 8.2 15.1 11.1 5.4 4.9 11.6 18.0 11.0 13.4 3.6 8.4 9.3 5.5 6.5 4.7 8.3 5.8 10.5 5.7 8.7 18.9 18.4 13.2 11.7 19.0 13.3 18.5 13.3 13.6 21.2 12.9 14.1 13.7 6.7 20.9 12.1 23.0 24.4 17.4 19.5 18.3 11.2 19.6 19.1 17.3 18.3 15.0 15.8 10.4 MRPS15 FLJ11564 ENSG00000116898 "Mitochondrial ribosomal protein S15" P82914 1 36455718-36464437 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028100, HPA028134, HPA067137" Supported Supported Mitochondria Mitochondria "HPA028100: AB_10600216, HPA028134: AB_10600890, HPA067137: " "unprognostic (2.05e-2)" "unprognostic (6.98e-2)" "unprognostic (7.57e-2)" "unprognostic (4.53e-1)" "unprognostic (3.29e-2)" "unprognostic (1.44e-1)" "prognostic unfavourable (3.59e-4)" "unprognostic (2.20e-2)" "unprognostic (3.28e-2)" "prognostic favourable (7.83e-4)" "unprognostic (8.48e-2)" "unprognostic (1.45e-1)" "prognostic unfavourable (3.55e-4)" "unprognostic (2.31e-1)" "unprognostic (1.44e-1)" "unprognostic (8.94e-2)" "unprognostic (1.39e-1)" 22.6 20.7 17.8 16.9 17.3 24.0 23.8 9.5 16.0 13.2 19.9 9.3 13.7 14.3 13.3 23.0 23.0 10.4 16.6 43.2 15.0 15.2 30.6 61.7 16.6 23.3 17.5 10.6 13.8 23.3 14.3 14.3 23.7 18.3 15.0 18.2 13.8 24.0 14.7 89.5 14.1 18.4 15.7 12.3 17.3 18.8 65.5 10.6 20.3 19.1 41.3 19.3 16.0 12.9 24.5 40.7 7.0 28.7 20.3 28.1 28.6 40.2 22.4 24.5 29.9 24.4 35.4 60.9 22.5 32.3 55.8 51.3 39.6 43.4 37.3 36.8 29.6 35.5 35.7 56.8 50.4 24.2 45.3 38.1 29.1 43.2 45.7 47.1 27.0 32.6 50.8 49.7 40.3 45.5 41.1 29.5 34.4 27.6 45.3 50.5 44.0 39.5 35.1 43.1 54.5 49.3 33.9 36.4 20.1 31.2 39.8 57.7 24.6 32.4 21.4 31.5 33.4 38.8 47.4 29.7 40.7 52.1 35.8 32.1 43.9 4.9 26.7 7.0 22.0 28.7 27.2 24.5 25.2 25.0 40.7 21.6 23.9 23.2 1.8 20.3 18.9 27.7 28.1 28.6 17.8 17.3 9.5 16.0 15.0 15.2 17.5 10.6 18.3 10.6 MRPS2 CGI-91 ENSG00000122140 "Mitochondrial ribosomal protein S2" Q9Y399 9 135499984-135504673 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029487, HPA057261" Approved Supported Mitochondria Mitochondria "HPA029487: , HPA057261: " "unprognostic (3.18e-3)" "unprognostic (9.42e-3)" "unprognostic (1.46e-1)" "unprognostic (7.81e-2)" "unprognostic (3.55e-1)" "unprognostic (8.45e-2)" "unprognostic (1.63e-1)" "unprognostic (5.63e-3)" "unprognostic (3.83e-1)" "unprognostic (2.90e-2)" "unprognostic (4.81e-2)" "unprognostic (7.58e-2)" "prognostic favourable (6.96e-9)" "unprognostic (2.74e-2)" "unprognostic (1.06e-1)" "unprognostic (8.29e-2)" "unprognostic (2.24e-1)" 18.5 31.7 15.6 14.8 18.4 17.7 32.1 17.9 28.9 15.2 19.6 12.6 31.3 20.9 19.7 15.7 20.7 33.3 20.6 43.6 15.0 15.5 24.5 48.6 17.8 32.7 15.4 15.1 25.6 37.1 21.7 15.5 16.5 14.1 18.3 16.2 15.0 25.7 29.3 43.0 19.7 16.0 22.0 12.8 18.4 20.6 12.3 10.6 18.5 22.5 28.4 18.2 18.5 15.7 20.6 16.2 7.3 15.8 14.5 22.3 13.7 16.2 27.0 9.9 13.5 11.3 12.7 17.1 12.0 10.9 20.3 15.1 40.6 15.4 20.7 16.4 11.0 37.0 24.9 28.1 7.9 12.7 39.1 10.2 27.4 27.2 19.8 20.7 12.6 16.9 21.9 22.1 15.9 18.9 33.6 15.3 11.8 50.1 20.2 36.2 22.7 43.7 22.2 16.3 43.5 16.8 13.9 30.0 15.8 16.3 31.3 17.2 26.0 16.5 11.7 14.9 16.8 25.6 21.5 16.9 33.0 22.9 15.3 18.9 13.7 4.8 15.8 7.3 18.0 14.9 20.4 20.6 18.1 19.2 16.2 20.3 19.7 19.6 1.3 14.5 12.2 13.9 22.3 13.7 15.6 18.4 17.9 28.9 15.0 15.5 15.4 15.1 14.1 10.6 MRPS21 ENSG00000266472 "Mitochondrial ribosomal protein S21" 1 150293720-150308979 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078289 Supported Mitochondria Mitochondria "HPA078289: " "unprognostic (3.48e-2)" "unprognostic (1.94e-2)" "unprognostic (5.46e-2)" "unprognostic (2.33e-1)" "unprognostic (2.88e-1)" "unprognostic (8.45e-2)" "prognostic unfavourable (2.62e-4)" "unprognostic (1.15e-2)" "unprognostic (2.60e-1)" "unprognostic (3.14e-2)" "unprognostic (4.13e-2)" "unprognostic (9.71e-2)" "unprognostic (7.59e-2)" "unprognostic (2.12e-2)" "unprognostic (4.02e-2)" "unprognostic (3.97e-2)" "unprognostic (1.46e-1)" 10.5 17.7 10.8 8.6 16.5 8.6 14.2 8.7 18.8 9.7 8.5 8.1 9.7 10.1 10.4 15.1 9.5 12.1 9.3 15.0 8.9 13.3 12.2 8.1 10.3 8.4 16.7 16.4 11.5 10.9 13.6 8.3 15.9 9.3 7.5 10.0 9.9 12.2 16.9 9.0 8.6 10.3 7.9 9.6 9.9 10.3 9.3 6.2 13.8 11.7 11.7 8.7 9.4 37.8 43.7 15.7 25.8 21.2 36.9 30.3 26.6 22.3 28.8 14.6 27.7 27.4 23.8 19.7 16.8 19.6 19.0 4.6 25.4 27.2 13.6 21.5 25.5 24.7 21.0 17.5 18.3 31.8 15.8 33.1 32.5 22.0 23.6 13.9 30.3 22.4 23.5 26.8 24.7 26.0 36.0 26.0 61.1 19.9 21.6 49.2 39.1 18.3 15.0 46.3 22.5 19.6 22.3 47.0 16.6 33.7 31.9 18.4 34.5 17.4 7.6 14.4 20.3 21.6 31.2 32.9 27.1 9.8 13.1 14.4 11.8 25.8 15.7 24.8 24.5 29.7 37.8 32.2 28.3 28.6 33.1 36.9 31.3 6.0 21.2 21.9 43.7 30.1 30.3 MRPS22 "C3orf5, GIBT, GK002, MRP-S22" ENSG00000175110 "Mitochondrial ribosomal protein S22" P82650 3 139005806-139357223 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006083, HPA007830" Enhanced Supported Mitochondria "Intracellular and membrane" Mitochondria "HPA006083: AB_1854122, HPA007830: AB_1854123" "unprognostic (8.38e-2)" "unprognostic (1.52e-2)" "unprognostic (3.04e-2)" "prognostic unfavourable (1.35e-5)" "unprognostic (5.22e-3)" "unprognostic (5.45e-3)" "unprognostic (4.85e-2)" "unprognostic (2.18e-2)" "unprognostic (2.78e-2)" "unprognostic (4.49e-3)" "prognostic unfavourable (1.55e-5)" "prognostic unfavourable (1.85e-4)" "unprognostic (3.22e-3)" "unprognostic (2.56e-2)" "unprognostic (1.49e-1)" "unprognostic (1.77e-1)" "unprognostic (3.40e-1)" 17.6 45.3 16.9 14.5 24.9 22.1 18.3 15.5 26.7 16.3 22.7 14.6 12.2 24.0 17.0 14.7 26.7 14.5 13.8 39.2 23.4 15.0 24.9 43.3 12.9 20.2 18.2 19.7 15.7 22.4 13.6 15.2 16.9 22.6 11.6 22.0 8.8 15.3 15.8 50.8 17.2 21.1 16.8 18.1 14.0 19.0 21.9 19.9 15.3 15.1 31.0 16.0 16.5 16.9 24.9 27.9 21.7 31.6 21.1 27.8 20.9 30.5 13.2 11.2 13.6 16.9 14.3 25.9 17.9 23.2 32.3 26.5 41.9 22.0 21.1 33.8 21.8 34.7 20.3 24.5 31.1 11.9 18.8 33.7 11.4 29.1 18.8 31.4 18.4 15.3 19.2 19.4 20.2 19.6 46.5 13.3 19.5 22.5 15.7 24.7 20.1 23.3 19.9 19.2 29.5 23.3 18.1 13.4 12.0 29.1 42.8 45.6 29.9 28.5 14.0 12.9 13.7 25.6 16.9 20.6 11.3 37.7 16.0 22.4 12.5 21.7 24.0 21.2 22.9 31.6 27.6 24.9 24.7 25.7 27.9 21.6 27.3 25.3 5.4 21.1 30.3 17.8 27.8 20.9 16.9 24.9 15.5 26.7 23.4 15.0 18.2 19.7 22.6 19.9 MRPS25 "DKFZp313H0817, FLJ00023, MRP-S25, RPMS25" ENSG00000131368 "Mitochondrial ribosomal protein S25" P82663 3 15042460-15065335 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043490 Approved Supported Mitochondria Mitochondria "HPA043490: AB_10794888" "unprognostic (3.98e-2)" "unprognostic (5.36e-2)" "unprognostic (4.58e-3)" "unprognostic (1.24e-2)" "unprognostic (4.66e-2)" "unprognostic (1.82e-2)" "unprognostic (3.33e-2)" "unprognostic (4.93e-3)" "unprognostic (2.23e-1)" "unprognostic (2.10e-1)" "unprognostic (6.29e-2)" "unprognostic (2.68e-3)" "prognostic favourable (3.60e-7)" "unprognostic (2.84e-2)" "unprognostic (1.93e-1)" "unprognostic (5.06e-2)" "unprognostic (2.91e-3)" 14.8 18.5 18.7 18.4 28.3 12.0 14.3 24.9 21.9 11.7 20.9 13.1 15.2 31.6 16.8 15.8 15.6 15.4 15.0 41.7 15.2 16.5 18.4 27.5 14.4 17.7 16.3 24.0 18.1 24.1 18.1 21.4 11.4 16.8 14.9 23.3 20.3 14.9 17.4 47.6 18.8 26.4 24.5 13.2 17.4 17.3 33.3 15.0 10.2 28.5 15.7 18.6 14.8 13.5 21.1 16.1 3.6 18.6 6.8 15.3 9.4 8.4 12.5 10.3 14.3 10.9 9.4 32.8 11.6 4.5 9.4 8.1 14.3 9.2 22.2 6.2 5.1 11.0 14.8 11.0 8.1 8.8 20.9 18.4 25.8 17.7 7.7 16.2 14.1 11.3 10.5 14.7 4.5 8.7 19.5 13.4 7.0 27.0 12.6 15.7 10.7 19.8 17.2 8.9 22.9 11.6 14.7 8.2 12.3 8.5 16.2 16.6 21.9 14.1 10.6 8.5 12.5 11.6 14.4 13.0 13.8 15.9 8.6 20.9 7.9 1.1 15.4 3.6 10.1 18.4 11.8 21.1 9.6 10.4 16.1 18.2 15.3 12.5 1.0 6.8 18.6 13.3 7.4 9.4 18.7 28.3 24.9 21.9 15.2 16.5 16.3 24.0 16.8 15.0 MRPS28 "HSPC007, MRP-S28, MRPS35" ENSG00000147586 "Mitochondrial ribosomal protein S28" Q9Y2Q9 8 79918717-80030289 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 89.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027202 Approved Supported Mitochondria Mitochondria "HPA027202: AB_1854126" "unprognostic (3.63e-3)" "unprognostic (6.41e-2)" "unprognostic (9.61e-3)" "unprognostic (1.31e-1)" "unprognostic (4.41e-2)" "unprognostic (1.43e-3)" "unprognostic (2.17e-1)" "unprognostic (1.27e-1)" "unprognostic (3.23e-1)" "unprognostic (4.55e-1)" "unprognostic (4.18e-1)" "unprognostic (2.11e-1)" "prognostic favourable (1.20e-6)" "unprognostic (4.48e-2)" "unprognostic (3.13e-1)" "unprognostic (1.18e-1)" "unprognostic (7.18e-2)" 18.1 36.9 27.4 13.2 26.7 10.9 19.9 16.7 23.3 14.1 20.9 20.5 10.9 13.4 11.5 16.5 18.1 14.7 12.0 40.4 24.0 24.7 32.5 44.2 12.2 13.7 32.2 17.9 13.4 19.1 20.6 20.2 18.7 21.9 13.1 17.2 16.7 14.2 14.8 56.9 11.8 12.7 13.4 27.8 12.6 14.0 9.7 19.0 18.1 22.4 27.8 15.7 14.0 11.7 19.6 41.7 26.0 28.1 25.4 26.7 18.0 20.3 20.3 18.4 4.3 15.7 20.4 20.2 22.8 21.3 31.2 26.5 17.7 16.5 25.7 26.5 18.5 16.8 25.4 26.0 25.1 20.3 22.4 31.2 18.5 27.5 17.6 13.9 14.1 17.2 22.4 18.2 24.9 20.1 22.0 10.8 30.8 19.5 31.7 22.6 7.5 34.7 21.7 14.7 14.8 39.2 19.7 8.7 14.7 10.1 89.7 21.2 21.6 16.7 14.4 11.7 29.4 20.4 20.0 11.7 18.7 22.9 19.9 16.1 9.0 26.0 20.7 10.9 19.0 28.1 20.7 18.7 21.4 23.8 36.7 19.6 25.9 24.9 4.5 25.4 24.9 41.7 26.7 18.0 27.4 26.7 16.7 23.3 24.0 24.7 32.2 17.9 21.9 19.0 MRPS34 "MGC2616, MRP-S12" ENSG00000074071 "Mitochondrial ribosomal protein S34" P82930 16 1771890-1773155 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 74.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042112 Supported Supported Mitochondria Mitochondria "HPA042112: AB_10796899" "unprognostic (2.02e-1)" "unprognostic (4.83e-2)" "unprognostic (6.79e-2)" "unprognostic (3.42e-2)" "unprognostic (2.27e-1)" "unprognostic (9.59e-2)" "unprognostic (1.42e-2)" "unprognostic (2.49e-1)" "unprognostic (3.03e-1)" "unprognostic (2.22e-2)" "unprognostic (1.81e-1)" "unprognostic (1.50e-1)" "unprognostic (3.52e-1)" "unprognostic (1.37e-2)" "unprognostic (6.60e-2)" "unprognostic (3.18e-1)" "unprognostic (5.44e-2)" 26.8 30.5 15.6 14.1 18.3 21.1 17.8 20.2 26.8 11.5 28.0 14.7 19.2 28.4 15.1 13.6 24.7 13.7 17.9 21.9 14.0 13.1 22.5 27.7 12.9 14.8 14.0 13.1 12.6 42.0 13.0 15.5 12.6 16.3 21.2 7.0 12.5 46.6 19.4 89.8 21.9 23.6 10.8 13.6 25.8 36.5 8.8 15.1 21.5 21.0 28.1 21.1 14.7 15.7 55.5 54.6 27.2 50.8 41.0 51.9 45.5 14.0 15.6 2.2 5.4 1.8 2.2 18.0 15.4 3.0 5.3 4.1 10.6 8.2 17.7 24.7 1.8 16.5 3.1 7.4 0.7 12.5 74.4 12.4 13.9 11.2 4.1 22.6 13.2 2.0 3.6 3.2 1.4 4.1 20.7 3.7 1.5 22.6 12.3 40.4 20.9 47.9 27.7 10.6 38.6 2.0 3.9 27.6 20.7 17.2 8.6 14.8 11.1 9.2 10.3 5.7 18.4 7.7 12.6 32.1 22.2 28.1 4.4 12.9 7.2 15.7 50.8 27.2 41.0 44.0 43.4 50.5 45.8 43.5 54.6 55.5 43.7 39.2 11.0 41.0 37.4 51.0 51.9 45.5 15.6 18.3 20.2 26.8 14.0 13.1 14.0 13.1 16.3 15.1 MRPS36 "DC47, MRP-S36" ENSG00000134056 "Mitochondrial ribosomal protein S36" P82909 5 69217760-69230129 "Predicted intracellular proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035802, HPA056795" Supported Enhanced Mitochondria Mitochondria "HPA035802: AB_10600933, HPA056795: " "unprognostic (1.19e-1)" "unprognostic (6.78e-3)" "unprognostic (4.08e-2)" "unprognostic (1.02e-1)" "unprognostic (1.92e-1)" "unprognostic (2.96e-3)" "unprognostic (1.99e-1)" "unprognostic (7.49e-2)" "unprognostic (1.49e-1)" "unprognostic (1.99e-2)" "unprognostic (1.38e-1)" "unprognostic (3.90e-1)" "prognostic favourable (5.02e-6)" "unprognostic (2.06e-1)" "unprognostic (2.49e-1)" "unprognostic (1.37e-2)" "unprognostic (4.84e-3)" 13.6 13.7 16.7 9.1 21.4 12.8 13.8 10.4 24.8 8.0 16.8 4.7 12.6 17.1 9.1 11.7 14.4 8.2 10.9 42.8 17.6 13.5 34.8 26.5 17.0 12.2 16.3 14.3 8.8 21.7 11.7 10.4 9.3 17.7 10.8 17.8 6.4 9.6 9.5 29.8 8.1 20.9 13.9 11.4 8.0 13.9 6.8 10.0 10.8 12.7 22.3 11.5 9.9 9.0 27.9 24.4 24.7 27.5 21.5 34.7 14.9 15.8 15.3 10.8 14.8 19.1 19.4 28.6 14.2 13.7 18.3 22.7 21.2 17.8 17.1 29.7 12.0 16.3 18.0 21.6 18.2 20.0 18.9 11.6 18.1 23.5 22.6 12.3 15.9 20.1 15.5 17.4 8.3 13.5 13.7 12.9 16.1 17.2 18.8 18.9 8.0 17.9 11.2 18.9 26.1 31.5 18.0 15.2 14.8 14.6 21.4 24.6 16.4 18.0 9.7 8.2 14.0 18.1 24.3 13.6 22.2 22.7 14.3 23.2 10.7 24.4 20.4 24.7 21.4 27.5 23.6 27.9 24.5 23.9 24.4 22.4 22.2 23.4 22.0 21.5 24.7 24.1 34.7 14.9 16.7 21.4 10.4 24.8 17.6 13.5 16.3 14.3 17.7 10.0 MRPS5 "MRP-S5, S5mt" ENSG00000144029 "Mitochondrial ribosomal protein S5" P82675 2 95087207-95149434 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055765 Approved Supported Mitochondria Mitochondria "HPA055765: " "unprognostic (1.18e-1)" "unprognostic (7.79e-2)" "unprognostic (1.73e-2)" "prognostic unfavourable (7.98e-7)" "unprognostic (7.51e-3)" "unprognostic (6.30e-3)" "prognostic unfavourable (7.73e-5)" "unprognostic (8.59e-2)" "unprognostic (1.87e-1)" "unprognostic (2.76e-2)" "unprognostic (1.11e-1)" "unprognostic (1.99e-2)" "unprognostic (1.32e-2)" "unprognostic (2.34e-2)" "unprognostic (1.29e-1)" "prognostic favourable (6.36e-4)" "unprognostic (1.25e-1)" 17.7 25.0 17.6 16.2 24.1 24.0 15.3 31.7 22.7 14.8 24.7 22.6 15.0 27.2 17.6 14.9 23.8 17.3 12.7 36.7 17.9 17.7 30.9 40.4 16.8 17.2 23.4 15.9 18.5 21.2 20.7 30.1 14.7 20.0 14.6 27.8 14.3 19.1 18.0 45.6 12.8 22.0 18.6 19.3 18.2 19.6 13.3 24.5 20.8 19.9 20.4 20.6 17.2 22.8 24.9 29.3 17.5 38.4 19.3 30.5 20.7 36.4 23.1 16.8 14.5 14.8 19.2 31.5 19.6 8.9 17.3 18.0 45.8 21.6 29.0 16.1 16.1 23.9 24.6 20.3 24.5 24.4 30.5 20.3 21.0 41.9 23.9 27.2 16.2 18.9 16.7 23.7 25.4 21.4 28.6 14.7 17.6 22.4 38.5 31.1 15.9 36.4 22.8 16.5 37.2 28.6 30.5 22.9 14.8 15.5 29.1 32.8 13.7 25.2 18.2 21.1 26.1 28.0 29.0 18.1 15.8 26.3 16.4 29.2 18.0 13.4 33.7 17.5 21.9 38.4 21.3 24.9 27.1 23.0 27.5 23.6 24.2 24.1 6.3 19.3 34.7 29.3 30.5 20.7 17.6 24.1 31.7 22.7 17.9 17.7 23.4 15.9 20.0 24.5 MRPS6 "C21orf101, MRP-S6, RPMS6" ENSG00000243927 "Mitochondrial ribosomal protein S6" P82932 21 34073224-34143034 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007861, HPA008163, HPA049676" Supported Supported Mitochondria Mitochondria "HPA007861: , HPA008163: , HPA049676: " "unprognostic (2.71e-2)" "unprognostic (4.85e-2)" "unprognostic (5.16e-3)" "unprognostic (4.01e-2)" "unprognostic (9.84e-3)" "unprognostic (3.72e-2)" "unprognostic (7.58e-3)" "unprognostic (1.80e-1)" "unprognostic (8.19e-2)" "unprognostic (2.28e-3)" "unprognostic (5.87e-2)" "unprognostic (2.52e-1)" "unprognostic (1.02e-3)" "unprognostic (9.37e-2)" "unprognostic (5.13e-2)" "unprognostic (5.51e-2)" "prognostic favourable (1.06e-5)" 25.3 29.3 26.1 17.5 27.3 8.5 62.4 20.6 25.3 12.6 28.7 12.9 23.6 14.1 21.8 24.5 14.8 22.7 14.0 23.3 28.6 25.6 67.4 24.2 14.4 23.7 28.9 13.0 18.8 9.9 9.6 17.4 28.3 33.2 15.7 18.8 28.0 12.1 25.7 41.7 20.2 16.1 20.1 35.6 12.4 21.0 26.4 22.8 15.8 98.7 12.4 25.3 19.6 52.1 30.9 42.8 22.2 21.1 41.7 40.5 29.9 15.4 12.2 46.8 16.9 16.4 16.5 16.0 17.4 38.0 14.4 15.1 39.5 28.9 23.6 11.8 20.7 6.2 27.2 22.8 13.8 41.5 15.4 20.1 7.5 9.3 8.1 9.3 6.7 7.2 23.2 27.5 24.8 9.8 25.2 5.8 27.7 13.1 15.8 23.2 30.3 28.3 22.3 8.7 22.1 60.6 10.9 42.3 11.2 18.6 9.0 21.7 19.3 11.3 5.6 14.2 8.4 24.3 9.5 29.7 25.8 20.5 46.3 25.2 13.8 22.0 21.1 22.2 38.8 20.2 30.2 30.9 30.9 36.3 22.0 19.4 40.5 39.9 17.5 41.7 20.1 42.8 29.9 29.9 26.1 27.3 20.6 25.3 28.6 25.6 28.9 13.0 33.2 22.8 MRPS7 "MRP-S, RP-S7, RPMS7" ENSG00000125445 "Mitochondrial ribosomal protein S7" Q9Y2R9 17 75261674-75266373 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022522, HPA023007" Supported Approved Mitochondria Mitochondria "HPA022522: AB_1854131, HPA023007: AB_1854132" "unprognostic (1.24e-1)" "unprognostic (4.74e-2)" "prognostic favourable (1.12e-4)" "unprognostic (5.82e-3)" "unprognostic (3.62e-2)" "unprognostic (5.05e-3)" "prognostic unfavourable (3.13e-4)" "unprognostic (1.32e-1)" "unprognostic (1.04e-1)" "unprognostic (4.95e-2)" "unprognostic (8.56e-3)" "unprognostic (1.03e-1)" "unprognostic (5.83e-2)" "unprognostic (1.03e-1)" "unprognostic (8.56e-2)" "unprognostic (1.76e-1)" "unprognostic (4.15e-1)" 17.4 22.1 16.8 15.7 17.9 11.6 15.3 15.6 23.5 11.0 19.6 11.2 15.5 19.8 11.2 14.0 20.9 15.0 16.7 56.7 15.0 14.7 22.9 30.6 12.3 15.0 17.8 13.1 12.2 18.1 15.7 14.0 19.6 14.9 13.6 17.1 13.9 16.9 16.9 79.5 11.1 19.6 13.5 12.1 15.1 16.2 29.4 9.4 17.4 16.2 33.9 15.8 13.4 12.2 30.6 38.0 9.9 33.6 26.4 30.8 43.9 23.4 40.5 15.7 12.5 12.8 7.4 30.5 15.7 11.5 28.2 20.5 44.1 20.0 20.9 13.9 15.3 22.6 24.6 25.9 16.0 11.2 42.8 28.1 27.5 41.2 12.0 26.0 14.8 11.1 25.6 21.6 21.4 34.0 27.6 18.9 17.0 43.9 29.9 23.4 18.5 40.4 20.9 49.0 28.9 24.6 24.2 29.0 26.9 20.5 50.5 29.1 39.4 22.6 15.5 26.5 27.7 13.7 31.6 21.4 12.5 21.7 19.1 18.3 20.0 7.1 33.6 9.9 26.1 33.2 28.0 30.6 25.9 28.3 36.8 27.5 30.8 28.1 2.6 26.4 27.8 38.0 29.0 43.9 16.8 17.9 15.6 23.5 15.0 14.7 17.8 13.1 14.9 9.4 MRPS9 "MRP-S9, RPMS9, S9mt" ENSG00000135972 "Mitochondrial ribosomal protein S9" P82933 2 105037983-105099960 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043476, HPA048479" Supported Enhanced Mitochondria Mitochondria "HPA043476: AB_2678498, HPA048479: AB_2680412" "unprognostic (8.10e-3)" "unprognostic (4.75e-3)" "unprognostic (3.69e-1)" "unprognostic (3.80e-3)" "unprognostic (5.25e-1)" "unprognostic (1.39e-1)" "prognostic unfavourable (4.43e-4)" "unprognostic (1.88e-1)" "unprognostic (1.16e-2)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (3.78e-1)" "unprognostic (2.62e-3)" "unprognostic (4.62e-2)" "unprognostic (5.28e-2)" "unprognostic (1.20e-1)" "unprognostic (1.12e-1)" 13.9 25.0 14.1 16.9 18.5 13.3 15.4 13.2 20.6 13.7 18.9 15.9 14.3 19.0 17.6 13.2 16.7 16.2 8.9 39.1 14.4 15.3 24.5 23.5 10.0 14.5 18.1 15.7 21.0 17.3 22.0 23.9 8.4 25.2 15.8 22.0 10.9 15.3 16.4 56.8 14.0 17.0 16.6 15.0 14.0 17.4 20.6 16.6 20.7 15.6 28.7 16.8 15.2 12.4 22.1 20.4 7.1 17.2 20.0 22.8 14.5 22.0 9.5 20.1 18.5 10.6 11.0 23.6 14.2 13.6 22.5 20.3 50.8 15.5 23.0 14.1 11.1 20.0 39.4 20.6 24.0 14.2 25.9 22.7 14.1 30.6 17.7 16.8 10.2 13.1 14.0 18.5 15.5 17.2 32.4 12.1 15.3 17.7 22.6 22.1 31.8 21.0 28.9 17.3 32.0 28.2 15.5 17.5 10.5 16.4 24.1 19.1 19.8 17.1 11.2 13.3 26.9 13.2 15.2 11.1 13.1 18.4 11.5 25.8 11.1 7.1 11.6 4.6 19.9 14.6 22.0 22.1 22.0 20.9 20.4 16.5 22.3 21.9 1.3 20.0 17.2 15.2 22.8 14.5 14.1 18.5 13.2 20.6 14.4 15.3 18.1 15.7 25.2 16.6 MT-CO1 "COI, COX1, MTCO1" ENSG00000198804 "Mitochondrially encoded cytochrome c oxidase I" P00395 MT 5904-7445 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Deafness, Disease mutation, Leber hereditary optic neuropathy, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 396.5;heart muscle: 345.0;skeletal muscle: 380.7" "Cell line enhanced" "Detected in all" "HeLa: 859.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016241, HPA069328" Enhanced Supported Mitochondria Mitochondria "CAB016241: AB_2229888, HPA069328: " "unprognostic (4.39e-1)" "unprognostic (2.45e-1)" "unprognostic (1.39e-1)" "unprognostic (2.21e-1)" "unprognostic (1.59e-1)" "unprognostic (3.31e-1)" "prognostic favourable (2.29e-4)" "unprognostic (8.28e-2)" "unprognostic (1.01e-1)" "unprognostic (5.56e-3)" "unprognostic (1.20e-2)" "unprognostic (6.60e-2)" "unprognostic (2.83e-2)" "unprognostic (5.06e-3)" "unprognostic (4.50e-2)" "unprognostic (2.15e-2)" "unprognostic (2.44e-2)" 57.6 82.5 184.1 22.2 164.2 26.4 37.4 40.6 117.1 31.5 80.8 78.1 25.7 42.7 43.5 24.8 32.4 345.0 161.8 111.7 151.0 150.5 20.9 22.6 126.3 23.7 42.5 62.3 10.1 29.0 35.8 84.4 65.6 54.2 380.7 68.9 60.0 38.2 61.2 28.1 65.5 27.8 23.8 21.9 31.6 15.3 292.2 232.9 177.4 396.5 182.8 192.4 130.5 112.7 170.5 232.0 252.3 531.8 243.6 246.0 257.3 85.7 65.0 108.8 205.2 367.8 298.0 123.7 195.5 428.5 26.5 228.0 93.1 140.8 162.5 178.9 859.1 383.8 73.7 103.2 226.6 284.1 237.4 64.2 142.7 78.2 113.5 213.9 192.4 273.1 84.4 462.1 58.9 139.6 110.6 69.3 178.8 329.5 298.3 110.9 147.9 89.2 345.8 160.5 198.4 347.4 311.5 260.6 177.4 255.7 129.0 101.3 97.0 67.6 128.7 272.4 126.6 177.4 396.5 169.3 156.6 236.0 176.4 255.6 154.9 171.8 163.0 292.2 159.7 192.4 93.5 182.8 260.1 232.9 138.6 130.5 MT-CYB "COB, CYTB, MTCYB, UQCR3" ENSG00000198727 "Mitochondrially encoded cytochrome b" P00156 MT 14747-15887 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Cardiomyopathy, Cataract, Deafness, Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 324.2;skeletal muscle: 302.1" "Cell line enhanced" "Detected in all" "ASC diff: 483.1;HeLa: 486.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032215, HPA068400" Enhanced Approved Mitochondria Mitochondria "CAB032215: AB_2261378, HPA068400: " "unprognostic (4.50e-1)" "unprognostic (2.56e-1)" "unprognostic (9.12e-2)" "unprognostic (3.88e-2)" "unprognostic (9.22e-2)" "unprognostic (3.50e-1)" "prognostic favourable (5.96e-4)" "unprognostic (1.63e-2)" "unprognostic (8.53e-2)" "unprognostic (1.49e-2)" "unprognostic (1.01e-3)" "unprognostic (6.09e-2)" "unprognostic (1.40e-1)" "unprognostic (7.90e-3)" "unprognostic (3.07e-1)" "unprognostic (4.09e-2)" "unprognostic (1.54e-2)" 78.0 52.4 98.5 14.7 143.5 14.4 32.3 38.4 59.6 30.9 54.0 55.6 25.0 43.6 28.0 25.0 21.2 222.5 93.9 68.0 128.7 144.7 19.6 13.7 83.6 25.3 51.4 33.6 23.7 32.6 32.9 57.7 59.2 49.5 302.1 63.5 37.2 37.4 44.3 15.7 55.2 20.2 20.9 20.6 23.6 14.7 183.7 78.7 324.2 155.7 90.0 146.7 57.6 72.3 97.8 121.2 129.4 483.1 77.7 97.7 83.4 34.6 21.9 37.9 96.2 160.1 185.5 40.9 98.8 228.2 17.9 102.5 53.7 90.5 80.3 103.6 486.1 171.4 91.1 58.1 126.7 167.8 153.0 41.4 89.2 55.4 52.9 116.7 111.4 199.8 54.0 119.9 26.9 66.4 63.9 47.6 116.1 173.6 169.1 43.2 76.4 58.1 109.9 82.2 160.2 200.7 173.5 76.7 100.4 139.7 64.0 32.1 42.9 79.4 46.1 90.7 48.2 324.2 155.7 235.1 102.8 94.4 135.3 150.5 118.7 132.0 78.0 183.7 128.3 146.7 148.0 90.0 96.8 78.7 79.8 57.6 MT-ND4L "MTND4L, NAD4L, ND4L" ENSG00000212907 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L" P03901 MT 10470-10766 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 434.4;skeletal muscle: 294.4" "Cell line enhanced" "Detected in all" "HeLa: 879.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075648 Approved Mitochondria Mitochondria "HPA075648: " "unprognostic (5.81e-2)" "unprognostic (3.46e-2)" "unprognostic (2.76e-2)" "unprognostic (7.91e-2)" "unprognostic (5.64e-2)" "unprognostic (1.05e-1)" "prognostic favourable (4.47e-4)" "unprognostic (1.97e-1)" "unprognostic (4.04e-2)" "unprognostic (4.63e-3)" "unprognostic (6.61e-2)" "unprognostic (7.38e-3)" "unprognostic (1.39e-1)" "unprognostic (3.09e-1)" "unprognostic (3.73e-1)" "unprognostic (2.97e-2)" "unprognostic (5.68e-2)" 101.1 71.9 102.4 20.3 114.5 13.2 39.4 41.5 73.3 39.4 83.8 48.0 26.1 34.1 30.7 23.9 23.4 187.5 102.7 79.1 123.5 185.7 20.2 13.1 88.6 26.2 43.4 29.7 18.5 30.9 34.2 80.0 43.2 75.4 294.4 31.8 38.4 38.6 59.2 16.1 62.5 27.5 24.6 24.4 25.8 14.3 200.8 111.2 434.4 139.9 112.1 153.0 66.8 96.4 89.7 161.9 164.8 567.3 119.4 71.4 207.0 51.9 32.5 59.4 149.1 89.1 239.3 84.9 139.8 183.9 25.1 221.6 64.7 94.2 103.6 172.0 879.2 276.9 83.3 176.8 154.7 209.0 227.1 61.9 216.8 65.0 94.8 171.6 119.0 172.3 67.2 226.9 40.8 108.4 39.0 69.8 106.4 172.8 203.7 49.1 66.5 101.6 160.9 69.4 114.4 222.6 207.8 85.3 106.2 124.8 79.2 155.3 72.7 127.4 61.2 240.6 39.8 434.4 139.9 290.0 102.4 110.6 140.6 166.9 110.0 117.5 86.1 200.8 132.4 153.0 78.4 112.1 99.4 111.2 79.0 66.8 MTCH2 SLC25A50 ENSG00000109919 "Mitochondrial carrier 2" Q9Y6C9 11 47617315-47642623 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038390 Approved Supported Mitochondria 55000 Mitochondria "HPA038390: AB_10669723" "unprognostic (4.94e-2)" "unprognostic (3.29e-1)" "unprognostic (1.93e-2)" "unprognostic (1.43e-1)" "unprognostic (4.27e-1)" "unprognostic (7.63e-3)" "unprognostic (1.80e-1)" "unprognostic (7.03e-2)" "unprognostic (1.51e-1)" "unprognostic (1.53e-2)" "unprognostic (1.08e-1)" "unprognostic (1.14e-1)" "prognostic favourable (9.05e-6)" "unprognostic (1.12e-2)" "unprognostic (8.75e-2)" "unprognostic (2.25e-1)" "unprognostic (1.77e-1)" 13.6 19.6 15.6 12.8 20.3 8.3 12.5 14.1 21.3 10.4 22.3 19.3 8.7 28.3 12.6 15.1 21.6 9.9 11.6 15.0 14.0 13.8 40.8 74.8 9.1 13.9 15.2 12.2 9.3 14.4 16.8 9.3 9.5 15.4 11.8 24.7 13.6 13.4 10.0 31.4 12.1 33.9 16.1 11.4 11.4 10.1 44.2 10.2 15.1 15.5 24.9 16.4 11.6 10.7 13.7 25.7 7.9 21.3 12.1 13.6 17.5 19.0 20.9 17.9 24.1 21.2 19.6 13.2 20.6 18.9 27.9 26.5 16.5 19.4 26.3 11.2 25.3 24.0 32.1 27.2 34.1 13.1 29.9 15.0 29.8 33.0 29.2 31.3 15.2 22.2 21.5 18.5 27.8 25.2 27.8 15.8 34.0 27.7 23.9 23.5 19.3 31.7 22.4 27.2 18.9 32.3 24.7 21.3 15.0 28.3 28.6 14.6 41.1 14.7 20.9 25.8 22.5 42.6 26.5 16.9 19.1 29.7 21.3 27.3 23.0 5.9 19.8 7.9 12.7 21.3 12.0 13.7 11.1 11.7 25.7 10.9 9.7 11.2 1.9 12.1 17.0 16.9 13.6 17.5 15.6 20.3 14.1 21.3 14.0 13.8 15.2 12.2 15.4 10.2 MTERF1 MTERF ENSG00000127989 "Mitochondrial transcription termination factor 1" Q99551 7 91692008-91880720 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Transcription termination" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044894, HPA069560" Uncertain Supported Mitochondria Mitochondria "HPA044894: AB_10966284, HPA069560: " "unprognostic (5.57e-2)" "unprognostic (7.31e-2)" "unprognostic (2.15e-2)" "unprognostic (1.50e-2)" "unprognostic (2.55e-1)" "unprognostic (1.81e-1)" "unprognostic (3.15e-3)" "unprognostic (1.25e-2)" "unprognostic (1.46e-3)" "unprognostic (7.62e-2)" "unprognostic (2.67e-1)" "unprognostic (5.19e-2)" "unprognostic (3.21e-2)" "unprognostic (1.14e-1)" "unprognostic (3.90e-2)" "unprognostic (2.67e-1)" "unprognostic (2.22e-3)" 8.9 11.5 16.1 10.9 18.1 13.9 14.4 23.2 18.9 10.4 11.8 12.1 10.0 11.5 11.6 11.0 13.4 9.8 8.3 8.7 15.2 10.5 13.2 17.6 8.3 19.4 20.3 13.1 14.7 11.4 10.0 18.0 10.6 18.8 11.6 12.1 8.5 12.5 9.2 9.3 9.9 13.6 9.7 22.7 17.6 12.5 10.0 18.5 11.9 12.2 10.3 19.0 12.0 11.4 15.0 9.4 24.8 8.8 9.8 19.0 10.0 10.3 9.0 8.7 5.8 8.5 8.9 7.6 8.8 9.0 9.5 11.8 10.9 9.9 21.3 7.3 7.0 9.2 13.0 7.9 13.6 1.2 9.5 9.7 9.8 8.5 7.6 17.0 10.7 10.6 10.5 10.5 11.2 8.2 17.5 8.9 11.1 13.2 17.8 19.5 13.1 10.1 5.1 11.6 14.6 9.8 11.3 8.1 15.4 8.9 18.8 17.8 6.6 12.2 5.3 11.3 13.9 15.3 8.9 12.7 12.8 28.9 8.2 5.6 15.8 24.8 8.8 11.9 10.6 7.5 12.7 14.6 13.8 15.2 9.4 15.0 19.0 15.1 4.2 9.8 8.2 7.4 13.2 10.0 16.1 18.1 23.2 18.9 15.2 10.5 20.3 13.1 18.8 18.5 MTFP1 "HSPC242, MTP18" ENSG00000242114 "Mitochondrial fission process 1" Q9UDX5 22 30425530-30429053 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077396 Approved Mitochondria Mitochondria "HPA077396: " "unprognostic (2.19e-2)" "unprognostic (1.18e-1)" "unprognostic (3.12e-1)" "unprognostic (6.20e-2)" "unprognostic (4.86e-2)" "unprognostic (1.72e-3)" "unprognostic (1.52e-3)" "unprognostic (8.98e-2)" "unprognostic (2.07e-1)" "unprognostic (1.65e-1)" "unprognostic (6.37e-3)" "unprognostic (1.54e-1)" "unprognostic (1.49e-1)" "unprognostic (6.40e-2)" "unprognostic (3.06e-2)" "unprognostic (3.84e-1)" "unprognostic (1.66e-2)" 8.9 9.6 6.4 13.0 6.6 9.8 13.5 3.7 6.5 7.6 13.3 2.8 14.5 11.7 2.9 16.2 12.3 2.8 10.2 18.3 5.0 6.0 27.4 20.8 8.3 17.3 7.2 2.2 9.3 12.9 10.3 5.7 9.2 9.8 8.5 12.9 9.8 9.0 4.4 14.6 4.6 10.2 4.1 3.8 17.4 11.3 3.2 5.9 5.3 11.2 8.9 13.0 7.7 5.6 13.0 7.6 0.7 6.4 4.8 25.7 9.9 26.0 19.3 6.7 10.9 1.4 0.7 8.1 2.4 1.7 14.9 23.2 9.2 15.8 27.7 7.1 1.4 12.1 23.6 18.1 13.0 14.9 26.8 8.0 11.5 19.1 4.0 20.2 15.6 2.1 7.1 8.0 13.8 10.2 12.7 10.9 4.9 31.2 18.3 22.8 12.2 19.8 23.5 6.7 26.5 18.9 6.8 12.2 12.7 5.3 28.2 10.2 8.6 10.0 5.1 15.9 21.3 8.1 6.6 5.6 3.9 24.8 6.2 22.8 6.6 0.0 5.5 0.0 19.3 6.4 25.7 13.0 16.2 16.5 7.6 9.3 16.8 19.6 0.7 4.8 3.8 3.7 13.3 9.9 6.4 6.6 3.7 6.5 5.0 6.0 7.2 2.2 9.8 5.9 MTG1 GTPBP7 ENSG00000148824 "Mitochondrial ribosome associated GTPase 1" Q9BT17 10 133394094-133421307 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA037826, HPA037827" Approved Supported Mitochondria Mitochondria "HPA037826: , HPA037827: AB_10670959" "unprognostic (2.94e-2)" "unprognostic (8.08e-2)" "unprognostic (5.90e-3)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (1.29e-2)" "unprognostic (5.85e-2)" "unprognostic (6.20e-2)" "unprognostic (1.32e-1)" "unprognostic (2.21e-1)" "prognostic favourable (5.08e-4)" "unprognostic (4.63e-3)" "prognostic unfavourable (6.79e-7)" "unprognostic (3.88e-2)" "unprognostic (5.96e-2)" "unprognostic (5.19e-2)" "prognostic favourable (1.03e-5)" 14.5 29.4 16.5 20.2 19.0 14.8 17.9 23.9 19.2 16.1 19.7 23.0 16.7 26.6 19.9 13.5 21.7 20.5 17.9 14.1 14.4 13.1 26.6 47.0 14.4 19.3 17.3 14.5 20.0 27.9 18.1 22.3 16.6 16.4 19.8 16.4 16.9 23.8 24.4 26.4 18.2 22.5 17.7 14.1 27.3 21.3 29.1 20.8 21.3 19.5 12.3 21.2 15.1 15.8 22.9 20.2 10.4 18.2 21.0 14.2 9.9 16.5 20.3 12.8 27.6 7.8 6.1 18.3 9.8 10.5 18.4 15.6 25.7 12.0 12.3 15.0 10.0 14.3 14.0 19.5 8.7 11.5 18.5 11.9 10.5 23.1 19.7 8.7 13.0 15.6 11.0 17.4 28.0 26.4 10.4 2.1 14.1 21.2 8.5 12.2 17.2 7.0 12.0 12.2 2.9 16.1 13.5 4.8 15.9 13.9 14.5 21.5 13.2 13.0 14.9 6.5 12.2 6.6 11.1 4.0 2.8 17.5 11.7 7.9 9.1 0.2 10.6 10.4 13.9 16.1 14.2 18.7 12.4 11.6 9.7 22.9 9.7 10.2 1.5 21.0 18.2 20.2 12.5 9.9 16.5 19.0 23.9 19.2 14.4 13.1 17.3 14.5 16.4 20.8 MTHFD1L "DKFZP586G1517, FLJ21145, FTHFSDC1" ENSG00000120254 "Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like" Q6UB35 6 150865549-151101887 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "One-carbon metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015006, HPA029040, HPA029041, HPA050052, HPA074911" Approved Supported Mitochondria Mitochondria "HPA015006: AB_1854178, HPA029040: AB_2672879, HPA029041: AB_2672880, HPA050052: , HPA074911: " "unprognostic (3.66e-2)" "prognostic unfavourable (1.68e-5)" "unprognostic (1.02e-1)" "prognostic unfavourable (7.28e-4)" "unprognostic (3.25e-1)" "prognostic unfavourable (5.10e-4)" "prognostic unfavourable (8.33e-5)" "unprognostic (6.35e-3)" "unprognostic (2.45e-1)" "unprognostic (1.44e-1)" "unprognostic (1.02e-1)" "unprognostic (1.32e-1)" "unprognostic (1.11e-2)" "unprognostic (2.93e-2)" "unprognostic (3.51e-1)" "unprognostic (2.91e-1)" "prognostic unfavourable (8.69e-5)" 10.4 10.6 8.0 12.1 8.1 12.2 7.1 32.4 10.5 6.5 6.2 7.8 10.2 3.4 8.5 7.2 6.4 8.0 7.3 10.7 7.5 7.9 9.5 6.9 17.1 11.0 12.3 7.6 22.2 13.7 7.1 9.1 15.5 8.5 5.0 9.1 12.7 3.4 10.5 2.5 5.7 4.7 10.9 10.2 8.7 5.6 13.6 6.6 6.7 12.2 5.0 11.4 8.7 5.1 1.1 3.0 0.2 0.8 1.0 5.0 0.6 11.8 10.3 13.5 33.2 3.5 12.4 33.0 18.7 20.5 18.9 23.2 20.8 11.2 43.8 12.5 28.5 12.7 21.6 18.2 23.4 18.0 19.6 18.3 18.4 19.0 22.3 33.3 3.0 14.6 23.3 18.2 33.3 31.4 43.2 23.0 19.4 25.0 16.3 6.9 13.7 9.6 19.6 10.1 19.5 12.7 5.8 13.5 10.0 24.7 11.0 15.3 3.4 23.3 23.8 12.6 27.7 28.0 26.5 19.1 17.8 45.7 21.0 31.2 16.3 0.2 0.7 0.0 0.8 0.8 1.3 0.8 1.9 2.1 3.0 1.1 1.8 1.9 0.0 1.0 0.8 1.5 5.0 0.6 8.0 8.1 32.4 9.5 7.5 7.9 12.3 7.6 8.5 6.6 MTIF2 IF-2mt ENSG00000085760 "Mitochondrial translational initiation factor 2" P46199 2 55236595-55269347 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006021, HPA061422" Uncertain Enhanced Mitochondria Mitochondria "HPA006021: AB_2147687, HPA061422: " "unprognostic (2.91e-2)" "unprognostic (9.58e-2)" "unprognostic (1.52e-2)" "unprognostic (1.87e-3)" "unprognostic (8.86e-2)" "unprognostic (5.57e-2)" "unprognostic (9.76e-3)" "unprognostic (1.88e-1)" "unprognostic (6.85e-3)" "unprognostic (3.01e-2)" "unprognostic (6.58e-3)" "unprognostic (1.76e-1)" "unprognostic (3.98e-2)" "unprognostic (2.54e-2)" "unprognostic (1.66e-1)" "unprognostic (9.45e-3)" "unprognostic (1.33e-1)" 13.8 17.8 13.6 12.0 15.8 9.6 15.5 9.4 17.7 12.0 21.1 11.2 17.7 21.0 10.0 15.9 17.5 10.6 11.2 24.5 13.5 12.1 27.4 32.2 10.6 17.5 15.5 11.8 10.4 24.6 20.2 20.2 12.5 22.6 12.2 25.1 9.7 16.3 14.3 31.5 12.3 26.9 15.0 16.9 16.3 16.3 9.0 14.6 16.1 20.6 27.1 15.2 14.5 11.6 9.6 13.9 9.4 12.8 17.2 12.7 6.9 15.2 14.8 8.8 15.0 10.9 15.0 20.1 14.1 11.3 13.6 11.9 17.6 14.8 25.2 26.7 12.9 13.7 20.8 20.2 22.5 27.9 16.1 23.2 11.6 32.4 20.9 36.5 13.8 16.4 21.0 18.8 39.4 10.9 41.0 14.4 14.1 12.7 11.2 24.6 18.7 18.3 11.9 28.2 24.3 13.2 13.5 15.8 10.1 12.5 20.7 25.4 11.0 12.2 10.7 14.2 16.4 16.9 23.0 27.1 24.2 6.9 15.1 27.3 11.2 5.4 11.0 9.4 10.1 12.8 12.6 8.3 10.3 9.4 13.9 9.6 12.5 12.7 4.2 17.2 10.7 6.8 11.7 6.9 13.6 15.8 9.4 17.7 13.5 12.1 15.5 11.8 22.6 14.6 MTPAP "FLJ10486, mtPAP, PAPD1, SPAX4" ENSG00000107951 "Mitochondrial poly(A) polymerase" Q9NVV4 10 30309801-30374448 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, Transcription" "Nucleotidyltransferase, RNA-binding, Transferase" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038620, HPA058232" Approved Supported Mitochondria Mitochondria "HPA038620: AB_10673015, HPA058232: " "unprognostic (2.76e-2)" "unprognostic (2.04e-1)" "unprognostic (1.73e-1)" "unprognostic (3.43e-3)" "unprognostic (3.05e-2)" "unprognostic (1.01e-1)" "prognostic unfavourable (4.20e-6)" "unprognostic (1.16e-1)" "unprognostic (2.04e-1)" "unprognostic (4.78e-2)" "unprognostic (1.77e-1)" "unprognostic (3.56e-2)" "unprognostic (9.02e-2)" "unprognostic (6.28e-3)" "unprognostic (3.77e-1)" "unprognostic (1.14e-2)" "unprognostic (4.39e-2)" 10.9 12.7 9.9 10.2 12.4 32.8 11.1 12.4 16.1 9.6 9.9 7.3 6.5 11.0 10.4 7.0 12.6 9.5 7.6 11.5 7.8 7.2 10.6 11.1 9.4 10.5 11.9 13.0 11.4 18.9 9.5 7.2 10.0 11.4 8.0 12.0 8.2 10.7 10.2 22.3 13.1 10.0 14.3 9.0 9.3 9.7 10.6 8.3 6.7 11.0 12.4 10.5 11.7 9.1 15.6 22.9 18.4 24.4 16.9 17.1 8.3 14.2 14.2 9.0 13.1 8.9 8.4 11.7 9.9 3.5 10.1 10.6 15.0 20.0 20.3 7.1 6.5 16.8 17.4 11.5 12.4 10.2 13.6 20.6 13.4 15.1 9.3 13.4 16.2 8.2 10.8 11.3 6.8 11.0 22.2 16.0 7.6 11.9 16.1 11.9 6.1 7.7 16.3 16.0 18.9 9.3 9.5 14.9 12.0 9.0 9.4 13.8 9.0 8.7 10.5 10.7 13.8 14.9 11.0 3.6 8.6 27.8 9.2 24.7 3.7 16.4 18.5 18.4 16.2 24.4 17.1 15.6 15.4 15.6 22.9 13.1 16.7 16.8 3.0 16.9 18.1 12.0 15.5 8.3 9.9 12.4 12.4 16.1 7.8 7.2 11.9 13.0 11.4 8.3 MTX1 "MTX, MTXN" ENSG00000173171 "Metaxin 1" Q13505 1 155208699-155213824 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011543 Uncertain Supported Mitochondria Mitochondria "HPA011543: AB_1853824" "unprognostic (2.57e-1)" "unprognostic (9.51e-3)" "unprognostic (3.27e-1)" "unprognostic (5.98e-3)" "unprognostic (1.60e-1)" "unprognostic (2.62e-2)" "unprognostic (1.12e-2)" "unprognostic (1.80e-1)" "unprognostic (8.38e-2)" "unprognostic (1.28e-2)" "unprognostic (1.71e-1)" "unprognostic (6.78e-2)" "prognostic unfavourable (3.39e-4)" "unprognostic (1.30e-2)" "unprognostic (1.70e-1)" "unprognostic (1.37e-1)" "unprognostic (1.96e-2)" 15.4 19.8 11.6 9.9 12.6 22.9 15.8 5.7 18.1 15.8 15.9 12.2 14.8 12.4 14.9 13.9 18.0 21.4 13.5 11.8 10.8 10.0 24.4 36.4 12.8 18.7 11.8 12.9 14.0 26.3 23.4 12.0 28.4 11.7 12.3 12.7 14.6 20.7 19.2 10.4 13.8 13.7 12.7 10.2 17.1 14.7 60.0 9.0 14.5 19.3 14.3 18.0 11.6 11.5 14.4 23.1 43.8 26.8 12.2 14.0 14.4 17.2 28.4 9.1 12.9 17.0 15.4 28.8 8.9 18.1 26.6 18.5 35.3 28.9 14.2 29.6 20.5 17.3 13.3 25.2 9.7 10.4 31.4 9.0 22.7 34.0 26.9 16.6 12.7 19.6 23.6 27.4 18.5 23.4 18.2 7.1 15.7 41.9 18.6 20.9 18.1 33.0 15.4 5.7 33.8 23.9 15.0 14.9 18.5 11.1 35.2 10.2 28.5 27.0 9.7 12.7 14.4 8.4 15.0 13.7 11.4 14.5 16.8 8.6 13.5 10.2 26.8 6.3 9.8 13.7 9.2 14.4 12.1 10.3 23.1 12.4 12.1 10.9 43.8 12.2 7.9 12.4 14.0 14.4 11.6 12.6 5.7 18.1 10.8 10.0 11.8 12.9 11.7 9.0 MTX3 ENSG00000177034 "Metaxin 3" Q5HYI7 5 79976731-79991265 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047858, HPA062061" Approved Approved Mitochondria Mitochondria "HPA047858: , HPA062061: " "unprognostic (2.56e-2)" "unprognostic (2.32e-1)" "unprognostic (2.47e-2)" "unprognostic (4.21e-2)" "unprognostic (4.59e-1)" "unprognostic (1.88e-2)" "prognostic unfavourable (5.08e-5)" "unprognostic (4.02e-2)" "unprognostic (2.65e-2)" "prognostic unfavourable (2.54e-4)" "unprognostic (8.58e-2)" "unprognostic (8.46e-2)" "unprognostic (5.08e-2)" "unprognostic (1.01e-2)" "unprognostic (1.11e-2)" "unprognostic (3.09e-2)" "unprognostic (2.28e-1)" 9.4 13.9 11.8 8.9 18.7 8.6 12.0 10.9 20.7 9.9 9.4 8.5 5.9 6.2 13.4 10.1 10.6 11.2 6.4 8.5 14.5 5.8 10.7 6.5 7.6 11.8 7.4 10.8 17.7 9.9 21.0 11.1 6.8 15.9 12.0 7.6 8.3 12.0 11.1 11.6 10.0 12.2 13.0 12.0 8.5 9.3 6.2 8.2 2.8 12.3 7.0 11.6 12.2 10.1 3.7 0.9 1.2 1.1 1.4 3.6 1.0 6.7 4.6 10.2 5.7 4.9 10.0 2.6 6.1 5.0 5.7 6.7 1.7 7.5 10.8 2.0 6.2 7.8 0.0 14.7 10.1 2.8 7.1 4.3 11.2 4.7 9.4 0.0 5.4 7.7 13.8 9.8 16.7 4.0 2.5 6.7 9.2 6.9 0.0 0.1 10.4 4.2 0.0 15.6 4.5 4.5 8.0 14.1 10.4 8.8 5.6 11.9 9.6 6.8 4.0 10.1 8.4 8.0 13.9 9.0 8.9 9.7 14.5 0.0 11.5 0.7 0.8 1.2 2.6 1.1 1.9 3.7 2.9 3.5 0.4 2.6 3.6 2.8 1.0 1.4 0.5 0.9 1.4 1.0 11.8 18.7 10.9 20.7 14.5 5.8 7.4 10.8 15.9 8.2 MYOM2 ENSG00000036448 "Myomesin 2" P54296 8 2045040-2165552 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "heart muscle: 170.7;skeletal muscle: 75.9" "Group enriched" "Detected in some" 8 "HEK 293: 9.9;SCLC-21H: 4.2;U-266/84: 5.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.9" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "HPA001765, HPA005953" Enhanced Approved Mitochondria 120000 Mitochondria "HPA001765: AB_1079443, HPA005953: AB_1854258" "unprognostic (2.81e-2)" "unprognostic (1.11e-3)" "unprognostic (8.19e-2)" "unprognostic (1.35e-3)" "unprognostic (2.11e-1)" "unprognostic (1.86e-2)" "unprognostic (2.30e-5)" "unprognostic (1.10e-1)" "unprognostic (5.17e-2)" "unprognostic (1.34e-2)" "unprognostic (9.56e-2)" "unprognostic (2.54e-2)" "unprognostic (3.89e-2)" "unprognostic (2.71e-2)" "unprognostic (9.01e-2)" "unprognostic (3.22e-1)" "unprognostic (1.14e-1)" 2.0 0.0 0.3 0.1 0.4 0.0 1.7 0.9 0.9 0.2 0.2 0.0 0.2 0.0 0.5 2.7 1.2 0.1 0.1 170.7 0.3 0.1 0.7 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.2 1.2 1.0 75.9 0.2 0.1 0.3 0.1 0.4 0.0 0.2 0.0 0.0 0.6 8.9 1.2 0.3 0.1 1.9 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 9.9 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.4 0.2 0.0 1.9 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.4 0.9 0.9 0.3 0.1 0.2 0.0 0.1 0.0 MYORG "KIAA1161, NET37" ENSG00000164976 "Myogenesis regulating glycosidase (putative)" Q6NSJ0 9 34366670-34376853 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 56.1" "Cell line enhanced" "Detected in many" "Hep G2: 17.4;SK-BR-3: 29.1;T-47d: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060533, HPA067487" Approved Approved Mitochondria Mitochondria "HPA060533: , HPA067487: " "unprognostic (6.56e-2)" "unprognostic (1.51e-1)" "unprognostic (3.03e-2)" "prognostic unfavourable (6.96e-4)" "unprognostic (2.44e-1)" "unprognostic (1.20e-1)" "unprognostic (2.44e-1)" "unprognostic (2.03e-2)" "unprognostic (1.55e-1)" "unprognostic (4.68e-3)" "unprognostic (1.91e-3)" "unprognostic (3.20e-1)" "prognostic favourable (1.20e-13)" "unprognostic (4.08e-3)" "unprognostic (3.68e-1)" "unprognostic (3.09e-1)" "unprognostic (1.00e-3)" 6.3 5.6 16.7 4.7 20.5 2.1 3.5 6.9 16.0 2.0 19.9 9.8 1.3 20.9 2.2 2.8 4.8 3.6 11.6 2.9 11.1 8.7 11.7 31.8 3.1 1.7 11.2 12.6 1.6 16.6 2.0 4.0 15.4 10.7 3.2 13.1 0.5 4.7 4.9 56.1 3.6 26.7 4.8 7.0 1.7 9.9 1.7 6.9 0.0 2.2 6.4 2.1 3.5 1.9 1.1 0.8 1.9 0.8 1.9 3.3 0.6 4.0 2.9 4.8 2.9 2.0 0.7 10.3 0.8 0.6 0.4 0.7 7.1 4.3 2.2 8.3 0.7 8.4 3.4 7.8 0.6 0.7 1.9 0.4 12.9 17.4 0.3 0.4 1.4 1.0 3.7 1.3 1.6 1.9 0.5 2.4 1.0 6.7 1.2 0.7 2.9 2.3 2.1 2.5 0.7 2.6 1.5 0.7 6.7 5.8 29.1 0.5 27.0 0.7 1.7 1.1 6.0 0.9 1.8 1.5 3.2 0.9 0.9 1.6 0.9 1.9 0.6 1.2 3.3 0.6 2.6 0.8 2.0 1.9 0.3 1.1 1.3 1.6 1.6 1.9 0.8 0.8 2.6 0.6 16.7 20.5 6.9 16.0 11.1 8.7 11.2 12.6 10.7 6.9 NAGS "AGAS, ARGA, NAT7" ENSG00000161653 "N-acetylglutamate synthase" Q8N159 17 44004546-44009063 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Urea cycle" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 16.4;liver: 30.2" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.3;HHSteC: 6.4;TIME: 7.9;U-87 MG: 11.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA027300 Supported Mitochondria "Intracellular and membrane" Mitochondria "HPA027300: " "unprognostic (1.51e-3)" "unprognostic (9.24e-2)" "unprognostic (1.68e-1)" "unprognostic (8.67e-2)" "unprognostic (1.44e-2)" "unprognostic (1.30e-3)" "unprognostic (2.38e-2)" "unprognostic (1.98e-1)" "unprognostic (3.14e-2)" "unprognostic (2.73e-2)" "unprognostic (2.53e-3)" "unprognostic (1.46e-1)" "unprognostic (5.19e-2)" "unprognostic (6.99e-2)" "unprognostic (1.29e-2)" "unprognostic (1.22e-1)" "unprognostic (2.27e-1)" 0.6 0.6 0.5 0.4 2.4 0.0 1.0 0.7 1.5 0.3 7.2 0.5 5.6 16.4 0.5 2.6 0.9 0.3 0.3 0.9 0.7 1.5 4.4 30.2 2.5 0.2 1.8 0.6 0.5 0.3 3.6 0.4 0.4 1.2 0.8 0.4 0.1 0.9 6.5 0.1 0.6 13.4 0.3 2.0 0.5 0.3 0.4 1.1 0.2 2.9 0.0 0.1 0.8 0.8 1.5 2.0 2.3 2.7 1.0 3.5 1.3 3.4 0.2 0.0 0.5 0.0 6.3 0.1 0.6 0.0 0.2 0.0 2.2 0.8 0.0 1.3 0.0 1.4 0.0 1.2 0.1 0.3 0.8 0.1 0.2 2.6 6.4 0.0 0.0 2.7 0.1 0.2 0.0 1.2 0.2 0.0 0.0 0.1 0.0 0.0 0.4 2.6 0.1 0.2 0.0 0.0 0.0 2.6 0.0 1.2 0.0 0.0 0.2 0.1 7.9 3.0 0.8 0.2 0.7 0.2 0.2 0.2 11.9 0.1 0.4 1.8 1.4 2.3 3.5 1.5 2.8 1.2 2.2 2.9 2.0 1.5 1.1 1.7 0.8 1.0 2.7 0.3 1.7 1.3 0.5 2.4 0.7 1.5 0.7 1.5 1.8 0.6 1.2 1.1 NAT14 KLP1 ENSG00000090971 "N-acetyltransferase 14 (putative)" Q8WUY8 19 55485004-55487568 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Activator, Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 42.2" "Cell line enhanced" "Detected in many" "HEK 293: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047187 Approved Mitochondria Mitochondria "HPA047187: " "unprognostic (5.96e-2)" "unprognostic (1.10e-1)" "unprognostic (2.92e-2)" "unprognostic (5.43e-2)" "unprognostic (1.32e-1)" "unprognostic (3.59e-2)" "unprognostic (1.69e-2)" "unprognostic (7.01e-2)" "unprognostic (1.94e-1)" "unprognostic (2.97e-1)" "unprognostic (9.12e-2)" "unprognostic (6.41e-2)" "prognostic unfavourable (3.61e-4)" "unprognostic (7.00e-2)" "unprognostic (6.74e-2)" "unprognostic (9.85e-2)" "unprognostic (1.58e-1)" 3.6 10.1 15.8 5.7 19.6 4.5 5.5 25.8 25.8 8.2 7.0 8.9 3.1 3.5 12.6 10.1 2.9 24.1 6.5 5.9 15.4 16.7 9.2 2.5 7.8 4.6 10.8 15.5 14.1 5.6 11.2 19.2 8.5 10.6 6.8 3.1 7.8 5.0 10.5 2.9 4.1 3.4 11.1 6.5 3.7 5.6 4.9 9.5 42.2 9.8 1.3 3.8 6.0 4.3 1.8 1.8 2.3 0.3 0.3 1.0 0.6 2.4 8.8 9.7 17.9 4.1 5.0 6.1 9.1 10.6 10.0 14.2 3.0 7.8 1.0 3.2 5.8 3.2 6.3 5.6 6.2 9.8 54.7 7.9 11.8 6.7 7.3 5.9 8.0 7.2 2.1 7.3 1.9 7.2 9.8 2.7 5.8 2.9 9.8 8.9 13.8 4.9 9.7 6.2 3.5 22.8 4.6 29.9 20.4 3.6 5.3 8.0 4.3 5.6 8.7 3.7 10.1 0.5 7.3 5.7 2.2 4.2 8.1 1.0 9.1 0.0 0.3 0.2 0.5 0.3 1.0 0.6 0.4 0.3 0.0 1.8 0.7 0.7 2.3 0.3 0.3 1.8 0.0 0.6 15.8 19.6 25.8 25.8 15.4 16.7 10.8 15.5 10.6 9.5 NAT8L "FLJ37478, Hcml3" ENSG00000185818 "N-acetyltransferase 8 like" Q8N9F0 4 2059512-2069089 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 45.9;brain: 45.9;testis: 11.8" "Cell line enhanced" "Detected in many" "NB-4: 14.4;SCLC-21H: 18.6;SK-MEL-30: 14.8" "Group enriched" "Detected in many" 6 "endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 28 "plasmacytoid DC: 3.8" "Lineage enriched" "Detected in single" 28 "dendritic cells: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040677 Approved Mitochondria Mitochondria "HPA040677: AB_10794745" "unprognostic (1.32e-2)" "unprognostic (8.62e-2)" "unprognostic (3.02e-3)" "prognostic unfavourable (1.01e-5)" "unprognostic (2.56e-1)" "unprognostic (2.63e-4)" "unprognostic (6.58e-2)" "unprognostic (1.79e-1)" "unprognostic (2.90e-2)" "unprognostic (4.54e-1)" "unprognostic (3.70e-2)" "unprognostic (7.06e-2)" "unprognostic (1.78e-3)" "unprognostic (7.24e-3)" "unprognostic (1.14e-2)" "unprognostic (2.10e-2)" "unprognostic (1.35e-2)" 45.9 2.0 23.5 1.3 28.3 1.2 7.9 16.4 45.9 1.2 1.5 7.4 0.3 1.3 1.6 2.8 1.3 2.4 1.3 2.1 20.8 12.9 8.2 1.2 1.2 1.4 16.4 12.6 1.4 3.9 1.2 5.6 1.3 12.8 2.4 1.3 1.2 3.8 3.2 7.3 2.4 1.5 1.4 6.5 1.5 1.6 11.8 8.2 0.0 1.6 0.0 1.2 1.2 0.1 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 6.5 3.6 7.2 0.7 0.0 4.1 0.1 0.0 0.2 0.0 2.9 0.2 0.0 1.3 0.0 0.1 8.0 0.0 0.1 0.0 9.4 0.1 1.4 4.6 1.2 9.9 4.9 0.0 0.1 0.0 0.0 0.0 7.7 0.0 0.2 4.3 0.1 14.4 10.1 2.9 0.5 1.7 0.2 0.1 0.3 18.6 6.2 4.7 0.0 14.8 0.5 5.8 0.0 0.0 2.4 0.1 3.8 0.0 0.0 0.1 0.0 4.2 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 23.5 28.3 16.4 32.7 20.8 12.9 16.4 12.6 12.8 8.2 NDUFA10 CI-42k ENSG00000130414 "NADH:ubiquinone oxidoreductase subunit A10" O95299 2 239892450-240025402 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059529, HPA067045, CAB070846" Approved Supported Mitochondria "Intracellular and membrane" 12000 Mitochondria "CAB070846: AB_11152346, HPA059529: , HPA067045: " "unprognostic (2.12e-2)" "unprognostic (8.94e-3)" "unprognostic (8.73e-2)" "unprognostic (2.02e-2)" "unprognostic (8.96e-2)" "unprognostic (2.53e-1)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (2.95e-4)" "unprognostic (5.71e-2)" "unprognostic (2.47e-2)" "unprognostic (1.05e-1)" "prognostic favourable (2.09e-7)" "unprognostic (1.16e-1)" "unprognostic (4.96e-2)" "unprognostic (1.98e-1)" "unprognostic (2.95e-1)" 19.0 37.5 19.7 18.2 30.4 20.3 19.5 26.2 31.5 14.5 31.0 24.5 18.6 30.4 14.8 18.4 28.5 18.8 17.1 66.0 28.6 18.7 36.3 40.6 13.1 13.8 21.4 27.7 19.8 23.5 25.1 15.5 15.9 33.4 13.7 34.7 16.2 20.6 26.7 67.0 26.1 24.3 18.6 27.0 13.8 24.9 15.4 19.8 13.2 16.9 34.1 20.2 19.3 17.7 24.6 35.7 11.0 27.7 21.2 24.6 24.5 16.8 16.6 12.3 20.7 14.9 24.8 20.2 14.3 18.5 20.7 20.8 16.5 21.1 12.5 6.6 15.9 22.6 27.8 25.7 26.5 16.6 18.4 16.4 15.6 35.3 22.5 22.4 13.3 24.1 21.0 16.5 22.6 26.2 24.9 8.8 22.1 25.8 21.2 23.0 14.5 18.0 21.7 27.5 21.9 29.3 33.1 19.5 12.8 14.1 32.0 22.3 29.8 22.7 16.3 14.8 15.0 18.7 15.9 15.2 6.8 19.9 16.0 20.5 17.6 6.3 26.1 11.0 18.9 27.7 24.6 24.6 19.1 20.5 35.7 18.3 19.0 19.0 5.8 21.2 23.4 12.7 22.0 24.5 19.7 30.4 26.2 31.5 28.6 18.7 21.4 27.7 33.4 19.8 NDUFA11 B14.7 ENSG00000174886 "NADH:ubiquinone oxidoreductase subunit A11" Q86Y39 19 5891276-5904006 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA072209 Uncertain Mitochondria Mitochondria "HPA072209: " "unprognostic (2.24e-1)" "prognostic favourable (4.54e-5)" "unprognostic (8.20e-3)" "prognostic favourable (3.38e-5)" "unprognostic (4.54e-2)" "unprognostic (7.73e-2)" "unprognostic (6.30e-2)" "unprognostic (7.26e-3)" "unprognostic (3.95e-1)" "unprognostic (4.20e-2)" "unprognostic (1.67e-3)" "unprognostic (9.02e-2)" "unprognostic (1.12e-2)" "unprognostic (2.91e-1)" "unprognostic (1.16e-1)" "unprognostic (3.40e-2)" "unprognostic (6.16e-3)" 32.3 70.8 50.2 40.9 41.3 43.4 49.3 29.9 75.2 35.3 45.1 25.8 41.2 41.6 35.9 36.9 53.1 38.4 41.4 149.3 41.9 45.8 44.1 59.8 37.9 51.9 48.3 45.8 38.4 70.9 13.5 33.8 32.5 35.9 35.1 19.6 35.9 76.3 41.1 106.0 32.4 39.5 45.2 40.2 31.5 38.8 21.2 27.0 37.3 37.8 72.1 30.5 38.3 37.2 63.3 90.2 54.3 87.4 44.8 73.7 121.4 49.1 38.1 28.4 46.1 23.3 37.9 31.8 34.0 39.3 62.4 57.7 45.4 26.2 48.7 53.8 32.4 32.6 19.5 39.7 15.1 41.9 73.4 20.0 36.6 72.6 60.9 29.7 29.7 51.8 36.1 35.4 16.8 40.7 42.1 54.2 31.4 37.5 77.0 53.0 42.9 95.8 53.4 35.5 69.6 38.5 32.9 41.1 43.7 26.5 43.5 59.9 33.5 63.4 36.4 34.8 33.5 69.3 55.6 82.5 71.5 63.0 58.8 71.3 44.7 54.3 87.4 47.7 53.5 68.0 54.8 63.3 59.6 54.0 74.9 54.6 56.7 49.5 39.2 44.8 57.7 90.2 73.7 121.4 50.2 41.3 29.9 75.2 41.9 45.8 48.3 45.8 35.9 27.0 NDUFA12 "B17.2, DAP13" ENSG00000184752 "NADH:ubiquinone oxidoreductase subunit A12" Q9UI09 12 94897055-95003770 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 129.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039903 Supported Supported Mitochondria Mitochondria "HPA039903: AB_10795516" "unprognostic (2.76e-1)" "unprognostic (5.32e-3)" "unprognostic (1.17e-1)" "unprognostic (2.56e-2)" "unprognostic (2.85e-1)" "unprognostic (4.03e-2)" "unprognostic (3.05e-2)" "unprognostic (6.68e-2)" "unprognostic (1.67e-1)" "unprognostic (2.47e-2)" "unprognostic (1.89e-1)" "unprognostic (1.64e-1)" "unprognostic (3.13e-3)" "unprognostic (2.32e-1)" "unprognostic (1.65e-1)" "unprognostic (6.13e-2)" "unprognostic (3.27e-2)" 24.0 24.8 36.0 17.9 36.8 19.7 19.7 27.2 36.5 17.9 35.5 12.5 20.0 27.4 17.0 21.9 23.3 19.4 14.4 82.8 31.2 32.0 33.2 34.6 18.1 20.1 37.0 29.9 17.0 18.4 22.3 22.4 21.1 31.3 19.1 35.7 13.1 18.7 20.7 129.0 17.4 26.7 24.0 24.2 23.9 20.9 14.2 23.5 21.0 27.9 40.0 28.1 21.9 21.4 60.8 78.4 69.7 67.9 59.1 93.8 100.6 40.9 44.6 37.3 26.5 30.6 28.5 27.7 19.6 28.8 42.8 38.8 55.0 21.2 47.2 11.6 29.9 31.0 38.3 45.2 48.6 40.6 46.0 39.4 37.2 55.4 31.5 55.9 48.2 30.6 57.1 35.9 44.0 35.0 36.8 21.9 41.4 59.5 38.7 86.5 28.3 77.6 29.6 32.3 53.8 41.9 61.6 35.5 21.5 33.2 48.4 25.4 47.8 36.9 40.0 22.7 23.1 33.0 33.3 35.9 53.2 72.0 13.6 46.8 34.7 69.7 59.5 29.8 52.1 67.9 48.2 60.8 71.6 62.5 78.4 50.7 93.8 68.6 8.6 59.1 63.3 48.0 74.8 100.6 36.0 36.8 27.2 36.5 31.2 32.0 37.0 29.9 31.3 23.5 NDUFA13 "B16.6, CDA016, CGI-39, GRIM-19, GRIM19" ENSG00000186010 "NADH:ubiquinone oxidoreductase subunit A13" Q9P0J0 19 19515736-19529054 "Disease related genes, Predicted membrane proteins" "Apoptosis, Electron transport, Host-virus interaction, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 116.3;testis: 140.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041213 Supported Supported Mitochondria Mitochondria "HPA041213: AB_10794988" "unprognostic (2.87e-1)" "unprognostic (2.88e-3)" "unprognostic (9.98e-2)" "unprognostic (1.11e-1)" "unprognostic (3.36e-2)" "unprognostic (5.78e-2)" "unprognostic (6.00e-2)" "unprognostic (3.30e-2)" "unprognostic (2.81e-1)" "unprognostic (1.83e-3)" "unprognostic (1.26e-2)" "unprognostic (1.13e-1)" "unprognostic (1.45e-2)" "unprognostic (1.33e-1)" "unprognostic (2.37e-1)" "unprognostic (2.15e-2)" "unprognostic (2.15e-2)" 17.9 16.9 20.0 11.7 23.9 15.4 14.4 20.7 25.2 11.0 19.2 8.7 16.5 16.5 9.7 19.6 12.2 11.7 12.9 68.0 16.4 13.9 18.9 20.8 8.4 11.9 19.9 22.3 10.6 17.8 10.6 12.1 12.1 20.0 12.9 11.9 9.8 15.2 15.5 79.7 9.5 14.9 12.1 13.4 10.1 15.0 140.2 16.2 7.6 11.3 28.1 8.4 9.6 10.2 73.7 74.9 61.4 76.8 44.8 72.7 116.3 33.7 24.9 46.0 45.8 47.0 38.2 43.2 40.2 44.5 45.3 44.3 40.3 50.7 44.9 94.6 48.5 27.4 32.6 43.6 18.7 27.4 73.7 34.3 39.7 49.4 42.1 64.4 48.4 51.2 39.7 31.8 36.7 32.6 37.8 64.3 36.0 67.1 76.4 64.0 46.9 69.4 43.9 29.9 68.6 66.1 48.5 43.8 55.4 40.9 48.2 40.0 29.8 88.7 33.9 44.5 15.1 51.8 49.9 45.8 36.0 48.3 39.2 50.0 32.4 61.4 76.8 57.8 51.2 72.9 45.5 73.7 58.9 56.0 74.9 60.5 56.9 51.1 26.9 44.8 60.8 61.2 72.7 116.3 20.0 23.9 20.7 25.2 16.4 13.9 19.9 22.3 20.0 16.2 NDUFA4 "CI-9k, MLRQ" ENSG00000189043 "NDUFA4, mitochondrial complex associated" O00483 7 10931951-10940256 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 149.9;skeletal muscle: 151.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055323 Supported Mitochondria 18000 Mitochondria "HPA055323: " "unprognostic (1.83e-1)" "unprognostic (6.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.51e-1)" "unprognostic (2.16e-1)" "unprognostic (4.97e-3)" "unprognostic (3.85e-1)" "unprognostic (2.25e-1)" "unprognostic (1.69e-1)" "unprognostic (3.90e-2)" "unprognostic (8.65e-3)" "unprognostic (1.74e-1)" "prognostic favourable (4.61e-8)" "unprognostic (1.24e-1)" "unprognostic (1.94e-1)" "unprognostic (1.44e-3)" "unprognostic (2.08e-1)" 21.9 22.0 72.8 13.6 55.3 19.8 27.0 33.1 74.4 20.5 18.3 12.0 16.8 25.1 16.9 29.6 15.8 20.2 16.7 149.9 56.1 32.1 46.2 46.7 15.9 13.5 47.6 48.9 17.1 23.7 18.9 5.6 11.4 33.0 23.1 20.4 14.1 36.0 31.1 151.6 12.1 17.3 21.4 26.3 13.6 23.6 7.4 23.2 6.8 20.4 60.1 15.6 15.8 11.6 29.0 41.1 52.8 39.6 21.7 37.5 48.0 12.6 21.8 37.2 42.7 21.1 19.8 17.1 16.1 15.3 15.1 13.3 27.3 34.8 24.7 15.3 23.1 22.4 24.7 19.1 16.5 12.2 18.0 20.7 25.6 25.4 18.4 28.5 20.4 21.3 19.3 18.5 16.4 21.0 30.7 33.6 31.5 24.4 12.7 25.1 40.7 44.2 17.3 26.5 27.7 38.3 27.5 23.3 24.2 25.5 73.5 14.5 46.4 35.0 18.3 18.1 24.9 25.9 26.5 20.4 26.1 28.3 24.9 30.9 56.0 52.8 32.5 44.4 23.4 38.6 27.4 29.0 32.7 29.3 41.1 22.0 34.1 29.7 7.4 21.7 39.6 38.5 37.5 48.0 72.8 55.3 33.1 74.4 56.1 32.1 47.6 48.9 33.0 23.2 NDUFA4L2 "FLJ26118, NUOMS" ENSG00000185633 "NDUFA4, mitochondrial complex associated like 2" Q9NRX3 12 57234903-57240715 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 82.5;skin 1: 93.4" "Cell line enriched" "Detected in many" 7 "AN3-CA: 54.1" "Cancer enhanced" "Detected in all" "renal cancer: 356.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.4;T-reg: 2.8" "Group enriched" "Detected in many" 24 "B-cells: 2.4;T-cells: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055323 Approved Mitochondria Mitochondria "HPA055323: " "unprognostic (1.25e-1)" "unprognostic (1.60e-1)" "unprognostic (2.11e-3)" "unprognostic (3.23e-3)" "unprognostic (5.06e-2)" "unprognostic (1.22e-2)" "unprognostic (2.25e-2)" "unprognostic (3.53e-1)" "unprognostic (6.67e-2)" "unprognostic (5.79e-2)" "unprognostic (2.13e-1)" "unprognostic (2.89e-1)" "prognostic unfavourable (1.37e-5)" "unprognostic (9.10e-3)" "unprognostic (1.31e-1)" "unprognostic (6.41e-2)" "unprognostic (2.74e-2)" 24.5 9.6 8.3 4.9 15.5 1.3 11.5 7.7 10.4 19.1 4.4 8.3 1.1 4.6 4.6 5.4 82.5 3.6 11.0 30.9 9.8 7.3 5.4 4.2 12.7 4.6 10.9 10.7 6.1 6.7 4.6 6.2 42.7 13.2 6.8 2.4 13.7 10.3 7.4 19.0 93.4 4.7 5.6 5.6 29.9 4.3 3.0 8.9 0.7 12.0 14.8 11.9 10.2 31.4 2.4 0.1 0.0 0.0 0.0 2.8 0.3 0.3 0.5 0.1 54.1 2.2 1.3 0.1 0.8 0.6 0.2 0.5 0.0 0.6 2.1 2.3 0.8 0.4 0.3 0.4 0.0 1.1 0.1 0.2 0.1 0.0 7.8 1.6 0.8 5.0 1.0 0.1 1.9 0.0 0.2 2.9 0.1 1.0 0.4 0.0 0.1 0.9 0.8 0.4 4.1 0.0 0.0 2.9 1.0 0.1 0.1 1.8 0.6 5.7 0.2 0.5 0.0 0.4 0.2 4.1 1.3 0.9 2.0 3.8 0.3 0.0 0.0 0.0 0.6 0.0 0.0 2.4 0.7 0.0 0.1 0.4 1.1 0.0 0.0 0.0 0.0 0.0 2.8 0.3 8.3 15.5 7.7 10.4 9.8 7.3 10.9 10.7 13.2 8.9 NDUFA7 B14.5a ENSG00000267855 "NADH:ubiquinone oxidoreductase subunit A7" O95182 19 8308768-8321396 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 110.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA059251, HPA071866" Enhanced Supported Mitochondria Mitochondria "HPA059251: AB_2683960, HPA071866: " "unprognostic (6.55e-2)" "unprognostic (1.02e-3)" "unprognostic (1.11e-1)" "unprognostic (3.85e-1)" "unprognostic (2.18e-1)" "unprognostic (5.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.43e-2)" "unprognostic (3.40e-1)" "unprognostic (1.13e-3)" "unprognostic (1.81e-2)" "unprognostic (1.43e-1)" "unprognostic (1.09e-2)" "unprognostic (5.53e-2)" "unprognostic (1.29e-2)" "unprognostic (2.59e-2)" "unprognostic (9.35e-3)" 17.7 30.0 28.0 15.5 30.5 15.3 18.9 15.4 32.0 9.0 17.2 11.3 15.7 12.6 9.9 32.1 18.9 26.2 16.1 69.1 22.1 21.0 26.5 30.9 20.3 22.1 25.9 19.7 10.1 28.5 11.9 30.2 13.0 26.7 20.5 17.6 16.7 23.0 20.7 110.6 16.2 16.0 13.1 18.5 14.7 19.3 13.8 11.1 19.3 22.0 47.5 16.8 14.3 9.1 30.6 65.5 25.1 39.7 24.9 33.5 26.7 15.5 13.3 17.0 8.7 11.6 6.2 9.6 4.4 5.8 16.7 11.2 14.1 13.2 8.8 6.9 10.7 13.6 7.7 23.4 7.9 23.0 48.6 6.5 20.5 33.3 18.1 9.8 9.0 12.5 15.2 9.0 8.3 19.5 11.1 45.9 20.8 17.0 18.7 48.6 13.7 50.9 10.4 3.1 19.1 34.0 9.3 14.3 10.9 6.4 20.0 11.1 7.5 16.2 5.7 9.4 7.6 13.2 12.6 17.9 13.8 10.6 13.4 17.0 14.8 14.2 38.9 25.1 22.6 39.7 24.4 29.9 24.7 22.2 47.9 30.6 24.1 23.4 9.7 24.9 34.4 65.5 33.5 26.7 28.0 30.5 15.4 32.0 22.1 21.0 25.9 19.7 26.7 11.1 NDUFA8 "MGC793, PGIV" ENSG00000119421 "NADH:ubiquinone oxidoreductase subunit A8" P51970 9 122144058-122159819 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 105.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041510, HPA041600" Enhanced Supported Mitochondria 14000 Mitochondria "HPA041510: AB_10794379, HPA041600: AB_10796778" "unprognostic (2.90e-1)" "unprognostic (2.27e-3)" "unprognostic (3.58e-1)" "unprognostic (3.42e-2)" "unprognostic (2.32e-1)" "unprognostic (2.20e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-2)" "unprognostic (2.33e-2)" "unprognostic (6.98e-2)" "unprognostic (1.46e-2)" "unprognostic (4.12e-2)" "prognostic favourable (4.17e-6)" "unprognostic (1.80e-1)" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (4.62e-2)" 15.4 20.0 35.9 9.5 40.5 7.3 16.5 18.8 36.8 14.2 23.4 12.4 19.6 19.4 12.6 26.9 17.0 18.9 16.9 105.4 32.3 27.5 29.0 23.6 10.9 11.2 31.3 30.3 11.3 16.8 21.8 15.3 14.1 22.4 17.9 26.6 14.6 25.1 19.7 68.3 11.1 17.4 22.0 19.1 10.9 18.0 25.1 16.8 10.0 18.5 30.9 15.8 15.6 15.3 29.7 39.7 22.2 34.3 25.5 30.8 24.3 19.4 36.0 23.9 31.4 25.8 23.7 29.6 22.6 26.9 31.1 26.2 45.6 19.4 28.4 22.4 26.4 48.9 45.2 48.9 30.6 27.8 31.3 22.4 60.4 39.3 27.8 39.5 23.1 25.9 47.9 31.1 20.0 44.6 34.1 21.4 35.4 49.4 24.5 25.7 21.8 69.3 19.6 37.7 41.4 44.7 27.0 41.4 16.3 35.6 42.3 28.1 44.8 19.1 28.9 17.3 17.4 32.4 25.3 24.2 39.0 28.1 36.0 25.6 28.5 5.1 29.4 22.2 29.1 34.3 27.8 29.7 27.0 28.4 38.1 29.3 29.0 30.5 4.8 25.5 28.8 39.7 30.8 24.3 35.9 40.5 18.8 36.8 32.3 27.5 31.3 30.3 22.4 16.8 NDUFAF2 "B17.2L, mimitin, MMTN, NDUFA12L" ENSG00000164182 "NADH:ubiquinone oxidoreductase complex assembly factor 2" Q8N183 5 60945129-61153037 "Disease related genes, Predicted intracellular proteins" Chaperone "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048082, HPA054776" Supported Enhanced Mitochondria Mitochondria "HPA048082: AB_2680254, HPA054776: AB_2682598" "unprognostic (7.28e-2)" "unprognostic (6.83e-2)" "unprognostic (1.37e-1)" "unprognostic (2.46e-3)" "unprognostic (2.41e-2)" "unprognostic (2.74e-2)" "prognostic unfavourable (2.56e-4)" "unprognostic (1.06e-1)" "unprognostic (4.76e-2)" "unprognostic (8.40e-3)" "unprognostic (1.28e-1)" "unprognostic (2.71e-1)" "prognostic unfavourable (2.49e-4)" "unprognostic (1.79e-2)" "unprognostic (6.10e-2)" "unprognostic (2.37e-1)" "unprognostic (4.66e-2)" 25.5 25.9 22.5 16.7 24.9 11.4 27.1 13.6 24.4 16.9 20.5 11.7 8.2 16.0 16.3 12.2 19.3 12.6 15.0 33.6 19.9 21.2 19.1 27.2 11.9 13.4 20.5 14.2 23.5 41.2 14.2 25.3 9.8 18.5 19.0 18.2 13.2 16.0 16.8 56.3 12.9 13.3 23.9 18.3 10.0 17.2 20.1 12.6 4.9 17.7 16.0 12.3 26.9 19.5 15.9 20.9 1.5 13.1 17.3 20.3 9.1 31.0 16.4 11.3 36.5 22.1 31.3 21.4 36.4 19.4 23.1 28.4 27.3 22.5 39.1 37.7 24.7 12.9 19.4 31.8 28.7 20.7 27.8 13.5 29.3 25.5 33.3 19.5 8.0 16.9 34.4 21.0 63.9 20.6 22.2 20.9 24.1 24.6 17.3 28.8 9.4 39.0 19.1 31.2 53.0 22.0 13.4 23.9 10.7 22.7 19.7 35.3 23.5 13.8 19.1 16.7 25.4 35.8 40.2 15.3 22.0 43.0 22.1 35.1 19.3 0.0 13.1 1.5 12.5 11.9 14.3 15.9 15.9 14.6 20.9 11.0 13.9 14.3 0.6 17.3 9.1 7.5 20.3 9.1 22.5 24.9 13.6 24.4 19.9 21.2 20.5 14.2 18.5 12.6 NDUFAF4 "bA22L21.1, C6orf66, HRPAP20, HSPC125, My013" ENSG00000123545 "NADH:ubiquinone oxidoreductase complex assembly factor 4" Q9P032 6 96889313-96897881 "Disease related genes, Predicted intracellular proteins" Calmodulin-binding "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046560 Uncertain Supported Mitochondria Mitochondria "HPA046560: AB_10966700" "prognostic unfavourable (1.31e-4)" "unprognostic (1.32e-1)" "unprognostic (1.09e-2)" "unprognostic (1.14e-3)" "unprognostic (2.89e-1)" "unprognostic (7.53e-3)" "unprognostic (6.89e-2)" "unprognostic (1.27e-1)" "unprognostic (5.57e-2)" "unprognostic (2.78e-2)" "unprognostic (2.03e-2)" "unprognostic (1.13e-1)" "unprognostic (4.20e-3)" "unprognostic (6.32e-2)" "unprognostic (1.11e-1)" "unprognostic (4.87e-2)" "unprognostic (1.31e-1)" 7.9 10.1 16.1 5.4 19.0 2.7 9.0 20.4 27.4 8.9 9.1 5.0 5.7 6.2 7.3 6.4 7.1 6.0 6.0 30.2 18.7 17.3 17.3 18.1 4.3 5.4 18.1 12.3 10.4 7.2 7.3 6.5 6.1 28.5 9.5 9.7 4.5 7.7 12.8 25.0 6.2 6.5 7.3 9.6 7.6 6.4 5.7 8.4 4.9 9.5 11.2 5.8 8.2 5.1 6.4 4.5 0.6 4.3 3.3 10.0 4.1 1.5 4.2 7.4 9.9 7.4 4.3 3.9 4.1 3.9 6.1 4.7 5.7 2.6 13.9 7.5 3.8 3.0 17.1 6.3 6.0 9.7 13.5 15.4 2.3 4.9 8.0 16.1 6.5 4.0 9.9 5.3 5.4 4.8 13.8 9.5 9.6 4.7 10.3 8.7 14.0 6.9 4.9 4.1 7.1 10.2 4.1 12.6 5.9 2.1 7.5 11.7 2.3 10.8 4.0 3.2 2.4 11.3 6.7 2.2 3.5 13.7 4.4 12.1 4.7 0.2 2.2 0.6 5.1 4.3 6.6 6.4 6.7 6.7 3.8 6.3 10.0 8.8 0.4 3.3 2.6 4.5 6.8 4.1 16.1 19.0 20.4 27.4 18.7 17.3 18.1 12.3 28.5 8.4 NDUFAF8 C17orf89 ENSG00000224877 "NADH:ubiquinone oxidoreductase complex assembly factor 8" A1L188 17 81239239-81241281 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057732 Uncertain Approved Mitochondria Mitochondria "HPA057732: " "unprognostic (4.33e-3)" "unprognostic (2.01e-1)" "unprognostic (1.04e-1)" "unprognostic (4.62e-2)" "unprognostic (1.97e-1)" "unprognostic (9.32e-2)" "unprognostic (3.06e-1)" "unprognostic (4.21e-2)" "unprognostic (2.60e-1)" "unprognostic (2.71e-2)" "unprognostic (2.40e-3)" "unprognostic (2.31e-1)" "prognostic unfavourable (1.70e-6)" "unprognostic (5.74e-2)" "unprognostic (2.00e-1)" "unprognostic (1.54e-1)" "unprognostic (1.05e-2)" 21.6 24.6 44.7 16.6 45.9 19.1 18.2 16.9 33.3 13.0 18.5 18.3 14.0 13.6 10.1 22.5 12.6 12.1 17.5 28.5 36.6 25.0 23.9 30.0 13.4 14.8 34.8 23.2 13.3 24.5 14.6 15.8 9.3 17.0 14.7 19.3 15.0 22.9 15.1 78.1 9.0 11.7 19.1 22.8 11.5 15.4 10.8 16.4 8.4 11.3 29.0 19.2 10.3 8.8 34.2 46.7 22.9 27.8 25.7 36.5 25.3 29.1 44.4 16.5 16.1 18.5 19.5 17.2 25.4 10.9 18.5 10.7 22.5 13.3 26.8 12.6 18.8 14.6 15.3 25.7 22.2 6.5 85.7 20.9 47.5 50.3 19.4 29.4 13.3 26.1 31.4 13.3 28.4 29.5 24.9 17.3 23.8 28.0 39.8 30.3 8.9 56.1 24.5 23.5 20.8 19.8 21.0 18.9 23.6 21.4 18.4 25.6 25.6 27.8 16.5 23.1 33.3 16.4 26.0 22.5 7.9 25.9 20.8 15.6 17.7 12.9 27.8 22.9 26.4 21.3 27.0 34.2 29.9 32.8 28.7 29.3 36.5 35.2 3.7 25.7 24.2 46.7 29.3 25.3 44.7 45.9 16.9 33.3 36.6 25.0 34.8 23.2 17.0 16.4 NDUFB11 "ESSS, Np15, NP17.3" ENSG00000147123 "NADH:ubiquinone oxidoreductase subunit B11" Q9NX14 X 47142216-47145504 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 164.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030367 Supported Approved Mitochondria Mitochondria "HPA030367: AB_10603882" "unprognostic (2.20e-1)" "unprognostic (6.77e-3)" "unprognostic (1.39e-1)" "unprognostic (1.33e-1)" "unprognostic (9.80e-2)" "unprognostic (8.84e-2)" "unprognostic (3.31e-2)" "unprognostic (2.05e-1)" "unprognostic (5.18e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "unprognostic (2.19e-1)" "unprognostic (6.58e-2)" "unprognostic (3.27e-1)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "unprognostic (8.46e-3)" 16.9 33.4 26.1 21.2 24.8 25.2 29.2 18.9 29.7 17.6 23.3 10.5 24.7 24.2 14.3 25.1 23.3 18.8 24.0 64.4 22.4 20.6 24.4 48.8 18.1 36.5 22.5 22.0 14.9 50.9 15.6 24.5 14.2 24.4 18.1 21.2 13.0 37.0 30.2 164.0 17.3 22.8 16.0 18.3 19.2 22.8 9.7 12.3 30.4 38.5 53.6 21.2 14.3 20.5 58.9 69.0 22.2 44.7 27.7 54.6 59.5 19.5 29.1 23.0 26.6 19.9 17.1 24.5 14.3 16.6 23.4 22.7 31.0 24.0 24.1 12.3 15.5 25.1 25.9 15.1 15.6 23.3 69.2 13.8 39.8 25.6 20.0 23.1 21.3 18.7 13.9 20.2 13.4 17.4 16.5 31.8 13.1 44.2 27.2 64.1 36.0 53.6 29.7 22.8 54.8 23.7 20.9 42.5 31.4 27.1 31.2 21.5 44.8 30.4 13.2 16.4 22.3 30.4 16.6 31.4 27.4 27.0 17.8 14.5 21.8 22.2 44.7 19.8 34.0 32.0 42.2 58.9 48.4 39.0 52.8 52.8 54.6 43.6 9.5 27.7 23.7 69.0 51.0 59.5 26.1 24.8 18.9 29.7 22.4 20.6 22.5 22.0 24.4 12.3 NDUFB6 "B17, CI" ENSG00000165264 "NADH:ubiquinone oxidoreductase subunit B6" O95139 9 32552999-32573184 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044001, HPA053334" Supported Enhanced Mitochondria Mitochondria "HPA044001: AB_10959448, HPA053334: " "unprognostic (4.09e-1)" "prognostic favourable (3.18e-4)" "unprognostic (1.81e-2)" "unprognostic (1.53e-2)" "unprognostic (1.50e-1)" "unprognostic (1.49e-1)" "unprognostic (1.14e-1)" "unprognostic (6.10e-2)" "unprognostic (1.18e-1)" "unprognostic (1.35e-3)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "prognostic favourable (7.47e-10)" "unprognostic (2.70e-1)" "unprognostic (1.82e-1)" "unprognostic (1.26e-1)" "unprognostic (1.83e-1)" 21.9 26.8 33.9 17.7 31.8 16.0 18.7 22.6 28.3 13.7 21.9 15.5 17.3 26.5 16.8 17.4 18.6 15.4 15.9 58.6 27.6 27.9 32.8 36.6 13.9 15.4 28.4 27.2 14.1 19.5 15.4 17.8 15.5 22.9 15.1 18.2 14.6 22.7 16.1 87.2 14.6 25.5 16.4 25.9 13.5 20.0 28.9 17.1 19.2 22.2 34.4 14.5 14.1 13.5 26.0 38.8 77.4 27.3 22.2 27.5 26.5 29.8 18.4 20.5 23.4 13.9 13.0 13.1 20.0 16.4 18.5 20.5 18.0 13.5 22.3 20.9 13.8 17.0 19.3 22.1 14.0 30.6 30.9 53.0 28.2 18.5 13.6 26.4 13.7 13.4 10.8 16.7 12.7 16.7 16.9 25.2 20.7 17.3 35.5 62.4 21.6 40.9 24.5 17.2 20.6 20.7 11.3 20.6 23.3 23.2 26.7 13.5 25.2 20.5 14.8 20.3 30.7 22.3 29.4 11.2 21.0 36.2 33.9 18.6 9.5 25.0 25.8 33.3 21.0 23.1 20.2 26.0 22.4 21.6 27.6 21.8 23.0 24.3 77.4 22.2 27.3 38.8 27.5 26.5 33.9 31.8 22.6 28.3 27.6 27.9 28.4 27.2 22.9 17.1 NDUFB8 "ASHI, CI-ASHI" ENSG00000166136 "NADH:ubiquinone oxidoreductase subunit B8" O95169 10 100523740-100530000 "Plasma proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003886 Supported Approved Mitochondria Mitochondria "HPA003886: AB_1079463" "unprognostic (4.07e-2)" "unprognostic (1.95e-3)" "unprognostic (2.28e-1)" "unprognostic (7.33e-2)" "unprognostic (4.88e-2)" "unprognostic (5.78e-2)" "unprognostic (3.02e-1)" "unprognostic (6.46e-2)" "unprognostic (8.33e-2)" "unprognostic (9.09e-2)" "unprognostic (1.25e-2)" "unprognostic (8.23e-2)" "unprognostic (4.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (5.10e-2)" 35.2 39.8 86.7 27.0 67.4 35.6 26.1 39.3 81.5 25.4 37.7 23.8 23.1 38.8 24.7 42.3 36.8 28.8 28.2 110.0 70.6 62.8 50.4 50.6 19.8 28.1 63.9 54.1 27.7 36.3 31.5 31.4 19.9 49.9 26.6 36.2 25.7 39.7 34.5 88.5 24.3 33.8 41.5 38.9 22.1 31.5 12.0 41.4 18.3 28.3 49.2 27.8 25.2 21.5 76.6 88.6 62.2 74.4 60.5 105.9 129.7 41.8 70.6 38.2 67.7 28.9 28.1 42.2 28.6 62.2 44.0 47.7 95.7 48.8 44.4 25.8 32.0 50.2 28.5 46.5 35.0 29.1 72.9 31.2 59.9 77.4 39.2 63.7 53.8 34.6 42.0 43.9 59.2 48.1 32.4 28.2 37.8 50.8 61.4 80.2 25.5 65.9 42.9 41.7 58.5 51.5 47.9 26.4 37.1 21.0 40.2 41.5 59.7 57.1 32.2 25.2 28.5 26.8 50.0 51.2 46.5 55.1 50.0 67.5 28.0 35.1 74.4 62.2 59.0 72.9 69.5 76.6 73.6 67.8 80.4 64.1 79.8 76.7 17.1 60.5 61.4 88.6 105.9 129.7 86.7 67.4 39.3 81.5 70.6 62.8 63.9 54.1 49.9 41.4 NDUFB9 "B22, LYRM3, UQOR22" ENSG00000147684 "NADH:ubiquinone oxidoreductase subunit B9" Q9Y6M9 8 124539103-124568510 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 221.3" "Cell line enhanced" "Detected in all" "SK-BR-3: 254.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042768 Approved Supported Mitochondria Mitochondria "HPA042768: AB_10797508" "unprognostic (1.18e-2)" "unprognostic (2.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.03e-3)" "unprognostic (8.32e-2)" "unprognostic (9.71e-2)" "unprognostic (3.25e-1)" "unprognostic (1.14e-1)" "unprognostic (4.16e-2)" "unprognostic (3.80e-2)" "unprognostic (1.51e-1)" "unprognostic (3.64e-1)" "prognostic favourable (3.42e-5)" "unprognostic (9.54e-2)" "unprognostic (9.64e-2)" "unprognostic (4.94e-2)" "unprognostic (2.74e-1)" 26.9 20.8 61.0 19.6 45.1 43.7 33.3 26.9 63.7 20.7 40.4 15.0 25.4 35.5 17.4 30.0 27.9 19.4 23.8 125.1 44.2 39.0 50.1 52.9 23.8 38.2 60.0 49.1 16.8 51.7 20.6 16.3 15.8 46.7 20.6 37.5 13.4 39.9 24.0 221.3 18.0 26.1 31.3 44.8 15.3 28.9 44.1 31.1 13.5 27.7 80.7 19.3 16.7 16.5 53.8 52.7 52.1 54.4 37.5 71.2 64.2 28.8 26.7 20.5 27.7 21.4 18.2 17.2 14.2 16.2 25.9 19.6 35.1 27.9 28.6 36.9 16.3 32.9 29.7 22.6 24.5 33.2 40.5 69.6 19.0 42.0 28.5 21.6 19.0 21.2 33.0 23.7 51.4 23.5 43.0 24.1 20.7 90.2 34.0 43.3 20.6 59.4 23.0 15.6 39.0 34.1 24.4 28.6 22.4 30.9 254.7 30.4 35.0 29.3 18.7 15.1 39.4 14.1 33.4 31.1 41.4 32.8 26.3 43.3 19.9 52.1 54.4 27.5 48.3 37.2 47.9 53.8 64.0 53.9 52.7 42.5 63.4 52.2 11.2 37.5 27.2 39.6 71.2 64.2 61.0 45.1 26.9 63.7 44.2 39.0 60.0 49.1 46.7 31.1 NDUFC1 KFYI ENSG00000109390 "NADH:ubiquinone oxidoreductase subunit C1" O43677 4 139266880-139302551 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 164.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044556 Approved Supported Mitochondria Mitochondria "HPA044556: AB_10794402" "unprognostic (6.07e-2)" "unprognostic (4.61e-3)" "unprognostic (1.76e-2)" "prognostic favourable (8.23e-5)" "unprognostic (7.11e-2)" "unprognostic (1.74e-1)" "unprognostic (1.23e-1)" "unprognostic (1.40e-1)" "unprognostic (7.62e-2)" "unprognostic (3.60e-2)" "unprognostic (3.58e-2)" "unprognostic (1.17e-2)" "prognostic favourable (9.96e-4)" "unprognostic (2.33e-1)" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "prognostic favourable (7.25e-4)" 7.4 17.0 15.2 6.4 15.8 5.6 8.3 12.2 15.7 8.5 13.1 11.8 7.0 15.2 6.6 12.0 11.7 8.3 7.7 55.5 12.4 14.6 20.3 17.1 8.4 6.7 13.0 12.1 9.7 13.1 11.4 14.3 8.9 10.0 8.1 12.6 11.3 10.9 10.5 164.1 9.1 16.4 7.2 10.4 10.5 11.9 27.1 8.5 6.1 11.6 57.6 9.4 7.0 7.3 32.7 40.0 40.8 24.4 12.8 31.4 26.1 8.6 3.6 10.6 13.1 7.6 8.3 8.4 10.7 7.1 7.9 6.0 6.4 10.8 3.8 3.9 7.5 5.1 20.6 7.0 6.3 5.4 6.6 6.0 7.1 10.2 9.5 5.0 3.3 11.9 10.5 7.5 11.1 7.8 13.8 16.2 5.4 6.1 7.3 12.3 8.1 4.9 6.2 6.5 28.7 12.7 5.6 8.9 6.8 7.6 9.4 4.9 10.3 9.7 3.8 7.8 3.7 5.4 6.0 13.0 22.9 9.5 8.4 13.1 6.2 16.0 24.4 40.8 21.7 17.3 17.3 28.3 24.4 23.2 24.0 32.7 31.4 23.1 15.4 12.8 18.8 40.0 28.3 26.1 15.2 15.8 12.2 15.7 12.4 14.6 13.0 12.1 10.0 8.5 NDUFC2 "B14.5b, HLC-1" ENSG00000151366 "NADH:ubiquinone oxidoreductase subunit C2" O95298 11 78068304-78080219 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA038873, HPA056195" Approved Supported Mitochondria Mitochondria "HPA038873: AB_10673480, HPA056195: " "unprognostic (7.32e-2)" "unprognostic (5.91e-3)" "unprognostic (4.00e-2)" "unprognostic (6.14e-2)" "unprognostic (1.94e-1)" "unprognostic (8.97e-2)" "unprognostic (1.60e-1)" "unprognostic (4.23e-3)" "unprognostic (4.75e-3)" "unprognostic (3.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.11e-1)" "prognostic favourable (5.00e-5)" "unprognostic (6.32e-2)" "unprognostic (3.01e-1)" "unprognostic (4.18e-2)" "unprognostic (3.61e-3)" 55.0 70.8 40.8 23.3 44.4 32.3 46.2 51.4 58.4 22.5 41.1 31.2 68.0 63.4 31.8 32.8 41.8 35.6 31.9 60.4 41.0 44.5 37.5 89.6 30.1 36.4 43.2 47.0 27.3 48.4 25.3 34.7 31.8 40.8 27.3 20.3 29.7 79.5 59.0 122.8 29.0 55.3 23.7 41.1 24.5 36.6 28.6 23.2 26.9 63.5 43.7 23.3 31.9 24.1 50.3 78.2 70.3 73.2 44.5 46.3 81.2 36.1 45.2 24.6 15.5 23.4 14.8 30.3 44.3 26.6 35.2 25.1 121.1 40.7 21.7 81.3 20.9 38.2 18.5 26.0 13.5 41.1 52.3 23.3 46.9 95.3 40.0 50.9 23.2 20.4 24.2 27.0 10.2 23.9 45.9 36.6 19.6 62.4 33.2 91.8 27.7 57.1 29.1 46.8 73.3 26.6 54.5 34.8 30.8 31.5 65.0 22.8 51.5 42.3 31.2 34.3 42.3 81.7 37.9 33.7 66.1 49.9 19.5 30.6 32.8 65.8 73.2 70.3 39.4 58.2 36.2 50.3 45.6 41.5 77.2 45.5 39.6 41.3 21.0 44.5 48.0 78.2 46.3 81.2 40.8 44.4 51.4 58.4 41.0 44.5 43.2 47.0 40.8 23.2 NDUFC2-KCTD14 ENSG00000259112 "NDUFC2-KCTD14 readthrough" E9PQ53 11 78016971-78079865 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 10.3;EFO-21: 8.4;RPMI-8226: 7.4;U-2 OS: 12.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA038873, HPA056195" Approved Supported Mitochondria Mitochondria "HPA038873: AB_10673480, HPA056195: " 7.1 11.3 6.3 5.8 7.9 9.7 8.9 13.8 11.7 9.6 7.4 5.5 13.8 27.3 8.8 5.9 9.5 9.7 5.6 11.3 7.7 7.1 6.9 18.7 6.6 6.7 6.4 9.1 6.6 8.8 5.4 5.6 5.6 7.7 8.4 6.3 5.1 18.0 11.8 10.1 5.7 10.6 5.9 5.9 5.9 15.9 4.9 3.7 4.5 12.7 8.3 4.8 4.6 6.1 30.7 37.7 30.7 33.7 16.5 33.2 39.7 0.0 2.1 0.6 0.6 0.6 0.0 1.3 1.5 0.9 1.2 2.9 10.3 1.2 0.2 8.4 0.0 0.3 1.7 0.0 0.7 5.9 0.0 1.2 0.0 0.0 0.7 0.8 2.1 0.0 0.3 0.3 1.8 0.9 0.3 0.1 0.2 0.0 3.0 1.1 5.2 0.3 1.0 0.1 7.4 0.0 0.0 1.5 2.3 0.0 1.1 3.3 0.6 1.1 0.9 0.5 12.9 4.2 0.0 1.2 1.4 2.9 0.8 0.3 1.4 22.5 33.7 30.7 24.5 24.1 19.3 30.7 22.8 23.0 37.7 23.7 20.5 21.5 10.0 16.5 25.7 37.5 33.2 39.7 6.3 7.9 13.8 11.7 7.7 7.1 6.4 9.1 7.7 3.7 NDUFS1 CI-75k ENSG00000023228 "NADH:ubiquinone oxidoreductase core subunit S1" P28331 2 206114817-206159603 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 99.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064605, CAB070844" Approved Supported Mitochondria Mitochondria "CAB070844: , HPA064605: " "prognostic unfavourable (3.85e-4)" "unprognostic (1.76e-1)" "unprognostic (9.22e-3)" "unprognostic (5.01e-2)" "unprognostic (8.63e-3)" "unprognostic (3.75e-1)" "unprognostic (3.72e-2)" "unprognostic (6.18e-2)" "unprognostic (2.30e-2)" "unprognostic (3.28e-1)" "unprognostic (2.00e-2)" "unprognostic (1.28e-1)" "prognostic favourable (1.47e-12)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" "unprognostic (4.76e-2)" "unprognostic (4.73e-2)" 13.9 29.0 12.1 8.3 22.1 7.6 10.3 11.6 26.4 9.1 17.4 16.4 9.2 18.3 9.1 7.7 15.7 7.7 7.3 62.6 11.3 11.7 29.5 30.7 8.3 7.7 13.3 13.8 8.2 9.3 22.1 11.6 10.8 24.2 10.7 18.9 13.5 12.8 10.9 99.5 11.0 19.9 11.1 10.8 8.4 14.9 8.8 11.1 11.2 10.8 34.7 10.5 11.6 9.4 10.7 15.3 15.7 21.4 12.5 16.1 8.9 12.9 13.0 18.8 13.6 17.6 14.3 21.9 19.1 20.7 31.9 23.2 33.5 15.2 14.7 16.9 23.8 18.2 25.1 18.5 28.4 6.7 11.8 29.4 32.1 30.0 18.3 21.1 13.3 17.4 10.9 25.0 19.7 24.8 31.7 14.9 20.8 16.2 17.4 14.0 17.5 23.1 17.7 26.3 25.4 26.4 23.8 18.4 14.4 22.0 21.6 31.2 19.0 20.5 18.9 17.6 15.7 17.2 18.1 14.4 17.3 21.9 17.7 17.6 18.0 12.0 13.3 15.7 13.6 15.4 10.8 10.7 12.2 13.0 15.3 9.5 10.9 12.4 9.6 12.5 21.4 8.2 16.1 8.9 12.1 22.1 11.6 26.4 11.3 11.7 13.3 13.8 24.2 11.1 NDUFS2 CI-49 ENSG00000158864 "NADH:ubiquinone oxidoreductase core subunit S2" O75306 1 161197104-161214395 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 104.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055140, HPA061953" Enhanced Supported Mitochondria 16000 Mitochondria "HPA055140: AB_2682713, HPA061953: AB_2684646" "unprognostic (2.13e-2)" "unprognostic (2.24e-2)" "unprognostic (8.47e-2)" "unprognostic (7.78e-2)" "unprognostic (9.81e-2)" "unprognostic (2.70e-1)" "unprognostic (1.10e-2)" "unprognostic (1.51e-1)" "unprognostic (3.10e-1)" "unprognostic (1.57e-2)" "unprognostic (3.17e-2)" "unprognostic (1.11e-1)" "prognostic favourable (2.32e-4)" "unprognostic (2.35e-1)" "unprognostic (2.80e-1)" "unprognostic (1.13e-1)" "unprognostic (1.82e-1)" 14.6 30.7 16.6 8.0 25.4 10.2 15.5 23.4 25.4 13.0 25.6 17.9 11.7 23.6 12.3 11.2 16.7 14.5 10.6 75.4 17.6 14.8 37.4 52.6 12.8 9.2 28.0 25.0 14.1 14.3 25.6 10.7 11.5 24.1 12.7 27.2 11.4 14.6 14.5 104.9 14.0 22.1 15.7 16.1 13.0 19.4 8.8 25.3 10.4 12.3 37.1 15.1 13.2 10.5 18.9 47.3 26.6 42.2 20.3 29.2 32.4 18.0 29.1 18.4 21.3 27.0 24.0 15.9 16.4 24.1 32.4 25.6 31.8 18.8 22.9 30.9 25.2 24.2 29.3 29.3 28.7 15.2 24.7 22.4 21.8 27.8 28.0 24.2 20.8 34.6 25.9 26.2 30.0 37.1 28.6 12.5 30.4 20.8 15.3 12.9 33.5 26.8 13.3 19.0 32.2 38.5 21.6 19.5 29.0 19.8 48.9 27.9 44.0 63.4 23.7 15.8 13.5 11.0 22.1 17.6 27.9 19.2 24.1 20.5 20.3 26.6 35.9 18.9 20.5 42.2 19.9 18.9 20.9 20.7 47.3 15.7 21.6 21.8 20.2 20.3 37.0 31.8 29.2 32.4 16.6 25.4 23.4 25.4 17.6 14.8 28.0 25.0 24.1 25.3 NDUFS4 "AQDQ, CI-18" ENSG00000164258 "NADH:ubiquinone oxidoreductase subunit S4" O43181 5 53560633-53683340 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003884 Supported Supported Mitochondria Mitochondria "HPA003884: AB_1079465" "unprognostic (1.25e-1)" "unprognostic (3.61e-3)" "unprognostic (3.44e-2)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" "unprognostic (6.73e-3)" "unprognostic (6.93e-2)" "unprognostic (1.11e-1)" "unprognostic (3.93e-1)" "unprognostic (4.38e-1)" "unprognostic (1.72e-2)" "unprognostic (3.11e-1)" "prognostic favourable (3.85e-6)" "unprognostic (9.19e-2)" "unprognostic (1.24e-1)" "unprognostic (1.65e-1)" "unprognostic (1.81e-1)" 27.5 26.5 29.8 15.7 35.7 14.3 34.0 23.3 35.3 20.8 30.0 12.9 21.3 27.6 24.0 24.2 27.0 22.9 20.9 65.1 24.4 23.2 45.3 48.1 18.7 14.9 28.5 34.4 35.7 19.5 22.2 24.9 20.7 26.7 22.9 30.5 16.4 24.4 26.3 105.5 23.0 25.5 34.3 27.0 13.6 24.1 20.9 24.6 12.9 25.1 67.3 19.3 21.7 22.4 24.3 41.0 6.7 32.8 24.5 25.2 21.9 30.0 26.7 53.2 31.4 36.4 52.8 44.8 36.6 35.8 40.8 50.0 32.5 39.6 21.4 48.3 31.2 22.2 18.8 43.7 47.1 19.8 36.0 14.7 26.6 29.2 38.8 35.4 25.6 43.8 50.6 28.1 49.6 35.4 12.5 23.4 37.2 28.1 26.6 29.7 16.1 30.2 32.1 30.1 42.1 43.4 29.1 24.6 26.6 25.1 24.4 43.0 39.1 37.3 27.0 25.1 26.7 18.2 47.8 18.0 22.4 25.8 26.7 52.0 36.0 6.7 28.9 2.4 17.5 32.8 19.5 24.3 22.2 20.2 41.0 16.5 25.1 25.2 2.4 24.5 32.4 31.0 23.5 21.9 29.8 35.7 23.3 35.3 24.4 23.2 28.5 34.4 26.7 24.6 NDUFS8 "CI-23k, TYKY" ENSG00000110717 "NADH:ubiquinone oxidoreductase core subunit S8" O00217 11 68030617-68036644 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 156.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018524 Approved Supported Mitochondria "Intracellular and membrane" Mitochondria "HPA018524: AB_1854355" "unprognostic (2.90e-1)" "unprognostic (1.41e-3)" "unprognostic (2.41e-1)" "unprognostic (5.20e-2)" "unprognostic (1.37e-1)" "unprognostic (1.30e-3)" "unprognostic (1.36e-1)" "unprognostic (7.75e-2)" "unprognostic (3.15e-1)" "unprognostic (1.77e-2)" "unprognostic (3.81e-2)" "unprognostic (1.81e-1)" "prognostic favourable (3.27e-8)" "unprognostic (2.29e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (9.45e-2)" 26.0 62.0 29.9 16.9 40.5 21.0 19.1 18.4 50.1 18.6 24.7 19.7 24.3 34.7 18.2 15.1 28.3 19.0 22.7 82.4 26.5 27.5 50.3 47.6 16.3 19.1 28.3 22.4 20.8 41.3 25.4 26.7 18.0 25.9 22.9 18.3 30.1 41.3 32.2 156.6 17.3 26.7 19.8 18.2 20.3 25.0 21.1 15.7 29.6 29.2 53.9 24.2 19.1 14.8 37.3 66.6 23.6 46.1 59.0 39.6 42.6 26.8 66.7 18.5 25.1 13.8 12.4 24.3 19.1 16.6 29.6 23.0 62.1 28.7 20.8 34.8 16.5 33.2 21.2 23.2 10.6 24.8 48.8 18.9 42.5 32.6 33.0 17.7 20.9 15.6 24.1 21.7 24.9 19.8 19.4 22.6 19.3 63.7 38.9 37.9 22.7 56.6 27.1 17.9 67.3 37.2 21.8 23.2 18.9 13.9 32.2 67.5 44.2 19.4 15.3 28.7 25.3 41.6 26.3 30.9 32.5 17.6 46.2 21.3 20.0 15.8 46.1 23.6 39.6 45.1 37.0 37.3 34.2 36.0 63.3 30.2 33.0 36.7 4.4 59.0 24.9 66.6 39.6 42.6 29.9 40.5 18.4 50.1 26.5 27.5 28.3 22.4 25.9 15.7 NDUFV2 CI-24k ENSG00000178127 "NADH:ubiquinone oxidoreductase core subunit V2" P19404 18 9102630-9134345 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003404, HPA077896" Supported Supported Mitochondria Mitochondria "HPA003404: AB_1079466, HPA077896: " "unprognostic (1.18e-1)" "unprognostic (3.89e-2)" "unprognostic (2.89e-1)" "unprognostic (8.22e-2)" "unprognostic (1.32e-2)" "unprognostic (6.72e-3)" "unprognostic (1.36e-2)" "unprognostic (1.18e-1)" "unprognostic (6.72e-3)" "unprognostic (1.32e-3)" "unprognostic (2.39e-1)" "unprognostic (6.84e-2)" "unprognostic (1.70e-1)" "unprognostic (5.51e-2)" "unprognostic (1.31e-1)" "unprognostic (6.56e-2)" "unprognostic (1.95e-3)" 20.0 34.5 25.2 18.0 23.7 31.1 25.6 20.6 37.3 15.6 26.1 13.1 20.3 23.1 14.7 21.5 27.5 13.9 17.6 82.6 22.7 23.8 40.7 89.1 17.2 29.9 26.7 19.4 11.2 36.3 14.9 14.9 21.6 26.2 20.8 27.8 17.8 20.1 20.2 122.6 17.4 24.4 23.5 20.8 19.3 25.2 19.0 12.7 20.5 20.5 59.5 22.7 20.4 14.1 55.6 74.7 49.3 45.1 27.0 53.5 48.1 19.6 20.7 23.9 22.2 17.8 25.3 20.3 24.8 39.5 32.9 31.2 38.6 16.3 30.4 22.8 23.3 10.0 23.2 25.8 31.5 15.3 20.5 19.4 21.3 52.1 20.5 54.0 24.2 21.3 21.6 20.2 22.0 35.4 30.9 96.1 30.1 24.7 37.7 47.4 20.0 25.8 18.0 17.7 115.3 52.4 32.0 25.2 18.7 24.5 28.0 31.2 26.2 41.2 21.6 41.9 29.8 30.0 32.2 27.8 41.2 34.1 29.8 24.0 27.0 49.3 39.9 44.1 30.2 45.1 37.6 55.6 45.5 35.7 56.6 43.6 40.0 36.9 18.0 27.0 41.6 74.7 53.5 48.1 25.2 23.7 20.6 37.3 22.7 23.8 26.7 19.4 26.2 12.7 NDUFV3 CI-10k ENSG00000160194 "NADH:ubiquinone oxidoreductase subunit V3" P56181 21 42879644-42913304 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 129.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019791, HPA020463, HPA030427, CAB034142" Enhanced Enhanced Mitochondria Mitochondria "CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024" "unprognostic (1.62e-1)" "unprognostic (2.17e-3)" "unprognostic (1.31e-1)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.11e-2)" "unprognostic (4.69e-1)" "unprognostic (2.97e-2)" "unprognostic (1.05e-1)" "unprognostic (3.13e-1)" "unprognostic (3.85e-3)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (6.56e-2)" "unprognostic (9.30e-3)" "unprognostic (2.14e-1)" "unprognostic (1.94e-1)" 18.1 14.1 16.9 11.1 17.2 15.8 14.6 11.8 23.2 12.0 15.9 11.9 14.6 15.2 15.1 15.7 15.6 12.7 15.4 54.9 14.2 11.0 15.1 24.3 10.8 12.5 14.0 18.6 16.0 17.7 13.2 13.1 11.6 19.2 13.6 11.4 12.2 19.4 21.8 129.5 15.4 13.5 16.9 16.0 13.3 14.3 20.3 13.3 6.6 11.6 18.5 10.6 13.3 11.8 9.9 22.9 16.0 22.8 10.5 8.8 10.3 9.6 11.3 11.0 18.0 13.6 11.8 13.6 19.2 11.0 11.4 9.6 20.7 11.9 10.7 15.2 7.1 10.5 12.8 16.9 7.5 6.1 15.4 35.2 13.3 16.2 21.3 12.0 18.5 13.3 14.7 11.6 18.4 14.4 27.9 13.9 13.1 18.9 8.0 18.2 14.3 22.4 13.8 8.0 33.4 15.4 12.8 8.0 8.4 19.2 22.8 12.7 19.5 15.9 16.9 10.8 7.5 13.8 13.6 20.8 13.7 12.1 14.1 21.6 16.2 3.7 21.4 16.0 8.0 22.8 8.1 8.1 7.6 6.7 22.9 9.9 8.8 7.7 3.8 10.5 19.6 11.3 8.8 10.3 16.9 17.2 11.8 23.2 14.2 11.0 14.0 18.6 19.2 13.3 NEK9 "DKFZp434D0935, MGC16714, Nek8, NERCC" ENSG00000119638 "NIMA related kinase 9" Q8TD19 14 75079353-75127344 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001405 Approved Approved Mitochondria 190000 Mitochondria "HPA001405: AB_1079467" "unprognostic (1.00e-1)" "unprognostic (5.37e-2)" "unprognostic (9.97e-3)" "unprognostic (2.64e-2)" "unprognostic (3.86e-1)" "unprognostic (2.77e-1)" "unprognostic (1.12e-1)" "unprognostic (5.60e-3)" "unprognostic (2.81e-1)" "unprognostic (1.15e-1)" "prognostic favourable (5.63e-4)" "unprognostic (8.58e-2)" "unprognostic (1.36e-2)" "unprognostic (4.54e-2)" "unprognostic (9.22e-2)" "unprognostic (2.61e-1)" "unprognostic (1.57e-2)" 17.0 20.4 12.7 17.7 17.4 7.3 15.1 15.4 13.3 18.6 18.7 18.3 23.5 14.0 25.0 13.8 15.6 20.0 15.9 23.5 11.4 8.7 14.0 13.3 12.9 16.2 20.2 10.6 25.6 15.7 24.7 23.6 14.3 13.0 15.3 8.1 15.4 12.4 18.9 36.2 10.6 15.3 24.7 14.5 14.7 14.8 16.6 18.2 21.5 17.0 14.1 14.4 23.6 18.7 6.0 6.4 7.5 5.4 5.5 6.2 3.1 10.1 12.0 15.2 16.9 19.5 26.8 17.3 16.5 11.6 8.1 7.9 10.1 8.9 17.4 0.1 11.3 14.0 11.6 6.4 9.0 14.2 6.7 8.5 12.0 7.3 12.8 5.1 11.4 18.3 7.6 8.4 6.4 10.1 9.6 11.3 9.7 1.1 10.8 5.2 9.0 6.1 17.5 19.4 9.0 6.1 12.4 7.3 18.7 13.3 6.4 12.7 15.8 14.8 15.2 12.3 5.2 14.3 6.4 18.3 19.5 17.6 9.0 8.7 8.3 7.5 5.4 5.8 4.2 5.0 5.9 2.8 4.8 3.9 6.4 6.0 6.2 5.9 5.5 5.5 3.5 1.8 2.6 3.1 12.7 17.4 15.4 13.3 11.4 8.7 20.2 10.6 13.0 18.2 NF1 ENSG00000196712 "Neurofibromin 1" P21359 17 31094927-31382116 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "GTPase activation" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "B-cells: 2.3;granulocytes: 6.5;T-cells: 8.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045502 Uncertain Approved Mitochondria Mitochondria "HPA045502: " "unprognostic (6.69e-2)" "unprognostic (8.73e-2)" "unprognostic (8.26e-2)" "unprognostic (1.76e-2)" "unprognostic (2.06e-2)" "unprognostic (2.79e-2)" "unprognostic (1.38e-1)" "unprognostic (1.07e-1)" "unprognostic (1.11e-1)" "unprognostic (1.30e-2)" "unprognostic (3.14e-2)" "unprognostic (3.88e-2)" "unprognostic (1.00e-2)" "unprognostic (2.19e-1)" "unprognostic (1.53e-1)" "unprognostic (1.40e-1)" "unprognostic (3.70e-1)" 12.9 15.9 22.6 13.3 25.9 5.5 18.5 30.2 26.0 17.6 13.6 19.8 12.2 11.0 16.9 17.0 10.5 15.2 13.1 17.3 21.6 19.6 20.0 15.1 12.7 11.5 19.4 25.6 22.9 16.5 34.1 19.0 19.4 20.9 16.1 14.7 12.1 14.4 20.5 14.8 12.0 12.1 14.5 21.4 11.9 13.0 15.4 21.5 11.6 31.1 7.6 12.4 15.3 19.5 2.3 0.7 6.5 0.4 0.9 8.4 1.0 9.7 12.7 15.5 8.3 13.2 17.2 7.8 8.4 15.3 12.5 14.2 11.4 6.6 9.4 2.4 15.8 17.1 14.0 11.9 21.3 4.5 8.8 8.3 12.0 5.8 9.4 14.8 6.9 13.6 7.6 13.3 16.3 6.0 11.9 9.4 11.9 7.7 12.3 5.4 4.5 4.2 9.7 23.7 7.5 9.5 14.0 6.4 9.6 15.7 5.3 8.7 16.0 9.5 8.8 10.0 14.0 11.8 3.2 8.5 4.1 10.4 8.2 6.3 10.4 6.5 0.4 0.9 2.3 0.2 1.6 2.3 4.4 3.9 0.5 2.1 3.3 3.2 1.0 0.9 0.4 0.7 8.4 1.0 22.6 25.9 30.2 23.5 21.6 19.6 19.4 25.6 20.9 21.5 NFKBID "IkappaBNS, TA-NFKBH" ENSG00000167604 "NFKB inhibitor delta" Q8NI38 19 35887653-35902303 "Predicted intracellular proteins, Transcription factors" "Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 21.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043573 Approved Mitochondria Mitochondria "HPA043573: AB_10795983" "prognostic favourable (6.01e-4)" "unprognostic (9.60e-2)" "unprognostic (1.00e-1)" "unprognostic (3.28e-2)" "unprognostic (1.51e-2)" "prognostic favourable (5.43e-4)" "unprognostic (4.21e-2)" "unprognostic (7.68e-2)" "unprognostic (3.83e-1)" "unprognostic (4.10e-2)" "unprognostic (1.47e-3)" "unprognostic (5.64e-2)" "unprognostic (6.83e-2)" "unprognostic (1.04e-1)" "unprognostic (5.21e-2)" "unprognostic (2.71e-2)" "prognostic favourable (8.34e-6)" 4.1 2.8 0.9 13.5 2.5 21.0 7.0 4.5 2.4 1.9 2.1 4.4 0.9 1.9 2.3 2.7 3.0 3.7 6.9 2.1 0.7 1.1 3.4 1.8 11.4 9.1 2.3 0.4 4.3 3.5 1.9 5.5 1.6 2.0 2.6 1.5 2.7 2.3 3.4 0.9 3.6 4.8 5.1 2.4 6.8 2.8 1.5 1.1 14.4 5.1 1.0 14.7 2.8 7.4 9.4 1.9 4.8 1.6 2.0 2.3 0.6 4.7 4.4 0.9 3.0 0.6 0.7 2.1 2.9 3.5 3.2 2.3 1.0 3.8 5.7 2.3 3.0 2.5 3.1 2.3 1.3 3.3 0.6 3.4 6.1 1.0 0.8 2.9 10.3 1.0 1.6 5.8 1.4 1.1 0.7 3.6 0.6 3.7 2.4 3.5 1.3 0.9 1.3 0.7 1.2 2.8 2.0 1.6 1.2 3.9 3.0 0.3 1.3 3.0 1.2 4.9 4.5 2.2 2.0 2.5 0.9 6.7 2.7 7.0 0.7 0.0 1.4 2.5 2.3 0.9 1.7 5.4 1.0 1.8 1.4 9.4 1.7 1.0 4.8 2.0 1.6 1.9 2.2 0.6 0.9 2.5 4.5 2.4 0.7 1.1 2.3 0.4 2.0 1.1 NHLRC4 ENSG00000257108 "NHL repeat containing 4" P0CG21 16 566996-569495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 21.1;fallopian tube: 17.3" "Cell line enhanced" "Detected in some" "HEL: 4.5;HMC-1: 13.6;RPMI-8226: 5.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 5.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" HPA077301 Approved Mitochondria Mitochondria "HPA077301: " "unprognostic (7.95e-2)" "unprognostic (5.87e-2)" "unprognostic (4.28e-3)" "unprognostic (2.53e-2)" "unprognostic (1.08e-1)" "unprognostic (5.95e-3)" "unprognostic (2.21e-1)" "unprognostic (2.48e-1)" "unprognostic (2.28e-1)" "unprognostic (3.34e-1)" "unprognostic (2.20e-3)" "unprognostic (1.19e-2)" "unprognostic (1.16e-2)" "unprognostic (5.16e-3)" "unprognostic (1.25e-1)" "unprognostic (1.67e-2)" "unprognostic (1.60e-1)" 1.3 6.9 1.6 1.4 2.3 3.4 1.4 1.4 1.8 2.4 0.9 1.7 9.5 1.4 2.5 21.1 0.7 17.3 1.5 1.8 2.4 2.4 7.0 0.3 4.8 3.8 0.5 0.9 5.1 0.2 5.9 1.4 1.5 2.0 2.2 0.3 2.1 3.1 10.9 2.3 0.3 1.7 0.5 0.8 4.8 0.8 2.8 0.7 7.8 0.4 0.4 1.2 1.3 0.7 1.1 4.4 5.0 0.5 0.7 1.5 0.7 0.0 0.0 0.6 0.1 0.1 0.3 0.1 0.0 0.8 0.2 0.2 0.1 0.2 0.8 0.6 0.1 0.1 0.0 0.1 0.0 2.3 0.2 4.5 0.0 1.0 1.0 0.3 13.6 2.8 0.0 0.1 0.3 0.3 1.4 1.6 0.0 0.0 0.4 3.3 0.3 0.0 3.5 0.0 5.7 0.3 0.2 0.0 1.3 0.0 0.0 0.5 0.6 0.7 0.7 0.0 0.1 0.0 0.0 2.1 1.9 0.9 0.0 0.1 0.3 0.0 0.5 5.0 0.4 0.2 0.7 1.1 1.3 0.6 0.6 0.7 1.5 0.8 0.0 0.7 0.2 4.4 1.4 0.7 1.6 2.3 1.4 1.8 2.4 2.4 0.5 0.9 2.0 0.7 NIPSNAP2 GBAS ENSG00000146729 "Nipsnap homolog 2" O75323 7 55951793-56000181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 97.3;skeletal muscle: 144.4" "Cell line enhanced" "Detected in all" "A-431: 78.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063084 Enhanced Supported Mitochondria Mitochondria "HPA063084: " "unprognostic (6.88e-2)" "unprognostic (6.53e-3)" "unprognostic (8.20e-3)" "unprognostic (4.95e-2)" "unprognostic (5.79e-2)" "unprognostic (1.53e-3)" "unprognostic (5.95e-3)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" "unprognostic (6.38e-3)" "unprognostic (2.47e-1)" "unprognostic (1.31e-1)" "prognostic favourable (3.02e-8)" "unprognostic (1.79e-2)" "unprognostic (1.88e-1)" "unprognostic (6.65e-3)" "unprognostic (3.59e-1)" 14.5 19.3 18.4 8.4 22.9 8.6 16.6 11.8 24.5 12.6 14.6 8.9 11.8 8.1 11.0 11.1 12.9 13.4 8.0 97.3 18.7 15.9 16.6 5.2 13.2 16.6 17.0 16.7 9.5 13.5 11.8 8.6 8.0 17.2 14.3 14.2 6.8 18.9 15.5 144.4 6.3 8.3 21.6 19.3 6.5 11.6 5.8 12.1 7.4 22.6 39.8 7.2 12.4 7.8 14.3 34.1 14.1 33.1 15.2 14.1 24.7 78.8 14.0 18.5 30.7 10.7 18.7 9.1 6.6 15.7 19.2 14.9 9.7 17.5 11.6 11.2 12.4 10.5 13.9 14.0 19.1 7.3 20.5 8.2 8.4 12.3 15.4 17.7 8.3 17.0 21.6 6.5 17.9 20.2 14.5 11.4 14.9 3.5 17.6 18.4 18.1 14.2 17.9 8.6 23.7 25.9 12.5 19.8 22.3 15.1 18.3 20.6 35.4 19.2 11.8 8.8 13.3 3.1 13.7 9.4 7.9 21.4 9.7 11.2 25.9 13.4 33.1 14.1 8.7 31.8 10.6 14.3 11.7 9.3 34.1 12.3 14.1 10.1 5.8 15.2 23.9 14.1 13.6 24.7 18.4 22.9 11.8 24.5 18.7 15.9 17.0 16.7 17.2 12.1 NLGN2 KIAA1366 ENSG00000169992 "Neuroligin 2" Q8NFZ4 17 7404874-7419860 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.0" "Cell line enhanced" "Detected in many" "AF22: 26.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Low region specificity" "Detected in all" "HPA055321, HPA069278" Enhanced Approved Mitochondria Mitochondria "HPA055321: , HPA069278: " "unprognostic (1.31e-1)" "unprognostic (1.87e-2)" "unprognostic (4.35e-3)" "unprognostic (2.58e-1)" "unprognostic (1.12e-1)" "unprognostic (9.79e-3)" "unprognostic (2.92e-1)" "unprognostic (1.56e-1)" "unprognostic (6.50e-2)" "unprognostic (2.24e-2)" "unprognostic (5.58e-3)" "unprognostic (1.23e-2)" "prognostic unfavourable (3.44e-4)" "unprognostic (1.69e-1)" "unprognostic (2.85e-1)" "unprognostic (5.50e-3)" "unprognostic (1.81e-2)" 13.0 10.9 31.3 9.9 45.3 2.4 7.4 32.7 47.0 16.9 11.3 18.3 9.5 4.4 25.3 16.4 9.0 13.8 15.5 6.6 28.8 16.0 5.7 3.3 6.2 6.1 13.9 27.5 24.3 7.4 20.7 8.3 8.5 21.3 11.6 5.9 11.2 6.5 19.2 6.3 8.7 5.4 24.3 19.4 7.5 5.9 4.8 15.9 0.0 4.8 1.7 5.0 9.8 11.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 4.2 6.0 26.4 15.2 8.1 11.3 0.6 7.1 11.2 12.1 11.1 1.3 1.5 0.0 3.5 9.8 2.4 4.9 2.9 6.5 6.4 4.9 1.8 5.4 1.0 4.1 1.8 6.5 9.1 2.4 9.9 1.6 4.1 1.7 3.4 5.0 4.0 0.8 1.8 4.5 2.8 7.6 3.2 0.8 3.5 0.9 0.4 10.6 3.3 1.5 1.8 4.3 0.2 5.6 10.4 13.3 6.5 3.4 4.0 1.3 0.7 10.8 1.7 3.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 31.3 45.3 32.7 37.2 28.8 16.0 13.9 27.5 21.3 15.9 NLN "AGTBP, KIAA1226" ENSG00000123213 Neurolysin Q9BYT8 5 65722196-65871725 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 4.7;intermediate monocyte: 5.9;myeloid DC: 4.1;non-classical monocyte: 4.1" "Group enriched" "Detected in many" 5 "dendritic cells: 4.1;monocytes: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031862 Approved Approved Mitochondria 53000 Mitochondria "HPA031862: AB_10600827" "unprognostic (5.91e-3)" "unprognostic (4.52e-2)" "unprognostic (1.34e-3)" "unprognostic (4.37e-2)" "unprognostic (3.85e-1)" "unprognostic (1.45e-2)" "unprognostic (7.29e-3)" "unprognostic (3.24e-2)" "unprognostic (3.19e-1)" "unprognostic (3.58e-1)" "prognostic unfavourable (7.51e-4)" "unprognostic (1.27e-1)" "prognostic favourable (5.58e-7)" "unprognostic (1.52e-2)" "unprognostic (1.98e-1)" "unprognostic (1.29e-1)" "unprognostic (6.18e-3)" 4.5 2.4 7.6 4.7 10.5 2.9 7.3 2.8 11.9 4.1 6.8 5.8 1.0 2.4 5.8 5.0 5.2 3.3 2.7 5.1 7.2 7.6 7.5 18.9 3.4 5.1 8.7 8.5 4.0 11.0 3.6 2.4 4.9 9.8 5.4 6.5 2.0 4.3 2.6 15.0 5.7 5.3 5.5 10.9 5.8 7.5 2.4 6.2 1.8 5.5 7.9 4.0 4.3 3.3 0.9 4.1 0.6 5.9 0.9 0.7 1.8 9.2 8.9 5.3 8.7 6.6 11.4 10.6 9.3 3.9 5.5 6.0 5.0 5.5 13.2 11.8 11.2 7.4 6.8 14.4 9.6 3.9 4.6 3.6 6.6 12.8 5.7 8.3 2.2 8.7 7.9 7.6 9.1 15.5 7.8 2.8 11.8 7.1 5.7 7.5 16.1 2.5 6.7 11.2 20.8 9.0 4.1 16.3 8.5 7.5 7.8 7.7 9.3 9.9 8.9 3.7 4.4 5.3 7.0 2.4 4.8 5.8 5.6 16.3 5.5 0.2 4.7 0.2 0.2 5.9 0.3 0.9 0.4 0.3 4.1 0.9 0.7 0.5 0.6 0.9 4.1 0.2 0.1 1.8 7.6 10.5 2.8 11.9 7.2 7.6 8.7 8.5 9.8 6.2 NLRP4 "CLR19.5, CT58, FLJ32126, NALP4, PAN2, PYPAF4, RNH2" ENSG00000160505 "NLR family pyrin domain containing 4" Q96MN2 19 55836578-55881854 "Predicted intracellular proteins" "Inflammatory response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 9.4;lymphoid tissue: 9.0;testis: 12.1" "Cell line enriched" "Detected in some" 8 "Daudi: 41.8" "Cancer enriched" "Detected in single" 8 "testis cancer: 1.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "naive B-cell: 2.4" "Lineage enriched" "Detected in single" 5 "B-cells: 2.4" HPA062128 Approved Mitochondria Mitochondria "HPA062128: " "unprognostic (2.48e-1)" "unprognostic (7.01e-2)" "unprognostic (4.21e-2)" "unprognostic (1.34e-2)" "unprognostic (3.11e-1)" "unprognostic (1.81e-1)" "unprognostic (2.36e-3)" "unprognostic (3.72e-2)" "unprognostic (2.36e-1)" "unprognostic (3.89e-1)" "unprognostic (2.02e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-2)" 0.2 0.2 1.9 1.0 1.8 0.0 0.2 0.2 2.9 0.2 0.2 2.7 0.0 0.0 0.1 0.2 0.2 0.2 0.1 0.2 1.0 0.3 0.2 0.2 0.2 2.8 5.1 0.6 0.4 0.2 0.1 0.3 0.0 2.9 0.2 0.1 0.0 0.8 0.0 0.2 0.2 0.3 0.1 9.4 0.3 0.2 12.1 2.2 0.0 0.2 0.4 9.0 0.2 0.2 2.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 41.8 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 1.8 0.2 2.9 1.0 0.3 5.1 0.6 2.9 2.2 NME4 "NDPKD, nm23-H4, NM23H4" ENSG00000103202 "NME/NM23 nucleoside diphosphate kinase 4" O00746 16 396725-410367 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid transport, Nucleotide metabolism, Transport" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB045997, HPA072588" Approved Supported Mitochondria Mitochondria "CAB045997: AB_11126630, HPA072588: " "unprognostic (3.27e-1)" "prognostic unfavourable (6.53e-4)" "unprognostic (3.70e-2)" "unprognostic (7.16e-3)" "unprognostic (1.32e-1)" "unprognostic (2.00e-1)" "unprognostic (4.40e-2)" "unprognostic (4.46e-3)" "unprognostic (1.98e-1)" "unprognostic (3.12e-1)" "unprognostic (3.74e-2)" "unprognostic (7.79e-3)" "prognostic unfavourable (1.61e-7)" "unprognostic (3.78e-2)" "unprognostic (2.16e-1)" "unprognostic (6.04e-2)" "unprognostic (3.08e-1)" 34.5 34.4 21.5 13.9 17.6 46.8 34.6 10.4 13.6 25.6 44.6 12.8 40.7 9.7 21.7 33.7 25.1 20.0 39.9 26.9 16.6 16.5 20.2 61.2 13.5 27.5 16.9 11.3 31.9 19.2 22.0 17.3 19.4 11.7 46.9 10.6 32.2 44.4 44.0 13.7 7.5 15.3 83.9 12.4 17.8 27.1 13.3 10.9 19.6 21.0 14.2 14.5 64.1 27.5 13.1 28.6 18.2 6.3 1.2 13.7 5.2 0.1 49.5 44.0 60.4 17.6 31.0 9.8 23.3 28.0 35.3 30.3 33.0 28.8 0.4 17.6 37.1 0.6 23.8 25.0 10.4 19.9 35.5 24.0 6.7 44.0 33.3 17.4 8.8 39.9 13.2 21.6 2.1 22.6 24.8 4.3 26.2 40.5 15.2 22.0 44.8 11.0 76.9 9.8 12.5 24.4 0.2 12.9 69.6 5.9 0.4 21.6 29.4 41.0 28.1 25.2 36.7 16.8 5.8 0.5 0.3 13.1 11.0 3.2 29.0 4.1 6.3 18.2 7.5 5.6 6.5 12.3 7.7 8.3 8.7 13.1 13.7 7.1 2.2 1.2 4.8 28.6 0.4 5.2 21.5 17.6 10.4 13.6 16.6 16.5 16.9 11.3 11.7 10.9 NME7 "CFAP67, FLJ37194, NM23-H7" ENSG00000143156 "NME/NM23 family member 7" Q9Y5B8 1 169132531-169367967 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038014, HPA054289" Uncertain Approved Mitochondria Mitochondria "HPA038014: AB_10673037, HPA054289: " "unprognostic (1.28e-1)" "unprognostic (8.52e-2)" "unprognostic (6.21e-2)" "unprognostic (6.30e-2)" "unprognostic (1.11e-1)" "unprognostic (7.44e-3)" "prognostic unfavourable (3.24e-5)" "unprognostic (1.42e-1)" "unprognostic (1.96e-1)" "unprognostic (2.90e-1)" "unprognostic (1.05e-1)" "unprognostic (2.00e-1)" "unprognostic (6.63e-2)" "unprognostic (2.67e-2)" "unprognostic (1.12e-1)" "unprognostic (7.75e-2)" "unprognostic (2.74e-1)" 7.7 12.1 13.5 8.0 22.8 3.7 12.8 14.6 16.8 15.6 11.5 5.5 13.4 4.6 16.0 15.8 8.6 31.1 11.2 8.4 18.9 11.3 13.9 8.6 8.9 6.0 9.5 11.5 17.0 8.1 18.9 39.9 5.6 15.6 9.6 6.7 9.3 5.9 14.3 5.1 4.9 5.5 17.2 9.5 5.2 8.1 17.2 9.6 11.9 15.9 5.8 7.0 10.0 8.2 8.5 5.2 1.7 7.1 9.1 12.0 4.7 10.5 11.3 12.3 9.6 12.4 12.5 4.4 7.3 11.1 13.3 16.9 6.4 16.0 3.1 13.4 6.5 7.4 6.9 15.8 21.8 11.0 5.7 5.6 10.8 6.5 8.5 10.2 3.6 9.1 9.6 13.4 18.2 19.0 5.3 4.3 13.3 3.4 9.2 7.5 12.1 11.6 7.2 13.3 6.8 21.6 3.1 13.3 19.2 11.1 3.3 8.2 11.4 7.4 11.3 8.3 27.5 7.3 17.7 5.2 8.8 6.5 9.1 3.6 8.2 1.4 3.3 1.7 8.3 5.1 10.1 8.5 10.8 8.8 5.2 7.0 9.3 10.6 1.0 9.1 7.1 4.4 12.0 4.7 13.5 22.8 14.6 16.8 18.9 11.3 9.5 11.5 15.6 9.6 NMNAT3 PNAT3 ENSG00000163864 "Nicotinamide nucleotide adenylyltransferase 3" Q96T66 3 139560180-139678017 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 22.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA039077, HPA057402" Approved Supported Mitochondria Mitochondria "HPA039077: , HPA057402: " "unprognostic (9.45e-3)" "prognostic favourable (9.67e-4)" "unprognostic (2.29e-1)" "unprognostic (1.56e-3)" "unprognostic (2.33e-2)" "unprognostic (2.33e-1)" "unprognostic (2.77e-3)" "unprognostic (6.22e-2)" "unprognostic (9.69e-2)" "unprognostic (1.92e-1)" "prognostic favourable (7.29e-5)" "unprognostic (4.57e-2)" "prognostic favourable (1.95e-5)" "unprognostic (4.13e-2)" "unprognostic (1.63e-1)" "unprognostic (1.44e-1)" "unprognostic (3.07e-1)" 6.2 6.3 9.9 7.0 9.8 14.1 10.8 7.7 9.8 7.4 7.4 6.8 2.7 7.8 7.9 7.3 6.5 11.6 7.9 12.6 11.9 8.1 7.9 6.2 4.7 3.6 7.7 14.0 17.9 10.0 6.2 6.6 1.8 6.7 7.6 6.4 12.7 7.5 4.8 21.9 14.9 6.5 7.3 7.0 4.2 4.8 16.8 8.4 2.4 8.3 9.0 4.8 6.3 6.8 7.2 4.2 11.9 5.0 6.1 5.1 2.1 6.8 2.9 3.3 3.7 0.8 0.7 4.4 2.9 0.3 0.5 0.4 3.9 5.2 4.8 8.7 0.6 3.5 2.2 1.0 0.7 4.3 3.9 22.2 6.3 5.0 1.8 4.2 4.3 1.2 5.8 0.9 1.4 0.4 3.8 10.5 0.5 4.7 3.9 3.7 7.4 2.9 3.5 3.7 3.2 0.9 5.2 7.2 4.4 6.8 3.8 2.5 9.5 11.1 3.9 4.7 10.3 5.6 4.3 17.4 8.3 3.3 3.1 6.7 4.3 11.9 5.0 3.0 4.1 4.5 3.0 3.6 3.6 3.4 3.6 7.2 5.1 5.1 10.8 6.1 4.4 4.2 2.2 2.1 9.9 9.8 7.7 9.8 11.9 8.1 7.7 14.0 6.7 8.4 NNT ENSG00000112992 "Nicotinamide nucleotide transhydrogenase" Q13423 5 43602692-43707405 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004829, CAB004975, HPA066564" Enhanced Approved Mitochondria 1100000 Mitochondria "CAB004975: AB_425908, HPA004829: AB_1079495, HPA066564: " "unprognostic (1.51e-1)" "unprognostic (1.07e-1)" "unprognostic (3.33e-2)" "unprognostic (4.81e-2)" "unprognostic (5.02e-2)" "unprognostic (1.81e-1)" "unprognostic (4.04e-2)" "unprognostic (1.96e-3)" "unprognostic (2.20e-2)" "unprognostic (3.98e-2)" "unprognostic (1.65e-1)" "unprognostic (8.33e-2)" "prognostic favourable (1.22e-15)" "unprognostic (8.24e-2)" "unprognostic (1.11e-1)" "unprognostic (2.76e-2)" "unprognostic (2.58e-1)" 10.8 10.5 11.7 8.3 14.0 7.3 9.1 8.3 19.0 7.6 11.2 7.3 8.8 9.2 7.1 8.8 7.9 5.4 7.1 62.1 10.8 8.2 26.0 48.5 7.2 9.6 9.2 10.3 5.8 12.2 15.6 6.2 5.8 10.0 8.5 12.1 6.7 14.4 7.8 100.0 6.0 8.9 14.7 6.1 6.5 13.6 4.2 6.1 14.0 14.0 32.6 8.7 10.9 6.2 11.4 25.5 13.1 18.5 18.2 19.1 13.5 8.3 6.1 14.2 26.4 16.5 18.4 4.4 8.3 14.2 10.3 9.3 7.1 13.7 8.5 10.4 15.8 7.9 56.2 2.0 10.9 13.5 15.1 12.3 33.0 8.6 9.6 20.6 18.3 15.8 6.3 5.9 8.4 20.3 8.8 34.1 24.4 5.6 22.1 11.1 2.8 5.5 24.8 33.5 30.5 19.5 7.3 21.0 17.4 30.6 0.4 18.9 21.4 20.7 11.1 15.1 14.6 6.3 4.0 18.4 18.9 13.1 3.1 27.4 9.7 9.3 14.2 13.1 14.4 18.4 14.8 11.4 15.6 14.5 25.5 10.3 14.6 13.3 2.4 18.2 18.5 9.2 19.1 13.5 11.7 14.0 8.3 19.0 10.8 8.2 9.2 10.3 10.0 6.1 NOA1 "C4orf14, hAtNOS1, hNOA1, MGC3232, MTG3" ENSG00000084092 "Nitric oxide associated 1" Q8NC60 4 56963370-56978823 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 22.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035838, HPA035839" Approved Supported Mitochondria "Intracellular and membrane" Mitochondria "HPA035838: AB_10669531, HPA035839: AB_10669658" "unprognostic (6.61e-2)" "unprognostic (1.66e-1)" "unprognostic (1.65e-3)" "unprognostic (5.19e-2)" "unprognostic (9.06e-2)" "unprognostic (1.49e-2)" "unprognostic (2.04e-2)" "unprognostic (1.29e-1)" "unprognostic (1.75e-1)" "unprognostic (1.01e-3)" "unprognostic (3.64e-2)" "unprognostic (1.33e-1)" "prognostic favourable (2.38e-4)" "unprognostic (8.97e-2)" "unprognostic (6.87e-2)" "unprognostic (1.79e-2)" "unprognostic (4.27e-2)" 4.5 4.7 2.6 3.0 3.2 5.4 5.3 4.3 2.8 4.3 5.3 7.0 5.9 3.8 6.1 6.0 2.9 3.5 2.5 2.1 3.6 2.8 3.3 5.1 2.1 5.6 13.9 3.6 2.1 2.3 3.8 4.9 5.9 3.7 10.5 6.8 4.9 3.2 2.6 3.8 6.0 1.7 4.0 5.8 6.7 4.5 20.2 16.5 7.0 14.1 20.3 22.3 14.3 7.5 6.9 5.2 9.1 9.5 17.0 14.2 5.9 10.7 6.8 6.9 11.9 14.0 26.8 10.3 5.0 8.1 9.8 10.5 6.5 4.9 12.6 6.7 6.2 12.8 7.4 12.2 7.3 15.8 12.8 6.3 11.1 11.4 11.3 9.7 9.2 10.8 17.4 16.3 6.7 10.7 12.2 5.5 10.1 9.8 11.2 11.9 10.1 6.1 24.8 8.8 11.1 8.7 7.5 5.5 13.3 6.7 11.0 12.5 5.2 14.0 5.7 7.8 7.0 6.2 14.1 7.0 12.2 13.0 18.3 20.2 18.2 15.2 16.5 17.0 22.3 18.4 4.8 20.3 11.2 13.3 21.1 14.3 NOD1 "CARD4, CLR7.1, NLRC1" ENSG00000106100 "Nucleotide binding oligomerization domain containing 1" Q9Y239 7 30424527-30478784 "Predicted intracellular proteins" "Apoptosis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA074367 Approved Mitochondria Mitochondria "HPA074367: " "unprognostic (2.58e-1)" "unprognostic (1.56e-2)" "unprognostic (9.73e-2)" "unprognostic (8.09e-3)" "unprognostic (2.07e-2)" "unprognostic (1.70e-1)" "unprognostic (1.01e-3)" "unprognostic (6.63e-2)" "unprognostic (2.26e-1)" "unprognostic (2.74e-1)" "unprognostic (8.78e-2)" "unprognostic (1.45e-1)" "prognostic unfavourable (6.68e-4)" "unprognostic (6.62e-2)" "unprognostic (1.46e-1)" "prognostic favourable (1.95e-4)" "unprognostic (2.64e-1)" 15.2 3.2 3.9 11.1 3.7 6.6 18.3 2.0 2.4 6.5 6.2 4.3 5.0 2.2 8.7 8.9 6.1 7.3 10.1 10.9 2.9 2.1 5.0 2.9 13.8 6.0 3.2 2.2 13.6 4.6 3.8 4.6 13.3 4.7 5.5 4.7 6.4 7.7 7.6 7.2 7.1 6.2 16.3 4.7 12.4 6.9 3.2 3.5 5.1 27.2 6.4 11.1 7.6 6.1 10.9 8.2 13.3 6.2 8.7 9.8 2.4 4.2 2.2 3.2 9.5 2.1 9.7 4.9 2.9 2.1 5.0 6.4 2.0 5.1 6.0 3.5 3.7 10.0 3.1 5.1 3.4 3.1 2.7 8.5 6.9 2.0 2.6 3.7 6.4 8.9 2.3 3.2 2.8 16.5 4.4 2.1 4.5 2.5 5.3 6.7 3.7 4.0 6.4 3.6 5.4 1.6 3.4 0.6 11.5 3.7 9.7 3.2 3.2 8.5 6.9 4.4 7.3 5.4 4.0 2.0 6.7 0.2 3.2 13.3 4.6 12.7 3.9 13.3 8.8 5.2 9.8 7.6 6.1 5.7 3.4 10.9 5.6 4.5 3.0 8.7 6.2 8.2 4.6 2.4 3.9 3.7 2.0 2.4 2.9 2.1 3.2 2.2 4.7 3.5 NUBPL "C14orf127, FLJ12660, huInd1, IND1" ENSG00000151413 "Nucleotide binding protein like" Q8TB37 14 31489956-31861224 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029203 Approved Approved Mitochondria "Intracellular and membrane" Mitochondria "HPA029203: AB_10602810" "unprognostic (1.49e-1)" "unprognostic (1.71e-2)" "unprognostic (5.21e-3)" "unprognostic (8.28e-2)" "unprognostic (8.25e-2)" "unprognostic (1.94e-3)" "unprognostic (1.67e-1)" "unprognostic (1.93e-2)" "unprognostic (1.15e-1)" "unprognostic (1.35e-1)" "unprognostic (2.15e-1)" "unprognostic (2.80e-1)" "prognostic favourable (3.64e-8)" "unprognostic (2.82e-2)" "unprognostic (6.60e-2)" "unprognostic (3.67e-3)" "unprognostic (1.56e-2)" 12.0 16.0 11.4 11.6 10.7 2.1 12.1 5.7 11.5 7.5 10.1 10.6 9.1 6.6 14.7 13.3 7.6 9.0 7.4 22.5 11.5 9.2 16.5 16.2 10.2 6.9 11.0 8.9 11.3 7.8 14.1 19.0 7.4 12.7 8.9 10.7 10.0 15.4 9.0 16.7 8.1 7.7 11.3 13.5 8.5 8.0 19.2 12.2 6.2 10.8 6.3 8.7 9.7 7.5 4.9 7.5 0.7 2.0 4.1 5.4 1.5 10.3 6.5 5.0 2.5 7.2 13.2 8.7 5.2 6.4 6.7 8.2 4.5 11.9 7.4 7.1 7.0 9.2 6.7 11.5 12.2 5.3 8.5 2.7 4.9 23.1 7.1 7.8 2.4 8.6 13.5 4.7 10.3 3.9 4.8 3.9 7.6 5.6 5.7 5.4 4.1 10.0 6.4 10.3 4.0 8.1 7.7 4.8 4.9 9.0 8.5 11.0 16.7 4.1 3.8 6.8 4.7 4.4 5.2 6.3 6.2 7.3 4.6 5.6 6.1 0.0 2.0 0.6 3.9 2.0 3.1 4.9 4.5 4.2 7.5 2.9 5.4 4.2 0.7 4.1 1.1 3.6 2.5 1.5 11.4 10.7 5.7 11.5 11.5 9.2 11.0 8.9 12.7 12.2 OCIAD1 "Asrij, FLJ20455, OCIA, TPA018" ENSG00000109180 "OCIA domain containing 1" Q9NX40 4 48805212-48861817 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044803 Approved Approved Mitochondria Mitochondria "HPA044803: AB_10961287" "unprognostic (8.18e-2)" "unprognostic (1.60e-2)" "unprognostic (4.82e-2)" "unprognostic (7.39e-2)" "unprognostic (1.69e-1)" "unprognostic (4.17e-2)" "unprognostic (2.53e-1)" "unprognostic (1.60e-1)" "unprognostic (4.10e-1)" "unprognostic (2.83e-3)" "unprognostic (1.34e-1)" "unprognostic (5.42e-2)" "unprognostic (1.47e-3)" "unprognostic (9.23e-2)" "unprognostic (2.86e-1)" "unprognostic (1.56e-1)" "unprognostic (1.16e-2)" 28.8 43.6 59.9 24.7 73.5 21.8 35.9 55.3 82.2 37.4 37.6 36.1 35.4 33.5 34.1 49.3 28.1 41.6 29.9 47.9 62.7 61.9 57.8 79.0 27.7 32.0 51.4 60.7 40.4 34.6 52.4 53.5 29.0 53.6 34.8 39.6 29.1 34.8 36.4 53.5 23.9 30.1 33.4 51.0 23.7 31.0 23.7 35.1 29.1 55.1 37.2 31.0 31.6 24.0 33.2 35.9 30.7 33.6 41.9 43.2 30.0 24.9 18.3 37.8 25.8 37.4 45.2 29.1 40.9 64.0 42.1 49.3 17.9 71.0 28.9 40.9 35.9 21.9 35.7 37.8 51.1 24.0 24.0 45.1 18.6 14.5 55.4 46.4 48.9 48.2 55.4 33.0 40.7 43.0 50.2 16.3 48.8 17.0 39.8 46.4 31.1 17.3 27.8 36.7 30.6 81.5 25.3 22.2 40.8 20.1 15.9 45.2 32.2 40.7 32.5 27.9 32.2 19.2 50.9 42.2 58.4 45.6 33.9 37.3 34.0 17.6 26.0 30.7 30.5 28.5 41.6 33.2 34.7 36.2 32.5 29.3 43.2 37.2 21.2 41.9 33.6 35.9 29.0 30.0 59.9 73.5 55.3 82.2 62.7 61.9 51.4 60.7 53.6 35.1 OCIAD2 MGC45416 ENSG00000145247 "OCIA domain containing 2" Q56VL3 4 48885019-48906937 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 56.5;U-251 MG: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040979, HPA041090" Enhanced Enhanced Mitochondria Mitochondria "HPA040979: AB_10795497, HPA041090: AB_10796236" "unprognostic (4.29e-1)" "unprognostic (2.69e-1)" "unprognostic (3.76e-2)" "prognostic favourable (7.37e-4)" "unprognostic (3.49e-2)" "unprognostic (1.66e-2)" "unprognostic (9.05e-2)" "unprognostic (1.23e-1)" "unprognostic (2.00e-1)" "prognostic favourable (6.56e-4)" "prognostic unfavourable (6.89e-4)" "unprognostic (1.38e-1)" "prognostic favourable (2.67e-5)" "unprognostic (1.10e-1)" "unprognostic (8.54e-2)" "unprognostic (8.24e-3)" "prognostic favourable (2.34e-4)" 4.0 10.7 24.5 15.7 18.3 4.7 8.1 3.7 14.0 7.2 23.0 1.9 14.0 41.6 8.9 19.5 12.4 7.7 22.3 7.2 19.9 11.7 51.6 43.6 6.6 10.7 9.7 9.9 3.7 13.2 9.4 18.7 2.9 8.8 8.8 17.3 6.6 18.3 12.9 1.8 9.0 37.5 5.2 4.1 5.2 27.9 4.1 5.7 24.9 14.9 5.8 13.3 9.3 8.5 29.7 22.9 32.7 0.6 27.1 60.8 26.1 34.6 18.4 0.2 0.0 0.0 0.0 0.5 9.0 4.1 4.9 4.6 0.0 43.0 6.0 40.3 5.1 11.2 5.1 56.5 5.0 14.1 3.8 0.0 13.6 0.0 4.6 16.9 0.0 2.7 25.8 0.0 11.0 20.2 0.0 3.0 5.2 13.0 28.5 11.5 17.7 25.0 6.4 0.0 10.0 50.2 22.8 40.0 12.1 13.0 4.4 0.9 4.5 4.2 33.6 0.0 37.4 0.2 67.1 8.6 9.8 19.1 28.8 0.0 0.0 32.7 0.6 12.4 20.4 0.2 27.0 29.7 38.4 29.2 3.4 27.0 50.2 33.6 2.1 27.1 0.2 22.9 60.8 26.1 24.5 18.3 3.7 14.0 19.9 11.7 9.7 9.9 8.8 5.7 OGDH E1k ENSG00000105953 "Oxoglutarate dehydrogenase" Q02218 7 44606572-44709066 "Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Glycolysis Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 99.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019514, HPA020347" Supported Enhanced Mitochondria 53000 Mitochondria "HPA019514: AB_1854772, HPA020347: AB_1854773" "unprognostic (1.96e-2)" "unprognostic (1.40e-1)" "unprognostic (4.39e-1)" "unprognostic (5.64e-3)" "unprognostic (3.02e-3)" "unprognostic (1.20e-1)" "unprognostic (3.45e-1)" "unprognostic (7.58e-2)" "unprognostic (1.74e-1)" "unprognostic (1.52e-2)" "unprognostic (3.38e-1)" "unprognostic (3.30e-2)" "prognostic favourable (2.22e-14)" "unprognostic (1.53e-1)" "unprognostic (1.62e-1)" "unprognostic (2.23e-2)" "unprognostic (5.88e-3)" 18.9 20.8 12.3 14.5 18.5 8.7 11.0 14.3 23.7 10.1 19.4 15.9 13.5 29.0 16.2 11.1 19.5 11.1 11.8 73.9 11.3 12.8 28.8 14.8 13.0 11.1 14.2 11.7 9.8 13.0 25.5 11.0 14.5 22.2 12.3 13.3 22.3 23.7 15.9 99.3 15.6 35.5 16.4 10.1 12.1 14.9 11.3 11.0 11.3 17.8 39.8 15.8 13.0 10.8 7.2 13.4 7.5 20.4 11.2 25.7 11.6 10.8 22.8 13.7 20.8 21.2 23.3 13.4 17.0 16.6 19.4 16.9 20.8 22.5 47.8 20.2 24.7 33.8 27.0 25.4 18.9 27.9 7.1 14.5 46.2 10.2 10.8 17.9 16.3 21.6 19.3 27.4 19.7 26.2 16.7 14.3 20.4 15.3 17.7 10.3 12.6 25.8 17.0 9.6 53.7 22.2 32.4 23.4 11.2 24.6 34.1 10.6 20.2 18.0 20.6 14.0 12.6 24.2 19.6 13.0 24.9 26.4 25.3 20.3 25.3 4.8 12.1 7.3 11.7 17.7 12.8 7.2 13.5 11.7 13.4 5.9 5.8 7.0 7.5 11.2 20.4 6.6 25.7 11.6 12.3 18.5 14.3 23.7 11.3 12.8 14.2 11.7 22.2 11.0 OSGEPL1 "OSGEPL, Qri7" ENSG00000128694 "O-sialoglycoprotein endopeptidase like 1" Q9H4B0 2 189746660-189763227 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030693 Uncertain Supported Mitochondria Mitochondria "HPA030693: AB_10601978" "unprognostic (1.10e-1)" "unprognostic (8.72e-2)" "unprognostic (8.19e-2)" "unprognostic (6.70e-2)" "unprognostic (6.07e-2)" "unprognostic (6.38e-2)" "prognostic unfavourable (3.71e-4)" "unprognostic (4.18e-3)" "unprognostic (1.06e-3)" "prognostic favourable (3.19e-4)" "unprognostic (2.33e-1)" "unprognostic (1.80e-2)" "unprognostic (3.34e-2)" "unprognostic (2.68e-1)" "unprognostic (1.51e-2)" "unprognostic (6.39e-2)" "unprognostic (1.55e-3)" 6.6 17.0 8.6 6.5 12.1 2.6 11.1 12.9 10.9 7.3 5.6 14.8 2.9 5.0 11.8 9.1 7.0 8.1 4.8 13.0 8.4 7.3 13.0 11.6 5.8 11.2 18.9 9.3 13.8 6.1 7.5 9.8 6.1 11.6 6.9 6.1 9.0 9.7 6.1 16.6 9.2 6.5 8.1 13.4 9.6 5.8 9.4 15.4 10.6 8.2 7.3 9.2 8.0 5.8 9.3 6.0 2.1 2.6 6.6 11.5 3.0 5.7 3.2 14.1 10.8 11.2 6.2 8.4 8.9 6.3 12.7 13.7 3.7 6.0 3.8 10.0 3.7 8.4 12.5 10.6 14.5 9.8 9.6 12.4 7.8 4.8 5.9 7.0 6.5 6.8 9.0 9.6 4.7 9.4 4.5 6.1 8.3 3.2 5.5 8.0 6.8 14.6 6.0 11.3 6.5 8.2 3.2 8.6 9.5 6.0 10.9 19.4 8.5 7.7 3.9 8.3 7.3 12.1 5.5 6.2 5.2 6.2 11.0 9.0 9.0 0.2 2.6 2.1 7.3 2.4 10.5 7.4 7.7 8.4 3.5 9.3 11.5 10.2 0.4 6.6 2.1 6.0 5.9 3.0 8.6 12.1 12.9 10.9 8.4 7.3 18.9 9.3 11.6 15.4 OTC ENSG00000036473 "Ornithine carbamoyltransferase" P00480 X 38352545-38421450 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "intestine: 59.1;liver: 90.3" "Cell line enhanced" "Detected in some" "NB-4: 1.8;RPMI-8226: 1.0;SH-SY5Y: 1.1;SiHa: 1.8" "Cancer enriched" "Detected in some" 20 "liver cancer: 59.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000243, HPA000570" Enhanced Supported Mitochondria 1800000 Mitochondria "HPA000243: AB_1079535, HPA000570: AB_1079534" "unprognostic (6.93e-2)" "unprognostic (2.48e-1)" "unprognostic (1.89e-3)" "unprognostic (4.38e-2)" "unprognostic (3.15e-1)" "unprognostic (1.33e-1)" "unprognostic (4.19e-2)" "unprognostic (7.70e-3)" "unprognostic (5.61e-2)" 0.4 0.1 0.1 0.4 0.2 0.0 0.2 0.1 0.1 0.8 16.5 0.0 0.2 26.9 1.1 0.2 0.2 0.3 5.3 0.2 0.1 0.2 0.1 90.3 0.7 2.3 0.2 0.0 0.2 0.8 0.0 0.1 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.1 0.1 59.1 0.8 0.3 0.1 0.4 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.6 1.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.0 OXA1L "MGC133129, OXA1" ENSG00000155463 "OXA1L, mitochondrial inner membrane protein" Q15070 14 22766522-22773041 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003531 Approved Supported Mitochondria Mitochondria "HPA003531: AB_1079539" "unprognostic (4.04e-3)" "unprognostic (2.41e-2)" "unprognostic (3.39e-1)" "unprognostic (2.24e-2)" "unprognostic (7.25e-2)" "unprognostic (1.42e-2)" "unprognostic (1.08e-2)" "unprognostic (1.06e-2)" "unprognostic (1.92e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (1.78e-1)" "prognostic favourable (4.82e-4)" "unprognostic (8.35e-2)" "unprognostic (1.62e-1)" "unprognostic (4.37e-2)" "unprognostic (1.15e-3)" 27.8 36.0 11.9 21.2 15.5 25.1 28.4 13.5 23.0 25.4 30.9 18.5 24.3 27.2 22.7 23.9 30.2 21.5 30.6 48.3 12.9 13.0 31.9 58.4 25.8 45.0 15.2 10.9 31.4 59.6 30.0 12.3 18.3 17.9 25.3 24.2 28.1 24.9 27.5 76.3 24.9 32.8 23.9 13.5 32.9 29.9 17.0 10.3 32.7 37.3 49.0 38.3 31.3 22.3 22.1 39.9 7.2 29.4 16.3 22.6 19.9 20.9 29.0 13.0 21.8 37.0 55.2 24.1 16.0 33.7 23.3 26.9 21.7 24.0 39.4 21.5 18.6 30.0 25.1 31.1 23.5 16.4 16.2 19.5 20.0 79.3 41.5 36.3 24.3 54.0 34.6 19.2 29.8 66.9 14.4 32.2 25.5 30.8 21.5 14.1 13.2 36.5 22.1 21.6 30.0 29.7 26.3 8.9 17.2 23.2 51.7 30.6 22.1 29.5 21.3 13.9 16.2 25.3 18.3 24.3 19.3 18.5 10.9 21.0 14.9 4.8 27.9 7.2 13.4 29.4 16.3 22.1 19.2 16.9 39.9 21.9 21.9 16.3 6.3 16.3 22.9 11.3 22.6 19.9 11.9 15.5 13.5 23.0 12.9 13.0 15.2 10.9 17.9 10.3 OXCT1 "OXCT, SCOT" ENSG00000083720 "3-oxoacid CoA-transferase 1" P55809 5 41730065-41870519 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 108.8" "Cell line enhanced" "Detected in many" "HeLa: 56.1;SiHa: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012047, HPA061425" Enhanced Enhanced Mitochondria "Intracellular and membrane" 1000000 Mitochondria "HPA012047: AB_1854857, HPA061425: AB_2684515" "unprognostic (4.26e-2)" "unprognostic (2.10e-2)" "unprognostic (2.89e-2)" "unprognostic (1.51e-1)" "unprognostic (5.51e-2)" "unprognostic (1.82e-2)" "prognostic unfavourable (1.03e-4)" "unprognostic (7.42e-3)" "unprognostic (1.74e-3)" "unprognostic (1.67e-1)" "unprognostic (2.80e-2)" "unprognostic (3.62e-1)" "prognostic favourable (1.86e-8)" "unprognostic (2.66e-2)" "unprognostic (9.99e-2)" "unprognostic (5.86e-3)" "unprognostic (2.28e-3)" 21.9 8.0 17.3 7.5 30.3 5.8 9.5 26.6 36.8 6.7 9.2 8.3 10.7 4.4 8.6 8.7 13.1 6.9 7.5 108.8 19.3 15.2 25.3 1.2 4.2 9.5 13.1 25.7 7.2 3.0 20.9 8.4 2.8 21.2 12.5 10.4 6.6 8.5 14.7 13.4 10.7 6.5 17.0 8.9 5.2 14.6 6.2 5.3 22.8 13.0 10.7 11.8 8.0 7.5 8.0 4.6 3.3 1.6 7.5 15.6 5.1 7.8 0.3 6.5 7.7 20.1 10.8 0.0 14.1 8.9 11.7 7.1 1.2 5.4 20.4 3.5 10.7 4.6 17.8 12.7 13.8 17.4 2.0 14.3 56.1 2.6 8.8 27.7 4.8 10.1 3.4 11.5 19.4 10.7 2.9 26.3 13.4 1.0 23.1 1.3 1.4 5.6 18.4 18.2 15.4 9.5 0.6 6.5 6.7 72.9 0.0 8.6 0.1 6.0 6.4 9.3 12.2 15.9 11.3 4.3 3.6 0.8 14.1 20.4 7.1 1.0 1.0 3.3 9.1 1.1 10.9 8.0 9.2 9.8 4.6 6.1 10.8 8.9 0.3 7.5 1.6 1.8 15.6 5.1 17.3 30.3 26.6 36.8 19.3 15.2 13.1 25.7 21.2 5.3 PACS2 "KIAA0602, PACS1L" ENSG00000179364 "Phosphofurin acidic cluster sorting protein 2" Q86VP3 14 105300563-105398147 "Predicted intracellular proteins, Transporters" "Apoptosis, Host-virus interaction" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 65.7;skeletal muscle: 63.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077892 Approved Mitochondria Mitochondria "HPA077892: " "unprognostic (4.31e-2)" "unprognostic (2.61e-1)" "unprognostic (4.53e-2)" "unprognostic (1.24e-1)" "unprognostic (3.09e-2)" "unprognostic (4.08e-2)" "prognostic unfavourable (3.11e-5)" "unprognostic (1.18e-2)" "unprognostic (1.37e-1)" "unprognostic (1.90e-1)" "prognostic favourable (2.95e-4)" "unprognostic (1.49e-1)" "prognostic favourable (1.56e-4)" "unprognostic (2.08e-1)" "unprognostic (3.80e-1)" "unprognostic (2.58e-1)" "unprognostic (1.30e-1)" 15.3 10.8 18.8 7.7 25.5 6.1 13.3 20.5 29.8 8.0 7.7 41.7 6.5 8.4 10.0 8.1 8.9 9.6 8.7 15.1 23.9 18.0 6.8 3.7 9.3 6.1 36.8 13.9 11.8 21.3 10.3 8.1 6.9 26.3 7.6 5.5 6.7 11.8 9.8 63.8 7.2 9.1 8.1 65.7 10.9 7.4 13.4 26.8 2.7 7.1 7.0 4.4 8.3 7.3 0.6 5.4 0.3 4.0 2.1 2.0 0.9 9.1 12.7 11.9 11.2 12.0 11.6 14.2 7.0 8.1 6.0 5.3 5.5 17.4 10.0 11.9 10.6 10.6 7.3 10.0 4.3 12.5 6.0 4.5 5.0 8.1 15.8 3.7 8.3 13.5 9.6 4.2 9.8 10.9 2.8 9.3 5.2 28.7 6.3 5.0 4.6 10.5 14.1 7.2 6.3 5.1 21.1 26.9 14.3 6.7 6.0 10.4 15.2 6.9 16.4 8.9 4.1 14.0 6.9 12.4 8.0 3.7 13.6 6.8 8.6 0.0 1.6 0.2 0.9 2.7 1.7 0.2 0.8 1.0 2.7 0.6 0.3 1.0 0.3 2.1 4.0 5.4 2.0 0.9 18.8 25.5 20.5 18.9 23.9 18.0 36.8 13.9 26.3 26.8 PAGE5 "CT16.1, CT16.2, PAGE-5" ENSG00000158639 "PAGE family member 5" Q96GU1 X 55220355-55224108 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 32.0" "Group enriched" "Detected in some" 164 "Karpas-707: 65.5;U-266/84: 138.3" "Group enriched" "Detected in many" 6 "liver cancer: 5.4;melanoma: 11.8;testis cancer: 6.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.5" "Lineage enriched" "Detected in single" 14 "T-cells: 4.5" "HPA052619, HPA055869" Supported Approved Mitochondria Mitochondria "HPA052619: , HPA055869: " "unprognostic (4.03e-1)" "unprognostic (4.51e-2)" "unprognostic (7.86e-4)" "unprognostic (1.39e-2)" "unprognostic (7.21e-2)" "unprognostic (1.06e-4)" "unprognostic (2.29e-1)" "unprognostic (1.94e-1)" "unprognostic (3.44e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 32.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.0 4.5 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.5 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.6 138.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 4.5 0.3 3.8 1.6 0.0 0.0 0.8 1.4 0.0 0.0 0.0 0.3 3.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAPSS2 ATPSK2 ENSG00000198682 "3'-phosphoadenosine 5'-phosphosulfate synthase 2" O95340 10 87659613-87747705 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 59.2;liver: 49.0" "Cell line enhanced" "Detected in many" "BJ: 34.9;fHDF/TERT166: 88.3;HHSteC: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 5.3;myeloid DC: 2.7;non-classical monocyte: 9.7" "Group enriched" "Detected in many" 7 "dendritic cells: 2.7;monocytes: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071224, HPA075267" Enhanced Approved Mitochondria Mitochondria "HPA071224: , HPA075267: " "unprognostic (3.98e-3)" "unprognostic (7.06e-2)" "unprognostic (4.95e-3)" "unprognostic (1.02e-1)" "unprognostic (2.67e-1)" "unprognostic (1.61e-2)" "unprognostic (4.96e-2)" "unprognostic (1.15e-1)" "prognostic unfavourable (1.33e-6)" "unprognostic (3.50e-2)" "prognostic favourable (6.58e-4)" "unprognostic (1.14e-1)" "unprognostic (4.90e-2)" "unprognostic (6.72e-3)" "unprognostic (1.73e-1)" "prognostic unfavourable (3.21e-5)" "unprognostic (3.46e-3)" 16.0 59.2 3.5 18.1 6.0 0.3 18.1 1.9 4.3 8.6 25.5 2.2 1.9 9.2 4.0 7.0 3.7 5.3 10.7 9.1 3.9 2.1 9.9 49.0 31.3 15.6 4.4 1.6 10.8 21.2 0.4 1.7 19.0 5.2 3.8 21.2 6.2 6.2 2.0 4.8 1.7 19.4 5.5 3.4 2.9 2.9 3.6 4.3 0.8 7.3 6.2 11.0 5.7 5.3 0.0 2.7 0.8 9.7 0.0 0.1 0.8 3.5 3.6 1.1 0.0 25.3 32.3 0.0 34.9 29.9 21.2 15.4 0.1 0.7 0.0 1.8 88.3 1.5 2.6 2.4 24.3 0.0 1.9 1.6 2.6 0.0 38.3 0.0 0.7 11.4 0.0 12.2 1.0 17.7 0.0 16.5 14.9 13.3 0.0 0.1 1.3 4.5 0.0 0.0 0.0 22.1 1.5 0.1 0.3 17.0 0.6 0.2 2.5 0.9 22.0 7.2 4.2 24.4 2.5 0.0 0.1 0.0 3.4 0.0 0.0 0.0 1.4 0.0 0.0 5.3 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.8 0.0 9.7 0.0 0.0 0.8 3.5 6.0 1.9 4.3 3.9 2.1 4.4 1.6 5.2 4.3 PARL "PRO2207, PSARL, PSARL1, RHBDS1" ENSG00000175193 "Presenilin associated rhomboid like" Q9H300 3 183829271-183884933 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA019545 Approved Approved Mitochondria Mitochondria "HPA019545: AB_1855796" "unprognostic (2.10e-1)" "unprognostic (1.53e-3)" "unprognostic (5.88e-2)" "unprognostic (1.17e-2)" "unprognostic (5.76e-2)" "unprognostic (9.55e-2)" "unprognostic (3.17e-3)" "unprognostic (8.97e-2)" "unprognostic (1.81e-1)" "unprognostic (3.62e-3)" "unprognostic (1.52e-1)" "unprognostic (2.13e-2)" "unprognostic (4.28e-2)" "unprognostic (5.49e-2)" "unprognostic (2.58e-1)" "unprognostic (1.73e-1)" "prognostic favourable (9.11e-5)" 24.2 20.6 26.2 19.2 30.1 21.2 30.4 22.1 29.6 22.7 29.0 24.4 19.4 21.5 20.2 43.8 21.4 19.6 21.2 30.9 23.1 23.4 27.0 26.7 20.3 26.5 28.4 20.3 20.3 47.5 22.0 20.6 18.5 19.5 22.1 31.3 25.9 35.1 33.4 41.2 22.3 27.0 38.1 19.4 22.3 24.5 22.2 18.9 22.1 20.7 25.4 24.3 23.2 18.2 21.5 45.4 44.3 50.0 21.5 25.9 35.4 32.1 15.3 11.3 9.6 11.0 12.7 23.5 12.1 16.4 23.3 18.3 46.9 16.8 14.3 26.9 15.3 14.3 18.0 18.6 26.3 20.4 22.1 21.6 10.2 25.6 16.6 21.4 18.3 17.2 23.9 16.3 20.0 16.5 12.2 13.4 19.1 34.8 40.9 52.5 30.3 15.7 18.1 22.1 26.0 21.7 26.9 11.4 16.3 14.4 46.4 29.5 47.7 40.7 9.7 8.7 18.9 17.9 30.7 26.9 18.2 33.0 16.6 21.9 10.4 27.6 50.0 44.3 19.0 35.4 21.7 21.5 21.6 22.1 45.4 19.9 25.9 21.1 14.5 21.5 26.2 27.0 24.4 35.4 26.2 30.1 22.1 29.6 23.1 23.4 28.4 20.3 19.5 18.9 PARP15 "FLJ40597, pART7" ENSG00000173200 "Poly(ADP-ribose) polymerase family member 15" Q460N3 3 122577602-122639047 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 22.9;lymphoid tissue: 40.4" "Cell line enhanced" "Detected in some" "HEL: 10.7;REH: 5.0;THP-1: 5.1;TIME: 12.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 9.3;MAIT T-cell: 6.5;memory B-cell: 11.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 6.4;naive B-cell: 11.9;naive CD4 T-cell: 4.3;naive CD8 T-cell: 5.9;NK-cell: 5.2;T-reg: 4.5" "Group enriched" "Detected in many" 6 "B-cells: 11.9;NK-cells: 5.2;T-cells: 9.3" "Low region specificity" "Detected in many" HPA035757 Approved Mitochondria "Intracellular and membrane" Mitochondria "HPA035757: AB_10669656" "unprognostic (8.19e-3)" "unprognostic (2.88e-3)" "unprognostic (1.12e-1)" "unprognostic (1.18e-3)" "unprognostic (1.22e-1)" "unprognostic (9.01e-5)" "unprognostic (4.79e-2)" "unprognostic (1.83e-2)" "unprognostic (3.91e-2)" "unprognostic (5.40e-2)" "unprognostic (1.61e-1)" "unprognostic (9.63e-2)" "unprognostic (9.24e-7)" "unprognostic (9.03e-2)" "unprognostic (2.07e-2)" "unprognostic (1.52e-1)" "unprognostic (1.22e-2)" 2.4 0.9 0.5 24.5 0.4 9.8 1.3 0.3 0.8 1.2 2.8 1.2 0.5 1.0 1.5 2.3 1.9 1.4 2.8 1.5 0.6 0.5 1.5 1.9 5.6 20.3 0.6 0.6 1.1 2.7 0.0 1.0 1.0 0.6 1.3 2.1 1.8 5.5 0.2 2.6 0.7 22.9 0.9 0.9 40.4 1.7 1.7 0.4 9.4 1.9 1.7 34.8 3.6 1.2 11.9 1.2 1.3 0.6 5.2 9.3 2.7 0.6 0.2 0.5 0.5 0.2 0.3 0.6 0.3 0.2 0.1 0.1 0.3 1.0 0.8 0.6 0.2 0.6 0.1 0.0 0.0 1.9 0.2 10.7 0.8 0.5 0.2 0.7 0.5 2.2 0.1 0.4 0.2 2.4 0.3 2.1 0.0 0.5 3.2 0.7 0.7 0.3 5.0 0.4 0.6 0.0 1.0 0.8 0.5 0.3 0.2 0.3 0.8 5.1 12.7 0.4 1.1 0.5 0.4 1.0 0.7 2.4 0.7 0.3 0.2 1.3 0.2 0.1 9.3 0.5 6.5 11.2 5.0 6.4 0.9 11.9 4.3 5.9 0.7 5.2 0.6 1.2 4.5 2.7 0.5 0.4 0.3 0.8 0.6 0.5 0.6 0.6 0.6 0.4 PC PCB ENSG00000173599 "Pyruvate carboxylase" P11498 11 66848233-66958376 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Gluconeogenesis, Lipid biosynthesis, Lipid metabolism" "Ligase, Multifunctional enzyme" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 41.1;liver: 76.0" "Cell line enhanced" "Detected in many" "HeLa: 27.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 2.6;monocytes: 3.8;T-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033742, HPA043922, HPA058765" Enhanced Enhanced Mitochondria 96000 Mitochondria "CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812" "unprognostic (2.10e-1)" "unprognostic (1.51e-1)" "unprognostic (1.36e-2)" "unprognostic (8.24e-3)" "unprognostic (3.67e-1)" "unprognostic (3.18e-2)" "unprognostic (2.97e-1)" "unprognostic (3.00e-1)" "unprognostic (3.63e-1)" "prognostic unfavourable (7.86e-5)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "prognostic favourable (8.22e-5)" "unprognostic (8.58e-3)" "unprognostic (5.67e-2)" "unprognostic (9.15e-3)" "unprognostic (1.05e-1)" 41.1 10.7 11.1 2.8 14.6 3.1 12.9 13.1 14.9 2.4 3.8 10.7 21.4 5.6 2.1 2.4 5.0 2.7 2.9 4.0 11.3 8.9 18.7 76.0 2.1 1.6 15.5 11.5 4.4 4.3 19.4 4.0 4.1 10.9 5.4 3.1 3.4 24.2 24.4 5.7 2.8 6.7 1.8 9.4 1.5 3.3 6.1 13.1 0.6 4.2 2.5 2.5 2.2 2.1 0.6 2.6 0.0 3.8 0.3 2.9 2.0 2.9 8.9 3.3 8.1 13.7 5.4 3.5 1.8 7.8 3.5 3.4 4.4 3.2 0.0 3.7 2.9 3.8 3.7 20.6 1.0 1.7 5.2 4.4 27.7 17.0 10.7 0.0 5.7 20.6 5.3 2.8 6.4 2.9 8.4 0.0 1.2 19.0 5.0 2.4 6.3 7.4 3.7 6.9 1.8 3.2 0.9 7.2 10.2 17.3 9.2 7.0 7.5 1.2 3.2 3.9 3.6 4.6 2.0 1.9 2.2 0.0 4.0 2.8 3.3 0.0 3.8 0.0 1.2 0.9 1.4 0.2 0.5 1.9 2.6 0.6 2.9 1.6 0.0 0.3 0.5 1.0 1.5 2.0 11.1 14.6 13.1 13.6 11.3 8.9 15.5 11.5 10.9 13.1 PCCA ENSG00000175198 "Propionyl-CoA carboxylase alpha subunit" P05165 13 100089015-100530437 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 106.7" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 53.2;SCLC-21H: 29.5;U-937: 41.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041716, HPA047792" Enhanced Supported Mitochondria 120000 Mitochondria "HPA041716: , HPA047792: " "unprognostic (1.18e-1)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (4.71e-2)" "unprognostic (1.11e-2)" "unprognostic (1.71e-2)" "unprognostic (1.55e-1)" "unprognostic (5.90e-3)" "unprognostic (2.41e-1)" "unprognostic (1.55e-1)" "unprognostic (6.14e-2)" "unprognostic (1.42e-1)" "prognostic favourable (0.00e+0)" "unprognostic (7.08e-2)" "unprognostic (1.12e-1)" "unprognostic (1.18e-1)" "unprognostic (9.32e-2)" 15.6 26.2 9.7 11.3 11.1 3.2 12.0 24.0 10.7 12.0 17.5 12.0 14.3 6.7 16.4 106.7 8.8 8.4 7.6 12.4 9.5 7.5 51.3 44.3 8.1 4.0 11.2 8.2 9.7 12.7 5.5 12.4 10.5 12.6 13.1 13.7 11.7 12.2 10.4 10.7 7.7 7.8 17.0 12.0 8.2 16.1 4.7 10.9 4.2 11.9 5.0 6.9 10.8 8.8 3.7 13.0 1.6 10.8 7.3 6.1 4.7 3.2 5.8 9.6 3.1 9.2 8.0 5.4 3.2 4.8 3.0 2.8 7.2 4.4 0.2 4.9 3.2 3.7 2.8 4.5 5.0 5.3 3.2 7.5 4.1 15.4 5.1 0.3 3.7 7.4 4.8 2.8 4.7 6.2 3.0 4.3 5.5 3.5 0.8 16.9 5.9 2.6 6.6 4.1 5.2 53.2 6.4 29.5 3.5 2.2 12.3 5.4 8.9 13.4 4.5 3.1 2.6 2.1 2.2 4.2 3.8 0.1 6.0 41.0 2.2 1.5 8.5 1.6 4.6 10.3 6.1 3.7 3.0 4.3 13.0 2.6 4.1 5.1 1.3 7.3 10.8 1.1 6.0 4.7 9.7 11.1 24.0 10.7 9.5 7.5 11.2 8.2 12.6 10.9 PCDHB15 PCDH-BETA15 ENSG00000113248 "Protocadherin beta 15" Q9Y5E8 5 141245349-141249365 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 9.2;LHCN-M2: 7.6;WM-115: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "memory CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "HPA007172, CAB026471, HPA074676" Uncertain Approved Mitochondria Mitochondria "CAB026471: , HPA007172: AB_1079576, HPA074676: " "unprognostic (1.39e-1)" "unprognostic (1.58e-1)" "unprognostic (7.37e-3)" "unprognostic (1.75e-1)" "unprognostic (2.06e-2)" "unprognostic (6.19e-2)" "unprognostic (1.60e-1)" "unprognostic (4.12e-2)" "unprognostic (1.87e-2)" "unprognostic (7.58e-2)" "unprognostic (7.01e-2)" "unprognostic (6.00e-2)" "unprognostic (9.37e-2)" "unprognostic (1.08e-2)" "unprognostic (2.02e-1)" "unprognostic (1.08e-1)" "unprognostic (1.59e-1)" 8.6 3.6 7.9 5.5 8.4 0.6 4.0 15.1 17.1 8.5 5.3 8.0 0.3 1.5 12.9 6.0 3.5 7.2 4.7 8.6 5.9 4.1 3.8 2.6 5.4 2.0 4.9 6.0 13.6 5.7 2.7 5.7 3.6 8.9 6.4 2.6 3.7 3.1 5.1 2.9 2.6 2.7 9.1 9.4 5.6 4.8 9.1 7.6 0.0 4.5 4.4 1.6 5.6 5.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.1 9.2 1.1 2.5 2.6 0.1 0.7 1.8 0.1 0.5 0.0 0.5 0.0 1.8 1.4 0.2 0.2 0.0 0.3 0.0 0.0 0.0 1.0 0.3 0.3 0.0 0.0 1.1 2.1 0.1 0.3 0.4 0.1 1.7 7.6 0.0 0.0 0.2 2.2 0.1 0.3 0.6 0.0 0.6 0.0 0.5 1.3 0.3 0.5 2.4 0.4 0.0 0.0 0.7 1.0 2.9 0.1 0.1 1.2 0.0 1.2 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 8.4 15.1 7.3 5.9 4.1 4.9 6.0 8.9 7.6 PCK2 "PEPCK, PEPCK2" ENSG00000100889 "Phosphoenolpyruvate carboxykinase 2, mitochondrial" Q16822 14 24094053-24110598 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Gluconeogenesis "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "intestine: 156.3;liver: 115.1" "Cell line enhanced" "Detected in many" "HHSteC: 34.9;hTCEpi: 33.9;SK-MEL-30: 32.1" "Cancer enhanced" "Detected in all" "liver cancer: 91.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018734, HPA051162, HPA053502" Enhanced Enhanced Mitochondria 3300000 Mitochondria "CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171" "unprognostic (3.38e-2)" "unprognostic (1.13e-1)" "unprognostic (1.50e-2)" "unprognostic (4.07e-1)" "unprognostic (3.11e-1)" "unprognostic (2.10e-1)" "prognostic favourable (2.81e-4)" "unprognostic (3.91e-2)" "unprognostic (1.04e-1)" "unprognostic (2.18e-2)" "unprognostic (1.26e-1)" "unprognostic (3.67e-2)" "unprognostic (1.33e-2)" "unprognostic (2.81e-1)" "unprognostic (3.71e-1)" "unprognostic (2.82e-2)" "unprognostic (1.17e-1)" 8.2 2.5 1.0 4.9 1.9 1.0 4.3 1.3 1.3 1.3 69.7 1.4 6.9 51.8 1.3 8.5 4.5 1.2 4.2 2.6 1.5 1.0 26.4 115.1 6.0 4.4 1.7 1.2 1.8 8.5 3.4 1.7 1.2 1.8 2.0 5.4 1.9 11.5 4.9 1.0 2.7 156.3 1.1 1.7 6.7 3.3 3.9 1.3 1.3 5.8 1.9 4.6 2.8 1.9 8.8 10.8 2.4 15.1 1.5 6.5 3.9 5.4 3.1 0.9 5.8 3.6 3.7 14.8 6.8 8.2 5.7 9.3 5.1 6.3 13.9 0.8 10.5 8.0 6.0 8.8 4.7 7.1 0.2 2.5 1.7 27.2 34.9 4.8 11.0 4.3 33.9 3.6 8.8 4.6 7.1 25.8 2.2 23.7 1.2 2.4 1.0 4.1 2.8 3.4 7.9 1.7 8.5 3.7 5.9 5.2 6.8 32.1 9.1 7.5 0.8 1.2 6.6 1.8 1.9 17.7 5.5 3.4 3.5 7.7 3.0 0.1 8.2 2.4 3.1 15.1 3.4 8.8 3.5 3.5 10.8 6.1 2.2 2.0 1.0 1.5 14.4 1.9 6.5 3.9 1.0 1.9 1.3 1.3 1.5 1.0 1.7 1.2 1.8 1.3 PDCD2L MGC13096 ENSG00000126249 "Programmed cell death 2 like" Q9BRP1 19 34404384-34426168 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA052181 Approved Approved Mitochondria Mitochondria "HPA052181: " "unprognostic (5.39e-2)" "unprognostic (3.48e-1)" "unprognostic (1.51e-1)" "unprognostic (6.99e-2)" "unprognostic (1.07e-1)" "unprognostic (3.22e-1)" "prognostic unfavourable (5.81e-4)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (8.78e-2)" "unprognostic (1.30e-2)" "unprognostic (2.39e-1)" "prognostic unfavourable (1.23e-5)" "unprognostic (1.75e-1)" "unprognostic (1.72e-1)" "unprognostic (3.00e-2)" "unprognostic (5.98e-2)" 6.2 6.6 7.7 7.3 8.9 4.5 6.1 8.8 15.6 5.4 5.8 6.8 6.3 4.6 5.8 6.1 5.8 6.9 6.3 9.3 7.1 7.8 4.5 9.7 4.0 7.1 5.8 6.2 6.9 16.0 4.0 6.8 4.4 5.7 5.7 6.1 5.5 8.9 8.1 26.7 7.4 4.2 5.4 5.8 5.8 7.3 22.9 4.3 6.2 6.1 12.2 7.7 5.3 4.2 9.9 17.4 0.5 3.8 8.5 10.5 4.1 10.7 18.6 2.4 4.5 1.1 2.3 7.4 3.5 2.6 5.9 6.0 17.3 8.0 9.0 15.5 2.0 3.7 9.4 7.9 6.0 13.3 19.5 8.9 2.9 13.5 7.8 17.1 5.0 2.8 7.0 3.4 11.7 6.0 17.7 4.8 5.3 13.8 6.4 6.4 9.1 18.5 9.8 4.2 13.3 7.6 6.3 13.8 4.8 0.3 11.4 6.2 4.9 7.2 3.1 3.9 4.8 4.7 11.7 10.7 16.3 16.4 4.9 15.2 3.2 0.0 2.5 0.0 7.3 3.8 10.0 9.9 7.2 7.0 5.1 7.5 10.5 8.0 0.5 8.5 2.3 17.4 8.1 4.1 7.7 8.9 8.8 15.6 7.1 7.8 5.8 6.2 5.7 4.3 PDHA1 PDHA ENSG00000131828 "Pyruvate dehydrogenase E1 alpha 1 subunit" P08559 X 19343893-19361705 "Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 107.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047487, HPA047864, HPA063053" Approved Supported Mitochondria "Intracellular and membrane" 15000 Mitochondria "HPA047487: , HPA047864: , HPA063053: " "unprognostic (5.71e-3)" "unprognostic (2.46e-3)" "unprognostic (5.71e-2)" "unprognostic (3.36e-3)" "unprognostic (3.12e-2)" "unprognostic (2.27e-2)" "unprognostic (1.37e-2)" "unprognostic (4.28e-1)" "unprognostic (1.01e-1)" "unprognostic (7.01e-3)" "unprognostic (6.90e-2)" "unprognostic (8.68e-2)" "prognostic favourable (1.13e-7)" "unprognostic (3.72e-2)" "unprognostic (3.03e-1)" "unprognostic (1.92e-2)" "unprognostic (9.06e-2)" 22.5 16.1 14.7 11.7 24.3 20.4 14.7 18.6 25.0 12.3 28.6 13.0 27.7 22.7 13.0 21.6 17.2 12.4 11.8 89.3 15.5 12.2 36.6 26.6 10.5 8.9 14.8 19.9 12.2 28.7 25.0 11.6 14.9 19.0 10.8 28.2 12.7 41.8 18.3 107.3 12.7 21.1 21.2 12.7 11.5 24.9 6.3 12.0 11.3 15.0 44.9 14.9 13.1 12.4 39.4 45.1 34.8 46.1 35.5 36.6 31.9 25.7 32.1 23.3 24.5 22.6 17.3 28.6 17.8 15.9 37.0 28.6 45.7 16.6 44.1 13.2 21.4 33.7 71.4 30.9 39.0 14.6 39.8 21.9 55.3 40.2 24.0 34.9 17.9 22.3 28.8 34.1 33.8 22.4 19.2 18.7 25.8 34.1 29.1 35.9 23.7 56.2 30.1 39.0 54.0 63.6 26.4 12.9 13.7 28.4 36.0 32.2 38.0 24.5 13.9 19.1 17.2 52.0 22.5 15.9 16.4 29.2 18.0 24.5 16.5 34.8 35.0 24.2 30.3 46.1 36.6 39.4 29.4 32.8 45.1 29.3 29.0 30.6 6.1 35.5 39.1 29.8 31.1 31.9 14.7 24.3 18.6 25.0 15.5 12.2 14.8 19.9 19.0 12.0 PDHA2 PDHAL ENSG00000163114 "Pyruvate dehydrogenase E1 alpha 2 subunit" P29803 4 95840019-95841474 "Citric acid cycle related proteins, Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 146 "testis: 60.5" "Cell line enhanced" "Detected in single" "BEWO: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047487, HPA047864, HPA063053" Approved Supported Mitochondria Mitochondria "HPA047487: , HPA047864: , HPA063053: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PDP2 "KIAA1348, PPM2B, PPM2C2" ENSG00000172840 "Pyruvate dehyrogenase phosphatase catalytic subunit 2" Q9P2J9 16 66878589-66895754 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019950, HPA062059" Approved Supported Mitochondria Mitochondria "HPA019950: AB_1855156, HPA062059: " "unprognostic (8.42e-2)" "unprognostic (1.09e-1)" "unprognostic (1.19e-2)" "unprognostic (1.31e-1)" "unprognostic (2.31e-2)" "unprognostic (5.44e-2)" "unprognostic (1.17e-1)" "unprognostic (4.90e-3)" "unprognostic (1.57e-1)" "unprognostic (7.24e-2)" "unprognostic (1.03e-1)" "unprognostic (1.39e-1)" "prognostic favourable (9.75e-7)" "unprognostic (1.89e-1)" "unprognostic (5.10e-1)" "unprognostic (3.20e-1)" "unprognostic (6.15e-2)" 10.7 7.2 7.4 3.7 10.5 3.2 8.7 11.5 16.5 4.9 7.5 10.1 5.7 10.4 7.9 7.2 8.9 7.2 6.0 4.8 7.4 7.1 18.1 16.5 8.6 5.0 9.0 9.4 14.9 13.8 12.0 7.0 7.7 16.0 7.8 8.4 8.5 7.1 6.9 6.3 4.7 6.2 4.6 6.3 4.0 6.7 8.6 8.9 4.6 18.0 4.0 5.9 6.3 5.5 3.3 1.3 1.8 0.4 6.1 6.3 2.0 7.2 8.8 5.5 10.7 14.7 7.6 6.9 3.7 14.7 8.8 13.2 17.9 5.1 10.0 5.4 5.3 9.1 15.8 8.5 8.5 2.3 8.0 5.0 4.4 11.6 8.0 6.4 8.9 5.7 6.4 12.4 12.9 3.7 9.6 7.2 7.8 4.7 12.5 4.6 6.4 11.2 12.3 7.6 15.8 4.6 7.7 11.0 6.2 12.1 5.0 4.5 6.6 3.1 3.5 5.4 7.3 3.2 5.5 12.8 11.8 10.0 7.4 5.1 5.3 1.3 0.4 1.8 6.3 0.3 5.2 1.8 3.1 5.1 1.3 3.3 4.5 5.0 1.3 6.1 0.2 0.8 0.9 2.0 7.4 10.5 11.5 16.5 7.4 7.1 9.0 9.4 16.0 8.9 PDPR PDP3 ENSG00000090857 "Pyruvate dehydrogenase phosphatase regulatory subunit" Q8NCN5 16 70113626-70162537 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048092, HPA070386" Uncertain Approved Mitochondria Mitochondria "HPA048092: , HPA070386: " "unprognostic (8.30e-2)" "unprognostic (1.32e-1)" "unprognostic (7.91e-2)" "unprognostic (1.52e-1)" "unprognostic (2.57e-1)" "unprognostic (9.04e-3)" "unprognostic (6.81e-2)" "unprognostic (2.67e-1)" "unprognostic (1.41e-1)" "unprognostic (1.18e-2)" "unprognostic (2.55e-1)" "unprognostic (2.90e-1)" "prognostic favourable (8.36e-4)" "unprognostic (8.85e-2)" "unprognostic (1.96e-2)" "unprognostic (2.17e-1)" "unprognostic (6.24e-2)" 11.9 13.3 12.0 13.3 15.4 14.4 11.6 21.1 16.0 14.0 12.5 23.8 10.4 9.3 18.7 14.5 11.1 12.9 11.7 14.7 9.9 6.7 18.4 7.7 9.8 15.8 10.2 12.6 15.1 13.5 14.2 9.9 10.8 10.7 10.0 12.9 15.4 11.1 17.3 20.9 11.9 13.4 19.7 9.0 14.1 12.0 19.9 10.3 16.0 13.5 9.5 12.6 16.4 10.0 6.0 5.4 5.1 5.0 3.2 7.1 3.1 3.6 10.3 9.7 16.9 16.8 11.4 6.4 5.8 10.4 9.5 7.2 12.9 7.2 7.2 10.2 18.5 14.0 13.9 12.3 11.2 1.8 4.8 18.5 6.3 8.5 4.8 20.5 15.0 14.8 11.5 13.6 12.3 10.0 12.6 3.5 7.8 10.3 12.8 11.2 14.4 5.1 25.4 9.9 7.8 7.0 8.6 4.4 6.5 16.1 3.1 4.3 12.8 6.1 5.8 11.0 14.9 9.3 9.2 8.2 9.0 27.2 4.9 7.0 7.0 5.1 4.9 4.5 5.0 5.0 7.1 3.5 3.9 4.8 5.4 6.0 4.8 5.2 4.1 3.2 4.6 5.2 4.3 3.1 12.0 15.4 21.1 16.0 9.9 6.7 10.2 12.6 10.7 10.3 PGAM5 "BXLBv68, MGC5352" ENSG00000247077 "PGAM family member 5, mitochondrial serine/threonine protein phosphatase" Q96HS1 12 132710819-132722734 "Enzymes, Predicted intracellular proteins" Necrosis Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036978, HPA036979, CAB068215" Enhanced Supported Mitochondria "Intracellular and membrane" Mitochondria "CAB068215: , HPA036978: AB_10964347, HPA036979: AB_10960559" "unprognostic (9.57e-2)" "unprognostic (2.00e-2)" "unprognostic (3.83e-2)" "unprognostic (3.11e-2)" "unprognostic (3.46e-1)" "unprognostic (1.39e-1)" "prognostic unfavourable (1.13e-6)" "unprognostic (3.32e-2)" "unprognostic (1.47e-1)" "unprognostic (5.67e-2)" "unprognostic (1.23e-1)" "unprognostic (6.92e-2)" "unprognostic (6.42e-3)" "unprognostic (1.63e-2)" "unprognostic (1.71e-1)" "unprognostic (1.19e-1)" "unprognostic (5.53e-2)" 12.2 16.5 11.7 14.3 14.0 12.5 18.6 14.6 22.1 8.4 13.9 8.3 9.9 13.6 10.4 9.9 22.0 11.5 13.4 22.6 14.2 12.1 13.9 26.3 8.5 17.6 9.9 11.8 11.9 30.2 8.1 9.6 10.3 10.4 10.1 10.4 8.5 16.0 11.4 27.4 15.2 12.0 10.2 7.5 13.0 11.7 13.6 5.1 17.6 16.3 17.4 14.5 11.6 12.9 4.0 6.7 7.7 3.1 3.3 3.7 1.4 19.1 36.9 7.9 22.2 5.6 4.5 18.5 9.9 6.1 16.7 9.4 46.0 11.1 24.8 18.3 8.5 16.8 37.0 18.6 6.8 12.2 29.1 29.7 17.3 23.9 12.7 28.1 17.4 5.5 13.7 19.4 20.9 12.1 37.2 10.3 6.5 34.7 38.1 28.1 29.9 26.2 29.2 8.8 19.8 10.8 26.6 29.0 16.3 17.1 24.1 10.6 30.4 15.6 10.4 8.5 18.5 17.0 24.0 21.5 31.5 35.6 11.0 23.1 14.2 7.7 2.4 0.7 2.5 2.5 3.7 3.6 2.9 2.8 2.0 4.0 2.9 3.6 2.0 3.3 3.1 6.7 2.0 1.4 11.7 14.0 14.6 22.1 14.2 12.1 9.9 11.8 10.4 5.1 PGM2L1 "BM32A, FLJ32029" ENSG00000165434 "Phosphoglucomutase 2 like 1" Q6PCE3 11 74330318-74398473 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Isomerase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 48.6" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 13.1;LHCN-M2: 15.7;RH-30: 15.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056995, HPA060948" Enhanced Approved Mitochondria 64000 Mitochondria "HPA056995: , HPA060948: " "unprognostic (7.44e-3)" "unprognostic (1.33e-1)" "unprognostic (7.28e-3)" "unprognostic (8.91e-2)" "unprognostic (6.16e-2)" "unprognostic (1.55e-1)" "unprognostic (7.16e-6)" "unprognostic (1.43e-1)" "unprognostic (1.95e-1)" "unprognostic (5.97e-3)" "unprognostic (1.70e-2)" "unprognostic (2.98e-1)" "unprognostic (9.33e-3)" "unprognostic (3.71e-1)" "unprognostic (1.97e-1)" "unprognostic (3.04e-1)" "unprognostic (1.03e-2)" 3.0 4.0 30.6 4.9 19.8 4.0 3.2 6.3 48.6 6.1 4.5 1.3 1.0 2.3 6.1 1.9 2.1 4.7 4.8 1.6 30.1 15.1 2.5 2.1 2.7 4.0 9.7 20.4 1.7 4.4 1.4 4.5 2.1 11.7 3.8 5.1 2.9 3.2 2.5 7.1 1.7 2.6 5.6 2.6 2.5 3.4 2.3 0.3 10.0 4.1 1.3 4.0 5.2 2.6 2.4 1.7 2.5 0.6 3.0 7.5 1.1 2.0 2.9 11.5 2.1 3.5 1.5 0.3 2.7 2.1 2.4 2.6 1.0 5.4 0.2 6.8 1.8 1.0 2.3 0.5 2.3 0.8 1.2 1.6 1.6 0.9 0.4 1.9 2.6 0.8 0.5 5.4 1.0 13.1 2.1 1.4 15.7 0.3 7.4 1.6 2.3 2.6 2.3 15.0 0.1 6.2 0.4 0.5 2.3 4.4 1.0 2.0 0.2 0.3 10.9 5.3 5.0 2.1 2.8 1.9 2.8 0.2 0.5 2.6 1.2 2.5 0.6 1.1 2.1 0.6 2.8 2.4 3.5 2.3 0.5 1.8 3.3 1.9 0.7 3.0 0.3 1.7 7.5 1.1 30.6 19.8 6.3 24.4 30.1 15.1 9.7 20.4 11.7 0.3 PHB2 "Bap37, BCAP37, p22, REA" ENSG00000215021 "Prohibitin 2" Q99623 12 6965327-6970825 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014889, CAB026335, HPA039874" Supported Enhanced Mitochondria 780000 Mitochondria "CAB014889: , CAB026335: AB_2283865, HPA039874: AB_2616448" "unprognostic (4.64e-3)" "unprognostic (4.32e-2)" "unprognostic (9.65e-2)" "prognostic unfavourable (3.80e-4)" "unprognostic (3.07e-3)" "unprognostic (1.67e-1)" "unprognostic (2.53e-1)" "unprognostic (1.62e-1)" "unprognostic (1.98e-1)" "unprognostic (7.18e-2)" "unprognostic (1.46e-1)" "unprognostic (2.85e-1)" "unprognostic (1.04e-1)" "unprognostic (5.65e-2)" "unprognostic (1.07e-1)" "unprognostic (8.17e-2)" "unprognostic (5.61e-2)" 36.2 46.2 20.0 41.5 21.3 33.5 37.1 21.6 29.7 42.7 48.6 19.8 42.8 40.0 46.3 36.2 55.6 37.7 29.1 44.3 17.9 17.2 36.0 72.8 24.0 64.9 18.8 18.8 68.9 92.3 28.0 22.1 27.4 17.2 48.6 39.5 25.8 62.7 29.1 72.9 39.5 46.3 56.0 17.5 36.6 37.5 20.5 19.0 57.2 50.4 77.4 45.7 46.4 39.9 36.4 47.6 20.9 35.9 38.1 41.6 34.4 36.5 35.3 29.6 40.1 24.0 42.0 66.2 25.9 33.4 45.9 36.4 55.7 38.5 76.1 11.4 25.0 29.9 54.1 45.7 37.2 42.2 45.2 40.0 22.9 52.3 40.4 64.4 29.4 43.3 31.2 29.0 63.4 45.0 35.6 17.5 32.3 36.3 59.1 58.9 113.3 31.5 41.5 47.6 47.3 36.7 41.1 15.3 53.0 20.9 59.7 66.9 9.4 51.6 27.1 19.8 32.4 15.6 54.6 17.6 21.3 78.3 26.7 33.6 28.1 20.9 30.0 14.6 30.8 35.9 37.3 36.4 35.3 35.8 47.6 34.8 32.0 31.8 12.4 38.1 30.4 44.4 41.6 34.4 20.0 21.3 21.6 29.7 17.9 17.2 18.8 18.8 17.2 19.0 PHYKPL "AGXT2L2, MGC15875" ENSG00000175309 "5-phosphohydroxy-L-lysine phospho-lyase" Q8IUZ5 5 178208497-178232791 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036461, HPA063608" Approved Approved Mitochondria 190000 Mitochondria "HPA036461: AB_10670717, HPA063608: " "unprognostic (3.29e-3)" "unprognostic (2.60e-1)" "unprognostic (5.51e-2)" "unprognostic (9.75e-2)" "unprognostic (1.28e-1)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "unprognostic (1.06e-2)" "unprognostic (1.68e-2)" "unprognostic (3.29e-1)" "unprognostic (5.38e-2)" "unprognostic (1.02e-3)" "prognostic unfavourable (3.82e-5)" "unprognostic (3.66e-2)" "unprognostic (1.55e-1)" "unprognostic (1.02e-1)" "unprognostic (2.41e-3)" 18.7 13.1 10.5 25.0 10.8 9.8 15.5 8.3 10.9 13.9 24.3 13.4 14.4 15.1 13.5 14.9 10.7 13.6 17.5 15.5 8.9 4.9 18.1 44.4 14.7 16.8 13.7 9.3 13.2 18.0 11.9 11.9 11.8 10.2 12.4 23.9 12.1 12.3 13.7 20.2 7.6 29.8 14.1 10.7 20.2 15.3 16.4 11.7 16.3 16.6 10.5 17.4 14.0 11.8 13.9 32.8 16.7 21.7 10.7 14.0 14.3 5.7 2.4 5.7 2.3 14.4 11.4 8.6 3.6 4.0 4.8 7.7 6.1 7.3 7.5 10.9 11.0 3.7 4.9 9.2 5.6 15.3 4.9 9.6 9.6 4.3 23.4 5.4 6.1 13.1 9.7 6.0 14.8 16.0 6.9 17.3 7.2 8.4 7.5 2.8 1.1 7.9 5.0 2.7 15.0 8.8 5.2 3.5 3.3 5.7 3.3 6.0 3.6 4.4 6.4 5.0 4.6 3.2 3.8 11.1 3.0 4.5 1.4 5.8 3.3 6.3 19.5 16.7 10.0 21.7 10.1 13.9 11.3 11.4 25.2 12.6 14.0 11.3 4.4 10.7 21.3 32.8 12.9 14.3 10.5 10.8 8.3 10.9 8.9 4.9 13.7 9.3 10.2 11.7 PILRB "FDFACT1, FDFACT2" ENSG00000121716 "Paired immunoglobin-like type 2 receptor beta" Q9UKJ0 7 100352176-100367733 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 80.1" "Cell line enhanced" "Detected in all" "SK-BR-3: 79.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 51.1;neutrophil: 34.8" "Group enriched" "Detected in many" 8 "granulocytes: 51.1;monocytes: 16.8" HPA026750 Approved Approved Mitochondria "Intracellular and membrane" Mitochondria "HPA026750: AB_10670828" "unprognostic (8.33e-3)" "unprognostic (9.31e-2)" "unprognostic (1.32e-2)" "unprognostic (9.15e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-1)" "unprognostic (3.62e-2)" "unprognostic (3.17e-1)" "unprognostic (1.20e-1)" "unprognostic (8.76e-2)" "unprognostic (2.54e-2)" "unprognostic (6.27e-2)" "prognostic unfavourable (1.42e-4)" "unprognostic (4.85e-3)" "unprognostic (1.66e-1)" "unprognostic (4.40e-2)" "unprognostic (3.35e-3)" 10.6 11.3 8.2 11.2 8.2 11.2 10.2 25.2 10.3 9.9 8.2 8.2 8.2 11.4 10.3 12.6 8.2 10.0 8.8 8.2 8.2 5.0 18.6 17.6 8.2 13.2 8.2 8.2 12.1 12.9 19.0 27.6 9.8 8.2 13.6 10.2 8.2 12.0 10.7 12.3 15.8 10.1 8.2 10.5 16.7 9.2 80.1 8.2 8.2 18.3 8.2 11.0 9.9 8.2 0.3 4.3 51.1 16.8 4.0 2.9 4.7 13.7 11.6 13.4 23.2 14.9 3.4 13.0 8.3 3.7 5.9 5.8 8.2 16.0 11.2 15.9 4.3 14.8 7.4 8.8 4.1 9.2 10.8 10.4 39.0 7.1 3.3 10.4 26.9 4.3 10.4 8.0 16.4 5.0 11.0 27.4 4.2 18.5 16.3 54.1 5.8 6.2 9.6 3.9 11.4 26.9 22.6 12.5 9.0 7.1 79.5 9.8 13.9 16.1 11.9 21.3 13.6 13.6 10.7 16.5 21.1 13.6 5.9 15.5 12.5 4.1 8.5 51.1 2.9 14.0 1.7 0.1 0.3 1.8 4.3 0.3 0.3 0.7 34.8 4.0 16.8 0.1 0.1 4.7 8.2 8.2 25.2 10.3 8.2 5.0 8.2 8.2 8.2 8.2 PITRM1 "hMP1, KIAA1104, MP1, PreP" ENSG00000107959 "Pitrilysin metallopeptidase 1" Q5JRX3 10 3137728-3172841 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006753, HPA006754" Enhanced Supported Mitochondria Mitochondria "HPA006753: AB_1079624, HPA006754: AB_1079623" "unprognostic (1.83e-3)" "unprognostic (7.01e-3)" "unprognostic (2.19e-1)" "unprognostic (1.69e-1)" "unprognostic (3.20e-2)" "unprognostic (6.67e-2)" "unprognostic (1.55e-1)" "unprognostic (1.78e-1)" "unprognostic (6.31e-2)" "unprognostic (3.41e-1)" "unprognostic (1.00e-2)" "unprognostic (3.32e-1)" "unprognostic (7.10e-2)" "unprognostic (3.99e-1)" "unprognostic (5.80e-2)" "unprognostic (4.76e-3)" "unprognostic (2.08e-2)" 26.7 39.4 22.7 20.4 34.4 31.0 21.5 29.7 47.8 21.6 23.4 29.8 19.1 19.1 27.6 27.2 25.0 21.3 23.7 41.0 22.1 19.3 28.8 47.1 23.6 21.2 22.9 25.6 35.3 25.7 31.2 26.0 17.8 38.8 27.2 22.4 29.2 25.1 23.8 62.0 28.0 25.3 26.3 19.1 18.9 21.6 41.6 20.4 48.6 28.7 33.0 26.8 26.0 22.4 11.5 13.7 6.0 13.9 12.4 13.9 9.1 25.4 20.6 8.2 11.1 23.3 25.3 9.4 37.8 17.6 30.2 16.5 18.6 15.6 12.8 13.2 23.6 19.7 13.1 29.2 22.8 22.1 18.7 18.1 16.9 13.9 13.3 7.0 21.6 20.8 21.7 33.0 18.9 31.4 18.3 16.9 39.9 22.0 17.6 7.3 5.6 25.1 8.7 11.4 18.2 24.0 19.5 10.5 6.4 28.6 21.0 15.9 24.4 8.4 38.5 23.9 6.7 58.4 18.1 13.6 14.2 13.3 36.5 12.9 11.7 6.0 9.4 4.9 13.1 12.0 12.9 11.5 11.3 12.2 13.7 6.8 12.1 13.9 1.4 12.4 13.9 7.6 13.8 9.1 22.7 34.4 29.7 47.8 22.1 19.3 22.9 25.6 38.8 20.4 PJVK DFNB59 ENSG00000204311 Pejvakin Q0ZLH3 2 178451346-178461409 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 6.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 6.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042621 Supported Mitochondria Mitochondria "HPA042621: AB_10797503" "unprognostic (4.01e-2)" "unprognostic (4.28e-2)" "unprognostic (1.58e-2)" "unprognostic (2.64e-1)" "unprognostic (7.21e-3)" "unprognostic (9.36e-2)" "unprognostic (1.22e-1)" "unprognostic (1.14e-1)" "unprognostic (8.60e-3)" "unprognostic (4.57e-2)" "unprognostic (1.90e-3)" "unprognostic (9.13e-2)" "prognostic unfavourable (8.92e-4)" "unprognostic (1.22e-1)" "unprognostic (1.47e-1)" "unprognostic (2.41e-2)" "unprognostic (8.06e-3)" 2.2 1.4 2.5 1.0 3.5 0.7 4.4 1.3 3.7 2.1 1.5 1.2 3.5 0.7 3.5 7.2 2.2 2.6 2.6 1.0 2.7 2.2 2.1 2.2 1.0 1.3 2.8 4.4 7.0 1.0 1.4 3.9 1.0 2.0 2.3 0.9 2.4 2.1 2.7 2.7 3.5 1.3 1.7 2.7 1.0 0.9 35.2 1.3 1.0 2.3 1.7 1.2 1.6 1.2 1.5 6.5 0.6 0.3 0.4 1.3 0.1 0.4 3.1 4.0 3.2 5.4 5.9 2.1 2.5 2.5 2.3 3.5 1.2 5.2 3.6 2.6 1.5 1.5 2.9 1.6 1.5 1.1 1.1 1.1 4.3 0.7 5.2 0.9 0.3 5.5 3.9 2.6 5.6 2.6 0.6 2.2 2.6 0.5 3.4 2.2 4.8 1.3 4.4 3.0 2.1 3.6 1.6 2.8 2.4 1.2 0.6 1.0 1.2 1.0 1.7 2.6 1.0 0.8 0.3 7.3 4.5 1.1 1.2 2.0 1.0 0.0 0.3 0.0 0.3 0.2 0.4 0.8 0.4 0.2 0.1 1.5 1.3 0.7 0.6 0.4 0.0 6.5 0.0 0.1 2.5 3.5 1.3 3.7 2.7 2.2 2.8 4.4 2.0 1.3 PLA2G16 "AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-3, MGC118754." ENSG00000176485 "Phospholipase A2 group XVI" P53816 11 63573195-63616883 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Host-virus interaction, Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 113.6" "Cell line enhanced" "Detected in many" "A549: 32.3;ASC diff: 36.7;CAPAN-2: 59.1;HAP1: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 52.4" "Group enriched" "Detected in many" 5 "dendritic cells: 52.4;T-cells: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058997 Uncertain Uncertain Mitochondria Mitochondria "HPA058997: " "unprognostic (5.18e-2)" "unprognostic (3.67e-2)" "unprognostic (7.92e-2)" "unprognostic (3.89e-2)" "unprognostic (1.94e-1)" "unprognostic (1.78e-1)" "unprognostic (1.13e-1)" "unprognostic (3.06e-2)" "unprognostic (6.97e-2)" "unprognostic (1.14e-1)" "prognostic unfavourable (5.58e-6)" "unprognostic (6.38e-2)" "unprognostic (1.93e-3)" "unprognostic (1.62e-1)" "unprognostic (1.75e-1)" "prognostic favourable (2.54e-5)" "unprognostic (2.35e-1)" 113.6 15.2 32.0 4.4 39.4 1.6 33.9 4.8 30.2 6.1 7.2 46.6 6.1 4.0 5.0 11.5 5.9 13.9 12.9 39.0 37.6 25.2 24.7 28.9 13.5 4.5 58.4 22.2 30.9 13.2 15.1 8.1 16.2 30.5 5.9 3.7 8.8 10.1 13.2 37.8 2.4 7.5 8.0 70.4 6.4 10.2 17.8 48.9 0.1 17.1 11.1 2.3 8.0 4.7 2.1 52.4 0.4 6.2 5.3 16.0 6.4 20.4 32.3 0.9 0.0 36.7 6.3 5.9 0.7 6.5 5.4 2.7 7.3 59.1 0.0 13.6 1.6 1.0 30.6 1.6 4.1 25.2 1.2 0.3 7.8 1.2 21.9 0.0 0.3 3.8 0.1 13.5 0.5 8.5 0.3 2.3 5.7 3.5 0.0 0.1 2.6 10.4 0.0 0.0 2.0 17.1 2.9 0.4 2.4 4.4 12.4 6.7 26.9 1.0 12.5 2.4 0.1 8.2 1.8 9.7 6.3 0.0 9.8 0.0 0.2 0.0 6.2 0.0 16.0 2.4 8.8 2.1 3.7 11.6 1.7 0.3 1.2 9.4 0.4 5.3 0.1 52.4 2.4 6.4 32.0 39.4 4.8 21.9 37.6 25.2 58.4 22.2 30.5 48.9 PLEKHJ1 FLJ10297 ENSG00000104886 "Pleckstrin homology domain containing J1" Q9NW61 19 2230084-2237704 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA048989 Approved Approved Mitochondria Mitochondria "HPA048989: " "unprognostic (5.11e-1)" "unprognostic (4.84e-3)" "unprognostic (2.33e-1)" "unprognostic (9.82e-2)" "unprognostic (1.38e-1)" "unprognostic (7.83e-2)" "unprognostic (2.03e-3)" "unprognostic (2.89e-3)" "unprognostic (1.51e-1)" "unprognostic (1.71e-1)" "unprognostic (9.03e-3)" "unprognostic (3.49e-2)" "prognostic favourable (1.10e-5)" "prognostic favourable (6.99e-4)" "unprognostic (5.67e-2)" "unprognostic (1.15e-1)" "unprognostic (6.26e-3)" 13.6 18.0 15.2 30.2 15.6 18.7 15.7 10.1 22.9 9.5 41.3 10.6 12.0 58.9 10.1 15.7 16.8 9.1 30.0 17.9 14.3 11.9 27.5 21.0 18.2 26.1 14.9 14.5 13.6 36.7 5.0 11.0 14.2 15.8 12.1 19.6 9.6 30.4 12.1 43.6 13.9 51.4 11.3 9.3 18.4 35.5 29.0 10.0 18.5 24.3 17.7 16.3 10.2 11.8 47.3 55.9 43.2 34.7 16.9 38.0 30.8 26.2 10.9 19.9 24.2 6.5 8.5 11.8 14.8 6.9 15.9 14.5 27.9 12.4 24.9 12.4 10.1 20.5 19.0 9.7 4.8 25.3 24.0 13.0 12.1 36.4 10.4 27.6 20.2 12.4 10.1 7.6 6.9 10.1 27.5 29.6 11.5 17.3 26.7 24.7 35.8 14.9 32.1 13.9 30.5 16.2 26.3 50.2 27.6 9.3 17.2 29.0 22.8 27.5 10.7 6.8 20.3 20.3 16.0 43.4 26.6 28.0 20.1 26.7 8.6 23.8 27.4 43.2 32.8 33.0 28.7 42.5 32.3 34.0 28.4 47.3 26.5 25.7 23.2 16.9 34.7 55.9 38.0 30.8 15.2 15.6 10.1 22.9 14.3 11.9 14.9 14.5 15.8 10.0 PLEKHO1 "CKIP-1, OC120" ENSG00000023902 "Pleckstrin homology domain containing O1" Q53GL0 1 150149183-150164720 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 60.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061018 Supported Mitochondria Mitochondria "HPA061018: " "unprognostic (1.41e-2)" "unprognostic (7.04e-3)" "unprognostic (2.01e-2)" "unprognostic (1.78e-2)" "unprognostic (3.23e-2)" "unprognostic (4.77e-2)" "unprognostic (1.62e-2)" "unprognostic (8.33e-2)" "unprognostic (3.84e-2)" "unprognostic (3.18e-2)" "unprognostic (8.71e-2)" "unprognostic (3.21e-1)" "prognostic unfavourable (6.47e-11)" "unprognostic (9.30e-2)" "unprognostic (1.72e-1)" "unprognostic (1.87e-1)" "unprognostic (6.52e-2)" 10.9 17.0 14.2 34.4 22.1 10.2 10.5 17.0 14.4 9.6 44.5 5.4 6.4 11.8 16.9 7.7 16.8 11.9 14.1 17.8 10.2 6.9 5.8 5.8 12.9 29.0 8.2 13.1 13.5 2.5 1.4 3.5 10.1 8.0 18.2 8.3 7.9 4.7 12.1 15.8 3.6 17.4 60.7 6.5 29.4 22.3 24.8 7.3 15.0 3.8 3.1 17.4 29.3 17.7 11.0 16.0 18.7 15.8 2.1 5.1 5.4 5.1 1.2 17.2 13.4 5.5 4.9 1.4 8.9 12.3 12.1 10.7 0.3 0.1 0.1 1.7 10.4 0.4 8.6 0.4 3.9 30.6 4.3 0.9 0.7 3.1 10.5 7.0 29.1 7.2 0.4 15.0 2.3 11.4 1.9 13.4 16.4 2.3 26.7 13.9 16.1 2.3 24.2 9.3 5.8 2.0 1.4 10.8 17.6 0.7 0.0 6.7 0.9 7.0 15.9 8.0 9.1 8.2 10.6 5.1 0.1 3.2 31.8 0.0 3.0 1.5 15.8 0.3 3.5 14.1 3.8 11.0 5.1 3.7 11.7 10.5 3.5 3.0 18.7 2.1 12.8 16.0 3.7 5.4 14.2 22.1 17.0 14.4 10.2 6.9 8.2 13.1 8.0 7.3 PLGRKT "AD025, C9orf46, FLJ14688, MDS030, Plg-RKT" ENSG00000107020 "Plasminogen receptor with a C-terminal lysine" Q9HBL7 9 5357973-5437878 "Predicted intracellular proteins" "Chemotaxis, Inflammatory response, Plasminogen activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 72.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008214, HPA011144" Supported Uncertain Mitochondria Mitochondria "HPA008214: AB_1078363, HPA011144: AB_1078364" "prognostic favourable (5.56e-4)" "unprognostic (5.31e-2)" "unprognostic (2.96e-2)" "unprognostic (9.67e-2)" "unprognostic (1.05e-1)" "unprognostic (2.12e-2)" "unprognostic (1.72e-1)" "unprognostic (1.89e-2)" "unprognostic (3.85e-2)" "unprognostic (5.45e-3)" "unprognostic (2.19e-2)" "unprognostic (1.84e-1)" "prognostic favourable (5.09e-5)" "unprognostic (1.45e-2)" "unprognostic (1.47e-1)" "unprognostic (1.01e-1)" "unprognostic (2.02e-1)" 11.3 15.6 10.6 12.9 12.1 6.8 15.5 8.7 17.6 11.4 24.0 12.6 11.8 25.6 9.6 17.3 16.4 11.9 9.3 34.5 8.9 7.5 23.1 13.9 13.3 36.5 9.9 9.8 9.2 10.9 7.8 10.1 16.7 14.1 10.6 28.4 13.1 10.7 10.5 30.5 12.1 20.6 15.6 13.3 12.0 11.9 7.4 10.1 18.2 15.2 26.3 14.8 10.7 9.9 14.1 12.9 59.3 7.2 14.1 21.4 13.5 16.0 4.6 9.7 7.0 6.3 8.8 0.0 7.8 8.8 6.8 7.9 0.0 7.3 3.7 4.2 5.9 3.8 6.6 21.7 14.4 72.8 4.2 28.8 3.9 5.1 13.7 8.6 6.9 9.6 7.9 6.3 13.1 9.7 1.6 26.2 16.5 3.5 9.2 9.8 6.3 2.7 5.9 4.8 11.7 15.5 3.4 7.7 10.1 7.8 12.4 14.8 10.0 12.2 6.9 8.7 10.7 7.5 15.2 5.0 7.2 7.5 15.1 5.5 4.8 59.3 5.7 10.7 13.6 7.2 16.9 14.1 17.3 17.9 8.1 11.8 16.7 16.5 6.7 14.1 4.8 12.9 21.4 13.5 10.6 12.1 8.7 17.6 8.9 7.5 9.9 9.8 14.1 10.1 PLPP2 "LPP2, PAP-2c, PPAP2C" ENSG00000141934 "Phospholipid phosphatase 2" O43688 19 281040-291504 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 38.3;CAPAN-2: 41.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 4.4;MAIT T-cell: 9.4" "Lineage enriched" "Detected in single" 52 "T-cells: 9.4" "Low region specificity" "Detected in many" HPA055540 Uncertain Approved Mitochondria Mitochondria "HPA055540: " "prognostic unfavourable (4.55e-4)" "unprognostic (8.91e-3)" "unprognostic (1.06e-1)" "prognostic favourable (3.21e-8)" "unprognostic (2.95e-1)" "unprognostic (1.36e-1)" "unprognostic (3.83e-3)" "unprognostic (5.48e-2)" "unprognostic (1.59e-1)" "unprognostic (5.67e-2)" "unprognostic (1.18e-3)" "unprognostic (3.85e-1)" "unprognostic (3.53e-3)" "unprognostic (1.06e-2)" "unprognostic (1.71e-1)" "unprognostic (1.30e-3)" "unprognostic (1.36e-3)" 1.4 4.7 8.3 5.3 20.9 0.2 17.5 2.0 11.1 30.4 18.2 28.1 13.4 27.5 7.7 4.1 9.1 38.1 31.2 1.5 13.6 7.1 4.7 1.1 3.7 0.8 37.1 6.5 2.4 19.8 0.6 4.1 1.8 16.6 10.7 15.3 6.7 45.8 19.0 0.3 19.0 21.9 3.3 26.0 1.4 22.2 2.2 25.8 0.7 2.2 5.9 5.0 12.1 5.7 0.0 0.1 0.1 0.0 0.0 9.4 0.3 22.5 38.3 0.5 0.0 0.0 0.1 0.0 2.2 0.0 7.1 5.5 11.0 41.6 0.0 24.5 3.3 12.5 0.0 4.9 3.2 0.2 0.7 0.0 15.4 0.0 8.5 0.0 1.5 1.5 2.1 3.6 4.9 1.2 0.1 0.0 0.0 25.6 0.1 0.0 17.0 0.0 0.0 0.0 0.6 17.9 3.6 4.8 11.5 6.3 10.5 16.5 13.8 0.7 1.2 15.6 10.3 0.1 16.6 0.2 26.2 18.5 4.4 0.0 12.8 0.0 0.0 0.0 4.4 0.0 9.4 0.0 2.0 2.2 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 8.3 20.9 2.0 11.1 13.6 7.1 37.1 6.5 16.6 25.8 PLSCR3 ENSG00000187838 "Phospholipid scramblase 3" Q9NRY6 17 7389727-7394843 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048387, HPA068609" Supported Supported Mitochondria Mitochondria "HPA048387: , HPA068609: " "unprognostic (1.86e-2)" "unprognostic (5.29e-2)" "unprognostic (2.29e-2)" "unprognostic (1.56e-2)" "unprognostic (4.36e-2)" "unprognostic (5.02e-2)" "unprognostic (2.27e-2)" "unprognostic (9.71e-2)" "unprognostic (1.75e-3)" "unprognostic (1.91e-1)" "unprognostic (1.11e-2)" "unprognostic (1.77e-2)" "unprognostic (2.11e-5)" "unprognostic (1.24e-2)" "unprognostic (1.48e-1)" "unprognostic (1.97e-1)" "unprognostic (2.55e-2)" 21.9 11.5 6.2 17.8 6.1 5.2 31.0 4.4 7.9 24.0 12.7 7.4 16.3 5.6 29.2 22.0 21.6 15.6 17.7 25.3 5.6 5.7 15.3 12.9 25.0 67.2 5.8 7.6 19.9 10.0 10.1 9.0 17.3 8.4 15.4 6.3 10.2 12.5 17.8 16.1 17.8 10.5 21.4 13.1 29.0 11.6 8.6 6.4 12.1 12.2 26.0 21.0 21.5 20.1 12.9 9.5 1.9 13.3 6.6 30.8 12.1 14.2 3.2 2.7 8.4 10.3 18.1 3.6 13.0 11.9 11.1 10.4 4.9 3.3 3.6 10.6 18.6 19.5 3.4 21.2 5.6 9.8 1.9 3.4 4.3 3.4 13.9 1.2 4.5 13.1 14.4 11.1 16.7 17.1 2.0 2.8 14.4 7.3 3.8 1.0 2.5 9.2 7.8 2.3 3.8 10.4 9.2 2.4 8.1 6.6 4.8 3.0 8.2 0.6 27.8 7.6 7.8 8.7 5.4 3.2 3.6 1.4 11.9 4.3 8.8 1.9 10.0 1.1 16.8 13.3 17.1 12.9 30.5 17.1 9.5 12.0 25.2 15.0 1.0 6.6 10.9 1.1 30.8 12.1 6.2 6.1 4.4 7.9 5.6 5.7 5.8 7.6 8.4 6.4 PLXNC1 "CD232, VESPR" ENSG00000136040 "Plexin C1" O60486 12 94148723-94307675 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 43.5;retina: 40.6" "Cell line enhanced" "Detected in many" "HAP1: 14.9;SK-MEL-30: 18.5;U-266/70: 29.4;U-266/84: 30.6" "Cancer enhanced" "Detected in all" "melanoma: 24.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.2" "Group enriched" "Detected in many" 4 "granulocytes: 14.2;monocytes: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026155, HPA066899" Uncertain Approved Mitochondria 82000 Mitochondria "CAB026155: , HPA066899: " "unprognostic (1.49e-1)" "unprognostic (4.01e-2)" "unprognostic (5.60e-2)" "unprognostic (1.99e-1)" "unprognostic (2.33e-1)" "unprognostic (3.24e-2)" "unprognostic (4.67e-3)" "unprognostic (2.80e-2)" "unprognostic (3.49e-1)" "unprognostic (4.64e-2)" "unprognostic (1.78e-2)" "unprognostic (2.38e-1)" "unprognostic (4.02e-2)" "unprognostic (5.33e-3)" "unprognostic (3.19e-2)" "unprognostic (6.85e-3)" "unprognostic (5.48e-2)" 6.6 7.5 7.1 16.1 6.9 12.6 3.9 16.8 8.6 8.0 5.1 3.1 0.8 3.1 7.3 2.2 4.9 4.3 8.3 4.1 6.3 15.2 3.2 2.0 15.2 43.5 4.5 7.7 13.0 2.3 0.5 6.3 7.5 5.2 4.3 5.4 40.6 3.7 3.7 2.9 6.6 5.0 5.7 4.9 28.6 3.4 12.1 3.3 8.6 3.3 2.7 10.2 9.6 6.5 2.4 2.5 14.2 6.7 0.9 1.7 1.5 0.4 0.2 1.2 0.2 0.7 0.5 0.1 0.6 0.8 0.8 2.3 4.0 0.0 9.5 0.0 0.9 0.0 14.9 0.6 0.5 6.6 0.3 0.5 0.2 2.7 8.3 1.9 3.3 8.2 0.0 0.9 0.4 0.0 0.2 11.7 0.2 0.1 0.4 1.0 2.5 0.5 1.5 0.4 5.2 0.0 0.7 1.0 0.7 0.1 0.1 18.5 0.0 1.6 0.3 0.2 1.1 0.1 0.3 29.4 30.6 0.6 0.1 5.2 0.6 0.0 3.0 12.2 1.4 5.2 1.6 2.4 1.6 1.7 2.5 1.4 1.4 1.5 14.2 0.9 6.7 0.9 1.0 1.5 7.1 6.9 16.8 8.6 6.3 15.2 4.5 7.7 5.2 3.3 PMPCA "Alpha-MPP, INPP5E, KIAA0123" ENSG00000165688 "Peptidase, mitochondrial processing alpha subunit" Q10713 9 136410570-136423761 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021648, HPA063735" Supported Enhanced Mitochondria 6500 Mitochondria "HPA021648: AB_1855491, HPA063735: AB_2685108" "unprognostic (9.80e-2)" "unprognostic (1.96e-2)" "unprognostic (4.03e-1)" "unprognostic (1.69e-2)" "unprognostic (4.01e-2)" "unprognostic (8.19e-2)" "unprognostic (6.09e-2)" "unprognostic (1.19e-2)" "unprognostic (1.97e-1)" "unprognostic (3.32e-2)" "prognostic favourable (8.00e-5)" "unprognostic (9.47e-3)" "prognostic favourable (2.14e-6)" "unprognostic (4.27e-3)" "unprognostic (1.57e-2)" "unprognostic (2.40e-1)" "unprognostic (3.54e-2)" 15.2 27.3 19.8 14.6 23.8 20.1 13.2 20.3 24.3 12.3 15.1 13.0 10.4 18.6 14.2 14.1 16.5 13.6 14.9 37.0 15.6 14.8 17.0 48.3 12.3 18.4 15.2 21.9 15.5 18.2 14.7 19.5 15.6 16.8 15.2 11.9 12.8 20.3 17.1 56.7 17.5 17.0 13.8 14.1 18.9 16.3 23.2 12.5 14.0 15.0 19.8 15.3 13.1 13.4 25.5 30.1 17.0 25.1 32.1 30.8 28.2 14.3 26.9 12.9 26.0 9.8 14.3 19.8 15.0 12.1 21.0 15.3 30.7 17.2 20.1 15.8 15.2 33.6 23.8 22.0 9.3 28.9 28.8 16.2 34.7 37.1 17.3 21.0 14.1 21.0 15.2 16.3 8.4 17.7 41.0 13.3 13.0 39.8 19.8 27.1 26.3 25.5 24.7 18.3 44.5 14.4 10.3 26.5 17.4 20.2 28.8 17.5 39.2 28.7 14.6 15.0 16.1 12.3 19.0 8.2 10.9 21.7 19.7 18.4 13.4 15.4 25.1 17.0 27.2 24.4 26.4 25.5 25.7 29.3 30.1 23.7 30.8 26.9 5.9 32.1 23.2 15.3 24.3 28.2 19.8 23.8 20.3 24.3 15.6 14.8 15.2 21.9 16.8 12.5 PMPCB "MPPB, MPPP52" ENSG00000105819 "Peptidase, mitochondrial processing beta subunit" O75439 7 103297422-103329511 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040674, HPA074168" Approved Enhanced Mitochondria 57000 Mitochondria "HPA040674: AB_10961998, HPA074168: " "prognostic favourable (2.79e-4)" "unprognostic (3.11e-1)" "unprognostic (7.18e-3)" "unprognostic (3.03e-1)" "unprognostic (3.65e-2)" "unprognostic (1.72e-1)" "unprognostic (1.06e-1)" "unprognostic (7.67e-2)" "unprognostic (7.74e-2)" "unprognostic (1.21e-1)" "unprognostic (1.38e-1)" "unprognostic (1.42e-3)" "prognostic favourable (2.95e-8)" "unprognostic (2.59e-2)" "unprognostic (9.79e-2)" "unprognostic (2.40e-1)" "unprognostic (4.39e-2)" 29.1 41.8 31.8 23.0 34.3 41.5 31.6 41.1 38.4 29.0 26.9 21.6 28.2 35.1 32.0 25.9 27.9 26.9 23.5 41.4 27.7 20.1 45.9 47.2 21.9 31.3 32.6 35.0 36.8 40.6 41.1 33.9 24.8 34.2 31.6 31.5 20.8 30.6 31.0 31.5 31.6 31.0 25.7 27.8 27.9 33.6 31.3 35.9 37.2 33.2 24.2 30.0 30.7 27.9 19.5 18.4 9.7 16.1 12.9 21.9 15.7 12.1 17.6 20.8 27.9 12.6 25.6 15.7 11.3 19.5 22.9 27.3 18.8 14.0 31.3 18.2 19.3 15.8 24.9 18.2 21.9 10.9 29.7 10.8 30.2 25.0 15.4 14.8 12.8 23.4 17.0 17.9 17.3 12.1 20.9 31.8 20.9 28.3 24.6 35.0 25.4 22.1 17.2 14.5 31.8 21.5 21.8 26.1 31.9 15.3 45.2 22.3 18.5 19.9 10.0 20.3 24.3 36.0 21.0 24.4 31.2 24.0 15.0 24.0 15.9 9.7 14.1 9.3 14.7 16.1 16.1 19.5 17.1 14.7 18.4 14.3 21.5 17.4 4.4 12.9 13.6 9.4 21.9 15.7 31.8 34.3 41.1 38.4 27.7 20.1 32.6 35.0 34.2 35.9 PNKD "BRP17, DKFZp564N1362, DYT8, FKSG19, FPD1, KIAA1184, KIPP1184, MGC31943, MR-1, PDC, PKND1, TAHCCP2" ENSG00000127838 "Paroxysmal nonkinesigenic dyskinesia" Q8N490 2 218270392-218346793 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010134, HPA017068" Approved Enhanced Mitochondria 31000 Mitochondria "HPA010134: AB_1079645, HPA017068: AB_1855495" "unprognostic (3.15e-3)" "unprognostic (1.80e-2)" "unprognostic (5.86e-3)" "unprognostic (1.89e-2)" "unprognostic (1.90e-1)" "unprognostic (1.60e-1)" "unprognostic (3.81e-2)" "unprognostic (1.54e-1)" "unprognostic (1.37e-1)" "unprognostic (7.51e-2)" "unprognostic (3.29e-1)" "unprognostic (7.67e-2)" "prognostic unfavourable (5.13e-5)" "unprognostic (7.98e-2)" "unprognostic (2.17e-1)" "unprognostic (9.61e-2)" "unprognostic (1.44e-3)" 21.8 28.3 33.2 15.9 41.0 13.4 16.4 26.6 51.1 29.8 27.5 14.3 28.9 18.1 14.6 37.0 13.3 28.3 30.4 37.3 31.0 26.5 42.4 107.0 23.4 34.2 33.2 23.6 18.1 18.8 22.3 15.6 28.1 26.8 34.8 25.1 15.9 27.3 27.1 33.8 12.9 15.9 16.6 25.7 18.0 29.5 23.3 20.6 11.6 29.7 15.3 16.3 19.0 13.4 64.0 32.7 44.9 35.4 38.4 43.3 38.9 15.2 20.0 14.7 23.0 22.1 18.7 27.1 9.6 20.8 22.8 25.7 32.8 15.1 17.9 19.3 16.0 15.8 28.2 18.0 16.1 37.1 35.2 26.0 36.6 48.4 24.2 16.8 11.6 25.4 17.8 15.6 4.5 24.6 19.1 23.3 20.2 43.7 21.8 40.1 14.6 20.5 21.5 14.8 14.9 26.2 23.2 14.2 12.0 6.9 46.9 27.3 15.6 16.3 15.2 9.5 16.3 11.2 13.0 9.7 9.9 19.2 24.2 27.7 11.4 33.7 35.4 44.9 32.1 34.1 30.4 64.0 35.1 38.3 32.7 52.0 38.8 37.3 9.8 38.4 31.0 30.4 43.3 38.9 33.2 41.0 26.6 51.1 31.0 26.5 33.2 23.6 26.8 20.6 PNPT1 "DFNB70, old-35, OLD35, PNPase" ENSG00000138035 "Polyribonucleotide nucleotidyltransferase 1" Q8TCS8 2 55634265-55693910 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, Transport" "Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, RNA-binding, Transferase" "Deafness, Disease mutation, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033424, HPA034602, HPA034603" Supported Enhanced Mitochondria Mitochondria "CAB033424: AB_2299801, HPA034602: AB_2674243, HPA034603: AB_10603130" "unprognostic (9.09e-2)" "unprognostic (7.40e-2)" "unprognostic (2.30e-1)" "prognostic unfavourable (5.57e-4)" "unprognostic (3.40e-2)" "unprognostic (1.03e-2)" "prognostic unfavourable (1.95e-7)" "unprognostic (1.88e-1)" "unprognostic (5.93e-3)" "unprognostic (5.23e-2)" "prognostic unfavourable (5.44e-5)" "unprognostic (2.19e-2)" "unprognostic (2.11e-2)" "unprognostic (6.92e-2)" "unprognostic (1.94e-1)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" 11.1 11.7 13.3 6.5 21.7 11.7 10.8 13.3 18.8 5.7 8.2 12.8 5.4 5.7 8.3 8.8 9.5 7.9 5.8 11.0 12.4 10.9 9.8 11.4 9.1 7.1 24.1 7.4 6.9 9.1 7.4 14.3 5.1 15.2 7.7 10.1 4.2 9.0 6.3 23.5 10.1 7.0 7.9 17.6 10.4 7.6 13.5 22.5 9.6 10.0 7.8 5.9 5.3 7.4 9.8 7.4 6.1 6.5 3.8 8.6 4.7 6.7 3.6 5.0 2.3 3.6 6.3 6.7 10.0 6.1 15.9 10.7 10.5 3.2 14.1 4.2 4.7 5.4 6.4 7.8 7.4 5.0 14.2 8.1 4.6 5.3 9.5 18.3 5.5 7.0 5.4 6.6 5.7 4.9 8.5 3.2 6.3 3.8 11.2 12.8 12.1 6.1 11.1 8.4 12.4 6.7 4.2 12.2 7.3 3.6 11.1 12.2 3.0 8.1 5.1 3.8 3.2 3.3 10.2 14.3 1.1 3.0 7.2 16.0 6.4 4.2 6.5 6.1 8.1 5.7 4.8 5.4 3.7 8.6 2.8 9.8 6.9 7.9 6.1 3.8 5.1 7.4 2.4 4.7 13.3 21.7 13.3 18.8 12.4 10.9 24.1 7.4 15.2 22.5 POLDIP2 "DKFZP586F1524, PDIP38" ENSG00000004142 "DNA polymerase delta interacting protein 2" Q9Y2S7 17 28347177-28357522 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 113.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007700 Approved Mitochondria Mitochondria "HPA007700: " "unprognostic (5.71e-2)" "unprognostic (4.04e-1)" "unprognostic (2.03e-2)" "unprognostic (2.07e-2)" "unprognostic (3.23e-1)" "unprognostic (5.99e-2)" "unprognostic (1.14e-1)" "unprognostic (1.11e-1)" "unprognostic (2.46e-1)" "unprognostic (1.24e-1)" "unprognostic (2.98e-1)" "unprognostic (1.62e-1)" "unprognostic (3.04e-3)" "unprognostic (1.57e-1)" "unprognostic (2.13e-1)" "unprognostic (8.40e-2)" "unprognostic (4.39e-2)" 12.5 24.4 15.3 11.2 16.5 10.0 14.4 9.1 20.6 11.2 14.0 11.0 14.1 12.2 9.0 12.1 17.0 11.0 15.2 42.0 14.6 11.1 26.8 50.6 9.2 15.2 13.2 11.5 10.8 26.9 15.5 9.3 10.7 11.8 11.2 14.9 10.6 14.1 13.1 63.5 11.3 15.1 13.8 10.2 13.3 16.4 15.3 7.1 17.0 14.8 22.0 12.5 10.3 8.8 29.3 37.5 24.9 29.5 19.7 29.0 28.6 18.9 35.2 12.8 20.7 20.1 19.4 15.7 19.8 21.1 42.8 30.7 113.0 11.2 34.4 19.3 25.7 25.5 30.4 21.4 31.8 26.8 32.5 12.1 20.6 23.5 31.6 26.1 15.1 22.0 32.2 29.6 24.5 23.8 27.6 20.3 25.2 26.4 30.3 16.8 15.2 18.0 23.1 27.6 34.8 23.8 17.7 18.5 17.2 35.4 71.8 20.0 37.7 19.8 20.2 19.3 14.6 22.0 35.2 17.9 21.4 23.8 26.8 18.4 19.2 20.0 29.5 24.9 22.5 28.3 23.0 29.3 23.7 29.0 37.5 20.4 25.9 25.2 12.1 19.7 20.2 25.1 24.9 28.6 15.3 16.5 9.1 20.6 14.6 11.1 13.2 11.5 11.8 7.1 POLG "POLG1, POLGA" ENSG00000140521 "DNA polymerase gamma, catalytic subunit" P54098 15 89305198-89334861 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA replication" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Disease mutation, Epilepsy, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056821, HPA078482" Approved Supported Mitochondria Mitochondria "HPA056821: , HPA078482: " "unprognostic (1.87e-1)" "unprognostic (4.71e-2)" "unprognostic (2.61e-2)" "unprognostic (3.64e-1)" "unprognostic (1.62e-1)" "unprognostic (3.19e-1)" "unprognostic (2.22e-1)" "unprognostic (1.13e-1)" "unprognostic (8.41e-2)" "unprognostic (2.63e-1)" "unprognostic (1.41e-1)" "prognostic unfavourable (5.73e-4)" "unprognostic (2.65e-3)" "unprognostic (1.58e-2)" "unprognostic (4.29e-2)" "unprognostic (2.07e-1)" "unprognostic (3.45e-1)" 17.8 15.2 19.8 19.0 19.2 16.8 24.6 23.2 20.9 14.1 16.0 14.6 13.6 20.0 17.6 9.0 20.7 14.3 14.0 17.4 16.7 8.8 14.9 19.5 17.8 21.8 17.3 15.3 16.6 17.9 17.7 12.9 16.2 16.0 15.4 13.2 10.5 15.9 12.0 35.9 19.8 18.5 14.1 12.7 22.9 16.2 12.4 17.3 29.0 15.4 12.1 19.2 16.5 18.9 6.0 9.0 9.0 6.5 9.2 10.9 6.7 6.8 13.0 9.0 11.7 14.7 9.4 11.5 13.7 7.3 14.1 11.1 19.0 17.2 10.8 21.2 10.8 14.9 24.0 11.6 4.7 23.3 20.6 16.4 13.7 6.8 12.5 15.2 27.1 8.5 17.0 9.7 8.3 16.8 14.4 12.2 11.4 12.1 17.3 15.5 8.1 5.8 17.7 11.0 15.3 8.0 16.8 20.0 7.3 19.5 14.3 15.9 11.9 17.1 12.5 19.1 13.2 28.0 13.1 13.1 7.6 15.0 12.2 17.5 15.2 4.9 6.3 9.0 9.2 6.5 8.0 3.3 7.6 10.9 9.0 6.0 6.6 6.9 2.3 9.2 5.2 6.0 4.3 6.7 19.8 19.2 23.2 20.9 16.7 8.8 17.3 15.3 16.0 17.3 POLRMT "APOLMT, h-mtRPOL, MTRNAP, MTRPOL" ENSG00000099821 "RNA polymerase mitochondrial" O00411 19 617224-633604 "Enzymes, Predicted intracellular proteins" Transcription "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006366 Uncertain Supported Mitochondria Mitochondria "HPA006366: AB_1079654" "unprognostic (3.24e-1)" "unprognostic (4.31e-2)" "unprognostic (7.96e-2)" "prognostic favourable (4.50e-4)" "unprognostic (9.46e-2)" "unprognostic (2.94e-2)" "unprognostic (3.04e-2)" "unprognostic (9.41e-2)" "unprognostic (1.45e-1)" "unprognostic (3.48e-1)" "unprognostic (7.64e-3)" "unprognostic (1.81e-2)" "unprognostic (1.62e-1)" "unprognostic (1.28e-3)" "unprognostic (1.66e-1)" "unprognostic (2.92e-1)" "unprognostic (1.01e-1)" 10.2 10.7 10.1 16.3 11.9 6.9 8.1 12.1 20.7 9.5 11.6 12.3 4.4 16.7 9.8 12.2 14.4 8.7 12.7 24.7 11.5 8.9 12.9 21.4 7.3 11.8 9.4 15.1 10.1 15.9 9.5 10.7 6.2 9.7 10.2 8.8 8.5 9.6 11.7 42.2 16.7 12.8 10.8 8.4 12.8 11.2 32.1 6.3 11.6 11.1 8.6 10.4 10.1 7.8 8.2 7.3 3.1 5.5 7.5 9.0 5.3 10.4 19.0 4.3 19.1 9.1 5.2 16.0 4.9 5.8 7.3 6.7 19.1 7.2 10.8 10.0 4.5 10.9 16.1 9.4 5.4 12.1 38.3 8.4 11.8 24.5 9.5 14.1 16.0 5.0 13.3 7.4 9.1 10.3 15.7 10.8 6.7 14.8 18.7 19.4 17.3 13.4 18.1 6.0 18.4 9.7 9.0 14.0 9.9 4.4 12.2 12.2 6.9 12.9 6.1 7.9 10.2 12.4 14.4 25.8 21.2 16.5 17.0 11.8 9.7 0.0 3.7 3.1 9.0 5.2 7.1 7.8 6.7 6.6 7.3 8.2 5.7 6.3 0.6 7.5 5.5 7.2 4.1 5.3 10.1 11.9 12.1 20.7 11.5 8.9 9.4 15.1 9.7 6.3 PPFIBP2 Cclp1 ENSG00000166387 "PPFIA binding protein 2" Q8ND30 11 7513298-7657127 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 31.7;RT4: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001935, HPA003911" Enhanced Approved Mitochondria Mitochondria "HPA001935: AB_1079667, HPA003911: AB_1079666" "unprognostic (4.14e-2)" "unprognostic (7.04e-3)" "unprognostic (7.20e-3)" "unprognostic (5.79e-2)" "unprognostic (2.08e-1)" "prognostic favourable (2.32e-4)" "unprognostic (1.33e-1)" "prognostic favourable (2.26e-5)" "unprognostic (6.66e-3)" "unprognostic (2.90e-1)" "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "prognostic favourable (5.39e-8)" "unprognostic (1.78e-1)" "unprognostic (3.38e-1)" "unprognostic (2.52e-2)" "prognostic favourable (1.34e-5)" 6.9 6.0 9.2 11.6 13.3 3.1 8.5 6.6 12.9 7.0 13.7 21.4 38.7 12.2 5.7 17.3 17.7 8.4 14.0 6.3 10.0 6.3 17.2 22.1 5.9 6.5 24.0 4.0 8.4 6.0 56.2 3.3 10.0 10.2 12.0 13.3 15.3 34.9 55.9 12.4 20.3 15.4 7.0 10.8 8.0 20.2 18.7 19.3 0.8 17.7 10.2 15.9 20.0 15.3 12.1 7.0 5.4 11.8 2.0 6.1 4.5 0.6 12.6 2.2 1.4 3.0 0.1 31.7 2.9 6.5 1.9 1.8 10.2 1.8 3.5 1.4 1.9 5.9 9.1 0.9 1.6 1.7 0.9 0.0 0.0 6.5 4.1 7.5 3.4 5.0 2.9 0.0 2.3 0.6 0.3 10.7 1.5 6.9 0.0 7.0 14.8 0.0 1.1 0.0 5.8 0.0 43.9 0.5 4.9 0.4 11.6 8.3 1.7 5.7 0.1 0.7 1.1 2.4 0.2 5.2 3.8 3.1 0.9 1.7 5.0 2.0 7.9 5.4 2.8 9.4 2.1 12.1 4.4 2.0 7.0 7.1 6.1 4.5 3.8 2.0 11.8 0.5 0.8 4.5 9.2 13.3 6.6 12.9 10.0 6.3 24.0 4.0 10.2 19.3 PPIF "Cyp-D, hCyP3" ENSG00000108179 "Peptidylprolyl isomerase F" P30405 10 79347469-79355337 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Necrosis" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 32.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077416 Supported Mitochondria 27000000 Mitochondria "HPA077416: " "unprognostic (2.21e-1)" "unprognostic (5.48e-2)" "unprognostic (1.68e-1)" "unprognostic (1.72e-3)" "unprognostic (1.69e-1)" "unprognostic (3.16e-3)" "unprognostic (3.45e-1)" "unprognostic (4.33e-3)" "unprognostic (1.66e-1)" "unprognostic (1.97e-1)" "unprognostic (2.82e-1)" "unprognostic (9.37e-3)" "unprognostic (1.02e-3)" "unprognostic (1.23e-1)" "unprognostic (1.66e-1)" "unprognostic (1.69e-3)" "unprognostic (4.88e-2)" 16.5 76.2 12.1 15.7 18.8 52.0 16.9 7.1 21.3 8.3 18.1 27.1 13.2 13.3 5.2 7.6 21.0 8.8 10.0 36.5 13.0 14.5 21.0 73.1 9.4 19.4 23.3 16.6 7.2 42.0 12.0 6.2 11.3 25.2 6.6 19.9 7.5 12.7 21.9 44.4 22.5 11.1 9.9 28.0 19.6 34.0 20.8 18.0 8.8 10.0 73.9 19.8 12.5 11.0 8.0 18.6 32.8 14.9 3.6 5.0 6.5 35.1 15.0 10.5 20.7 9.8 12.8 13.5 20.5 27.0 45.2 42.8 35.0 17.1 36.6 11.4 14.4 21.1 32.6 19.1 70.5 11.6 30.7 57.3 14.7 61.6 16.7 39.4 13.6 30.0 13.8 44.8 44.9 7.9 55.7 45.2 15.3 18.1 10.2 33.0 8.8 83.4 17.6 16.3 18.7 17.5 32.9 21.0 15.6 10.5 42.7 15.8 18.7 30.5 7.1 19.8 18.0 23.3 39.5 21.0 21.3 29.6 19.6 51.4 5.3 5.1 14.9 7.3 4.7 11.4 5.0 8.0 4.2 4.3 18.6 3.9 3.8 3.7 32.8 3.6 4.1 2.3 4.2 6.5 12.1 18.8 7.1 21.3 13.0 14.5 23.3 16.6 25.2 18.0 PPM1K "BDP, DKFZp761G058, hPTMP, PP2Ckappa, PP2Cm" ENSG00000163644 "Protein phosphatase, Mg2+/Mn2+ dependent 1K" Q8N3J5 4 88257620-88284769 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 59.1" "Cell line enhanced" "Detected in many" "Daudi: 27.1;Karpas-707: 23.6;U-698: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020066, HPA020862, HPA023891" Approved Supported Mitochondria Mitochondria "HPA020066: AB_1855628, HPA020862: AB_1855629, HPA023891: AB_1855630" "unprognostic (2.38e-2)" "unprognostic (5.86e-2)" "unprognostic (7.42e-3)" "unprognostic (6.70e-3)" "unprognostic (1.18e-1)" "unprognostic (1.17e-3)" "unprognostic (1.87e-1)" "unprognostic (5.88e-2)" "unprognostic (5.50e-2)" "unprognostic (1.41e-2)" "unprognostic (9.25e-3)" "unprognostic (6.56e-2)" "unprognostic (9.82e-2)" "unprognostic (5.57e-2)" "unprognostic (1.34e-1)" "unprognostic (2.11e-1)" "unprognostic (2.28e-1)" 3.6 6.1 19.2 8.8 17.2 5.9 9.3 21.1 26.8 12.9 3.8 12.5 2.5 3.0 21.8 5.5 7.6 14.1 6.0 59.1 23.1 14.6 11.8 5.1 6.5 14.5 21.6 15.9 22.0 7.3 10.4 8.4 6.4 17.0 11.1 4.3 4.7 7.1 5.3 8.3 1.9 6.7 18.2 15.0 10.9 5.4 12.3 19.4 7.3 5.4 1.9 15.8 6.5 8.1 31.8 38.8 5.5 3.4 7.9 16.1 7.1 2.1 0.7 2.8 4.9 4.2 5.5 1.1 3.4 6.3 11.6 13.7 5.6 0.5 27.1 3.8 2.2 0.2 8.2 2.6 4.6 20.9 3.4 4.8 2.1 5.0 3.3 6.6 2.6 3.6 1.3 7.1 6.2 1.9 7.2 23.6 3.3 3.1 8.7 3.6 1.7 1.1 5.0 4.6 10.3 4.0 0.9 2.2 1.9 2.1 0.2 2.5 11.2 1.8 0.3 4.0 2.1 1.3 2.0 7.4 6.8 22.7 4.4 5.4 6.7 5.5 2.9 2.3 12.4 3.4 16.1 30.4 11.8 12.4 5.5 31.8 11.7 14.1 0.9 7.9 0.9 38.8 13.3 7.1 19.2 17.2 21.1 26.8 23.1 14.6 21.6 15.9 17.0 19.4 PPP3CB "CALNA2, CALNB, CNA2, PP2Bbeta" ENSG00000107758 "Protein phosphatase 3 catalytic subunit beta" P16298 10 73436428-73496024 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 133.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008233, HPA008823" Uncertain Approved Mitochondria Mitochondria "HPA008233: AB_1855661, HPA008823: " "unprognostic (3.05e-1)" "unprognostic (2.54e-1)" "unprognostic (1.50e-1)" "unprognostic (4.93e-2)" "unprognostic (8.93e-2)" "unprognostic (4.28e-2)" "prognostic unfavourable (9.59e-4)" "unprognostic (1.14e-1)" "unprognostic (1.34e-1)" "unprognostic (2.12e-2)" "prognostic favourable (6.96e-5)" "unprognostic (4.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-1)" "unprognostic (2.66e-1)" "unprognostic (1.68e-2)" 17.3 16.1 40.0 11.7 36.3 7.6 22.5 44.5 42.7 13.4 16.1 7.9 9.5 10.1 17.0 15.0 14.0 12.3 12.0 16.7 39.7 20.5 11.9 9.1 9.8 13.1 18.2 40.7 17.2 10.5 19.3 16.8 10.6 21.1 16.8 12.8 9.5 10.4 17.6 133.0 10.9 9.4 23.0 18.1 10.0 10.7 11.6 11.9 8.4 10.1 10.0 14.3 14.1 14.4 4.2 5.7 4.8 3.8 4.5 10.6 2.7 19.1 10.6 19.0 19.6 27.3 37.9 9.1 17.6 24.2 17.3 17.2 6.7 9.9 17.0 5.7 25.4 10.3 15.3 13.5 24.4 23.8 12.6 7.3 9.6 12.7 16.4 16.0 15.1 26.8 16.3 16.3 22.0 11.9 9.0 20.1 34.8 6.0 14.3 14.9 7.7 31.0 9.6 10.3 8.0 16.8 9.3 10.2 11.8 10.3 25.9 12.9 19.4 15.5 13.0 13.8 12.7 11.0 23.8 13.4 36.6 11.9 17.1 23.1 7.8 3.2 2.9 4.8 6.2 3.8 7.3 4.2 6.7 6.6 3.0 3.0 5.3 7.9 1.7 4.5 2.3 5.7 10.6 2.7 40.0 36.3 44.5 42.7 39.7 20.5 18.2 40.7 21.1 11.9 PRDX1 "NKEFA, PAGA" ENSG00000117450 "Peroxiredoxin 1" Q06830 1 45511036-45523047 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004682, HPA007730" Approved Supported Mitochondria 110000000 Mitochondria "CAB004682: AB_437046, HPA007730: AB_1855204" "unprognostic (1.28e-2)" "unprognostic (4.64e-1)" "unprognostic (2.22e-2)" "unprognostic (3.65e-1)" "unprognostic (2.38e-1)" "unprognostic (3.95e-2)" "prognostic unfavourable (1.17e-5)" "unprognostic (2.47e-1)" "unprognostic (1.31e-1)" "unprognostic (4.68e-2)" "unprognostic (3.05e-2)" "unprognostic (2.90e-1)" "unprognostic (2.39e-2)" "unprognostic (5.99e-2)" "unprognostic (2.88e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (2.89e-4)" 43.3 58.2 71.0 43.8 57.4 12.0 75.5 31.6 60.0 46.9 51.1 72.2 42.6 78.5 40.8 75.7 136.1 49.7 46.9 84.2 56.5 73.0 121.7 136.5 52.9 51.0 99.1 51.2 43.0 20.4 34.1 34.3 58.3 87.8 42.2 53.0 48.8 53.5 52.2 78.9 46.9 77.6 52.4 98.3 46.5 52.5 25.7 72.6 29.7 130.1 114.3 91.0 49.1 56.3 44.7 50.3 64.4 64.5 20.4 72.3 58.7 65.4 120.6 49.7 63.2 56.4 48.3 106.4 74.4 77.4 80.8 67.2 59.9 28.3 57.8 78.6 79.8 67.8 107.9 71.9 80.0 44.5 83.3 43.7 170.2 167.6 24.5 50.5 57.2 41.4 53.8 80.2 19.0 92.6 79.8 20.0 80.2 52.5 67.7 49.3 155.8 126.4 119.4 62.7 76.1 145.2 56.4 66.2 33.3 68.3 185.5 4.8 50.4 40.9 78.7 32.3 73.1 69.1 99.0 14.0 78.1 110.1 53.4 35.2 18.9 64.4 55.6 18.4 28.5 60.6 37.5 44.7 45.5 37.9 50.3 36.2 28.3 31.0 2.4 20.4 64.5 33.5 72.3 58.7 71.0 57.4 31.6 60.0 56.5 73.0 99.1 51.2 87.8 72.6 PRDX5 "ACR1, AOEB166, B166, MGC117264, MGC142283, MGC142285, PLP, PMP20, PRDX6, PRXV, SBBI10" ENSG00000126432 "Peroxiredoxin 5" P30044 11 64318088-64321811 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008661, HPA037915, HPA037916" Enhanced Enhanced Mitochondria 19000000 Mitochondria "CAB008661: AB_1620988, HPA037915: AB_2675735, HPA037916: AB_2675736" "unprognostic (2.75e-1)" "unprognostic (4.08e-1)" "unprognostic (1.33e-1)" "unprognostic (1.46e-1)" "unprognostic (9.43e-2)" "unprognostic (6.71e-3)" "unprognostic (1.08e-3)" "unprognostic (3.11e-1)" "unprognostic (9.30e-2)" "unprognostic (1.07e-3)" "unprognostic (1.57e-2)" "unprognostic (2.20e-1)" "prognostic favourable (1.24e-5)" "unprognostic (8.19e-2)" "unprognostic (2.30e-1)" "unprognostic (9.63e-2)" "unprognostic (5.03e-2)" 28.7 69.7 70.3 38.6 60.3 57.0 35.5 69.3 73.9 47.2 79.3 31.9 49.0 49.5 26.6 54.8 69.6 94.9 44.8 102.4 56.7 74.2 57.3 54.2 50.3 25.0 68.6 70.2 42.2 72.0 36.0 53.7 49.1 71.4 30.7 71.2 33.9 77.5 62.6 104.7 27.0 51.2 30.9 44.1 27.3 64.5 35.0 29.3 25.1 82.0 64.8 33.5 34.4 50.4 55.2 69.2 115.0 66.9 48.4 40.5 75.3 26.0 53.2 32.3 53.3 34.8 52.3 37.3 32.7 52.4 24.0 30.0 38.7 53.6 38.3 57.2 52.2 59.7 30.1 69.4 15.3 53.1 23.7 38.6 83.8 44.1 71.4 14.6 32.9 53.0 90.7 40.3 40.9 36.5 21.7 91.0 33.8 66.2 25.5 63.5 48.9 68.2 24.6 33.1 135.2 90.0 51.8 27.4 52.0 27.3 60.7 93.2 44.4 33.3 35.1 34.4 32.0 39.7 14.4 46.6 55.4 45.0 41.6 29.5 26.8 79.8 66.9 85.4 37.7 59.6 32.7 53.8 35.0 30.8 52.4 55.2 34.8 35.0 115.0 48.4 52.5 69.2 40.5 75.3 70.3 60.3 69.3 73.9 56.7 74.2 68.6 70.2 71.4 29.3 PRKAR2B PRKAR2 ENSG00000005249 "Protein kinase cAMP-dependent type II regulatory subunit beta" P31323 7 107044649-107161811 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "adipose tissue: 80.2;breast: 114.1" "Cell line enhanced" "Detected in many" "AN3-CA: 19.7;Daudi: 27.0;K-562: 16.3;U-698: 69.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008421, HPA063879" Enhanced Uncertain Mitochondria 1600000 Mitochondria "HPA008421: AB_1855421, HPA063879: " "unprognostic (3.18e-1)" "unprognostic (2.48e-2)" "prognostic favourable (6.38e-4)" "unprognostic (1.63e-2)" "unprognostic (3.33e-3)" "unprognostic (2.43e-3)" "unprognostic (2.76e-1)" "unprognostic (8.14e-3)" "unprognostic (1.70e-1)" "unprognostic (5.97e-2)" "prognostic favourable (4.03e-4)" "unprognostic (1.50e-1)" "unprognostic (5.12e-3)" "unprognostic (2.39e-1)" "unprognostic (1.11e-1)" "prognostic unfavourable (8.74e-4)" "unprognostic (7.15e-2)" 80.2 21.5 9.4 6.0 17.2 8.4 114.1 4.5 17.0 3.9 9.1 1.9 2.4 3.1 5.1 3.9 8.4 3.4 4.7 9.0 8.8 8.6 4.5 2.4 3.2 3.0 8.4 12.1 19.5 6.5 5.6 8.1 10.7 3.0 6.4 5.5 2.6 6.8 3.9 2.2 1.6 4.7 7.4 3.4 11.1 4.1 14.5 4.6 0.8 1.6 2.8 3.3 8.4 11.8 0.2 3.1 1.3 1.5 0.5 0.1 2.5 0.0 0.4 2.5 19.7 10.6 0.0 0.0 1.0 3.2 0.8 0.7 0.0 0.0 27.0 0.2 0.6 0.0 1.9 0.0 1.5 0.7 2.2 9.0 0.0 0.0 2.9 0.1 1.2 0.1 0.0 0.0 0.0 11.9 16.3 0.8 0.0 2.0 3.7 0.1 4.8 0.7 1.0 0.0 0.0 0.0 0.0 3.2 4.7 1.4 0.3 1.0 0.6 1.9 6.7 0.9 2.6 0.0 1.9 0.6 0.0 69.4 0.7 4.7 9.4 1.3 1.5 0.0 0.0 1.4 0.1 0.2 0.0 0.0 3.1 0.0 0.1 0.1 0.7 0.5 0.7 1.1 0.0 2.5 9.4 17.2 4.5 17.0 8.8 8.6 8.4 12.1 3.0 4.6 PTCD1 KIAA0632 ENSG00000106246 "Pentatricopeptide repeat domain 1" O75127 7 99416739-99466163 "Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA020106, HPA047679" Uncertain Approved Mitochondria Mitochondria "HPA020106: AB_2176551, HPA047679: " "unprognostic (4.70e-2)" "unprognostic (3.38e-2)" "unprognostic (4.19e-2)" "unprognostic (6.05e-2)" "unprognostic (1.17e-1)" "unprognostic (2.11e-2)" "prognostic unfavourable (2.34e-4)" "unprognostic (4.39e-2)" "unprognostic (2.00e-1)" "unprognostic (4.09e-2)" "unprognostic (1.14e-2)" "unprognostic (8.87e-2)" "prognostic unfavourable (1.13e-4)" "unprognostic (1.49e-1)" "unprognostic (1.50e-1)" "unprognostic (7.71e-2)" "unprognostic (7.10e-3)" 10.3 11.4 9.9 12.0 11.9 21.9 10.6 13.9 16.3 9.4 15.7 5.3 12.0 13.2 12.4 10.6 17.7 12.7 13.2 22.9 10.5 9.1 18.3 29.5 11.5 14.8 9.2 13.1 13.5 19.9 9.3 9.7 9.8 10.7 13.4 7.4 9.1 17.4 13.6 43.8 19.7 18.9 6.4 8.6 15.8 11.6 18.0 7.5 16.0 12.2 30.8 11.3 12.4 10.5 6.2 4.7 4.5 5.0 4.1 8.0 3.2 3.5 7.3 2.5 7.0 2.4 2.0 7.2 5.0 1.8 3.6 2.6 21.9 4.3 7.1 5.8 1.3 3.9 3.0 4.5 1.2 5.6 8.5 3.7 5.9 5.3 3.7 3.5 7.0 1.6 2.8 2.9 3.0 1.1 7.3 4.9 1.7 10.0 6.6 9.4 4.7 6.1 4.0 3.3 8.8 1.9 3.9 4.7 5.1 5.5 18.4 4.7 3.9 3.9 2.0 5.5 6.3 10.6 5.3 7.5 6.4 7.7 5.6 5.0 7.4 3.5 4.5 1.8 8.0 5.0 5.2 4.2 5.0 5.2 3.2 6.2 5.9 7.1 4.5 4.1 3.5 4.7 3.3 3.2 9.9 11.9 13.9 16.3 10.5 9.1 9.2 13.1 10.7 7.5 PTCD3 "DKFZp666K071, FLJ20758" ENSG00000132300 "Pentatricopeptide repeat domain 3" Q96EY7 2 86106182-86142157 "Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041154, HPA041382" Supported Supported Mitochondria Mitochondria "HPA041154: AB_10795488, HPA041382: AB_10795695" "unprognostic (1.16e-2)" "unprognostic (4.47e-2)" "unprognostic (1.37e-2)" "unprognostic (9.30e-3)" "unprognostic (2.40e-2)" "unprognostic (2.54e-1)" "unprognostic (4.92e-3)" "unprognostic (2.06e-2)" "unprognostic (4.78e-2)" "unprognostic (3.78e-1)" "unprognostic (7.42e-3)" "unprognostic (5.49e-3)" "unprognostic (1.26e-1)" "prognostic favourable (6.77e-4)" "unprognostic (3.69e-1)" "unprognostic (7.79e-2)" "prognostic favourable (6.86e-4)" 13.9 18.6 18.5 12.2 23.2 18.0 14.5 24.5 22.7 13.0 17.5 19.7 11.3 14.3 15.2 15.5 12.7 13.6 9.6 35.0 17.7 16.6 18.0 21.9 11.7 15.4 20.2 19.0 20.2 13.8 17.9 22.7 13.2 21.4 13.0 19.7 11.4 11.1 12.9 45.4 14.2 14.2 13.4 17.9 15.8 14.8 22.8 20.5 20.4 14.9 13.1 15.3 12.4 13.0 13.4 9.4 6.3 11.1 11.9 14.7 7.5 7.6 18.5 11.0 9.2 8.2 8.6 13.2 17.0 6.8 9.0 9.1 34.4 7.4 19.3 6.0 8.9 14.2 22.2 8.7 11.6 8.6 19.5 15.3 11.5 28.4 8.6 12.4 11.6 10.2 6.4 6.8 12.3 7.8 15.9 7.3 7.9 7.1 10.2 14.8 10.0 11.9 13.8 15.5 14.6 12.3 15.5 12.0 7.4 7.4 12.4 14.5 6.6 7.6 5.5 7.2 7.7 7.3 9.3 17.4 22.3 15.6 7.0 14.2 5.5 3.4 8.6 6.3 11.6 5.9 13.6 13.4 10.5 12.2 9.4 13.4 14.7 10.7 0.3 11.9 11.1 9.4 11.8 7.5 18.5 23.2 24.5 22.7 17.7 16.6 20.2 19.0 21.4 20.5 PTGES2 "C9orf15, FLJ14038" ENSG00000148334 "Prostaglandin E synthase 2" Q9H7Z7 9 128120693-128128462 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020631, HPA020733" Approved Approved Mitochondria Mitochondria "HPA020631: AB_1855887, HPA020733: " "unprognostic (1.23e-1)" "unprognostic (1.86e-2)" "unprognostic (1.60e-1)" "unprognostic (1.95e-2)" "unprognostic (1.55e-1)" "unprognostic (1.68e-2)" "unprognostic (5.13e-3)" "unprognostic (2.56e-1)" "unprognostic (1.57e-1)" "unprognostic (7.10e-2)" "unprognostic (2.81e-2)" "unprognostic (4.33e-2)" "prognostic favourable (5.83e-7)" "unprognostic (2.10e-2)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" 9.3 17.0 16.5 9.2 17.8 4.4 7.4 15.3 24.1 7.1 14.8 9.9 7.6 17.7 8.1 9.0 12.6 8.4 10.0 36.4 17.4 14.0 13.2 13.0 5.8 10.2 14.2 11.6 9.2 18.3 11.7 14.3 10.7 10.5 8.0 7.0 13.2 16.2 12.0 73.5 9.3 13.2 5.9 7.0 9.5 14.3 5.8 9.8 9.3 10.5 16.2 13.3 8.5 7.3 5.2 8.2 1.2 6.3 3.7 6.5 2.9 12.6 35.4 3.9 14.7 3.6 3.7 12.1 9.7 5.4 12.3 6.6 26.4 19.8 11.2 15.5 3.9 32.9 5.7 12.0 1.7 8.0 15.4 5.7 26.8 24.6 11.0 11.6 11.5 5.0 8.7 9.9 6.8 8.4 12.6 7.0 4.0 39.1 13.8 22.1 12.6 28.7 10.5 7.9 28.5 8.4 9.5 19.8 11.8 14.0 22.4 9.4 20.0 6.2 11.0 12.6 15.7 17.0 17.6 16.1 7.8 10.9 9.6 9.0 11.7 1.2 6.0 1.0 5.6 6.3 6.5 5.2 3.7 5.9 6.7 4.5 4.3 5.1 1.1 3.7 2.8 8.2 4.2 2.9 16.5 17.8 15.3 24.1 17.4 14.0 14.2 11.6 10.5 9.8 PTPMT1 "DUSP23, MOSP, PLIP" ENSG00000110536 "Protein tyrosine phosphatase, mitochondrial 1" Q8WUK0 11 47565430-47573461 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040348, HPA043932" Approved Supported Mitochondria Mitochondria "HPA040348: , HPA043932: " "unprognostic (6.61e-2)" "unprognostic (2.09e-1)" "unprognostic (1.28e-1)" "unprognostic (2.37e-3)" "unprognostic (1.02e-1)" "unprognostic (1.26e-2)" "prognostic unfavourable (3.04e-5)" "unprognostic (3.29e-2)" "unprognostic (2.77e-2)" "unprognostic (1.93e-3)" "unprognostic (6.76e-2)" "unprognostic (1.72e-1)" "unprognostic (2.68e-3)" "unprognostic (1.21e-1)" "unprognostic (5.39e-1)" "unprognostic (2.17e-2)" "unprognostic (1.75e-1)" 24.0 24.5 22.3 13.1 23.2 19.8 23.3 16.5 25.2 15.7 14.8 18.5 17.5 14.6 14.7 21.4 14.3 16.9 17.9 17.1 18.5 21.9 20.1 21.8 25.1 16.7 23.1 16.2 15.7 39.3 18.3 18.7 21.8 14.4 15.8 11.5 20.1 26.4 19.5 23.4 11.2 13.1 12.7 17.6 14.7 16.9 44.6 10.3 10.8 19.9 15.7 15.0 11.0 11.5 20.4 40.8 22.1 24.4 15.4 17.5 16.8 22.0 12.5 1.5 10.0 11.6 8.9 4.3 13.0 12.3 13.0 12.4 20.7 11.8 15.9 14.4 9.7 18.9 10.3 13.5 13.9 19.4 31.0 7.3 25.6 26.0 17.0 14.2 9.7 8.8 15.3 6.1 18.7 9.2 18.6 12.2 9.5 41.6 12.1 18.3 9.3 23.2 22.2 8.4 13.5 15.6 14.1 9.3 11.4 19.7 7.2 11.7 33.5 15.3 9.9 9.7 14.8 15.6 19.5 18.6 12.4 10.8 7.6 12.3 5.8 6.0 24.4 22.1 16.0 20.9 15.4 20.4 15.2 17.3 27.7 18.0 15.2 14.4 1.9 15.4 19.4 40.8 17.5 16.8 22.3 23.2 16.5 25.2 18.5 21.9 23.1 16.2 14.4 10.3 PTPRH SAP-1 ENSG00000080031 "Protein tyrosine phosphatase, receptor type H" Q9HD43 19 55181248-55209506 "Enzymes, Predicted membrane proteins" Apoptosis "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "gallbladder: 29.6;intestine: 84.3;lymphoid tissue: 21.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.0;HHSteC: 10.4;K-562: 12.1;PC-3: 8.2;SK-MEL-30: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.5" "Lineage enhanced" "Detected in single" "monocytes: 1.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042300 Approved Mitochondria Mitochondria "HPA042300: AB_10796900" "unprognostic (1.87e-1)" "unprognostic (1.10e-1)" "unprognostic (2.59e-1)" "unprognostic (7.57e-3)" "unprognostic (5.01e-3)" "unprognostic (8.14e-2)" "unprognostic (1.15e-1)" "unprognostic (1.96e-3)" "unprognostic (1.60e-2)" "unprognostic (1.06e-1)" "unprognostic (9.96e-2)" "unprognostic (6.16e-2)" "unprognostic (1.47e-11)" "unprognostic (4.08e-3)" "unprognostic (2.47e-1)" "unprognostic (1.52e-2)" "unprognostic (1.57e-1)" 0.5 8.9 0.5 5.2 0.7 0.0 0.5 0.5 1.0 0.7 39.9 0.6 0.5 30.1 0.5 0.5 0.6 0.0 29.6 0.5 1.3 1.6 0.6 7.8 0.6 0.5 3.0 0.5 0.6 2.8 0.0 3.0 0.6 0.5 1.0 9.6 0.6 0.5 0.5 0.5 0.0 84.3 0.7 6.9 21.2 10.2 0.5 0.5 0.5 0.5 1.0 0.8 1.1 2.4 0.0 0.7 0.0 1.5 0.0 0.0 0.0 5.6 3.5 0.0 1.4 1.1 3.1 0.1 0.1 3.0 0.6 1.2 1.5 8.0 0.0 0.3 0.5 0.0 0.0 0.0 0.7 0.0 0.1 0.4 0.1 4.0 10.4 0.0 4.1 0.8 2.5 2.0 3.1 0.1 12.1 0.5 0.0 0.0 0.0 0.2 0.0 8.2 0.0 0.0 0.4 0.0 0.0 0.3 0.8 0.0 3.6 18.2 0.0 1.6 0.0 0.8 1.2 0.4 0.0 0.0 3.0 0.0 0.9 0.1 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.7 0.5 0.5 1.3 1.6 3.0 0.5 0.5 0.5 PTRH2 "BIT1, CFAP37, CGI-147, PTH2" ENSG00000141378 "Peptidyl-tRNA hydrolase 2" Q9Y3E5 17 59674636-59707626 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Apoptosis Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012897 Supported Supported Mitochondria Mitochondria "HPA012897: AB_1855949" "unprognostic (2.26e-1)" "unprognostic (2.80e-2)" "unprognostic (1.02e-2)" "unprognostic (3.89e-2)" "unprognostic (1.31e-2)" "unprognostic (3.38e-2)" "prognostic unfavourable (1.50e-4)" "unprognostic (6.38e-2)" "unprognostic (2.02e-1)" "unprognostic (9.59e-3)" "unprognostic (2.72e-1)" "unprognostic (1.40e-1)" "prognostic unfavourable (1.01e-8)" "unprognostic (5.43e-3)" "unprognostic (6.82e-2)" "unprognostic (1.32e-1)" "unprognostic (1.49e-2)" 15.9 22.9 17.1 12.4 17.1 9.9 20.7 12.5 22.1 15.6 17.2 11.8 16.3 11.6 14.3 36.7 16.4 13.8 13.1 12.6 19.3 17.8 14.8 34.7 12.1 12.5 16.7 15.2 14.2 19.9 10.3 18.3 13.6 21.0 15.9 20.7 8.1 13.7 18.7 23.3 11.4 11.0 16.8 17.1 15.5 14.3 15.7 18.1 9.0 11.8 13.5 16.9 13.0 10.5 15.6 21.6 12.6 29.3 13.1 15.5 13.0 19.8 37.9 12.2 11.1 23.2 20.0 13.1 19.1 16.9 16.4 24.0 24.4 15.6 14.4 29.0 16.0 19.8 26.2 24.6 23.9 27.7 35.7 25.7 19.7 44.8 35.8 22.7 14.6 22.5 32.1 25.4 29.6 27.2 28.6 16.1 24.3 47.9 19.4 18.5 10.5 30.0 10.6 20.5 21.0 27.3 28.6 15.8 20.5 9.9 10.8 23.4 25.2 16.2 17.9 21.4 21.7 12.8 20.7 20.9 23.2 21.4 14.1 14.2 16.3 1.9 25.8 1.1 9.2 24.4 12.4 15.6 10.8 10.4 18.5 13.1 15.5 11.1 12.6 13.1 29.3 21.6 12.3 13.0 17.1 17.1 12.5 22.1 19.3 17.8 16.7 15.2 21.0 18.1 PYCR2 P5CR2 ENSG00000143811 "Pyrroline-5-carboxylate reductase 2" Q96C36 1 225919877-225924340 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis" Oxidoreductase "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA056873 Approved Approved Mitochondria Mitochondria "HPA056873: " "unprognostic (1.11e-1)" "unprognostic (8.08e-2)" "prognostic unfavourable (5.02e-5)" "unprognostic (2.91e-2)" "unprognostic (1.76e-1)" "unprognostic (1.03e-1)" "unprognostic (4.20e-3)" "unprognostic (1.56e-2)" "unprognostic (6.89e-2)" "unprognostic (1.12e-1)" "unprognostic (9.07e-3)" "unprognostic (1.56e-1)" "prognostic unfavourable (1.42e-6)" "unprognostic (9.69e-2)" "unprognostic (2.61e-1)" "unprognostic (6.44e-2)" "unprognostic (1.16e-3)" 21.4 37.2 25.7 24.0 28.2 29.5 17.2 14.3 38.2 21.8 17.4 40.0 25.8 16.1 25.3 20.0 17.7 33.2 24.6 38.0 27.9 28.3 23.4 35.0 22.0 30.3 34.0 30.8 34.5 29.0 26.6 29.8 22.2 29.5 22.4 13.7 21.5 26.3 32.1 36.0 15.3 16.7 22.3 38.4 25.9 20.1 17.6 24.7 35.0 19.2 20.0 23.5 24.6 16.2 19.3 25.9 16.4 12.7 28.3 36.1 18.1 16.7 13.8 8.5 14.2 9.6 10.0 17.9 17.7 11.1 12.1 10.8 18.1 14.0 29.5 38.1 13.0 19.4 12.1 13.9 6.9 35.4 25.4 28.1 14.4 18.1 14.9 24.7 46.3 9.6 17.6 13.6 15.8 11.5 40.6 19.8 12.2 13.8 31.0 28.1 47.3 19.3 27.9 19.0 61.1 15.6 13.4 10.7 13.8 14.8 11.8 37.0 15.1 47.3 9.6 9.5 11.4 20.1 24.3 31.7 34.7 29.2 15.0 18.9 26.2 15.1 8.7 16.4 21.1 12.7 22.2 15.9 20.6 19.5 13.6 19.3 36.1 29.2 6.0 28.3 10.8 25.9 18.6 18.1 25.7 28.2 14.3 38.2 27.9 28.3 34.0 30.8 29.5 24.7 PYROXD2 "C10orf33, FLJ23849" ENSG00000119943 "Pyridine nucleotide-disulphide oxidoreductase domain 2" Q8N2H3 10 98383565-98415184 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 50.8" "Cell line enhanced" "Detected in many" "U-937: 21.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "eosinophil: 50.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 50.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037566, HPA037567, HPA067394" Uncertain Approved Mitochondria Mitochondria "HPA037566: AB_10670385, HPA037567: AB_2675550, HPA067394: " "unprognostic (2.35e-2)" "unprognostic (1.38e-1)" "unprognostic (1.79e-2)" "unprognostic (2.41e-2)" "unprognostic (1.10e-3)" "unprognostic (6.76e-2)" "unprognostic (1.27e-2)" "unprognostic (3.38e-2)" "unprognostic (2.69e-1)" "unprognostic (3.34e-1)" "unprognostic (2.20e-1)" "unprognostic (1.63e-1)" "unprognostic (9.05e-2)" "unprognostic (2.74e-1)" "unprognostic (1.33e-1)" "unprognostic (1.26e-2)" "prognostic favourable (3.37e-4)" 11.0 15.5 5.1 9.0 7.0 2.7 9.2 2.6 6.3 12.2 6.5 12.0 14.2 2.5 8.3 15.5 4.1 11.6 13.1 9.5 5.3 3.8 6.7 11.7 8.6 2.9 12.6 3.0 11.5 4.3 7.5 6.0 5.0 9.6 12.9 5.8 12.5 26.9 11.3 9.6 3.2 4.1 12.2 8.1 5.2 5.5 3.7 10.7 4.3 9.2 2.3 3.0 11.9 6.9 0.0 0.5 50.8 0.0 11.3 1.8 0.4 2.4 6.1 3.4 0.1 5.4 10.9 1.3 4.0 12.4 2.3 4.3 0.0 8.5 0.0 7.2 4.2 1.2 1.0 1.3 2.3 0.2 1.0 4.9 10.0 0.5 7.0 0.0 11.4 6.4 1.8 1.8 2.2 1.7 0.1 0.1 3.4 7.5 0.1 11.6 1.0 2.1 1.5 1.3 0.1 3.3 3.7 0.2 0.1 4.3 0.5 3.0 3.5 5.5 2.3 0.0 2.6 0.7 3.9 0.8 0.5 0.0 4.1 21.4 0.3 1.1 0.0 50.8 1.8 0.0 0.4 0.0 0.6 1.5 0.5 0.0 0.3 1.1 0.1 11.3 0.0 0.1 0.1 0.4 5.1 7.0 2.6 6.3 5.3 3.8 12.6 3.0 9.6 10.7 QDPR "DHPR, PKU2, SDR33C1" ENSG00000151552 "Quinoid dihydropteridine reductase" P09417 4 17460261-17512234 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" Oxidoreductase "Disease mutation, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 114.1;liver: 64.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058951, HPA065649" Enhanced Approved Mitochondria 1800000 Mitochondria "HPA058951: AB_2683861, HPA065649: AB_2685526" "unprognostic (1.30e-2)" "unprognostic (4.29e-1)" "unprognostic (8.27e-2)" "unprognostic (2.52e-1)" "unprognostic (1.21e-1)" "unprognostic (1.20e-1)" "unprognostic (3.29e-3)" "unprognostic (3.80e-3)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" "unprognostic (6.82e-3)" "unprognostic (2.07e-1)" "prognostic favourable (7.84e-6)" "unprognostic (1.58e-1)" "unprognostic (2.60e-1)" "unprognostic (9.01e-2)" "unprognostic (3.19e-1)" 22.5 25.9 67.8 3.4 111.9 4.4 7.4 16.0 54.1 5.7 7.5 56.3 2.6 9.1 5.5 12.5 5.2 6.4 6.3 15.0 80.7 58.2 36.1 64.8 8.0 3.7 114.1 36.7 6.7 10.3 13.7 6.2 4.1 82.5 10.3 5.9 2.6 12.4 7.5 34.2 4.6 8.1 6.4 93.6 4.8 9.1 4.1 94.7 0.7 7.7 2.8 4.4 4.5 2.6 7.5 42.5 1.0 21.9 9.9 15.0 12.3 11.3 22.3 8.8 12.3 21.4 10.9 15.6 16.3 6.9 15.2 13.4 17.8 15.1 4.2 10.5 9.0 6.5 12.5 18.4 9.5 12.9 2.5 11.5 11.6 42.1 12.9 15.0 1.0 13.5 11.7 9.6 13.1 7.6 12.4 9.7 16.3 5.9 22.3 24.1 15.0 15.1 9.3 6.8 16.9 15.7 6.3 16.7 21.4 10.8 1.8 46.3 4.9 5.8 13.2 8.8 15.8 8.7 12.9 15.1 23.5 29.6 17.6 13.3 14.6 0.0 14.4 1.0 12.3 21.9 11.1 7.5 13.3 12.8 18.0 6.2 15.0 12.9 0.4 9.9 16.3 42.5 6.9 12.3 67.8 111.9 16.0 54.1 80.7 58.2 114.1 36.7 82.5 94.7 QTRT1 TGT ENSG00000213339 "Queuine tRNA-ribosyltransferase catalytic subunit 1" Q9BXR0 19 10701430-10713437 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042695, HPA048651, HPA049440" Approved Approved Mitochondria Mitochondria "HPA042695: , HPA048651: , HPA049440: AB_2680767" "unprognostic (6.19e-2)" "prognostic favourable (7.63e-5)" "unprognostic (2.90e-2)" "unprognostic (3.05e-1)" "unprognostic (4.90e-2)" "prognostic favourable (4.90e-4)" "unprognostic (2.52e-1)" "unprognostic (8.76e-3)" "unprognostic (3.88e-1)" "unprognostic (4.81e-3)" "prognostic favourable (2.13e-4)" "unprognostic (1.14e-2)" "prognostic unfavourable (1.13e-6)" "unprognostic (2.04e-2)" "unprognostic (1.66e-1)" "unprognostic (3.13e-1)" "unprognostic (1.01e-3)" 14.0 18.4 20.6 13.4 29.1 14.2 11.5 18.0 21.3 11.3 14.5 13.3 19.4 12.8 15.3 11.6 14.6 15.8 13.5 19.5 19.7 13.1 11.8 18.9 8.4 13.5 22.9 19.3 22.1 33.9 5.8 12.0 9.8 19.9 13.7 6.6 10.5 26.6 12.7 20.5 12.6 14.2 13.3 12.7 11.5 12.5 5.0 22.2 5.3 19.0 11.9 10.3 12.0 10.3 19.6 19.1 0.9 14.4 18.5 18.8 10.4 17.1 13.9 6.6 19.3 6.9 8.4 8.6 8.8 7.9 10.3 10.2 11.0 6.6 19.4 21.7 5.0 11.6 6.0 10.6 3.4 11.4 8.3 12.8 5.6 23.3 12.1 18.9 11.3 12.4 9.1 6.7 9.8 10.5 14.0 22.4 5.1 26.9 16.3 23.7 17.4 21.5 17.2 8.8 30.0 8.4 11.0 21.5 9.3 13.5 14.8 11.5 9.4 8.0 8.1 15.9 8.8 25.4 20.5 24.7 19.0 9.5 8.6 23.1 19.2 0.9 8.3 0.2 15.1 14.4 18.8 19.6 16.3 13.1 16.4 19.0 17.5 13.9 0.6 18.5 7.3 19.1 17.7 10.4 20.6 29.1 18.0 21.3 19.7 13.1 22.9 19.3 19.9 22.2 RASGEF1C FLJ35841 ENSG00000146090 "RasGEF domain family member 1C" Q8N431 5 180100791-180209153 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 27.4;testis: 7.1" "Cell line enhanced" "Detected in some" "BEWO: 3.6;HEK 293: 2.7;MCF7: 3.8;SCLC-21H: 12.4;U-2 OS: 3.8" "Cancer enhanced" "Detected in some" "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.4" "Lineage enriched" "Detected in single" 14 "monocytes: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028242 Uncertain Approved Mitochondria Mitochondria "HPA028242: AB_10602294" "unprognostic (2.21e-1)" "unprognostic (2.18e-1)" "unprognostic (2.23e-1)" "unprognostic (4.75e-4)" "unprognostic (4.65e-2)" "unprognostic (4.04e-2)" "unprognostic (3.84e-2)" "unprognostic (1.02e-3)" "unprognostic (2.02e-1)" "unprognostic (1.16e-1)" "unprognostic (2.35e-2)" "unprognostic (2.34e-1)" "unprognostic (1.65e-4)" "unprognostic (5.89e-2)" "unprognostic (8.25e-3)" "unprognostic (3.70e-1)" "unprognostic (1.77e-2)" 1.1 1.1 7.0 1.1 5.4 0.6 1.4 27.4 22.0 1.4 2.3 9.2 0.0 0.8 0.6 0.8 1.2 1.7 1.2 1.5 4.5 2.8 0.6 0.6 0.6 0.6 5.1 4.9 0.8 0.9 0.8 0.2 0.8 7.7 0.8 1.1 0.4 3.0 2.7 0.7 1.1 1.4 1.0 8.3 0.7 0.8 7.1 4.7 0.0 2.1 0.0 0.6 0.8 0.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 3.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.6 0.0 0.0 0.3 0.2 0.0 0.0 0.0 3.8 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 7.0 5.4 27.4 11.1 4.5 2.8 5.1 4.9 7.7 4.7 RBFA "C18orf22, FLJ21172, HsT169" ENSG00000101546 "Ribosome binding factor A" Q8N0V3 18 80034358-80046397 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040485, HPA041479" Approved Supported Mitochondria Mitochondria "HPA040485: AB_10795368, HPA041479: AB_10795697" "unprognostic (5.31e-3)" "unprognostic (3.21e-2)" "unprognostic (1.87e-1)" "unprognostic (4.55e-2)" "unprognostic (7.33e-2)" "unprognostic (5.00e-3)" "prognostic unfavourable (2.06e-6)" "unprognostic (2.98e-1)" "unprognostic (7.98e-2)" "unprognostic (7.22e-2)" "unprognostic (4.28e-2)" "unprognostic (3.76e-2)" "unprognostic (2.43e-1)" "unprognostic (3.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.82e-1)" "unprognostic (5.00e-3)" 19.4 21.0 11.3 14.4 15.8 16.7 30.9 20.4 17.3 12.1 12.5 15.9 10.0 14.8 13.6 14.3 17.7 11.4 12.9 13.8 10.6 8.6 14.5 36.9 11.0 18.5 12.5 14.2 12.3 20.0 12.5 9.7 12.6 12.7 11.8 12.7 11.3 13.4 12.3 21.3 18.6 11.1 18.3 13.8 13.2 12.1 13.8 12.8 9.9 11.6 18.6 15.7 14.0 14.2 10.7 8.3 0.3 10.1 7.5 11.7 5.7 14.2 16.0 11.3 10.4 11.5 13.7 14.6 12.1 7.7 17.9 16.1 9.4 12.5 30.0 4.6 10.9 13.5 12.5 15.6 14.4 10.9 13.0 17.8 11.6 24.7 8.8 28.1 8.8 13.1 15.3 11.8 17.2 15.0 9.5 18.7 10.9 13.7 27.9 19.4 11.8 15.9 18.8 10.5 36.6 17.2 16.7 19.5 11.8 10.9 13.0 8.3 9.4 14.2 10.2 20.3 19.0 3.0 13.1 6.9 11.9 25.1 11.8 24.5 11.6 0.0 5.1 0.0 7.5 7.0 11.7 10.7 7.6 7.3 8.3 8.3 8.4 7.9 0.3 7.5 10.1 6.5 5.8 5.7 11.3 15.8 20.4 17.3 10.6 8.6 12.5 14.2 12.7 12.8 RICTOR "AVO3, KIAA1999, MGC39830, PIA" ENSG00000164327 "RPTOR independent companion of MTOR complex 2" Q6R327 5 38937919-39074408 "Predicted intracellular proteins" "Host-virus interaction" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 22.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 22.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037802, HPA037803" Approved Approved Mitochondria Mitochondria "HPA037802: AB_10672286, HPA037803: " "unprognostic (2.25e-2)" "unprognostic (8.30e-2)" "unprognostic (4.02e-1)" "unprognostic (7.94e-3)" "unprognostic (5.47e-2)" "unprognostic (2.95e-3)" "unprognostic (2.95e-3)" "unprognostic (1.33e-1)" "unprognostic (3.55e-2)" "unprognostic (4.37e-1)" "unprognostic (2.73e-2)" "unprognostic (8.29e-2)" "unprognostic (2.41e-1)" "unprognostic (2.58e-1)" "unprognostic (3.42e-1)" "unprognostic (1.51e-1)" "unprognostic (1.64e-2)" 15.4 10.0 12.4 14.2 15.7 35.5 16.4 25.6 20.1 14.7 12.7 18.8 9.8 9.4 17.7 12.7 10.8 12.7 11.0 16.1 13.6 9.8 12.7 13.2 18.7 17.7 20.0 10.1 18.0 12.7 14.3 20.0 21.6 24.1 12.1 11.8 10.0 12.9 9.7 22.1 15.2 15.3 17.9 16.3 16.4 12.4 15.2 21.4 31.6 15.1 8.3 15.3 17.1 14.4 3.5 3.6 22.2 2.2 2.5 4.6 0.5 4.6 8.5 6.3 6.2 8.0 9.3 9.2 6.5 15.3 7.2 7.3 5.2 8.5 7.7 2.5 6.4 7.7 5.5 7.1 8.7 6.8 4.9 9.0 20.3 6.2 5.2 7.5 12.1 7.8 5.3 8.9 9.8 11.9 7.3 14.8 4.8 2.4 7.7 12.7 4.0 6.7 6.2 11.2 6.7 6.0 7.8 5.3 3.6 17.1 6.4 8.8 4.4 8.4 10.1 14.7 7.2 5.9 4.9 6.6 4.1 7.7 6.3 10.2 5.4 6.1 1.0 5.6 3.7 1.0 3.0 2.6 3.7 3.2 1.0 3.5 3.9 4.6 22.2 2.5 2.2 3.6 2.2 0.5 12.4 15.7 25.6 20.1 13.6 9.8 20.0 10.1 24.1 21.4 RMND1 "bA351K16.3, C6orf96, FLJ20627, RMD1" ENSG00000155906 "Required for meiotic nuclear division 1 homolog" Q9NWS8 6 151404762-151452181 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031397, HPA031398, HPA031399" Approved Supported Mitochondria Mitochondria "HPA031397: , HPA031398: , HPA031399: AB_10601156" "unprognostic (1.12e-1)" "unprognostic (4.45e-2)" "unprognostic (9.70e-3)" "unprognostic (6.67e-2)" "unprognostic (2.65e-2)" "prognostic unfavourable (6.96e-4)" "unprognostic (1.50e-3)" "unprognostic (6.56e-2)" "unprognostic (1.02e-1)" "unprognostic (1.73e-1)" "unprognostic (2.03e-1)" "unprognostic (3.57e-1)" "unprognostic (1.47e-1)" "unprognostic (1.55e-1)" "unprognostic (1.80e-1)" "unprognostic (9.74e-2)" "unprognostic (1.04e-1)" 12.9 15.7 9.0 6.8 12.1 4.0 17.0 14.5 15.6 10.5 12.8 7.7 6.4 13.2 10.9 11.7 8.3 12.2 8.0 11.4 9.9 11.7 34.0 29.1 7.8 8.2 10.1 13.5 15.7 9.9 6.9 11.2 14.4 14.0 8.0 11.5 10.5 7.3 8.0 10.9 7.9 14.9 11.2 8.9 6.9 8.0 8.6 7.0 11.2 18.9 6.0 9.5 10.6 11.9 11.3 7.2 6.8 12.2 13.2 11.3 5.0 8.0 3.7 8.3 17.2 11.2 25.5 11.3 12.7 12.3 9.8 13.6 10.6 6.1 7.7 9.1 8.1 7.0 15.2 7.9 17.1 8.8 12.1 12.1 5.9 21.7 22.9 27.1 3.9 17.8 10.2 14.0 21.4 12.7 13.2 6.2 14.9 26.3 9.2 8.7 6.1 7.4 10.5 10.2 9.5 13.9 3.6 13.9 13.4 9.0 11.4 15.1 19.1 17.5 7.2 7.7 10.1 16.0 9.9 6.4 8.4 8.8 19.3 21.2 8.9 2.1 5.9 6.8 7.1 8.2 11.2 11.3 8.5 9.9 7.2 9.0 11.2 10.2 2.9 13.2 12.2 3.3 11.3 5.0 9.0 12.1 14.5 15.6 9.9 11.7 10.1 13.5 14.0 7.0 RNF138 "NARF, STRIN" ENSG00000134758 "Ring finger protein 138" Q8WVD3 18 32091855-32131561 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway, Wnt signaling pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 43.8;bone marrow: 40.4;lymphoid tissue: 28.3;testis: 73.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041101 Approved Mitochondria Mitochondria "HPA041101: AB_10805837" "unprognostic (2.37e-2)" "unprognostic (4.63e-3)" "unprognostic (2.03e-3)" "unprognostic (1.01e-1)" "unprognostic (2.34e-1)" "unprognostic (2.93e-2)" "unprognostic (1.47e-2)" "unprognostic (9.64e-2)" "unprognostic (1.29e-2)" "unprognostic (1.90e-2)" "unprognostic (6.90e-2)" "unprognostic (1.27e-2)" "unprognostic (6.15e-2)" "unprognostic (9.52e-3)" "unprognostic (2.77e-1)" "unprognostic (9.58e-2)" "unprognostic (1.90e-1)" 8.2 5.0 6.5 11.0 7.4 40.4 7.7 9.9 7.1 6.5 11.0 9.0 5.8 8.0 7.5 6.3 7.4 9.7 7.1 5.0 6.8 6.4 5.9 10.1 7.6 17.9 10.6 6.3 9.0 7.8 5.6 8.7 7.2 6.7 6.5 10.0 4.5 6.9 4.9 5.1 5.6 11.2 5.6 9.1 14.3 6.6 73.4 8.1 28.3 7.0 5.7 9.9 6.1 6.8 14.4 24.3 25.7 24.9 16.4 43.8 24.2 8.9 5.3 22.0 10.9 2.8 6.0 12.5 9.2 5.2 11.5 13.4 6.2 6.3 21.6 11.5 6.0 9.4 11.5 10.4 15.7 12.0 19.2 17.0 6.9 7.6 11.3 46.8 15.1 5.8 10.4 12.7 18.1 11.7 23.4 8.9 7.4 8.5 31.6 21.0 24.6 7.4 32.7 13.8 12.4 10.5 6.7 25.0 12.5 12.3 7.1 9.5 4.6 19.8 9.0 13.9 10.2 3.4 10.2 14.8 19.5 37.5 7.6 26.2 13.6 8.0 24.9 24.0 10.5 18.6 13.4 14.0 22.9 14.8 24.3 14.4 43.8 27.9 25.7 16.4 15.3 10.5 16.7 24.2 6.5 7.4 9.9 7.1 6.8 6.4 10.6 6.3 6.7 8.1 RPLP2 "D11S2243E, LP2, MGC71408, P2, RPP2" ENSG00000177600 "Ribosomal protein lateral stalk subunit P2" P05387 11 809647-812880 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 314.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053635 Approved Approved Mitochondria "Intracellular and membrane" 730000 Mitochondria "HPA053635: " "unprognostic (6.98e-3)" "unprognostic (2.21e-1)" "unprognostic (4.57e-2)" "unprognostic (8.63e-2)" "unprognostic (2.30e-2)" "unprognostic (2.39e-1)" "prognostic unfavourable (9.14e-4)" "unprognostic (1.63e-1)" "unprognostic (2.98e-1)" "unprognostic (1.93e-1)" "unprognostic (2.08e-1)" "unprognostic (2.99e-1)" "prognostic unfavourable (2.19e-6)" "unprognostic (6.52e-2)" "unprognostic (1.67e-1)" "unprognostic (1.16e-1)" "unprognostic (3.31e-2)" 165.8 66.1 52.7 134.4 47.8 132.4 240.5 28.0 42.6 110.3 108.3 43.2 78.6 82.6 103.7 95.7 160.7 76.7 99.1 129.1 45.8 37.0 67.4 118.5 103.2 499.1 51.9 28.5 190.5 241.9 20.4 49.2 75.3 35.9 118.4 70.3 53.1 154.6 97.8 160.3 125.6 95.7 108.6 52.4 176.3 75.7 60.0 32.4 207.7 111.3 106.1 155.0 136.0 190.6 232.5 127.3 27.8 82.7 82.7 233.6 233.4 78.5 83.8 45.5 62.2 64.5 68.1 64.0 47.2 32.3 51.9 42.1 130.0 66.4 100.2 35.0 43.3 75.5 52.7 74.0 25.5 46.3 314.4 51.0 71.3 188.1 73.4 97.8 58.2 87.8 112.0 20.9 66.2 52.3 91.2 67.5 35.9 97.2 90.8 158.6 99.2 222.3 104.8 42.1 111.3 50.6 62.1 61.7 91.0 30.8 97.4 107.9 36.3 132.6 50.7 32.8 42.7 29.0 60.9 114.4 91.8 97.7 53.3 75.4 39.1 27.8 82.7 27.2 100.7 65.2 140.1 232.5 189.1 142.1 94.0 222.8 233.6 178.0 11.9 82.7 51.5 127.3 106.4 233.4 52.7 47.8 28.0 42.6 45.8 37.0 51.9 28.5 35.9 32.4 RTP3 "LTM1, TMEM7, Z3CXXC3" ENSG00000163825 "Receptor transporter protein 3" Q9BQQ7 3 46497491-46500949 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 91 "liver: 43.3" "Cell line enriched" "Detected in some" 9 "SiHa: 14.8" "Group enriched" "Detected in some" 17 "liver cancer: 22.9;testis cancer: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA075932 Uncertain Mitochondria Mitochondria "HPA075932: " "unprognostic (2.09e-1)" "unprognostic (1.64e-1)" "prognostic favourable (3.11e-6)" "unprognostic (1.08e-1)" "unprognostic (1.58e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 S100A10 "42C, ANX2LG, CAL1L, CLP11, P11" ENSG00000197747 "S100 calcium binding protein A10" P60903 1 151982915-151994390 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 148.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 148.1;monocytes: 89.2;T-cells: 85.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003340, CAB025484" Enhanced Approved Mitochondria 230000 Mitochondria "CAB025484: , HPA003340: AB_1856531" "unprognostic (2.13e-1)" "unprognostic (1.51e-3)" "unprognostic (1.01e-1)" "unprognostic (3.15e-1)" "unprognostic (6.20e-2)" "prognostic unfavourable (3.33e-4)" "prognostic unfavourable (1.00e-4)" "prognostic unfavourable (2.66e-5)" "unprognostic (1.09e-2)" "unprognostic (9.48e-2)" "prognostic unfavourable (3.88e-4)" "unprognostic (1.36e-1)" "prognostic unfavourable (3.80e-8)" "unprognostic (1.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.33e-1)" "prognostic unfavourable (3.84e-4)" 36.7 19.9 7.3 12.1 9.4 4.5 30.7 7.3 10.7 19.0 42.3 8.4 7.3 23.4 7.3 10.1 87.1 8.5 10.7 16.7 7.3 4.4 19.1 10.2 33.5 7.3 7.3 7.3 11.5 7.3 1.6 7.3 18.7 11.1 8.5 49.8 9.5 21.1 7.3 7.3 21.8 21.7 14.0 9.6 7.3 8.6 61.4 7.3 7.3 7.3 22.1 13.6 8.1 37.7 17.8 148.1 21.4 89.2 25.9 85.4 74.8 70.5 72.4 0.2 15.0 81.9 109.3 54.0 40.0 54.0 35.9 36.4 130.0 98.3 0.0 38.9 69.7 123.3 20.6 155.5 33.5 12.7 5.9 8.6 32.9 30.5 29.4 3.2 7.4 28.4 131.1 39.1 45.0 79.3 0.1 0.2 47.6 61.2 0.6 20.6 9.7 80.5 0.0 14.0 1.4 151.1 21.0 0.6 0.5 65.3 23.4 30.4 51.7 8.3 84.2 17.2 43.1 81.4 27.9 1.9 0.4 12.1 101.1 2.9 60.2 21.4 89.2 21.0 33.3 54.4 35.2 17.8 52.6 42.3 148.1 8.6 19.6 29.5 3.2 25.9 46.5 24.2 85.4 74.8 7.3 9.4 7.3 10.7 7.3 4.4 7.3 7.3 11.1 7.3 S1PR4 EDG6 ENSG00000125910 "Sphingosine-1-phosphate receptor 4" O95977 19 3172346-3180332 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 44.2;bone marrow: 14.9;lymphoid tissue: 35.9" "Cell line enhanced" "Detected in some" "HDLM-2: 10.8;HL-60: 14.4;NB-4: 14.2;REH: 40.1;U-937: 13.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA060601, HPA067232" Supported Mitochondria Mitochondria "HPA060601: , HPA067232: " "prognostic favourable (3.13e-4)" "prognostic favourable (1.33e-4)" "unprognostic (2.58e-2)" "prognostic favourable (2.22e-4)" "unprognostic (2.98e-2)" "prognostic favourable (1.45e-6)" "unprognostic (1.27e-2)" "unprognostic (8.73e-2)" "unprognostic (1.21e-3)" "unprognostic (6.64e-3)" "unprognostic (3.59e-1)" "unprognostic (2.20e-1)" "prognostic unfavourable (2.87e-4)" "unprognostic (2.97e-1)" "unprognostic (1.12e-1)" "unprognostic (2.06e-1)" "unprognostic (6.15e-3)" 2.0 0.5 0.7 8.3 0.3 14.9 1.3 0.6 0.7 0.5 0.9 0.4 0.2 0.8 0.7 0.7 1.2 1.4 0.7 2.1 0.3 0.2 1.2 1.4 6.4 35.9 0.3 0.4 0.7 0.3 0.0 0.2 1.7 0.6 0.7 0.0 1.0 1.3 0.2 1.1 0.4 7.1 0.2 0.5 34.2 3.9 0.3 0.3 10.2 1.5 0.2 10.7 1.9 0.6 14.1 7.3 44.2 15.3 5.4 23.1 7.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.1 0.0 0.1 0.0 0.0 0.0 10.8 0.0 4.6 0.1 0.0 0.0 14.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 40.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 13.7 0.0 16.4 10.4 27.4 11.8 11.6 10.5 11.3 14.7 11.4 7.3 14.1 12.4 11.9 44.2 5.4 15.3 6.6 23.1 7.2 0.7 0.3 0.6 0.7 0.3 0.2 0.3 0.4 0.6 0.3 SAMD13 ENSG00000203943 "Sterile alpha motif domain containing 13" Q5VXD3 1 84298366-84389957 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 19.4" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "basophil: 11.2" "Lineage enriched" "Detected in many" 8 "granulocytes: 11.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA058929 Enhanced Approved Mitochondria Mitochondria "HPA058929: " "unprognostic (3.78e-2)" "unprognostic (4.93e-2)" "unprognostic (8.51e-3)" "unprognostic (7.55e-2)" "prognostic favourable (1.14e-8)" "unprognostic (1.78e-1)" "unprognostic (1.65e-6)" "unprognostic (2.05e-1)" "unprognostic (5.50e-2)" "unprognostic (2.80e-3)" "unprognostic (9.42e-2)" "unprognostic (3.29e-1)" "unprognostic (1.98e-7)" "unprognostic (3.99e-2)" "unprognostic (1.81e-1)" "unprognostic (1.17e-1)" "unprognostic (7.56e-3)" 1.2 5.2 4.9 1.0 12.9 2.1 2.0 9.1 5.8 1.5 16.6 7.4 0.6 2.6 1.8 4.5 1.1 3.7 1.4 1.7 4.8 2.3 1.7 0.4 0.7 0.8 7.9 6.5 0.5 2.3 1.0 2.3 0.5 4.5 3.4 19.4 0.4 13.6 1.9 7.6 1.2 3.0 2.1 5.1 1.5 5.6 12.4 8.5 3.5 8.6 2.0 0.4 2.7 0.7 0.6 1.4 11.2 0.8 0.7 0.5 0.3 0.7 2.6 1.2 4.1 4.3 4.3 2.7 0.3 0.3 0.3 0.3 0.2 4.1 4.3 7.6 0.2 0.8 0.4 1.4 0.6 2.3 2.1 1.5 1.8 0.4 1.1 4.9 0.1 1.5 2.0 0.1 1.2 10.2 0.6 1.2 1.2 1.2 6.3 0.6 4.1 2.6 0.7 3.1 1.6 8.0 2.7 1.7 6.3 0.1 0.2 9.3 1.2 4.6 1.6 1.4 0.4 0.4 1.1 3.3 0.6 7.3 0.5 4.4 1.3 11.2 0.4 0.0 0.1 0.8 0.3 0.2 0.1 0.1 0.9 0.6 0.5 0.5 0.2 0.7 0.3 1.4 0.0 0.3 4.9 12.9 9.1 5.8 4.8 2.3 7.9 6.5 4.5 8.5 SAMM50 "CGI-51, OMP85, SAM50, TOB55, TRG-3, YNL026W" ENSG00000100347 "SAMM50 sorting and assembly machinery component" Q9Y512 22 43955421-44010531 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034537 Enhanced Supported Mitochondria 3700000 Mitochondria "HPA034537: AB_10602794" "unprognostic (2.92e-1)" "unprognostic (1.01e-1)" "unprognostic (1.95e-3)" "prognostic favourable (2.63e-7)" "unprognostic (2.43e-3)" "unprognostic (2.28e-1)" "unprognostic (5.28e-3)" "unprognostic (1.70e-3)" "unprognostic (3.37e-2)" "unprognostic (1.95e-1)" "unprognostic (2.42e-1)" "unprognostic (3.52e-1)" "prognostic favourable (4.43e-8)" "unprognostic (1.08e-1)" "unprognostic (1.51e-1)" "unprognostic (2.41e-1)" "unprognostic (1.60e-1)" 21.7 25.1 12.4 13.9 13.6 10.2 16.0 10.5 20.1 17.4 15.6 11.2 17.2 18.9 12.6 13.5 14.6 16.3 18.2 34.3 11.3 11.9 18.5 18.8 8.9 18.6 12.7 14.7 16.0 16.7 60.6 12.2 7.6 16.4 10.4 13.7 14.3 19.3 13.6 79.5 15.8 21.2 14.2 12.3 12.2 18.5 11.5 8.6 17.4 10.8 34.6 15.1 11.5 11.0 27.7 34.0 22.4 19.6 18.2 29.3 18.5 21.9 20.9 20.4 24.6 26.4 28.0 28.5 21.6 23.2 32.0 27.6 29.8 16.2 36.5 15.9 24.6 26.6 30.1 28.9 28.8 10.0 37.2 19.7 27.5 35.1 18.5 62.5 29.8 32.3 23.2 27.5 12.8 32.8 16.8 12.1 28.6 31.3 24.4 24.5 19.9 25.1 28.7 22.1 29.5 26.6 28.2 12.2 19.9 23.9 25.6 35.3 24.0 20.6 20.1 20.7 25.0 19.1 17.6 18.0 24.7 28.1 26.0 22.8 20.7 19.2 19.6 22.4 21.2 19.2 29.3 27.7 19.8 21.5 34.0 24.5 20.8 19.5 3.2 18.2 14.7 13.4 22.7 18.5 12.4 13.6 10.5 20.1 11.3 11.9 12.7 14.7 16.4 8.6 SARDH "DMGDHL1, SDH" ENSG00000123453 "Sarcosine dehydrogenase" Q9UL12 9 133663560-133739955 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 25.3;liver: 52.8;pancreas: 39.4" "Cell line enhanced" "Detected in many" "AN3-CA: 10.9;Hep G2: 18.4;MOLT-4: 13.3;RH-30: 11.4;RPMI-8226: 23.0;SH-SY5Y: 9.2" "Cancer enriched" "Detected in many" 8 "liver cancer: 18.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 4.1;naive CD4 T-cell: 8.4;T-reg: 9.7" "Lineage enriched" "Detected in single" 15 "T-cells: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057267, HPA058086" Approved Approved Mitochondria 190000 Mitochondria "HPA057267: , HPA058086: " "unprognostic (3.64e-2)" "unprognostic (4.87e-2)" "unprognostic (2.31e-2)" "unprognostic (1.38e-1)" "prognostic unfavourable (4.62e-4)" "unprognostic (5.83e-2)" "unprognostic (1.42e-3)" "unprognostic (2.21e-1)" "unprognostic (1.58e-1)" "unprognostic (1.43e-1)" "unprognostic (2.23e-1)" "unprognostic (1.74e-1)" "unprognostic (7.74e-3)" "unprognostic (2.78e-1)" "unprognostic (3.48e-1)" "unprognostic (9.73e-2)" "unprognostic (1.30e-2)" 0.5 1.1 1.7 1.0 1.8 0.3 0.4 0.8 1.9 0.9 0.5 1.1 2.9 0.8 1.4 25.3 0.3 0.9 1.2 1.1 1.1 1.4 5.8 52.8 1.3 1.7 1.2 2.1 3.4 39.4 2.0 1.9 0.3 1.2 1.4 0.1 3.7 8.2 0.9 0.3 0.2 0.6 0.6 0.6 0.7 1.2 1.1 0.8 2.2 0.8 0.2 1.2 0.6 0.6 0.4 0.3 0.6 0.1 0.1 9.7 1.6 0.0 0.1 0.8 10.9 0.0 0.3 1.4 0.1 0.4 0.5 0.7 0.2 0.1 0.0 1.5 0.1 0.0 0.0 0.2 0.4 0.0 0.2 1.5 0.0 18.4 1.2 0.0 0.2 2.6 0.0 1.3 0.0 0.1 0.0 0.2 6.9 1.9 13.3 1.4 1.7 0.1 0.9 11.4 23.0 0.0 0.1 1.0 9.2 0.0 0.3 2.3 1.5 0.1 0.0 2.1 1.9 0.2 0.0 0.1 0.0 0.7 1.3 0.8 0.0 0.1 0.1 0.1 0.4 0.0 1.0 0.0 4.1 1.0 0.0 0.4 8.4 1.5 0.6 0.1 0.0 0.3 9.7 1.6 1.7 1.8 0.8 1.9 1.1 1.4 1.2 2.1 1.2 0.8 SBK3 SgK110 ENSG00000231274 "SH3 domain binding kinase family member 3" P0C264 19 55540656-55545543 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "heart muscle: 24.2" "Cell line enhanced" "Detected in some" "A549: 9.2;CACO-2: 3.2;CAPAN-2: 5.4;NTERA-2: 2.5;RH-30: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA078322 Approved Mitochondria Mitochondria "HPA078322: " "unprognostic (2.15e-1)" "unprognostic (1.99e-3)" "unprognostic (2.71e-1)" "unprognostic (1.39e-3)" "unprognostic (7.52e-2)" "unprognostic (2.83e-1)" "unprognostic (5.47e-5)" "unprognostic (4.64e-3)" "unprognostic (7.24e-2)" "unprognostic (1.65e-1)" "unprognostic (3.38e-1)" "unprognostic (3.08e-3)" "unprognostic (1.21e-2)" "unprognostic (4.92e-2)" "unprognostic (2.41e-1)" "unprognostic (1.79e-1)" 2.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.1 24.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.8 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.3 3.2 5.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.0 0.0 0.0 2.5 0.6 0.2 4.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 1.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCO2 "MYP6, SCO1L" ENSG00000130489 "SCO2, cytochrome c oxidase assembly protein" O43819 22 50523568-50525606 "Disease related genes, Predicted membrane proteins" Chaperone "Cardiomyopathy, Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA046943, HPA056254" Approved Approved Mitochondria Mitochondria "HPA046943: , HPA056254: " "unprognostic (8.79e-2)" "unprognostic (4.44e-2)" "unprognostic (1.62e-1)" "unprognostic (6.14e-3)" "unprognostic (3.74e-1)" "unprognostic (5.86e-3)" "unprognostic (1.27e-3)" "unprognostic (1.32e-1)" "unprognostic (4.05e-3)" "unprognostic (6.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.95e-1)" "prognostic unfavourable (1.67e-4)" "unprognostic (5.53e-2)" "unprognostic (1.42e-1)" "unprognostic (2.64e-1)" "unprognostic (4.51e-2)" 13.0 11.6 8.8 20.6 9.0 27.9 16.6 15.2 14.7 8.1 25.1 4.5 7.9 21.6 7.4 9.0 19.7 22.9 10.1 19.7 8.8 10.9 21.3 28.0 14.9 12.3 7.4 11.3 8.0 18.4 2.6 8.9 10.0 7.2 7.7 6.6 5.5 22.1 4.6 9.9 14.3 18.8 8.1 8.0 13.9 8.9 8.4 5.0 6.9 12.2 13.8 14.1 10.1 6.9 17.4 23.8 7.0 7.9 11.7 22.1 15.1 14.9 14.2 6.8 9.2 6.8 9.2 10.3 10.1 8.2 13.4 11.7 17.5 8.4 20.3 7.9 8.0 17.8 6.9 11.7 2.4 5.7 38.0 6.5 21.9 23.0 15.7 17.1 12.6 13.7 17.8 6.9 5.8 8.9 7.2 27.7 5.7 27.9 8.4 34.3 7.1 23.5 14.0 8.7 22.8 10.2 10.5 10.3 12.7 11.4 32.5 23.2 12.6 16.4 10.6 11.7 11.3 13.1 11.1 13.2 6.7 9.1 15.9 13.2 10.0 5.2 6.3 2.9 22.1 7.3 20.9 17.4 18.6 21.8 10.6 15.4 14.6 17.0 7.0 11.7 7.9 23.8 15.4 15.1 8.8 9.0 15.2 14.7 8.8 10.9 7.4 11.3 7.2 5.0 SCO2 ENSG00000284194 "SCO2, cytochrome c oxidase assembly protein" 22 50523568-50526439 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 17.6;bone marrow: 13.0" "Cell line enhanced" "Detected in many" "RPMI-8226: 13.5" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA046943, HPA056254" Uncertain Approved Mitochondria Mitochondria "HPA046943: , HPA056254: " 2.4 1.1 0.7 6.3 0.6 13.0 6.7 0.6 1.2 1.5 2.3 0.0 1.1 0.6 0.6 0.7 4.6 0.8 2.4 4.3 0.1 2.8 4.2 3.7 9.3 0.4 0.0 1.2 0.8 0.0 0.0 0.9 0.6 1.6 0.5 0.1 4.2 0.2 0.7 1.8 3.5 1.6 1.7 5.7 1.9 0.4 0.6 10.6 1.0 1.4 2.6 1.6 0.7 10.3 17.6 10.4 12.6 4.0 10.3 10.7 4.0 2.7 0.1 2.6 0.0 0.5 2.3 2.8 1.9 2.4 1.9 0.4 3.7 6.9 2.0 0.9 2.5 1.0 0.0 0.0 1.3 10.6 3.5 0.7 0.4 4.9 9.3 2.8 3.3 1.2 1.2 0.5 0.4 4.4 9.4 1.4 1.5 1.1 9.8 1.4 4.1 6.4 0.7 13.5 1.8 1.1 0.6 2.3 1.2 0.4 9.5 1.4 7.2 3.1 1.7 3.7 2.9 2.4 8.0 2.5 9.6 3.9 2.1 1.6 8.4 12.6 8.7 7.2 7.3 8.7 10.3 9.4 7.8 17.6 8.9 6.9 5.5 10.4 4.0 6.8 12.6 10.3 10.7 SDHAF1 LYRM8 ENSG00000205138 "Succinate dehydrogenase complex assembly factor 1" A6NFY7 19 35995199-35996315 "Disease related genes, Predicted intracellular proteins" Chaperone "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064277 Approved Mitochondria Mitochondria "HPA064277: " "unprognostic (2.01e-1)" "unprognostic (3.46e-2)" "unprognostic (2.22e-2)" "unprognostic (3.11e-2)" "unprognostic (1.81e-1)" "unprognostic (4.47e-2)" "unprognostic (5.25e-2)" "unprognostic (2.29e-2)" "unprognostic (1.24e-1)" "unprognostic (3.78e-2)" "unprognostic (6.89e-3)" "unprognostic (1.83e-2)" "prognostic favourable (2.11e-4)" "unprognostic (1.38e-2)" "unprognostic (2.59e-1)" "unprognostic (2.24e-1)" "unprognostic (3.59e-2)" 11.2 15.7 13.5 11.1 14.7 7.3 14.0 24.5 23.4 14.0 16.7 17.0 13.1 25.0 12.4 13.1 14.8 12.1 11.9 11.1 14.8 13.7 14.4 23.5 10.4 17.6 19.0 10.3 13.6 24.5 11.2 15.1 10.5 12.5 13.9 10.0 9.9 23.7 13.8 17.4 12.4 20.6 15.3 14.3 15.0 16.8 7.7 14.4 14.4 21.9 12.6 11.2 15.8 14.0 31.5 28.5 33.4 26.4 32.7 33.2 20.9 6.0 16.0 4.8 11.0 4.7 6.0 8.3 5.9 6.5 6.5 7.6 11.4 4.7 11.4 11.6 3.9 6.1 6.3 3.3 3.1 21.3 14.7 5.0 6.6 14.9 5.7 5.9 8.3 5.2 10.9 3.9 4.3 3.6 15.4 12.5 2.8 14.9 11.3 11.8 7.4 7.8 12.4 5.3 12.7 6.3 7.9 18.8 14.0 9.6 15.7 10.1 9.0 10.1 4.7 7.5 11.2 7.1 9.0 16.9 7.8 13.2 6.5 11.5 6.6 23.3 22.1 33.4 27.5 24.3 29.4 27.6 29.4 26.5 22.7 31.5 33.2 27.8 12.1 32.7 26.4 28.5 30.2 20.9 13.5 14.7 24.5 23.4 14.8 13.7 19.0 10.3 12.5 14.4 SERPINA5 "PAI3, PCI, PLANH3, PROCI" ENSG00000188488 "Serpin family A member 5" P05154 14 94561442-94593120 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Fertilization, Lipid transport, Transport" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 100.4;ductus deferens: 126.6;liver: 112.4;seminal vesicle: 106.7;testis: 146.5" "Cell line enriched" "Detected in some" 14 "Hep G2: 74.3" "Cancer enhanced" "Detected in many" "liver cancer: 121.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA056919 Approved Mitochondria "Secreted to blood" 2300000000 Mitochondria "HPA056919: " "unprognostic (5.94e-3)" "unprognostic (2.64e-4)" "unprognostic (1.13e-1)" "prognostic favourable (7.72e-4)" "unprognostic (3.34e-3)" "unprognostic (6.10e-3)" "unprognostic (3.94e-2)" "unprognostic (1.39e-3)" "unprognostic (5.36e-1)" "unprognostic (1.50e-1)" "unprognostic (6.16e-2)" "unprognostic (1.87e-2)" "unprognostic (8.39e-3)" "unprognostic (3.38e-3)" "unprognostic (9.92e-2)" "unprognostic (8.08e-2)" "unprognostic (3.23e-1)" 1.1 100.4 0.4 1.8 1.8 0.0 7.7 0.2 0.5 4.0 1.0 1.6 126.6 0.6 4.8 5.0 0.5 3.6 34.3 5.6 0.6 0.4 33.6 112.4 0.3 1.9 3.1 0.3 6.4 33.8 0.0 0.8 0.2 1.9 1.9 0.0 0.9 10.9 106.7 6.6 0.7 0.7 0.4 1.5 36.1 2.0 146.5 0.6 0.1 0.9 1.5 0.6 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.9 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.3 0.1 0.1 0.0 0.5 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 1.2 0.0 0.1 5.1 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.8 0.2 0.5 0.6 0.4 3.1 0.3 1.9 0.6 SETD3 "C14orf154, FLJ23027" ENSG00000183576 "SET domain containing 3" Q86TU7 14 99397746-99480889 "Enzymes, Predicted intracellular proteins" "Actin-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003591, HPA003639" Approved Approved Mitochondria Mitochondria "HPA003591: AB_1079930, HPA003639: AB_1079931" "unprognostic (6.82e-2)" "unprognostic (2.66e-2)" "unprognostic (8.07e-2)" "unprognostic (2.16e-2)" "unprognostic (2.42e-1)" "prognostic unfavourable (6.46e-4)" "unprognostic (1.04e-2)" "unprognostic (3.24e-2)" "unprognostic (3.29e-1)" "unprognostic (2.73e-2)" "unprognostic (2.01e-1)" "unprognostic (4.42e-1)" "prognostic favourable (1.89e-15)" "unprognostic (6.81e-2)" "unprognostic (3.21e-1)" "unprognostic (2.20e-1)" "unprognostic (2.62e-3)" 17.1 12.5 24.7 13.3 26.8 9.2 16.6 14.6 23.8 14.3 22.7 18.7 26.9 16.2 14.2 39.6 16.9 21.7 13.4 34.1 24.1 17.9 43.4 21.0 16.7 11.9 23.7 13.9 11.7 16.9 17.4 14.5 19.4 18.4 16.9 17.6 16.2 24.9 20.2 68.7 14.1 16.5 26.0 25.3 13.7 15.4 39.1 15.3 11.5 25.6 20.3 10.9 24.0 21.4 9.2 18.6 19.9 17.4 16.0 18.2 11.3 13.7 15.9 12.0 11.4 14.0 15.8 42.7 17.5 13.4 18.4 18.8 15.3 23.5 13.6 14.4 19.7 18.0 14.6 19.7 29.4 13.3 7.8 12.3 10.3 13.9 17.5 18.5 18.6 11.0 25.9 16.3 23.9 22.8 9.7 20.5 20.2 25.9 19.2 20.1 7.1 18.1 11.7 24.6 11.1 26.3 17.1 21.5 10.0 15.7 16.4 13.4 22.2 16.1 20.1 8.3 11.5 55.8 13.3 14.7 16.6 14.6 15.6 18.4 12.6 6.4 15.0 19.9 15.5 17.4 18.2 9.2 13.4 14.5 18.6 7.6 11.2 13.9 9.4 16.0 14.8 11.7 9.7 11.3 24.7 26.8 14.6 23.8 24.1 17.9 23.7 13.9 18.4 15.3 SFXN1 "FLJ12876, SLC56A1" ENSG00000164466 "Sideroflexin 1" Q9H9B4 5 175477062-175529742 "Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid transport, One-carbon metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 66.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "granulocytes: 34.2;T-cells: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019543, HPA063745" Uncertain Enhanced Mitochondria Mitochondria "HPA019543: AB_1856789, HPA063745: " "unprognostic (4.77e-3)" "unprognostic (5.26e-2)" "unprognostic (1.54e-2)" "unprognostic (3.62e-3)" "unprognostic (2.35e-1)" "unprognostic (1.30e-2)" "unprognostic (3.59e-2)" "unprognostic (8.58e-3)" "unprognostic (2.47e-2)" "unprognostic (1.17e-2)" "unprognostic (2.48e-2)" "unprognostic (1.51e-1)" "unprognostic (1.31e-1)" "unprognostic (7.30e-2)" "unprognostic (4.98e-1)" "unprognostic (1.08e-3)" "unprognostic (4.23e-2)" 5.6 14.0 15.2 12.0 20.9 12.9 8.1 20.7 24.5 6.5 18.8 7.9 5.3 13.2 6.5 6.0 12.6 6.6 7.1 9.4 14.5 18.3 28.3 66.8 5.3 17.0 15.3 17.0 13.6 9.7 7.4 11.8 10.4 15.1 7.6 12.5 5.7 7.7 8.0 11.7 6.3 13.4 8.1 15.0 8.2 10.1 5.0 11.0 13.9 7.7 7.3 17.8 11.3 9.1 4.5 3.0 34.2 2.6 4.8 16.0 5.6 10.0 32.0 16.4 17.7 5.6 12.2 26.4 25.8 10.9 21.8 21.2 40.1 20.4 21.1 20.1 13.5 13.0 31.4 45.0 23.7 51.6 26.3 15.5 28.9 17.5 8.3 30.2 19.6 9.9 8.8 24.1 10.6 16.7 22.2 16.8 15.8 35.3 35.3 2.4 12.9 10.6 29.7 16.8 22.6 8.2 39.7 28.0 17.9 24.9 23.6 12.6 11.4 10.0 16.2 17.3 27.4 12.6 33.6 21.4 25.2 48.2 28.3 27.3 17.9 34.2 2.1 10.4 11.3 2.6 9.4 4.5 16.0 12.6 3.0 3.8 12.7 12.9 0.6 4.8 1.7 1.4 12.7 5.6 15.2 20.9 20.7 24.5 14.5 18.3 15.3 17.0 15.1 11.0 SFXN2 SLC56A2 ENSG00000156398 "Sideroflexin 2" Q96NB2 10 102714538-102743492 "Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 28.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018150, HPA026834" Enhanced Approved Mitochondria Mitochondria "HPA018150: AB_1856790, HPA026834: AB_1856791" "unprognostic (1.70e-2)" "prognostic favourable (2.28e-4)" "unprognostic (3.30e-2)" "unprognostic (2.95e-1)" "unprognostic (6.10e-2)" "unprognostic (1.44e-2)" "prognostic favourable (9.95e-4)" "unprognostic (4.24e-2)" "unprognostic (9.69e-2)" "unprognostic (3.98e-2)" "unprognostic (1.32e-1)" "unprognostic (8.98e-3)" "prognostic favourable (2.28e-5)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (3.77e-2)" "prognostic favourable (6.52e-4)" 2.4 3.1 2.3 5.1 5.8 3.8 4.0 2.9 3.5 3.3 4.4 3.7 6.3 3.7 4.8 8.3 2.9 6.0 3.5 1.8 2.4 1.9 24.2 13.7 3.0 10.1 2.8 1.4 8.4 8.1 11.0 9.2 4.7 3.1 4.1 4.3 7.3 17.5 6.4 1.5 2.6 3.3 1.7 1.7 3.3 4.9 2.2 2.5 15.3 7.1 2.0 6.8 3.0 2.3 5.6 3.2 2.5 1.2 3.3 6.3 1.4 2.9 1.5 2.6 2.7 1.0 0.7 3.7 1.0 0.4 1.3 0.6 5.1 1.4 6.5 2.0 0.9 2.2 0.5 3.5 0.7 1.1 2.0 9.4 2.9 3.2 0.4 5.3 0.8 0.8 0.5 1.3 1.4 1.2 4.2 3.1 0.8 2.9 7.8 1.8 1.6 0.6 3.9 3.2 0.9 1.3 2.3 1.9 2.0 0.9 2.2 0.4 28.1 1.1 0.9 1.1 3.3 1.3 2.2 3.3 4.4 5.6 1.3 6.5 0.8 2.5 1.2 0.4 3.7 0.5 3.5 1.6 3.9 3.9 1.5 5.6 6.3 5.3 2.5 3.3 0.9 3.2 3.8 1.4 2.3 5.8 2.9 3.5 2.4 1.9 2.8 1.4 3.1 2.5 SFXN3 "SFX3, SLC56A3" ENSG00000107819 "Sideroflexin 3" Q9BWM7 10 101031234-101041244 "Predicted membrane proteins" "Amino-acid transport, One-carbon metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008028, HPA048105" Approved Enhanced Mitochondria 81000 Mitochondria "HPA008028: AB_1079938, HPA048105: " "unprognostic (2.55e-1)" "unprognostic (3.32e-2)" "unprognostic (4.94e-2)" "unprognostic (2.82e-2)" "unprognostic (4.94e-3)" "prognostic unfavourable (3.79e-4)" "unprognostic (3.84e-3)" "unprognostic (8.46e-2)" "unprognostic (1.05e-2)" "unprognostic (9.09e-3)" "unprognostic (1.04e-3)" "unprognostic (1.48e-1)" "prognostic unfavourable (4.94e-4)" "unprognostic (3.56e-1)" "unprognostic (3.05e-2)" "unprognostic (3.70e-2)" "unprognostic (1.71e-1)" 14.4 8.1 11.5 8.7 13.9 4.1 10.7 40.2 22.9 14.5 19.0 15.5 13.6 24.4 13.8 17.7 6.5 14.9 12.9 11.3 12.5 9.8 9.2 3.4 16.4 5.4 18.3 13.7 10.6 7.0 17.1 6.9 16.2 18.4 8.8 8.4 9.1 8.4 13.8 2.7 15.7 44.8 19.9 13.7 8.3 8.2 5.6 16.9 4.3 7.5 5.1 5.5 10.7 11.2 2.2 15.7 8.9 14.8 4.3 9.8 8.3 15.4 6.0 0.6 1.8 16.3 17.3 1.6 9.4 33.5 12.1 9.8 9.9 17.1 0.6 9.1 22.1 11.4 2.8 20.6 5.3 4.3 3.6 1.8 10.0 7.1 11.2 1.4 15.1 11.9 3.0 10.6 10.0 26.5 0.1 0.5 19.6 2.5 0.6 2.2 0.7 14.6 1.5 11.9 4.2 17.8 2.4 3.3 16.2 5.1 0.6 14.0 5.0 11.0 21.7 10.7 8.4 9.4 4.6 2.4 0.9 0.0 26.1 8.4 8.5 8.9 14.8 7.1 9.8 11.1 7.5 2.2 6.7 6.6 15.7 1.0 4.1 5.1 2.8 4.3 6.1 2.5 7.0 8.3 11.5 13.9 40.2 22.9 12.5 9.8 18.3 13.7 18.4 16.9 SGIP1 DKFZp761D221 ENSG00000118473 "SH3 domain GRB2 like endophilin interacting protein 1" Q9BQI5 1 66533383-66748299 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.5" "Cell line enhanced" "Detected in some" "BJ: 16.8;BJ hTERT+: 21.7;fHDF/TERT166: 13.7;RPTEC TERT1: 16.0;SH-SY5Y: 8.7;U-138 MG: 15.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017963 Approved Approved Mitochondria Mitochondria "HPA017963: AB_10964882" "unprognostic (1.74e-2)" "unprognostic (2.77e-1)" "unprognostic (2.86e-1)" "unprognostic (1.07e-1)" "unprognostic (1.74e-1)" "unprognostic (9.04e-2)" "unprognostic (9.51e-2)" "unprognostic (7.64e-2)" "unprognostic (1.86e-1)" "unprognostic (1.61e-1)" "unprognostic (1.83e-1)" "unprognostic (1.95e-1)" "unprognostic (3.48e-7)" "unprognostic (1.77e-2)" "unprognostic (1.29e-1)" "unprognostic (4.25e-2)" "unprognostic (9.63e-2)" 6.2 7.5 19.6 3.8 30.2 1.3 2.7 26.2 36.5 7.5 2.7 11.4 1.3 3.4 17.1 8.0 5.2 4.7 8.1 6.8 22.9 12.4 14.0 1.7 9.6 2.0 10.8 26.3 3.6 1.2 1.9 7.0 3.9 26.4 5.4 3.4 5.8 3.5 9.1 3.2 1.7 3.2 7.0 11.3 1.4 5.1 7.4 14.9 0.0 8.0 0.8 1.5 6.1 5.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.4 0.0 16.8 21.7 1.3 2.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 2.5 0.0 0.0 0.6 0.2 0.0 3.9 0.0 0.0 2.4 0.0 1.3 0.0 6.3 0.0 0.0 7.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.4 8.7 0.0 0.0 0.0 0.0 0.6 1.1 15.9 0.0 0.4 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 19.6 30.2 26.2 35.0 22.9 12.4 10.8 26.3 26.4 14.9 SH3GL3 "CNSA3, EEN-B2, HsT19371, SH3D2C, SH3P13" ENSG00000140600 "SH3 domain containing GRB2 like 3, endophilin A3" Q99963 15 83447228-83618743 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 30.3;testis: 31.6" "Group enriched" "Detected in some" 4 "HAP1: 21.7;HEK 293: 10.7;K-562: 16.9;RH-30: 6.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039381, HPA077877" Enhanced Approved Mitochondria Mitochondria "HPA039381: AB_10794635, HPA077877: " "unprognostic (1.10e-3)" "unprognostic (6.62e-2)" "unprognostic (4.25e-2)" "unprognostic (1.86e-1)" "unprognostic (6.01e-2)" "unprognostic (2.37e-1)" "unprognostic (9.76e-2)" "unprognostic (2.26e-1)" "unprognostic (8.20e-3)" "unprognostic (2.72e-3)" "unprognostic (1.43e-6)" "unprognostic (4.42e-2)" "unprognostic (3.59e-2)" "unprognostic (2.93e-1)" "unprognostic (5.78e-4)" 1.1 1.3 12.5 1.1 26.6 1.4 1.3 6.3 30.3 1.2 1.1 28.2 0.0 1.2 1.8 2.0 2.9 3.5 1.1 1.2 14.2 9.9 2.3 1.1 4.1 1.3 25.5 14.6 1.2 1.0 1.1 0.7 1.8 17.6 1.7 1.2 0.0 1.0 1.8 1.0 1.6 1.2 1.2 16.7 1.1 1.2 31.6 26.0 1.2 1.2 0.5 1.9 1.6 0.7 0.4 0.7 0.7 0.3 0.0 0.4 0.3 0.0 0.0 1.8 1.3 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 21.7 1.3 0.0 0.0 10.7 3.2 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 16.9 0.0 0.0 0.6 1.3 0.0 2.6 0.8 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 1.9 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.2 0.1 0.1 0.3 0.0 0.0 0.4 0.4 0.3 0.7 0.0 0.1 0.7 0.2 0.3 12.5 26.6 6.3 18.5 14.2 9.9 25.5 14.6 17.6 26.0 SHPRH "bA545I5.2, FLJ90837, KIAA2023" ENSG00000146414 "SNF2 histone linker PHD RING helicase" Q149N8 6 145864245-145964423 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Helicase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034854, HPA034950" Approved Approved Mitochondria Mitochondria "HPA034854: AB_10964488, HPA034950: " "unprognostic (3.10e-2)" "unprognostic (4.46e-2)" "unprognostic (5.61e-3)" "unprognostic (1.53e-2)" "unprognostic (7.40e-3)" "unprognostic (2.20e-2)" "unprognostic (2.63e-1)" "unprognostic (1.83e-1)" "unprognostic (1.36e-1)" "unprognostic (8.66e-3)" "unprognostic (5.03e-1)" "unprognostic (7.90e-2)" "unprognostic (6.01e-3)" "unprognostic (3.29e-2)" "unprognostic (2.70e-1)" "unprognostic (1.13e-1)" "unprognostic (3.01e-1)" 10.9 7.3 8.3 11.0 10.0 5.5 10.4 38.0 11.5 10.6 8.0 4.5 10.8 6.0 14.1 9.2 8.5 9.8 6.7 7.2 7.2 4.2 8.4 6.5 7.1 9.0 7.6 5.9 18.8 8.7 11.4 19.7 6.6 8.5 8.3 7.4 7.3 10.2 13.7 11.4 13.9 8.2 11.0 10.3 8.8 8.5 10.7 8.7 8.4 12.5 7.2 8.0 10.7 11.5 6.7 4.8 4.4 2.4 3.4 4.3 1.2 2.9 2.3 11.4 6.7 5.3 5.7 5.5 3.5 2.9 4.4 5.7 5.2 2.1 10.4 4.4 2.7 5.1 7.0 5.0 5.8 4.7 8.0 10.5 5.2 4.4 4.0 22.0 6.5 3.9 5.8 4.1 6.0 4.7 14.6 5.9 3.7 2.6 14.1 8.2 7.7 4.0 10.2 17.8 3.5 6.0 2.9 9.4 6.6 6.3 5.8 3.9 3.1 10.6 5.2 2.8 5.3 5.5 4.1 4.8 6.8 12.4 2.9 9.5 4.3 1.6 2.3 4.4 4.3 2.4 3.7 3.9 3.6 2.9 2.7 6.7 4.1 3.3 0.1 3.4 2.4 4.8 3.3 1.2 8.3 10.0 38.0 11.5 7.2 4.2 7.6 5.9 8.5 8.7 SIRT5 ENSG00000124523 "Sirtuin 5" Q9NXA8 6 13574529-13615158 "FDA approved drug targets, Predicted intracellular proteins" Transferase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021798, HPA022002, HPA022992" Approved Supported Mitochondria Mitochondria "HPA021798: AB_1856911, HPA022002: AB_1856913, HPA022992: AB_1856915" "unprognostic (8.53e-2)" "unprognostic (7.79e-2)" "unprognostic (4.71e-2)" "unprognostic (5.26e-3)" "unprognostic (6.19e-2)" "unprognostic (1.63e-1)" "unprognostic (8.72e-2)" "unprognostic (1.38e-1)" "unprognostic (8.54e-3)" "unprognostic (2.77e-3)" "unprognostic (1.02e-1)" "unprognostic (1.65e-1)" "prognostic favourable (8.76e-10)" "unprognostic (2.39e-1)" "unprognostic (6.88e-2)" "unprognostic (6.86e-2)" "unprognostic (2.36e-3)" 5.9 6.2 8.8 6.8 10.4 5.9 9.2 11.1 13.5 4.9 7.2 6.4 12.5 8.1 6.8 6.7 5.7 8.0 6.6 22.9 8.5 8.3 9.9 29.9 9.8 6.9 9.5 6.9 8.8 10.5 12.9 7.6 5.3 8.3 6.5 8.3 6.2 8.6 8.7 25.8 8.8 8.5 6.2 6.9 9.5 7.6 6.6 6.1 7.5 8.5 7.0 6.5 6.8 6.0 9.2 4.6 10.9 9.3 7.3 10.0 5.6 6.0 4.7 6.0 7.8 3.8 5.0 4.6 3.1 3.3 3.4 5.1 7.6 7.2 8.7 18.9 2.4 9.8 4.2 6.1 5.2 4.0 7.0 5.5 4.4 12.2 6.3 4.4 4.8 5.4 12.4 3.0 10.8 6.1 7.8 3.3 4.0 7.3 4.8 8.8 5.1 7.5 8.7 3.9 15.8 7.0 6.6 10.0 3.6 3.5 6.1 13.8 7.0 2.9 5.4 5.2 3.0 3.2 3.4 8.1 9.1 5.9 2.9 4.4 5.0 0.5 4.5 10.9 8.1 6.1 8.2 9.2 10.0 7.9 4.6 9.1 9.5 8.5 1.5 7.3 9.3 4.6 7.2 5.6 8.8 10.4 11.1 13.5 8.5 8.3 9.5 6.9 8.3 6.1 SLC11A2 "DCT1, DMT1, NRAMP2" ENSG00000110911 "Solute carrier family 11 member 2" P49281 12 50979401-51028566 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032139, HPA032140" Uncertain Supported Mitochondria Mitochondria "HPA032139: AB_10964213, HPA032140: AB_10962932" "unprognostic (4.40e-3)" "unprognostic (1.41e-2)" "unprognostic (1.50e-1)" "unprognostic (2.07e-3)" "unprognostic (2.35e-1)" "unprognostic (1.92e-1)" "unprognostic (2.09e-1)" "prognostic favourable (3.07e-6)" "unprognostic (1.06e-2)" "unprognostic (1.99e-2)" "unprognostic (1.15e-1)" "unprognostic (7.28e-2)" "unprognostic (2.29e-1)" "unprognostic (3.20e-2)" "unprognostic (2.61e-1)" "unprognostic (2.32e-2)" "unprognostic (2.24e-1)" 11.3 15.1 12.8 9.6 26.2 9.6 20.8 14.7 22.1 20.8 11.3 38.2 8.4 35.3 12.3 12.7 17.3 15.4 12.1 12.9 14.5 14.2 16.1 18.0 18.6 7.9 40.0 15.4 10.4 20.6 29.8 21.7 16.4 29.7 18.0 11.8 18.7 26.9 14.8 17.6 15.6 11.6 11.0 33.1 9.5 12.5 8.7 31.0 15.8 29.9 8.7 16.5 12.9 13.9 4.1 9.8 3.0 9.5 8.3 7.1 4.6 7.5 9.8 13.1 12.0 14.5 12.3 43.7 8.3 30.1 7.9 9.3 12.4 14.4 4.7 16.4 9.2 10.6 11.8 7.8 9.3 6.8 7.1 11.2 12.0 14.1 15.4 7.6 22.7 13.5 9.8 14.7 15.0 9.4 9.7 2.4 9.2 8.8 9.0 5.1 19.3 6.8 5.8 11.9 8.3 9.6 11.4 9.0 8.0 6.3 19.2 8.4 21.6 5.1 11.3 8.1 6.8 9.0 4.3 5.9 8.0 1.9 22.8 4.1 3.4 0.7 6.6 2.4 6.4 9.5 5.8 3.6 5.0 6.3 9.8 4.1 7.1 6.6 3.0 8.3 6.0 4.1 3.8 4.6 12.8 26.2 14.7 22.1 14.5 14.2 40.0 15.4 29.7 31.0 SLC16A12 MCT12 ENSG00000152779 "Solute carrier family 16 member 12" 10 89430299-89556641 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 28.0;kidney: 55.6" "Group enriched" "Detected in some" 4 "ASC TERT1: 22.3;HSkMC: 7.9" "Cancer enriched" "Detected in many" 10 "renal cancer: 18.0" "Region enriched" "Detected in many" 6 "pons and medulla: 11.7" "Cell type enhanced" "Detected in single" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037587 Approved Mitochondria Mitochondria "HPA037587: AB_10671876" "unprognostic (5.38e-2)" "unprognostic (1.29e-1)" "unprognostic (2.79e-2)" "unprognostic (2.28e-2)" "unprognostic (3.51e-1)" "unprognostic (5.35e-2)" "unprognostic (2.45e-1)" "unprognostic (1.32e-1)" "unprognostic (1.78e-2)" "unprognostic (2.42e-1)" "unprognostic (9.60e-2)" "unprognostic (2.31e-1)" "prognostic favourable (4.50e-12)" "unprognostic (3.84e-2)" "unprognostic (7.91e-2)" "unprognostic (8.29e-2)" "unprognostic (1.84e-3)" 2.3 1.3 1.0 0.1 0.7 0.0 2.4 1.3 0.6 4.9 1.6 2.6 6.2 0.1 2.0 28.0 0.5 2.2 0.1 4.0 1.8 0.8 55.6 1.0 3.3 0.1 0.8 0.3 1.8 13.3 0.0 5.0 5.9 11.7 1.4 0.1 16.3 0.9 7.9 4.4 1.1 0.8 0.5 0.6 0.1 1.7 2.4 0.3 0.0 3.8 0.7 0.0 1.8 1.5 0.7 0.5 1.8 0.3 0.9 0.3 0.0 0.2 0.0 0.1 0.1 2.9 22.3 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.3 0.1 3.6 0.0 0.0 7.9 0.2 1.1 1.4 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.4 0.1 0.0 0.8 0.0 2.7 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.8 0.3 0.3 0.2 0.3 0.2 0.3 0.2 0.2 0.0 0.7 0.2 0.3 0.8 0.9 0.1 0.5 0.0 0.0 1.0 0.7 1.3 0.6 1.8 0.8 0.8 0.3 11.7 0.3 SLC22A4 "DFNB60, MGC34546, OCTN1" ENSG00000197208 "Solute carrier family 22 member 4" Q9H015 5 132294443-132344206 "Disease related genes, Predicted membrane proteins" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 34.4;U-138 MG: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 23.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 23.0" "Region enhanced" "Detected in all" "cerebellum: 72.4" "Low region specificity" "Detected in all" "CAB015468, HPA036974" Approved Approved Mitochondria Mitochondria "CAB015468: , HPA036974: " "unprognostic (1.33e-1)" "unprognostic (2.20e-1)" "unprognostic (3.91e-2)" "unprognostic (8.42e-3)" "unprognostic (6.17e-2)" "unprognostic (6.22e-3)" "unprognostic (4.17e-3)" "unprognostic (3.33e-1)" "unprognostic (1.30e-1)" "unprognostic (9.79e-2)" "unprognostic (1.95e-3)" "unprognostic (7.82e-2)" "unprognostic (1.74e-2)" "unprognostic (2.31e-3)" "unprognostic (1.20e-1)" "unprognostic (1.95e-2)" "unprognostic (4.06e-2)" 2.7 4.1 3.5 3.8 5.0 22.4 3.1 3.1 4.7 2.4 5.9 4.4 1.8 4.6 2.1 3.2 0.8 14.7 2.6 3.0 3.9 4.9 15.4 1.6 7.2 3.8 3.2 2.0 5.0 1.0 7.7 6.9 6.8 12.6 5.4 3.1 13.8 2.6 4.1 9.2 1.7 18.1 1.5 9.9 7.7 2.2 0.9 2.7 0.5 1.0 2.7 0.8 2.5 2.2 0.0 1.7 23.0 3.5 0.0 0.0 0.6 1.1 1.7 0.1 0.4 0.7 0.6 0.5 7.4 34.4 5.7 6.0 0.6 1.9 0.3 2.1 4.3 1.8 0.0 1.2 4.0 1.4 0.2 0.1 3.2 0.1 0.6 2.3 0.0 1.4 0.2 3.1 2.9 2.5 2.9 3.9 4.4 0.6 0.0 5.3 0.2 1.9 0.0 0.4 0.2 0.9 0.1 0.4 0.2 8.1 0.5 0.2 0.3 1.4 3.0 14.6 1.4 5.7 1.9 0.0 1.5 0.0 4.3 2.7 1.7 0.0 3.5 3.5 0.0 0.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 23.0 0.0 0.2 0.2 0.0 0.6 3.5 5.0 3.1 4.7 3.9 4.9 3.2 2.0 12.6 2.7 SLC22A5 "CDSP, OCTN2, SCD" ENSG00000197375 "Solute carrier family 22 member 5" O76082 5 132369752-132395614 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 42.3;skeletal muscle: 93.6" "Cell line enhanced" "Detected in many" "HeLa: 21.8;SiHa: 22.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA063062 Approved Mitochondria Mitochondria "HPA063062: " "unprognostic (3.88e-1)" "unprognostic (1.69e-1)" "unprognostic (2.19e-2)" "prognostic favourable (2.87e-5)" "unprognostic (5.37e-3)" "unprognostic (1.18e-1)" "unprognostic (1.50e-2)" "unprognostic (9.24e-2)" "unprognostic (1.57e-1)" "unprognostic (5.09e-2)" "prognostic favourable (7.36e-4)" "unprognostic (3.53e-2)" "prognostic favourable (8.36e-4)" "unprognostic (1.12e-2)" "unprognostic (2.98e-2)" "unprognostic (2.17e-2)" "unprognostic (1.17e-2)" 3.0 4.7 4.0 1.9 4.9 0.6 4.4 9.0 4.2 4.4 10.6 3.6 15.0 11.8 3.6 12.6 2.5 7.4 5.2 7.2 3.8 3.8 42.3 4.5 2.3 1.5 3.5 3.2 3.9 5.2 17.9 8.5 8.1 3.9 8.2 8.3 5.9 4.2 21.8 93.6 3.5 19.6 2.9 3.8 1.7 4.4 2.5 2.7 1.0 5.0 3.2 2.4 3.9 3.2 1.4 6.4 0.4 4.1 1.5 4.0 2.1 3.5 8.5 0.5 6.9 2.7 1.3 11.8 1.6 1.7 2.7 3.8 6.3 7.3 1.7 3.7 1.5 8.6 5.6 4.2 3.2 2.1 6.9 0.9 21.8 2.8 4.6 1.4 1.5 1.3 7.9 1.8 9.7 0.7 3.9 1.1 2.6 6.0 2.0 1.4 0.6 3.7 0.8 0.0 9.2 8.2 8.9 3.0 2.0 22.5 17.6 4.4 8.2 1.8 0.4 0.4 2.4 5.7 2.0 3.7 7.2 0.1 1.8 3.5 1.6 0.0 4.1 0.0 2.6 2.2 2.8 1.4 2.4 3.1 6.4 1.4 2.6 3.0 0.4 1.5 0.7 0.6 4.0 2.1 4.0 4.9 9.0 4.2 3.8 3.8 3.5 3.2 3.9 2.7 SLC25A13 "ARALAR2, CITRIN, CTLN2" ENSG00000004864 "Solute carrier family 25 member 13" Q9UJS0 7 96120220-96322147 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 79.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018997 Approved Supported Mitochondria Mitochondria "HPA018997: AB_1857023" "unprognostic (3.61e-2)" "unprognostic (7.99e-2)" "unprognostic (6.99e-2)" "unprognostic (7.19e-2)" "unprognostic (1.14e-1)" "unprognostic (3.44e-2)" "unprognostic (1.42e-2)" "unprognostic (6.67e-2)" "unprognostic (2.31e-2)" "unprognostic (5.46e-2)" "unprognostic (1.01e-1)" "unprognostic (6.99e-2)" "prognostic favourable (9.14e-4)" "unprognostic (1.15e-1)" "unprognostic (1.05e-1)" "unprognostic (3.32e-1)" "unprognostic (7.09e-2)" 7.7 10.3 4.2 4.9 11.8 4.1 6.7 3.0 7.5 5.4 12.5 21.1 15.6 8.9 5.1 8.0 6.9 5.9 6.7 4.5 5.6 5.3 17.7 79.1 5.5 4.9 14.5 4.8 5.9 7.3 8.2 8.8 8.9 12.4 5.9 10.2 12.6 5.7 17.3 4.6 8.2 9.7 5.0 13.1 7.2 7.9 4.3 12.6 1.8 7.9 3.0 4.8 5.0 5.3 3.7 8.9 3.1 6.7 2.8 2.4 2.1 16.4 14.6 16.8 5.8 2.9 2.3 23.6 4.2 3.2 10.1 10.3 26.1 15.5 7.4 19.9 2.6 9.8 18.8 6.0 12.0 2.9 12.4 8.4 13.7 20.3 6.8 10.7 6.7 6.2 6.4 8.7 7.8 11.6 23.7 2.8 4.9 18.1 0.0 10.0 29.6 9.0 4.2 10.0 17.1 24.3 15.6 8.1 26.5 14.5 30.7 24.8 9.1 8.2 6.8 7.6 16.9 17.8 12.7 5.8 14.5 4.7 9.3 10.3 12.4 0.6 4.6 3.1 2.2 6.3 2.4 3.7 1.8 2.0 8.9 2.0 1.2 1.5 0.8 2.8 6.7 4.7 1.8 2.1 4.2 11.8 3.0 7.5 5.6 5.3 14.5 4.8 12.4 12.6 SLC25A14 "BMCP1, UCP5" ENSG00000102078 "Solute carrier family 25 member 14" O95258 X 130339888-130373361 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060316 Approved Mitochondria "Intracellular and membrane" Mitochondria "HPA060316: " "unprognostic (1.65e-2)" "prognostic favourable (1.72e-5)" "unprognostic (1.82e-1)" "unprognostic (2.74e-1)" "unprognostic (1.27e-1)" "unprognostic (1.16e-1)" "unprognostic (3.36e-3)" "unprognostic (8.92e-3)" "unprognostic (3.52e-2)" "unprognostic (2.95e-3)" "prognostic favourable (1.78e-4)" "unprognostic (2.18e-2)" "prognostic unfavourable (5.52e-6)" "unprognostic (6.05e-2)" "unprognostic (1.12e-1)" "unprognostic (6.92e-2)" "prognostic favourable (1.39e-5)" 3.1 9.3 9.2 3.4 18.3 3.7 5.5 13.6 20.6 4.8 3.8 6.1 4.2 2.2 6.7 11.0 4.3 9.7 4.6 7.7 8.7 15.8 5.2 4.1 4.6 4.1 7.3 11.4 6.8 4.5 5.6 15.0 3.6 11.2 5.1 4.1 5.7 5.1 6.7 3.4 4.7 3.6 7.7 5.3 3.5 4.8 10.2 4.2 4.2 5.7 4.6 5.3 3.1 3.8 7.5 9.3 8.7 7.2 8.1 9.5 4.9 6.8 9.0 6.5 4.7 4.4 4.1 3.5 5.2 6.9 10.0 10.1 3.6 4.1 4.7 18.0 6.9 3.9 9.3 3.8 10.0 5.9 11.8 1.5 8.3 8.4 6.1 5.9 2.8 3.8 4.7 12.7 3.8 5.5 4.1 6.6 15.9 10.5 6.1 8.2 5.4 14.8 5.2 8.4 9.3 5.8 3.0 8.1 7.2 5.5 5.5 8.7 3.5 3.3 3.7 5.4 3.5 12.3 10.4 6.2 15.9 4.1 9.8 7.2 4.8 5.8 7.2 5.2 6.4 5.8 7.8 7.5 5.4 6.1 7.5 4.6 4.2 7.0 8.7 8.1 5.2 9.3 9.5 4.9 9.2 18.3 13.6 15.6 8.7 15.8 7.3 11.4 11.2 4.2 SLC25A16 "D10S105E, GDA, HGT.1, ML7" ENSG00000122912 "Solute carrier family 25 member 16" P16260 10 68477999-68527474 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036243, HPA044580" Uncertain Approved Mitochondria Mitochondria "HPA036243: , HPA044580: AB_10962723" "unprognostic (1.71e-1)" "unprognostic (1.54e-1)" "unprognostic (3.08e-2)" "unprognostic (1.27e-1)" "unprognostic (6.75e-2)" "unprognostic (2.68e-2)" "unprognostic (1.23e-2)" "unprognostic (9.13e-3)" "unprognostic (1.92e-1)" "unprognostic (4.13e-2)" "unprognostic (8.65e-2)" "unprognostic (1.17e-1)" "unprognostic (8.37e-3)" "unprognostic (2.10e-1)" "unprognostic (2.79e-1)" "unprognostic (2.06e-2)" "unprognostic (1.44e-3)" 18.7 8.0 6.4 5.5 8.9 7.0 15.5 9.6 13.5 5.1 6.9 8.1 4.8 8.1 7.7 7.8 5.9 5.4 8.8 5.9 8.4 7.3 12.0 22.6 10.2 9.2 7.8 8.6 6.3 21.1 6.9 7.3 7.1 9.2 17.3 6.4 8.5 15.0 6.6 9.4 6.5 11.0 8.4 6.3 6.4 9.4 3.5 6.6 6.4 7.8 4.8 7.7 6.4 5.4 3.2 2.9 5.0 2.7 2.4 2.5 1.2 2.9 1.2 3.5 4.8 4.7 5.7 3.8 4.1 4.5 2.7 2.9 7.0 2.0 3.1 2.9 8.0 1.8 10.9 2.0 6.7 2.3 6.7 1.7 3.2 3.1 5.7 5.3 3.8 4.8 5.3 5.0 7.0 2.2 1.9 5.4 5.6 2.7 3.1 3.9 0.8 15.7 1.7 2.5 1.0 7.3 9.7 2.4 2.0 5.8 5.7 4.5 3.2 2.2 9.4 4.0 5.3 6.6 4.7 5.4 2.9 5.1 3.9 4.4 1.8 4.0 2.7 2.7 1.7 1.9 1.6 1.7 1.6 1.4 1.8 3.2 1.6 2.5 5.0 2.4 1.5 2.9 1.7 1.2 6.4 8.9 9.6 13.5 8.4 7.3 7.8 8.6 9.2 6.6 SLC25A23 "APC2, FLJ30339, MGC2615" ENSG00000125648 "Solute carrier family 25 member 23" Q9BV35 19 6436079-6465203 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009675, HPA050883" Approved Supported Mitochondria Mitochondria "HPA009675: , HPA050883: " "unprognostic (3.51e-1)" "unprognostic (1.53e-3)" "unprognostic (1.52e-1)" "prognostic unfavourable (1.29e-4)" "unprognostic (2.05e-2)" "unprognostic (3.65e-3)" "unprognostic (3.43e-2)" "unprognostic (1.31e-3)" "unprognostic (1.27e-1)" "unprognostic (3.82e-1)" "unprognostic (1.30e-1)" "unprognostic (3.25e-1)" "prognostic favourable (1.10e-12)" "unprognostic (8.95e-2)" "unprognostic (3.20e-1)" "unprognostic (5.44e-2)" "unprognostic (4.22e-1)" 12.1 13.0 68.2 5.2 97.6 0.4 6.3 21.5 51.7 12.5 22.3 17.6 10.3 18.2 13.0 11.9 31.2 16.1 10.1 36.2 66.2 25.1 17.9 13.0 11.3 4.0 25.6 33.1 15.8 10.0 24.5 5.5 2.2 28.0 14.3 23.5 12.2 32.1 20.3 37.0 11.9 18.6 30.7 16.9 4.3 9.9 3.7 25.9 1.2 29.2 9.7 14.1 16.8 9.3 2.5 0.9 0.8 0.0 0.7 4.5 0.9 19.8 8.0 11.7 36.7 15.7 6.9 5.3 5.7 9.5 11.3 13.6 20.2 13.3 11.1 14.2 14.6 16.9 23.8 13.8 9.0 0.0 20.0 8.0 17.0 16.1 14.6 0.5 19.0 19.8 12.2 10.0 4.4 11.7 23.1 14.2 2.2 14.5 7.0 11.4 8.4 24.7 3.4 3.1 17.1 30.2 3.6 0.8 11.5 4.1 25.6 10.5 13.3 17.6 4.0 3.5 15.3 0.9 3.8 2.6 3.5 9.8 1.6 18.9 5.6 0.8 0.0 0.0 4.5 0.0 1.1 2.5 2.7 2.3 0.4 1.0 4.0 3.4 0.0 0.7 0.0 0.9 2.6 0.9 68.2 97.6 21.5 51.7 66.2 25.1 25.6 33.1 28.0 25.9 SLC25A24 "APC1, DKFZp586G0123" ENSG00000085491 "Solute carrier family 25 member 24" Q6NUK1 1 108134036-108200849 "Predicted intracellular proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA028519, HPA063636" Enhanced Enhanced Mitochondria 8900 Mitochondria "HPA028519: AB_10603890, HPA063636: AB_2685068" "unprognostic (1.94e-2)" "unprognostic (7.30e-3)" "prognostic favourable (1.01e-4)" "unprognostic (7.11e-2)" "unprognostic (1.64e-2)" "unprognostic (2.91e-1)" "unprognostic (8.54e-4)" "unprognostic (1.51e-2)" "unprognostic (7.39e-2)" "unprognostic (1.29e-1)" "unprognostic (1.15e-3)" "unprognostic (6.18e-2)" "unprognostic (6.76e-2)" "unprognostic (2.21e-1)" "unprognostic (1.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.29e-1)" 19.8 10.8 3.0 13.1 3.3 3.8 25.2 2.3 4.5 15.9 26.6 3.9 9.6 13.6 12.4 11.8 11.4 9.0 16.1 12.4 2.8 3.3 15.3 2.9 17.8 10.8 3.0 2.7 13.5 7.2 13.2 7.7 10.4 5.3 12.4 18.2 9.8 11.2 9.7 7.4 6.9 42.4 9.7 4.0 17.0 9.0 5.1 1.5 10.3 13.7 10.8 9.4 10.8 18.2 2.9 4.8 4.4 7.1 1.7 4.3 2.1 23.9 5.3 16.4 5.1 11.3 14.9 8.2 8.4 9.9 15.0 16.5 6.5 8.0 0.0 7.7 15.4 9.4 4.8 13.5 20.3 5.9 2.5 1.5 8.0 3.1 9.3 3.9 3.2 11.1 9.6 8.7 11.2 11.4 4.0 8.1 18.8 15.7 2.2 0.8 9.7 6.2 4.0 21.5 7.2 10.1 12.4 3.1 5.4 11.8 8.5 11.1 8.2 6.8 7.7 8.5 4.3 15.1 9.0 2.2 1.3 0.0 2.9 7.0 5.0 2.8 4.9 4.4 2.3 5.7 2.9 2.9 2.7 2.3 4.8 2.3 1.3 2.3 0.6 1.7 7.1 1.4 4.3 2.1 3.0 3.3 2.3 4.5 2.8 3.3 3.0 2.7 5.3 1.5 SLC25A26 ENSG00000144741 "Solute carrier family 25 member 26" Q70HW3 3 66133610-66388116 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026887 Supported Supported Mitochondria Mitochondria "HPA026887: AB_2189921" "unprognostic (1.93e-1)" "unprognostic (1.29e-1)" "unprognostic (1.38e-2)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (7.83e-2)" "unprognostic (7.94e-2)" "unprognostic (5.38e-2)" "unprognostic (1.53e-1)" "unprognostic (3.54e-1)" "unprognostic (9.21e-2)" "unprognostic (8.43e-2)" "prognostic favourable (1.73e-5)" "unprognostic (4.73e-2)" "unprognostic (2.59e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-1)" 11.8 12.9 20.2 8.5 14.8 13.3 16.5 7.9 27.2 10.3 12.6 15.8 9.2 9.7 11.1 12.9 14.3 13.1 10.1 19.5 16.9 12.8 15.7 22.7 10.0 15.2 17.6 11.8 20.0 21.2 16.2 11.6 11.9 14.6 10.8 13.4 12.6 16.1 12.6 29.8 16.5 11.0 16.8 14.3 11.4 12.7 18.3 12.6 12.0 19.0 14.2 12.9 13.4 10.8 12.0 12.2 3.6 7.1 10.5 14.4 9.1 6.3 6.1 3.8 7.7 8.4 8.7 8.0 5.3 10.1 7.2 6.8 8.1 8.5 6.5 3.2 9.7 4.7 4.4 9.9 7.4 6.7 10.3 9.8 4.9 11.7 10.2 13.8 8.4 11.9 19.6 5.7 13.7 5.3 4.3 8.7 8.6 7.9 5.7 15.8 11.1 3.6 6.0 6.9 11.0 5.9 4.7 2.9 8.9 7.7 6.7 12.6 5.6 10.9 6.0 7.6 7.2 9.5 9.3 12.9 16.7 8.4 10.4 13.2 8.2 1.3 6.8 3.6 10.9 7.1 9.9 12.0 12.1 11.1 12.2 10.2 14.4 12.3 0.4 10.5 4.1 11.6 11.1 9.1 20.2 14.8 7.9 27.2 16.9 12.8 17.6 11.8 14.6 12.6 SLC25A27 "FLJ33552, UCP4" ENSG00000153291 "Solute carrier family 25 member 27" O95847 6 46652915-46678193 "Plasma proteins, Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 25.8;hTCEpi: 14.6;U-698: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069732 Supported Mitochondria Mitochondria "HPA069732: " "unprognostic (2.16e-2)" "unprognostic (2.19e-1)" "unprognostic (9.86e-3)" "unprognostic (4.93e-2)" "unprognostic (1.87e-1)" "unprognostic (2.03e-1)" "unprognostic (2.81e-1)" "unprognostic (1.24e-1)" "unprognostic (1.22e-1)" "unprognostic (1.35e-1)" "prognostic favourable (6.16e-4)" "unprognostic (3.82e-3)" "unprognostic (1.01e-1)" "unprognostic (7.53e-2)" "unprognostic (1.18e-1)" "unprognostic (1.74e-1)" "unprognostic (7.47e-3)" 13.3 15.0 18.5 6.6 28.8 1.5 18.7 63.8 30.2 11.8 13.2 20.2 11.3 5.0 28.4 50.9 7.6 13.9 14.2 11.9 17.6 10.5 12.6 12.2 10.1 4.2 24.7 28.9 39.4 9.7 25.8 37.8 2.6 19.6 31.0 11.5 23.6 14.3 17.9 11.2 28.1 6.8 17.0 18.0 6.3 9.1 12.6 26.9 0.4 21.7 7.7 3.8 11.4 17.6 0.0 0.4 0.3 0.0 0.0 0.3 0.0 2.0 1.3 2.3 7.8 8.9 6.2 0.1 1.1 3.6 1.1 0.2 0.0 2.8 0.8 5.4 1.9 4.0 1.1 3.4 0.7 0.0 11.6 0.0 25.8 2.8 4.7 0.1 0.3 9.6 14.6 0.0 9.2 0.2 0.1 0.0 0.9 0.8 0.0 0.1 1.2 3.0 0.0 3.0 0.1 5.9 7.3 7.1 0.7 5.4 0.3 2.9 5.8 0.0 0.8 4.9 3.3 0.5 0.9 3.1 0.0 15.9 0.7 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 18.5 28.8 63.8 30.2 17.6 10.5 24.7 28.9 19.6 26.9 SLC25A3 PHC ENSG00000075415 "Solute carrier family 25 member 3" Q00325 12 98593591-98606379 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 233.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045709 Supported Mitochondria 5500000 Mitochondria "HPA045709: AB_10965843" "unprognostic (1.16e-2)" "unprognostic (4.68e-1)" "unprognostic (1.95e-2)" "unprognostic (1.52e-1)" "unprognostic (1.56e-2)" "unprognostic (6.38e-2)" "unprognostic (3.25e-3)" "unprognostic (9.41e-2)" "unprognostic (4.98e-2)" "unprognostic (6.43e-2)" "unprognostic (5.65e-2)" "unprognostic (7.40e-2)" "prognostic favourable (8.11e-7)" "unprognostic (3.45e-1)" "unprognostic (2.99e-1)" "unprognostic (8.66e-3)" "unprognostic (4.72e-2)" 35.7 71.2 23.6 38.3 27.2 24.6 48.9 25.1 50.2 29.8 69.6 22.4 33.8 53.9 38.5 35.9 54.6 30.1 55.1 233.5 22.9 25.3 60.2 72.6 47.0 75.5 27.8 26.0 39.6 59.7 55.5 29.1 34.2 31.6 33.8 53.3 30.9 53.5 33.5 190.6 33.8 76.0 46.7 19.6 35.6 51.4 16.9 15.1 42.0 41.5 125.8 44.4 38.5 31.9 46.8 82.3 33.4 78.5 43.3 56.6 76.3 75.6 59.1 78.4 64.9 71.4 118.8 101.1 66.4 88.5 86.1 72.0 106.1 39.8 103.4 39.5 80.4 65.2 79.5 89.7 90.8 38.9 63.4 61.6 43.6 70.3 88.0 72.1 49.0 112.3 80.3 62.5 90.0 121.5 66.4 30.7 102.6 56.4 66.9 80.5 72.6 97.1 76.5 81.7 114.7 111.3 76.0 40.3 54.0 79.5 71.5 109.6 96.6 78.9 81.6 48.0 45.3 52.6 66.4 52.0 61.1 72.3 37.8 42.6 61.7 24.4 59.5 33.4 40.1 77.2 47.4 46.8 45.7 44.3 82.3 33.3 47.9 45.3 26.4 43.3 78.5 50.3 56.6 76.3 23.6 27.2 25.1 50.2 22.9 25.3 27.8 26.0 31.6 15.1 SLC25A31 "ANT4, DKFZP434N1235" ENSG00000151475 "Solute carrier family 25 member 31" Q9H0C2 4 127730378-127774299 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 687 "testis: 68.6" "Cell line enhanced" "Detected in single" "hTCEpi: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA015064, HPA016841, HPA046835, HPA071684" Uncertain Enhanced Mitochondria Mitochondria "HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: , HPA071684: " "unprognostic (8.15e-2)" "unprognostic (1.62e-1)" "unprognostic (2.70e-1)" "unprognostic (5.32e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC25A32 MFTC ENSG00000164933 "Solute carrier family 25 member 32" Q9H2D1 8 103398635-103415189 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024763, HPA047402" Uncertain Supported Mitochondria Mitochondria "HPA024763: , HPA047402: " "unprognostic (2.45e-3)" "unprognostic (8.19e-2)" "unprognostic (3.87e-3)" "prognostic unfavourable (7.23e-4)" "unprognostic (2.06e-2)" "unprognostic (6.50e-3)" "unprognostic (1.22e-2)" "prognostic unfavourable (2.09e-4)" "unprognostic (9.47e-2)" "unprognostic (8.43e-2)" "unprognostic (2.08e-1)" "unprognostic (9.21e-2)" "prognostic unfavourable (1.53e-6)" "unprognostic (7.82e-2)" "unprognostic (2.12e-1)" "unprognostic (1.62e-1)" "unprognostic (4.49e-2)" 24.1 14.9 11.1 19.6 17.0 21.6 21.6 22.1 21.9 16.3 14.7 15.4 8.8 11.0 19.4 13.0 13.1 18.8 19.6 16.4 12.6 16.5 15.2 29.6 16.1 23.9 16.4 11.6 21.0 13.4 17.3 30.1 16.5 24.2 14.9 14.2 15.7 13.0 13.1 17.8 13.9 14.1 18.5 14.1 25.1 14.4 15.3 13.6 17.2 14.9 11.7 19.8 18.3 14.2 8.9 5.0 1.8 4.6 5.7 9.3 6.5 14.9 5.4 7.3 8.9 10.1 11.7 4.9 12.7 18.0 14.3 14.9 6.5 9.2 32.5 12.1 13.7 9.6 10.5 10.7 22.2 19.8 7.5 24.0 4.6 8.3 17.5 11.7 10.9 11.5 8.9 16.1 24.0 14.8 14.8 12.8 14.2 6.0 19.9 9.6 8.8 10.8 15.0 7.8 22.4 9.7 6.9 20.5 9.0 6.2 10.2 21.3 9.1 8.4 10.2 17.8 11.8 20.4 16.3 9.1 8.6 33.9 15.1 17.2 13.1 0.7 3.9 1.8 7.7 4.4 9.3 8.9 8.3 8.8 5.0 6.5 8.6 8.7 1.1 5.7 4.6 4.3 6.5 6.5 11.1 17.0 22.1 21.9 12.6 16.5 16.4 11.6 24.2 13.6 SLC25A34 DKFZp781A10161 ENSG00000162461 "Solute carrier family 25 member 34" Q6PIV7 1 15736405-15741396 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 38.8;skeletal muscle: 22.2" "Cell line enhanced" "Detected in many" "SK-MEL-30: 7.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "cerebellum: 10.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069806 Approved Mitochondria Mitochondria "HPA069806: " "unprognostic (2.06e-1)" "unprognostic (4.72e-1)" "unprognostic (1.15e-1)" "unprognostic (2.43e-1)" "unprognostic (2.58e-1)" "unprognostic (8.08e-3)" "unprognostic (1.98e-2)" "unprognostic (9.92e-2)" "unprognostic (1.55e-1)" "unprognostic (1.55e-1)" "unprognostic (1.80e-4)" "unprognostic (5.74e-2)" "unprognostic (6.10e-2)" "unprognostic (4.02e-1)" "unprognostic (1.82e-1)" "unprognostic (4.04e-2)" "unprognostic (2.40e-4)" 2.5 2.4 1.2 0.9 1.9 2.8 0.7 10.4 1.8 1.1 25.9 0.8 0.5 13.5 1.7 1.4 1.6 1.3 3.6 13.3 1.5 1.2 7.3 3.9 1.1 1.1 0.7 1.8 2.4 18.6 0.6 2.1 1.2 1.5 1.1 1.9 3.7 11.1 0.8 22.2 0.8 38.8 1.0 1.1 1.9 1.4 2.3 1.2 0.5 1.9 11.0 1.9 0.7 1.1 0.7 0.5 2.0 0.5 2.2 4.1 1.1 0.7 0.5 3.5 1.6 1.7 0.7 1.5 0.5 0.3 0.9 0.7 1.5 1.9 0.9 0.8 0.7 0.7 0.6 0.6 0.8 1.2 0.7 1.5 1.2 0.5 0.6 0.4 2.2 0.8 2.7 1.1 0.5 0.4 0.6 3.3 0.6 1.8 3.7 2.0 2.9 1.0 2.0 3.1 1.0 0.3 0.1 0.7 2.8 0.8 1.0 7.5 1.9 2.5 1.8 1.7 2.2 2.3 0.6 3.9 3.6 0.7 0.6 2.2 1.4 1.2 0.5 0.4 1.4 0.2 3.1 0.5 3.0 2.0 0.2 0.7 4.1 2.3 2.0 2.2 0.2 0.5 1.3 1.1 1.2 1.9 10.4 1.8 1.5 1.2 0.7 1.8 1.5 1.2 SLC25A4 "ANT1, PEO2, PEO3, T1" ENSG00000151729 "Solute carrier family 25 member 4" P12235 4 185143241-185150382 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction, Transport" "Cardiomyopathy, Disease mutation, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 163.7;skeletal muscle: 92.5;tongue: 62.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.5;dendritic cells: 3.0;T-cells: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria Mitochondria "HPA046835: , HPA071684: " "unprognostic (4.19e-2)" "unprognostic (1.06e-2)" "unprognostic (3.11e-1)" "unprognostic (8.85e-2)" "unprognostic (1.37e-1)" "unprognostic (2.90e-3)" "unprognostic (8.25e-2)" "unprognostic (1.26e-2)" "unprognostic (7.87e-2)" "unprognostic (1.60e-1)" "prognostic favourable (3.41e-4)" "unprognostic (2.05e-1)" "prognostic favourable (0.00e+0)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (1.73e-1)" "unprognostic (8.28e-3)" 3.0 4.2 6.9 2.0 10.8 1.4 3.1 19.4 14.4 2.6 6.6 3.7 2.9 2.8 3.0 3.4 6.7 3.7 3.5 163.7 7.4 7.3 8.3 4.3 3.0 2.0 6.3 6.1 3.6 3.0 4.6 4.6 2.2 12.8 6.2 3.4 7.9 4.4 8.5 92.5 2.3 4.1 5.5 4.5 2.1 5.3 3.1 2.3 0.0 4.6 62.4 3.4 4.4 2.1 3.5 3.0 0.4 0.0 0.7 4.1 1.5 0.7 3.2 2.7 5.4 2.9 0.3 4.9 2.7 0.9 3.3 3.3 7.0 1.8 2.3 1.9 3.2 2.6 10.3 2.8 2.1 4.0 8.8 1.6 4.9 8.2 6.0 1.4 1.6 2.2 7.0 5.0 1.4 2.4 3.8 1.8 2.0 5.1 1.6 3.1 4.3 7.0 2.6 1.4 3.3 7.4 5.0 8.7 6.6 3.2 1.4 12.4 2.5 1.2 1.8 0.2 1.5 1.6 3.4 7.8 3.5 3.0 2.4 0.3 3.0 0.0 0.0 0.0 4.1 0.0 3.1 3.5 1.4 3.5 0.1 2.2 1.2 3.0 0.4 0.7 0.0 3.0 1.2 1.5 6.9 10.8 19.4 14.1 7.4 7.3 6.3 6.1 12.8 2.3 SLC25A42 MGC26694 ENSG00000181035 "Solute carrier family 25 member 42" Q86VD7 19 19063999-19112888 "Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 42.3" "Cell line enhanced" "Detected in many" "K-562: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 5.1;MAIT T-cell: 2.8;memory B-cell: 6.2;memory CD4 T-cell: 2.9;memory CD8 T-cell: 4.3;naive B-cell: 5.1;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.8;NK-cell: 2.8;T-reg: 2.9" "Group enriched" "Detected in many" 6 "B-cells: 6.2;NK-cells: 2.8;T-cells: 5.1" "Low region specificity" "Detected in all" HPA049449 Approved Supported Mitochondria Mitochondria "HPA049449: AB_2680772" "unprognostic (2.27e-1)" "prognostic favourable (5.04e-4)" "unprognostic (5.79e-2)" "unprognostic (5.67e-2)" "unprognostic (1.35e-1)" "unprognostic (3.42e-3)" "unprognostic (1.27e-3)" "prognostic favourable (4.11e-4)" "unprognostic (6.89e-2)" "unprognostic (2.73e-1)" "unprognostic (1.37e-3)" "unprognostic (3.04e-2)" "unprognostic (5.29e-3)" "unprognostic (1.76e-1)" "unprognostic (2.39e-2)" "unprognostic (4.17e-2)" "unprognostic (2.03e-2)" 4.8 5.7 13.8 4.5 12.2 7.5 4.9 22.5 15.4 7.0 4.8 5.9 4.5 5.7 6.8 4.4 4.5 7.4 4.7 8.9 9.7 7.8 26.7 42.3 5.4 8.5 5.9 7.8 13.8 7.4 6.5 9.6 3.2 7.9 7.6 3.0 12.2 11.0 6.3 26.7 5.2 5.6 5.7 6.1 7.3 4.6 4.5 8.1 6.6 17.1 7.3 12.2 5.5 5.4 6.2 0.7 0.2 0.6 2.8 5.1 1.5 6.3 0.8 1.6 2.9 6.3 5.2 2.6 3.1 4.7 4.8 5.5 1.2 12.8 4.6 7.3 2.9 1.2 3.3 2.6 2.8 1.1 6.3 1.6 1.7 10.2 5.0 0.7 3.2 5.2 1.8 3.6 2.2 2.1 17.8 8.3 2.5 5.7 7.6 7.3 0.9 6.6 5.9 2.9 8.8 1.9 1.2 1.8 1.3 3.3 0.1 1.4 5.8 3.6 1.9 3.6 2.0 7.4 3.0 9.6 5.2 3.6 3.8 9.8 1.8 0.0 0.2 0.2 5.1 0.5 2.8 6.2 2.9 4.3 0.3 5.1 1.9 2.8 0.0 2.8 0.6 0.7 2.9 1.5 13.8 12.2 22.5 15.4 9.7 7.8 5.9 7.8 7.9 8.1 SLC25A46 ENSG00000164209 "Solute carrier family 25 member 46" Q96AG3 5 110738136-110765161 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039601, HPA071582" Approved Supported Mitochondria Mitochondria "HPA039601: , HPA071582: " "unprognostic (1.86e-1)" "unprognostic (3.29e-1)" "prognostic favourable (8.41e-4)" "unprognostic (4.91e-2)" "unprognostic (2.27e-2)" "unprognostic (2.25e-1)" "unprognostic (2.34e-1)" "unprognostic (1.77e-2)" "unprognostic (5.14e-2)" "unprognostic (1.97e-2)" "unprognostic (1.67e-1)" "unprognostic (2.40e-1)" "unprognostic (2.25e-2)" "unprognostic (2.26e-1)" "unprognostic (2.62e-1)" "prognostic unfavourable (2.52e-4)" "unprognostic (1.98e-1)" 16.9 15.6 11.9 12.7 19.3 11.3 13.6 17.6 25.7 12.5 14.0 12.2 8.5 15.7 13.4 9.5 16.4 9.5 10.0 20.8 10.4 10.0 18.7 22.0 11.4 13.7 14.5 14.8 10.2 12.4 12.7 20.2 11.5 27.7 10.2 14.7 8.3 14.2 10.7 55.6 13.0 15.4 13.9 15.0 12.1 12.9 15.8 12.3 20.4 12.5 14.3 17.5 13.1 10.9 14.6 15.1 20.2 17.3 17.7 16.3 14.9 12.4 9.6 9.1 7.4 21.2 20.0 3.7 15.6 20.3 17.9 22.4 13.2 10.6 33.6 16.0 18.2 10.3 14.4 25.8 20.3 21.5 8.3 14.4 14.0 9.5 18.9 12.6 14.5 16.9 7.6 21.1 14.9 11.1 10.9 21.1 18.5 10.0 18.3 5.3 6.8 9.7 9.0 20.4 25.0 11.4 14.6 16.1 11.9 13.5 10.4 16.4 11.4 10.4 14.6 15.8 8.0 14.3 18.7 40.6 25.4 25.2 16.4 14.7 8.4 20.2 14.7 11.5 12.3 17.3 12.4 14.1 13.7 12.6 15.1 14.6 14.8 14.8 6.2 17.7 15.2 10.6 16.3 14.9 11.9 19.3 17.6 25.7 10.4 10.0 14.5 14.8 27.7 12.3 SLC25A5 "2F1, ANT2, T2, T3" ENSG00000005022 "Solute carrier family 25 member 5" P05141 X 119468400-119471319 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Chromosome partition, Host-virus interaction, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria 7800000 Mitochondria "HPA046835: , HPA071684: " "unprognostic (1.25e-2)" "prognostic favourable (7.35e-4)" "prognostic favourable (7.47e-4)" "unprognostic (1.48e-1)" "unprognostic (4.58e-2)" "unprognostic (1.45e-2)" "unprognostic (2.73e-2)" "unprognostic (1.36e-1)" "unprognostic (6.52e-2)" "unprognostic (2.47e-1)" "unprognostic (1.60e-1)" "unprognostic (2.17e-1)" "prognostic favourable (8.06e-6)" "unprognostic (1.41e-1)" "unprognostic (2.65e-1)" "unprognostic (4.36e-2)" "unprognostic (3.03e-1)" 26.0 28.9 26.8 32.2 29.5 36.5 36.6 21.8 39.0 23.0 74.1 16.3 26.0 120.7 22.5 18.3 64.1 17.5 39.5 31.4 22.5 18.8 80.7 71.0 38.3 53.8 27.2 23.8 18.1 128.2 22.5 14.6 30.7 24.2 18.9 84.9 20.1 58.3 21.5 16.6 42.1 157.5 33.6 20.5 34.3 68.2 16.8 17.1 87.0 31.1 59.9 47.0 30.8 33.8 51.6 97.8 18.5 113.2 33.4 48.0 84.9 81.9 78.8 30.9 53.1 19.8 29.2 57.4 30.6 33.4 64.7 58.0 65.5 52.0 104.1 41.3 29.4 57.7 75.7 64.0 59.2 27.5 73.0 35.1 47.6 46.6 25.1 95.2 58.0 31.7 72.0 66.6 42.5 67.1 28.1 43.1 35.3 182.5 84.2 96.7 65.0 127.1 46.3 39.1 80.8 49.3 66.0 37.4 35.4 52.7 80.2 62.1 33.1 48.2 27.9 30.6 44.3 68.2 109.9 50.6 62.9 83.3 33.9 97.4 49.5 10.1 68.1 18.5 20.7 113.2 23.9 51.6 30.1 26.9 97.8 39.7 30.1 28.3 11.3 33.4 84.9 53.9 48.0 84.9 26.8 29.5 21.8 39.0 22.5 18.8 27.2 23.8 24.2 17.1 SLC25A51 "CG7943, MCART1, MGC14836" ENSG00000122696 "Solute carrier family 25 member 51" Q9H1U9 9 37879400-37904353 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 13.4" "Low lineage specificity" "Detected in all" "HPA046388, HPA058261" Uncertain Approved Mitochondria Mitochondria "HPA046388: , HPA058261: " "unprognostic (5.46e-2)" "unprognostic (2.28e-1)" "unprognostic (2.67e-2)" "unprognostic (5.63e-2)" "unprognostic (1.00e-2)" "unprognostic (1.35e-2)" "prognostic unfavourable (5.67e-5)" "unprognostic (6.87e-2)" "unprognostic (1.04e-1)" "unprognostic (7.98e-3)" "unprognostic (1.26e-3)" "unprognostic (5.37e-2)" "prognostic favourable (1.52e-4)" "unprognostic (8.27e-3)" "unprognostic (2.31e-1)" "prognostic unfavourable (2.21e-4)" "unprognostic (2.08e-2)" 17.6 9.1 11.7 9.9 12.9 21.2 27.6 11.3 14.2 12.0 10.7 12.0 10.8 15.3 10.3 10.2 12.6 8.1 10.7 11.5 12.9 9.3 13.3 9.7 14.6 10.8 11.9 14.9 11.0 16.7 20.6 12.8 9.7 11.9 10.5 9.0 8.2 13.3 8.4 15.9 11.7 13.4 12.2 11.4 12.6 9.7 18.8 12.4 14.4 9.8 7.6 12.9 9.1 10.2 3.1 1.4 13.4 3.9 2.1 3.6 1.1 8.1 6.5 5.1 7.9 24.3 10.6 5.1 7.0 7.2 6.1 8.9 8.5 3.5 17.2 4.1 16.4 4.0 13.5 9.8 11.6 11.8 4.1 5.2 18.0 11.8 13.7 8.2 7.7 10.6 11.4 9.0 11.6 10.8 11.5 13.7 12.9 4.7 9.9 1.9 6.2 4.7 7.0 6.7 10.6 6.0 6.0 10.6 6.8 5.6 6.7 4.0 3.6 9.0 11.8 10.2 12.0 4.8 8.6 5.3 11.1 12.0 13.4 6.0 8.4 13.4 1.9 3.2 2.1 3.9 3.6 3.1 2.3 3.0 1.4 2.2 2.2 2.5 1.5 2.1 1.6 0.6 3.4 1.1 11.7 12.9 11.3 14.2 12.9 9.3 11.9 14.9 11.9 12.4 SLC25A52 MCART2 ENSG00000141437 "Solute carrier family 25 member 52" 18 31759562-31760880 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 17 "testis: 18.2" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "pons and medulla: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046388, HPA058261" Uncertain Approved Mitochondria Mitochondria "HPA046388: , HPA058261: " "unprognostic (8.97e-2)" "unprognostic (4.85e-2)" "unprognostic (2.93e-1)" "unprognostic (4.87e-1)" "unprognostic (2.50e-1)" "unprognostic (9.05e-2)" "unprognostic (2.97e-2)" "unprognostic (1.30e-4)" "unprognostic (7.15e-3)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (1.41e-1)" "unprognostic (3.34e-2)" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.3 0.4 0.4 0.0 0.8 0.4 0.5 1.3 0.4 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.3 1.2 0.5 0.0 1.0 0.0 0.3 0.2 0.5 0.0 0.9 2.4 0.6 0.0 1.4 1.1 0.0 0.2 0.0 0.3 0.0 0.7 1.0 0.0 0.0 1.3 0.1 0.3 0.0 1.1 0.9 0.0 0.0 0.4 0.7 1.5 0.8 1.0 0.2 0.6 1.7 1.3 0.6 0.5 0.5 0.7 1.3 1.4 0.7 0.8 0.6 1.2 0.8 0.1 0.1 0.2 0.3 0.2 0.1 0.1 0.2 0.2 0.2 0.4 0.4 0.0 0.4 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 SLC25A6 "ANT3, ANT3Y, MGC17525" ENSG00000169100 "Solute carrier family 25 member 6" P12236 X 1386152-1392724 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 85.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria 7200000 Mitochondria "HPA046835: , HPA071684: " "unprognostic (1.13e-1)" "unprognostic (1.65e-2)" "unprognostic (4.79e-2)" "unprognostic (1.45e-1)" "unprognostic (2.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.01e-3)" "unprognostic (1.34e-1)" "unprognostic (8.07e-2)" "unprognostic (1.48e-1)" "unprognostic (1.37e-3)" "unprognostic (2.51e-1)" "unprognostic (3.96e-2)" "unprognostic (2.73e-1)" "unprognostic (1.69e-1)" "unprognostic (2.85e-1)" "unprognostic (4.57e-3)" 18.5 19.7 12.1 12.2 14.0 23.7 14.4 8.2 12.2 9.8 16.5 28.9 14.3 4.8 16.4 10.4 7.0 9.4 10.3 8.2 18.4 5.4 11.1 14.4 9.4 25.6 38.7 10.1 14.0 8.6 12.4 8.8 45.0 12.5 6.1 14.9 23.3 7.7 5.8 15.4 19.2 2.4 16.3 9.5 14.2 11.2 62.2 85.7 3.7 69.0 30.1 43.6 71.2 22.0 48.3 34.3 35.0 23.8 46.4 37.1 33.8 32.4 24.9 24.8 63.8 27.0 81.9 27.3 22.2 14.3 23.0 40.3 7.9 20.5 73.1 44.8 33.1 72.8 55.8 32.2 54.7 76.5 74.3 19.5 28.7 37.0 31.2 19.3 24.4 46.9 59.6 61.7 43.5 65.0 30.1 28.4 63.5 30.4 55.4 56.0 88.0 22.8 69.4 96.1 38.5 66.4 42.2 25.5 14.3 49.7 33.6 50.1 8.0 55.3 3.8 31.1 13.8 2.4 58.1 3.7 29.4 69.0 43.6 62.2 40.4 34.8 85.7 47.5 38.1 37.2 3.0 30.1 67.9 41.0 38.7 71.2 SLC35F2 FLJ13018 ENSG00000110660 "Solute carrier family 35 member F2" Q8IXU6 11 107790991-107928293 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 43.2" "Cell line enhanced" "Detected in many" "PC-3: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048185, HPA050695, HPA060150" Approved Approved Mitochondria Mitochondria "HPA048185: , HPA050695: , HPA060150: " "unprognostic (7.73e-2)" "unprognostic (3.28e-3)" "unprognostic (8.37e-3)" "unprognostic (5.77e-2)" "unprognostic (1.38e-3)" "unprognostic (3.07e-2)" "unprognostic (7.26e-2)" "prognostic unfavourable (4.03e-4)" "unprognostic (6.22e-2)" "unprognostic (8.20e-2)" "prognostic unfavourable (5.92e-6)" "unprognostic (1.24e-1)" "unprognostic (4.10e-2)" "unprognostic (1.34e-1)" "unprognostic (7.33e-2)" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" 3.0 2.5 2.4 7.4 2.2 1.3 2.7 2.1 2.4 7.4 8.1 1.8 3.8 8.4 2.6 4.8 5.0 6.2 5.9 2.4 3.7 2.6 5.6 2.0 4.0 7.7 2.4 2.2 3.4 3.4 0.3 2.6 9.7 1.9 10.6 9.8 5.2 43.2 2.7 2.3 8.5 7.4 1.8 4.2 2.7 2.8 3.7 2.3 1.8 3.2 6.7 6.9 3.4 3.7 9.3 5.9 0.5 0.2 2.9 11.2 1.6 8.5 5.6 0.6 7.9 4.7 6.9 8.0 2.0 1.1 5.2 6.8 24.0 8.9 14.1 20.1 5.8 17.7 11.2 18.0 10.5 11.8 10.3 7.8 5.5 9.9 7.7 18.3 3.9 4.8 10.4 17.4 37.6 27.3 20.6 5.8 3.7 5.1 7.5 17.7 6.0 54.3 15.3 7.1 18.4 28.1 7.7 13.7 5.8 6.4 14.8 3.9 10.9 3.9 20.3 9.7 16.0 0.2 20.2 15.3 17.2 15.5 6.1 5.8 6.3 0.1 0.2 0.0 2.8 0.1 7.3 9.3 4.8 4.9 5.9 6.1 1.8 2.5 0.5 2.9 0.0 0.3 11.2 1.6 2.4 2.2 2.1 2.4 3.7 2.6 2.4 2.2 1.9 2.3 SLC37A4 "G6PT1, G6PT2, G6PT3, GSD1b, GSD1c, GSD1d" ENSG00000137700 "Solute carrier family 37 member 4" 11 119024114-119030906 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 42.2" "Cell line enhanced" "Detected in many" "CACO-2: 16.0;HEK 293: 17.0;Hep G2: 21.1;MCF7: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038939, HPA038940" Enhanced Approved Mitochondria Mitochondria "HPA038939: , HPA038940: " "unprognostic (4.77e-2)" "unprognostic (3.49e-1)" "unprognostic (2.08e-2)" "unprognostic (2.35e-2)" "unprognostic (4.70e-2)" "unprognostic (6.95e-3)" "unprognostic (1.09e-1)" "unprognostic (1.39e-1)" "unprognostic (4.08e-2)" "unprognostic (8.27e-3)" "unprognostic (4.72e-2)" "unprognostic (3.89e-1)" "unprognostic (1.98e-1)" "unprognostic (4.04e-2)" "unprognostic (2.60e-1)" "unprognostic (4.34e-2)" "unprognostic (5.39e-2)" 2.1 3.7 4.8 4.8 3.7 1.4 3.7 7.8 5.9 1.7 5.0 2.7 13.6 26.0 2.6 15.9 2.5 4.0 6.9 4.6 3.7 4.9 29.6 42.2 3.3 4.7 3.7 3.1 3.3 15.5 5.9 2.2 3.3 2.3 4.3 5.3 3.0 4.6 13.6 27.7 2.0 6.7 1.9 3.1 3.4 1.8 4.5 1.4 2.9 3.3 3.3 2.4 1.7 2.3 1.2 0.7 2.7 3.7 2.0 4.1 1.2 0.4 7.0 2.5 1.9 4.6 1.9 1.5 0.2 5.8 1.6 4.0 16.0 1.2 1.8 3.9 2.3 0.4 1.1 8.0 2.5 2.1 17.0 5.3 1.5 21.1 1.7 3.0 0.9 0.0 2.2 0.8 4.3 5.3 2.1 4.7 2.7 14.8 0.1 6.8 0.1 8.4 4.3 0.0 8.4 1.8 7.4 3.3 3.3 0.0 0.4 2.6 3.2 2.3 0.0 0.0 2.5 0.1 2.8 0.8 1.3 0.5 0.7 7.7 0.7 0.0 1.9 2.7 3.3 3.7 2.8 1.2 1.9 4.1 0.7 1.1 1.6 2.3 0.0 2.0 1.5 0.2 2.1 1.2 4.8 3.7 7.8 5.9 3.7 4.9 3.7 3.1 2.3 1.4 SLC41A1 MgtE ENSG00000133065 "Solute carrier family 41 member 1" Q8IVJ1 1 205789093-205813748 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 78.1;pancreas: 36.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014721, HPA015138" Uncertain Approved Mitochondria Mitochondria "HPA014721: , HPA015138: AB_1857160" "unprognostic (1.18e-1)" "prognostic unfavourable (1.48e-4)" "unprognostic (2.77e-2)" "unprognostic (1.30e-2)" "unprognostic (2.30e-1)" "unprognostic (1.38e-2)" "unprognostic (2.37e-3)" "unprognostic (5.23e-2)" "unprognostic (5.53e-3)" "unprognostic (1.11e-1)" "unprognostic (1.87e-2)" "unprognostic (4.46e-2)" "unprognostic (3.09e-3)" "unprognostic (2.60e-1)" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" "unprognostic (1.65e-1)" 6.0 7.2 6.2 4.0 7.3 3.3 3.4 9.0 8.3 3.6 3.9 10.8 4.0 1.6 5.0 5.9 3.8 7.3 4.7 78.1 7.2 3.8 6.1 1.2 5.3 4.5 7.8 4.9 7.5 36.8 5.8 3.6 2.6 6.9 5.1 1.5 5.8 2.8 4.8 26.5 2.6 2.7 4.0 8.5 3.3 6.6 11.6 7.3 2.1 11.2 11.9 4.5 5.2 5.0 1.8 0.0 0.1 0.3 1.0 4.6 2.0 10.7 9.5 6.0 9.6 7.5 7.4 8.1 11.0 10.9 11.3 9.9 4.7 6.1 15.5 7.0 10.1 11.2 5.9 8.1 3.9 28.4 8.8 3.8 9.4 0.7 7.2 0.0 10.9 9.4 6.8 12.8 9.2 6.9 6.9 6.5 9.0 6.6 6.9 1.1 7.2 4.3 8.2 18.1 3.7 2.6 13.4 5.0 6.4 8.5 7.6 6.9 5.4 4.0 8.6 13.4 8.7 12.2 11.4 21.7 14.4 5.1 10.4 4.9 8.3 0.0 0.1 0.1 3.6 0.3 4.6 1.5 3.4 3.4 0.0 1.8 3.2 3.3 0.0 1.0 0.0 0.0 3.3 2.0 6.2 7.3 9.0 8.3 7.2 3.8 7.8 4.9 6.9 7.3 SLC6A1 "GABATHG, GABATR, GAT1" ENSG00000157103 "Solute carrier family 6 member 1" P30531 3 10992186-11039249 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 56.2;liver: 75.6" "Cell line enhanced" "Detected in many" "HeLa: 4.5" "Group enriched" "Detected in some" 16 "glioma: 16.1;liver cancer: 24.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013341, CAB022293" Enhanced Uncertain Mitochondria Mitochondria "CAB022293: , HPA013341: AB_1849509" "unprognostic (1.66e-3)" "unprognostic (1.30e-3)" "unprognostic (4.12e-3)" "unprognostic (1.70e-1)" "unprognostic (2.53e-1)" "unprognostic (2.53e-1)" "prognostic favourable (3.20e-4)" "unprognostic (1.05e-1)" "unprognostic (4.27e-2)" "unprognostic (8.26e-2)" "unprognostic (2.90e-1)" "unprognostic (2.69e-1)" "prognostic unfavourable (5.05e-6)" "unprognostic (7.32e-3)" "unprognostic (2.36e-1)" "unprognostic (1.35e-1)" "unprognostic (5.34e-2)" 1.8 2.1 32.2 1.6 31.0 3.0 1.8 15.1 56.2 2.0 1.7 25.4 0.0 1.7 1.9 3.9 4.3 2.4 2.3 3.3 22.2 16.6 2.1 75.6 2.5 1.7 22.7 25.3 2.4 1.4 9.3 1.0 2.0 17.0 2.1 1.8 1.7 1.6 5.0 3.3 1.7 1.7 1.8 13.7 1.9 1.7 4.4 14.3 0.5 1.9 0.0 1.7 1.9 0.9 1.0 0.8 1.2 0.3 0.2 0.8 0.2 0.8 0.6 1.8 1.3 1.5 0.4 1.0 0.7 0.2 0.8 1.1 1.4 1.0 1.6 0.3 0.4 1.3 2.3 0.9 0.7 0.2 1.7 1.3 4.5 2.7 0.7 2.2 2.2 1.1 0.2 0.2 1.2 0.3 1.1 3.6 0.2 1.0 0.7 1.7 0.8 1.4 1.2 0.2 0.1 0.6 1.7 0.8 0.3 1.0 0.6 0.2 1.0 1.0 0.3 0.8 0.5 0.7 0.6 1.1 0.3 1.2 0.9 1.7 0.4 0.3 0.3 1.1 0.5 0.1 0.8 0.9 0.6 0.5 0.3 1.0 0.3 0.5 1.2 0.2 0.3 0.8 0.3 0.2 32.2 31.0 15.1 41.5 22.2 16.6 22.7 25.3 17.0 14.3 SLIRP "C14orf156, DC50" ENSG00000119705 "SRA stem-loop interacting RNA binding protein" Q9GZT3 14 77708071-77761104 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020291 Approved Supported Mitochondria 38000 Mitochondria "HPA020291: AB_1845563" "unprognostic (9.28e-2)" "unprognostic (4.88e-2)" "unprognostic (1.87e-1)" "unprognostic (3.62e-1)" "unprognostic (1.34e-1)" "prognostic unfavourable (4.88e-4)" "unprognostic (1.18e-1)" "unprognostic (8.23e-2)" "unprognostic (2.19e-1)" "unprognostic (1.14e-2)" "unprognostic (1.92e-2)" "unprognostic (1.35e-1)" "unprognostic (9.95e-3)" "unprognostic (1.52e-1)" "unprognostic (2.39e-1)" "unprognostic (3.60e-2)" "unprognostic (1.37e-1)" 31.9 36.0 65.2 25.0 55.1 33.6 49.9 24.3 54.7 29.2 49.8 30.6 23.2 37.2 23.7 65.1 38.1 24.4 26.5 63.6 47.5 50.5 57.5 69.8 19.1 24.3 53.7 40.6 26.1 49.3 19.3 34.8 30.0 44.9 25.2 46.7 27.8 36.9 30.6 105.7 20.5 42.1 31.9 46.3 26.3 32.0 31.7 34.4 16.5 27.4 72.9 34.6 27.9 23.5 35.2 52.2 20.9 59.6 18.3 33.0 40.5 41.2 82.0 33.7 32.8 22.2 22.4 45.4 23.4 22.1 46.6 40.7 110.9 37.9 30.0 24.8 26.6 40.9 61.4 47.8 61.9 16.4 68.9 30.3 77.6 110.2 34.1 20.0 21.8 23.9 31.5 37.3 41.6 38.3 29.6 17.2 40.5 133.5 30.6 54.9 52.2 116.0 28.2 28.2 33.5 47.8 78.7 43.1 28.2 24.8 52.8 33.8 55.3 35.6 22.2 23.8 42.8 25.7 40.8 18.6 33.8 56.1 32.7 39.4 30.5 17.4 59.6 20.9 23.8 56.5 25.0 35.2 31.7 23.3 50.8 31.2 33.0 27.3 19.1 18.3 56.9 52.2 31.7 40.5 65.2 55.1 24.3 54.7 47.5 50.5 53.7 40.6 44.9 34.4 SLITRK3 KIAA0848 ENSG00000121871 "SLIT and NTRK like family member 3" O94933 3 165186720-165197109 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;liver: 12.8" "Cell line enhanced" "Detected in some" "AF22: 6.5;HAP1: 5.4;Karpas-707: 1.5;SCLC-21H: 3.5" "Cancer enriched" "Detected in single" 22 "glioma: 7.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017636, HPA048042" Enhanced Approved Mitochondria 1400000 Mitochondria "HPA017636: AB_1857232, HPA048042: " "unprognostic (8.91e-2)" "unprognostic (1.44e-1)" "unprognostic (4.08e-2)" "unprognostic (1.96e-1)" "unprognostic (5.16e-2)" "unprognostic (1.76e-1)" "unprognostic (9.59e-2)" "unprognostic (2.95e-2)" "unprognostic (1.03e-1)" "unprognostic (2.22e-1)" "unprognostic (6.74e-3)" "unprognostic (5.03e-1)" "unprognostic (2.38e-1)" "unprognostic (8.03e-4)" 0.6 0.6 7.4 2.0 12.0 0.4 0.5 10.6 17.4 9.9 3.0 1.5 0.3 1.1 12.1 2.0 7.6 12.6 0.8 1.0 13.2 5.5 0.6 12.8 0.9 0.5 3.7 6.5 2.5 0.4 0.4 0.3 0.4 4.2 3.3 3.1 0.3 0.8 9.6 0.9 0.5 1.5 6.2 2.3 0.4 0.8 1.0 2.4 0.0 0.6 0.0 0.5 0.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 1.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 12.0 10.6 15.7 13.2 5.5 3.7 6.5 4.2 2.4 SMIM12 "C1orf212, FLJ90372" ENSG00000163866 "Small integral membrane protein 12" Q96EX1 1 34712737-34859816 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065331 Approved Approved Mitochondria Mitochondria "HPA065331: " "unprognostic (2.21e-1)" "unprognostic (2.26e-1)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (1.40e-1)" "prognostic unfavourable (1.18e-4)" "unprognostic (2.64e-1)" "unprognostic (2.05e-1)" "unprognostic (5.71e-2)" "unprognostic (3.57e-2)" "unprognostic (1.93e-1)" "prognostic favourable (1.15e-5)" "unprognostic (7.33e-2)" "unprognostic (6.70e-2)" "unprognostic (3.58e-2)" "unprognostic (2.52e-2)" 26.6 28.8 16.4 19.0 21.9 16.0 21.0 14.2 27.1 12.2 22.6 14.2 12.4 22.6 14.8 15.5 22.4 13.9 15.7 25.5 15.6 21.7 31.7 61.5 17.1 21.4 19.0 18.7 13.3 25.5 10.9 15.3 19.3 19.8 11.3 21.8 15.4 17.3 16.8 32.2 15.7 23.1 23.9 13.8 19.2 17.0 13.7 13.1 20.3 18.1 20.1 20.1 15.7 16.8 25.7 38.5 54.4 35.1 25.5 36.6 35.3 21.6 16.6 18.7 13.6 24.5 19.3 13.0 23.6 20.6 30.5 26.4 16.7 27.7 22.8 21.3 24.2 21.9 23.7 31.7 23.5 27.6 16.7 40.5 26.6 19.9 22.8 44.1 24.0 29.3 31.0 33.1 26.9 31.1 28.7 31.1 26.9 15.8 21.3 22.8 30.2 21.7 18.2 18.3 29.6 27.0 22.8 18.0 14.2 21.9 20.7 33.2 14.1 12.5 29.1 21.0 21.5 32.0 27.6 17.5 24.1 23.1 19.8 26.4 13.7 36.4 34.7 54.4 31.1 35.1 36.6 25.4 29.2 33.9 38.5 25.7 24.4 31.4 22.8 25.5 28.0 27.6 32.5 35.3 16.4 21.9 14.2 27.1 15.6 21.7 19.0 18.7 19.8 13.1 SMYD5 "NN8-4AG, RAI15, RRG1, ZMYND23" ENSG00000135632 "SMYD family member 5" Q6GMV2 2 73214222-73227237 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015514, HPA049002" Uncertain Approved Mitochondria Mitochondria "HPA015514: , HPA049002: AB_2680595" "unprognostic (1.75e-1)" "unprognostic (3.39e-1)" "unprognostic (5.22e-2)" "unprognostic (6.66e-3)" "unprognostic (3.86e-1)" "unprognostic (1.16e-1)" "prognostic unfavourable (6.58e-7)" "unprognostic (1.28e-1)" "unprognostic (1.60e-2)" "unprognostic (3.84e-2)" "unprognostic (3.84e-1)" "unprognostic (2.49e-1)" "unprognostic (3.03e-2)" "unprognostic (3.94e-1)" "unprognostic (1.47e-1)" "unprognostic (1.91e-1)" "unprognostic (2.40e-1)" 13.9 16.5 16.9 14.9 23.6 11.2 20.1 18.3 24.5 14.5 11.3 18.5 16.0 8.3 16.2 23.0 17.0 22.7 9.4 19.1 16.4 18.2 15.9 19.0 10.6 18.3 15.3 15.0 33.4 27.1 22.6 13.9 15.2 15.7 13.4 13.2 17.1 13.4 16.4 16.4 15.0 10.3 16.8 13.1 14.7 9.7 15.7 14.5 9.4 16.4 13.2 17.2 12.4 17.6 6.8 3.2 0.0 4.1 4.2 12.0 4.3 11.8 22.9 13.7 13.1 10.1 14.9 23.3 11.4 11.5 22.2 13.7 29.3 12.2 21.1 10.7 19.1 12.2 21.2 24.6 20.1 12.7 14.9 20.4 9.2 32.1 13.6 20.0 8.4 12.5 15.9 20.2 24.3 13.4 21.5 10.2 14.0 16.6 18.8 13.2 21.4 18.3 12.6 25.7 17.4 14.5 17.2 8.9 13.3 10.3 15.5 13.0 12.6 7.2 9.2 15.3 24.1 18.5 18.6 11.3 8.3 18.9 17.2 17.3 12.2 0.0 1.3 0.0 5.5 3.8 12.0 6.5 7.6 7.3 3.2 6.8 7.7 8.3 0.0 4.2 4.1 3.0 3.1 4.3 16.9 23.6 18.3 24.5 16.4 18.2 15.3 15.0 15.7 14.5 SNX19 "CHET8, KIAA0254" ENSG00000120451 "Sorting nexin 19" Q92543 11 130875436-130916509 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013447 Uncertain Supported Mitochondria Mitochondria "HPA013447: AB_1857347" "unprognostic (8.79e-3)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (1.56e-1)" "unprognostic (2.97e-2)" "unprognostic (2.43e-1)" "unprognostic (4.17e-2)" "unprognostic (9.19e-2)" "unprognostic (3.43e-2)" "unprognostic (4.05e-2)" "unprognostic (2.89e-1)" "unprognostic (4.97e-2)" "prognostic favourable (3.56e-5)" "unprognostic (1.05e-1)" "unprognostic (2.77e-1)" "unprognostic (2.92e-2)" "unprognostic (1.55e-2)" 22.3 23.1 24.0 16.9 30.6 10.0 17.2 18.0 38.0 17.1 23.8 35.6 25.3 17.1 22.9 32.5 17.9 19.8 20.4 22.6 22.8 22.2 24.1 25.6 17.5 15.3 31.0 15.3 20.6 26.6 32.9 28.5 18.5 28.0 21.7 22.2 23.7 23.1 27.2 26.4 19.0 17.8 26.0 30.8 18.5 22.3 36.2 28.2 24.6 31.1 12.1 18.1 23.0 16.4 5.9 5.4 11.3 6.6 3.6 6.2 5.2 6.7 7.4 9.6 13.4 28.9 20.4 6.3 18.0 21.4 9.1 9.5 8.4 13.0 6.4 12.6 19.8 12.3 1.4 12.9 11.7 10.3 5.8 11.6 7.4 0.0 21.0 0.0 9.1 23.2 16.0 9.3 10.2 11.1 10.2 0.0 19.4 4.9 9.4 7.7 2.9 9.5 7.2 9.1 3.7 9.9 12.2 9.4 8.7 7.7 12.4 6.1 22.0 7.3 14.7 12.8 9.5 10.4 10.5 2.2 0.0 0.0 5.3 7.7 14.6 11.3 6.0 4.4 4.8 6.4 6.2 5.9 4.7 5.7 5.3 4.4 5.6 4.4 3.6 3.6 6.6 5.4 4.1 5.2 24.0 30.6 18.0 38.0 22.8 22.2 31.0 15.3 28.0 28.2 SOD2 ENSG00000112096 "Superoxide dismutase 2" 6 159669057-159745186 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 254.9;skeletal muscle: 475.1" "Cell line enhanced" "Detected in all" "BJ hTERT+: 181.9;HSkMC: 80.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 11 "neutrophil: 254.9" "Lineage enriched" "Detected in many" 11 "granulocytes: 254.9" "HPA001814, CAB002013" Supported Enhanced Mitochondria Mitochondria "CAB002013: , HPA001814: AB_1080134" "unprognostic (2.47e-2)" "unprognostic (2.77e-3)" "unprognostic (1.14e-1)" "unprognostic (1.57e-2)" "unprognostic (1.31e-1)" "unprognostic (1.69e-1)" "unprognostic (1.49e-1)" "unprognostic (3.10e-2)" "unprognostic (1.37e-1)" "unprognostic (6.67e-2)" "unprognostic (2.76e-2)" "unprognostic (7.14e-2)" "prognostic unfavourable (1.72e-4)" "unprognostic (8.12e-2)" "unprognostic (4.14e-2)" "unprognostic (5.99e-2)" "unprognostic (1.82e-1)" 77.8 28.6 6.2 82.8 13.8 147.9 32.5 3.6 12.5 13.1 25.6 5.7 3.6 9.1 13.3 16.6 20.3 12.6 19.9 42.4 5.8 6.4 157.4 197.5 33.9 52.7 14.3 2.6 31.8 24.9 6.9 7.0 10.0 16.1 27.1 6.1 6.4 39.9 7.4 475.1 9.0 8.1 27.9 25.5 18.4 13.8 13.6 7.3 3.0 36.8 20.8 11.8 43.4 52.8 2.3 5.8 254.9 22.7 0.9 4.5 15.0 3.6 4.6 4.1 9.4 26.6 44.5 2.1 5.3 181.9 6.5 15.1 9.5 2.1 7.5 16.0 5.9 6.3 4.3 4.6 4.9 7.3 8.9 7.9 7.8 16.2 19.7 7.5 3.4 80.3 7.7 20.6 15.4 3.3 10.8 9.0 6.2 3.9 6.2 4.8 6.9 5.8 8.4 5.6 6.9 12.1 6.0 7.8 3.0 11.2 5.7 2.3 3.5 3.5 3.1 19.1 6.9 10.1 9.2 3.8 9.8 9.0 21.1 5.8 2.4 6.2 19.2 9.4 2.2 14.9 2.4 2.3 3.1 2.2 5.8 1.8 2.6 2.1 254.9 0.9 22.7 0.8 4.5 15.0 6.2 13.8 3.6 12.5 5.8 6.4 14.3 2.6 16.1 7.3 SP9 ZNF990 ENSG00000217236 "Sp9 transcription factor" P0CG40 2 174334946-174338492 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 12.4;fallopian tube: 5.1;skin 1: 4.5" "Cell line enhanced" "Detected in some" "A549: 8.8;fHDF/TERT166: 6.7;HEK 293: 2.7;THP-1: 14.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 6.0;olfactory region: 14.4" "Group enriched" "Detected in many" 5 "basal ganglia: 8.3;olfactory region: 44.8" HPA062616 Uncertain Approved Mitochondria Mitochondria "HPA062616: " "unprognostic (2.04e-2)" "unprognostic (6.94e-3)" "unprognostic (1.44e-1)" "unprognostic (3.95e-1)" "unprognostic (7.55e-3)" "unprognostic (8.54e-2)" "unprognostic (3.12e-1)" "unprognostic (1.01e-1)" 0.7 0.3 4.6 0.3 12.4 0.3 1.1 0.0 6.1 0.6 0.3 0.4 0.0 0.3 0.4 0.3 0.3 5.1 0.3 0.3 2.3 2.2 0.3 0.3 0.3 0.4 1.1 4.3 0.3 0.3 0.3 0.0 1.1 1.0 0.3 0.3 0.0 0.4 0.3 0.6 4.5 0.3 0.3 0.5 0.3 0.3 2.0 1.4 0.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 8.8 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 6.7 0.1 0.2 0.0 0.0 0.0 2.7 0.6 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 1.2 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 12.4 0.0 6.1 2.3 2.2 1.1 4.3 1.0 1.4 SPACA9 "C9orf9, Mast" ENSG00000165698 "Sperm acrosome associated 9" Q96E40 9 132878027-132890201 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "epididymis: 55.8;fallopian tube: 29.1;testis: 53.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA022243, HPA051600" Enhanced Approved Mitochondria Mitochondria "HPA022243: AB_1845844, HPA051600: " "unprognostic (2.69e-1)" "unprognostic (2.14e-3)" "unprognostic (8.00e-3)" "prognostic favourable (8.61e-4)" "unprognostic (1.59e-1)" "unprognostic (5.73e-2)" "unprognostic (3.76e-3)" "unprognostic (2.60e-1)" "unprognostic (6.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.15e-2)" "unprognostic (9.51e-2)" "prognostic favourable (8.31e-4)" "unprognostic (5.11e-2)" "unprognostic (1.22e-2)" "unprognostic (1.20e-1)" "unprognostic (1.22e-2)" 2.7 6.0 7.8 1.6 8.4 1.7 3.9 4.3 9.3 5.1 4.8 8.5 7.9 1.7 5.3 55.8 5.3 29.1 4.5 7.0 7.0 8.9 7.0 1.8 4.6 2.1 7.2 7.3 9.2 2.8 2.7 5.8 3.0 6.9 4.1 2.1 5.7 7.7 6.2 1.5 8.0 1.7 4.3 7.7 2.3 3.1 53.8 5.1 6.2 10.2 3.6 3.0 2.9 3.8 6.0 3.0 5.6 3.3 7.8 3.5 1.6 2.7 3.0 4.6 3.7 6.4 8.3 5.5 1.7 3.3 2.5 2.7 0.8 8.6 0.7 4.1 8.0 3.9 1.9 5.0 2.3 3.2 3.6 0.7 2.1 0.9 9.4 2.0 0.3 9.4 10.8 6.1 6.7 2.8 0.8 2.3 6.7 5.9 6.8 7.8 1.0 2.8 3.3 1.0 1.9 10.0 1.1 1.2 4.5 7.4 1.3 5.9 9.8 0.7 2.7 5.4 3.6 5.1 0.7 0.9 1.5 2.4 9.9 0.8 2.6 5.6 2.2 3.6 2.2 2.0 2.5 6.0 2.4 1.3 3.0 4.7 2.9 2.6 3.1 7.8 3.3 1.0 3.5 1.6 7.8 8.4 4.3 9.3 7.0 8.9 7.2 7.3 6.9 5.1 SPATA18 FLJ32906 ENSG00000163071 "Spermatogenesis associated 18" Q8TC71 4 52051331-52097292 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 41.7;testis: 65.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 19.7;BEWO: 14.8;BJ hTERT+: 9.5;HSkMC: 18.2;hTCEpi: 17.5" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons and medulla: 12.5" "Cell type enriched" "Detected in single" 23 "naive B-cell: 2.2" "Lineage enriched" "Detected in single" 23 "B-cells: 2.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036854, HPA036855" Enhanced Supported Mitochondria Mitochondria "HPA036854: AB_10670927, HPA036855: AB_2675352" "unprognostic (6.54e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-1)" "prognostic favourable (1.32e-5)" "unprognostic (1.02e-2)" "unprognostic (1.53e-2)" "unprognostic (7.27e-2)" "unprognostic (4.49e-2)" "unprognostic (1.76e-1)" "unprognostic (2.73e-1)" "unprognostic (3.13e-1)" "unprognostic (3.13e-2)" "prognostic favourable (3.73e-9)" "unprognostic (4.38e-1)" "unprognostic (1.39e-1)" "unprognostic (1.01e-2)" "unprognostic (4.00e-2)" 2.1 4.2 2.6 1.2 3.3 0.0 3.7 0.1 1.1 6.8 2.3 3.6 5.3 1.2 2.5 9.9 4.9 41.7 11.5 1.5 3.1 2.8 3.7 4.4 12.0 0.3 0.6 0.6 7.6 1.6 4.2 6.1 1.8 12.5 3.5 3.5 1.4 13.2 6.0 1.1 4.3 2.8 1.8 0.8 0.5 2.9 65.7 0.8 1.3 1.6 4.1 3.1 2.3 2.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.1 0.0 7.9 19.7 14.8 5.5 9.5 0.3 0.4 0.0 0.9 0.0 0.0 7.2 0.1 0.0 4.2 0.2 0.0 0.6 0.0 0.0 4.6 7.0 0.0 0.0 18.2 17.5 0.6 2.7 4.1 0.0 0.0 0.0 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 1.1 1.2 0.6 0.0 0.0 0.0 0.1 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.3 0.1 1.1 3.1 2.8 0.6 0.6 12.5 0.8 SPATA9 "FLJ35906, NYD-SP16" ENSG00000145757 "Spermatogenesis associated 9" Q9BWV2 5 95652181-95698711 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 29.5" "Cell line enhanced" "Detected in some" "ASC diff: 2.7;HaCaT: 2.8;NB-4: 2.3;THP-1: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 20 "eosinophil: 2.0" "Lineage enriched" "Detected in single" 20 "granulocytes: 2.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA010848, HPA076967" Approved Approved Mitochondria Mitochondria "HPA010848: AB_1857422, HPA076967: " "unprognostic (4.46e-2)" "unprognostic (4.02e-2)" "unprognostic (1.37e-1)" "unprognostic (1.22e-1)" "unprognostic (9.60e-2)" "unprognostic (5.69e-2)" "unprognostic (1.33e-2)" "unprognostic (2.08e-1)" "unprognostic (3.27e-2)" "unprognostic (7.58e-2)" "unprognostic (1.28e-2)" "unprognostic (3.08e-2)" "unprognostic (9.49e-13)" "unprognostic (3.39e-1)" "unprognostic (2.37e-1)" "unprognostic (1.26e-2)" "unprognostic (2.87e-2)" 0.9 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 29.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.0 2.7 0.0 0.0 0.2 0.3 0.0 0.4 0.0 0.1 0.0 0.5 0.3 2.8 0.0 0.0 0.0 0.2 0.5 1.7 0.2 0.0 0.6 0.5 0.4 1.6 0.0 0.6 0.0 0.5 1.7 0.0 2.1 0.0 0.7 2.3 0.8 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.4 0.0 3.9 0.0 0.7 0.2 0.5 0.4 0.0 0.2 0.0 0.0 0.4 1.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SPSB3 "C16orf31, SSB-3" ENSG00000162032 "SplA/ryanodine receptor domain and SOCS box containing 3" Q6PJ21 16 1776712-1793700 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 138.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046602 Uncertain Approved Mitochondria Mitochondria "HPA046602: " "unprognostic (1.18e-1)" "unprognostic (2.37e-2)" "unprognostic (1.79e-1)" "unprognostic (1.15e-3)" "unprognostic (1.82e-1)" "unprognostic (8.91e-4)" "unprognostic (1.07e-2)" "unprognostic (8.31e-2)" "unprognostic (5.65e-2)" "unprognostic (8.43e-2)" "unprognostic (3.41e-2)" "unprognostic (4.83e-2)" "unprognostic (5.25e-7)" "unprognostic (2.16e-2)" "unprognostic (2.02e-1)" "unprognostic (3.77e-1)" "unprognostic (4.72e-4)" 8.5 19.4 7.8 8.2 8.3 12.8 9.5 25.3 11.3 10.5 10.4 10.1 11.0 10.0 7.6 9.5 14.1 9.0 17.7 9.1 6.7 5.7 8.2 138.5 8.3 7.8 11.1 8.8 15.9 19.5 7.5 5.6 7.6 8.4 9.3 4.2 10.6 14.0 12.9 29.4 18.1 8.3 9.4 6.9 8.3 8.6 5.8 8.3 16.3 10.5 6.5 8.9 8.5 9.3 18.0 15.9 32.6 16.8 15.6 34.5 17.0 3.4 5.2 6.4 7.6 9.0 8.8 10.5 4.2 7.0 7.5 8.3 3.8 11.6 1.7 8.5 3.9 6.9 3.2 6.6 1.2 6.0 7.7 3.4 7.5 5.0 12.5 1.3 6.0 7.7 17.2 4.9 5.7 11.5 3.9 9.1 3.7 12.5 8.7 8.6 4.4 2.6 14.7 2.5 14.0 6.7 0.7 8.5 8.4 5.5 17.1 15.6 8.4 8.1 8.1 3.5 5.2 6.1 2.9 13.5 15.6 4.4 2.8 4.9 3.9 32.3 16.8 29.7 26.1 15.2 32.6 18.0 24.4 24.1 15.4 16.8 17.6 18.4 32.6 15.6 13.3 15.9 34.5 17.0 7.8 8.3 25.3 11.3 6.7 5.7 11.1 8.8 8.4 8.3 SPTLC2 "hLCB2a, KIAA0526, LCB2, LCB2A" ENSG00000100596 "Serine palmitoyltransferase long chain base subunit 2" O15270 14 77505997-77616773 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027552 Approved Mitochondria Mitochondria "HPA027552: AB_10601717" "unprognostic (3.16e-1)" "unprognostic (2.82e-2)" "unprognostic (1.24e-1)" "unprognostic (4.41e-2)" "unprognostic (2.12e-1)" "unprognostic (1.42e-1)" "prognostic unfavourable (3.62e-4)" "unprognostic (1.46e-2)" "unprognostic (3.09e-1)" "unprognostic (4.05e-1)" "unprognostic (1.98e-2)" "unprognostic (2.51e-1)" "prognostic favourable (6.69e-8)" "unprognostic (1.29e-2)" "unprognostic (2.35e-1)" "unprognostic (4.94e-2)" "unprognostic (1.32e-1)" 30.0 12.8 15.4 11.4 27.0 27.3 25.6 6.9 18.5 15.3 17.0 32.4 8.5 13.4 10.2 7.6 22.8 13.7 11.1 7.8 20.8 14.1 17.1 7.2 12.2 17.5 33.1 13.3 10.2 7.6 12.8 9.8 18.8 21.2 8.2 18.8 6.0 16.6 9.6 5.5 11.3 15.8 11.0 47.6 23.5 18.8 4.7 34.9 10.0 10.3 8.8 12.0 13.2 17.1 4.8 18.2 15.1 18.2 10.0 4.2 6.9 11.9 7.9 6.1 6.6 6.3 7.9 10.3 17.8 13.2 12.3 12.9 10.0 26.7 12.0 4.5 18.1 14.8 16.1 10.0 18.7 5.2 4.7 33.9 6.1 5.9 5.3 3.4 11.3 5.1 4.9 8.0 8.9 17.3 6.6 5.8 7.0 10.3 9.0 11.7 3.9 7.1 9.7 6.2 4.1 14.2 26.9 5.9 7.4 6.4 21.5 6.7 26.4 6.3 10.8 11.3 8.1 4.1 4.1 3.3 5.4 8.1 7.5 12.2 6.4 8.8 18.2 15.1 3.8 13.8 3.5 4.1 3.2 4.2 18.2 4.8 2.2 3.6 11.2 10.0 16.7 6.5 3.3 6.9 15.4 27.0 6.9 18.5 20.8 14.1 33.1 13.3 21.2 34.9 SQOR "CGI-44, SQR, SQRDL" ENSG00000137767 "Sulfide quinone oxidoreductase" Q9Y6N5 15 45631148-45691294 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 64.4;RPTEC TERT1: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA017079, HPA041589" Enhanced Supported Mitochondria 30000 Mitochondria "HPA017079: AB_1857467, HPA041589: " "unprognostic (6.15e-2)" "unprognostic (3.28e-2)" "unprognostic (2.15e-1)" "prognostic favourable (2.57e-4)" "unprognostic (2.75e-2)" "unprognostic (5.51e-2)" "unprognostic (6.68e-3)" "prognostic unfavourable (8.80e-4)" "unprognostic (1.81e-1)" "unprognostic (3.77e-1)" "unprognostic (6.65e-3)" "unprognostic (2.37e-1)" "unprognostic (3.14e-3)" "unprognostic (2.29e-1)" "unprognostic (4.92e-2)" "unprognostic (7.44e-2)" "unprognostic (4.38e-1)" 23.6 8.6 4.4 33.5 5.7 12.0 16.7 1.6 3.8 11.9 54.7 3.0 12.1 14.2 11.7 11.4 38.7 8.4 15.2 12.2 2.8 2.3 16.9 34.2 27.1 22.4 6.8 2.3 8.7 27.7 7.4 7.5 7.0 4.8 18.0 48.5 11.2 21.5 15.2 66.9 14.3 31.5 21.5 4.9 21.4 19.7 4.6 3.1 11.7 19.0 36.6 30.3 24.6 20.7 11.0 27.8 62.3 43.5 10.0 29.2 29.2 7.6 13.8 0.0 0.8 28.5 34.3 0.0 8.3 28.3 5.1 7.7 0.5 12.1 7.2 8.2 6.4 6.9 0.4 64.4 3.1 24.2 0.2 0.5 3.0 9.6 8.3 3.9 1.1 10.0 19.1 11.9 27.1 14.1 0.0 8.9 5.4 6.1 2.4 9.1 0.0 8.3 0.3 1.4 9.6 40.8 11.3 0.2 0.2 2.0 5.6 2.7 11.9 12.5 15.6 2.0 0.5 30.0 1.8 11.3 11.7 0.4 20.6 21.2 2.2 18.4 43.5 16.2 16.3 32.9 22.8 11.0 21.6 18.3 27.8 9.5 11.3 12.2 62.3 10.0 29.0 8.1 29.2 29.2 4.4 5.7 1.6 3.8 2.8 2.3 6.8 2.3 4.8 3.1 SSBP1 "mtSSB, SSBP" ENSG00000106028 "Single stranded DNA binding protein 1" Q04837 7 141738321-141787922 "Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002866 Supported Supported Mitochondria 250000 Mitochondria "HPA002866: AB_1080092" "unprognostic (2.95e-1)" "unprognostic (2.99e-1)" "unprognostic (2.49e-2)" "unprognostic (3.62e-2)" "unprognostic (7.36e-3)" "unprognostic (2.86e-2)" "prognostic unfavourable (4.42e-4)" "unprognostic (3.68e-2)" "unprognostic (6.03e-2)" "prognostic favourable (3.40e-4)" "unprognostic (9.23e-3)" "unprognostic (4.02e-1)" "unprognostic (9.65e-3)" "unprognostic (1.62e-1)" "unprognostic (9.38e-2)" "unprognostic (1.25e-2)" "unprognostic (9.58e-2)" 41.1 52.5 45.4 40.9 52.6 41.7 51.6 26.8 44.3 41.7 42.4 33.9 38.7 36.9 45.2 58.9 61.0 37.1 36.8 57.8 38.6 38.6 55.2 83.4 31.0 56.0 42.7 41.0 45.2 49.6 40.7 44.4 47.2 44.4 38.8 44.8 34.1 41.2 39.0 62.9 42.4 40.8 45.5 36.7 50.7 44.6 38.3 33.3 62.9 45.6 67.4 54.7 42.8 38.6 42.6 41.2 31.3 35.9 36.3 48.7 40.8 39.1 45.4 40.6 51.1 18.1 29.4 37.3 28.3 27.2 36.2 40.7 47.9 44.9 61.2 40.1 23.7 29.5 47.0 49.4 51.4 29.4 49.0 30.0 34.2 42.3 35.8 88.0 23.9 27.7 33.7 37.8 53.3 44.0 75.6 25.9 49.4 57.5 62.3 114.9 89.5 56.8 36.1 36.9 79.7 47.3 38.6 36.6 50.2 33.0 43.9 43.9 29.7 38.8 31.7 25.7 24.9 39.7 75.0 46.8 61.9 109.6 52.8 79.3 56.1 31.3 29.1 26.6 30.1 35.5 44.0 42.6 48.7 40.2 36.8 37.0 45.1 48.1 7.5 36.3 35.9 41.2 46.4 40.8 45.4 52.6 26.8 44.3 38.6 38.6 42.7 41.0 44.4 33.3 STARD7 GTT1 ENSG00000084090 "StAR related lipid transfer domain containing 7" Q9NQZ5 2 96184859-96208825 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033965, HPA064958, HPA064978" Supported Approved Mitochondria "Intracellular and membrane" Mitochondria "CAB033965: AB_2302780, HPA064958: , HPA064978: " "unprognostic (3.75e-2)" "unprognostic (1.54e-2)" "unprognostic (1.67e-1)" "prognostic unfavourable (8.56e-5)" "prognostic favourable (3.89e-6)" "unprognostic (1.51e-1)" "prognostic unfavourable (2.22e-4)" "unprognostic (2.72e-3)" "unprognostic (2.38e-1)" "unprognostic (2.93e-1)" "unprognostic (4.66e-2)" "unprognostic (1.78e-1)" "prognostic favourable (4.38e-6)" "unprognostic (1.02e-1)" "unprognostic (2.04e-1)" "unprognostic (2.64e-2)" "unprognostic (2.42e-2)" 17.3 26.6 30.3 20.6 27.1 11.5 32.1 26.5 28.7 14.4 22.6 24.4 15.2 21.6 13.9 12.8 17.0 18.0 13.5 66.7 26.1 24.5 32.5 29.1 24.0 30.1 34.1 17.1 12.4 24.6 28.2 11.7 11.4 23.6 16.1 22.8 17.3 24.2 19.7 74.4 14.4 22.2 15.0 24.1 21.7 17.4 8.1 29.9 26.3 22.7 24.1 32.9 16.4 15.2 26.4 25.0 14.5 18.6 18.1 24.1 13.7 31.9 19.8 26.0 26.8 35.1 17.6 39.3 31.5 26.9 31.0 33.5 46.6 29.5 57.0 34.8 24.4 26.0 46.0 26.6 40.5 38.6 35.3 50.3 19.6 53.7 16.1 38.4 28.2 17.0 19.7 25.7 25.5 30.9 52.0 22.6 27.4 27.7 43.5 39.1 44.2 29.7 43.2 40.0 56.6 18.6 40.5 50.0 23.8 15.9 51.1 28.2 15.2 42.3 25.8 25.8 26.7 28.7 31.4 30.2 28.0 51.1 23.8 43.4 28.4 14.5 14.9 13.9 16.4 18.6 16.9 26.4 14.1 17.1 22.7 21.5 16.2 15.0 1.7 18.1 11.8 25.0 24.1 13.7 30.3 27.1 26.5 28.7 26.1 24.5 34.1 17.1 23.6 29.9 STMP1 "C7orf73, PL-5283" ENSG00000243317 "Short transmembrane mitochondrial protein 1" E0CX11 7 135662496-135693418 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 71.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 71.6" HPA065565 Approved Mitochondria "Intracellular and membrane" Mitochondria "HPA065565: " "unprognostic (3.94e-2)" "unprognostic (1.05e-1)" "unprognostic (8.76e-2)" "unprognostic (3.11e-2)" "unprognostic (3.64e-2)" "unprognostic (1.81e-1)" "unprognostic (2.99e-3)" "unprognostic (1.12e-1)" "unprognostic (4.43e-3)" "prognostic favourable (2.95e-4)" "unprognostic (1.93e-1)" "unprognostic (1.30e-1)" "unprognostic (7.21e-3)" "unprognostic (4.90e-2)" "unprognostic (9.99e-2)" "unprognostic (9.62e-3)" "unprognostic (6.81e-2)" 15.6 32.2 22.5 19.7 24.3 33.5 27.3 13.8 20.4 20.1 19.0 25.0 20.3 17.4 16.5 26.7 51.4 16.2 19.3 29.5 19.3 20.6 28.4 34.7 19.7 28.1 22.3 13.5 16.5 25.4 14.6 25.4 28.1 20.4 20.7 22.5 31.2 23.0 18.5 40.7 21.1 23.2 21.3 22.0 18.7 19.5 38.7 17.0 38.4 31.9 42.6 34.9 18.2 28.0 5.3 12.5 71.6 13.1 7.6 6.6 9.2 14.9 6.9 17.0 15.8 20.1 28.6 10.3 16.6 16.2 13.8 14.4 4.3 16.5 13.6 14.8 25.0 6.2 16.2 20.8 18.8 17.0 13.4 21.4 8.0 10.4 19.8 21.7 13.9 17.6 23.9 16.4 15.4 11.3 23.0 12.3 30.3 18.5 30.9 25.1 33.3 17.8 15.7 18.1 22.5 38.3 7.8 21.4 20.7 22.0 15.4 15.3 6.2 24.0 18.5 13.5 10.9 23.9 23.0 14.3 20.6 26.5 41.6 22.7 24.4 71.6 12.0 25.0 5.3 12.3 5.0 5.3 5.1 5.3 12.5 4.5 4.9 5.4 9.3 7.6 13.1 7.1 6.6 9.2 22.5 24.3 13.8 20.4 19.3 20.6 22.3 13.5 20.4 17.0 SUCLA2 ENSG00000136143 "Succinate-CoA ligase ADP-forming beta subunit" Q9P2R7 13 47745736-48037968 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039435, HPA039536, HPA061528" Enhanced Supported Enhanced Mitochondria 6600 Mitochondria "HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553" "unprognostic (5.66e-3)" "unprognostic (1.72e-2)" "unprognostic (1.14e-1)" "unprognostic (8.76e-2)" "unprognostic (1.60e-1)" "unprognostic (3.45e-2)" "unprognostic (2.48e-1)" "unprognostic (1.71e-1)" "unprognostic (4.70e-2)" "unprognostic (1.41e-2)" "unprognostic (1.10e-1)" "unprognostic (1.38e-1)" "prognostic favourable (7.59e-14)" "unprognostic (3.53e-1)" "unprognostic (2.19e-1)" "unprognostic (2.29e-1)" "prognostic unfavourable (1.22e-4)" 21.6 18.5 19.2 8.6 22.1 5.2 17.5 29.7 32.4 15.3 15.7 11.7 15.6 24.5 12.7 12.1 14.6 11.3 9.4 42.1 20.0 21.6 34.0 12.9 7.9 11.4 22.6 19.1 14.4 10.8 19.8 14.9 12.2 28.7 16.2 16.5 8.9 13.9 14.8 89.0 10.0 22.7 14.7 18.3 9.7 12.3 8.0 15.4 15.6 16.9 25.6 10.2 11.0 12.6 17.1 29.5 12.4 25.0 23.4 25.2 17.2 17.2 20.0 25.4 15.2 29.1 22.0 15.3 26.4 29.6 27.5 18.7 35.5 19.6 24.2 20.2 25.8 24.0 33.5 25.1 34.9 23.1 28.7 27.2 19.0 23.0 20.3 27.5 15.9 20.7 29.6 18.7 22.1 20.2 18.3 8.8 27.3 11.9 28.3 31.5 26.3 25.6 24.1 23.2 18.7 39.7 16.7 14.1 16.8 22.0 20.4 15.5 18.1 24.4 15.4 15.3 9.9 21.7 18.3 9.1 14.2 28.2 9.5 20.1 22.4 5.7 24.5 12.4 17.6 25.0 21.2 17.1 19.7 21.6 29.5 16.3 25.2 24.9 4.5 23.4 20.0 24.3 21.6 17.2 19.2 22.1 29.7 32.4 20.0 21.6 22.6 19.1 28.7 15.4 SUPV3L1 SUV3 ENSG00000156502 "Suv3 like RNA helicase" Q8IYB8 10 69180232-69209099 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038380, HPA038405" Supported Supported Mitochondria Mitochondria "HPA038380: AB_2675983, HPA038405: AB_10675797" "unprognostic (4.70e-2)" "unprognostic (1.85e-2)" "unprognostic (2.25e-1)" "unprognostic (1.19e-2)" "unprognostic (3.74e-2)" "unprognostic (3.32e-2)" "unprognostic (1.44e-2)" "unprognostic (1.78e-1)" "unprognostic (1.57e-1)" "unprognostic (9.47e-3)" "unprognostic (1.70e-1)" "unprognostic (1.06e-1)" "unprognostic (5.48e-3)" "unprognostic (5.03e-2)" "unprognostic (1.61e-1)" "unprognostic (5.27e-2)" "unprognostic (1.33e-1)" 12.8 17.0 11.1 12.6 17.3 26.1 17.7 21.9 19.9 10.8 14.4 12.6 7.8 11.2 13.5 12.4 13.2 11.9 12.6 19.2 12.0 11.3 16.4 22.2 9.6 15.2 9.9 13.1 15.8 18.2 15.4 14.7 10.9 16.1 11.4 16.7 12.4 11.8 13.9 31.1 15.6 12.5 13.9 9.9 15.5 13.0 26.6 9.9 12.7 14.1 13.4 14.8 12.4 11.6 10.1 7.3 5.6 7.7 7.4 13.7 6.2 11.3 7.9 7.1 21.8 8.0 6.8 9.4 7.0 10.9 14.3 13.5 20.3 9.6 20.4 5.8 7.1 13.0 17.1 11.0 13.8 8.5 13.4 8.9 6.2 10.7 20.3 21.1 6.8 8.6 13.9 13.1 30.2 8.2 23.2 10.6 7.8 7.3 12.8 13.1 8.5 43.4 11.8 10.1 8.9 6.5 5.5 10.2 7.7 9.7 20.4 18.5 6.3 9.3 5.1 5.7 10.3 8.6 13.6 8.4 9.8 19.0 9.4 22.4 3.6 5.6 5.2 4.3 12.3 7.7 13.7 10.1 8.9 10.5 7.3 8.3 9.9 10.6 0.9 7.4 5.2 4.0 8.7 6.2 11.1 17.3 21.9 19.9 12.0 11.3 9.9 13.1 16.1 9.9 SUV39H2 "FLJ23414, KMT1B" ENSG00000152455 "Suppressor of variegation 3-9 homolog 2" Q9H5I1 10 14878820-14904315 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Differentiation, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045901, HPA057554" Enhanced Approved Mitochondria Mitochondria "HPA045901: AB_10960702, HPA057554: " "prognostic unfavourable (5.55e-4)" "unprognostic (1.45e-1)" "unprognostic (2.98e-2)" "unprognostic (8.78e-3)" "unprognostic (6.80e-2)" "unprognostic (1.23e-3)" "prognostic unfavourable (2.01e-6)" "unprognostic (1.06e-1)" "unprognostic (9.15e-2)" "unprognostic (3.59e-3)" "unprognostic (2.42e-1)" "unprognostic (4.13e-3)" "prognostic unfavourable (5.71e-5)" "unprognostic (2.71e-2)" "unprognostic (1.40e-1)" "unprognostic (5.55e-2)" "unprognostic (1.39e-1)" 3.0 2.9 4.7 3.4 7.4 4.9 5.2 20.0 8.6 3.1 3.8 1.6 2.1 3.2 3.8 2.3 4.0 3.0 3.2 2.4 5.4 2.8 3.5 3.8 2.7 3.6 3.3 4.4 4.2 2.4 2.4 6.3 5.1 3.3 3.9 4.7 1.6 2.4 3.6 2.4 3.3 2.9 3.7 3.0 3.4 2.7 41.8 4.4 10.3 2.8 4.9 4.0 3.3 2.8 0.8 3.1 0.5 1.8 5.6 4.0 0.8 13.7 13.1 21.9 12.5 4.1 4.9 8.6 7.5 4.6 13.9 19.8 19.5 7.9 11.0 6.8 4.4 9.7 16.2 9.0 17.2 11.2 10.8 16.6 9.2 12.0 2.4 7.4 8.0 2.4 3.2 14.1 4.4 9.6 21.4 7.4 10.3 13.4 14.8 2.1 13.5 3.5 18.3 14.5 8.9 5.9 6.5 7.3 8.1 11.6 7.2 6.3 12.8 6.4 5.6 10.1 16.2 12.2 11.8 4.3 16.1 25.3 6.2 8.1 6.4 0.5 0.4 0.3 2.8 1.8 4.0 0.8 2.4 3.5 2.2 0.6 3.8 3.6 0.3 5.6 0.5 3.1 3.7 0.8 4.7 7.4 20.0 8.6 5.4 2.8 3.3 4.4 3.3 4.4 SYNJ2BP Arip2 ENSG00000213463 "Synaptojanin 2 binding protein" P57105 14 70366496-70417061 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000866 Approved Supported Approved Mitochondria Mitochondria "HPA000866: AB_2276678" "unprognostic (2.68e-1)" "unprognostic (1.76e-1)" "unprognostic (2.67e-1)" "unprognostic (3.31e-1)" "unprognostic (1.28e-1)" "unprognostic (1.04e-1)" "unprognostic (1.65e-1)" "unprognostic (1.60e-2)" "unprognostic (5.70e-2)" "unprognostic (6.14e-2)" "unprognostic (6.35e-3)" "unprognostic (1.44e-2)" "prognostic favourable (1.11e-16)" "unprognostic (2.81e-1)" "unprognostic (1.38e-1)" "unprognostic (5.35e-3)" "unprognostic (1.14e-2)" 12.0 13.8 10.8 8.2 13.0 1.7 11.2 15.8 13.7 11.8 20.1 14.1 14.1 21.0 12.5 10.4 16.3 9.5 11.7 15.7 10.5 8.9 32.0 25.9 10.4 6.8 11.0 6.4 10.3 11.0 28.9 22.2 12.0 13.4 15.3 16.7 11.6 13.2 15.0 27.4 6.7 32.2 15.2 12.4 11.3 16.8 16.9 9.9 7.0 16.9 14.4 7.9 15.4 9.1 4.6 5.1 0.6 5.3 3.8 7.4 1.9 9.6 6.2 10.9 7.3 8.4 9.8 7.6 7.4 7.7 5.3 6.0 6.0 9.1 0.0 7.1 8.5 8.3 10.9 8.1 12.6 1.3 5.5 3.5 9.5 7.8 7.4 0.0 1.2 7.6 6.7 6.6 3.7 11.5 2.0 2.0 9.4 6.9 4.9 1.4 7.9 7.6 6.2 15.8 2.6 11.5 14.5 8.0 13.9 10.2 8.6 6.0 16.0 2.5 12.6 12.6 8.8 4.8 6.0 2.7 10.1 0.0 11.2 1.2 10.4 0.6 5.3 0.1 4.3 5.1 4.9 4.6 5.2 5.0 5.1 3.9 7.4 5.9 0.6 3.8 3.3 3.2 3.9 1.9 10.8 13.0 15.8 13.7 10.5 8.9 11.0 6.4 13.4 9.9 SYNJ2BP-COX16 ENSG00000258644 "SYNJ2BP-COX16 readthrough" 14 70326064-70417074 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2 OS: 33.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000866, HPA062659" Approved Supported Approved Mitochondria Mitochondria "HPA000866: AB_2276678, HPA062659: " "unprognostic (9.44e-2)" "unprognostic (2.42e-1)" "unprognostic (4.33e-2)" "unprognostic (1.68e-2)" "unprognostic (1.06e-1)" "unprognostic (1.34e-1)" "unprognostic (8.70e-2)" "unprognostic (2.02e-1)" "unprognostic (1.96e-2)" "unprognostic (3.00e-1)" "unprognostic (2.21e-2)" "unprognostic (6.41e-2)" "unprognostic (6.73e-4)" "unprognostic (6.68e-2)" "unprognostic (6.93e-2)" "unprognostic (2.55e-1)" "unprognostic (2.12e-2)" 5.5 7.1 3.8 4.7 5.7 7.7 5.7 7.1 7.4 5.1 9.3 6.2 6.2 8.2 4.3 4.3 7.4 2.1 5.4 7.0 3.9 15.4 12.3 4.1 4.9 3.4 2.3 4.7 14.0 0.9 10.4 5.2 5.9 6.9 3.6 5.0 3.4 6.7 30.7 2.5 15.5 6.8 3.6 5.4 7.3 16.3 4.1 2.6 7.7 6.4 3.1 6.9 1.6 16.2 18.2 11.1 13.4 18.3 15.8 13.5 18.2 3.4 14.9 9.8 2.4 1.8 10.2 13.2 4.7 5.9 4.0 1.4 19.0 2.2 8.5 3.2 9.6 1.8 1.8 6.9 0.4 2.0 6.0 6.0 2.5 3.1 3.5 9.6 3.1 1.6 4.4 2.5 3.4 2.3 10.2 2.4 3.1 19.6 7.0 14.9 2.7 13.8 9.8 2.6 3.6 9.7 9.6 7.6 7.8 20.0 13.7 20.7 13.7 7.6 13.1 33.1 12.2 5.6 13.2 7.0 11.8 15.0 3.9 14.6 11.1 12.1 0.9 11.8 13.4 12.9 16.2 15.6 12.4 14.8 15.7 13.8 14.4 0.4 18.3 8.9 18.2 15.8 13.5 TACO1 CCDC44 ENSG00000136463 "Translational activator of cytochrome c oxidase I" Q9BSH4 17 63600872-63608365 "Disease related genes, Predicted intracellular proteins" "Translation regulation" Activator "Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021626, HPA021643, HPA024294" Enhanced Enhanced Mitochondria Mitochondria "HPA021626: AB_1846148, HPA021643: AB_1846149, HPA024294: AB_1846150" "unprognostic (1.26e-1)" "unprognostic (2.92e-2)" "unprognostic (4.55e-3)" "unprognostic (9.82e-2)" "unprognostic (1.30e-1)" "unprognostic (9.30e-3)" "unprognostic (2.83e-1)" "unprognostic (8.09e-2)" "unprognostic (2.09e-1)" "unprognostic (7.38e-2)" "prognostic favourable (3.73e-4)" "unprognostic (1.35e-1)" "unprognostic (4.12e-3)" "unprognostic (5.21e-3)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.60e-2)" 8.3 11.3 8.7 6.3 11.1 4.9 6.9 6.4 14.2 5.9 12.1 7.6 6.2 13.0 7.6 7.2 7.5 6.7 10.1 21.2 7.6 8.6 20.7 42.5 7.0 7.3 9.3 7.2 6.0 10.7 8.3 5.7 7.5 9.3 6.4 11.4 8.1 11.4 6.9 37.5 6.1 15.7 6.9 6.5 7.3 8.0 8.1 6.2 8.7 8.7 15.9 8.1 6.3 5.1 8.9 9.9 7.9 8.1 16.6 13.6 7.9 17.0 27.0 8.7 8.9 7.6 10.9 11.6 12.6 11.9 25.4 20.2 17.7 10.2 14.1 9.7 14.4 15.8 19.1 18.4 23.9 7.5 26.5 13.9 13.8 30.9 21.0 16.4 9.8 13.3 12.8 21.9 23.2 13.1 18.8 10.7 11.8 30.9 19.1 12.4 7.5 28.1 12.1 21.4 17.6 14.8 12.0 13.4 14.6 8.6 28.6 23.8 23.8 12.8 11.6 18.1 13.7 12.3 22.1 11.7 11.5 16.8 13.8 11.3 13.1 2.1 8.1 7.9 9.5 7.5 10.6 7.1 13.6 9.5 9.9 8.9 12.8 10.3 1.4 16.6 6.6 6.4 9.0 7.9 8.7 11.1 6.4 14.2 7.6 8.6 9.3 7.2 9.3 6.2 TAOK3 "DPK, JIK, MAP3K18" ENSG00000135090 "TAO kinase 3" Q9H2K8 12 118149801-118372945 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 41.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017160 Approved Uncertain Mitochondria Mitochondria "HPA017160: AB_1851994" "unprognostic (3.21e-1)" "unprognostic (1.31e-1)" "unprognostic (1.65e-1)" "unprognostic (3.74e-2)" "unprognostic (5.18e-2)" "unprognostic (2.09e-1)" "unprognostic (4.80e-1)" "unprognostic (5.86e-2)" "unprognostic (1.00e-1)" "unprognostic (7.38e-2)" "unprognostic (2.76e-2)" "unprognostic (8.23e-2)" "unprognostic (1.08e-2)" "unprognostic (2.08e-2)" "unprognostic (4.14e-3)" "unprognostic (2.56e-1)" "unprognostic (1.44e-1)" 14.6 16.2 31.9 24.1 31.0 30.8 14.6 44.3 33.5 11.6 21.2 17.2 10.3 23.1 15.2 11.4 16.0 9.8 16.9 15.1 27.8 31.7 14.0 15.3 19.4 26.3 25.7 20.8 17.5 10.9 20.2 23.6 11.9 20.7 25.6 21.3 12.0 13.6 14.6 18.5 17.0 31.6 15.3 23.7 24.2 20.9 8.9 28.6 28.3 18.1 9.9 26.9 18.5 18.3 20.9 22.4 38.2 37.8 36.4 27.8 17.1 8.2 5.7 4.3 3.7 10.5 12.8 4.9 8.6 9.8 5.0 6.6 2.9 12.8 25.2 2.8 11.5 7.4 3.7 7.7 7.9 9.1 3.2 29.7 2.9 3.7 12.3 30.4 41.9 8.7 9.3 15.9 23.3 16.1 17.2 3.0 9.2 5.8 16.0 20.0 1.6 3.0 9.4 5.8 2.6 4.7 14.3 0.8 4.2 8.0 3.6 11.0 7.4 22.8 24.9 8.7 1.5 8.1 7.4 2.9 2.8 19.9 12.3 21.0 11.6 38.2 17.0 37.6 27.8 23.3 26.2 20.9 21.2 24.1 22.4 19.3 18.8 24.5 37.7 36.4 37.8 20.9 19.3 17.1 31.9 31.0 44.3 33.5 27.8 31.7 25.7 20.8 20.7 28.6 TBC1D32 "bA57L9.1, BROMI, C6orf170, C6orf171, dJ310J6.1, FLJ30899, FLJ34235" ENSG00000146350 "TBC1 domain family member 32" Q96NH3 6 121079494-121334745 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 25.4" "Cell line enhanced" "Detected in many" "HDLM-2: 21.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013413 Uncertain Approved Mitochondria Mitochondria "HPA013413: AB_10602702" "unprognostic (3.31e-2)" "unprognostic (1.28e-1)" "unprognostic (9.12e-3)" "unprognostic (4.82e-2)" "unprognostic (2.44e-2)" "unprognostic (1.98e-2)" "unprognostic (3.60e-4)" "unprognostic (7.28e-2)" "unprognostic (1.02e-1)" "unprognostic (1.83e-1)" "unprognostic (8.14e-2)" "unprognostic (2.01e-2)" "unprognostic (3.73e-2)" "unprognostic (1.57e-2)" "unprognostic (7.62e-2)" "unprognostic (2.17e-1)" "unprognostic (2.06e-1)" 3.2 7.3 7.3 5.5 8.8 2.4 5.0 3.9 11.1 5.7 3.5 4.8 3.8 4.5 5.1 4.1 4.1 4.8 5.6 3.5 7.0 4.1 4.5 1.8 3.2 3.0 8.1 7.8 6.5 4.0 9.7 25.4 8.2 8.0 5.0 2.4 4.2 4.6 3.2 1.7 5.5 4.6 2.4 7.0 3.1 3.8 9.2 7.9 8.1 7.0 2.1 3.2 3.7 5.1 6.4 10.7 5.8 1.3 3.4 3.7 0.4 1.6 1.9 3.1 4.2 2.8 4.4 1.6 1.8 2.7 3.1 4.5 0.1 1.1 2.9 3.0 2.0 1.5 1.5 1.6 3.7 21.6 2.1 3.6 0.6 0.7 1.2 1.7 1.4 1.7 1.1 2.8 2.0 0.6 2.1 0.0 2.4 1.0 2.0 1.1 1.8 0.7 1.8 1.6 0.2 1.7 0.7 6.5 3.2 2.2 1.3 1.0 2.0 1.5 0.4 2.0 2.0 0.5 2.0 1.4 0.0 1.2 2.7 1.0 3.2 5.8 1.3 1.7 2.6 0.7 1.9 3.4 1.9 1.8 0.8 6.4 3.7 2.8 1.1 3.4 1.1 10.7 2.1 0.4 7.3 8.8 3.9 11.1 7.0 4.1 8.1 7.8 8.0 7.9 TBRG4 "Cpr2, FASTKD4, H_TD2522F11.8, KIAA0948" ENSG00000136270 "Transforming growth factor beta regulator 4" Q969Z0 7 45100100-45112047 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020582, HPA050430" Approved Enhanced Mitochondria Mitochondria "HPA020582: AB_1857804, HPA050430: " "unprognostic (2.22e-1)" "unprognostic (4.75e-2)" "unprognostic (1.19e-1)" "unprognostic (3.46e-3)" "unprognostic (1.41e-2)" "unprognostic (9.29e-3)" "prognostic unfavourable (1.40e-4)" "unprognostic (3.15e-2)" "unprognostic (1.86e-1)" "unprognostic (2.83e-1)" "unprognostic (4.53e-1)" "unprognostic (1.25e-2)" "unprognostic (3.66e-3)" "unprognostic (3.91e-2)" "unprognostic (3.84e-2)" "unprognostic (3.30e-1)" "unprognostic (1.52e-1)" 13.7 16.8 10.8 16.0 15.6 14.9 13.0 12.9 22.1 10.5 20.8 15.6 14.1 21.8 14.2 8.2 20.1 12.8 12.4 26.2 9.8 10.0 20.9 27.7 10.5 17.0 10.6 8.9 15.6 16.9 11.3 10.1 16.2 14.7 13.6 14.1 10.8 14.2 12.4 42.6 16.9 17.8 13.9 9.9 16.2 14.0 22.5 9.5 15.0 13.8 23.7 20.3 14.5 13.3 15.8 20.1 10.9 24.2 9.7 21.0 17.5 12.9 30.1 9.6 21.1 8.7 8.1 19.4 10.5 9.7 20.4 16.9 32.5 18.3 24.7 16.2 10.7 33.9 22.3 23.9 10.4 12.8 20.9 17.0 19.7 22.2 14.6 19.3 17.5 10.7 22.2 19.4 14.0 12.5 46.9 12.5 12.4 21.8 19.6 44.2 30.5 24.0 17.4 12.4 36.0 11.9 13.3 19.1 18.1 10.7 59.6 20.7 26.6 32.1 9.7 15.2 18.4 9.2 17.0 22.4 22.4 36.2 14.0 27.8 34.1 7.4 13.3 10.9 18.4 24.2 17.6 15.8 15.4 17.8 20.1 12.3 21.0 19.9 1.0 9.7 20.4 7.5 14.6 17.5 10.8 15.6 12.9 22.1 9.8 10.0 10.6 8.9 14.7 9.5 TCIRG1 "a3, Atp6i, ATP6N1C, ATP6V0A3, OC-116, OC116, TIRC7" ENSG00000110719 "T cell immune regulator 1, ATPase H+ transporting V0 subunit a3" Q13488 11 68039016-68050895 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 40.0;RPMI-8226: 39.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038742 Approved Approved Mitochondria Mitochondria "HPA038742: AB_10795138" "unprognostic (5.35e-2)" "unprognostic (5.01e-2)" "unprognostic (1.81e-2)" "unprognostic (1.50e-2)" "unprognostic (6.98e-3)" "unprognostic (1.25e-1)" "unprognostic (5.07e-2)" "unprognostic (6.43e-2)" "unprognostic (7.03e-2)" "unprognostic (2.47e-2)" "unprognostic (1.36e-1)" "unprognostic (2.15e-1)" "prognostic unfavourable (1.50e-11)" "unprognostic (2.48e-3)" "unprognostic (7.88e-3)" "unprognostic (2.50e-1)" "prognostic favourable (9.45e-6)" 25.8 24.1 5.0 20.1 7.2 39.5 10.2 1.3 5.4 20.1 21.8 3.9 19.9 20.1 14.1 27.1 11.9 12.5 16.4 5.9 2.4 1.6 8.9 25.2 24.1 20.7 7.1 2.2 11.4 69.6 2.6 4.7 14.4 6.9 15.7 4.1 6.8 18.3 11.0 3.5 5.2 25.8 10.8 7.7 44.7 17.4 4.2 5.5 7.5 11.7 8.3 24.3 13.0 13.4 3.3 13.4 40.4 36.8 8.2 4.9 10.7 9.1 16.8 0.2 0.0 7.7 6.1 11.8 18.2 8.8 5.2 5.0 0.3 27.4 0.8 9.9 6.4 11.5 1.1 7.0 1.1 23.7 0.5 6.3 20.5 5.4 7.2 4.6 40.0 7.0 4.1 6.4 0.4 3.5 3.3 2.5 1.7 3.1 0.2 27.8 1.0 4.3 7.8 0.2 39.8 4.9 5.2 0.9 0.2 7.6 10.0 4.9 10.9 12.0 12.4 10.1 8.0 28.1 3.2 0.4 0.3 1.3 22.6 7.7 4.8 5.5 16.6 18.8 4.5 28.8 3.7 3.3 3.4 4.9 13.4 2.2 2.0 2.1 40.4 8.2 36.8 9.0 3.3 10.7 5.0 7.2 1.3 5.4 2.4 1.6 7.1 2.2 6.9 5.5 TEFM "C17orf42, FLJ22729" ENSG00000172171 "Transcription elongation factor, mitochondrial" Q96QE5 17 30897336-30906820 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023788, HPA053044" Approved Enhanced Mitochondria Mitochondria "HPA023788: AB_1848818, HPA053044: " "unprognostic (1.22e-1)" "unprognostic (1.18e-2)" "unprognostic (1.11e-3)" "unprognostic (3.31e-2)" "unprognostic (7.89e-2)" "unprognostic (3.75e-1)" "prognostic unfavourable (9.20e-4)" "unprognostic (1.25e-1)" "prognostic unfavourable (8.64e-4)" "unprognostic (2.11e-1)" "unprognostic (6.18e-3)" "unprognostic (9.39e-2)" "unprognostic (4.79e-2)" "unprognostic (7.90e-2)" "unprognostic (1.92e-1)" "unprognostic (2.23e-1)" "unprognostic (8.37e-3)" 7.0 9.6 11.8 10.2 13.7 4.0 11.1 23.3 16.6 7.5 8.1 7.4 7.2 10.6 8.6 9.6 9.7 7.6 6.8 12.7 10.1 6.9 13.0 12.3 6.9 10.0 15.4 8.5 10.5 7.3 10.8 16.8 10.4 10.6 10.6 10.3 8.6 7.9 10.4 7.7 8.5 9.1 9.6 11.0 13.7 7.4 5.7 13.3 8.6 10.7 6.7 9.8 7.9 11.8 6.7 6.4 4.9 10.0 4.3 6.7 4.8 6.0 9.7 5.8 7.3 4.5 5.8 5.0 5.9 5.0 13.4 11.2 6.4 2.9 7.7 5.9 4.4 8.6 10.7 4.3 11.7 2.4 13.4 3.7 9.7 6.4 4.8 6.7 4.8 4.4 5.1 7.7 3.0 5.7 8.3 7.0 8.8 4.3 5.8 9.9 4.4 5.0 3.0 10.2 6.1 10.0 5.7 9.9 3.0 5.4 4.3 5.1 9.7 4.6 3.9 5.2 6.1 5.9 5.7 3.4 5.6 5.4 4.2 5.6 5.1 3.5 6.6 4.9 4.6 10.0 5.8 6.7 5.6 4.2 6.4 6.4 6.7 6.6 1.9 4.3 7.3 5.8 5.7 4.8 11.8 13.7 23.3 16.6 10.1 6.9 15.4 8.5 10.6 13.3 TFAM "TCF6, TCF6L2" ENSG00000108064 "Transcription factor A, mitochondrial" Q00059 10 58385022-58399221 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040648, HPA063684" Supported Enhanced Mitochondria "Intracellular and membrane" Mitochondria "HPA040648: AB_10795635, HPA063684: AB_2685089" "unprognostic (5.30e-2)" "unprognostic (1.14e-1)" "unprognostic (6.34e-3)" "prognostic unfavourable (8.73e-4)" "unprognostic (1.10e-2)" "unprognostic (3.40e-2)" "unprognostic (1.54e-2)" "unprognostic (3.23e-2)" "unprognostic (1.24e-2)" "prognostic favourable (2.74e-4)" "unprognostic (1.99e-2)" "unprognostic (5.39e-2)" "prognostic favourable (2.22e-5)" "unprognostic (1.31e-1)" "unprognostic (2.24e-1)" "unprognostic (1.79e-1)" "unprognostic (6.76e-2)" 19.3 21.2 11.1 21.0 12.1 28.5 15.3 15.4 13.9 16.8 21.0 7.7 12.5 17.6 20.7 12.1 17.4 15.3 11.0 15.9 10.2 11.2 22.4 31.4 11.5 21.5 12.5 10.7 18.4 14.3 12.3 23.9 22.2 12.9 17.2 14.7 9.2 16.3 10.6 21.7 10.2 18.7 16.1 10.8 21.0 14.5 40.2 11.6 35.4 22.2 14.8 18.4 16.6 11.8 13.1 14.1 7.2 9.5 14.3 13.1 6.8 21.3 12.2 13.7 14.2 4.1 5.1 15.7 9.7 9.7 12.2 13.6 42.8 22.9 42.5 14.3 4.4 16.7 25.1 13.6 19.4 18.1 22.3 16.1 9.3 15.9 6.3 40.8 13.3 5.0 6.3 14.8 13.6 10.5 38.0 19.6 8.5 11.6 32.2 16.0 26.0 12.7 25.7 29.6 19.1 7.5 14.4 18.4 12.6 19.4 27.0 23.8 29.4 12.2 8.1 9.1 29.1 10.3 26.0 19.9 30.4 53.6 11.6 31.5 6.8 1.0 9.5 3.7 8.5 9.0 11.0 12.2 10.3 8.9 11.5 13.1 13.1 10.4 7.2 14.3 7.2 14.1 8.5 6.8 11.1 12.1 15.4 13.9 10.2 11.2 12.5 10.7 12.9 11.6 TFB2M "FLJ22661, FLJ23182, Hkp1" ENSG00000162851 "Transcription factor B2, mitochondrial" Q9H5Q4 1 246540560-246566324 "Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028482, HPA028554, HPA030265" Approved Enhanced Mitochondria Mitochondria "HPA028482: , HPA028554: , HPA030265: AB_10696209" "unprognostic (4.38e-2)" "unprognostic (2.45e-2)" "unprognostic (3.79e-3)" "unprognostic (5.63e-2)" "unprognostic (1.10e-1)" "unprognostic (8.13e-2)" "unprognostic (8.76e-2)" "unprognostic (1.41e-1)" "unprognostic (2.51e-2)" "unprognostic (1.68e-2)" "unprognostic (2.46e-1)" "unprognostic (6.81e-2)" "unprognostic (5.26e-2)" "unprognostic (2.27e-1)" "unprognostic (9.44e-2)" "unprognostic (6.41e-2)" "unprognostic (3.53e-2)" 10.6 23.1 4.2 7.2 8.4 15.5 9.0 8.4 9.9 7.0 8.9 6.5 9.4 8.2 9.5 7.2 9.5 6.9 8.5 11.3 4.3 5.5 15.5 42.3 5.9 8.7 4.8 5.7 6.5 19.7 5.6 7.8 10.5 7.6 8.9 9.6 5.9 13.6 8.9 21.4 8.7 10.3 6.8 6.5 9.0 9.6 8.7 5.7 13.0 15.6 7.3 12.0 9.1 6.5 10.6 11.0 1.2 7.5 12.6 10.4 4.5 12.6 12.2 4.7 8.4 5.9 8.5 16.6 9.3 9.6 10.6 9.7 14.8 12.2 22.6 14.6 9.4 11.0 11.3 9.9 14.6 8.7 4.4 11.4 7.5 12.9 9.7 20.1 10.4 8.4 11.8 9.1 10.2 8.2 33.0 7.7 9.1 5.8 10.1 9.0 21.0 12.4 10.2 9.4 27.4 9.6 14.0 10.5 21.2 9.0 16.3 30.7 11.9 19.4 5.9 7.4 9.0 10.4 24.2 22.5 37.5 17.8 9.1 19.9 9.2 0.2 4.7 1.2 8.4 4.8 10.4 10.6 7.5 8.8 11.0 10.4 9.6 8.2 1.0 12.6 7.5 9.5 10.3 4.5 4.2 8.4 8.4 9.9 4.3 5.5 4.8 5.7 7.6 5.7 THAP9 FLJ34093 ENSG00000168152 "THAP domain containing 9" Q9H5L6 4 82900684-82919969 "Predicted intracellular proteins, Transcription factors" "DNA integration, DNA recombination" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037420, HPA037421" Uncertain Approved Mitochondria Mitochondria "HPA037420: , HPA037421: AB_10673631" "unprognostic (7.54e-3)" "unprognostic (8.52e-2)" "unprognostic (4.14e-2)" "unprognostic (1.51e-2)" "unprognostic (2.06e-1)" "unprognostic (1.18e-2)" "unprognostic (2.26e-1)" "unprognostic (4.51e-2)" "unprognostic (1.17e-1)" "unprognostic (2.30e-2)" "unprognostic (2.30e-2)" "unprognostic (2.65e-2)" "prognostic favourable (3.50e-5)" "unprognostic (1.39e-1)" "unprognostic (1.62e-1)" "unprognostic (4.64e-3)" "unprognostic (8.74e-4)" 3.5 4.0 6.1 4.8 11.4 4.2 7.6 5.6 7.8 4.9 3.7 5.0 6.8 3.6 5.9 8.8 3.4 4.4 3.4 5.9 7.0 5.5 7.3 7.4 4.6 3.9 11.8 4.3 7.9 6.1 8.5 10.3 5.9 7.5 6.0 4.1 3.0 6.6 10.5 20.5 4.2 3.9 3.7 8.8 3.7 3.5 14.0 13.4 6.0 9.8 5.9 3.9 4.6 5.2 3.7 2.6 0.3 4.0 1.5 3.5 1.7 1.5 2.1 8.2 4.5 2.5 3.0 5.7 1.5 2.6 1.6 1.5 3.1 2.8 8.6 2.9 2.1 2.0 6.4 2.6 2.0 3.3 2.4 3.7 3.2 4.0 2.9 3.4 3.0 3.1 4.2 0.8 4.0 2.5 3.2 5.9 2.0 2.1 8.2 4.1 6.6 1.2 7.5 3.4 5.0 2.9 1.8 6.9 4.7 3.1 4.2 5.6 2.6 3.0 1.6 2.1 2.3 1.6 1.1 3.9 1.7 8.5 2.5 2.0 3.1 0.0 2.3 0.3 1.6 4.0 2.0 3.7 1.1 1.4 2.6 3.1 3.5 2.9 0.1 1.5 2.7 1.7 0.6 1.7 6.1 11.4 5.6 7.8 7.0 5.5 11.8 4.3 7.5 13.4 TIMM10 "TIM10, TIM10A, TIMM10A" ENSG00000134809 "Translocase of inner mitochondrial membrane 10" P62072 11 57528463-57530803 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039946 Supported Enhanced Mitochondria Mitochondria "HPA039946: AB_10673023" "unprognostic (9.34e-3)" "unprognostic (1.16e-2)" "unprognostic (2.21e-1)" "unprognostic (2.01e-1)" "unprognostic (4.42e-2)" "unprognostic (1.25e-2)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "unprognostic (2.07e-1)" "unprognostic (3.40e-3)" "unprognostic (7.62e-2)" "unprognostic (1.18e-1)" "unprognostic (5.96e-2)" "unprognostic (9.87e-2)" "unprognostic (1.96e-1)" "unprognostic (1.62e-2)" "unprognostic (2.15e-2)" 22.2 19.5 29.1 16.7 28.5 18.3 27.4 14.8 34.3 16.6 21.6 17.1 25.9 16.8 13.7 29.1 20.2 16.0 15.4 25.2 25.1 22.7 26.7 41.3 13.1 25.1 27.2 24.6 13.0 25.8 18.3 14.3 13.8 19.9 14.4 23.1 15.8 23.8 20.2 32.3 15.3 12.4 17.2 21.0 20.1 15.9 20.5 16.1 18.4 18.5 25.9 29.8 13.6 12.1 45.1 38.8 5.9 22.6 16.5 33.4 32.4 26.9 41.2 19.4 18.5 16.8 14.4 24.5 23.1 18.6 37.0 21.1 30.3 23.7 51.4 26.6 20.5 20.7 27.5 26.8 33.5 17.4 20.3 32.6 15.8 38.9 17.8 42.6 36.8 13.5 21.8 35.8 25.0 22.8 36.0 23.5 27.1 57.4 22.9 57.1 20.4 44.4 38.6 40.8 44.8 18.7 18.7 15.7 20.2 24.4 48.7 29.5 36.3 16.3 14.3 21.4 39.9 36.6 44.3 32.9 43.0 41.3 19.7 21.5 35.5 5.9 22.6 5.0 19.9 21.4 22.8 45.1 24.5 21.9 38.7 41.9 33.4 29.1 1.3 16.5 19.8 38.8 21.3 32.4 29.1 28.5 14.8 34.3 25.1 22.7 27.2 24.6 19.9 16.1 TIMM23 TIM23 ENSG00000265354 "Translocase of inner mitochondrial membrane 23" O14925 10 45972449-46003734 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA031408 Approved Supported Mitochondria Mitochondria "HPA031408: AB_10600828" "unprognostic (4.09e-2)" "unprognostic (1.31e-1)" "unprognostic (9.01e-2)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" "unprognostic (1.15e-2)" "prognostic unfavourable (2.77e-5)" "unprognostic (1.74e-1)" "unprognostic (3.90e-2)" "prognostic favourable (6.79e-4)" "unprognostic (4.41e-2)" "unprognostic (7.30e-2)" "unprognostic (3.24e-1)" "unprognostic (7.78e-2)" "unprognostic (5.54e-2)" "unprognostic (7.20e-2)" "unprognostic (2.21e-1)" 5.7 4.6 1.2 6.8 3.8 6.0 13.6 4.1 8.6 2.6 4.2 1.5 5.8 6.1 2.9 7.3 4.2 2.4 3.2 11.5 5.3 6.6 8.3 4.8 9.9 1.6 2.5 2.2 2.8 3.0 3.4 8.1 5.5 3.4 4.1 2.6 7.5 5.2 16.2 2.4 3.5 3.6 2.2 2.5 2.8 17.2 1.4 4.5 4.5 4.0 4.4 3.3 1.7 29.5 39.7 18.5 45.3 26.7 29.8 39.6 40.4 42.7 28.4 28.6 23.6 22.2 27.7 33.5 40.3 40.8 43.4 53.8 32.3 36.3 27.8 35.2 35.0 43.3 35.8 40.5 26.9 42.7 23.1 32.1 57.8 38.1 42.9 25.9 26.5 31.9 34.9 49.7 37.7 40.9 20.5 35.8 40.6 38.3 59.7 34.3 13.3 29.7 27.4 26.6 45.8 28.4 33.4 30.7 18.6 41.4 33.4 43.8 25.7 27.6 19.8 34.5 25.2 47.5 21.9 36.1 50.9 36.8 62.2 16.4 15.7 35.6 18.5 28.0 45.3 28.7 29.5 27.1 29.8 39.7 27.9 24.6 27.2 8.2 26.7 39.3 32.8 29.6 39.6 TIMM44 TIM44 ENSG00000104980 "Translocase of inner mitochondrial membrane 44" O43615 19 7926718-7943920 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043052 Supported Enhanced Mitochondria Mitochondria "HPA043052: AB_10795713" "unprognostic (1.75e-1)" "unprognostic (7.44e-3)" "unprognostic (2.68e-2)" "unprognostic (1.03e-1)" "unprognostic (1.24e-1)" "unprognostic (1.45e-2)" "unprognostic (5.81e-3)" "unprognostic (8.78e-2)" "unprognostic (2.42e-1)" "unprognostic (8.81e-2)" "unprognostic (2.07e-3)" "unprognostic (8.93e-2)" "unprognostic (1.80e-2)" "unprognostic (6.01e-2)" "unprognostic (6.43e-2)" "unprognostic (2.07e-2)" "unprognostic (4.18e-2)" 12.8 15.3 11.8 13.0 12.4 7.5 12.7 16.2 17.2 10.8 15.3 8.5 14.1 16.1 12.1 11.8 19.4 10.8 12.6 39.2 12.9 10.3 13.5 19.7 9.0 9.2 11.7 7.7 13.8 20.2 7.4 10.3 8.9 12.3 10.8 6.3 8.5 17.3 21.4 48.8 12.6 10.5 17.7 9.0 12.2 12.2 9.4 11.6 5.8 12.5 26.6 8.8 13.0 9.4 9.0 16.2 10.1 12.2 9.6 12.1 8.4 18.2 10.7 5.7 10.0 10.0 9.3 8.4 11.0 9.0 15.3 13.9 23.6 3.9 26.8 12.8 9.2 12.8 23.5 12.4 3.9 12.5 35.8 13.5 9.1 19.8 24.5 16.1 5.6 10.8 15.9 13.0 16.2 9.7 24.7 9.6 6.6 18.6 14.0 10.6 16.6 45.4 14.8 8.2 12.6 6.7 11.8 13.7 7.1 9.8 13.4 31.3 8.2 15.7 5.1 7.3 11.5 18.5 20.8 18.8 23.7 26.1 5.2 23.5 12.3 10.1 11.7 3.7 12.1 12.2 10.7 8.7 11.1 11.2 16.2 9.0 10.7 10.4 0.6 9.6 7.2 13.2 9.4 8.4 11.8 12.4 16.2 17.2 12.9 10.3 11.7 7.7 12.3 11.6 TIMM8A "DDP, DFN1, MTS" ENSG00000126953 "Translocase of inner mitochondrial membrane 8A" O60220 X 101345659-101349196 "Disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Deafness, Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 74.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003628 Supported Supported Mitochondria Mitochondria "HPA003628: AB_1080284" "prognostic unfavourable (7.89e-5)" "unprognostic (1.36e-1)" "unprognostic (2.80e-1)" "prognostic unfavourable (8.87e-5)" "unprognostic (2.06e-1)" "unprognostic (9.28e-3)" "unprognostic (5.14e-3)" "unprognostic (8.32e-2)" "unprognostic (1.90e-2)" "unprognostic (1.86e-3)" "unprognostic (6.41e-2)" "unprognostic (8.57e-3)" "prognostic favourable (1.69e-4)" "unprognostic (1.14e-2)" "unprognostic (7.75e-2)" "unprognostic (1.70e-1)" "unprognostic (3.86e-2)" 6.8 6.9 7.6 7.5 12.2 7.0 8.0 5.2 13.3 5.6 7.8 6.1 3.1 6.9 6.5 5.7 10.4 6.2 4.1 11.8 7.6 7.2 12.1 27.7 4.9 8.4 8.6 8.2 7.2 17.0 5.5 4.5 6.9 11.9 7.5 8.6 5.7 6.7 4.2 10.1 8.1 7.4 5.4 6.1 6.3 5.6 4.0 6.5 6.5 7.1 16.4 9.4 4.9 6.5 14.1 11.6 1.9 5.3 5.8 11.1 4.8 10.6 9.3 5.3 9.9 4.2 4.5 6.9 7.4 3.6 6.7 13.3 8.3 6.7 11.0 10.1 5.7 8.3 14.0 8.2 9.8 5.1 9.4 21.4 12.3 13.8 3.9 12.1 74.9 4.3 6.6 9.5 5.9 6.7 15.3 12.6 8.5 15.8 5.8 12.0 17.9 15.6 9.5 9.7 15.5 5.8 7.2 7.0 6.2 9.3 7.1 6.7 6.0 6.1 5.0 8.7 10.7 12.1 8.3 6.1 13.9 14.6 4.7 16.3 6.6 1.9 4.4 0.2 6.7 5.3 7.8 12.2 7.3 7.7 5.1 14.1 11.1 9.3 0.6 5.8 3.0 11.6 3.8 4.8 7.6 12.2 5.2 13.3 7.6 7.2 8.6 8.2 11.9 6.5 TIMM9 TIM9A ENSG00000100575 "Translocase of inner mitochondrial membrane 9" Q9Y5J7 14 58408494-58427614 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002932 Approved Supported Mitochondria Mitochondria "HPA002932: AB_1080287" "prognostic favourable (8.04e-4)" "unprognostic (8.05e-2)" "unprognostic (3.08e-1)" "unprognostic (1.02e-1)" "unprognostic (2.54e-1)" "unprognostic (3.11e-2)" "prognostic unfavourable (9.89e-5)" "unprognostic (1.51e-1)" "unprognostic (1.84e-1)" "prognostic favourable (6.39e-5)" "unprognostic (3.41e-1)" "unprognostic (7.32e-2)" "unprognostic (7.16e-2)" "unprognostic (4.13e-2)" "unprognostic (1.54e-1)" "unprognostic (1.20e-1)" "unprognostic (5.77e-2)" 22.2 20.8 23.0 14.6 33.9 14.6 25.0 18.7 25.2 18.2 22.5 16.4 19.5 19.7 20.3 29.7 23.3 18.8 19.7 18.7 20.8 19.1 23.7 21.4 14.5 25.9 20.2 20.6 31.8 42.8 11.9 18.9 17.5 22.1 19.5 15.0 15.4 29.1 20.3 33.5 17.8 13.9 25.9 20.9 18.5 20.2 21.4 22.3 20.1 25.2 24.8 19.3 26.6 17.9 17.6 14.3 4.0 10.6 16.5 19.2 7.6 25.1 21.5 17.1 16.5 19.7 35.9 23.3 24.5 13.0 18.5 16.4 21.8 27.2 33.6 26.4 14.2 17.6 22.6 23.7 27.0 22.5 12.9 17.5 14.6 24.7 49.5 28.1 16.8 28.4 30.2 18.0 36.7 19.0 28.1 20.9 18.6 42.6 26.0 35.0 14.6 37.9 22.1 25.9 21.2 24.6 22.4 21.9 13.1 15.6 40.3 42.6 28.6 16.5 18.9 23.5 32.2 15.5 26.5 14.4 14.2 30.9 18.4 27.3 27.5 4.0 9.0 2.2 9.4 10.1 17.4 17.6 15.0 13.9 13.1 14.4 19.2 17.7 0.9 16.5 10.6 14.3 15.1 7.6 23.0 33.9 18.7 25.2 20.8 19.1 20.2 20.6 22.1 22.3 TMEM11 "C17orf35, PM1, PMI" ENSG00000178307 "Transmembrane protein 11" P17152 17 21197280-21214624 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051795, HPA062854" Uncertain Supported Mitochondria Mitochondria "HPA051795: , HPA062854: " "unprognostic (2.29e-1)" "unprognostic (1.09e-1)" "unprognostic (1.13e-2)" "unprognostic (2.00e-2)" "unprognostic (1.35e-2)" "unprognostic (3.55e-1)" "unprognostic (3.36e-3)" "unprognostic (1.45e-2)" "unprognostic (4.34e-2)" "unprognostic (3.08e-2)" "unprognostic (1.16e-1)" "unprognostic (1.90e-2)" "unprognostic (1.40e-1)" "unprognostic (1.19e-1)" "unprognostic (1.97e-1)" "unprognostic (2.17e-2)" "unprognostic (4.61e-2)" 9.7 6.5 5.5 6.2 5.8 13.2 9.7 6.2 8.7 6.1 6.1 6.3 4.3 5.4 6.8 7.6 8.5 5.1 5.2 8.3 5.1 5.1 8.0 9.0 5.9 5.0 5.6 4.5 6.2 10.7 4.5 5.1 10.6 6.5 7.4 4.1 6.4 11.0 6.2 30.2 8.2 7.2 6.3 5.3 6.0 6.5 8.4 4.5 7.3 8.8 12.8 7.9 5.9 5.7 8.0 7.0 11.7 12.2 5.5 6.5 7.6 4.4 3.2 4.6 3.2 6.7 3.7 5.7 9.1 2.5 8.0 5.6 10.5 2.0 4.3 5.0 7.0 5.8 6.5 6.6 1.8 4.5 6.5 3.0 3.0 1.8 7.5 3.5 4.3 5.1 5.3 9.1 4.2 3.9 3.8 1.6 3.7 2.7 5.7 5.4 5.0 2.7 4.0 8.7 2.6 3.6 1.3 2.7 4.6 3.6 4.3 4.4 2.7 3.1 3.2 4.5 6.8 6.4 8.5 2.2 2.1 10.2 3.6 4.6 2.6 4.7 12.2 11.7 5.4 8.7 4.9 6.1 5.5 4.9 7.0 8.0 6.5 4.9 9.8 5.5 10.9 6.1 4.9 7.6 5.5 5.8 6.2 8.7 5.1 5.1 5.6 4.5 6.5 4.5 TMEM126B HT007 ENSG00000171204 "Transmembrane protein 126B" Q8IUX1 11 85628573-85636539 "Predicted membrane proteins" Chaperone "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014480, HPA019186" Uncertain Supported Mitochondria Mitochondria "HPA014480: AB_1858083, HPA019186: AB_1858084" "unprognostic (1.11e-1)" "unprognostic (4.97e-2)" "unprognostic (1.10e-1)" "unprognostic (2.79e-2)" "unprognostic (5.67e-1)" "unprognostic (1.44e-1)" "unprognostic (5.55e-3)" "unprognostic (1.22e-1)" "unprognostic (1.45e-2)" "unprognostic (6.70e-3)" "unprognostic (4.42e-2)" "unprognostic (4.30e-2)" "unprognostic (1.94e-2)" "unprognostic (1.78e-1)" "unprognostic (6.50e-2)" "unprognostic (5.86e-2)" "unprognostic (2.66e-2)" 15.5 17.0 28.9 13.5 28.0 6.4 22.1 26.7 33.2 19.7 21.2 12.2 15.5 21.7 21.9 35.4 16.5 15.9 19.1 26.2 27.2 31.7 27.5 19.9 16.5 18.9 28.7 25.7 15.9 15.3 13.9 28.0 14.6 28.8 19.8 20.0 14.2 16.8 16.6 15.7 15.1 20.8 24.2 24.9 19.3 18.9 11.7 27.0 15.1 22.6 17.5 18.8 20.8 14.3 14.0 14.9 12.5 13.2 15.8 19.6 11.5 14.5 12.0 13.6 6.4 25.7 20.6 4.3 12.9 14.1 10.3 15.7 33.3 14.8 15.5 28.6 11.0 17.7 21.7 13.3 9.8 21.4 19.7 11.7 21.2 14.6 14.6 28.6 14.5 15.0 17.0 15.7 19.1 15.7 27.8 12.8 25.5 18.7 11.4 35.5 14.7 19.8 9.9 10.2 13.0 20.2 16.3 12.4 7.7 12.2 10.0 12.6 20.2 17.7 8.2 15.8 11.1 39.7 13.5 6.0 33.5 18.7 8.0 23.4 8.3 12.5 11.7 5.7 15.4 13.2 19.6 14.0 19.1 18.4 14.9 12.9 19.1 18.9 4.5 15.8 9.6 13.4 18.3 11.5 28.9 28.0 26.7 33.2 27.2 31.7 28.7 25.7 28.8 27.0 TMEM132A "FLJ20539, GBP, HSPA5BP1" ENSG00000006118 "Transmembrane protein 132A" Q24JP5 11 60924463-60937159 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.1" "Cell line enhanced" "Detected in many" "EFO-21: 45.3;MCF7: 44.8;SK-BR-3: 46.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051979, HPA060492" Enhanced Approved Mitochondria 1900000 Mitochondria "HPA051979: , HPA060492: " "unprognostic (2.52e-2)" "unprognostic (2.01e-1)" "unprognostic (3.75e-2)" "prognostic favourable (1.98e-5)" "unprognostic (7.94e-3)" "unprognostic (3.74e-1)" "unprognostic (4.42e-3)" "unprognostic (2.39e-2)" "unprognostic (1.99e-1)" "unprognostic (1.30e-1)" "unprognostic (2.88e-1)" "unprognostic (5.98e-2)" "prognostic unfavourable (1.55e-9)" "unprognostic (3.31e-1)" "unprognostic (9.74e-2)" "unprognostic (1.50e-1)" "unprognostic (8.41e-3)" 3.6 6.1 28.6 9.2 25.2 1.2 4.4 23.9 58.1 14.0 3.2 11.3 0.8 3.4 14.4 2.2 4.8 3.2 6.2 4.0 17.0 22.9 3.1 1.3 4.5 2.4 20.4 21.4 6.9 3.9 1.5 6.6 19.8 13.8 4.1 2.0 19.3 21.5 2.9 4.3 1.8 2.6 4.6 9.3 2.5 8.5 3.4 9.7 0.0 2.0 1.0 6.0 4.9 2.0 0.4 0.1 1.6 0.1 0.0 0.1 0.1 8.9 12.5 11.2 23.9 0.9 0.5 19.9 6.7 21.9 6.2 5.2 4.4 8.5 0.0 45.3 2.0 17.0 2.5 11.7 2.4 0.1 3.7 0.2 8.0 8.2 8.4 0.1 0.3 2.1 2.2 11.6 1.8 10.7 0.5 0.6 2.0 44.8 0.2 0.0 14.9 7.2 0.1 4.7 1.0 9.4 4.7 11.3 26.6 4.8 46.1 4.1 31.9 0.1 12.5 2.4 11.4 0.7 12.7 0.1 0.0 0.4 20.2 0.0 11.6 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 1.6 0.0 0.0 0.1 0.0 0.1 28.6 25.2 23.9 36.8 17.0 22.9 20.4 21.4 13.8 9.7 TMEM144 FLJ11155 ENSG00000164124 "Transmembrane protein 144" Q7Z5S9 4 158201604-158255411 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "brain: 88.7" "Cell line enhanced" "Detected in many" "BEWO: 23.3;hTCEpi: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.3;intermediate monocyte: 1.4;myeloid DC: 3.7;plasmacytoid DC: 4.3" "Group enriched" "Detected in many" 10 "dendritic cells: 4.3;monocytes: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063554 Approved Mitochondria Mitochondria "HPA063554: " "unprognostic (1.26e-2)" "unprognostic (7.05e-2)" "unprognostic (2.06e-2)" "prognostic favourable (2.89e-4)" "unprognostic (2.90e-1)" "unprognostic (1.71e-5)" "unprognostic (8.27e-2)" "unprognostic (3.32e-1)" "unprognostic (2.21e-1)" "unprognostic (3.33e-2)" "prognostic unfavourable (8.48e-4)" "unprognostic (9.34e-2)" "unprognostic (1.13e-2)" "unprognostic (1.35e-1)" "unprognostic (9.26e-2)" "unprognostic (3.88e-2)" "unprognostic (4.05e-2)" 4.7 6.7 20.7 2.0 60.9 1.5 9.2 4.7 37.7 4.7 7.4 88.7 0.2 14.3 3.7 8.3 3.1 3.9 6.8 8.2 31.5 18.3 1.9 1.7 3.5 0.9 80.4 26.6 8.6 3.8 3.0 1.4 3.5 48.9 5.4 8.6 0.0 3.1 7.2 1.4 1.9 9.6 4.2 79.2 2.2 5.4 15.8 67.4 0.0 9.2 0.0 0.8 5.1 1.9 0.0 4.3 0.1 3.3 0.4 0.1 0.7 2.5 7.0 0.1 1.4 5.1 7.7 23.3 1.1 1.9 1.0 1.6 8.8 9.6 0.0 1.4 0.3 1.2 3.2 10.8 1.4 0.0 3.2 4.3 2.1 7.8 1.8 5.4 1.3 5.5 13.4 4.6 1.6 5.8 2.8 0.1 8.0 3.0 0.0 0.0 1.8 1.7 0.0 0.0 0.3 2.0 7.4 1.1 0.0 0.2 9.5 2.6 6.7 1.5 1.1 2.2 1.7 0.4 1.3 0.0 0.6 0.6 3.0 0.8 1.5 0.0 3.3 0.0 0.0 1.4 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.4 0.7 4.3 0.0 0.7 20.7 60.9 4.7 35.1 31.5 18.3 80.4 26.6 48.9 67.4 TMEM176A "HCA112, MS4B1" ENSG00000002933 "Transmembrane protein 176A" Q96HP8 7 150800403-150805120 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 76.8;liver: 234.5" "Cell line enriched" "Detected in some" 30 "HSkMC: 124.2" "Cancer enhanced" "Detected in all" "liver cancer: 210.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 38.4;intermediate monocyte: 27.1" "Lineage enriched" "Detected in many" 4 "monocytes: 38.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008770 Approved Approved Mitochondria Mitochondria "HPA008770: AB_2256120" "unprognostic (4.70e-2)" "unprognostic (7.71e-2)" "unprognostic (5.71e-3)" "unprognostic (6.09e-2)" "unprognostic (3.96e-3)" "unprognostic (1.44e-2)" "unprognostic (2.51e-1)" "unprognostic (2.32e-1)" "unprognostic (4.19e-2)" "unprognostic (1.99e-1)" "unprognostic (1.47e-2)" "unprognostic (4.37e-2)" "unprognostic (4.79e-1)" "unprognostic (1.23e-2)" "unprognostic (1.98e-2)" "unprognostic (2.64e-1)" "unprognostic (4.91e-2)" 10.5 4.9 5.8 17.1 6.0 0.7 7.8 1.2 4.3 6.2 32.2 4.8 2.0 16.1 3.6 12.8 7.5 6.3 34.2 15.0 5.2 4.5 76.8 234.5 8.8 23.5 6.9 3.4 19.0 5.0 0.4 2.2 8.9 6.6 6.3 22.3 22.8 3.9 2.0 3.1 3.3 51.2 6.5 6.9 17.3 7.1 3.7 5.4 2.1 4.8 4.8 9.2 13.5 9.1 0.4 9.3 3.3 38.4 0.0 0.1 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 124.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 4.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.4 3.3 0.1 27.1 0.1 0.4 0.0 0.1 9.3 0.0 0.0 0.0 0.5 0.0 12.9 0.6 0.1 10.7 5.8 6.0 1.2 4.3 5.2 4.5 6.9 3.4 6.6 5.4 TMEM179 "C14orf90, FLJ42486, TMEM179A" ENSG00000258986 "Transmembrane protein 179" Q6ZVK1 14 104474678-104605647 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 20.2;brain: 30.4;pituitary gland: 23.0" "Cell line enhanced" "Detected in some" "NTERA-2: 6.4;SCLC-21H: 27.6;SH-SY5Y: 8.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002942 Uncertain Mitochondria Mitochondria "HPA002942: AB_1078113" "unprognostic (8.65e-2)" "unprognostic (8.24e-2)" "unprognostic (3.10e-2)" "unprognostic (1.29e-2)" "unprognostic (1.90e-2)" "unprognostic (1.08e-2)" "unprognostic (3.46e-2)" "unprognostic (2.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.09e-1)" "unprognostic (2.82e-3)" "unprognostic (1.09e-1)" "unprognostic (1.89e-4)" "unprognostic (8.68e-3)" "unprognostic (1.56e-1)" "unprognostic (9.71e-6)" "unprognostic (1.70e-2)" 1.1 20.2 11.8 1.5 18.9 0.9 0.9 10.3 30.4 1.0 1.8 3.4 0.0 1.4 1.0 1.6 1.1 1.1 1.1 1.2 12.4 21.7 1.0 1.1 0.9 0.9 13.7 7.2 1.0 4.8 1.0 23.0 2.3 8.3 1.4 1.4 2.2 1.1 1.3 1.0 1.0 1.8 1.4 6.1 0.9 1.8 3.1 4.5 0.0 1.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.1 0.0 0.0 27.6 8.7 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 18.9 10.3 16.7 12.4 21.7 13.7 7.2 8.3 4.5 TMEM18 "DKFZp434C1714, lncND" ENSG00000151353 "Transmembrane protein 18" Q96B42 2 667335-677439 "Predicted membrane proteins, Transporters" Transcription DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040233 Approved Approved Mitochondria Mitochondria "HPA040233: AB_10794737" "unprognostic (9.01e-3)" "unprognostic (2.45e-1)" "unprognostic (7.48e-2)" "unprognostic (1.77e-3)" "unprognostic (2.68e-2)" "unprognostic (1.61e-1)" "unprognostic (1.27e-2)" "unprognostic (4.11e-2)" "prognostic unfavourable (3.21e-4)" "unprognostic (6.05e-2)" "unprognostic (1.86e-1)" "unprognostic (9.45e-2)" "unprognostic (8.20e-2)" "unprognostic (2.49e-1)" "unprognostic (3.65e-1)" "unprognostic (4.98e-3)" "unprognostic (8.08e-2)" 18.9 22.1 13.7 11.3 14.4 12.9 23.4 10.0 18.7 17.6 17.4 16.0 12.0 13.9 19.3 19.5 16.1 15.6 18.1 12.3 13.4 14.5 17.3 18.1 12.2 12.5 14.8 15.6 43.7 31.7 13.2 13.5 19.6 12.3 19.2 9.5 18.3 19.5 16.5 28.3 14.2 15.5 18.4 21.9 12.5 13.4 19.1 11.4 23.9 23.1 19.7 13.8 15.0 14.1 17.3 19.7 5.8 14.4 16.2 14.8 11.2 9.8 9.5 11.6 13.2 13.0 19.9 12.4 13.7 10.9 12.3 11.7 1.8 16.2 14.1 25.8 16.8 14.1 4.7 15.8 10.2 21.9 11.4 8.2 5.7 20.3 16.7 8.2 7.5 14.2 16.1 20.8 14.3 3.7 8.4 8.7 16.5 33.5 19.3 20.0 8.5 14.0 11.2 6.3 10.6 11.3 10.8 9.7 15.7 7.9 14.8 14.8 9.9 15.5 11.7 11.3 15.5 7.4 20.6 11.7 19.1 12.2 13.9 9.1 7.9 3.7 14.4 5.8 11.3 13.8 11.8 17.3 12.5 9.2 14.9 13.6 14.8 13.9 1.2 16.2 14.1 19.7 14.4 11.2 13.7 14.4 10.0 18.7 13.4 14.5 14.8 15.6 12.3 11.4 TMEM246 "C9orf125, MGC12992" ENSG00000165152 "Transmembrane protein 246" Q9BRR3 9 101473171-101533537 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 14.4;hTCEpi: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "MAIT T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011318, HPA054041" Uncertain Approved Mitochondria Mitochondria "HPA011318: , HPA054041: " "unprognostic (2.58e-2)" "unprognostic (4.76e-2)" "unprognostic (5.52e-1)" "unprognostic (2.81e-3)" "unprognostic (2.72e-2)" "unprognostic (9.15e-2)" "unprognostic (1.20e-3)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (4.24e-1)" "unprognostic (3.51e-2)" "unprognostic (2.09e-1)" "prognostic favourable (1.55e-8)" "unprognostic (1.62e-1)" "unprognostic (1.91e-1)" "unprognostic (2.50e-1)" "unprognostic (9.16e-2)" 3.4 10.2 10.8 3.1 19.4 0.8 2.9 23.2 31.1 17.1 12.6 7.6 1.6 8.0 5.9 4.0 11.0 13.5 7.0 27.3 17.6 20.6 4.6 2.6 5.4 0.8 10.8 14.3 19.4 10.9 19.6 9.2 1.0 23.2 7.0 10.8 8.1 4.6 9.7 4.3 11.2 7.1 6.7 8.5 1.8 15.1 2.9 4.0 0.0 4.3 4.4 2.9 4.7 8.3 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 9.1 7.1 0.0 0.2 0.1 0.0 6.1 8.9 4.4 8.8 0.4 4.9 0.0 2.0 11.1 14.4 0.0 10.0 2.7 0.0 3.6 4.9 6.9 0.0 0.3 0.0 0.0 4.0 16.2 0.0 2.4 0.0 0.0 0.0 9.0 0.0 0.0 0.0 8.8 0.0 0.0 3.6 0.0 6.7 1.6 12.1 11.3 3.4 0.0 0.0 0.0 8.4 0.0 6.9 4.3 0.0 0.0 0.6 0.0 0.0 9.8 0.0 3.1 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 10.8 19.4 23.2 31.1 17.6 20.6 10.8 14.3 23.2 4.0 TMEM30A "C6orf67, CDC50A, FLJ10856" ENSG00000112697 "Transmembrane protein 30A" Q9NV96 6 75252924-75284968 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014561 Approved Supported Mitochondria Mitochondria "HPA014561: AB_10601823" "unprognostic (2.00e-1)" "unprognostic (2.00e-2)" "unprognostic (2.52e-1)" "unprognostic (1.27e-2)" "unprognostic (3.48e-1)" "unprognostic (1.02e-2)" "unprognostic (1.11e-1)" "unprognostic (1.10e-1)" "unprognostic (2.02e-1)" "unprognostic (1.06e-1)" "unprognostic (2.15e-1)" "unprognostic (4.80e-2)" "unprognostic (1.88e-1)" "unprognostic (5.06e-2)" "unprognostic (7.12e-2)" "unprognostic (8.96e-2)" "unprognostic (1.00e-1)" 29.9 29.6 42.7 28.3 63.3 23.8 27.2 40.3 55.1 33.4 31.3 36.8 22.3 21.2 31.9 25.7 30.1 24.6 30.6 22.9 45.6 48.2 39.6 48.1 45.0 23.9 43.8 41.0 25.2 41.0 57.0 45.5 29.4 50.5 33.6 36.8 20.5 31.9 31.7 18.6 19.4 22.5 39.8 45.3 28.9 28.0 14.1 40.3 21.1 43.1 17.0 29.3 32.8 22.8 9.1 24.3 42.7 26.8 13.1 16.3 16.7 10.4 10.1 18.7 15.6 47.1 44.3 15.4 42.6 33.5 16.6 25.4 10.8 24.4 12.2 29.5 37.4 12.3 8.3 23.7 44.4 15.6 12.3 11.7 11.0 11.1 26.9 14.1 20.6 41.0 23.5 23.0 12.9 52.7 11.4 21.6 32.3 6.9 4.9 10.2 6.6 8.7 8.2 13.2 15.3 64.3 25.7 13.1 12.8 21.6 10.7 14.3 11.8 44.1 45.7 21.0 23.5 13.1 30.0 17.8 24.2 5.2 16.6 27.2 32.9 12.3 26.8 17.7 12.7 26.6 15.3 9.1 13.0 12.2 24.3 7.5 12.5 12.6 42.7 13.1 25.6 10.6 16.3 16.7 42.7 63.3 40.3 52.7 45.6 48.2 43.8 41.0 50.5 40.3 TMEM71 FLJ33069 ENSG00000165071 "Transmembrane protein 71" Q6P5X7 8 132685007-132760712 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 65.7;lymphoid tissue: 31.3" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.0;HDLM-2: 32.3;Karpas-707: 6.9;U-937: 19.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 65.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 65.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA058401, HPA070655" Uncertain Enhanced Mitochondria Mitochondria "HPA058401: , HPA070655: " "unprognostic (1.39e-3)" "unprognostic (7.27e-2)" "unprognostic (8.82e-2)" "unprognostic (3.10e-3)" "unprognostic (7.94e-2)" "unprognostic (3.91e-3)" "unprognostic (4.18e-2)" "unprognostic (5.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.71e-1)" "unprognostic (1.63e-1)" "unprognostic (1.62e-1)" "unprognostic (8.83e-2)" "unprognostic (1.90e-2)" "unprognostic (6.29e-3)" "unprognostic (4.39e-2)" "unprognostic (2.73e-1)" 4.2 1.1 1.4 8.2 1.5 20.8 5.4 0.7 1.2 2.5 9.9 0.8 0.4 1.2 1.0 2.0 4.8 1.9 4.1 25.5 1.8 1.2 1.9 2.3 8.3 20.9 2.2 0.8 1.9 2.9 0.0 1.4 1.0 1.7 2.2 2.2 5.8 5.8 1.3 1.3 1.3 7.2 2.2 4.2 18.2 2.9 0.9 1.4 31.3 2.2 2.5 10.6 7.0 2.8 1.4 8.2 65.7 13.5 2.9 14.8 8.4 0.2 0.0 3.1 0.0 0.0 0.0 0.0 0.7 8.0 0.3 0.5 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.2 0.9 32.3 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 1.2 0.6 0.0 6.9 1.4 0.0 1.6 1.2 0.7 0.2 0.1 1.1 0.4 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.3 0.5 0.7 3.3 0.0 1.6 0.0 5.7 19.1 2.4 12.5 13.5 23.9 8.0 3.9 14.8 1.4 5.9 5.6 8.2 1.3 9.0 6.5 65.7 2.9 3.2 0.2 0.7 8.4 1.4 1.5 0.7 1.2 1.8 1.2 2.2 0.8 1.7 1.4 TMIGD1 "TMIGD, UNQ9372" ENSG00000182271 "Transmembrane and immunoglobulin domain containing 1" Q6UXZ0 17 30316333-30334059 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "intestine: 47.3" "Cell line enhanced" "Detected in some" "BEWO: 1.4;NB-4: 1.3;U-2197: 1.8;U-698: 1.9" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA021946 Approved Mitochondria Mitochondria "HPA021946: AB_1858140" "unprognostic (1.28e-1)" "unprognostic (1.30e-1)" "unprognostic (1.61e-1)" 0.2 0.0 0.2 1.1 0.2 0.0 0.2 0.2 0.2 0.2 26.8 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 1.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 33.9 0.2 0.2 0.2 0.2 0.0 47.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 1.9 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 TMLHE "BBOX2, FLJ10727, TMLH, XAP130" ENSG00000185973 "Trimethyllysine hydroxylase, epsilon" Q9NVH6 X 155490115-155669944 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carnitine biosynthesis" "Dioxygenase, Oxidoreductase" "Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034589, HPA040331" Approved Supported Mitochondria Mitochondria "HPA034589: AB_10670571, HPA040331: " "unprognostic (1.98e-1)" "unprognostic (9.15e-2)" "unprognostic (3.04e-1)" "unprognostic (5.41e-2)" "unprognostic (6.66e-3)" "unprognostic (1.10e-3)" "unprognostic (6.50e-2)" "unprognostic (1.00e-1)" "unprognostic (3.27e-1)" "unprognostic (4.08e-2)" "unprognostic (1.20e-3)" "unprognostic (6.97e-2)" "prognostic favourable (3.68e-6)" "unprognostic (1.69e-1)" "unprognostic (5.74e-2)" "unprognostic (2.73e-1)" "unprognostic (7.75e-2)" 10.1 15.0 8.5 6.7 10.5 6.7 10.4 17.1 13.5 11.3 10.5 10.0 9.1 10.7 10.9 10.1 9.5 9.5 7.4 22.3 10.3 7.5 15.8 16.9 6.9 14.6 12.5 7.4 12.4 10.7 18.4 17.5 7.6 11.5 7.7 11.6 10.6 16.2 9.6 28.1 7.8 10.0 13.8 13.7 9.2 9.8 3.1 11.2 12.2 10.5 5.3 8.7 10.2 9.1 9.1 10.3 14.7 15.7 4.3 5.6 4.5 15.2 7.5 6.2 18.1 7.7 11.9 0.0 6.2 9.1 7.8 20.4 5.3 8.6 0.0 25.0 10.8 8.3 13.2 6.0 8.9 6.2 9.1 6.8 12.2 6.2 10.8 6.4 4.9 12.6 12.7 8.7 13.2 12.3 9.5 5.6 12.9 5.7 7.7 7.2 1.9 0.1 7.7 9.9 5.8 9.4 5.2 5.9 8.9 5.8 0.3 6.7 6.7 7.3 10.3 6.6 6.3 13.0 7.6 7.0 7.5 5.9 8.0 10.0 6.0 1.9 10.1 11.3 3.9 11.4 2.9 6.2 4.3 3.3 10.3 9.1 5.6 4.9 14.7 4.3 15.7 4.7 4.2 4.5 8.5 10.5 17.1 13.5 10.3 7.5 12.5 7.4 11.5 11.2 TOMM20 "KIAA0016, MAS20, MOM19, TOM20" ENSG00000173726 "Translocase of outer mitochondrial membrane 20" Q15388 1 235109336-235128936 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005585, HPA011562" Supported Enhanced Mitochondria Mitochondria "CAB005585: AB_628381, HPA011562: AB_1080326" "unprognostic (1.30e-1)" "unprognostic (3.08e-3)" "unprognostic (1.66e-2)" "unprognostic (4.49e-2)" "unprognostic (8.65e-3)" "unprognostic (1.17e-2)" "unprognostic (7.09e-2)" "unprognostic (3.28e-1)" "unprognostic (3.18e-2)" "unprognostic (1.75e-1)" "unprognostic (1.16e-3)" "unprognostic (5.05e-2)" "unprognostic (7.08e-3)" "unprognostic (2.33e-2)" "unprognostic (1.17e-1)" "unprognostic (1.11e-1)" "unprognostic (3.97e-1)" 27.2 35.0 46.3 15.3 60.2 32.7 52.8 40.0 66.2 36.1 25.5 28.4 29.0 24.4 34.5 39.0 28.0 40.0 27.9 33.9 47.1 48.7 41.2 35.2 24.2 33.6 42.5 40.5 50.9 63.6 38.6 25.4 27.1 48.2 34.0 28.2 23.5 47.8 30.7 33.4 33.0 21.3 33.8 54.5 19.0 27.2 16.3 23.0 18.0 58.7 28.4 21.9 36.2 28.9 15.9 20.9 16.4 13.8 9.8 22.6 14.2 35.9 19.0 25.0 21.0 19.7 39.8 38.8 25.9 22.4 24.4 17.8 24.5 25.4 43.8 34.5 22.4 28.8 27.7 25.1 32.2 10.5 59.2 26.7 25.4 46.3 33.0 59.8 16.1 35.5 34.5 24.4 33.7 26.4 56.0 16.2 26.7 10.5 25.4 27.1 56.2 10.3 31.1 19.1 56.7 27.4 25.9 32.9 77.1 20.1 28.2 55.1 43.6 65.8 23.3 21.5 13.0 27.1 54.9 38.4 36.1 32.1 25.2 28.7 36.2 16.4 12.4 4.1 13.9 12.9 17.1 15.9 18.1 17.3 15.1 12.7 22.6 17.6 3.9 9.8 13.8 20.9 15.5 14.2 46.3 60.2 40.0 66.2 47.1 48.7 42.5 40.5 48.2 23.0 TOMM22 TOM22 ENSG00000100216 "Translocase of outer mitochondrial membrane 22" Q9NS69 22 38681948-38685421 "Predicted membrane proteins" "Protein transport, Translocation, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003037 Supported Enhanced Mitochondria Mitochondria "HPA003037: AB_1080329" "unprognostic (5.54e-2)" "unprognostic (5.04e-3)" "unprognostic (2.74e-3)" "unprognostic (1.48e-2)" "unprognostic (1.32e-1)" "unprognostic (1.85e-2)" "prognostic unfavourable (2.90e-5)" "unprognostic (1.01e-1)" "unprognostic (4.28e-1)" "unprognostic (7.01e-2)" "unprognostic (1.64e-2)" "unprognostic (7.39e-2)" "unprognostic (5.44e-2)" "unprognostic (5.32e-2)" "unprognostic (1.99e-1)" "unprognostic (7.86e-2)" "unprognostic (1.64e-1)" 27.6 26.2 25.6 30.1 24.3 29.5 29.4 17.6 28.2 22.2 26.8 14.7 22.4 28.0 20.1 25.6 34.1 24.4 23.8 31.6 23.2 21.0 29.4 46.0 18.1 32.1 24.0 19.8 27.8 47.5 10.9 12.6 27.6 18.5 21.0 32.8 15.8 31.4 26.7 38.2 24.6 29.7 22.8 20.0 27.7 23.3 24.7 11.3 44.2 27.4 40.4 33.5 24.1 30.2 22.5 29.7 6.9 22.9 18.0 21.3 28.6 19.6 11.6 17.9 18.9 13.2 12.3 19.3 16.3 11.4 23.9 18.0 21.1 11.8 20.0 13.5 15.9 16.4 27.1 24.7 19.3 17.2 29.8 26.9 9.1 20.2 17.3 71.1 19.1 16.8 17.6 21.5 14.1 17.5 20.3 16.0 15.9 15.3 21.3 33.1 27.3 23.7 23.7 23.2 18.9 15.9 14.5 21.0 13.9 19.1 24.2 18.5 16.8 23.6 17.8 14.7 27.6 13.4 24.6 22.2 26.8 31.0 18.4 24.7 20.0 4.7 22.9 6.9 16.9 22.0 21.3 22.5 18.3 17.8 29.7 18.0 18.7 20.0 2.2 18.0 18.1 25.8 21.1 28.6 25.6 24.3 17.6 28.2 23.2 21.0 24.0 19.8 18.5 11.3 TOMM5 "bA613M10.3, C9orf105, Tom5" ENSG00000175768 "Translocase of outer mitochondrial membrane 5" Q8N4H5 9 37582646-37592642 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA048712 Approved Supported Mitochondria Mitochondria "HPA048712: " "unprognostic (1.81e-2)" "unprognostic (1.96e-1)" "unprognostic (3.37e-2)" "unprognostic (3.34e-2)" "unprognostic (2.02e-1)" "unprognostic (2.82e-2)" "prognostic unfavourable (2.09e-4)" "unprognostic (9.89e-3)" "prognostic unfavourable (5.49e-4)" "prognostic favourable (2.37e-4)" "unprognostic (7.80e-2)" "unprognostic (1.60e-1)" "unprognostic (1.25e-1)" "unprognostic (3.23e-2)" "unprognostic (3.07e-2)" "unprognostic (2.37e-1)" "unprognostic (9.09e-2)" 33.2 37.8 34.5 31.2 39.7 28.3 44.1 24.3 38.5 26.7 34.7 13.1 28.3 37.5 28.7 32.7 36.9 25.4 31.1 39.6 30.9 34.7 44.3 45.3 24.4 37.4 37.6 26.3 27.4 83.8 12.7 28.8 19.6 32.3 25.2 31.2 17.3 49.6 36.2 51.5 24.1 34.8 34.1 23.9 38.9 31.2 33.0 27.2 24.5 36.3 46.1 37.8 26.7 35.3 59.1 43.1 14.0 33.9 40.2 54.9 50.5 54.3 63.5 37.7 33.7 43.3 42.5 20.8 41.5 26.6 40.5 43.4 67.5 22.6 37.3 34.1 39.3 18.9 33.4 49.5 42.3 52.3 52.9 32.8 88.3 96.7 35.6 53.6 21.7 36.7 27.2 44.6 44.2 46.1 79.7 41.9 41.1 43.6 45.1 47.2 65.5 40.3 38.4 31.4 54.8 46.3 34.1 32.6 30.0 21.3 29.0 30.3 20.3 62.9 31.2 28.1 60.1 44.1 64.0 15.9 46.2 62.2 34.4 46.4 43.2 12.3 32.2 14.0 43.0 33.9 52.7 59.1 53.1 47.7 39.0 49.1 54.9 50.5 3.7 40.2 28.5 43.1 42.1 50.5 34.5 39.7 24.3 38.5 30.9 34.7 37.6 26.3 32.3 27.2 TOMM6 "OBTP, Tom6" ENSG00000214736 "Translocase of outer mitochondrial membrane 6" Q96B49 6 41787662-41789898 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004801 Approved Supported Mitochondria Mitochondria "HPA004801: AB_1859553" 44.1 68.7 54.2 47.4 51.9 55.4 66.4 26.0 52.6 44.0 44.7 43.6 37.1 29.1 38.9 83.4 62.1 49.0 32.1 64.6 45.3 43.8 80.9 92.6 37.7 60.4 45.1 36.3 56.9 84.5 31.6 39.7 49.9 42.3 47.1 53.1 48.4 83.1 43.8 80.2 47.2 48.7 39.4 41.5 58.7 42.0 53.1 37.2 56.7 65.9 78.3 71.9 44.7 38.7 66.2 75.2 39.0 70.5 33.8 56.9 89.2 64.0 32.1 38.8 39.2 36.5 44.1 41.3 32.2 34.1 41.6 40.3 55.5 30.0 29.4 39.5 38.4 20.5 61.8 53.4 53.8 41.2 65.2 52.7 41.0 90.3 28.9 70.2 34.3 39.5 56.1 45.7 39.3 50.0 131.3 36.1 51.1 75.8 50.4 111.4 34.1 32.6 37.0 24.3 86.5 56.0 33.0 34.4 48.0 22.0 38.0 53.6 46.4 142.7 35.0 28.6 35.5 28.4 48.0 33.4 71.3 129.4 16.2 59.7 36.8 15.1 69.1 39.0 49.1 68.7 47.7 66.2 50.2 48.7 72.0 61.8 56.9 55.4 9.0 33.8 70.5 75.2 46.5 89.2 54.2 51.9 26.0 52.6 45.3 43.8 45.1 36.3 42.3 37.2 TOMM70 "KIAA0719, Tom70, TOMM70A" ENSG00000154174 "Translocase of outer mitochondrial membrane 70" O94826 3 100363431-100401398 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014589, CAB017156, HPA048020" Enhanced Enhanced Mitochondria 120000 Mitochondria "CAB017156: , HPA014589: AB_1858185, HPA048020: " "unprognostic (2.74e-2)" "unprognostic (2.25e-1)" "unprognostic (2.57e-2)" "unprognostic (2.69e-3)" "unprognostic (2.12e-2)" "unprognostic (5.96e-2)" "unprognostic (2.06e-3)" "unprognostic (5.01e-2)" "unprognostic (9.86e-2)" "unprognostic (1.21e-1)" "unprognostic (9.73e-3)" "unprognostic (5.38e-2)" "unprognostic (2.62e-3)" "unprognostic (1.73e-1)" "unprognostic (3.53e-1)" "unprognostic (3.34e-2)" "unprognostic (6.98e-3)" 21.7 16.1 16.2 12.4 52.4 9.6 21.3 23.6 26.5 16.9 18.2 12.5 13.8 19.4 17.4 15.0 20.8 14.2 12.2 25.2 16.5 19.8 24.9 40.7 10.5 13.5 16.1 20.6 21.7 18.0 20.1 17.1 15.5 29.0 19.0 20.6 13.3 14.5 19.4 42.8 13.3 17.8 22.3 14.0 12.1 14.8 14.7 15.6 18.7 20.5 19.9 16.6 22.3 22.5 4.3 3.0 2.5 2.5 5.6 5.4 1.8 23.6 16.6 14.2 20.3 20.0 21.8 18.4 20.3 17.3 18.5 19.2 23.5 13.6 28.3 17.9 17.1 23.5 25.5 18.5 27.4 10.7 11.8 32.5 11.0 22.8 12.5 39.5 15.0 19.4 17.2 16.5 27.0 13.5 23.1 23.1 22.1 17.5 26.7 16.0 19.5 35.4 24.6 28.7 30.1 15.0 17.9 25.7 21.4 14.7 23.7 26.4 30.7 22.5 12.2 16.4 21.8 9.1 15.1 25.2 35.9 48.1 15.8 23.9 12.4 2.2 2.2 2.5 4.1 2.2 5.1 4.3 5.1 4.5 2.9 3.1 5.3 5.4 0.6 5.6 2.5 3.0 2.0 1.8 16.2 52.4 23.6 26.5 16.5 19.8 16.1 20.6 29.0 15.6 TOP1MT ENSG00000184428 "DNA topoisomerase I mitochondrial" Q969P6 8 143304384-143359979 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "DNA-binding, Isomerase, Topoisomerase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001915, HPA021542" Approved Supported Mitochondria Mitochondria "HPA001915: AB_1080331, HPA021542: AB_1858186" "unprognostic (5.02e-3)" "unprognostic (3.79e-2)" "unprognostic (6.57e-2)" "unprognostic (6.92e-3)" "unprognostic (2.32e-2)" "unprognostic (1.04e-2)" "unprognostic (3.05e-3)" "unprognostic (1.44e-1)" "unprognostic (1.44e-1)" "unprognostic (1.13e-1)" "unprognostic (1.50e-2)" "unprognostic (4.42e-2)" "prognostic unfavourable (1.52e-7)" "unprognostic (3.66e-2)" "unprognostic (3.62e-2)" "unprognostic (8.55e-3)" "unprognostic (5.66e-3)" 11.7 13.5 8.1 13.7 9.8 33.0 22.1 2.2 10.3 14.7 10.7 4.5 3.9 6.0 10.0 7.4 14.9 11.3 11.0 5.9 8.8 5.6 9.6 22.5 8.5 11.4 6.9 8.1 27.0 15.9 5.9 8.6 5.9 7.3 14.7 8.0 5.9 11.0 10.8 5.7 15.4 8.3 8.8 6.8 11.4 9.3 18.1 6.4 25.1 19.2 9.6 11.4 14.0 30.9 16.7 18.8 11.7 5.5 0.2 14.3 4.7 7.5 11.6 4.9 18.2 7.0 7.8 8.7 3.5 4.5 6.4 6.6 14.5 10.9 22.2 13.2 4.9 8.1 10.4 6.5 5.5 8.7 15.9 19.5 6.5 14.6 7.9 13.0 21.2 7.9 6.9 5.3 7.8 7.6 23.3 8.7 5.6 31.5 57.7 25.9 8.5 19.9 7.3 6.4 33.2 4.7 12.2 8.7 10.6 10.0 9.0 18.1 5.9 21.7 5.0 4.4 18.1 5.0 9.0 4.7 4.9 11.3 7.5 19.5 5.3 11.7 5.5 0.2 3.5 3.2 3.6 16.7 6.4 4.8 18.8 8.0 14.3 10.4 0.4 0.2 0.6 16.4 1.7 4.7 8.1 9.8 2.2 10.3 8.8 5.6 6.9 8.1 7.3 6.4 TRAM1L1 MGC26568 ENSG00000174599 "Translocation associated membrane protein 1 like 1" Q8N609 4 117083554-117085576 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 9.5;U-138 MG: 11.6;U-266/70: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044560 Uncertain Approved Mitochondria Mitochondria "HPA044560: AB_10796097" "unprognostic (9.06e-2)" "unprognostic (2.87e-2)" "unprognostic (4.40e-2)" "unprognostic (2.17e-3)" "unprognostic (9.77e-2)" "unprognostic (2.37e-2)" "unprognostic (5.97e-2)" "unprognostic (3.02e-1)" "unprognostic (1.14e-1)" "unprognostic (3.25e-1)" "unprognostic (1.09e-3)" "unprognostic (1.56e-2)" "unprognostic (2.76e-2)" "unprognostic (1.68e-2)" "unprognostic (1.62e-1)" "unprognostic (4.82e-3)" "unprognostic (1.23e-2)" 2.1 4.3 7.8 1.1 10.0 0.3 7.3 5.6 14.9 4.6 1.8 9.4 0.0 0.9 3.4 10.5 1.6 6.8 3.1 2.2 8.8 8.6 11.9 0.5 2.9 1.0 8.5 5.9 4.1 5.0 0.6 8.5 1.2 10.3 7.5 2.2 4.5 2.5 4.7 0.7 4.1 1.1 3.6 10.3 1.2 3.2 5.9 7.4 0.0 8.4 0.3 0.9 3.2 1.2 0.1 0.2 0.0 0.0 0.1 0.2 0.0 1.4 1.0 4.4 2.2 0.0 0.0 0.0 0.6 0.5 0.9 2.7 0.1 5.2 0.0 0.5 1.2 0.1 2.1 2.3 3.6 0.0 0.1 1.2 1.2 0.6 1.3 1.3 0.0 4.9 2.0 1.1 0.0 0.0 0.0 2.7 7.2 0.3 2.3 0.0 0.3 1.1 0.0 5.7 0.0 0.7 0.3 2.6 9.5 0.0 3.7 4.4 6.4 1.4 3.1 11.6 5.2 0.1 1.8 9.5 2.1 0.0 4.5 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 7.8 10.0 5.6 13.9 8.8 8.6 8.5 5.9 10.3 7.4 TRAP1 "HSP75, HSP90L" ENSG00000126602 "TNF receptor associated protein 1" Q12931 16 3651639-3717597 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041082, HPA044227" Enhanced Enhanced Mitochondria 1100000 Mitochondria "HPA041082: AB_2677291, HPA044227: AB_2678864" "unprognostic (1.18e-1)" "unprognostic (1.51e-1)" "prognostic favourable (1.80e-4)" "unprognostic (7.10e-2)" "unprognostic (6.80e-2)" "unprognostic (2.76e-2)" "unprognostic (1.52e-2)" "unprognostic (9.61e-2)" "unprognostic (8.58e-2)" "unprognostic (5.71e-3)" "unprognostic (1.54e-1)" "unprognostic (7.69e-3)" "unprognostic (1.01e-2)" "unprognostic (2.24e-2)" "unprognostic (6.68e-2)" "unprognostic (9.90e-2)" "unprognostic (3.82e-2)" 19.1 20.3 19.1 15.9 29.7 14.2 17.5 21.1 38.5 16.8 23.0 18.1 13.1 18.6 17.1 14.2 34.4 28.5 20.8 40.0 22.1 20.4 24.6 62.6 12.3 20.6 17.1 30.7 23.5 54.7 18.3 13.6 15.5 23.2 15.4 17.8 16.4 19.7 13.7 80.3 31.2 14.1 20.9 12.3 15.2 19.7 20.0 15.1 16.4 16.0 39.8 21.2 17.2 18.2 20.0 24.6 1.3 17.0 12.7 22.3 13.8 18.9 47.7 9.9 26.2 11.0 11.3 29.4 11.5 10.5 26.8 16.9 59.2 27.1 61.1 21.9 11.1 35.7 38.6 28.8 11.8 23.4 42.2 17.8 40.9 41.4 18.9 31.9 12.3 13.3 20.1 21.2 33.3 18.3 55.9 22.3 8.7 62.0 22.9 23.7 18.4 24.3 52.7 20.8 84.3 19.8 14.1 47.3 18.0 12.0 44.4 23.1 32.1 23.2 10.3 11.3 20.2 19.7 16.8 23.8 26.2 48.1 7.0 25.8 15.3 0.0 10.8 0.3 11.7 17.0 22.3 20.0 17.1 14.8 24.6 13.9 20.3 17.1 1.3 12.7 12.3 3.6 14.2 13.8 19.1 29.7 21.1 38.5 22.1 20.4 17.1 30.7 23.2 15.1 TRIM3 "BERP, HAC1, RNF22, RNF97" ENSG00000110171 "Tripartite motif containing 3" O75382 11 6448613-6474459 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.0" "Cell line enhanced" "Detected in many" "SK-BR-3: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043396, HPA048233" Enhanced Approved Mitochondria Mitochondria "HPA043396: , HPA048233: " "unprognostic (1.24e-1)" "unprognostic (1.98e-1)" "unprognostic (2.31e-1)" "prognostic favourable (2.20e-4)" "unprognostic (4.01e-2)" "unprognostic (3.88e-2)" "unprognostic (1.61e-3)" "unprognostic (2.84e-1)" "unprognostic (2.24e-1)" "unprognostic (3.91e-1)" "prognostic favourable (5.49e-5)" "unprognostic (2.01e-1)" "prognostic unfavourable (1.07e-5)" "unprognostic (2.51e-1)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "unprognostic (1.93e-1)" 6.9 5.4 9.0 5.8 8.8 1.6 6.2 34.0 17.1 6.3 8.1 9.4 3.4 22.6 8.7 2.6 3.7 5.9 5.3 6.1 6.8 7.0 3.9 3.8 6.2 3.0 8.1 9.6 5.8 5.3 2.8 3.8 5.3 14.3 7.7 6.5 6.1 9.2 7.7 9.3 7.1 19.5 8.9 7.3 4.9 8.6 3.0 7.0 0.7 4.2 2.5 2.1 6.6 5.8 0.5 3.9 1.8 3.0 2.0 1.9 1.5 4.2 7.4 2.9 5.0 5.0 4.9 4.0 6.1 3.7 4.7 5.3 4.4 3.0 2.3 2.2 4.6 3.0 3.0 4.5 1.8 2.8 4.6 0.7 7.4 3.0 3.0 0.2 2.5 4.1 2.2 3.7 1.9 4.7 1.0 2.8 4.6 8.8 0.2 0.5 2.1 6.4 1.4 2.6 2.9 1.1 2.2 3.1 4.8 3.4 33.3 3.9 12.6 0.8 8.0 12.5 5.9 9.1 4.0 3.3 2.0 0.4 6.8 1.0 4.6 0.0 3.0 1.8 1.7 2.9 1.3 0.4 1.4 1.4 3.9 0.5 0.5 1.9 0.0 2.0 0.8 0.8 1.5 1.5 9.0 8.8 34.0 17.1 6.8 7.0 8.1 9.6 14.3 7.0 TRNT1 "CCA1, CGI-47, MtCCA" ENSG00000072756 "TRNA nucleotidyl transferase 1" Q96Q11 3 3126916-3150879 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Nucleotidyltransferase, RNA-binding, Transferase" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036938 Uncertain Supported Mitochondria Mitochondria "HPA036938: AB_10670566" "unprognostic (6.39e-3)" "unprognostic (1.58e-1)" "unprognostic (2.38e-3)" "unprognostic (4.69e-2)" "unprognostic (4.92e-2)" "unprognostic (2.41e-1)" "unprognostic (1.39e-2)" "unprognostic (2.68e-1)" "unprognostic (6.22e-2)" "unprognostic (5.65e-2)" "unprognostic (4.62e-2)" "unprognostic (1.41e-2)" "unprognostic (1.24e-2)" "unprognostic (6.50e-2)" "unprognostic (1.09e-1)" "unprognostic (3.78e-1)" "unprognostic (1.02e-1)" 15.2 16.9 17.5 17.8 20.7 8.7 18.2 14.5 22.7 12.9 13.2 13.2 17.4 11.1 18.4 14.7 15.9 12.2 15.6 13.9 17.1 16.0 21.1 16.1 13.7 19.0 17.5 15.6 14.6 13.9 14.3 31.0 19.0 21.3 23.9 16.4 10.1 13.2 13.1 14.8 15.3 12.5 15.3 19.3 20.5 15.5 13.5 15.1 22.1 20.9 10.6 19.8 17.8 13.0 15.1 10.5 29.0 12.0 15.1 16.6 7.4 11.9 17.3 13.4 7.6 16.0 13.7 14.3 13.7 11.4 13.7 14.2 16.0 14.7 21.8 9.1 13.2 8.6 17.7 12.4 17.5 16.2 8.5 20.3 18.4 16.0 21.4 21.4 16.5 12.8 17.5 14.1 4.8 13.5 15.7 9.2 23.6 22.3 13.8 19.4 10.6 12.6 13.2 18.1 21.2 18.3 17.8 7.7 11.0 19.8 14.4 11.4 13.3 12.2 11.0 15.5 13.5 16.0 17.5 9.4 18.8 27.5 11.6 19.3 17.2 29.0 8.8 22.5 12.1 11.8 11.9 15.1 15.0 12.7 10.5 9.5 16.6 14.3 11.7 15.1 12.0 9.6 11.1 7.4 17.5 20.7 14.5 22.7 17.1 16.0 17.5 15.6 21.3 15.1 TRPT1 MGC11134 ENSG00000149743 "TRNA phosphotransferase 1" Q86TN4 11 64223799-64226254 "Enzymes, Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038705, HPA038706" Uncertain Approved Mitochondria Mitochondria "HPA038705: , HPA038706: AB_10671863" "unprognostic (2.50e-2)" "unprognostic (1.72e-1)" "unprognostic (1.33e-1)" "unprognostic (3.59e-2)" "unprognostic (7.20e-2)" "unprognostic (1.53e-1)" "unprognostic (5.84e-2)" "unprognostic (8.56e-2)" "unprognostic (1.18e-1)" "unprognostic (3.26e-3)" "unprognostic (1.12e-1)" "unprognostic (7.71e-2)" "unprognostic (7.38e-2)" "unprognostic (2.49e-1)" "unprognostic (3.28e-1)" "unprognostic (1.99e-1)" "unprognostic (4.58e-3)" 8.1 12.2 10.8 11.1 12.6 4.4 9.1 6.4 12.1 8.8 15.1 10.9 37.4 12.5 7.8 15.3 13.3 10.4 13.5 34.4 10.9 10.3 16.9 13.7 7.0 8.3 13.6 8.5 8.7 23.3 9.1 11.6 8.5 10.8 11.3 10.8 9.9 22.3 33.5 58.8 10.8 13.1 7.0 10.1 10.3 12.2 18.9 10.3 17.2 13.3 23.9 13.2 11.9 7.7 22.9 31.7 14.5 16.2 12.4 13.2 6.5 10.7 10.7 11.9 19.1 14.8 10.8 14.7 7.2 14.1 12.9 10.9 7.0 16.4 10.9 29.3 11.9 15.1 5.2 15.7 4.5 10.5 6.4 5.5 10.8 12.1 21.4 6.9 9.8 8.1 9.2 14.3 12.7 9.0 9.6 12.1 10.7 25.5 12.8 14.8 7.6 11.9 16.9 8.9 30.7 33.1 12.9 10.5 15.3 5.8 14.3 21.1 16.6 11.2 10.5 8.9 6.8 17.2 7.1 24.4 6.0 6.9 21.3 3.6 14.2 6.0 9.4 14.5 10.9 16.2 8.4 20.8 10.5 11.2 13.0 22.9 11.9 13.2 8.3 12.4 13.9 31.7 13.2 6.5 10.8 12.6 6.4 12.1 10.9 10.3 13.6 8.5 10.8 10.3 TST RDS ENSG00000128311 "Thiosulfate sulfurtransferase" Q16762 22 37010859-37020183 "Enzymes, Predicted intracellular proteins" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 102.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 16.0" "Group enriched" "Detected in all" 6 "dendritic cells: 16.0;granulocytes: 14.3;monocytes: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003044, HPA003643, CAB009546" Enhanced Supported Mitochondria 2800000 Mitochondria "CAB009546: AB_2211220, HPA003044: AB_1858417, HPA003643: AB_1080411" "unprognostic (3.09e-2)" "unprognostic (2.70e-1)" "unprognostic (2.07e-1)" "unprognostic (1.21e-2)" "unprognostic (2.36e-2)" "unprognostic (1.11e-1)" "unprognostic (2.49e-2)" "unprognostic (2.38e-2)" "unprognostic (2.32e-1)" "unprognostic (7.96e-3)" "unprognostic (4.38e-2)" "unprognostic (1.78e-1)" "prognostic favourable (7.59e-6)" "unprognostic (6.08e-3)" "unprognostic (3.46e-1)" "unprognostic (1.16e-1)" "prognostic favourable (1.04e-4)" 8.5 29.7 6.0 13.5 7.6 5.7 6.1 5.0 10.5 9.5 38.4 12.9 10.9 37.4 5.9 4.0 16.6 6.8 38.4 14.1 5.1 4.9 19.7 102.1 6.2 3.2 8.2 7.0 7.2 23.9 1.8 2.3 5.0 5.9 8.1 21.6 6.2 13.6 6.9 8.3 5.4 39.5 3.8 4.7 3.5 22.8 3.3 6.7 1.8 8.5 12.8 10.5 7.2 9.2 1.6 16.0 14.3 11.5 2.2 1.2 5.2 15.1 33.7 4.3 14.4 10.4 4.1 8.0 8.4 7.2 4.9 7.4 9.8 10.0 4.0 7.1 6.6 13.1 3.1 8.4 1.1 11.7 18.9 4.2 6.4 19.0 26.1 5.8 10.0 8.0 9.6 3.6 3.1 12.0 5.0 7.0 2.3 34.7 0.2 18.8 7.3 14.8 13.6 4.6 7.0 13.8 14.2 2.5 6.5 8.9 16.0 11.4 16.5 14.8 9.0 5.6 10.5 9.3 2.6 5.3 5.3 1.2 2.0 16.9 3.3 5.3 11.5 4.9 0.6 3.0 1.1 1.6 0.5 0.4 16.0 0.8 0.3 0.2 14.3 2.2 0.8 1.1 1.2 5.2 6.0 7.6 5.0 10.5 5.1 4.9 8.2 7.0 5.9 6.7 TTC19 "FLJ20343, MGC19520" ENSG00000011295 "Tetratricopeptide repeat domain 19" Q6DKK2 17 15999380-16045015 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023010, HPA052380" Enhanced Enhanced Mitochondria "Intracellular and membrane" Mitochondria "HPA023010: AB_1858429, HPA052380: " "unprognostic (1.04e-2)" "unprognostic (4.90e-3)" "unprognostic (2.87e-2)" "unprognostic (4.80e-3)" "unprognostic (8.09e-2)" "unprognostic (2.86e-1)" "unprognostic (1.06e-2)" "unprognostic (2.84e-2)" "unprognostic (8.34e-2)" "unprognostic (1.72e-2)" "unprognostic (2.30e-3)" "unprognostic (5.14e-2)" "prognostic favourable (5.67e-4)" "unprognostic (1.31e-1)" "unprognostic (3.22e-1)" "unprognostic (4.85e-2)" "unprognostic (2.24e-1)" 8.5 13.6 10.3 10.1 16.6 16.4 11.2 16.5 22.6 10.1 13.8 10.3 10.5 18.7 11.1 8.9 9.3 9.9 11.8 13.4 17.0 10.4 15.4 13.2 10.8 7.9 9.2 15.3 12.7 24.8 11.5 15.5 10.1 15.7 12.0 9.6 13.1 14.0 12.7 8.6 13.9 16.1 7.2 8.9 8.3 13.3 6.3 6.8 6.0 18.7 8.0 8.4 10.0 10.9 3.5 2.8 9.0 2.0 1.7 3.3 1.0 7.2 6.1 6.2 10.5 5.3 5.2 4.7 6.1 4.3 2.9 3.2 6.0 12.9 10.2 13.5 3.4 9.2 8.5 7.0 3.6 16.7 14.4 8.4 7.5 5.1 8.1 8.4 13.0 5.3 5.8 2.4 10.1 6.1 4.9 7.3 6.0 6.9 9.0 5.2 10.3 4.2 13.6 7.0 7.3 9.2 8.6 6.5 4.9 7.8 8.4 15.5 7.2 3.7 11.3 4.0 1.7 5.6 7.7 6.0 2.6 4.8 9.5 9.4 9.0 9.0 2.0 3.8 2.0 2.0 3.3 2.8 2.5 3.3 2.5 3.5 2.8 3.1 1.7 1.7 1.6 2.8 2.6 1.0 10.3 16.6 16.5 22.6 17.0 10.4 9.2 15.3 15.7 6.8 TTC21B "FLJ11457, IFT139B, JBTS11, NPHP12, THM1" ENSG00000123607 "Tetratricopeptide repeat domain 21B" Q7Z4L5 2 165857475-165953843 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035494, HPA035495, HPA073293" Supported Supported Mitochondria Mitochondria "HPA035494: , HPA035495: AB_10672866, HPA073293: " "unprognostic (1.63e-2)" "unprognostic (1.17e-1)" "unprognostic (3.10e-1)" "unprognostic (1.60e-2)" "unprognostic (2.96e-1)" "unprognostic (2.51e-1)" "unprognostic (7.09e-3)" "unprognostic (2.81e-2)" "unprognostic (2.98e-2)" "unprognostic (7.57e-2)" "unprognostic (3.52e-2)" "unprognostic (3.29e-1)" "prognostic unfavourable (1.36e-4)" "unprognostic (1.32e-1)" "unprognostic (1.55e-1)" "unprognostic (2.37e-2)" "unprognostic (1.84e-2)" 10.4 9.0 11.3 7.0 18.3 8.6 11.7 39.6 19.8 12.3 9.2 7.1 5.3 6.5 13.8 10.0 6.7 15.3 7.5 10.4 10.1 8.1 12.5 8.9 9.4 8.9 12.3 11.9 17.5 10.1 10.4 17.6 9.8 15.7 14.9 8.9 6.3 9.1 10.2 16.4 10.7 8.2 9.7 12.2 8.4 8.5 9.7 13.8 16.2 9.4 7.1 8.0 9.8 11.8 3.8 3.1 8.7 2.7 3.7 4.7 1.8 4.9 3.8 17.4 7.1 11.8 11.4 4.6 9.9 8.1 8.0 7.9 5.4 3.3 11.5 6.0 7.0 5.2 11.7 6.2 9.5 8.0 5.8 9.4 6.7 13.1 6.9 8.8 0.0 6.2 4.0 9.2 6.7 8.6 12.4 8.7 10.1 2.7 10.8 7.0 7.2 9.4 12.0 14.0 3.9 6.2 10.6 12.5 7.3 7.8 1.9 8.7 2.9 6.3 6.3 14.1 6.3 7.8 7.3 5.0 7.0 10.6 5.9 5.5 8.8 8.7 1.9 3.3 2.9 2.3 4.2 3.8 3.4 2.9 3.1 3.2 4.4 4.7 0.8 3.7 2.7 1.6 4.2 1.8 11.3 18.3 39.6 19.8 10.1 8.1 12.3 11.9 15.7 13.8 TTLL4 KIAA0173 ENSG00000135912 "Tubulin tyrosine ligase like 4" Q14679 2 218710845-218755416 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027091, HPA050252" Approved Approved Mitochondria Mitochondria "HPA027091: AB_10601828, HPA050252: " "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (4.64e-1)" "unprognostic (1.49e-2)" "unprognostic (2.09e-1)" "unprognostic (1.66e-2)" "prognostic unfavourable (2.95e-5)" "unprognostic (3.83e-3)" "unprognostic (2.96e-2)" "unprognostic (1.21e-1)" "unprognostic (7.52e-2)" "unprognostic (2.42e-2)" "prognostic unfavourable (6.63e-12)" "unprognostic (9.84e-2)" "unprognostic (1.09e-1)" "unprognostic (1.85e-1)" "unprognostic (5.29e-3)" 6.1 9.0 10.6 11.1 15.1 7.1 9.0 11.2 12.7 5.9 7.7 17.7 5.9 7.9 8.5 5.5 9.2 10.5 7.0 5.9 10.9 6.8 6.3 7.7 8.7 8.0 16.6 6.3 6.9 9.1 8.8 14.5 11.0 13.1 8.4 9.3 11.2 8.9 5.8 7.0 10.8 8.0 7.6 16.7 7.6 12.6 39.1 14.1 8.6 5.3 5.3 11.9 6.1 7.7 4.0 6.8 13.5 11.3 1.8 3.2 3.9 9.2 6.2 16.6 8.3 4.2 3.3 23.4 6.4 4.9 10.2 8.7 26.2 10.8 7.3 5.4 4.7 10.3 17.4 8.5 12.0 8.6 15.9 9.4 9.3 24.8 6.1 11.4 6.9 5.4 5.2 9.1 10.4 9.6 26.5 11.4 5.6 5.2 6.3 7.8 19.0 4.4 15.1 7.5 9.5 10.2 7.2 6.9 6.6 4.7 7.0 12.1 5.6 5.9 4.1 9.1 9.5 6.3 6.0 6.0 5.0 16.4 4.8 7.3 11.8 0.1 11.3 0.7 3.2 5.7 2.9 4.0 2.3 2.2 6.8 3.2 1.5 1.4 13.5 1.8 7.4 4.0 1.4 3.9 10.6 15.1 11.2 12.7 10.9 6.8 16.6 6.3 13.1 14.1 TUFM "EF-TuMT, EFTu" ENSG00000178952 "Tu translation elongation factor, mitochondrial" P49411 16 28842411-28846408 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Elongation factor" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018991, HPA024087, CAB075730, CAB075731, CAB075732" Enhanced Enhanced Mitochondria 2800000 Mitochondria "CAB075730: , CAB075731: , CAB075732: , HPA018991: AB_1858458, HPA024087: AB_1858459" "unprognostic (1.40e-1)" "unprognostic (7.56e-2)" "unprognostic (1.29e-1)" "unprognostic (1.73e-2)" "unprognostic (2.36e-1)" "unprognostic (2.55e-2)" "unprognostic (3.39e-1)" "unprognostic (1.23e-3)" "unprognostic (8.05e-2)" "unprognostic (8.47e-2)" "unprognostic (1.80e-1)" "unprognostic (1.33e-1)" "prognostic favourable (2.69e-6)" "unprognostic (5.26e-2)" "unprognostic (1.09e-1)" "unprognostic (6.22e-2)" "unprognostic (7.36e-2)" 27.3 47.8 28.8 32.3 31.3 27.2 40.4 22.3 41.4 25.3 41.7 27.1 34.4 44.0 26.6 22.3 40.0 32.7 37.6 69.2 25.6 25.8 45.6 68.4 28.6 46.2 33.1 24.4 25.9 75.0 48.3 22.7 23.0 27.3 23.4 37.6 25.4 40.9 33.1 77.3 28.1 36.1 26.2 25.8 28.4 36.9 47.0 21.5 32.5 37.0 55.4 33.9 26.8 23.3 30.6 57.3 21.7 44.2 25.5 38.8 45.4 29.1 55.4 17.8 37.1 25.8 23.7 36.5 21.4 24.9 34.1 32.4 59.7 32.3 65.6 39.5 21.4 57.2 42.1 41.4 20.5 26.1 64.4 25.0 44.8 72.2 30.7 44.8 23.3 30.2 32.8 36.9 36.7 40.6 56.1 25.9 24.8 59.4 42.9 43.8 39.8 34.4 59.5 32.3 95.4 29.5 28.6 31.2 38.1 18.7 66.7 29.2 39.7 36.5 25.8 20.4 23.8 25.3 32.6 39.6 40.9 28.5 26.1 56.3 26.7 21.7 44.2 19.5 31.3 42.3 34.8 30.6 29.7 32.7 57.3 27.5 28.5 29.5 9.1 25.5 31.6 34.9 38.8 45.4 28.8 31.3 22.3 41.4 25.6 25.8 33.1 24.4 27.3 21.5 TXN2 MT-TRX ENSG00000100348 "Thioredoxin 2" Q99757 22 36467036-36482030 "Disease related genes, Predicted intracellular proteins" "Electron transport, Transport" "Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000994, CAB008681" Approved Enhanced Mitochondria Mitochondria "CAB008681: AB_1623682, HPA000994: AB_1080267" "unprognostic (5.11e-2)" "unprognostic (4.40e-3)" "unprognostic (4.40e-3)" "unprognostic (1.07e-2)" "unprognostic (5.85e-2)" "unprognostic (4.28e-2)" "unprognostic (4.02e-2)" "unprognostic (5.05e-2)" "unprognostic (2.15e-1)" "unprognostic (1.78e-1)" "unprognostic (3.17e-2)" "prognostic favourable (2.04e-4)" "prognostic favourable (1.17e-6)" "unprognostic (1.49e-2)" "unprognostic (2.78e-1)" "unprognostic (1.06e-1)" "unprognostic (2.05e-1)" 22.1 69.9 33.4 24.7 33.2 23.5 41.9 23.2 51.1 23.0 25.9 20.8 24.5 36.9 19.8 22.7 28.7 26.9 27.6 60.1 28.0 28.6 33.4 51.7 27.9 35.5 30.3 31.7 35.0 51.1 30.8 17.3 19.6 30.4 21.6 26.2 24.6 25.0 27.5 72.3 21.0 28.1 26.3 35.6 25.2 26.7 19.1 21.2 16.2 29.2 37.3 23.0 23.0 19.8 31.7 51.3 14.4 43.3 32.0 30.0 45.1 14.5 19.9 21.8 37.3 32.8 35.7 25.1 20.0 31.4 33.8 38.4 24.1 15.4 36.8 18.6 31.2 22.2 41.7 34.3 19.7 25.2 36.3 42.0 27.2 35.5 27.7 50.4 40.1 47.7 27.3 28.2 22.1 30.6 43.9 30.5 30.2 21.5 22.9 39.1 17.7 26.3 21.0 23.0 25.5 34.2 23.7 30.4 30.7 20.2 44.3 36.1 31.2 49.0 24.0 37.7 29.4 20.7 19.6 24.8 17.6 35.8 34.0 31.5 21.4 5.2 40.8 7.1 25.7 43.3 26.8 31.7 25.6 27.0 51.3 29.0 30.0 27.9 14.4 32.0 35.2 39.1 24.8 45.1 33.4 33.2 23.2 51.1 28.0 28.6 30.3 31.7 30.4 21.2 TXNDC16 KIAA1344 ENSG00000087301 "Thioredoxin domain containing 16" Q9P2K2 14 52430590-52552522 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002543 Approved Approved Mitochondria "Secreted - unknown location" Mitochondria "HPA002543: AB_1079199" "unprognostic (1.37e-1)" "unprognostic (7.79e-3)" "unprognostic (5.95e-3)" "unprognostic (2.36e-1)" "unprognostic (5.95e-3)" "unprognostic (9.73e-2)" "unprognostic (2.50e-1)" "unprognostic (1.43e-2)" "unprognostic (7.01e-2)" "unprognostic (1.49e-1)" "unprognostic (2.07e-2)" "unprognostic (1.21e-1)" "prognostic favourable (6.79e-4)" "unprognostic (1.39e-1)" "unprognostic (1.56e-1)" "unprognostic (3.55e-3)" "unprognostic (2.04e-1)" 7.0 5.2 10.2 5.9 12.5 5.4 8.6 20.5 15.0 12.1 7.0 7.4 16.1 5.1 8.5 18.4 4.8 5.4 6.5 5.6 9.2 9.4 6.4 8.9 6.1 5.0 9.5 11.3 13.4 7.8 8.6 9.4 7.0 8.9 32.8 7.4 8.1 5.6 24.2 4.2 6.5 5.9 5.6 14.0 11.5 7.4 8.2 10.5 9.7 5.1 3.4 4.8 7.8 7.3 1.2 5.3 3.6 6.3 1.1 4.7 2.2 5.9 0.6 6.7 3.7 5.0 3.7 5.3 2.0 2.6 3.4 6.7 2.2 4.9 9.8 6.8 1.6 5.7 7.7 2.7 5.3 4.1 10.1 4.5 5.0 2.0 3.6 5.3 2.2 6.8 2.5 4.4 3.2 3.8 5.7 15.3 2.9 2.9 6.6 3.7 7.4 3.6 13.3 12.8 8.9 4.3 6.2 22.1 7.6 9.8 10.2 2.8 6.5 3.9 2.0 4.6 2.3 5.2 3.3 4.2 5.7 9.9 1.3 5.6 2.6 2.4 6.3 2.5 2.7 4.8 2.9 1.2 2.8 2.0 5.3 0.8 1.4 1.4 3.6 1.1 5.2 2.2 4.7 2.2 10.2 12.5 20.5 15.0 9.2 9.4 9.5 11.3 8.9 10.5 UBE2H "GID3, UBC8, UBCH" ENSG00000186591 "Ubiquitin conjugating enzyme E2 H" P62256 7 129830732-129952949 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003302 Approved Supported Mitochondria Mitochondria "HPA003302: AB_1858526" "unprognostic (1.15e-1)" "unprognostic (5.85e-2)" "unprognostic (5.67e-3)" "unprognostic (2.76e-1)" "unprognostic (2.25e-1)" "unprognostic (3.08e-2)" "unprognostic (1.13e-1)" "unprognostic (1.37e-1)" "unprognostic (9.43e-2)" "unprognostic (6.19e-2)" "prognostic unfavourable (2.33e-5)" "unprognostic (1.13e-1)" "unprognostic (3.73e-2)" "unprognostic (2.37e-1)" "unprognostic (1.12e-1)" "unprognostic (3.58e-1)" "unprognostic (1.23e-1)" 29.0 49.9 31.1 16.6 31.0 22.5 24.5 36.1 30.2 31.1 27.3 33.2 26.6 15.2 35.5 25.3 32.1 29.4 26.6 61.0 26.4 25.4 27.6 28.1 26.3 17.5 28.1 23.4 27.6 52.3 41.8 29.5 37.9 33.3 24.1 16.8 22.9 28.5 28.8 46.3 21.3 16.5 31.5 26.2 19.1 22.7 24.7 29.5 24.7 37.7 23.6 29.5 25.5 34.3 6.1 3.7 7.8 2.2 1.3 6.5 1.9 22.7 12.3 14.6 14.8 36.4 31.3 25.3 21.1 27.2 12.9 14.4 6.6 24.4 9.4 26.4 20.7 17.3 12.5 22.4 16.9 11.6 6.6 3.2 18.1 7.9 28.6 6.5 10.4 42.0 29.8 17.4 28.0 25.1 7.7 27.4 19.9 8.1 8.6 7.1 23.0 14.7 6.7 7.5 20.1 27.0 29.9 5.6 16.9 19.3 43.2 11.3 4.5 6.4 25.5 14.1 7.1 19.8 20.9 25.0 18.0 15.6 28.0 7.8 13.7 3.5 2.2 5.1 4.7 1.7 6.4 3.8 4.7 4.2 2.0 6.1 6.0 6.4 7.8 1.3 2.1 3.7 6.5 1.9 31.1 31.0 36.1 30.2 26.4 25.4 28.1 23.4 33.3 29.5 UCP2 "BMIQ4, SLC25A8" ENSG00000175567 "Uncoupling protein 2" P55851 11 73974667-73983307 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 219.1;lymphoid tissue: 144.8" "Cell line enhanced" "Detected in many" "Daudi: 66.9;SK-BR-3: 86.1;U-698: 55.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025583, HPA075202" Approved Supported Mitochondria Mitochondria "CAB025583: , HPA075202: " "unprognostic (1.13e-1)" "prognostic favourable (4.65e-5)" "unprognostic (8.07e-2)" "unprognostic (1.21e-2)" "unprognostic (1.08e-1)" "unprognostic (1.15e-2)" "unprognostic (1.92e-1)" "unprognostic (1.82e-3)" "unprognostic (2.07e-1)" "unprognostic (4.59e-2)" "unprognostic (1.13e-3)" "unprognostic (1.37e-1)" "prognostic unfavourable (7.80e-6)" "unprognostic (3.77e-2)" "unprognostic (1.58e-1)" "unprognostic (3.77e-3)" "unprognostic (3.88e-3)" 19.8 9.8 5.3 40.4 9.5 24.5 15.9 1.1 4.9 8.1 7.7 10.2 20.3 11.4 4.2 12.0 4.5 37.9 13.1 11.5 4.4 5.5 12.8 10.6 20.2 85.6 7.8 2.4 7.2 4.7 1.2 6.2 8.7 6.5 6.5 8.9 14.2 17.4 17.2 45.3 4.3 24.7 6.4 9.0 91.1 12.3 5.5 5.9 144.8 17.9 19.3 55.7 19.4 2.9 141.6 219.1 101.8 135.3 119.8 180.2 172.1 0.1 14.1 3.2 9.6 1.8 0.0 2.4 2.3 1.6 9.7 2.8 24.7 12.0 66.9 33.5 3.6 0.6 2.3 0.0 4.5 16.9 0.8 39.0 5.9 5.1 5.8 20.5 16.4 2.1 0.0 9.1 0.0 1.2 17.9 27.3 1.9 24.1 21.2 11.1 2.6 2.8 19.6 22.3 37.9 27.0 39.9 4.9 6.0 12.6 86.1 4.8 25.4 18.3 1.8 0.0 12.4 2.8 4.6 9.4 4.4 55.7 1.7 8.1 0.1 45.7 81.5 101.8 112.6 135.3 69.9 141.6 92.3 95.0 88.4 134.2 86.9 91.1 11.4 119.8 111.3 219.1 180.2 172.1 5.3 9.5 1.1 4.9 4.4 5.5 7.8 2.4 6.5 5.9 UGT8 CGT ENSG00000174607 "UDP glycosyltransferase 8" Q16880 4 114598455-114678224 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 96.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 25.3;RH-30: 12.1;RPTEC TERT1: 25.0;SCLC-21H: 14.2;U-87 MG: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory B-cell: 7.3;naive B-cell: 10.6" "Lineage enriched" "Detected in single" 12 "B-cells: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014405, HPA065785" Enhanced Approved Mitochondria Mitochondria "HPA014405: AB_1858606, HPA065785: " "unprognostic (7.38e-3)" "unprognostic (2.07e-1)" "unprognostic (1.25e-2)" "unprognostic (2.38e-1)" "unprognostic (1.63e-1)" "unprognostic (1.63e-2)" "unprognostic (1.16e-2)" "unprognostic (2.38e-1)" "unprognostic (7.78e-2)" "unprognostic (1.56e-3)" "unprognostic (4.49e-2)" "unprognostic (2.76e-1)" "prognostic favourable (8.55e-5)" "unprognostic (2.80e-1)" "unprognostic (1.78e-2)" "unprognostic (7.53e-2)" "unprognostic (1.49e-1)" 0.9 0.8 13.2 2.8 30.0 1.0 3.1 2.7 44.8 4.9 15.5 66.6 0.0 18.4 2.7 0.6 1.2 3.0 7.1 0.9 24.2 12.4 20.1 0.8 1.0 3.2 53.9 15.9 0.8 4.8 0.3 0.9 0.5 38.3 0.9 17.3 0.0 4.5 0.8 0.8 1.8 16.1 1.5 96.6 1.3 10.0 3.3 42.6 0.0 8.5 0.0 3.4 0.8 1.0 10.6 0.0 0.9 0.0 0.0 0.6 0.3 0.3 0.1 2.0 0.3 0.1 0.0 0.3 0.1 0.0 0.0 1.5 6.8 25.3 7.6 0.6 0.1 10.7 0.0 0.0 0.0 0.1 5.3 0.1 11.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 6.4 1.5 0.0 0.1 0.1 0.8 3.0 3.8 0.7 12.1 0.2 25.0 0.3 14.2 2.1 0.1 2.2 0.3 0.4 2.4 0.5 0.5 8.6 0.3 7.9 2.5 0.4 0.2 12.5 0.4 7.8 0.2 0.0 0.9 0.0 0.0 0.6 7.3 0.1 0.0 0.0 10.6 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.3 13.2 30.0 2.7 24.4 24.2 12.4 53.9 15.9 38.3 42.6 UQCRC2 "QCR2, UQCR2" ENSG00000140740 "Ubiquinol-cytochrome c reductase core protein 2" P22695 16 21952660-21983660 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007998, HPA019146" Enhanced Enhanced Mitochondria 4000000 Mitochondria "HPA007998: AB_1858648, HPA019146: AB_1858649" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (1.49e-3)" "unprognostic (3.35e-1)" "unprognostic (1.26e-2)" "unprognostic (6.91e-2)" "unprognostic (2.71e-2)" "unprognostic (1.32e-1)" "unprognostic (1.72e-1)" "unprognostic (8.87e-2)" "unprognostic (1.67e-2)" "unprognostic (2.43e-2)" "prognostic favourable (6.58e-9)" "unprognostic (2.33e-1)" "unprognostic (9.78e-3)" "unprognostic (4.67e-3)" "unprognostic (7.36e-2)" 22.7 26.8 20.6 17.1 32.7 20.5 21.3 29.2 33.7 17.7 38.4 17.4 19.5 45.0 20.8 18.6 28.7 20.0 19.1 94.9 19.8 19.3 35.1 35.8 15.9 23.6 20.9 28.5 21.9 20.8 36.6 20.2 17.8 29.6 17.7 40.5 18.5 22.1 20.2 103.9 22.2 42.0 30.4 16.5 16.5 29.3 10.3 19.2 25.2 21.4 70.0 22.9 27.9 20.0 20.0 30.6 14.3 29.3 18.7 25.7 27.4 18.9 20.9 12.9 8.6 14.4 20.2 18.3 18.4 15.0 16.9 17.2 33.7 18.8 37.7 16.6 15.8 34.7 20.9 18.5 19.5 17.2 19.4 21.3 18.4 47.6 15.3 27.1 54.0 23.6 23.2 13.2 18.2 22.1 23.0 19.7 18.3 25.2 28.1 17.6 14.1 16.1 32.9 29.9 41.2 25.3 22.4 17.8 13.0 26.1 33.0 19.8 37.8 28.8 19.5 12.0 11.3 11.7 16.4 14.3 10.3 33.4 19.6 28.8 13.7 14.3 24.7 12.8 16.9 29.3 21.9 20.0 20.5 18.6 30.6 15.8 22.8 20.8 9.1 18.7 27.6 13.2 25.7 27.4 20.6 32.7 29.2 33.7 19.8 19.3 20.9 28.5 29.6 19.2 UQCRFS1 "RIP1, RIS1, RISP, UQCR5" ENSG00000169021 "Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1" P47985 19 29205321-29213541 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 112.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA041863, HPA050339" Enhanced Approved Mitochondria Mitochondria "HPA041863: AB_10794638, HPA050339: AB_2681095" "unprognostic (4.00e-2)" "unprognostic (2.23e-3)" "prognostic favourable (3.29e-4)" "unprognostic (7.91e-3)" "unprognostic (3.93e-2)" "unprognostic (8.68e-2)" "unprognostic (1.84e-1)" "unprognostic (7.53e-2)" "unprognostic (3.53e-2)" "prognostic unfavourable (3.84e-4)" "unprognostic (1.73e-2)" "unprognostic (1.66e-1)" "prognostic favourable (3.92e-9)" "unprognostic (6.11e-2)" "unprognostic (2.96e-1)" "unprognostic (1.45e-1)" "unprognostic (1.92e-2)" 15.2 27.1 20.1 10.8 18.3 25.4 28.2 18.3 33.4 11.9 27.3 9.1 9.8 24.3 10.5 14.3 16.9 11.9 14.2 95.3 19.4 14.8 34.9 33.8 12.0 21.2 18.3 13.1 9.1 26.4 15.9 10.6 10.8 17.6 11.8 30.3 11.5 17.0 13.9 112.3 12.9 27.0 19.6 11.5 11.3 18.8 16.6 6.5 17.7 12.9 55.0 14.5 13.7 10.0 18.5 35.6 14.9 29.9 15.0 22.1 45.1 23.0 38.9 14.5 13.0 23.8 18.2 16.1 18.0 18.9 25.0 27.7 23.5 14.3 21.0 19.0 20.3 24.5 31.6 21.4 30.2 14.2 31.7 29.7 15.4 21.4 20.2 28.2 26.1 21.8 23.2 17.0 26.0 19.9 21.0 13.2 26.7 21.3 19.7 21.1 15.1 15.1 18.0 19.3 15.9 31.0 27.8 17.6 8.6 16.4 32.6 20.6 15.1 23.5 12.5 16.9 25.8 11.6 18.6 6.3 11.9 19.3 14.9 24.6 12.0 14.9 29.9 14.0 17.9 29.3 17.8 18.5 19.2 18.3 35.6 15.7 20.4 19.4 9.1 15.0 24.3 19.7 22.1 45.1 20.1 18.3 18.3 33.4 19.4 14.8 18.3 13.1 17.6 6.5 UQCRQ "QCR8, QP-C, UQCR7" ENSG00000164405 "Ubiquinol-cytochrome c reductase complex III subunit VII" O14949 5 132866560-132868031 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 174.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046693, HPA053323" Approved Enhanced Mitochondria Mitochondria "HPA046693: AB_10968453, HPA053323: " "unprognostic (3.22e-1)" "unprognostic (1.06e-1)" "unprognostic (4.92e-2)" "prognostic favourable (4.23e-4)" "unprognostic (1.09e-1)" "unprognostic (9.03e-2)" "unprognostic (1.02e-1)" "unprognostic (3.45e-2)" "unprognostic (1.37e-1)" "unprognostic (3.72e-2)" "unprognostic (7.31e-2)" "unprognostic (3.49e-1)" "unprognostic (1.81e-3)" "unprognostic (1.06e-1)" "unprognostic (1.84e-1)" "unprognostic (2.33e-1)" "unprognostic (3.37e-2)" 26.4 38.4 43.2 24.5 34.2 20.9 30.9 18.0 37.5 22.5 49.7 13.8 44.0 42.5 15.4 41.8 32.1 15.3 42.7 111.1 33.2 31.7 48.8 112.5 18.8 21.5 42.0 30.4 12.3 64.6 14.0 23.1 17.0 30.5 32.0 44.8 19.7 44.6 39.6 174.9 16.4 40.5 21.2 25.4 15.2 37.4 16.1 20.8 14.3 24.6 71.5 16.8 22.6 20.5 56.6 95.8 67.9 99.9 53.8 56.7 106.3 45.6 63.9 37.7 91.2 56.6 46.0 32.7 33.1 46.9 53.1 66.3 89.9 53.4 18.8 70.1 43.4 46.3 34.3 80.8 45.7 34.3 72.2 24.9 100.7 70.6 49.1 28.2 42.9 49.0 56.4 37.9 52.3 41.4 31.8 60.6 55.6 86.5 64.8 65.1 26.7 57.7 42.5 41.8 80.7 68.7 89.2 63.3 52.7 41.0 46.3 70.8 69.0 65.0 25.7 48.7 61.5 39.9 67.0 67.0 88.9 33.6 64.8 52.6 48.4 67.9 99.9 61.1 47.0 76.6 48.3 56.6 54.9 53.5 87.4 46.0 53.6 51.5 47.4 53.8 70.2 95.8 56.7 106.3 43.2 34.2 18.0 37.5 33.2 31.7 42.0 30.4 30.5 20.8 USP54 "bA137L10.3, bA137L10.4, C10orf29, FLJ37318" ENSG00000166348 "Ubiquitin specific peptidase 54" Q70EL1 10 73497538-73625953 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.5" "Cell line enhanced" "Detected in many" "PC-3: 24.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047663 Approved Approved Mitochondria Mitochondria "HPA047663: " "unprognostic (2.46e-2)" "unprognostic (1.67e-1)" "unprognostic (3.17e-2)" "unprognostic (1.89e-2)" "unprognostic (2.48e-2)" "unprognostic (4.89e-3)" "unprognostic (6.63e-4)" "prognostic favourable (7.00e-4)" "unprognostic (6.24e-2)" "unprognostic (4.35e-2)" "unprognostic (8.91e-3)" "unprognostic (3.49e-1)" "unprognostic (1.95e-3)" "unprognostic (8.18e-2)" "unprognostic (6.88e-2)" "unprognostic (1.65e-2)" "unprognostic (1.31e-1)" 2.9 1.7 12.3 2.5 33.8 0.5 7.7 7.9 21.3 7.9 7.8 43.8 1.8 2.5 4.2 4.5 10.2 7.7 3.1 4.0 14.1 6.8 2.7 1.6 9.0 0.6 49.5 14.2 4.0 6.3 7.1 3.4 1.2 28.6 5.8 11.1 3.4 8.8 3.6 12.0 6.1 2.9 4.0 25.4 1.5 11.3 4.7 42.8 0.4 24.3 1.2 3.6 5.6 4.0 2.4 2.2 1.3 2.4 1.5 3.2 2.3 6.6 6.8 10.6 10.0 2.9 3.4 3.3 3.5 7.0 5.9 6.9 5.7 10.9 5.0 4.2 3.7 9.2 6.8 2.5 7.9 2.4 6.3 3.1 5.0 3.8 2.3 3.4 1.2 2.6 2.4 6.8 6.9 2.7 4.9 0.7 4.1 3.3 3.3 2.2 4.9 24.9 5.0 9.4 1.9 4.2 6.5 3.5 3.3 6.8 8.3 8.0 10.8 3.2 3.7 2.3 6.9 4.5 4.4 1.8 3.3 3.5 5.6 3.2 2.1 0.8 2.3 1.3 1.6 1.9 3.1 2.4 2.7 2.5 1.9 1.0 3.2 1.9 0.1 1.5 2.4 2.2 3.0 2.3 12.3 33.8 7.9 21.3 14.1 6.8 49.5 14.2 28.6 42.8 VARS2 "DKFZP434L1435, G7a, KIAA1885, VARS2L, VARSL" ENSG00000137411 "Valyl-tRNA synthetase 2, mitochondrial" Q5ST30 6 30908242-30926459 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062449, HPA070267" Approved Approved Mitochondria Mitochondria "HPA062449: , HPA070267: " "unprognostic (1.74e-1)" "unprognostic (8.24e-2)" "unprognostic (1.96e-3)" "unprognostic (2.50e-1)" "unprognostic (5.80e-2)" "unprognostic (3.05e-2)" "unprognostic (2.43e-2)" "unprognostic (1.66e-2)" "unprognostic (3.14e-1)" "unprognostic (8.98e-2)" "unprognostic (4.23e-2)" "unprognostic (2.60e-2)" "unprognostic (2.15e-3)" "unprognostic (1.04e-2)" "unprognostic (7.23e-2)" "unprognostic (1.19e-2)" "unprognostic (2.43e-2)" 7.2 7.8 6.3 12.5 8.6 6.9 6.8 21.4 11.4 4.2 6.5 8.9 6.2 6.2 8.8 6.2 20.6 6.3 7.4 4.9 7.4 6.4 12.0 13.5 7.3 12.9 5.6 9.3 8.8 12.5 8.5 9.7 5.1 7.9 6.0 8.1 4.6 8.2 10.5 9.4 11.0 7.4 4.4 6.3 7.8 8.6 8.3 3.4 13.4 8.2 4.6 10.0 4.8 6.1 1.8 1.3 0.1 0.9 0.2 1.8 0.5 8.5 6.9 3.7 14.8 3.1 2.3 0.1 1.2 0.8 1.2 1.1 6.0 4.9 6.5 5.1 0.9 0.0 10.3 0.0 1.9 3.3 8.9 7.8 5.8 0.6 2.7 1.6 0.0 1.8 2.6 3.7 0.8 0.9 0.0 7.4 3.0 0.0 2.5 0.0 0.9 0.9 6.1 0.0 6.3 4.9 0.0 4.5 0.1 0.0 3.3 3.7 10.1 4.1 1.6 9.2 0.6 0.5 0.1 6.8 10.5 13.4 0.0 0.3 6.1 0.0 0.2 0.0 1.1 0.9 1.8 1.8 1.0 1.6 1.0 0.7 0.6 0.3 0.1 0.2 0.6 1.3 1.2 0.5 6.3 8.6 21.4 11.4 7.4 6.4 5.6 9.3 7.9 3.4 VDAC2 ENSG00000165637 "Voltage dependent anion channel 2" P45880 10 75210154-75231448 "Predicted intracellular proteins, Transporters" "Ion transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043475 Enhanced Supported Mitochondria 4000000 Mitochondria "HPA043475: AB_10795615" "unprognostic (1.01e-2)" "unprognostic (1.22e-1)" "unprognostic (9.47e-2)" "unprognostic (9.00e-3)" "unprognostic (5.74e-2)" "prognostic unfavourable (4.51e-4)" "prognostic unfavourable (4.55e-4)" "unprognostic (1.83e-3)" "unprognostic (5.89e-2)" "unprognostic (2.45e-1)" "unprognostic (2.02e-2)" "unprognostic (1.56e-2)" "unprognostic (4.27e-2)" "unprognostic (1.40e-1)" "unprognostic (1.65e-1)" "unprognostic (6.28e-2)" "unprognostic (1.34e-2)" 26.2 31.9 27.8 18.7 40.5 25.1 59.7 34.2 55.4 29.0 39.1 24.2 19.9 31.8 25.5 20.3 63.7 25.0 18.5 141.7 28.1 24.1 38.2 24.4 23.2 23.0 27.6 37.7 29.6 38.9 37.6 18.4 24.1 36.5 24.2 40.3 23.0 30.5 30.6 99.7 30.7 30.5 43.7 27.9 17.8 31.1 30.4 16.9 15.6 27.5 31.9 30.0 33.7 39.1 44.8 63.2 39.0 62.9 36.0 49.6 54.6 41.6 34.5 41.8 52.9 37.2 50.8 43.8 54.3 61.2 59.6 56.3 52.0 39.9 49.7 30.6 45.3 56.2 76.5 53.8 58.6 26.9 44.5 28.9 29.2 58.6 37.3 54.9 32.2 44.9 63.8 50.8 108.7 44.0 48.8 40.6 62.5 30.8 35.3 44.7 35.9 133.5 42.4 33.1 31.5 58.6 26.2 26.5 31.3 29.9 100.4 63.5 58.5 24.7 33.9 29.8 40.8 43.9 58.1 32.7 44.5 51.3 43.1 54.4 25.2 39.0 51.5 38.0 32.5 54.0 39.6 44.8 44.7 36.4 63.2 36.0 45.5 41.7 17.7 36.0 62.9 30.8 49.6 54.6 27.8 40.5 34.2 55.4 28.1 24.1 27.6 37.7 36.5 16.9 VDAC3 HD-VDAC3 ENSG00000078668 "Voltage dependent anion channel 3" Q9Y277 8 42391624-42405897 "Plasma proteins, Predicted intracellular proteins" "Ion transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 187.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026864 Uncertain Supported Mitochondria 9300000 Mitochondria "HPA026864: AB_1858733" "unprognostic (2.55e-2)" "unprognostic (1.96e-2)" "unprognostic (9.88e-3)" "unprognostic (4.40e-2)" "unprognostic (1.26e-1)" "unprognostic (2.00e-1)" "unprognostic (4.98e-2)" "unprognostic (2.25e-2)" "unprognostic (1.40e-2)" "unprognostic (5.76e-2)" "unprognostic (3.74e-1)" "unprognostic (1.19e-2)" "unprognostic (6.16e-3)" "unprognostic (2.96e-2)" "unprognostic (1.76e-1)" "unprognostic (8.78e-3)" "unprognostic (6.94e-3)" 19.9 18.8 26.0 13.7 29.8 18.6 17.3 38.3 39.1 16.0 23.7 14.5 12.3 19.1 19.1 17.7 26.8 21.5 13.9 85.8 28.2 35.3 27.9 22.1 12.5 14.6 32.5 24.6 18.1 15.0 17.5 16.5 15.4 44.3 17.6 26.2 16.0 22.2 20.8 187.5 13.0 22.7 22.1 19.6 17.3 16.6 27.4 13.0 20.5 21.6 39.7 18.4 23.1 13.3 34.4 59.4 47.5 44.4 31.4 52.4 81.9 48.2 48.6 38.3 40.7 32.3 28.1 19.0 38.6 33.0 49.7 45.5 37.5 41.3 49.6 37.1 32.7 30.9 51.6 41.4 54.8 25.1 42.6 75.4 32.5 53.3 23.1 36.3 42.1 21.8 31.5 37.6 17.6 60.3 59.1 34.6 50.6 26.7 77.4 41.7 45.4 31.7 41.0 70.5 35.1 53.4 43.0 33.8 29.0 24.4 29.0 24.3 61.3 27.7 32.2 19.4 33.8 48.2 37.4 32.2 53.7 56.5 26.0 51.3 32.6 31.1 44.4 47.5 42.1 43.8 42.4 34.4 45.1 41.7 59.4 24.2 45.1 43.3 22.0 31.4 38.5 43.8 52.4 81.9 26.0 29.8 38.3 39.1 28.2 35.3 32.5 24.6 44.3 13.0 VPS26C "DCRA, DSCR3" ENSG00000157538 "VPS26 endosomal protein sorting factor C" O14972 21 37223420-37267919 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023288 Uncertain Approved Mitochondria Mitochondria "HPA023288: AB_1847872" "unprognostic (1.01e-3)" "unprognostic (6.42e-2)" "unprognostic (7.96e-3)" "unprognostic (2.15e-2)" "unprognostic (4.10e-3)" "unprognostic (2.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.40e-1)" "unprognostic (3.15e-1)" "unprognostic (7.76e-2)" "unprognostic (5.40e-2)" "unprognostic (1.97e-1)" "prognostic favourable (8.54e-4)" "unprognostic (1.72e-1)" "unprognostic (3.24e-1)" "unprognostic (5.24e-2)" "unprognostic (3.16e-1)" 23.5 29.1 14.2 15.9 17.4 16.5 17.0 17.1 19.4 16.2 23.4 20.8 12.1 25.5 17.8 13.8 20.6 15.4 17.6 21.3 17.1 11.9 29.2 28.6 19.9 18.1 18.3 16.9 16.8 23.9 14.5 14.7 20.9 15.6 15.9 23.7 22.1 17.3 15.3 30.8 16.8 31.2 19.7 17.4 24.6 21.5 7.4 17.8 21.3 16.7 13.3 20.6 23.0 16.1 19.6 24.2 40.3 30.2 24.9 26.9 24.5 12.2 5.8 12.8 10.8 23.6 21.2 14.2 12.3 27.3 11.3 16.6 8.0 13.4 8.8 4.6 28.2 6.1 13.6 13.2 10.9 21.0 9.8 14.9 5.9 7.7 20.6 11.0 10.1 18.4 13.0 13.0 21.1 21.0 9.3 19.6 21.5 5.8 18.8 9.4 14.2 5.6 17.5 6.1 12.8 13.8 9.5 10.3 13.9 8.4 16.5 26.0 15.7 8.9 16.6 12.9 4.5 13.6 7.1 30.2 30.4 12.2 20.3 18.8 14.1 23.5 24.5 40.3 26.9 30.2 25.0 19.6 23.2 24.4 24.2 14.7 21.5 22.6 25.4 24.9 26.3 9.6 26.7 24.5 14.2 17.4 17.1 19.4 17.1 11.9 18.3 16.9 15.6 17.8 VPS35L "C16orf62, MGC16824" ENSG00000103544 "VPS35 endosomal protein sorting factor like" Q7Z3J2 16 19555240-19706793 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042969, HPA053547" Uncertain Approved Mitochondria Mitochondria "HPA042969: AB_10794920, HPA053547: " "unprognostic (7.15e-2)" "unprognostic (6.54e-2)" "unprognostic (1.17e-1)" "unprognostic (7.20e-2)" "unprognostic (1.51e-1)" "unprognostic (2.67e-1)" "unprognostic (1.15e-1)" "unprognostic (2.74e-1)" "unprognostic (2.52e-1)" "unprognostic (1.22e-3)" "unprognostic (3.57e-2)" "unprognostic (2.06e-1)" "prognostic favourable (1.31e-8)" "unprognostic (1.82e-3)" "unprognostic (8.92e-2)" "unprognostic (5.08e-2)" "unprognostic (1.13e-2)" 19.1 22.5 21.3 13.5 28.6 10.6 15.3 20.1 35.0 21.4 16.5 44.4 9.9 12.5 27.9 21.4 16.1 18.6 16.4 16.1 21.8 21.1 20.7 15.9 14.7 13.9 23.5 14.0 22.7 14.3 37.9 24.6 18.7 28.8 15.4 18.4 22.6 15.4 18.6 18.2 12.5 13.5 23.8 23.9 25.5 12.6 26.1 21.6 16.0 21.5 9.3 15.3 17.2 14.5 11.7 25.5 12.6 23.8 21.9 14.7 15.6 9.0 16.1 15.0 12.0 19.3 27.1 2.3 13.4 22.4 14.7 17.0 2.3 15.8 11.0 29.2 22.1 2.5 11.8 7.1 16.2 0.6 6.5 6.4 14.5 0.2 25.7 10.4 13.5 19.4 10.3 13.5 8.7 23.4 8.8 2.6 23.9 6.4 9.1 2.7 9.7 2.0 7.8 4.8 2.7 16.2 2.0 9.3 9.4 16.5 0.5 7.4 5.5 9.1 24.3 7.5 7.1 10.5 1.4 10.1 17.9 4.1 14.7 8.5 11.9 12.6 21.1 9.4 11.9 23.8 14.7 9.2 11.5 11.7 25.5 11.7 13.4 11.9 2.5 21.9 20.8 6.7 12.0 15.6 21.3 28.6 20.1 35.0 21.8 21.1 23.5 14.0 28.8 21.6 WIPF3 "CR16, FLJ36931" ENSG00000122574 "WAS/WASL interacting protein family member 3" A6NGB9 7 29806486-29917066 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6;ovary: 44.7" "Cell line enhanced" "Detected in some" "HAP1: 18.1;HEK 293: 4.1;K-562: 6.2;NTERA-2: 5.1;RPMI-8226: 10.9;SK-MEL-30: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "hippocampal formation: 234.6" "HPA041145, HPA041211" Uncertain Uncertain Mitochondria Mitochondria "HPA041145: AB_10795001, HPA041211: AB_10795003" "prognostic favourable (7.93e-4)" "unprognostic (1.35e-1)" "unprognostic (1.37e-3)" "unprognostic (2.12e-3)" "unprognostic (3.65e-3)" "unprognostic (1.53e-1)" "unprognostic (8.95e-3)" "unprognostic (4.53e-2)" "unprognostic (3.49e-1)" "unprognostic (1.19e-2)" "unprognostic (1.08e-2)" "unprognostic (7.49e-2)" "unprognostic (1.61e-2)" "unprognostic (1.35e-1)" "unprognostic (2.27e-2)" "unprognostic (3.33e-2)" "unprognostic (1.41e-1)" 1.8 6.6 13.4 1.6 40.6 1.1 1.9 5.5 15.1 1.2 1.4 3.8 1.0 3.6 4.2 21.8 2.1 9.9 3.5 4.6 30.0 5.1 3.3 1.3 1.3 1.4 4.0 12.1 44.7 2.4 1.6 5.6 1.0 1.5 5.5 1.3 0.8 4.5 5.9 23.0 1.7 3.5 5.2 1.7 1.7 6.3 27.6 7.8 0.0 2.8 2.9 2.3 3.2 0.8 0.8 2.1 2.6 1.2 0.9 1.3 0.2 0.3 1.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.0 18.1 0.0 0.0 0.0 4.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.2 0.1 0.0 0.1 0.0 0.1 5.1 3.5 0.0 0.0 10.9 0.0 0.0 1.8 1.5 0.1 0.1 4.4 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.6 0.5 0.9 0.3 0.7 0.6 0.7 0.9 0.3 0.3 0.8 1.3 0.8 1.2 0.9 1.2 2.1 0.5 0.2 13.4 40.6 5.5 15.1 30.0 5.1 4.0 12.1 1.5 7.8 WSB1 "DKFZp564A122, DKFZp564B0482, SWIP1" ENSG00000109046 "WD repeat and SOCS box containing 1" Q9Y6I7 17 27294076-27315926 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003293 Approved Approved Mitochondria Mitochondria "HPA003293: AB_1858863" "unprognostic (1.73e-1)" "unprognostic (5.13e-2)" "unprognostic (1.25e-1)" "unprognostic (1.44e-1)" "unprognostic (2.14e-1)" "unprognostic (2.66e-1)" "prognostic unfavourable (4.07e-5)" "unprognostic (2.59e-2)" "unprognostic (5.40e-3)" "unprognostic (2.74e-1)" "unprognostic (9.22e-2)" "unprognostic (1.69e-2)" "prognostic unfavourable (1.02e-7)" "unprognostic (1.44e-1)" "unprognostic (3.18e-1)" "unprognostic (1.62e-1)" "unprognostic (3.74e-2)" 32.9 18.7 19.1 36.3 45.0 36.4 26.1 15.4 28.7 37.9 26.5 59.6 17.6 23.8 47.1 34.6 21.7 34.8 45.8 28.7 23.4 20.7 31.5 15.0 48.4 26.9 56.2 29.6 38.4 21.0 18.0 25.8 61.9 39.5 26.9 27.1 37.6 17.7 29.1 17.0 18.3 23.2 38.1 57.4 55.7 26.0 18.1 48.0 17.9 22.0 12.9 28.8 29.5 30.9 10.6 26.3 27.9 31.1 8.2 12.1 9.0 12.1 8.6 27.1 15.5 17.2 21.3 29.1 10.9 15.4 8.6 16.6 12.9 4.9 12.2 12.4 14.8 11.6 16.3 8.0 13.0 33.8 13.3 19.5 15.5 13.0 32.4 13.3 28.8 25.6 10.9 12.5 7.6 34.1 19.5 11.7 15.2 7.5 17.2 15.3 8.0 7.1 14.1 14.7 7.3 12.8 9.9 8.7 11.9 11.3 11.3 14.7 9.1 17.8 18.9 10.6 8.1 14.4 10.3 5.3 13.4 12.5 10.0 10.7 9.4 21.4 16.2 27.9 9.4 28.1 11.2 9.1 7.8 10.2 26.3 10.6 7.5 8.5 15.2 8.2 31.1 8.6 12.1 9.0 19.1 45.0 15.4 28.7 23.4 20.7 56.2 29.6 39.5 48.0 XKR9 ENSG00000221947 "XK related 9" Q5GH70 8 70669365-70790371 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 17.1" "Cell line enhanced" "Detected in some" "CACO-2: 5.3;hTCEpi: 10.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA044430 Enhanced Approved Mitochondria Mitochondria "HPA044430: AB_10961283" "unprognostic (1.79e-2)" "unprognostic (7.31e-2)" "unprognostic (1.42e-1)" "unprognostic (1.40e-3)" "unprognostic (1.85e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-2)" "unprognostic (9.33e-2)" "unprognostic (1.63e-1)" "unprognostic (2.63e-2)" "prognostic unfavourable (7.20e-4)" "unprognostic (2.29e-1)" "unprognostic (6.96e-6)" "unprognostic (3.65e-1)" "unprognostic (3.26e-1)" "unprognostic (4.04e-3)" "unprognostic (3.71e-2)" 0.9 3.4 1.9 0.8 4.3 0.9 1.1 0.6 6.4 0.9 1.7 1.9 0.0 4.9 0.7 2.5 1.1 0.7 4.1 1.0 2.3 1.5 1.0 7.5 2.1 1.0 1.3 7.3 1.0 1.3 0.3 2.1 0.8 7.4 1.4 1.0 2.6 2.0 0.2 0.9 1.7 9.6 3.5 1.7 1.0 3.6 17.1 0.7 0.0 1.0 0.0 1.0 2.5 1.2 1.2 0.3 0.9 0.2 0.6 3.1 0.2 3.8 0.3 0.8 0.4 0.0 1.0 0.6 1.6 0.8 0.5 1.6 5.3 0.4 0.5 2.7 0.1 0.1 0.1 0.9 2.0 0.7 0.5 0.4 0.3 0.6 0.1 1.2 2.2 1.1 10.9 0.3 0.0 0.0 0.2 3.9 0.3 0.5 0.7 0.6 2.1 0.5 0.5 1.1 0.2 0.3 2.9 2.3 0.4 0.9 1.6 0.5 0.5 0.1 0.4 0.5 1.1 0.8 0.6 3.4 0.9 2.5 0.2 0.4 0.3 0.9 0.1 0.3 0.9 0.1 1.7 0.9 1.7 0.8 0.1 1.2 2.6 1.7 0.6 0.6 0.2 0.3 3.1 0.2 1.9 4.3 0.6 6.4 2.3 1.5 1.3 7.3 7.4 0.7 YJEFN3 "FLJ44968, hYjeF_N3-19p13.11" ENSG00000250067 "YjeF N-terminal domain containing 3" A6XGL0 19 19528861-19537581 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 47.8" "Cell line enhanced" "Detected in some" "BEWO: 11.2;HEK 293: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA060789 Enhanced Approved Mitochondria Mitochondria "HPA060789: " "unprognostic (2.59e-2)" "unprognostic (2.50e-1)" "unprognostic (5.99e-6)" "unprognostic (1.65e-1)" "unprognostic (3.16e-1)" "unprognostic (2.28e-2)" "unprognostic (4.37e-4)" "unprognostic (2.38e-1)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "prognostic favourable (7.25e-4)" "unprognostic (2.11e-2)" "prognostic unfavourable (1.30e-7)" "unprognostic (1.17e-2)" "unprognostic (8.26e-2)" "unprognostic (2.48e-1)" "unprognostic (9.49e-3)" 1.2 0.9 24.2 1.4 47.8 0.8 1.0 0.8 26.5 1.1 1.3 1.1 0.0 1.0 1.3 6.6 1.0 1.6 0.9 0.8 29.5 8.3 1.0 0.8 1.4 1.4 7.7 10.2 1.1 1.0 1.7 0.8 1.3 3.6 2.0 1.6 4.1 0.9 1.5 1.6 3.0 1.6 1.2 1.0 1.1 1.4 7.1 5.1 0.0 1.7 0.0 1.3 1.5 0.0 0.5 0.5 0.3 1.1 0.0 2.2 0.3 0.2 0.8 1.9 0.8 0.3 0.5 11.2 0.5 0.1 0.4 0.7 0.9 0.6 0.4 1.4 0.1 1.1 0.3 0.2 0.0 0.1 13.1 0.0 1.5 0.0 0.1 0.3 0.5 0.1 0.5 0.2 0.4 0.0 0.9 0.6 0.0 0.9 0.0 0.1 3.5 2.6 2.1 0.4 0.4 0.0 0.1 0.3 3.1 0.2 0.0 0.2 1.2 1.6 0.7 0.3 0.7 3.4 0.7 3.2 2.1 0.6 0.2 1.7 0.4 0.0 0.7 0.0 0.7 1.1 0.8 0.3 1.2 0.6 0.5 0.5 0.7 1.1 0.3 0.0 0.7 0.0 2.2 0.3 24.2 47.8 0.8 26.5 29.5 8.3 7.7 10.2 3.6 5.1 YRDC "FLJ23476, IRIP, SUA5" ENSG00000196449 "YrdC N6-threonylcarbamoyltransferase domain containing" Q86U90 1 37802944-37808185 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "basophil: 9.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030147 Approved Approved Mitochondria Mitochondria "HPA030147: AB_10603327" "unprognostic (2.98e-2)" "unprognostic (6.29e-2)" "unprognostic (1.36e-3)" "unprognostic (2.08e-3)" "unprognostic (2.03e-1)" "unprognostic (1.39e-2)" "prognostic unfavourable (1.83e-6)" "unprognostic (5.43e-2)" "unprognostic (5.50e-2)" "unprognostic (1.66e-1)" "unprognostic (2.13e-1)" "unprognostic (2.10e-1)" "unprognostic (4.34e-3)" "unprognostic (3.33e-2)" "unprognostic (1.40e-1)" "unprognostic (1.69e-1)" "unprognostic (1.46e-2)" 10.8 10.0 7.7 9.3 8.0 41.6 13.0 10.6 13.1 8.2 9.6 9.8 7.2 8.2 8.3 8.8 16.3 8.8 13.5 9.0 8.6 9.0 11.7 22.5 9.3 16.2 8.1 7.4 8.1 19.7 7.5 11.3 22.2 8.5 9.2 12.2 8.7 12.5 6.6 13.0 14.6 11.9 9.5 7.5 11.2 10.2 20.6 7.0 13.5 9.3 11.5 12.0 9.1 9.2 1.6 1.6 9.6 1.1 0.9 2.1 0.7 10.3 7.4 8.0 10.2 5.6 6.5 23.2 8.6 7.0 13.6 8.6 9.9 10.0 25.0 14.1 8.5 8.5 15.1 13.8 12.7 15.1 15.1 17.4 9.1 10.3 12.3 22.7 18.1 6.7 20.8 15.1 21.9 9.5 27.1 11.3 10.8 7.3 13.2 13.4 30.2 15.9 13.4 13.0 16.3 11.2 10.6 21.0 21.7 9.3 12.0 29.4 6.6 10.1 8.8 11.8 12.2 12.8 28.3 23.3 32.5 20.8 10.3 14.8 18.7 9.6 1.1 0.9 1.2 1.1 1.1 1.0 1.7 0.9 0.9 1.6 1.9 2.1 1.3 0.9 0.7 1.6 1.7 0.7 7.7 8.0 10.6 13.1 8.6 9.0 8.1 7.4 8.5 7.0 ZBTB3 FLJ23392 ENSG00000185670 "Zinc finger and BTB domain containing 3" Q9H5J0 11 62748319-62754188 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035321, HPA035322" Approved Approved Mitochondria Mitochondria "HPA035321: , HPA035322: AB_10610567" "unprognostic (1.39e-1)" "unprognostic (2.08e-2)" "unprognostic (3.48e-2)" "unprognostic (1.83e-3)" "unprognostic (2.93e-1)" "unprognostic (5.52e-3)" "unprognostic (7.85e-2)" "unprognostic (1.37e-1)" "unprognostic (4.56e-2)" "unprognostic (5.02e-2)" "unprognostic (1.23e-2)" "unprognostic (1.83e-1)" "prognostic favourable (1.65e-5)" "prognostic favourable (9.98e-4)" "unprognostic (3.37e-3)" "unprognostic (4.15e-2)" "unprognostic (2.43e-2)" 4.7 6.0 5.8 5.3 10.7 5.5 7.7 6.5 10.9 5.3 6.0 17.8 7.4 5.8 7.9 5.3 6.2 11.1 5.9 7.6 6.1 4.8 5.6 6.8 7.3 5.5 13.1 7.1 6.8 11.5 6.8 4.2 5.6 8.5 5.2 5.6 7.2 8.6 6.2 6.3 14.2 6.7 4.8 6.6 7.9 12.2 9.7 12.1 10.8 7.2 4.2 7.2 5.9 6.0 6.0 7.2 12.3 10.0 6.7 7.9 7.4 3.2 4.9 4.1 5.5 7.9 4.0 3.5 3.4 3.8 4.0 3.7 3.2 4.3 5.2 5.3 3.7 7.0 3.6 3.9 1.9 5.9 6.2 2.8 10.4 3.9 3.9 4.3 5.9 4.3 4.6 3.2 4.8 3.4 4.8 5.7 4.0 6.5 5.1 4.7 12.2 2.5 3.9 3.2 5.1 3.2 4.2 3.9 3.6 3.6 4.7 2.5 6.7 3.1 3.0 6.3 2.8 4.4 2.0 5.7 4.1 4.4 5.9 2.5 2.4 2.2 10.0 12.3 6.0 7.8 7.2 6.0 6.1 7.1 7.2 5.5 7.1 5.5 3.6 6.7 6.4 2.1 7.9 7.4 5.8 10.7 6.5 10.9 6.1 4.8 13.1 7.1 8.5 12.1 ZNF19 "KOX12, MGC51021" ENSG00000157429 "Zinc finger protein 19" P17023 16 71464555-71565089 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 32.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063685 Approved Approved Mitochondria Mitochondria "HPA063685: " "unprognostic (5.59e-4)" "unprognostic (1.38e-1)" "unprognostic (1.39e-1)" "unprognostic (2.05e-4)" "unprognostic (6.02e-3)" "unprognostic (4.92e-2)" "unprognostic (3.34e-2)" "unprognostic (6.97e-3)" "unprognostic (2.23e-1)" "unprognostic (4.84e-2)" "unprognostic (8.90e-4)" "unprognostic (1.31e-1)" "unprognostic (3.04e-6)" "unprognostic (3.38e-1)" "unprognostic (1.03e-1)" "unprognostic (2.83e-2)" "unprognostic (4.87e-2)" 4.7 3.3 4.8 4.1 6.8 2.5 6.3 4.3 5.2 3.8 2.6 7.1 2.9 3.3 5.6 14.4 4.6 9.1 6.9 4.7 4.9 4.1 5.6 3.4 4.5 3.4 3.0 4.4 4.8 6.4 3.9 32.0 1.7 6.8 3.6 2.2 5.2 4.9 3.2 9.0 6.9 3.4 2.6 4.5 3.1 3.0 18.7 5.5 3.0 8.9 2.0 2.6 2.8 1.9 6.1 3.5 4.4 2.5 2.5 4.3 1.7 2.5 1.7 5.7 6.2 2.8 3.8 3.7 3.0 1.4 2.4 3.0 3.8 6.3 4.5 4.1 1.6 2.4 3.0 2.9 1.1 2.7 3.3 4.6 4.1 4.9 0.9 4.9 4.1 5.0 3.8 2.8 5.3 2.3 2.9 4.2 1.8 3.5 3.3 3.6 2.9 4.5 2.1 4.7 1.8 2.9 5.5 9.1 5.8 6.1 1.8 5.0 4.5 3.7 2.7 6.2 3.1 4.3 3.5 4.0 3.3 1.7 5.6 3.0 3.4 4.4 2.4 2.1 3.1 2.2 1.3 5.4 3.4 3.0 1.9 6.1 4.3 3.9 4.3 2.5 2.5 3.5 1.4 1.7 4.8 6.8 4.3 4.8 4.9 4.1 3.0 4.4 6.8 5.5 ZNF200 ENSG00000010539 "Zinc finger protein 200" P98182 16 3222325-3236221 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 27.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018981, HPA059310" Uncertain Approved Mitochondria Mitochondria "HPA018981: AB_1859021, HPA059310: " "unprognostic (1.74e-1)" "unprognostic (5.74e-2)" "unprognostic (3.21e-2)" "unprognostic (8.78e-2)" "unprognostic (9.72e-2)" "unprognostic (3.71e-2)" "unprognostic (1.31e-1)" "unprognostic (2.20e-1)" "unprognostic (7.55e-2)" "unprognostic (2.16e-1)" "unprognostic (3.80e-2)" "unprognostic (2.98e-2)" "unprognostic (2.68e-1)" "unprognostic (1.12e-2)" "unprognostic (1.89e-1)" "unprognostic (1.11e-1)" "unprognostic (5.23e-3)" 5.4 5.5 4.4 7.5 5.4 3.0 5.7 8.6 7.0 5.1 4.9 6.0 4.7 5.5 6.0 6.8 5.1 5.9 4.7 5.2 4.0 4.3 4.8 6.4 5.2 9.5 4.6 3.3 6.2 3.9 7.3 7.1 8.2 5.6 5.3 5.0 4.2 5.1 4.7 4.0 4.1 5.4 5.3 3.8 10.4 4.7 27.3 5.0 9.6 6.8 2.9 8.3 5.8 4.9 5.8 5.0 19.3 5.1 8.7 10.1 5.4 4.8 5.1 11.5 8.2 4.2 4.5 13.9 6.3 7.9 8.8 8.1 7.6 4.1 9.5 4.9 5.1 3.7 9.0 6.8 10.4 8.8 8.2 7.9 6.8 6.3 5.7 13.4 18.7 4.5 5.7 6.4 5.8 7.4 8.7 7.2 7.6 4.5 9.5 6.9 18.1 4.9 11.6 15.8 11.0 5.4 2.8 6.6 9.7 6.0 4.7 5.2 6.6 15.0 5.2 8.9 8.3 3.1 5.5 18.7 18.2 8.1 2.1 8.3 6.8 19.3 3.9 13.6 8.5 5.1 8.2 5.8 7.8 10.1 5.0 5.6 8.0 8.9 16.9 8.7 4.7 3.1 9.0 5.4 4.4 5.4 8.6 7.0 4.0 4.3 4.6 3.3 5.6 5.0 ZNF230 FDZF2 ENSG00000159882 "Zinc finger protein 230" Q9UIE0 19 44002948-44013926 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA006172 Approved Mitochondria Mitochondria "HPA006172: " "unprognostic (3.55e-3)" "unprognostic (5.21e-2)" "unprognostic (2.88e-2)" "unprognostic (1.78e-1)" "unprognostic (2.01e-2)" "unprognostic (4.27e-2)" "unprognostic (5.88e-2)" "unprognostic (3.89e-2)" "unprognostic (3.79e-2)" "unprognostic (1.35e-1)" "unprognostic (4.08e-4)" "unprognostic (2.45e-2)" "unprognostic (1.14e-2)" "unprognostic (8.59e-2)" "unprognostic (1.68e-1)" "unprognostic (4.62e-2)" "unprognostic (1.42e-5)" 7.2 6.0 6.0 7.8 6.4 7.2 8.3 13.3 7.8 8.1 5.2 4.4 5.2 3.4 6.2 5.8 4.3 6.6 4.2 4.7 5.1 4.2 5.3 5.6 6.2 8.9 6.9 4.4 11.3 4.3 7.7 10.2 6.1 5.9 7.2 5.3 6.2 5.3 6.8 2.6 7.3 6.4 4.9 7.2 11.1 5.2 6.8 5.5 16.6 8.6 3.9 9.6 9.0 9.3 5.5 4.3 13.9 4.8 3.2 6.0 3.4 2.9 2.4 5.0 5.1 4.0 5.0 1.9 4.2 4.2 3.8 7.0 1.5 1.6 2.4 2.9 3.1 2.5 4.1 3.8 5.8 3.0 5.2 4.1 5.3 1.7 2.3 5.2 3.6 3.7 3.6 4.3 4.5 2.6 0.7 0.1 4.0 1.5 5.9 3.8 2.9 2.3 4.4 7.0 1.2 2.3 3.5 2.8 6.4 5.9 2.0 3.0 1.8 12.3 3.3 6.1 4.5 1.8 3.2 3.1 2.9 0.4 2.9 3.9 3.7 7.6 4.1 9.8 4.7 4.8 4.9 4.8 5.3 4.8 4.3 5.5 6.0 5.5 13.9 3.2 2.3 2.6 4.5 3.4 6.0 6.4 13.3 7.8 5.1 4.2 6.9 4.4 5.9 5.5 ZNF467 "EZI, Zfp467" ENSG00000181444 "Zinc finger protein 467" Q7Z7K2 7 149764182-149773479 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 21.7;EFO-21: 10.9;HMC-1: 12.6;MCF7: 10.5;SK-BR-3: 9.8;T-47d: 12.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 27.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042907 Uncertain Approved Mitochondria Mitochondria "HPA042907: AB_10966965" "unprognostic (3.01e-1)" "unprognostic (2.41e-1)" "unprognostic (6.40e-4)" "unprognostic (5.99e-2)" "unprognostic (2.91e-1)" "unprognostic (1.33e-1)" "unprognostic (1.20e-1)" "unprognostic (1.46e-1)" "unprognostic (6.88e-2)" "unprognostic (5.14e-2)" "prognostic favourable (4.56e-4)" "unprognostic (2.12e-1)" "unprognostic (8.15e-2)" "unprognostic (3.19e-1)" "unprognostic (1.51e-1)" "unprognostic (2.53e-2)" "unprognostic (2.25e-2)" 10.6 8.2 10.5 8.8 16.5 20.1 15.2 3.5 7.4 7.9 6.7 3.2 22.1 2.9 8.5 6.4 4.2 10.0 7.5 11.6 10.1 4.6 14.9 9.2 15.8 24.2 6.3 2.9 8.9 10.8 3.5 11.0 6.2 5.8 5.1 3.7 20.4 12.3 18.4 4.3 11.8 5.2 7.0 9.9 21.4 10.4 2.3 11.0 9.6 11.8 4.0 5.6 4.6 13.3 0.0 3.5 27.7 5.4 0.1 0.4 1.4 0.0 2.7 3.1 21.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.7 6.7 0.1 10.9 0.1 0.3 1.6 0.0 0.1 0.1 0.3 1.1 0.0 0.0 6.7 0.0 12.6 4.5 1.1 0.0 0.1 2.3 2.0 0.5 0.0 10.5 0.4 1.1 0.3 6.8 1.6 0.0 8.0 1.5 0.0 1.2 1.0 0.0 9.8 0.0 12.2 1.3 5.3 0.1 3.6 0.0 0.0 0.5 0.0 0.1 0.1 3.7 0.1 0.0 5.4 2.2 0.2 2.2 0.1 0.0 0.2 0.2 3.5 0.0 0.4 0.1 27.7 0.1 0.7 1.6 0.0 1.4 10.5 16.5 3.5 7.4 10.1 4.6 6.3 2.9 5.8 11.0 ZNF48 "DKFZp762K013, FLJ31751, MGC43952, ZNF553" ENSG00000180035 "Zinc finger protein 48" Q96MX3 16 30378106-30400108 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023806 Uncertain Supported Mitochondria Mitochondria "HPA023806: AB_1859335" "unprognostic (5.35e-2)" "unprognostic (7.91e-3)" "unprognostic (2.41e-3)" "unprognostic (2.06e-1)" "unprognostic (5.20e-2)" "unprognostic (1.66e-2)" "unprognostic (2.77e-3)" "unprognostic (4.25e-2)" "unprognostic (6.06e-2)" "unprognostic (2.19e-1)" "prognostic favourable (1.20e-6)" "unprognostic (5.36e-2)" "prognostic favourable (7.50e-5)" "unprognostic (6.35e-2)" "unprognostic (1.19e-1)" "unprognostic (1.04e-1)" "unprognostic (2.45e-3)" 5.6 7.7 8.9 9.1 9.8 4.4 6.7 15.7 16.1 9.1 11.5 10.1 12.1 9.0 12.8 5.7 5.5 10.7 9.5 6.7 8.9 8.7 6.6 6.4 8.0 10.0 9.0 8.5 6.7 15.1 18.8 8.8 4.7 7.1 7.6 6.1 8.0 9.7 12.6 12.1 6.3 6.4 11.2 5.7 7.3 7.9 3.9 9.8 16.1 7.5 7.2 7.3 9.0 8.3 1.4 1.6 1.3 0.2 2.6 3.1 0.5 4.6 8.0 19.4 15.5 2.4 2.0 6.5 3.2 5.9 7.8 7.0 3.7 6.1 8.7 6.4 2.9 3.7 9.4 5.1 4.2 6.4 11.6 3.9 3.8 5.4 3.6 5.1 5.5 1.5 6.6 6.1 4.2 6.4 6.7 4.1 3.0 15.0 11.9 6.3 16.5 2.9 27.6 4.3 11.6 4.1 3.6 15.1 18.8 1.3 10.4 1.3 6.9 5.1 2.8 4.4 5.0 4.1 3.9 5.0 5.7 8.5 2.4 3.3 1.0 0.0 0.2 1.3 3.1 0.2 2.4 1.1 1.7 1.8 0.5 1.4 2.1 2.3 0.0 2.6 0.1 1.6 1.7 0.5 8.9 9.8 15.7 16.1 8.9 8.7 9.0 8.5 7.1 9.8 ZNF7 "HF.16, KOX4" ENSG00000147789 "Zinc finger protein 7" P17097 8 144827464-144847509 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030296, HPA059090" Uncertain Approved Mitochondria Mitochondria "HPA030296: AB_10671095, HPA059090: " "unprognostic (1.11e-1)" "unprognostic (4.47e-3)" "unprognostic (1.93e-1)" "unprognostic (1.36e-2)" "unprognostic (2.52e-1)" "unprognostic (2.97e-1)" "unprognostic (8.42e-3)" "unprognostic (3.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.33e-2)" "unprognostic (2.68e-1)" "unprognostic (7.95e-2)" "prognostic unfavourable (8.46e-8)" "unprognostic (1.15e-1)" "unprognostic (5.00e-1)" "unprognostic (5.43e-2)" "unprognostic (6.53e-2)" 18.5 12.7 11.4 14.9 17.5 14.7 20.4 34.1 21.1 18.3 15.5 17.9 19.8 12.1 18.4 22.2 18.1 16.7 15.5 14.3 11.9 11.0 13.3 14.7 14.1 16.0 15.1 18.3 22.8 21.3 19.1 16.2 17.0 14.7 19.5 15.5 15.7 16.0 17.4 24.3 21.0 16.0 15.7 11.8 21.2 13.6 24.8 15.2 15.8 19.0 14.9 17.8 16.7 18.0 15.7 10.4 22.5 14.6 12.9 18.6 7.6 9.9 13.7 13.4 13.1 11.5 17.6 12.3 10.7 13.6 14.5 12.5 6.9 12.8 13.9 12.6 11.6 8.7 12.1 15.6 15.9 9.2 10.0 24.9 17.8 8.0 13.3 7.2 11.7 16.8 19.1 11.3 28.1 9.0 24.7 10.1 16.1 16.4 19.5 7.8 13.6 16.5 13.6 11.9 11.0 10.2 13.8 13.2 16.1 23.4 13.5 12.9 16.2 11.6 10.0 11.0 19.6 8.3 10.2 8.2 5.7 15.2 11.4 9.4 13.4 22.5 9.3 8.8 12.5 8.4 15.2 15.7 14.1 10.8 10.4 13.6 18.6 12.7 9.4 12.9 14.6 8.3 13.1 7.6 11.4 17.5 34.1 21.1 11.9 11.0 15.1 18.3 14.7 15.2 ZNF862 ENSG00000106479 "Zinc finger protein 862" O60290 7 149838367-149867479 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024154 Uncertain Approved Mitochondria Mitochondria "HPA024154: AB_1859469" "unprognostic (1.82e-2)" "unprognostic (2.33e-1)" "unprognostic (3.32e-3)" "unprognostic (1.97e-1)" "unprognostic (8.87e-2)" "unprognostic (4.87e-3)" "unprognostic (4.72e-3)" "unprognostic (2.74e-2)" "unprognostic (6.76e-2)" "unprognostic (2.56e-2)" "unprognostic (2.38e-3)" "unprognostic (4.73e-2)" "unprognostic (5.88e-2)" "unprognostic (4.29e-2)" "unprognostic (8.90e-2)" "unprognostic (1.30e-2)" "prognostic favourable (8.66e-4)" 7.1 9.7 12.7 11.2 15.5 7.5 11.8 22.6 13.6 11.1 10.0 16.7 18.8 6.6 12.1 18.1 9.0 13.7 12.2 8.0 13.1 8.7 11.3 9.4 9.6 12.8 17.1 12.1 15.1 14.7 22.6 17.7 5.8 12.2 11.5 10.7 12.3 16.9 14.5 8.6 24.1 10.8 10.0 12.6 13.2 9.4 7.4 19.8 18.7 18.2 6.7 13.2 9.9 9.1 3.1 3.0 1.6 4.3 1.6 6.9 2.0 2.9 3.2 7.1 11.2 8.3 9.0 0.2 6.0 5.9 2.0 3.3 0.3 7.7 1.4 7.9 6.8 2.0 2.0 2.9 1.5 4.3 3.1 1.3 2.2 0.0 7.3 2.1 1.3 10.0 10.7 2.0 3.2 4.8 1.5 5.6 3.4 7.5 2.5 5.4 2.3 3.2 4.5 0.9 7.9 5.7 1.8 2.8 9.5 5.2 3.9 5.3 2.9 2.6 8.6 5.1 0.2 11.6 2.2 8.6 4.6 1.3 8.8 5.6 5.8 0.0 2.4 1.6 6.9 4.3 1.9 3.1 2.6 3.6 3.0 1.3 3.1 2.7 0.2 1.6 1.3 3.0 1.8 2.0 12.7 15.5 22.6 13.6 13.1 8.7 17.1 12.1 12.2 19.8 ZNFX1 "FLJ11277, KIAA1404" ENSG00000124201 "Zinc finger NFX1-type containing 1" Q9P2E3 20 49237946-49278426 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+ SV40 Large T+: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046629 Approved Approved Mitochondria Mitochondria "HPA046629: AB_2616451" "unprognostic (1.03e-1)" "unprognostic (2.80e-1)" "unprognostic (1.15e-1)" "unprognostic (3.21e-2)" "unprognostic (1.21e-1)" "unprognostic (3.58e-1)" "unprognostic (2.62e-2)" "unprognostic (2.55e-1)" "unprognostic (3.85e-2)" "unprognostic (1.49e-1)" "unprognostic (3.13e-2)" "unprognostic (2.09e-1)" "unprognostic (1.50e-1)" "unprognostic (2.79e-1)" "unprognostic (8.71e-3)" "unprognostic (7.40e-2)" "unprognostic (7.86e-2)" 27.2 14.9 13.2 21.5 15.1 32.8 19.3 14.4 19.7 16.6 16.0 20.1 12.1 14.5 21.3 17.4 13.1 17.2 19.2 16.5 12.3 12.0 16.5 13.4 28.2 20.5 13.4 13.8 18.3 12.2 23.8 14.6 17.4 17.1 15.5 14.4 21.1 14.4 13.7 23.0 17.6 20.6 18.3 14.4 25.9 16.2 23.9 14.6 18.6 21.4 14.4 22.7 16.8 15.0 5.7 5.1 30.0 14.0 5.6 8.3 5.4 5.7 9.0 2.1 3.0 11.9 9.4 3.7 7.9 18.6 49.5 20.7 10.2 4.8 4.8 10.2 15.6 11.2 4.0 10.7 17.2 4.5 1.3 5.7 6.5 4.5 10.3 4.6 7.0 9.9 10.0 11.0 8.2 7.4 4.3 6.0 12.3 2.4 4.9 3.1 2.0 7.5 3.1 7.3 1.3 8.1 8.0 2.2 1.6 11.6 22.7 8.1 5.8 3.9 18.5 24.3 6.9 8.8 7.6 4.0 1.4 2.6 9.8 3.1 5.3 8.8 6.7 10.8 8.3 8.8 7.3 5.7 8.3 7.8 5.1 4.6 8.0 6.1 30.0 5.6 14.0 3.0 6.0 5.4 13.2 15.1 14.4 19.7 12.3 12.0 13.4 13.8 17.1 14.6 ZNHIT3 TRIP3 ENSG00000273611 "Zinc finger HIT-type containing 3" Q15649 17 36486629-36499310 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060019, HPA078211" Approved Approved Mitochondria Mitochondria "HPA060019: , HPA078211: " "unprognostic (5.47e-2)" "unprognostic (1.29e-1)" "unprognostic (8.87e-2)" "unprognostic (1.20e-1)" "unprognostic (3.56e-2)" "unprognostic (1.56e-1)" "unprognostic (4.75e-3)" "unprognostic (6.03e-2)" "unprognostic (6.48e-3)" "unprognostic (2.55e-1)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (2.81e-2)" "unprognostic (1.47e-1)" "unprognostic (2.20e-1)" "unprognostic (1.84e-1)" "unprognostic (6.19e-2)" 5.0 8.2 9.7 7.4 12.9 8.6 9.9 9.1 18.4 6.2 6.5 6.1 6.8 6.0 6.9 11.1 6.9 7.8 5.4 7.8 8.2 9.4 9.5 6.6 10.0 10.2 9.6 10.7 9.1 7.8 5.7 5.9 9.9 7.4 9.2 4.1 7.1 8.0 14.2 6.2 5.4 7.4 12.3 5.8 5.2 11.8 8.6 8.8 9.0 7.3 10.9 7.6 3.9 23.8 18.0 15.8 16.5 12.9 24.1 15.6 14.6 22.4 24.1 16.1 11.3 17.3 12.7 13.5 17.9 20.5 23.1 18.2 17.6 21.9 13.6 11.5 13.3 18.2 17.6 22.9 13.9 30.6 13.1 14.3 21.3 14.3 27.2 11.5 12.8 18.8 13.3 20.6 13.7 23.6 13.8 21.8 15.7 29.6 29.1 15.3 17.3 13.3 24.7 18.5 20.2 12.7 18.4 15.3 17.5 8.1 21.5 27.5 20.9 10.9 9.9 22.3 15.9 19.0 15.0 23.6 27.5 17.0 16.2 15.4 15.8 13.0 9.6 17.8 13.5 21.4 23.8 20.8 18.0 16.5 21.8 24.1 22.2 6.9 12.9 16.5 18.0 22.5 15.6